,CID,name,smiles,7.1-Drug Indication,8.1-Pharmacodynamics,8.2-MeSH Pharmacological Classification,"8.5-Absorption, Distribution and Excretion",8.6-Metabolism/Metabolites,8.7-Biological Half-Life
0,130001,CID 130001,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N(CS2)C,,,,,,
1,130002,dimethylphosphoryl (3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]hexanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-4-oxobutanoate,CCCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(=O)OP(=O)(C)C)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)OC(C)(C)C,,,,,,
2,130003,"5-(3,5-Di-tert-butyl-4-hydroxybenzylidene)thiazolidin-4-one",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)NCS2,,,,,,
3,130004,CID 130004,CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCCNC1CC1)C)C)C,,,,,,
4,130005,CID 130005,CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCCN(C)C1CC1)C)C)C,,,,,,
5,130006,"2H-1-Benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1(2H)-pyridinyl)-, trans-(+-)-",CC1([C@@H]([C@H](C2=C(O1)C=CC(=C2)C#N)N3C=CC=CC3=O)O)C,,,,,,
6,130007,N-1-(Fur-3-ylethyl)-N-hydroxyurea,CC(C1=COC=C1)N(C(=O)N)O,,,,,,
7,130008,beta-Methylmelibiose,CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)O,,,,,,
8,130009,Ginsenoside La,CC(=C[C@H]1C[C@]([C@H]2CC[C@]3(C2[C@H](O1)C[C@H]4[C@H]3CCC5[C@@]4(CC[C@@H](C5(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,,,,,,
9,130010,"2-Amino-5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-epoxynaphthalene",COC1=C2C3CC(C(C2=C(C=C1)OC)O3)N,,,,,,
10,130011,"4,6-Diamino-5-guanidinopyrimidine",C1=NC(=C(C(=N1)N)N=C(N)N)N,,,,,,
11,130012,1-[2-(2-Azido-3-iodophenyl)ethyl]-4-(2-benzhydryloxyethyl)piperazine,C1CN(CCN1CCC2=C(C(=CC=C2)I)N=[N+]=[N-])CCOC(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
12,130013,Probestin,CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@H]([C@@H](CC3=CC=CC=C3)N)O,,,,,,
13,130014,"2,4-Dinitrophenyl-4-O-(4,4'-dimethoxytrityl)butyrate",COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCCCC(=O)OC4=C(C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-],,,,,,
14,130015,"cis-(+)-3-(Acetyloxy)-1-(2-(dimethylamino)ethyl)-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-7-(trifluoromethyl)-2H-1-benzazepin-2-one monohydrochloride",CC(=O)O[C@@H]1[C@@H](CC2=C(C=CC(=C2)C(F)(F)F)N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl,,,,,,
15,130016,"(3R)-3alpha-Acetyloxy-1-(2-dimethylaminoethyl)-4,5-dihydro-7-trifluoromethyl-4alpha-(4-methoxyphenyl)-1H-1-benzazepin-2(3H)-one",CC(=O)O[C@@H]1[C@@H](CC2=C(C=CC(=C2)C(F)(F)F)N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,,,,,,
16,130017,"N-Succinimidyl-4-O-(4,4'-dimethoxytrityl)butyrate",COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCCCC(=O)ON4C(=O)CCC4=O,,,,,,
17,130018,"N-(2,6-Dimethyltyrosyl)-2-[(3-phenylpropyl)amino]propanimidic acid",CC1=CC(=CC(=C1C[C@@H](C(=O)NC(=O)[C@@H](C)NCCCC2=CC=CC=C2)N)C)O,,,,,,
18,130019,CID 130019,C[C@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](CC4=CN=CN4)N,,,,,,
19,130020,"1,2-Dipalmitoyl-3-succinylglycerol",CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCC(=O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
20,130021,(3-Aminopropyl)(n-butyl)phosphinic acid,CCCCP(=O)(CCCN)O,"[""Investigated for use/treatment in alzheimer's disease, attention deficit/hyperactivity disorder (ADHD), memory loss, and schizophrenia and schizoaffective disorders.""]",,"['Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)']",,,['4 hours']
21,130022,3-Aminopropyl-cyclohexylmethylphosphinic acid,C1CCC(CC1)CP(=O)(CCCN)O,,,,,,
22,130023,3-Aminopropyl(hexyl)phosphinic acid,CCCCCCP(=O)(CCCN)O,,,,,,
23,130024,CID 130024,C[C@]12[C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8[N+]2(C7=C53)C)CNC6=O)C(=O)OOC,,,,,,
24,130025,N(alpha)-Benzoyl-arginyl-glycyl-phenylalanyl-prolyl-methoxy-beta-naphthylamide,COC1=CC(=CC2=CC=CC=C21)N3CCC[C@H]3C(=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)C5=CC=CC=C5,,,,,,
25,130026,Norgallopamil,CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC,,,,,,
26,130027,6-Arbutinphosphoglycerol,C1=CC(=CC=C1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COP(=O)(O)OCC(CO)O)O)O)O,,,,,,
27,130028,"1H-1,4-Benzodiazepin-1-ethanaminium, 7-chloro-2,3-dihydro-N,N,N-trimethyl-2-oxo-5-phenyl-",C[N+](C)(C)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,,,,,,
28,130029,"N,N-Dipropyl-4-iodophenyl-N-methylammonium",CCC[N+](C)(CCC)C1=CC=C(C=C1)[131I],,,,,,
29,130030,2-((3-(1H-Tetrazol-5-ylmethyl)phenoxyl)methyl)quinoline,C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=CC(=C3)CC4=NNN=N4,,,,,,
30,130031,Ftfmp-fpim,CC1=C(SC(=N1)NC=O)C(=O)NC2=CN(C(=C2)C(=O)NCCC(=N)N)C.Cl,,,,,,
31,130032,Thiotropsin,CC1=C(SC(=N1)NC=O)C(=O)NC2=CN(C(=C2)C(=O)NCCC(=N)N)C,,,,,,
32,130033,CID 130033,C1=CC(=O)C(=O)C=C1C=CN(O)O,,,,,,
33,130034,Lexitropsin 1,CC1=C(SC(=N1)NC(=O)C2=CC(=CN2C)NC=O)C(=O)NCCC(=N)N,,,,,,
34,130035,Dipinacoline glutamate,CC(C(C)(C)C)OC(=O)CC[C@@H](C(=O)OC(C)C(C)(C)C)N,,,,,,
35,130036,Barminomycin II,CC1C2C(CC(O1)OC3CC(CC4=C3C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)O)O)(C(=O)C)O)NC(C(OC(O2)CC(C)O)C)O,,,,,,
36,130037,[(2R)-2-decanoyloxy-3-octadecanoyloxypropyl] 3-(trimethylazaniumyl)propyl phosphate,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCC[N+](C)(C)C)OC(=O)CCCCCCCCC,,,,,,
37,130038,3-[[(2R)-2-decanoyloxy-3-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxypropyl-trimethylazanium,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCC[N+](C)(C)C)OC(=O)CCCCCCCCC,,,,,,
38,130039,Tyrosyl-glycyl-tryptophyl-methionyl-aspartyl-phenylalanyl-glycine,CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
39,130040,N-Ethylhomocholine,CC[N+](C)(C)CCCO,,,,,,
40,130041,CID 130041,C1=NC2=C(N1CCCC=O)C(=O)N=C(N2)N,,,,,,
41,130042,5-Methoxy-4-[2-methyl-3-(3-methylbut-2-EN-1-YL)oxiran-2-YL]-1-oxaspiro[2.5]octan-6-OL,CC(=CCC1[C@@](O1)(C)C2C(C(CCC23CO3)O)OC)C,,,,,,
42,130043,CID 130043,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NC(=O)[C@H](CC1=CN=CN1)N[C@H](CC(C)C)CN[C@@H](CC2=CC=CC=C2)C(=O)N)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](CC5=CC=CC=C5)N,,,,,,
43,130044,Trinitrophenylglutamyllysine,C1=CC=C(C=C1)N(C(=O)[C@H](CCC(=O)O)N)[C@](C(=O)O)(C(CCCN)([N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
44,130045,"1-Methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine",CN1CCC(=CC1)C2=CC=CC=C2N,,,,,,
45,130046,3-Aminomethyl-4-hydroxybiphenyl,C1=CC=C(C=C1)C2=CC(=C(C=C2)O)CN,,,,,,
46,130047,1-Hydroxy-2-aminomethyl-4-cyclohexylbenzene,C1CCC(CC1)C2=CC(=C(C=C2)O)CN,,,,,,
47,130048,"Carboxy 3-oxo-1,2,4,5,6,7-hexahydroindazole-5-carboxylate",C1CC2=C(CC1C(=O)OC(=O)O)C(=O)NN2,,,,,,
48,130049,"2H-Imidazol-2-one, 4-((3,4-dibutoxyphenyl)methyl)-1,3-dihydro-",CCCCOC1=C(C=C(C=C1)CC2=CNC(=O)N2)OCCCC,,,,,,
49,130050,(1R)-1-(6-aminopyridin-3-yl)-2-(tert-butylamino)ethanol,CC(C)(C)NC[C@@H](C1=CN=C(C=C1)N)O,,,,,,
50,130051,Conduritol aziridine,[C@H]12[C@H](N1)[C@@H]([C@H]([C@@H]([C@H]2O)O)O)O,,,,,,
51,130052,"N-(1-Methyl-3,3-diphenylpropyl)formamide",CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC=O,,,,,,
52,130053,"7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-N-(2-pyrrolidinylmethyl)-, monohydrochloride, (S)-",C1C[C@H](NC1)CNC(=O)C2=CC(=C(C3=C2OCC3)N)Cl.Cl,,,,,,
53,130054,"7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-N-(2-pyrrolidinylmethyl)-, (S)-",C1C[C@H](NC1)CNC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,,,,,,
54,130055,"3,3'-(Hydroxyimino)bispropanenitrile",C(CN(CCC#N)O)C#N,,,,,,
55,130056,Asimicin,CCCCCCCCCCC(C1CCC(O1)C2CCC(O2)C(CCCCCCCCCCC(CC3=CC(OC3=O)C)O)O)O,,,,,,
56,130057,8-Bromo-6-(dimethylamino)-9-(3-formamidobenzyl)-9H-purine,CN(C)C1=NC=NC2=C1N=C(N2CC3=CC(=CC=C3)NC=O)Br,,,,,,
57,130058,"N-Methyl-3,4-methylenedioxyphenylisobutylamine",CC(C)CN(C)C1=CC2=C(C=C1)OCO2,,,,,,
58,130059,CID 130059,CCC(CC)(C(CC[C@@H](C)[C@H]1CCC2[C@@]1(CCCC2=CC=C3C[C@H](CC(C3=C)O)O)C)(F)F)O,,,,,,
59,130060,"3-Ribofuranosyl-4,9-dihydro-4,6,7-trimethyl-9-oxoimidazo(1,2-a)purine",CC1=C(N2C(=O)C3=C(N(C2=N1)C)N(C=N3)C4[C@@H]([C@@H]([C@H](O4)CO)O)O)C,,,,,,
60,130061,5-(N-Ethyl-(2'-methoxy-5'-nitrobenzyl))amiloride,CCN(CC1=C(C=CC(=C1)[N+](=O)[O-])OC)C2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N,,,,,,
61,130062,2'-Iododiazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3I,,,,,,
62,130063,1-(2-Methoxyethyl)-1-nitrosourea,COCCN(C(=O)N)N=O,,,,,,
63,130064,Ethyl 4-[[2-[[4-(aminomethyl)cyclohexanecarbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]benzoate,CCOC(=O)C1=CC=C(C=C1)NC(=O)C(CCCN=C(N)N)NC(=O)C2CCC(CC2)CN,,,,,,
64,130065,CID 130065,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=C(C=C2)CN3C=CN=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,,,,,,
65,130066,"5-(Hydroxymethyl)-11-methyl-6H-pyrido(4,3-b)carbazole N-methylcarbamate",CC1=C2C=NC=CC2=C(C3=C1C4=CC=CC=C4N3)COC(=O)NC,,,,,,
66,130067,"8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(5-chloro-3,4,8,9,10,10a-hexahydronaphth(1,8-cd)azepin-2(1H)-yl)butyl)-, monohydrochloride",C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCC3CC4CCCC5=C4C(=C(C=C5)Cl)CN3.Cl,,,,,,
67,130068,"8-[4-(8-Chloro-11-azatricyclo[7.4.1.05,14]tetradeca-5(14),6,8-trien-12-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione",C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCC3CC4CCCC5=C4C(=C(C=C5)Cl)CN3,,,,,,
68,130069,Mono(4-azido-2-nitrophenyl) diphosphate,C1=CC(=C(C=C1N=[N+]=[N-])[N+](=O)[O-])OP(=O)(O)OP(=O)(O)O,,,,,,
69,130070,Tyrosyl-tyrosyl-phenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N,,,,,,
70,130071,(2R)-N-methyl-2-(2-methylpropylamino)propanamide,C[C@H](C(=O)NC)NCC(C)C,,,,,,
71,130072,"(1R,2R,4S,4aR,6aR,6aS,6bR,10S,12aR,14bR)-4,10-dihydroxy-1,4a,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-2-carboxylic acid",C[C@H]1[C@@H](C[C@@H]([C@]2([C@H]1C3=CC[C@@H]4[C@]5(CC[C@@H](C(C5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C)O)C(=O)O,,,,,,
72,130073,Seryl-glutamyl-lysyl-aspartyl-glutamyl-leucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N,,,,,,
73,130074,Unii-xnp7UO129A,CC1=C2C3=C(C4=C5C6=C3C(=C(C(=C(C6=CC(=C5C(=CC4=O)OC)OC)O)O)OC)C1)C(=O)C(=C2C(=O)C)OC,,,['Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)'],,,
74,130075,Xylazole,CC1=C(C(=CC=C1)C)NC2=NC=CS2.Cl,,,,,,
75,130076,"N-(2,6-dimethylphenyl)-1,3-thiazol-2-amine",CC1=C(C(=CC=C1)C)NC2=NC=CS2,,,,,,
76,130077,"Piperazine, 1-(4-oxo-4-phenylbutyl)-4-[(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)carbonyl]-",C1CC(=O)NC2=C1C=C(C=C2)C(=O)N3CCN(CC3)CCCC(=O)C4=CC=CC=C4,,,,,,
77,130078,"1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxyic acid",CC1=CC(=CC(=N1)C)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)F,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)'],,,
78,130079,6-Hydroxy-8-isocyano-8-[1-isocyano-2-(4-methoxyphenyl)ethenyl]bicyclo[4.2.0]oct-4-en-3-one,COC1=CC=C(C=C1)C=C(C2(CC3(C2CC(=O)C=C3)O)[N+]#[C-])[N+]#[C-],,,,,,
79,130080,Ampgd,COC1(C2(C3CC4CC(C3)CC2C4)OO1)C5=CC=CC(=C5)[C@]6([C@H]([C@H]([C@H](OC6O)CO)O)O)O,,,,,,
80,130081,"N-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-2H-tetrazole-5-carboxamide",COC1=CC=C(C=C1)C2=NC(=CS2)NC(=O)C3=NNN=N3,,,,,,
81,130082,Prolyl-leucyl-alanine hydroxamic acid,C[C@@H](C(=O)NO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1,,,,,,
82,130083,CID 130083,C[C@H](C=C[C@](C)(C(C)(CO)O)O)[C@H]1CCC2[C@@]1(CCCC2=CC=C3C[C@H](CCC3=C)O)C,,,,,,
83,130084,CID 130084,C1=CC(=CC(=C1)NC2=NC(=O)C3=C(N2)N=CN3)C(F)(F)F,,,,,,
84,130085,CID 130085,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)NC(=O)[C@H](CC(C)C)NC)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CN=CN4)NC(=O)C(C)C,,,,,,
85,130086,"2-Methyl-5-piperazinyl-11H-(1,2,4)triazolo(1,5-C)(1,3)benzodiazepine",CC1=NN2C(=N1)CC3=CC=CC=C3N=C2N4CCNCC4,,,,,,
86,130087,"2-methyl-5-(4-methylpiperazin-1-yl)-6-oxido-11H-[1,2,4]triazolo[1,5-c][1,3]benzodiazepin-6-ium",CC1=NN2C(=N1)CC3=CC=CC=C3[N+](=C2N4CCN(CC4)C)[O-],,,,,,
87,130088,"(1R)-5-[2-[(1R,7aR)-1-[(2R,5S)-5-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C[C@H](C=C[C@](C)(C(C)C)O)[C@H]1CCC2[C@@]1(CCCC2=CC=C3C[C@H](CC(C3=C)O)O)C,,,,,,
88,130089,Lysyl-histidyl-phenylalanyl-arginyl-tryptophyl-glycinamide,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)NCC(=O)N)NC(=O)[C@H](CC4C=NC=N4)NC(=O)[C@H](CCCCN)N,,,,,,
89,130090,2-(1-Sulfanylcyclohexyl)acetic acid,C1CCC(CC1)(CC(=O)O)S,,,,,,
90,130091,Transfectam,CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)CC(=O)NC(=O)[C@H](CCCNCCCN)NCCCN,,,,,,
91,130092,"(4R)-2-methyl-4-[(2R,3R,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]-1,3-dioxolane-2-carboxylic acid",CC1(OC[C@@H](O1)[C@H]2[C@@H]([C@H]([C@@H](O2)O)O)O)C(=O)O,,,,,,
92,130093,Stobadine N-oxide,CC1=CC2=C(C=C1)N[C@H]3[C@@H]2C[N+](CC3)(C)[O-],,,,,,
93,130094,"1-Piperazineethanol, alpha-cyclohexyl-4-(iminomethyl)-alpha-phenyl-, monohydrochloride",C1CCC(CC1)C(CN2CCN(CC2)C=N)(C3=CC=CC=C3)O.Cl,,,,,,
94,130095,alpha-Cyclohexyl-4-(iminomethyl)-alpha-phenyl-1-piperazineethanol,C1CCC(CC1)C(CN2CCN(CC2)C=N)(C3=CC=CC=C3)O,,,,,,
95,130096,4-[(1R)-2-[butyl(nitroso)amino]-1-hydroxyethyl]-2-diazoniophenolate,CCCCN(C[C@@H](C1=CC(=C(C=C1)[O-])[N+]#N)O)N=O,,,,,,
96,130097,5-[(1R)-2-[butyl(nitroso)amino]-1-hydroxyethyl]-2-hydroxybenzenediazonium,CCCCN(C[C@@H](C1=CC(=C(C=C1)O)[N+]#N)O)N=O,,,,,,
97,130098,Bal-ari8,CN(CC(=O)O)S(=O)(=O)C1=CC2=C(C=C1)OC3=C(C2=O)C=C(C=C3)F,,,,,,
98,130099,Adci,C1C2C3=CC=CC=C3C(N2)(C4=CC=CC=C41)C(=O)N,,,,,,
99,130100,CID 130100,C[C@H](CCCC(C)(C)O)[C@@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)N=[N+]=[N-])C,,,,,,
100,130101,Ethyl 2-[3-hydroxy-5-(hydroxymethyl)-2-methyl-4-[(pyridin-2-ylhydrazinylidene)methyl]pyridin-1-ium-1-yl]acetate;bromide,CCOC(=O)C[N+]1=C(C(=C(C(=C1)CO)C=NNC2=CC=CC=N2)O)C.[Br-],,,,,,
101,130102,1-[(Ethoxycarbonyl)methyl]-3-hydroxy-5-(hydroxymethyl)-2-methyl-4-[[(E)-2-(2-pyridinyl)hydrazono]methyl]pyridinium,CCOC(=O)C[N+]1=C(C(=C(C(=C1)CO)C=NNC2=CC=CC=N2)O)C,,,,,,
102,130103,"(2S,4R)-1-[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-phenylpropanoyl]-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidine-2-carboxamide",CSCC[C@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2C[C@@H](C[C@H]2C(=O)N)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
103,130104,"S-(2,2-Dichloro-1,1-difluoroethyl)-L-cysteine",C([C@@H](C(=O)O)N)SC(C(Cl)Cl)(F)F,,,,,,
104,130105,"4-Hydroxy-5-(1,2,3,4-tetrahydroxybutyl)imidazolidin-2-one",C(C(C(C(C1C(NC(=O)N1)O)O)O)O)O,,,,,,
105,130106,CID 130106,C[C@H]1C=CC(=O)NCC[C@@H](C[C@@H](C(=O)N1)NC(=O)[C@H]([C@@H](C)O)N)O,,,,,,
106,130107,CID 130107,CCCCCCCCCC=CC=CC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H]1C[C@H](CCNC(=O)C=C[C@@H](NC1=O)C)O,,,,,,
107,130108,"2-Methyl-1-oxido-4-(3,7,11-trimethyldodeca-2,6,10-trienyl)quinolin-1-ium-3-ol",CC1=[N+](C2=CC=CC=C2C(=C1O)CC=C(C)CCC=C(C)CCC=C(C)C)[O-],,,,,,
108,130109,CID 130109,CC=CC=CC(=O)OCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCOC(=O)C=CC=CC,,,,,,
109,130110,CID 130110,CC=CC=CC(=O)OCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCOC(=O)C=CC=CC,,,,,,
110,130111,"2-methyl-3-(3,7,11-trimethyldodeca-2,6,10-trienyl)-1H-quinolin-4-one",CC1=C(C(=O)C2=CC=CC=C2N1)CC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
111,130112,"1-Hydroxy-2-methyl-3-(3,7,11-trimethyldodeca-2,6,10-trienyl)quinolin-4-one",CC1=C(C(=O)C2=CC=CC=C2N1O)CC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
112,130113,"6,10-Dimethyl-2-(4-methyl-5-oxido-1,2-dihydrofuro[2,3-c]quinolin-5-ium-2-yl)undeca-5,9-dien-2-ol",CC1=[N+](C2=CC=CC=C2C3=C1OC(C3)C(C)(CCC=C(C)CCC=C(C)C)O)[O-],,,,,,
113,130114,Dimethylethyltin,CC[Sn](C)(C)Br,,,,,,
114,130115,Methyldiethyltin,CC[Sn](C)(CC)Cl,,,,,,
115,130116,Scuteamoenoside,COC1=CC(=C2C(=O)C[C@H](OC2=C1)C3=C(C=CC=C3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
116,130117,Gweicurculactone,C[C@@H]1CCC2=C(C=C3C(=C(C(=O)O3)C)C=C12)C,,,,,,
117,130118,Heritonin,C[C@@H]1C[C@H]2C(=C(C(=O)O2)C)C3=C1C=C(C(=C3)C)OC,,,,,,
118,130119,Naltiazem,CC(=O)O[C@@H]1[C@@H](SC2=C(C=CC3=CC=CC=C32)N(C1=O)CCN(C)C)C4=CC=C(C=C4)OC,,,,,,
119,130120,CID 130120,CC(C=CCCCCC(C)(C)O)C1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,,,,,,
120,130121,Naltiazem hydrochloride,CC(=O)O[C@@H]1[C@@H](SC2=C(C=CC3=CC=CC=C32)N(C1=O)CCN(C)C)C4=CC=C(C=C4)OC.Cl,,,,,,
121,130122,CID 130122,C[C@H](CC[C@H](C)C(C)(C)O)[C@@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CC(=O)C3=C)O)C,,,,,,
122,130123,"7,8-Dihydroxy-3-[(4-methoxyphenyl)methylidene]chromen-4-one",COC1=CC=C(C=C1)C=C2COC3=C(C2=O)C=CC(=C3O)O,,,,,,
123,130124,CID 130124,CN1CC(=NC2=C1NC(=NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O,,,,,,
124,130125,CID 130125,CC(C)(C=C)C1=C(C=C(C(=C1)C2=COC3=CC(=O)C=C(C3=C2O)O)O)O,,,,,,
125,130126,CID 130126,CC(=CCC1=C(C(=CC(=C1O)C(C)(C)C=C)C2=COC3=CC(=O)C=C(C3=C2O)O)O)C,,,,,,
126,130127,"1H,5H-Benzo(ij)quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-5-methyl-8-(4-methyl-1-piperazinyl)-1,7-dioxo-, monohydrochloride",CC1CC(=O)C2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.Cl,,,,,,
127,130128,"9-Fluoro-5-methyl-8-(4-methyl-1-piperazinyl)-1,7-dioxo-6,7-dihydro-1H,5H-benzo[ij]quinolizine-2-carboxylic acid",CC1CC(=O)C2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,,,,,,
128,130129,5-N-(3-Aminophenyl)amiloride,C1=CC(=CC(=C1)NC2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N)N,,,,,,
129,130130,CID 130130,CC(C)(C)OC(=O)NCC(=O)NC(=CC1=CC=CC=C1)C(=O)NC,,,,,,
130,130131,Ovothiol A,CN1C=NC(=C1C[C@@H](C(=O)O)N)S,,,,,,
131,130132,Ptfdpugp,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCOC(C)C1=CC=C(C=C1)N2C(=N2)C(F)(F)F,,,,,,
132,130133,2-[[3-Hexadecanoyloxy-2-[8-[1-[4-[3-(trifluoromethyl)diazirin-1-yl]phenyl]ethoxy]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCOC(C)C1=CC=C(C=C1)N2C(=N2)C(F)(F)F,,,,,,
133,130134,N-Benzoylphenylalanine naphthyl ester,C1=CC=C(C=C1)CC(C(=O)OC2=CC=CC3=CC=CC=C32)NC(=O)C4=CC=CC=C4,,,,,,
134,130135,"4H-Pyrido(1,2-a)pyrimidin-4-one, 9-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)-3-(1H-tetrazol-5-yl)-",CCCC1=C(C=CC(=C1O)C(=O)C)OCC2=CC=CN3C2=NC=C(C3=O)C4=NNN=N4,,,,,,
135,130136,3-Methoxymethamphetamine,CC(CC1=CC(=CC=C1)OC)NC,,,,,,
136,130137,2-(2-Amino-1-hydroxycyclobutyl)acetic acid,C1CC(C1N)(CC(=O)O)O,,,,,,
137,130138,Acetylphenylalanyl-prolyl-bor-arginine,B(C(CCCN=C(N)N)N1CCC[C@H]1C(=O)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)C)(O)O,,,,,,
138,130139,"1-Cyclopropyl-6-fluoro-7-(8-methyl-3,8-diazabicyclo[3.2.1]octan-3-yl)-4-oxoquinoline-3-carboxylic acid",CN1C2CCC1CN(C2)C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F,,,,,,
139,130140,6-Hydroxyaldosterone,C[C@]12CCC(=O)C=C1C(C[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4CCO)C=O)O)O,,,,,,
140,130141,N-[2-[[3-[4-[2-[2-(cyclopropylmethoxy)ethoxy]ethyl]phenoxy]-2-hydroxypropyl]amino]ethyl]-4-hydroxypiperidine-1-carboxamide,C1CC1COCCOCCC2=CC=C(C=C2)OCC(CNCCNC(=O)N3CCC(CC3)O)O,,,,,,
141,130142,CID 130142,COC1=CC=C(C=C1)[C@H]2[C@H](C(=O)N(C3=CC=CC=C3S2)CCN=C(C4=CC=C(C=C4)N[N+]#N)[O-])O,,,,,,
142,130143,CID 130143,COC1=CC=C(C=C1)[C@H]2[C@H](C(=O)N(C3=CC=CC=C3S2)CCNC(=O)C4=CC=C(C=C4)N[N+]#N)O,,,,,,
143,130144,Tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
144,130145,2-(furan-2-ylmethylsulfinyl)-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]acetamide,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CS(=O)CC3=CC=CO3,,,,,,
145,130146,"2-(2,2-Bis(4-(dimethylamino)phenyl)ethyl)benzenesulfonic acid",CN(C)C1=CC=C(C=C1)C(CC2=CC=CC=C2S(=O)(=O)O)C3=CC=C(C=C3)N(C)C,,,,,,
146,130147,"2-(2-Ethylaminobenzylsulfinyl)-5,6-dimethoxybenzimidazole",CCNC1=CC=CC=C1CS(=O)C2=NC3=CC(=C(C=C3N2)OC)OC,,,['Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)'],,,
147,130148,1-[(4-Chlorophenyl)methyl]-5-oxopyrrolidine-2-carboxylate,C1CC(=O)N(C1C(=O)[O-])CC2=CC=C(C=C2)Cl,,,,,,
148,130149,1-[(4-Chlorophenyl)methyl]-5-oxopyrrolidine-2-carboxylic acid,C1CC(=O)N(C1C(=O)O)CC2=CC=C(C=C2)Cl,,,,,,
149,130150,N-(2-Pyridylmethyl)-2-pyrrolidone-5-carboxylate,C1C=C(NC1=O)C(=O)NCC2=CC=CC=N2,,,,,,
150,130151,"5,5'-Dihydroxy-4,4'-bitryptamine",C1=CC(=C(C2=C1NC=C2CCN)C3=C(C=CC4=C3C(=CN4)CCN)O)O,,,,,,
151,130152,"4,5-Dihydro-5-methyl-6-(4-((phenylmethyl)amino)-7-quinazolinyl)-3(2H)-pyridazinone",CC1CC(=O)NN=C1C2=CC3=C(C=C2)C(=NC=N3)NCC4=CC=CC=C4,,,,,,
152,130153,CID 130153,CN(C)CCN1C2=CC=CC=C2S[C@H](C(C1=O)OC(=O)C=CCN=[N+]=[N-])C3=CC=C(C=C3)OC,,,,,,
153,130154,"4,6-Dibenzamidopyrazole(3,4-d)pyrimidine",C1=CC=C(C=C1)C(=O)NC2=NC(=NC3=C2C=NN3)NC(=O)C4=CC=CC=C4,,,,,,
154,130155,N-((Aminocarbonyl)methyl)-2-fluoro-6-methoxy-5-(trifluoromethyl)-1-naphthalenecarboxamide,COC1=C(C2=C(C=C1)C(=C(C=C2)F)C(=O)NCC(=O)N)C(F)(F)F,,,,,,
155,130156,"methyl (2R,7R,8S)-8-bromo-4-hydroxy-7-methyl-1-oxo-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,7,8,9-tetrahydro-2H-pyrrolo[3,2-f]quinoline-2-carboxylate",C[C@@H]1[C@H](CC2=C3C(=O)[C@@H](NC3=C(C=C2N1C(=O)C4=CC5=CC(=C(C(=C5N4)OC)OC)OC)O)C(=O)OC)Br,,,,,,
156,130157,CID 130157,CC1=NC=C([N+]1(C)C(=O)C)NO,,,,,,
157,130158,2-Propylpentanal dimethyl acetal,CCCC(CCC)C(OC)OC,,,,,,
158,130159,2-Propylpentanal diethyl acetal,CCCC(CCC)C(OCC)OCC,,,,,,
159,130160,CID 130160,CC1=NC=C([N+]1(C)C(=O)C)NOC(=O)C,,,,,,
160,130161,2-Propylpentanal diisopropyl acetal,CCCC(CCC)C(OC(C)C)OC(C)C,,,,,,
161,130162,"1-(2,4-Dihydroxyphenyl)-3-(3-hydroxyphenyl)propan-2-ol",C1=CC(=CC(=C1)O)CC(CC2=C(C=C(C=C2)O)O)O,,,,,,
162,130163,CID 130163,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O)OC(=O)CCC1=CC=C(C=C1)C=CC=CC=CC2=CC=CC=C2,,,,,,
163,130164,"1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)propan-2-ol",C1=CC(=C(C=C1CCC(C2=C(C=C(C=C2)O)O)O)O)O,,,,,,
164,130165,"4,4-Dimethyl-3,4-dihydro-2H-1,2-benzoselenazine",CC1(CN[Se]C2=CC=CC=C21)C,['Investigated for use/treatment in cardiovascular disorders and diabetes mellitus type 1 and 2.'],,,['24.15 (+/-2.38) (ml min-1kg-1).'],,['2.08 (+/-0.17) hours.']
165,130166,CID 130166,CCC(=O)NC1=CCC(C(=C1)NC(=O)C2=CC=C(C=C2)C(=O)O)(CC)C(=O)[O-].[Na+],,,,,,
166,130167,"2-[(4-Carboxybenzoyl)amino]-1-ethyl-4-(propanoylamino)cyclohexa-2,4-diene-1-carboxylic acid",CCC(=O)NC1=CCC(C(=C1)NC(=O)C2=CC=C(C=C2)C(=O)O)(CC)C(=O)O,,,,,,
167,130168,Peptide 84,CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N,,,,,,
168,130169,Silahexocyclium,C[N+]1(CCN(CC1)C[Si](C2CCCCC2)(C3=CC=CC=C3)O)C,,,,,,
169,130170,Glutarylleucine,CC(C)C[C@@H](C(=O)O)NC(=O)CCCC(=O)O,,,,,,
170,130171,N(sup 6)-(Iodoacetyl)-L-lysine,C(CCNC(=O)CI)C[C@@H](C(=O)O)N,,,,,,
171,130172,CID 130172,C[C@H](CCCC(C)(C)O)C1=CC[C@@H]2[C@@]1(CCCC2=CCC3C=C(C[C@H](C3=C)O)O)C,,,,,,
172,130173,17(R)-Hdha,CCC=CCC(C=CC=CCC=CCC=CCC=CCCC(=O)O)O,,,,,,
173,130174,CID 130174,CCCCCCC(=O)CCCCCCC=CCC1C(O1)C(CO)(C(=O)O)N,,,,,,
174,130175,CID 130175,C[C@@H](C(=O)NC(=O)CNCCC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N,,,,,,
175,130176,2-[2-(Methylamino)-2-(3-methylthiophen-2-yl)ethyl]aniline,CC1=C(SC=C1)C(CC2=CC=CC=C2N)NC,,,,,,
176,130177,N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea monohydrochloride,CC1=C(C(=CC=C1)Cl)NC(=O)NC2=CC=NC=C2.Cl,,,,,,
177,130178,"Urea, N-(2-chloro-6-methylphenyl)-N'-4-pyridinyl-",CC1=C(C(=CC=C1)Cl)NC(=O)NC2=CC=NC=C2,,,,,,
178,130179,"(2S,3R,4R,5R,6S)-2-[(2S,3R,4S,5S,6R)-2-(4-ethenylphenoxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC=C(C=C3)C=C)CO)O)O)O)O)O,,,,,,
179,130180,alpha-Acetamido-N-benzyl-alpha-(furan-2-yl)acetamide,CC(=O)NC(C1=CC=CO1)C(=O)NCC2=CC=CC=C2,,,,,,
180,130181,alpha-Acetamido-N-(4-fluorobenzyl)-alpha-(furan-2-yl)acetamide,CC(=O)NC(C1=CC=CO1)C(=O)NCC2=CC=C(C=C2)F,,,,,,
181,130182,"6-Chloro-3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5-(1-methylethyl)imidazo(1,5-a)quinoxalin-4(5H)-one",CC(C)N1C2=C(C=CC=C2Cl)N3C=NC(=C3C1=O)C4=NOC(=N4)C5CC5,,,,,,
182,130183,N-p-Methylphenyl-1-deoxy-D-fructosylamine,CC1=CC=C(C=C1)NCC2([C@H]([C@@H]([C@@H](CO2)O)O)O)O,,,,,,
183,130184,Palmitoyl tetrapeptide,CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O,,,,,,
184,130185,"1,1'-Dimethylpurpurate-3,3'-diacetic acid",CN1C(=O)C(C(=O)N(C1=O)CC(=O)O)N=C2C(=O)N(C(=O)N(C2=O)CC(=O)O)C,,,,,,
185,130186,1-(2-(Bis-(4-fluorophenyl)methoxy)ethyl)-4-(2-(4-azido-3-iodophenyl)ethyl)piperazine,C1CN(CCN1CCC2=CC(=C(C=C2)N=[N+]=[N-])I)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,,,,,
186,130187,1alpha-(4-(N-Succinimidoxycarbonyl)butyryl)mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4C(=O)CCCC(=O)ON5C(=O)CCC5=O)N,,,,,,
187,130188,(Methylpyridazine piperidine propyloxyphenyl)ethylacetate,CCOC(=O)C1=CC=C(C=C1)OCCCC2CCN(CC2)C3=NN=C(C=C3)C,,,,,,
188,130189,1-(2-Chloro-6-methylphenyl)-3-(pyridin-4-ylmethyl)urea,CC1=C(C(=CC=C1)Cl)NC(=O)NCC2=CC=NC=C2,,,,,,
189,130190,6-Thioguainine disulfide,C1=NC2=C(N1)C(=NC(=N2)N)SSC3=NC(=NC4=C3NC=N4)N,,,,,,
190,130191,Gesamtgonen,CCC12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CCCC[C@H]34,,,,,,
191,130192,"5-Hydroxy-N-methyl-7H-dibenzo(c,g)carbazole",CN1C2=C(C3=CC=CC=C3C=C2)C4=C1C=C(C5=CC=CC=C54)O,,,,,,
192,130193,CID 130193,C[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CCCCN)NC(=O)CNS(=O)(=O)C5=CC=CC6=C5C=CC=C6N(C)C,,,,,,
193,130194,"N-Hydroxymethyl-7H-dibenzo(c,g)carbazole",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3CO)C=CC5=CC=CC=C54,,,,,,
194,130195,Biefm,CC1(O[C@@H]2[C@@H]([C@H](O[C@@H]2O1)C3=CC(=O)NC3=O)OCC4=CC=CC=C4)C,,,,,,
195,130196,"(1,4,10-Trioxa-7,13-diazacyclopentadecane-7,13-diylbis(5-methoxy-6,2-benzofurandiyl))bis-1,2-benzenedicarboxylic acid",COC1=C(C=C2C(=C1)C=C(O2)C3=C(C(=CC=C3)C(=O)O)C(=O)O)N4CCOCCN(CCOCCOCC4)C5=C(C=C6C=C(OC6=C5)C7=C(C(=CC=C7)C(=O)O)C(=O)O)OC,,,,,,
196,130197,8-Chloro-4-(2-chloro-4-fluorophenoxy)quinoline,C1=CC2=C(C=CN=C2C(=C1)Cl)OC3=C(C=C(C=C3)F)Cl,,,,,,
197,130198,2-((2-(1-Cyclohexen-1-yl)ethyl)amino)adenosine,C1CCC(=CC1)CCNC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,,,,
198,130199,2-((2-Cyclohexylethyl)amino)adenosine,C1CCC(CC1)CCNC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,,,,
199,130200,"4-Demethoxy-10,10-dimethyldaunomycin",CC1C(C(CC(O1)OC2CC(C(C3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C)C)(C(=O)C)O)N)O,,,,,,
200,130201,"5-((((9H-Fluoren-9-ylmethoxy)carbonyl)amino)(4-methoxyphenyl)methyl)-2,4-dimethoxybenzenepropanoic acid",COC1=CC=C(C=C1)C(C2=C(C=C(C(=C2)CCC(=O)O)OC)OC)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35,,,,,,
201,130202,2-(2-Furoyl)-4(5)-(2-furanyl)-1H-imidazole,C1=COC(=C1)C2=CN=C(N2)C(=O)C3=CC=CO3,,,,,,
202,130203,Tranexamic acid isobenzedrine ester,C1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCCN,,,,,,
203,130204,N-(2-Hydroxypropyl)valine,CC(C)[C@@H](C(=O)O)NCC(C)O,,,,,,
204,130205,1-(2-Ethoxy-2-oxoethyl)-6-methoxyquinolinium,CCOC(=O)C[N+]1=CC=CC2=C1C=CC(=C2)OC,,,,,,
205,130206,"S-(1-(((2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)methoxy)methyl)-2,5-dioxo-3-pyrrolidinyl)-L-cysteine",C1C(C(=O)N(C1=O)COCN2C(=O)C=CC2=O)SC[C@@H](C(=O)O)N,,,,,,
206,130207,CID 130207,CC=C(C1=CC=C(C=C1)N([C@@H](CC2=CC=C(C=C2)N(CCCl)CCCl)C(=O)O)C(=O)C)C(=CC)C3=CC=C(C=C3)N([C@@H](CC4=CC=C(C=C4)N(CCCl)CCCl)C(=O)O)C(=O)C,,,,,,
207,130208,"2-(4,5-Dihydro-2-(2-hydroxyphenyl)-4-thiazolyl)-3,4-dimethyl-4-thiazolidinecarboxylic acid",CC1(CSC(N1C)C2CSC(=N2)C3=CC=CC=C3O)C(=O)O,,,,,,
208,130209,Sulfinosine,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=C(N=C2S(=O)N)N,,,,,,
209,130210,"alpha-(3-(1,1-Dimethylethyl)-2-hydroxyphenyl)-1-methyl-5-nitro-1H-imidazole-2-methanol",CC(C)(C)C1=CC=CC(=C1O)C(C2=NC=C(N2C)[N+](=O)[O-])O,,,,,,
210,130211,N-Isobutyryl-L-cysteine,CC(C)C(=O)N[C@@H](CS)C(=O)O,,,,,,
211,130212,Mea cholate,CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.C[C@H](CCC(=O)[O-])[C@@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
212,130213,"(4R)-4-[(3R,5S,7R,10S,12S,13R,17S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C[C@H](CCC(=O)O)[C@@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
213,130214,"(2S,3S,4S,5R)-2-[6-[(2-hydroxycyclopentyl)amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",C1CC(C(C1)O)NC2=C3C(=NC=N2)N(C=N3)[C@@H]4[C@H]([C@@H]([C@H](O4)CO)O)O,,,"['Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Agonists.)', 'Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)']",,,
214,130215,"2-((1-Oxyl-2,2,5,5-tetramethyl-3-pyrrolin-3-yl)methenyl)indane-1,3-dione",CC1(C=C(C(N1[O])(C)C)C=C2C(=O)C3=CC=CC=C3C2=O)C,,,,,,
215,130216,"2-(4-(2,2-Dichlorocyclopropyl)phenoxy)propane",CC(C)OC1=CC=C(C=C1)C2CC2(Cl)Cl,,,,,,
216,130217,"2-Heptadeca-8,11,14-trienyl-6-hydroxybenzoic acid",CCC=CCC=CCC=CCCCCCCCC1=C(C(=CC=C1)O)C(=O)O,,,,,,
217,130218,"N-(3,5-dichloro-4-hydroxyphenyl)-5-[5-hydroxy-4-(3-hydroxy-4-methyloct-1-en-6-ynyl)-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanamide",CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)NC3=CC(=C(C(=C3)Cl)O)Cl)C2)O)O,,,,,,
218,130219,Mitomycin phosphate,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)NCCOP(=O)(O)O,,,,,,
219,130220,"(8S,9S,10S,13R,14S,17S)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-1,3,5,6-tetrol",C[C@H](CCC(=C)C(C)C)[C@@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(C4([C@@]3(C(CC(C4)O)O)C)O)O)C,,,,,,
220,130221,2-Iodoimipramine,CN(C)CCCN1C2=C(CCC3=CC=CC=C31)C=C(C=C2)I,,,,,,
221,130222,2-Oxo-3-tert-butyloxycarbonylamino-7-thia-1-azabicyclo(4.3.0)nonane-9-carboxylic acid,CC(C)(C)OC(=O)NC1CCC2N(C1=O)C(CS2)C(=O)O,,,,,,
222,130223,CID 130223,C[C@H](C(=O)[O-])NNC.C[C@@H](C(=O)[O-])NNC.[Cu+2],,,,,,
223,130224,(2R)-2-(2-methylhydrazinyl)propanoic acid,C[C@H](C(=O)O)NNC,,,,,,
224,130225,CID 130225,C[C@H](C(=O)[O-])NNC.C[C@@H](C(=O)[O-])NNC.[Zn+2],,,,,,
225,130226,Bri-cellobioside,C1=CC2=C(C=C1Br)C(=CN2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
226,130227,"(8S,9S,13S,14S,17S)-17-(tert-butylcarbamoyl)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3-carboxylic acid",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CCC4=C3C=CC(=C4)C(=O)O,,,,,,
227,130228,CID 130228,C1CN(CCC12C(=O)N(CN2C3=CC=CC=C3)CC=CI)CCCC(=O)C4=CC=C(C=C4)F,,,,,,
228,130229,"3-Quinolinecarboxylic acid, 7-(3-amino-3-methyl-1-azetidinyl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-",CC1(CN(C1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)F)N,,,,,,
229,130230,"9-Fluoro-3-methyl-10-(3-amino-3-methylazetidin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido-(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid",C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CC(C4)(C)N)F)C(=O)O,,,,,,
230,130231,"2-(n-Butyl)-1-(N-methyl-N-(2-(N',N'-dimethylamino)ethyl)amino)-5,6-methylenedioxyindane",CCCCC1CC2=CC3=C(C=C2C1N(C)CCN(C)C)OCO3,,,,,,
231,130232,Pyrene-1-carbonyl cyanide,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)C(=O)C#N,,,,,,
232,130233,Salvinone,CC(=O)C1=C(C=C2C3=C(C=CC2=C1)C(CCC3)(C)C)O,,,,,,
233,130234,2-((2-Ethoxycarbonyloxy)tetradecanoylamino)-2-deoxyglucose,CCCCCCCCCCCCC(C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)OC(=O)OCC,,,,,,
234,130235,2-(3-Hydroxydodecanoylamino)-2-deoxyglucose,CCCCCCCCCC(CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
235,130236,"10-[(3-Chloro-4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-(4-phenylbut-3-en-2-yl)-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone",CC1CNC(=O)C(NC(=O)C=CCC(OC(=O)C(OC1=O)CC(C)C)C(C)C=CC2=CC=CC=C2)CC3=CC(=C(C=C3)OC)Cl,,,,,,
236,130237,"1-(2,4-Dihydroxy-3-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one",COC1=CC=C(C=C1)C=CC(=O)C2=C(C(=C(C=C2)O)OC)O,,,,,,
237,130238,"1-(2,4-Dihydroxy-3-methoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",COC1=C(C=CC(=C1O)C(=O)C=CC2=CC=C(C=C2)O)O,,,,,,
238,130239,"1-(2,5-Dimethoxyphenyl)-3-[4-(dimethylamino)phenyl]-2-methylprop-2-en-1-one",CC(=CC1=CC=C(C=C1)N(C)C)C(=O)C2=C(C=CC(=C2)OC)OC,,,,,,
239,130240,"(4R)-4-[(8R,9S,10S,13R,14S,17S)-7-ethyl-3,7-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid",CCC1(CC2CC(CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@H]([C@]4(CC3)C)[C@H](C)CCC(=O)O)C)O)O,,,,,,
240,130241,"(4R)-4-[(8R,9S,10S,13R,14S,17S)-3,7-dihydroxy-10,13-dimethyl-7-propyl-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid",CCCC1(CC2CC(CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@H]([C@]4(CC3)C)[C@H](C)CCC(=O)O)C)O)O,,,,,,
241,130242,S-Acetylthiorphan,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)O,,,,,,
242,130243,CID 130243,CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)N=C(N3)N)SC2=O)OC(=O)C)OC(=O)C,,,,,,
243,130244,2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5-(trifluoromethyl)imidazole-4-carboxylic acid,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(F)(F)F,,,,,,
244,130245,Descyclopropyl Abacavir,C1[C@@H](C=C[C@@H]1N2C=NC3=C(N=C(N=C32)N)N)CO,,,,,,
245,130246,3-(1-Hydroxybutyl)-4-methyloxolan-2-one,CCCC(C1C(COC1=O)C)O,,,,,,
246,130247,"6-tert-Butyl-2-(hydroxy-tert-butyl)-4-methylene-2,5-cyclohedanedienone",CC(C)(C)C1=CC(=C)C=C(C1=O)C(C)(C)CO,,,,,,
247,130248,"2-(3,4,5-Trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione",CCC1(C(=O)N(OC1=O)C(=O)C2=CC(=C(C(=C2)OC)OC)OC)CC,,,,,,
248,130249,CID 130249,C[C@H](C(=O)O)NC(=O)C[C@@H](CC(=O)O)N,,,,,,
249,130250,Dihydrocaffeiyl methyl amide quinone,CNC(=O)CCC1=CC(=O)C(=O)C=C1,,,,,,
250,130251,Snp nonapeptide,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O,,,,,,
251,130252,9-Hydroxy-1-nitropyrene,C1=CC2=C3C(=C1)C(=CC4=C(C=CC(=C43)C=C2)[N+](=O)[O-])O,,,,,,
252,130253,2-(3-Propyloxiran-2-yl)quinoline,CCCC1C(O1)C2=NC3=CC=CC=C3C=C2,,,,,,
253,130254,"2-Imino-1-methyl-1,3-diazaspiro(4.5)decane hydrobromide",CN1C(=NCC12CCCCC2)N.Br,,,,,,
254,130255,"1,3-Diazaspiro94.5)dec-2-en-2-amine, 1-methyl-",CN1C(=NCC12CCCCC2)N,,,,,,
255,130256,"(3R,4S,5S)-2-(7-amino-2H-pyrazolo[4,3-d]pyrimidin-3-yl)-5-(methylsulfanylmethyl)oxolane-3,4-diol",CSC[C@@H]1[C@H]([C@H](C(O1)C2=C3C(=NN2)C(=NC=N3)N)O)O,,,,,,
256,130257,1-Ethyl-2-imino-5-(1-naphthalenyl)imidazolidine hydrobromide,CCN1C(CN=C1N)C2=CC=CC3=CC=CC=C32.Br,,,,,,
257,130258,"1-Ethyl-5-naphthalen-1-yl-4,5-dihydroimidazol-2-amine",CCN1C(CN=C1N)C2=CC=CC3=CC=CC=C32,,,,,,
258,130259,4-Hydroxy-N-nitroso-N-methyl-N-cyclohexylamine,CN(C1CCC(CC1)O)N=O,,,,,,
259,130260,2-hydroxy-3-(2-phenylethenyl)-2H-furan-5-one,C1=CC=C(C=C1)C=CC2=CC(=O)OC2O,,,,,,
260,130261,6-Bromo-2-piperazin-1-yl-quinoline,C1CN(CCN1)C2=NC3=C(C=C2)C=C(C=C3)Br,,,,,,
261,130262,"Cholesteryl 2,6-dimethyl-3-iodobenzoate",CC1=C(C(=C(C=C1)I)C)C(=O)OC2CC[C@@]3(C4CC[C@@]5([C@H](CCC5C4CC=C3C2)[C@H](C)CCCC(C)C)C)C,,,,,,
262,130263,H 261 Oligopeptide,CC[C@H](C)[C@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@@H](C[C@@H]([C@H](CC(C)C)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CN=CN5)N)O)C(C)C,,,,,,
263,130264,"[(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-iodo-2,6-dimethylbenzoate",CC1=C(C(=C(C=C1)I)C)C(=O)O[C@H]2CC[C@@]3([C@H]4CC[C@]5([C@H]([C@@H]4CC=C3C2)CC[C@@H]5C(=O)C)C)C,,,,,,
264,130265,N-(4-Iodophenyl)cholesteryl 3-carbamate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)NC5=CC=C(C=C5)I)C)C,,,,,,
265,130266,"2,2,4,4-Tetrakis(aziridin-1-yl)-1,3,5,7,11-pentaza-2lambda5,4lambda5,6lambda5-triphosphaspiro[5.5]undeca-1(6),2,4-triene",C1CNP2(=NP(=NP(=N2)(N3CC3)N4CC4)(N5CC5)N6CC6)NC1,,,,,,
266,130267,2-Amino-4-((bicylco(2.2.1)hept-2-yl)amino-N-((1-methylethyl)amino)carbonyl)-5-pyrimidinesulfonamide,CC(C)NC(=O)NS(=O)(=O)C1=CN=C(N=C1NC2CC3CCC2C3)N,,,,,,
267,130268,"2,2,4,4-Tetrakis(aziridin-1-yl)-1,3,5,7,12-pentaza-2lambda5,4lambda5,6lambda5-triphosphaspiro[5.6]dodeca-1(6),2,4-triene",C1CCNP2(=NP(=NP(=N2)(N3CC3)N4CC4)(N5CC5)N6CC6)NC1,,,,,,
268,130269,Calphostin B,CC(CC1=C2C3=C(C(=C(C4=C3C(=C5C2=C(C(=O)C=C5OC)C(=C1OC)O)C(=CC4=O)OC)O)OC)CC(C)OC(=O)C6=CC=CC=C6)O,,,,,,
269,130270,"5-(2-bromoethenyl)-1-[(1S,3R,4S)-3-hydroxy-4-(hydroxymethyl)cyclopentyl]pyrimidine-2,4-dione",C1[C@@H](C[C@H]([C@@H]1CO)O)N2C=C(C(=O)NC2=O)C=CBr,,,,,,
270,130271,"1H-Pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-9-methyl-2-(3-(4-phenyl-1-piperazinyl)propyl)-, dihydrochloride",CN1C2=CC=CC=C2C3=C1C(=O)N(CC3)CCCN4CCN(CC4)C5=CC=CC=C5.Cl.Cl,,,,,,
271,130272,"1H-Pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-9-methyl-2-(3-(4-phenyl-1-piperazinyl)propyl)-",CN1C2=CC=CC=C2C3=C1C(=O)N(CC3)CCCN4CCN(CC4)C5=CC=CC=C5,,,,,,
272,130273,(3beta)-3-((((4-Iodophenyl)amino)carbonyl)oxy)pregn-5-en-20-one,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)NC5=CC=C(C=C5)I)C)C,,,,,,
273,130274,CID 130274,C1[C@@H](C[C@H]([C@@H]1CO)O)N2C=C(C(=O)NC2=O)C=CI,,,,,,
274,130275,O-4-Propylthymine,CCCOC1=C(C=NC(=O)N1)C,,,,,,
275,130276,"2-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,6-dimethyl-5,7-dihydro-1H-indol-4-one",CC1(CC2=C(C=C(N2)C3C[C@@H]([C@H](O3)CO)O)C(=O)C1)C,,,,,,
276,130277,"3-Oxo-5,10-epoxyestran-17-yl acetate",CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC45C3(O4)CCC(=O)C5)C,,,,,,
277,130278,"(8R,9R,12S)-8-acetyl-9-formyl-12-hydroxyheptadeca-5,10-dienoic acid",CCCCC[C@@H](C=C[C@@H](C=O)[C@@H](CC=CCCCC(=O)O)C(=O)C)O,,,,,,
278,130279,(S)-N2-((4-((2-Naphthalenylcarbonyl)amino)phenyl)acetyl)-L-arginyl-L-isoleucyl-L-alpha-aspartyl-N-(2-methylbutyl)-L-argininamide,CC[C@H](C)CN[C@@H](CCCN=C(N)N)C(=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CC1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C=C2,,,,,,
279,130280,S-(N-Methylcarbamate) cysteine ethyl ester,CCOC(=O)[C@H](CSC(=O)NC)N,,,,,,
280,130281,"N-((1-Butyl-2-pyrrolidinyl)methyl)-2-methyl-5-sulfamoyl-2,3-dihydrobenzofuran-7-carboxamide",CCCCN1CCCC1CNC(=O)C2=CC(=CC3=C2OC(C3)C)S(=O)(=O)N.Cl,,,,,,
281,130282,"N-(1-butyl-2-pyrrolidinylmethyl)-2-methyl-5-sulfamoyl-2,3-dihydrobenzofuran-7-carboxamide",CCCCN1CCCC1CNC(=O)C2=CC(=CC3=C2OC(C3)C)S(=O)(=O)N,,,,,,
282,130283,"3,24-Dimethoxy-2-methyl-4-methylimino-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21(26),22,24,27-nonaen-16-one",CC12C(C(=NC)CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=C(N2C7=C53)C=C(C=C8)OC)CNC6=O)OC,,,,,,
283,130284,Calphostin I,CC(CC1=C2C3=C(C(=C(C4=C3C(=C5C2=C(C(=O)C=C5OC)C(=C1OC)O)C(=CC4=O)OC)O)OC)CC(C)OC(=O)C6=CC=C(C=C6)O)OC(=O)C7=CC=C(C=C7)O,,,,,,
284,130285,4-Deoxyverrucarol,CC1=C[C@@H]2[C@](CC1)([C@]3(CC[C@@H](C34CO4)O2)C)CO,,,,,,
285,130286,Nitrobenzoxadiazol-N-cholytaurine,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)NC5=CC=C(C6=NON=C56)[N+](=O)[O-])O)C,,,,,,
286,130287,"Platinum(2+) ethanedioate-cyclohexane-1,1-diyldimethanamine(1:1:1)",C1CCC(CC1)(CN)CN.C(=O)(C(=O)[O-])[O-].[Pt+2],,,,,,
287,130288,N-(6-(Ethylenedioxy)hexyl)biotinamide,C1COC(O1)CCCCCNC(=O)CCCC[C@@H]2[C@@H]3[C@@H](CS2)NC(=O)N3,,,,,,
288,130289,CID 130289,CC1=C(C2=C(C=C1)NC3=NC(=O)NC3=C2)C,,,,,,
289,130290,"1H-Azepinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3-(acetyloxy)-17-(1-oxobutoxy)-2-(1-piperidinyl)androstan-16-yl)hexahydro-1-methyl-, bromide",CCCC(=O)O[C@H]1[C@H](CC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCCC6)C.[Br-],,,,,,
290,130291,CID 130291,CCCC(=O)O[C@H]1[C@H](CC2[C@@]1(CCC3C2CCC4[C@@]3(C[C@@H]([C@H](C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCCC6)C,,,,,,
291,130292,Celikalim,CC1([C@H]([C@@H](C2=C(O1)C=CC(=C2)OC(F)(F)F)N3CC4=CC=CC=C4C3=O)O)C,,,,,,
292,130293,"14-Pentyl-1-oxacyclotetradeca-10,12-dien-2-one",CCCCCC1C=CC=CCCCCCCCC(=O)O1,,,,,,
293,130294,CID 130294,CCCCCC(=CC(=O)O[C@@H]1[C@H]2C(=C)[C@H]([C@]3([C@H]4[C@@]2(CO3)[C@@H](C[C@@H]5[C@@]4([C@@H](C(=O)C=C5C)O)C)OC1=O)O)O)C,,,,,,
294,130295,"2,3-Dimethoxy-5-iodo-N-((1-(4'-fluorobenzyl)-2-pyrrolidinyl)methyl)benzamide",COC1=CC(=CC(=C1OC)C(=O)NC[C@H]2CCCN2CC3=CC=C(C=C3)F)[123I],,,,,,
295,130296,Cymobarbatol,C[C@@]12CC[C@@H](C([C@@H]1CC3=CC(=C(C=C3O2)Br)O)(C)C)Br,,,,,,
296,130297,"5-[[5-(4-bromophenyl)-6-hydroxy-3,6-dihydro-1,3,4-oxadiazin-2-ylidene]methyl]-1H-pyrimidine-2,4-dione",C1=CC(=CC=C1C2=NNC(=CC3=CNC(=O)NC3=O)OC2O)Br,,,,,,
297,130298,"1-Chloro-3-ethynyl-2,4-dimethoxybenzene",COC1=C(C(=C(C=C1)Cl)OC)C#C,,,,,,
298,130299,Tyrosine-4'-dimethylaminophenylalanine,CN(C)C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
299,130300,"2-Propenoic acid, 2-(((4-methoxyphenyl)acetyl)amino)-",COC1=CC=C(C=C1)CC(=O)NC(=C)C(=O)O,,,,,,
300,130301,(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-aminophenyl)propanoic acid,C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)N,,,,,,
301,130302,4-(2-Pyridyldithio)butyramidine,C1=CC=NC(=C1)SSCCCC(=N)N,,,,,,
302,130303,4-Mercaptobutyramidine,C(CC(=N)N)CS,,,,,,
303,130304,"2-(3,4-Dichlorobenzyl)-5-nitrobenzoic acid",C1=CC(=C(C=C1CC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)O)Cl)Cl,,,,,,
304,130305,Phleichrome,CC(CC1=C2C3=C(C(=C(C4=C3C(=C5C2=C(C(=O)C=C5OC)C(=C1OC)O)C(=CC4=O)OC)O)OC)CC(C)O)O,,,['Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)'],,,
305,130306,"2-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-6-cyano-3-oxo-2,7-dihydro-1H-pyrazolo[1,2-a]pyrazole-5-carboxylic acid",CON=C(C1=CSC(=N1)N)C(=O)NC2CN3CC(=C(N3C2=O)C(=O)O)C#N,,,,,,
306,130307,"2-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-6-methylsulfonyl-3-oxo-2,7-dihydro-1H-pyrazolo[1,2-a]pyrazole-5-carboxylic acid",CON=C(C1=CSC(=N1)N)C(=O)NC2CN3CC(=C(N3C2=O)C(=O)O)S(=O)(=O)C,,,,,,
307,130308,1'-Methylascorbigen,CN1C=C(C2=CC=CC=C21)C[C@]3(C(=O)O[C@H]4[C@@]3(OC[C@@H]4O)O)O,,,,,,
308,130309,Dihydropanaxacol,CCCCCCC[C@H]([C@@H](CC#CC#C[C@H](CC)O)O)O,,,,,,
309,130310,5-[11-Hydroxy-11-[5-[5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl]undecyl]-3-(2-oxopropyl)oxolan-2-one,CCCCCCCCCCC(C1CCC(O1)C2CCC(O2)C(CCCCCCCCCCC3CC(C(=O)O3)CC(=O)C)O)O,,,,,,
310,130311,15-Bromosafracin A,CC1=C(C(=C2C3C4CC5=C(C(N4CC(N3C)CC2=C1Br)CNC(=O)C(C)N)C(=O)C(=C(C5=O)C)OC)O)OC,,,,,,
311,130312,Sulperazone,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O.CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C,,,"['Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)']",,,
312,130313,Sulbactam,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C,"['Sulbactam is currently available in combination products with ampicillin. Within this formulation it is indicated  for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli, Klebsiella spp. (including K. pneumoniae), Proteus mirabilis, Bacteroides fragilis, Enterobacter spp., and Acinetobacter calcoaceticus. Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K. pneumoniae), Bacteroides spp. (including B. fragilis), and Enterobacter spp. Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis).']",,"['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)']","['Peak serum concentrations are reached almost immediately following a 15-minute intravenous infusion of sulbactam + ampicillin. Mean peak serum levels for sulbactam range from 48 to 88 mcg/mL following intravenous administration of 2000 mg of ampicillin plus 1000 mg sulbactam. After an intramuscular injection of 1000 mg ampicillin plus 500 mg sulbactam, peak sulbactam serum levels ranging from 6 to 24 mcg/mL are attained.', 'Approximately 75 to 85% of both ampicillin and sulbactam are excreted unchanged in the urine during the first 8 hours after administration.', 'Penetration of both ampicillin and sulbactam into cerebrospinal fluid in the presence of inflamed meninges has been demonstrated after IV administration.']",,['~1 hr']
313,130314,CID 130314,C1CCC(C(C1)N)N.C(C(C1C(=O)C(=C(O1)[O-])O)O)O.C(C(C1C(=O)C(=C(O1)[O-])O)O)O.[Pt+2],,,,,,
314,130315,AphiG,C[C@]12CC[C@H]([C@@]([C@@H]1CC[C@@H]3[C@@]24CC[C@@]([C@H](C3)C4)(COC(=O)CN)O)(C)CO)O.Cl,,,,,,
315,130316,CID 130316,C[C@]12CCC([C@@]([C@@H]1CC[C@@H]3[C@@]24CC[C@@]([C@H](C3)C4)(COC(=O)CN)O)(C)CO)O,,,,,,
316,130317,"2,4,6-Cycloheptatrien-1-one, 3,3'-((4-methoxyphenyl)methylene)bis(2-hydroxy-6-(1-methylethyl)-",CC(C)C1=CC(=O)C(=C(C=C1)C(C2=CC=C(C=C2)OC)C3=C(C(=O)C=C(C=C3)C(C)C)O)O,,,,,,
317,130318,"(3'S-(1'(R*(R*)),3'alpha,5'beta))-1'-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)spiro(bicyclo(2.2.2)octane-2,3'-pyrrolidine)-5'-carboxylic acid",CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3(CC4CCC3CC4)CC2C(=O)O,,,,,,
318,130319,Trifluoroacetylprimaquine,CC(CCCN)NC1=CC(=C(C2=C1N=CC=C2)C(=O)C(F)(F)F)OC.C(=O)(C(=O)O)O,,,,,,
319,130320,"1-[8-(5-Aminopentan-2-ylamino)-6-methoxyquinolin-5-yl]-2,2,2-trifluoroethanone",CC(CCCN)NC1=CC(=C(C2=C1N=CC=C2)C(=O)C(F)(F)F)OC,,,,,,
320,130321,Cnc-alanylalanine,C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)N(CCCl)N=O,,,,,,
321,130322,3-Aminobenzylguanidine,C1=CC(=CC(=C1)N)CN=C(N)N,,,,,,
322,130323,3-Nitrobenzylguanidine,C1=CC(=CC(=C1)[N+](=O)[O-])CN=C(N)N,,,,,,
323,130324,"3-(2,3-Dihydroxypropyl)thymidine",CC1=CN(C(=O)N(C1=O)CC(CO)O)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
324,130325,"4-[3-(3,5-Ditert-butylphenyl)-3-oxoprop-1-enyl]benzoic acid",CC(C)(C)C1=CC(=CC(=C1)C(=O)C=CC2=CC=C(C=C2)C(=O)O)C(C)(C)C,,,,,,
325,130326,"4-[3-Oxo-3-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid",CC1(CCC(C2=C1C=CC(=C2)C(=O)C=CC3=CC=C(C=C3)C(=O)O)(C)C)C,,,,,,
326,130327,5-(6-Aminohexanamido)valeric acid,C(CCC(=O)NCCCCC(=O)O)CCN,,,,,,
327,130328,"Ethyl 6-(4-((5-(1H-imidazol-1-yl)pentyl)oxy)phenoxy)-2,2-dimethylhexanoate",CCOC(=O)C(C)(C)CCCCOC1=CC=C(C=C1)OCCCCCN2C=CN=C2,,,,,,
328,130329,"Azanide;cyclohexanamine;2-hydroxypropane-1,2,3-tricarboxylate;platinum(2+)",C1CCC(CC1)N.C1CCC(CC1)N.C1CCC(CC1)N.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[NH2-].[NH2-].[NH2-].[Pt+2].[Pt+2].[Pt+2],,,,,,
329,130330,Platuran,C1CCC(CC1)N.C1CCC(CC1)N.[C@H]([C@@H]([C@@H](C(=O)[O-])O)O)([C@H](C(=O)[O-])O)O.[NH2-].[NH2-].[Pt+2].[Pt+2],,,,,,
330,130331,"2-(1,1'-Biphenyl-4-yl)-5-chloro-3-methyl-4-quinolinecarboxylic acid sodium salt",CC1=C(C2=C(C=CC=C2Cl)N=C1C3=CC=C(C=C3)C4=CC=CC=C4)C(=O)O,,,,,,
331,130332,1-((2-Hydroxy-1-(aminomethyl)ethoxy)methyl)-5-benzyluracil,C1=CC=C(C=C1)CC2=CN(C(=O)NC2=O)COC(CN)CO,,,,,,
332,130333,"9-Hydroxy-6-methyl-2,3,8-trimethoxy-11H-indeno(1,2-c)isoquinolinium chloride",C[N+]1=CC2=CC(=C(C=C2C3=C1C4=CC(=C(C=C4C3)O)OC)OC)OC.[Cl-],,,,,,
333,130334,"2,3,8-trimethoxy-6-methyl-11H-indeno[1,2-c]isoquinolin-6-ium-9-ol",C[N+]1=CC2=CC(=C(C=C2C3=C1C4=CC(=C(C=C4C3)O)OC)OC)OC,,,,,,
334,130335,"Nonacosane-6,8-diol",CCCCCCCCCCCCCCCCCCCCCC(CC(CCCCC)O)O,,,,,,
335,130336,5-Oxoprolinal,C1CC(=O)N[C@@H]1C=O,,,,,,
336,130337,CID 130337,C[C@H](CCCC(C)(C)O)[C@H]1CCC2[C@@]1(CCCC2=CC3=C4C[C@H](CCC4=C(O3)O)O)C,,,,,,
337,130338,"3-{[3-(Acetyloxy)-4-(hexadecyloxy)butyl]sulfanyl}-n,n,n-trimethylpropan-1-aminium iodide",CCCCCCCCCCCCCCCCOCC(CCSCCC[N+](C)(C)C)OC(=O)C.[I-],,,,,,
338,130339,3-(3-Acetyloxy-4-hexadecoxybutyl)sulfanylpropyl-trimethylazanium,CCCCCCCCCCCCCCCCOCC(CCSCCC[N+](C)(C)C)OC(=O)C,,,,,,
339,130340,"1,4-Butanediamine, N-ethyl-N'-(3-(ethylamino)propyl)-",CCNCCCCNCCCNCC,,,,,,
340,130341,CID 130341,C1OC2=C(O1)C(=O)C3=C(C(=COC3=C2)C4=CC=CC=C4O)O,,,,,,
341,130342,"(S)-9,10,12,13,14,14a,15,16-Octahydro-2,3,6-trimethoxyphenanthro(9,10-g)pyrrolo(1,2-b)isoquinoline",COC1=CC2=C(C=C1)C3=C(CC4=C(C3)CN5CCC[C@H]5C4)C6=CC(=C(C=C62)OC)OC,,,,,,
342,130343,"3-Methyl-8-phenylocta-3,5,7-trien-2-one",CC(=CC=CC=CC1=CC=CC=C1)C(=O)C,,,,,,
343,130344,"[3-[(8S,10S,11S,13S,14S,16R,17R)-16-acetyloxy-11,17-dideuteriooxy-9-fluoro-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2,3-dioxopropyl] acetate",[2H]O[C@H]1C[C@]2([C@@H](C[C@H]([C@]2(C(=O)C(=O)COC(=O)C)O[2H])OC(=O)C)[C@H]3C1([C@]4(C=CC(=O)C=C4CC3)C)F)C,,,,,,
344,130345,"4,5-Dihydro-6-(4-((2-methyl-3-oxo-1-cyclopentenyl)amino)phenyl)-3(2H)-pyridazinone",CC1=C(CCC1=O)NC2=CC=C(C=C2)C3=NNC(=O)CC3,,,,,,
345,130346,"3-(2,6-Diaminopurin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol",C1C(C(C(C1N2C=NC3=C(N=C(N=C32)N)N)O)O)CO,,,,,,
346,130347,"1,6-Diamino-3,4-dihydroxyhexane",C(CN)C(C(CCN)O)O,,,,,,
347,130348,"5'-O-(4,4'-Dimethoxytrityl)thymidine-3'-O-(2,4-dinitrophenyl) succinate",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OC(=O)CCC(=O)OC6=C(C=C(C=C6)[N+](=O)[O-])[N+](=O)[O-],,,,,,
348,130349,"4,5-Dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopentenyl)amino)phenyl)-3-(2H)-pyridazinone",CC1CC(=O)NN=C1C2=CC=C(C=C2)NC3=C(C(=O)CC3)C,,,,,,
349,130350,6-Hydroxy-2-[2-(4-methoxyphenyl)ethyl]chromen-4-one,COC1=CC=C(C=C1)CCC2=CC(=O)C3=C(O2)C=CC(=C3)O,,,,,,
350,130351,1-[6-(4-Amino-2-methylquinolin-1-ium-1-yl)hexyl]-2-methylquinolin-1-ium-4-amine,CC1=[N+](C2=CC=CC=C2C(=C1)N)CCCCCC[N+]3=C(C=C(C4=CC=CC=C43)N)C,,,,,,
351,130352,1-Hexyl-2-methylquinolin-1-ium-4-amine,CCCCCC[N+]1=C(C=C(C2=CC=CC=C21)N)C,,,,,,
352,130353,"3-(1,5-dihydroxy-4-methylpent-3-enyl)-4-hydroxy-7-methoxy-2,3,8-trimethyl-2H-benzo[g][1]benzofuran-6,9-dione",CC1C(C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)C(CC=C(C)CO)O,,,,,,
353,130354,CID 130354,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CCC(C4)OC(=O)CCCCCCCCCCCNC(=O)C5=CC(=C(C=C5[O-])N[N+]#N)I)C)C,,,,,,
354,130355,CID 130355,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CCC(C4)OC(=O)CCCCCCCCCCCNC(=O)C5=CC(=C(C=C5O)N[N+]#N)I)C)C,,,,,,
355,130356,"4-(2-(Ethylamino)propyl)-1,2-benzenediol hydrobromide",CCNC(C)CC1=CC(=C(C=C1)O)O.Br,,,,,,
356,130357,"3,4-Dihydroxyethylamphetamine",CCNC(C)CC1=CC(=C(C=C1)O)O,,,,,,
357,130358,CID 130358,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC[C@@H](C=CC=CCC=CCC=CCCCCC)O,,,,,,
358,130359,CID 130359,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCC[C@@H](C=CC=CCC=CCC=CCCCCC)O,,,,,,
359,130360,3-Methyl-6-(3-(3-(trifluoromethyl)phenyl)-1-pyrrolidinyl)pyridazine,CC1=NN=C(C=C1)N2CCC(C2)C3=CC(=CC=C3)C(F)(F)F,,,,,,
360,130361,"(3R,4R,6S)-4-[tert-butyl(dimethyl)silyl]oxy-6-methyl-3-(2-oxopropyl)oxan-2-one",C[C@H]1C[C@H]([C@H](C(=O)O1)CC(=O)C)O[Si](C)(C)C(C)(C)C,,,,,,
361,130362,CID 130362,CCCCC[C@@H](C=CC=CCC=CCC=CCCCC(=O)OC)O,,,,,,
362,130363,4-Amino-5-fluoropentanoic acid,C(CC(=O)O)C(CF)N,,,,,,
363,130364,"3,8-Dihydroxy-4-methoxycoumarin",COC1=C(C(=O)OC2=C1C=CC=C2O)O,,,,,,
364,130365,CID 130365,C[C@@H](C(=O)N[C@H](C)C(=O)N1CCC[C@H]1C(=O)NC(=O)[C@H](C(C)C)NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)CCC(=O)OC,,,,,,
365,130366,CID 130366,CC1=C2C(=CC=C1)OC(=C(C2=O)C3=CC(=O)C4=CC=C(OC4=C3O)O)O,,,,,,
366,130367,"N,N-Bis(2-bromoethyl)-3-methyl-1-naphthalenamine",CC1=CC2=CC=CC=C2C(=C1)N(CCBr)CCBr,,,,,,
367,130368,"1H-Imidazole-1-ethanol, alpha-2-naphthalenyl-",C1=CC=C2C=C(C=CC2=C1)C(CN3C=CN=C3)O,,,,,,
368,130369,"2-Propanol, 1-(octadecylamino)-, hydrobromide",CCCCCCCCCCCCCCCCCCNCC(C)O.Br,,,,,,
369,130370,1-(Octadecylamino)propan-2-ol,CCCCCCCCCCCCCCCCCCNCC(C)O,,,,,,
370,130371,1-Octadecyl-3-pyrrolidinemethanol hydrochloride,CCCCCCCCCCCCCCCCCCN1CCC(C1)CO.Cl,,,,,,
371,130372,(1-Octadecylpyrrolidin-3-yl)methanol,CCCCCCCCCCCCCCCCCCN1CCC(C1)CO,,,,,,
372,130373,"8,14-Dimethoxy-9-methyl-7-(methylamino)-6,7,8,9-tetrahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-16-ol",C[C@@]12[C@H]([C@@H](C[C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)[C@H](NC6=O)OC)NC)OC,,,,,,
373,130374,S-(6-Purinyl)cysteine,C1=NC2=C(N1)C(=NC=N2)SC[C@@H](C(=O)O)N,,,,,,
374,130375,CID 130375,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC=CCC=CCC=CC=C[C@H](CCCCC)O,,,,,,
375,130376,CID 130376,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCC=CCC=CCC=CC=C[C@H](CCCCC)O,,,,,,
376,130377,Spectramide,CNC1=C(C=C(C(=C1)OC)C(=O)NCCN(C)CC2=CC=C(C=C2)I)Cl,,,,,,
377,130378,"5,5-Dimethyl-2-(2-nitrophenyl)amino-1,3,2-dioxaphosphorinane 2-selenide",CC1(COP(=[Se])(OC1)NC2=CC=CC=C2[N+](=O)[O-])C,,,,,,
378,130379,5-(1-Cyano-4-((2-(2-ethoxyphenoxy)ethyl)amino)-1-isopropylbutyl)-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNCCCC(C#N)(C2=CC(=C(C=C2)OC)S(=O)(=O)N)C(C)C,,,,,,
379,130380,Eclanamine,CCC(=O)N([C@@H]1CCC[C@H]1N(C)C)C2=CC(=C(C=C2)Cl)Cl,,,,,,
380,130381,Monoacetone glucose 3-butyrate,CCCC(=O)O[C@@H]1[C@@H]2[C@H](O[C@@H]1[C@@H](CO)O)OC(O2)(C)C,,,,,,
381,130382,Monoacetone glucose 6-butyrate,CCCC(=O)OC[C@H]([C@@H]1[C@@H]([C@@H]2[C@H](O1)OC(O2)(C)C)O)O,,,,,,
382,130383,"2-(4-Aminobutyl)-1,3-propanediol",C(CCN)CC(CO)CO,,,,,,
383,130384,Adenosine-N(6)-methyl-propylthioether-N-pyridoxamine,CC1=NC=C(C(=C1O)CNCCCSCNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)CO,,,,,,
384,130385,"1-Nitro-4,5-dihydro-4,5-dihydroxypyrene",C1=CC2=C3C(=C1)C(C(C4=C3C(=C(C=C4)[N+](=O)[O-])C=C2)O)O,,,,,,
385,130386,Sdz mns 949,CC1=CC2=CC(=C(C=C2C(=N1)C3=CC(=CC(=C3)OCCOC)OCCOC)OC)OC,,,,,,
386,130387,CID 130387,B(C1=CN=C(NC1=O)S)(O)O,,,,,,
387,130388,Methotrexate-gamma-glycerophosphatidylethanolamine,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N(CCOP(=O)(O)OCC(CO)O)[C@@H](CCC(=O)N)C(=O)O,,,,,,
388,130389,"Pentanoic acid, 5-amino-4-((4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)amino)-5-oxo-, (S)-",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)N,,,,,,
389,130390,"Methyl 4-pentadeca-1,3,6,9-tetraenylsulfanylbutanoate",CCCCCC=CCC=CCC=CC=CSCCCC(=O)OC,,,,,,
390,130391,"1-Cyclopentyl-5-[[(2S,6S,11S)-1,2,3,4,5,6-hexahydro-8-hydroxy-3,6,11-trimethyl-2,6-methano-3-benzazocin]-11-yl]-3-pentanone",C[C@@]12CCN([C@H]([C@@]1(C)CCC(=O)CCC3CCCC3)CC4=C2C=C(C=C4)O)C,,,,,,
391,130392,"Butanedinitrile, ((4-methoxyphenyl)methylene)methylene-, (Z)-",COC1=CC=C(C=C1)C=C=C(CC#N)C#N,,,,,,
392,130393,Culpin,CC(=CCC1=CC(=C(C=C1O)C#CC(=C)C)O)C,,,,,,
393,130394,4-(4-Guanidinobenzoyloxy)phenylacetic acid,CS(=O)(=O)O.C1=CC(=CC=C1CC(=O)O)OC(=O)C2=CC=C(C=C2)N=C(N)N,,,,,,
394,130395,4-(4-Guanidinobenzoyloxy)phenylacetate,C1=CC(=CC=C1CC(=O)O)OC(=O)C2=CC=C(C=C2)N=C(N)N,,,,,,
395,130396,N-(1'-Benzyl-4'-piperidyl-N-oxide)-4-amino-5-chloro-2-methoxybenzamide,COC1=CC(=C(C=C1C(=O)NC2CC[N+](CC2)(CC3=CC=CC=C3)[O-])Cl)N,,,,,,
396,130397,"(2S,3S,3aS,6S,7S,7aS)-2-hydroxy-2,3,7-trimethyl-6-(1-phenylmethoxypropan-2-yl)-3a,6,7,7a-tetrahydro-3H-furo[3,2-c]pyran-4-one",C[C@H]1[C@H]2[C@H]([C@@H]([C@@](O2)(C)O)C)C(=O)O[C@H]1C(C)COCC3=CC=CC=C3,,,,,,
397,130398,"13-(Phenylmethyl)-1,4,7,10-tetraoxa-13-azacyclopentadecane",C1COCCOCCOCCOCCN1CC2=CC=CC=C2,,,,,,
398,130399,"1-Acetyl-2,7-dimethoxynaphthalene",CC(=O)C1=C(C=CC2=C1C=C(C=C2)OC)OC,,,,,,
399,130400,Ersentilide,CS(=O)(=O)NC1=CC=C(C=C1)OCC(CNCCOC2=CC=C(C=C2)N3C=CN=C3)O,,,,,,
400,130401,"4-[4-(4-Hydroxyphenyl)hex-3-en-3-yl]benzene-1,2-diol",CCC(=C(CC)C1=CC(=C(C=C1)O)O)C2=CC=C(C=C2)O,,,,,,
401,130402,2-Di-n-propylaminoindan,CCCN(CCC)C1CC2=CC=CC=C2C1,,,,,,
402,130403,Hovenitin II,COC1=CC(=CC(=C1O)O)[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O,,,,,,
403,130404,CID 130404,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C(C=C(C=C2)C=C3C(=O)N(C(=S)S3)CC(=O)[O-])OC)CO)O)O.[NH4+],,,,,,
404,130405,CID 130405,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C(C=C(C=C2)C=C3C(=O)N(C(=S)S3)CC(=O)O)OC)CO)O)O,,,,,,
405,130406,CID 130406,C[C@H](CCC[C@]1([C@H](CCC(=CCO)CO1)O)C)C(=O)C=C(C)C(C)C,,,,,,
406,130407,(-)-Lentiginosine,C1CCN2C[C@H]([C@@H]([C@H]2C1)O)O,,,,,,
407,130408,"15,17-Dihydroxyprogesterone",CC(=O)[C@]1(C[C@H]([C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O)O,,,,,,
408,130409,3-Chloroquinoline-8-carboxylic acid,C1=CC2=CC(=CN=C2C(=C1)C(=O)O)Cl,,,,,,
409,130410,3-NP-ADP,C1=CC=C2C(=C1)C=CC=C2C(=O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=NC5=C(N=CN=C54)N)COP(=O)(O)OP(=O)(O)O,,,,,,
410,130411,CID 130411,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@H]3CC4C(C[C@@H](C5[C@@]4(CC[C@@H]5[C@](C)(C=CC(C(C)C)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)[C@@]7(C3C(C(CC7)O)(C)C)C)CO)O)O)O)O)O,,,,,,
411,130412,CID 130412,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@H]3CC4C(C[C@@H](C5[C@@]4(CC[C@@H]5[C@](C)(CC=CC(C)(C)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)[C@@]7(C3C(C(CC7)O)(C)C)C)CO)O)O)O)O)O,,,,,,
412,130413,CID 130413,CC(C)C(C=C[C@@](C)([C@H]1CC[C@]2([C@H]1[C@H](CC3C2CCC4[C@@]3(CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O,,,,,,
413,130414,Drevogenin I,CC(CC(=O)O)C[C@]1(C[C@@H]2[C@]3(CC[C@@H](C[C@@H]3CCC2([C@@]4([C@]1([C@](CC4)(C(C)(CC(C)CC(=O)O)O)O)C)O)O)O)C)O,,,,,,
414,130415,"4-Pregnene-3,20-diol",C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C[C@@H](CC[C@]34C)O)C)O,,,,,,
415,130416,CID 130416,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC(=NC3=O)NC4=C(C=CC5=C4C=CC6=CC=CC=C65)N)CO)O,,,,,,
416,130417,"5-Bromo-6-ethoxy-5,6-dihydro-2',3'-isopropylidine-beta-ribofuranosyluracil",CCO[C@@H]1[C@H](C(=O)NC(=O)N1[C@H]2[C@H]3[C@@H]([C@H](O2)CO)OC(O3)(C)C)Br,,,,,,
417,130418,D-Mannitol 1-phosphate,C([C@H]([C@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O)O)O,,,,,,
418,130419,CID 130419,C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)OC)NC(=O)C)O[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)NC(=O)C,,,,,,
419,130420,3-Carboxyphenyl phenylacetamidomethylphosphonate,C1=CC=C(C=C1)CC(=O)NCP(=O)(O)OC2=CC=CC(=C2)C(=O)O,,,['Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)'],,,
420,130421,8-Bromo-9-beta-D-xylofuranosyladenine,C1=NC(=C2C(=N1)N(C(=N2)Br)[C@@H]3[C@@H]([C@H]([C@H](O3)CO)O)O)N,,,,,,
421,130422,gamma-tert-Butyloxy-glu-gly-arg-3-carboxy-4-hydroxyanilide,CC(C)(C)C([C@H](CCCN=C(N)N)NC1=CC(=C(C=C1)O)C(=O)O)(NC(=O)CNC(=O)[C@@H](CCC(=O)O)N)O.Cl.Cl,,,,,,
422,130423,CID 130423,CC(C)(C)C([C@H](CCCN=C(N)N)NC1=CC(=C(C=C1)O)C(=O)O)(NC(=O)CNC(=O)C(CCC(=O)O)N)O,,,,,,
423,130424,"1H-3-Benzazepin-7-ol, 5-(7-benzofuranyl)-8-chloro-2,3,4,5-tetrahydro-3-methyl-, (S)-",CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC4=C3OC=C4)O)Cl,,,,,,
424,130425,Rhizochaline,CC(C(CCCCCCCC(=O)CCCCCCCCCCCCCCC(C(C)N)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)O)N,,,,,,
425,130426,"2',3'-Dideoxy-3'-fluoroaristeromycin",C1[C@H](C[C@@H]([C@H]1CO)F)N2C=NC3=C(N=CN=C32)N,,,,,,
426,130427,"N-(1-Azabicyclo(2.2.2)octan-3-yl)-2-chloro-5a,6,7,8,9,9a-hexahydrodibenzofuran-4-carboxamide",C1CCC2C(C1)C3=C(O2)C(=CC(=C3)Cl)C(=O)NC4CN5CCC4CC5,,,,,,
427,130428,"6-Hydroxy-1,2-dihydrocyclobuta[a]naphthalene-2-carboxylic acid",C1C(C2=C1C3=C(C=C2)C=C(C=C3)O)C(=O)O,,,,,,
428,130429,CID 130429,C=CC=CC[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)OCC2=CC=CC=C2)OCC3=CC=CC=C3)OCC4=CC=CC=C4CC5=CC=CC=C5,,,,,,
429,130430,8-Azidoadenosine 5'-(4-(fluorosulfonyl)benzoate),C1=CC(=CC=C1C(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3N=[N+]=[N-])N)O)O)S(=O)(=O)F,,,,,,
430,130431,"6-Chloro-7,8-diethylcarbamoyl-1-(4'-ethylcarbmoylphenyl)-2,3,4,5-tetrahydr-1H-3-benzazepine",CCNC(=O)OC1=CC=C(C=C1)[C@H]2CNCCC3=C(C(=C(C=C23)OC(=O)NCC)OC(=O)NCC)Cl.Cl,,,,,,
431,130432,SKF-R-105058 free base,CCNC(=O)OC1=CC=C(C=C1)[C@H]2CNCCC3=C(C(=C(C=C23)OC(=O)NCC)OC(=O)NCC)Cl,,,,,,
432,130433,"6-Chloro-7,8-diethylcarbamoyl-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine",CCC1=CC2=C(CCN(CC2C3=CC=C(C=C3)O)C(=O)N)C(=C1CC)Cl,,,,,,
433,130434,CID 130434,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)N=C(C5=CC=C(C=C5)N[N+]#N)[O-])O)C,,,,,,
434,130435,CID 130435,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)NC(=O)C5=CC=C(C=C5)N[N+]#N)O)C,,,,,,
435,130436,CID 130436,C1=CC2=C(C(=C1)O)C(=O)C3=C(C2C(=O)C=CC(=O)O)C=CC=C3O,,,,,,
436,130437,Glutapyrone,CCOC(=O)C1=C(NC(=C(C1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])C(=O)OCC)C)C.[Na+].[Na+],,,,,,
437,130438,"(2S)-2-[[3,5-bis(ethoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-4-carbonyl]amino]pentanedioic acid",CCOC(=O)C1=C(NC(=C(C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)OCC)C)C,,,,,,
438,130439,CID 130439,CC(C)C[C@H](C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2CCCC2)NC(CC3CCCCC3)C(O)P(=O)(OC)OC,,,,,,
439,130440,"(1S,2R,3R,5R)-5-(6-aminopurin-9-yl)-2-fluoro-3-(hydroxymethyl)cyclopentan-1-ol",C1[C@@H]([C@H]([C@H]([C@@H]1N2C=NC3=C(N=CN=C32)N)O)F)CO,,,,,,
440,130441,Bipinnatifidusoside F1,CC(=C)C(CC[C@@](C)([C@H]1CC[C@]2([C@H]1[C@H](CC3C2CCC4[C@@]3(CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O,,,,,,
441,130442,Methyl 3-O-galactopyranosylmannopyranoside,CO[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O,,,,,,
442,130443,(2S)-2-(2-hydroxyethylamino)propanoic acid,C[C@@H](C(=O)O)NCCO,,,,,,
443,130444,6-(1-Hydroxyethyl)-2-(5-chloro-2-oxobenzoxazolin-3-yl)-1-methyl-1-carbapen-2-em-3-carboxylic acid,C[C@@H]1[C@@H]2[C@@H](C(=O)N2C(=C1N3C4=C(C=CC(=C4)Cl)OC3=O)C(=O)O)[C@@H](C)O,,,,,,
444,130445,2-Benzylamino-4-methyl-7-diethylaminobenzopyrylium monotetrafluoroborate,CCN(CC)C1=CC2=C(C=C1)C(=CC(=[NH+]CC3=CC=CC=C3)O2)C,,,,,,
445,130446,CID 130446,CC(C)CC(C(=O)O)N=C(NC1=CC=CC=C1N)S,,,,,,
446,130447,Ethyl phenyl selenone,CC[Se](=O)(=O)C1=CC=CC=C1,,,,,,
447,130448,CID 130448,C1=CC=C(C(=C1)N)NC(=NCC(=O)O)S,,,,,,
448,130449,CID 130449,C1CC(N(C1)C(=NC2=CC=CC=C2N)S)C(=O)O,,,,,,
449,130450,CID 130450,CS(=O)(=O)C1=CC=C(C=C1)OP(=O)(OCCOCN2C=NC3=C2NC(=NC3=O)N)OCCOCN4C=NC5=C4NC(=NC5=O)N,,,,,,
450,130451,"n,n'-(6,6'-Dihydroxybiphenyl-3,3'-diyl)diacetamide",CC(=O)NC1=CC(=C(C=C1)O)C2=C(C=CC(=C2)NC(=O)C)O,,,,,,
451,130452,CID 130452,CS(=O)(=O)C1=CC=C(C=C1)OP(=O)(OC2(CN(C(=O)NC2=O)[C@H]3C[C@@H]([C@H](O3)CO)O)C=CBr)OC4(CN(C(=O)NC4=O)[C@H]5C[C@@H]([C@H](O5)CO)O)C=CBr,,,,,,
452,130453,1-Acetamidopyren-3-ol,CC(=O)NC1=CC(=C2C=CC3=CC=CC4=C3C2=C1C=C4)O,,,,,,
453,130454,Aspartyl-seryl-aspartyl-glycyl-lysine,C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N,,,,,,
454,130455,"5-Hydroxy-6-sulfanylicosa-7,9,11,14-tetraenoic acid",CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)S,,,,,,
455,130456,Acdcp,C1CCC(CC1)N.N.[Cl-].[Cl-].[Pt+2],,,,,,
456,130457,Drevogenin II,CC([C@]1(CC[C@]2([C@@]1([C@@H](C[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)OC(=O)C)C)O)O)OC(=O)C5=CC=CC=C5,,,,,,
457,130458,"N-((2S,3R)-3-Amino-2-hydroxy-4-(4-methylsulfonylphenyl)-1-oxobutyl)-1-aminocyclopentanecarboxylic acid",CS(=O)(=O)C1=CC=C(C=C1)C[C@H]([C@@H](C(=O)NC2(CCCC2)C(=O)O)O)N,,,,,,
458,130459,N-(3-Amino-2-hydroxy-4-(4-methylsulfonylphenyl)-1-oxobutyl)leucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=C(C=C1)S(=O)(=O)C)N)O,,,,,,
459,130460,Tbemp,CCOC(C)SCC(=O)NCC(CCC(=O)OC1=C(C(=CC(=C1F)F)F)F)NC(=O)CSC(C)OCC,,,,,,
460,130461,2-(4-Amino-4-carboxybutyl)-2-aziridinecarboxylic acid,C1C(N1)(CCCC(C(=O)O)N)C(=O)O,,,,,,
461,130462,2-[Bis(2-chloroethyl)amino]-2-[4-[4-[1-[bis(2-chloroethyl)amino]-2-oxoethyl]phenyl]phenyl]acetaldehyde,C1=CC(=CC=C1C2=CC=C(C=C2)C(C=O)N(CCCl)CCCl)C(C=O)N(CCCl)CCCl,,,,,,
462,130463,N-(2-hydroxyethyl)-3-methylsulfanylprop-2-enamide,CSC=CC(=O)NCCO,,,,,,
463,130464,CID 130464,CC1(CC(=C)C(=O)O1)CN2C=NC3=C2NC=NC3=O,,,,,,
464,130465,"phosphono (2R,3S,4S)-2,3,4,5-tetrahydroxy-5-iodopentanoate",[C@@H]([C@@H](C(O)I)O)([C@H](C(=O)OP(=O)(O)O)O)O,,,,,,
465,130466,"2-Morpholinomethyl-2',3',4'-trimethoxyacrylophenone",COC1=C(C(=C(C=C1)C(=O)C(=C)CN2CCOCC2)OC)OC,,,,,,
466,130467,"3-Hydroxy-19-nor-1,3,5(10)-cholatrien-24-oic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)O)C,,,,,,
467,130468,4-O-Acetyl-N-acetylneuraminic acid,CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)O)OC(=O)C,,,,,,
468,130469,"2-Propenoic acid, 3-(2-furanyl)-, phosphono ester",C1=COC(=C1)C=CC(=O)OP(=O)(O)O,,,,,,
469,130470,"D-glycero-D-altro-Octulose 1,8-bisphosphate",C([C@@H]([C@H]([C@H]([C@H]([C@@H](C(=O)COP(=O)(O)O)O)O)O)O)O)OP(=O)(O)O,,,,,,
470,130471,"1,2-Bis(6-methoxy-1h-benzimidazol-2-yl)ethane-1,2-diol",COC1=CC2=C(C=C1)N=C(N2)C(C(C3=NC4=C(N3)C=C(C=C4)OC)O)O,,,,,,
471,130472,Dicarboxymethyldithiocarbamate,C(C(=O)[O-])N(CC(=O)[O-])C(=S)[S-].[NH4+].[NH4+].[NH4+].O,,,,,,
472,130473,"Glycine, N-(carboxymethyl)-N-(dithiocarboxy)-",C(C(=O)O)N(CC(=O)O)C(=S)S,,,,,,
473,130474,"5-(2-Naphthalenylsulfonyl)-2,4-thiazolidinedione",C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)C3C(=O)NC(=O)S3,,,,,,
474,130475,"(2S,4R)-4-(2H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid",C1CN[C@@H](C[C@@H]1CC2=NNN=N2)C(=O)O,,,,,,
475,130476,"(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S,3R)-2-acetamido-3-hydroxybutanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-N-[(2S)-5-amino-1-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]hexanamide",CCCC[C@@H](C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N)NC(=O)[C@H](CCCC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)C,,,,,,
476,130477,"5-((3-Bromo-2,6-dimethoxybenzamido)methyl)-5-hydroxy-2-pyrrolidone",COC1=C(C(=C(C=C1)Br)OC)C(=O)NCC2(CCC(=O)N2)O,,,,,,
477,130478,"5-(Diethylamino)-1-[4-[5-(diethylamino)-4,4-dimethyl-3-oxopent-1-enyl]phenyl]-4,4-dimethylpent-1-en-3-one;dihydrobromide",CCN(CC)CC(C)(C)C(=O)C=CC1=CC=C(C=C1)C=CC(=O)C(C)(C)CN(CC)CC.Br.Br,,,,,,
478,130479,"5-(Diethylamino)-1-[4-[5-(diethylamino)-4,4-dimethyl-3-oxopent-1-enyl]phenyl]-4,4-dimethylpent-1-en-3-one",CCN(CC)CC(C)(C)C(=O)C=CC1=CC=C(C=C1)C=CC(=O)C(C)(C)CN(CC)CC,,,,,,
479,130480,"1-(3,4-dihydro-2H-chromen-2-yl)-2-[[2-(3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol",C1CC2=CC=CC=C2OC1C(CNCC(C3CCC4=CC=CC=C4O3)O)O,,,,,,
480,130481,CID 130481,CC=C(C)C(C(C)C=C(C)C=CCC(C)(C=CC1=C(C(=O)C(=C(N1)OC)OC)C)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
481,130482,Malptll,CCOC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC,,,,,,
482,130483,CID 130483,CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCC=CC=C[C@@H]([C@@H](C2=CC(=CC=C2)C(F)(F)F)O)SC3=CC4=C(C=C3)C(=O)C=C(O4)C(=O)[O-].[Na+],,,,,,
483,130484,"7-[(1R,2S)-10-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-hydroxy-1-[3-(trifluoromethyl)phenyl]deca-3,5-dien-2-yl]sulfanyl-4-oxochromene-2-carboxylic acid",CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCC=CC=C[C@@H]([C@@H](C2=CC(=CC=C2)C(F)(F)F)O)SC3=CC4=C(C=C3)C(=O)C=C(O4)C(=O)O,,,,,,
484,130485,CID 130485,CCCCCCCCCC(=O)C1=C(OC(=C)C1=O)O,,,,,,
485,130486,CID 130486,C[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N,,,,,,
486,130487,Gro-pip,C(C(COP(=O)(O)OC1[C@H]([C@H](C([C@H]([C@@H]1O)O)OP(=O)(O)O)O)O)O)O,,,,,,
487,130488,"2,4(1H,3H)-Pyrimidinedione, 5,6-dihydro-6-(((1-methyl-2-phenylethyl)amino)methyl)-, monohydrochloride",CC(CC1=CC=CC=C1)NCC2CC(=O)NC(=O)N2.Cl,,,,,,
488,130489,"6-[(1-Phenylpropan-2-ylamino)methyl]-1,3-diazinane-2,4-dione",CC(CC1=CC=CC=C1)NCC2CC(=O)NC(=O)N2,,,,,,
489,130490,"6-t-Butyl-1,3,8-trichlorodibenzofuran",CC(C)(C)C1=CC(=CC2=C1OC3=C2C(=CC(=C3)Cl)Cl)Cl,,,,,,
490,130491,"6-Cyclohexyl-1,3,8-trichlorodibenzofuran",C1CCC(CC1)C2=CC(=CC3=C2OC4=C3C(=CC(=C4)Cl)Cl)Cl,,,,,,
491,130492,"6-Nitro-1,3,8-trichlorodibenzofuran",C1=C(C=C(C2=C1C3=C(O2)C=C(C=C3Cl)Cl)[N+](=O)[O-])Cl,,,,,,
492,130493,"1-(4-(4-Chloro-alpha,alpha-dimethylbenzyl)-2-methoxyphenyl)-1,2,4-triazole-3-carboxamide",CC(C)(C1=CC=C(C=C1)Cl)C2=CC(=C(C=C2)N3C=NC(=N3)C(=O)N)OC,,,,,,
493,130494,Acryloylproline methyl ester,COC(=O)[C@@H]1CCCN1C(=O)C=C,,,,,,
494,130495,CID 130495,CCC(CCO)(CNCCNCC(CC)(CCO)O)O,,,,,,
495,130496,N-Myristoyl-lysyl-arginyl-threonyl-leucyl-arginine,CCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
496,130497,5-Trifluoromethylthioribose,C(=S)[C@@H]([C@@H]([C@@H](C(C(F)(F)F)O)O)O)O,,,,,,
497,130498,Trimethylacetamidomethylcysteine,CC(C)(C)C(=O)NCN[C@@H](CS)C(=O)O,,,,,,
498,130499,CID 130499,[B+3].CN(C)C(=[N+](C)C)ON1C2=CC=CC=C2N=N1.[F-].[F-].[F-].[F-],,,,,,
499,130500,O-benzotriazol-1-yl-tetramethyluronium,CN(C)C(=[N+](C)C)ON1C2=CC=CC=C2N=N1,,,,,,
500,130501,"[(8S,10S,13S,14S)-17-ethanethioyl-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate",CC1C[C@H]2[C@@H]3CC(C4=CC(=O)C=C[C@@]4(C3(C(C[C@@]2(C1(C(=S)C)OC(=O)C)C)O)F)C)F,,,,,,
501,130502,N-(3-Pyridyl)-3-phenylsuccinimide,C1C(C(=O)N(C1=O)C2=CN=CC=C2)C3=CC=CC=C3,,,,,,
502,130503,CID 130503,CC(=CCC1=C(C(=CC(=C1)C2=COC3=CC(=O)C=C(C3=C2O)OC)O)O)C,,,,,,
503,130504,Hpatt,C1C=C2C3=CC=CC=C3C(=O)N2CC1(C4=CC=CC=C4)O,,,,,,
504,130505,"2,6-Dimethyl-4-(2-thiophen-2-ylethenyl)phenol",CC1=CC(=CC(=C1O)C)C=CC2=CC=CS2,,,,,,
505,130506,"4-[2-(4-Fluorophenyl)ethenyl]-2,6-dimethylphenol",CC1=CC(=CC(=C1O)C)C=CC2=CC=C(C=C2)F,,,,,,
506,130507,CID 130507,CC1=CC(=O)CC(C1(CC(=O)C(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=C=C2C(CC(CC2(C)O)O)(C)C)C)C)O)(C)C,,,,,,
507,130508,Cholecystokinin C-terminal flanking peptide,C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)OS(=O)(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)OS(=O)(=O)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N,,,,,,
508,130509,Lactoquinomycin B,CC1C(C(CC(O1)C2=C(C3=C(C=C2)C(=O)C45C6C(CC(=O)O6)OC(C4(C3=O)O5)C)O)N(C)C)O,,,,,,
509,130510,"alpha,alpha-Difluorothymidine",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)F)CO)O,,,,,,
510,130511,"Diglycidyl-(3-(3,3-bisphosphono-3-hydroxypropylamino)-2-hydroxypropyl)urazol",C1C(O1)CN2C(=O)N(C(=O)N2CC3CO3)CC(CNCCC(O)(P(=O)(O)O)P(=O)(O)O)O,,,,,,
511,130512,Omeprazole cyclic sulfenamide,C1C2=CC=CC=[N+]2C3=NC4=CC=CC=C4N3S1,,,,,,
512,130513,Antibiotic FR 900482,C1[C@@H]2[C@@H](N2)[C@]3([C@H](C4=C(N1O3)C=C(C=C4O)C=O)COC(=O)N)O,,,,,,
513,130514,N-Hydroxytryptacene,CC(C)(C)N(C1=CC2=C(C=C1)C3(C4=CC=CC=C4C2(C5=CC=CC=C53)OC)OC)O,,,,,,
514,130515,"2-[4-(Dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-1-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy-6,8-dihydroxy-3-methylbenzo[a]anthracene-7,12-dione",CC1C(C(CC(O1)C2=C(C3=C4C(=C(C=C3C=C2C)O)C(=O)C5=C(C4=O)C=CC=C5O)OC6CC(C(C(O6)C)O)N(C)C)N(C)C)O,,,,,,
515,130516,"1(2H)-Pyrimidinecarboxamide, 3,4-dihydro-N-(2-((2-(dimethylphenylsilyl)ethyl)thio)ethyl)-dioxo-5-fluoro-",C[Si](C)(CCSCCNC(=O)N1C=C(C(=O)NC1=O)F)C2=CC=CC=C2,,,,,,
516,130517,CID 130517,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N=C(C6=CC=C(C=C6)N[N+]#N)[O-])O,,,,,,
517,130518,CID 130518,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C6=CC=C(C=C6)N[N+]#N)O,,,,,,
518,130519,"(+-)-5-(3-Aminophenyl)-8-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepin-7-ol",CN1CCC2=CC(=C(C=C2C(C1)C3=CC(=CC=C3)N)O)Cl,,,,,,
519,130520,CID 130520,C[C@]1(CC[C@@H]2[C@@H]1[C@H]3[C@H](C3(C)C)[C@H](CC2=C)OC(=O)C=CC4=CC=CC=C4)O,,,,,,
520,130521,Guayulin D,C[C@]1(CC[C@@H]2[C@@H]1[C@H]3[C@H](C3(C)C)[C@H](CC2=C)OC(=O)C4=CC=C(C=C4)OC)O,,,,,,
521,130522,CID 130522,C1=CC(=C(C=C1N[N+]#N)I)[O-],,,,,,
522,130523,CID 130523,C1=CC(=C(C=C1N[N+]#N)I)O,,,,,,
523,130524,1'-Hydroxybenzbromarone,CC(C1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br)O,,,,,,
524,130525,Methylenemescaline trimer,COC1=CC(=CC(=C1OC)OC)CCN2CN(CN(C2)CCC3=CC(=C(C(=C3)OC)OC)OC)CCC4=CC(=C(C(=C4)OC)OC)OC,,,,,,
525,130526,"(4S)-4-amino-5-[[(2S)-1-[[(2S)-1-[[(2S)-2-[[(2S)-4-methyl-2-[[(2S)-pyrrolidine-2-carbonyl]amino]pentanoyl]amino]-4-methylsulfanylbutanoyl]-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-oxopentanoic acid",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N([C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)N)NC(=O)[C@@H]4CCCN4,,,,,,
526,130527,"(2R)-2-amino-3-(3,7,11-trimethyldodeca-2,6,10-trienylthio)propanoic acid methyl ester",CC(=CCCC(=CCCC(=CCSC[C@@H](C(=O)OC)N)C)C)C,,,,,,
527,130528,Bis(furan)lexitropsin,C1=C(OC(=C1)NC=O)C(=O)NC2=CC=C(O2)C(=O)NCCC(=N)N.Cl,,,,,,
528,130529,N-[5-[(3-amino-3-iminopropyl)carbamoyl]furan-2-yl]-5-formamidofuran-2-carboxamide,C1=C(OC(=C1)NC=O)C(=O)NC2=CC=C(O2)C(=O)NCCC(=N)N,,,,,,
529,130530,CID 130530,C[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
530,130531,"Somatostatin (7-10), desamino-trp",C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)CCC3=CC=CC=C3)O,,,,,,
531,130532,3-(1-Hydroxyheptyl)-4-(hydroxymethyl)oxolan-2-one,CCCCCCC(C1C(COC1=O)CO)O,,,,,,
532,130533,Unii-B43B1P643W,CC(=O)O[C@@H]1[C@@H](CC2=C(C=CC=C2N(C1=O)CCN(C)C)C(F)(F)F)C3=CC=C(C=C3)OC.Cl,,,,,,
533,130534,SQ-31765 free base,CC(=O)O[C@@H]1[C@@H](CC2=C(C=CC=C2N(C1=O)CCN(C)C)C(F)(F)F)C3=CC=C(C=C3)OC,,,,,,
534,130535,CID 130535,CCNC(=O)CNC(=O)C(=CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C,,,,,,
535,130536,11-Addtddo,CC1C(CC2=C(C3C(CC12C=C(C3O)C(C)C)CN)C)C(C)C,,,,,,
536,130537,3-[4-(Diethylamino)-2-hydroxyphenyl]-2-methylprop-2-enoic acid,CCN(CC)C1=CC(=C(C=C1)C=C(C)C(=O)O)O,,,,,,
537,130538,2-Hydroxyacetyl-7-acetylxanthone,CC(=O)C1=CC2=C(C=C1)OC3=C(C2=O)C=C(C=C3)C(=O)CO,,,,,,
538,130539,Neodarutoside,CC1(C2CCC3=CC(CCC3C2(CCC1O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C)(C)C(CO)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C,,,,,,
539,130540,"4-amino-1-[(2R,3S,4S)-2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]pyrimidin-2-one",C1[C@H]([C@@H]([C@@H](C1N2C=CC(=NC2=O)N)O)O)CO,,,,,,
540,130541,"alpha,2-Dimethyl-1,3-benzodioxole-5-ethanamine",CC1OC2=C(O1)C=C(C=C2)CC(C)N.Cl,,,,,,
541,130542,"3,4-Ethylidenedioxyamphetamine",CC1OC2=C(O1)C=C(C=C2)CC(C)N,,,,,,
542,130543,"alpha,2,2-Trimethyl-1,3-benzodioxole-5-ethanamine",CC(CC1=CC2=C(C=C1)OC(O2)(C)C)N.Cl,,,,,,
543,130544,"1-(2,2-Dimethyl-1,3-benzodioxol-5-yl)propan-2-amine",CC(CC1=CC2=C(C=C1)OC(O2)(C)C)N,,,,,,
544,130545,Pivenfrine,CC(C)(C)C(=O)OC1=CC=CC(=C1)C(CNC)O,,,,,,
545,130546,"4,5,6,7-Tetrahydroisoxazolo[3,4-c]pyridin-3-ol",C1CNCC2=C1C(=O)ON2,,,,,,
546,130547,2-(m-(o-Chlorophenoxy)phenyl)propionic acid,CC(C1=CC(=CC=C1)OC2=CC=CC=C2Cl)C(=O)O,,,,,,
547,130548,"Pyrrolo(2,3-b)indole, 6-bromo-3a-(1,1-dimethyl-2-propenyl)-1,2,3,3a,8,8a-hexahydro-1-methyl-8-(3-methyl-2-butenyl)-, cis-",CC(=CCN1[C@H]2[C@](CCN2C)(C3=C1C=C(C=C3)Br)C(C)(C)C=C)C,,,,,,
548,130549,Flustramine B,CC(=CC[C@]12CCN([C@H]1N(C3=C2C=CC(=C3)Br)CC=C(C)C)C)C,,,,,,
549,130550,4-Hydroxy-3-nitrophenylglyoxal,C1=CC(=C(C=C1C(=O)C=O)[N+](=O)[O-])O,,,,,,
550,130551,N-Acetyltyrosine 1-naphthyl ester,CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)OC2=CC=CC3=CC=CC=C32,,,,,,
551,130552,"2,4,6-Trimethyl-5-hydroxypyrimidine",CC1=C(C(=NC(=N1)C)C)O,,,,,,
552,130553,Diethylamine hydrogen sulfite,CCN(CC)OS(=O)O,,,,,,
553,130554,CID 130554,CCCCC(=O)[C@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CCCCCCCCC(=O)O)O)O)O,,,,,,
554,130555,CID 130555,C1=CC=C2C(=C1)C=C(C(=N2)S)N,,,,,,
555,130556,Proanthocyanidin B2,C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)O)O)O)C6=CC(=C(C=C6)O)O)O,,,,,,
556,130557,Icotidine hydrochloride,CC1=NC=C(C=C1)CC2=CN=C(NC2=O)NCCCCC3=C(C=CC=N3)OC.Cl.Cl.Cl,,,,,,
557,130558,Methyl 3-[(3-hydroxybenzoyl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate,CN1[C@@H]2CCC1CC(C2C(=O)OC)OC(=O)C3=CC(=CC=C3)O,,,,,,
558,130559,"4-Diazomethyl-N,N-dimethylbenzenesulfonamide",CN(C)S(=O)(=O)C1=CC=C(C=C1)C=[N+]=[N-],,,,,,
559,130560,Zincov,C[C@@H](C(=O)NCC(=O)N)NC(=O)C(CC(C)C)C(=O)NO,,,['Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)'],,,
560,130561,2-O-Glucopyranosylribitol-1-phosphate,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H](COP(=O)(O)O)[C@H]([C@H](CO)O)O)O)O)O)O,,,,,,
561,130562,"Dibenzo(b,f)thiepin-3-carboxylic acid, 5,5-dioxide",C1=CC=C2C(=C1)C=CC3=C(S2(=O)=O)C=C(C=C3)C(=O)O,,,,,,
562,130563,"N-(3,4-Dihydroxyphenyl)maleimide",C1=CC(=C(C=C1N2C(=O)C=CC2=O)O)O,,,['Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)'],,,
563,130564,Esomeprazole magnesium,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2],,,"['Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)', 'Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)']",,,
564,130565,Esomeprazole magnesium trihydrate,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.O.O.O.[Mg+2],,,,,,
565,130566,CID 130566,CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)CO.C(=CC(=O)O)C(=O)O,,,,,,
566,130567,1-[[5-(hydroxymethyl)-1H-indol-3-yl]methylideneamino]-2-pentylguanidine,CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)CO,,,,,,
567,130568,CID 130568,CS(=O)CC1NC=C(N1CS(=O)C)[N+](=O)[O-].C1=C(NC=N1)[N+](=O)[O-].[Cl-].[Cl-].[Ru+2],,,,,,
568,130569,CID 130569,CS(=O)CC1NC=C(N1CS(=O)C)[N+](=O)[O-],,,,,,
569,130570,1-Pmhbc,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(=O)OCC5=C6C=CC7=CC=CC8=C7C6=C(C=C8)C=C5,,,,,,
570,130571,"1,2-Bfpedp",C1=CC(=CC=C1C(C(C2=CC=C(C=C2)F)N)N)F.[Cl-].[Cl-].[Pt+2],,,,,,
571,130572,"1,2-Bis(4-fluorophenyl)ethane-1,2-diamine",C1=CC(=CC=C1C(C(C2=CC=C(C=C2)F)N)N)F,,,,,,
572,130573,Tetrapropylporphycene,CCCC1=CC2=NC1=CC=C3C(=CC(=N3)C4=CC(=C(N4)C=CC5=C(C=C2N5)CCC)CCC)CCC,,,,,,
573,130574,"(9S,12S,15S)-9-Amino-12-(2-amino-2-oxoethyl)-4-hydroxy-10,13-dioxo-2-oxa-11,14-diazatricyclo[15.2.2.13,7]docosa-1(19),3,5,7(22),17,20-hexaene-15-carboxylic acid",C1[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC2=CC=C(C=C2)OC3=C(C=CC1=C3)O)C(=O)O)CC(=O)N)N,,,,,,
574,130575,Of 4949-III,COC1=C2C=C(C[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC3=CC=C(O2)C=C3)C(=O)O)CC(=O)N)N)C=C1,,,,,,
575,130576,CID 130576,C#CCN(CC1CCC2=C(C1)C(=O)N=C(N2)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
576,130577,"4-((1,4,8,11-Tetraazacyclotetradec-1-yl)methyl)benzoic acid",C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)C(=O)O,,,,,,
577,130578,"N-[(2S,3R)-3-hydroxy-1-[[(5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]-1-oxobutan-2-yl]dodeca-2,4-dienamide",CCCCCCCC=CC=CC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H]1C[C@H](CCNC(=O)C=C[C@@H](NC1=O)C)O,,,,,,
578,130579,"1,5-Bis(oxiran-2-yl)pentane-1,2,3,4,5-pentol",C1C(O1)C(C(C(C(C(C2CO2)O)O)O)O)O,,,,,,
579,130580,"(8R,9S,13S,14S)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,6,17-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CC(C4=C3C=CC(=C4)O)O,,,,,,
580,130581,"3-[Bis(2-chloroethyl)amino]-1-(2-methoxyphenyl)pyrrolidine-2,5-dione",COC1=CC=CC=C1N2C(=O)CC(C2=O)N(CCCl)CCCl,,,,,,
581,130582,"3-[Bis(2-chloroethyl)amino]-1-(4-butoxyphenyl)pyrrolidine-2,5-dione",CCCCOC1=CC=C(C=C1)N2C(=O)CC(C2=O)N(CCCl)CCCl,,,,,,
582,130583,"5-(2,2-Difluorovinyl)-2'-deoxyuridine",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=C(F)F)CO)O,,,,,,
583,130584,"7-Methylpyrido(4,3-c)psoralen",CC1=C2C(=CC3=C1OC(=O)C4=C3C=NC=C4)C=CO2,,,,,,
584,130585,"(N-(4-Amino-4-deoxy-N(10)-methylpteroyl)amino)-3-chloro-4,5-dihydro-5-isoxazoleacetic acid",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H]([C@@H]4CC(=NO4)Cl)C(=O)O,,,"['Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Folic Acid Antagonists.)']",,,
585,130586,"1,2-(Palmitoyl-nbd-aminocaproyl)phosphatidylethanolamine",CCCCCCCCCCCCCCCC(=O)OC[C@@H](COP(=O)(O)OCCN)OC(=O)CCCCCNC1=CC=C(C2=NON=C12)[N+](=O)[O-],,,,,,
586,130587,3-Carbamyl-(3'-picolyl)-4-methoxy-1-benzamide,COC1=C(C=C(C=C1)C(=O)N)C(=O)NCC2=CN=CC=C2,,,,,,
587,130588,Diperdipine,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCN3CCCCC3)C)C,,,,,,
588,130589,CID 130589,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=O)C4=C3[O-])OS(=O)(=O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O.[Na+],,,,,,
589,130590,CID 130590,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=O)C4=C3O)OS(=O)(=O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O,,,,,,
590,130591,"1,N(2)-Ethenodeoxyguanosine",C1[C@@H]([C@H](O[C@@H]1N2C=NC3=C2NC4=NC=CN4C3=O)CO)O,,,,,,
591,130592,"4-[2-(3,5-Dimethoxyphenyl)ethenyl]-2-methoxyphenol",COC1=CC(=CC(=C1)C=CC2=CC(=C(C=C2)O)OC)OC,,,,,,
592,130593,"5-[2-(3,5-Dimethoxyphenyl)ethenyl]-2-methoxyphenol",COC1=C(C=C(C=C1)C=CC2=CC(=CC(=C2)OC)OC)O,,,,,,
593,130594,Nbd-colcemid,CN([C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC)C4=CC=C(C5=NON=C45)[N+](=O)[O-],,,,,,
594,130595,(2S)-2-[[(2S)-2-aminohexanoyl]amino]-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]pentanediamide,CCCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1C=NC=N1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N)N,,,,,,
595,130596,"2-(2-((2-Hydroxyethyl)amino)ethyl)-5-(2-((2-hydroxyethyl)aminoethyl)amino)anthra(1,9-cd)pyrazol-6(2H)one",C1=CC=C2C(=C1)C3=NN(C4=C3C(=C(C=C4)NCCNCCO)C2=O)CCNCCO.Cl.Cl,,,,,,
596,130597,"methyl 2-(3,6-diamino-4-iodo-9H-xanthen-9-yl)benzoate",COC(=O)C1=CC=CC=C1C2C3=C(C=C(C=C3)N)OC4=C2C=CC(=C4I)N,,,,,,
597,130598,Lu49888 HCl,CC(C)C(CCCN(C)CCC1=CC(=CC=C1)N=[N+]=[N-])(C#N)C2=CC(=C(C(=C2)OC)OC)OC.Cl,,,,,,
598,130599,"5-[2-(3-Azidophenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile",CC(C)C(CCCN(C)CCC1=CC(=CC=C1)N=[N+]=[N-])(C#N)C2=CC(=C(C(=C2)OC)OC)OC,,,,,,
599,130600,2-Methoxyisobutylisonitrile,CC(C)(C[N+]#[C-])OC,,,,,,
600,130601,"5,6-Dihydroxy-5,6-dihydro-2'-deoxyuridine",C1[C@@H]([C@H](O[C@H]1N2C(C(C(=O)NC2=O)O)O)CO)O,,,,,,
601,130602,CID 130602,C1CC(=O)N(C1=O)OC(=O)CCN=C(C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)N[N+]#N)I)[O-],,,,,,
602,130603,CID 130603,C1CC(=O)N(C1=O)OC(=O)CCNC(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)N[N+]#N)I,,,,,,
603,130604,7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine,C1CCN(C1)C2=NC(=NC3=C2N=C(C(=N3)NCC4=CC=CC=C4)Cl)N5CCNCC5,,,,,,
604,130605,CID 130605,C1=CC=C(C(=C1)C=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3NC(=NC4=O)N)O)OP(=O)(O)O,,,,,,
605,130606,N-(6-Methoxy-8-quinolyl)-4-toluenesulfonamide,CC1=CC=C(C=C1)S(=O)(=O)NC2=C3C(=CC(=C2)OC)C=CC=N3,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
606,130607,"2-[4-[(1S,2R)-1,2-diphenylbutyl]phenoxy]-N,N-dimethylethanamine",CC[C@@H](C1=CC=CC=C1)[C@@H](C2=CC=CC=C2)C3=CC=C(C=C3)OCCN(C)C,,,,,,
607,130608,CID 130608,COC1=C(C=CC(=C1)C=CC(=O)O[C@@H]([C@H](CO)O)[C@H](C=O)O)O,,,,,,
608,130609,"1-Methyl-4-(methylpyrrol-2-yl)-1,2,3,6-tetrahydropyridine",CN1CCC(=CC1)C2=CC=CN2C,,,,,,
609,130610,"1-[6-[5-[(3aS,4R,6aS)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid",C1[C@@H]2[C@@H]([C@H](S1)CCCCC(=O)NCCCCCC(=O)ON3C(=O)CC(C3=O)S(=O)(=O)O)NC(=O)N2,,,,,,
610,130611,Kifunensine,C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H]2N1C(=O)C(=O)N2)O)O)O)O,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
611,130612,CID 130612,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCC[C@]2(C=CC3=CC(=O)CCC3=C)O)C,,,,,,
612,130613,"8-Amino-6(N)-methyl-2-ribofuranosyl-1,2,3,5,6,7-hexaazaacenaphthylene",CN1C2=NC=NC3=C2C(=NN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(=N1)N,,,,,,
613,130614,Iodohydroxynitrobenzylthioinosine,C1=C(C=C(C(=C1CSC2=NC=NC3=C2N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)O)I)[N+](=O)[O-],,,,,,
614,130615,CID 130615,CCCCCCCCCCOC1=C2C3=C4C(=C(O2)O)C=C(C(=C4OC(=O)C3=CC1=O)O)O,,,,,,
615,130616,"1,1-Bis(4-(3-chloropropionyloxyphenyl))-2-phenylbut-1-ene",CCC(=C(C1=CC=C(C=C1)OC(=O)CCCl)C2=CC=C(C=C2)OC(=O)CCCl)C3=CC=CC=C3,,,,,,
616,130617,"1,1-Bis(4-(3-bromopropionyloxyphenyl))-2-phenylbut-1-ene",CCC(=C(C1=CC=C(C=C1)OC(=O)CCBr)C2=CC=C(C=C2)OC(=O)CCBr)C3=CC=CC=C3,,,,,,
617,130618,"1,1-Bis(4-(N,N-bis-2-chloroethylcarbamoyloxy)phenyl)-2-phenylbut-1-ene",CCC(=C(C1=CC=C(C=C1)OC(=O)N(CCCl)CCCl)C2=CC=C(C=C2)OC(=O)N(CCCl)CCCl)C3=CC=CC=C3,,,,,,
618,130619,"1,1-Bis(4-acryloyloxyphenyl)-2-phenylbut-1-ene",CCC(=C(C1=CC=C(C=C1)OC(=O)C=C)C2=CC=C(C=C2)OC(=O)C=C)C3=CC=CC=C3,,,,,,
619,130620,8-(2-Anthryl)octanoic acid,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)CCCCCCCC(=O)O,,,,,,
620,130621,"Phenol, 4-[(1Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-",CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCNC)C3=CC=CC=C3,,,,,,
621,130622,(3-Hexadecoxy-2-methoxy-2-methylpropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCOCC(C)(COP(=O)([O-])OCC[N+](C)(C)C)OC,,,,,,
622,130623,2-[(3-Hexadecoxy-2-methoxy-2-methylpropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCOCC(C)(COP(=O)(O)OCC[N+](C)(C)C)OC,,,,,,
623,130624,"2,3-Dihydrolinderazulene",CC1COC2=CC(=C3C=CC(=C3C=C12)C)C,,,,,,
624,130625,CID 130625,CCNC(=O)CC(SC)SC,,,,,,
625,130626,Diphenyl-1-pyrenylphosphine,C1=CC=C(C=C1)P(C2=CC=CC=C2)C3=C4C=CC5=CC=CC6=C5C4=C(C=C6)C=C3,,,,,,
626,130627,"N-(3,N'-Morpholinopropyl)-2-(3-nitropyrrolo-(2,3-b)pyridine-1-yl)ethanoic acid amide",C1COCCN1CCCNC(=O)CN2C=C(C3=C2N=CC=C3)[N+](=O)[O-],,,,,,
627,130628,3-Sulfoglucuronic acid,C(=O)[C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O)O)OS(=O)(=O)O)O,,,,,,
628,130629,"3-Hydroxy-3,4-dihydro-1H-benzo[g]isochromene-5,10-dione",C1C(OCC2=C1C(=O)C3=CC=CC=C3C2=O)O,,,,,,
629,130630,"1,2-Bis(methylsulfonyl)-1-methylhydrazine",CN(NS(=O)(=O)C)S(=O)(=O)C,,,,,,
630,130631,Taxamairin A,CC(C)C1=C(C(=C2C=C3C=CC(=O)C(C3=CC(=O)C2=C1)(C)C)O)OC,,,,,,
631,130632,Taxamairin B,CC(C)C1=C(C(=C2C=C3C=CC(=O)C(C3=CC(=O)C2=C1)(C)C)OC)OC,,,,,,
632,130633,Aabcap,CC(=O)N[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)CC5=CC=C(C=C5)N(CCCl)CCCl)C)C,,,,,,
633,130634,"2-Butyne-1,4-diamine, N,N'-bis(3-aminopropyl)-",C(CN)CNCC#CCNCCCN,,,,,,
634,130635,Aaceap,CC(=O)N[C@H]1CCC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(CC[C@@H](C4)OC(=O)CC5=CC=C(C=C5)N(CCCl)CCCl)C)C,,,,,,
635,130636,7-Aptadd,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)[C@@H](CC4=CC(=O)C=C[C@]34C)SC5=CC=C(C=C5)N,,,,,,
636,130637,"(4S,6R)-4-(3-carboxyoxy-3-oxopropyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid",C1[C@@H](N[C@H](C2=C1NC=N2)CCC(=O)OC(=O)O)C(=O)O,,,,,,
637,130638,"[(3R,4aS,5R,6R,6aR,10R,10aS,10bR)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] 4-(4-methylpiperazin-1-yl)butanoate",C[C@@]1(CC(=O)[C@]2([C@@]3([C@@H](CCC([C@H]3[C@H]([C@H]([C@@]2(O1)C)OC(=O)CCCN4CCN(CC4)C)O)(C)C)O)C)O)C=C,,,,,,
638,130639,"4-[5-({2-[4-(Diphenylmethoxy)piperidin-1-yl]ethyl}amino)-5-oxopenta-1,3-dien-1-yl]-2-methoxyphenyl ethyl carbonate",CCOC(=O)OC1=C(C=C(C=C1)C=CC=CC(=O)NCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4)OC,,,,,,
639,130640,2-(N-Nitroso-N-methylamino)propiophenone,CC(C(=O)C1=CC=CC=C1)N(C)N=O,,,,,,
640,130641,"1,3-di-(4(N-(4,6-dimethyl-2-pyrimidinyl))sulfamoylphenyl)triazene",CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)NN=NC3=CC=C(C=C3)S(=O)(=O)NC4=NC(=CC(=N4)C)C)C,,,,,,
641,130642,"1-(N-Aziridinyl)-6,7-bis(4-hydroxyphenyl)-5-nonanone",CCC(C1=CC=C(C=C1)O)[C@@H](C2=CC=C(C=C2)O)C(=O)CCCC[C@@H]3CN3,,,,,,
642,130643,Glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginine,CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN,,,,,,
643,130644,CID 130644,CN(C)C(=O)C=CC1=CN2C(C1)[C@H](NC3=C(C2=O)C=CC=C3OC)OC,,,,,,
644,130645,CID 130645,CN(C)C(=O)C=CC1=CN2C(C1)[C@H](NC3=C(C2=O)C=CC=C3OC)O,,,,,,
645,130646,CID 130646,C1=CC(=C(C=C1CC(=C(NCCSSCCNC(=C(CC2=CC(=C(C=C2)O)Br)N=O)O)O)N=O)Br)O,,,,,,
646,130647,CID 130647,CCCCCCCCCCCCCC=C[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)NC(=O)CCCCCCCCCC2=C3C=CC4=CC=CC5=C4C3=C(C=C5)C=C2)O,,,,,,
647,130648,CID 130648,CC(=CC1=CC=C(C=C1)O)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,,,,,,
648,130649,CID 130649,C1=CC=C(C=C1)N2C=NC3=C2C(=O)N=C(N3)N,,,,,,
649,130650,"(2S)-2-[[3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]-4-methylpentanoic acid",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)N[C@@H](CC(C)C)C(=O)O)C)C,,,,,,
650,130651,"13,14,17,19-Tetrahydroxy-7,10,12,19,20,24-hexamethyl-22-methylidene-9,27-dioxabicyclo[24.1.0]heptacosa-2,6,20-triene-8,15-dione",CC1CC2C(O2)C=CCCC=C(C(=O)OC(CC(C(C(C(=O)CC(CC(C(=CC(=C)C1)C)(C)O)O)O)O)C)C)C,,,,,,
651,130652,"2-[[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]acetic acid",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NCC(=O)O)C)C,,,,,,
652,130653,"(2R,4S)-2,4,5-trihydroxy-3,4-dihydro-2H-naphthalen-1-one",C1[C@@H](C2=C(C=CC=C2O)C(=O)[C@@H]1O)O,,,,,,
653,130654,"2,4,8-Trihydroxy-1-tetralone, cis-(-)-",C1[C@@H](C2=C(C(=CC=C2)O)C(=O)[C@@H]1O)O,,,,,,
654,130655,"N-pyridin-4-yl-2-(3,4,4-trimethyldioxetan-3-yl)acetamide",CC1(C(OO1)(C)CC(=O)NC2=CC=NC=C2)C,,,,,,
655,130656,4-Ethylaminoglutethimide,CC[C@@H]1CC(=O)NC(=O)[C@@]1(CC)C2=CC=C(C=C2)N,,,,,,
656,130657,4-Propylaminoglutethimide,CCC[C@@H]1CC(=O)NC(=O)[C@@]1(CC)C2=CC=C(C=C2)N,,,,,,
657,130658,Heptadecanoyl dihydroxyacetone phosphate,CCCCCCCCCCCCCCCCC(=O)OP(=O)(O)OC(C(=O)C)O,,,,,,
658,130659,Gemcitabine triphosphate,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)(F)F,,,,,,
659,130660,CID 130660,C1=CC2=NC3=C(C=CC4=C3C(=NN4CCNCCO)C2=CC1=O)N(O)O,,,,,,
660,130661,N-Demethyl-N-formyldehydronuciferine,COC1=C(C2=C3C(=C1)CCN(C3=CC4=CC=CC=C42)C=O)OC,,,,,,
661,130662,Dstbulet,C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O,,,,,,
662,130663,Tyrosyl-seryl(O-t-butyl)-glycyl-phenylalanyl-leucyl-threonine(O-t-butyl),C[C@H]([C@@H](C(=O)OC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O,,,,,,
663,130664,Panaxydol chlorohydrin,CCCCCCCC(C(CC#CC#CC(C=C)O)O)Cl,,,,,,
664,130665,CID 130665,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCCC2=NC3=C(C=C2)NC(=NC3=O)N,,,,,,
665,130666,CID 130666,C1CC2=C(C(=O)N=C(N2)N)N[C@H]1CCNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
666,130667,Glycyl-arginyl-glycyl-aspartyl-seryl-prolyl-lysine,C1C[C@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
667,130668,1-(2-Hydroxy-3-methyoxypropyl)-2-chloro-4-nitroimidazole,COCC(CN1C=C(N=C1Cl)[N+](=O)[O-])O,,,,,,
668,130669,"Naphtho[1,2-b]fluoranthene",C1=CC=C2C(=C1)C=CC3=C4C=CC=C5C4=C(C=C32)C6=CC=CC=C65,,,,,,
669,130670,"1,4-Dihydro-4-oxo-2,5,11-trimethyl-6H-pyrido(3,2-b)carbazole",CC1=CC(=O)C2=C(N1)C(=C3C4=CC=CC=C4NC3=C2C)C,,,,,,
670,130671,"2,6-Dimethyl-1,4-dihydropyridine-3,5-dicarboxylic hydroxyacetate",CC1=C(CC(=C(N1)C)C(=O)C(C(=O)O)O)C(=O)C(C(=O)O)O,,,,,,
671,130672,Darienine,CC1=C2C(=NC=C1)C3=C(C(=C(C=C3C2=O)O)OC)OC,,,,,,
672,130673,N-Acetylmuramyl-alanyl-isoglutaminyl-(3'-iodo-4'-azidophenylalanine) methyl ester,C[C@@H](C(=O)N[C@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC(=C(C=C1)N=[N+]=[N-])I)C(=O)OC)NC(=O)C(C)O[C@@H]2[C@H]([C@H](O[C@@H]([C@H]2O)CO)O)NC(=O)C,,,,,,
673,130674,1-Methyl-4-phenyl-5-nitrosoimidazole,CN1C=NC(=C1N=O)C2=CC=CC=C2,,,,,,
674,130675,CID 130675,C1=NN=C(S1)N=C=[N-].[Na+],,,,,,
675,130676,CID 130676,C1=NN=C(S1)N=C=N,,,,,,
676,130677,"6,6-Difluorospermidine",C(CN)CNCC(CCN)(F)F,,,,,,
677,130678,"6,6-Difluorospermine",C(CN)CNCCC(CNCCCN)(F)F,,,,,,
678,130679,Xanthoxylol,COC1=C(C=CC(=C1)C2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)O,,,,,,
679,130680,3-Hydroxyethyldeoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=CC(=O)N(C2=O)CCO)CO)O,,,,,,
680,130681,C-2 Triptofordin,CC(=O)O[C@@H]1[C@@H](C[C@@](C23[C@]1([C@@H]([C@@H]([C@H]([C@H]2OC(=O)C)C(O3)(C)C)OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)C)(C)O)O,,,,,,
681,130682,CID 130682,C[C@H]1[C@H]2[C@@H]3[C@@H](C[C@@H]4[C@@H]([C@H]3[C@H]([C@@H](CO1)OC2=O)O)[C@@](C(=O)C=C4C)(C)O)O,,,,,,
682,130683,CID 130683,CC1=C(OC2=C(C(=CC(=O)C2=C1O)OC)OC)C=CC3=CC(=CC(=C3)O)O,,,,,,
683,130684,CID 130684,C1[C@H](C(=N[C@@H]1C(=O)NC2=CNC(=C2)C(=O)N=CC=C(N)N)N)O,,,,,,
684,130685,18-Hydroxy-19-norcorticosterone,C1C[C@@H]([C@@]2([C@@H]1[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@H](C2)O)CO)C(=O)CO,,,,,,
685,130686,Desmethylnafoxidine aziridine,C1CC(=C(C2=C1C=C(C=C2)O)C3=CC=C(C=C3)OCCN4CC4)C5=CC=CC=C5,,,,,,
686,130687,CID 130687,CCCCCCCCCCCCCC=C[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)NC(=O)CCCCCCCCCCCC2=C3C=CC4=CC=CC5=C4C3=C(C=C5)C=C2)OS(=O)(=O)O,,,,,,
687,130688,CID 130688,C[C@H](C1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C)OCCC(C)C,,,,,,
688,130689,Methyl prednisolone-16alpha-carboxylate,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)C(=O)OC)CCC4=CC(=O)C=C[C@]34C)O,,,,,,
689,130690,"3-Bis((2-chloroethyl)amino)methyl-1,8-dihydroxy-9,10-anthraquinone",C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)CN(CCCl)CCCl,,,,,,
690,130691,Bnadd,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NCCCCCCCCCCCCNC4=C5C(=NC=N4)N(C=N5)[C@H]6[C@@H]([C@@H]([C@H](O6)CO)O)O,,,,,,
691,130692,4'-Iododoxorubicinol,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)N)I,,,,,,
692,130693,"3,4-Dihydroxy-3,4-dihydro-7-ethylbenz(a)anthracene",CCC1=C2C=CC3=C(C2=CC4=CC=CC=C41)C=C[C@@H]([C@H]3O)O,,,,,,
693,130694,N-Hydroxy-2-glycolylaminofluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)N(C(=O)CO)O,,,,,,
694,130695,4-(3-(2-Hydroxy-2-phenyl)ethylamino-3-methylbutyl)benzamide,CC(C)(CCC1=CC=C(C=C1)C(=O)N)NC[C@@H](C2=CC=CC=C2)O,,,,,,
695,130696,"(11beta,17beta)-11-Fluoro-17-hydroxyandrostan-3-one",C[C@]12CCC(=O)CC1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4O)C)F,,,,,,
696,130697,"(11beta,17beta)-11-Fluoro-17-hydroxyestran-3-one",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4[C@@H]3CCC(=O)C4)F,,,,,,
697,130698,Ethyleneglycol bis(succinimidyl succinate)hydroxyethylethylenediamine triacetic acid,C1=CC(=CC=C1C[C@@H](CN(CCO)CC(=O)O)N(CC(=O)O)CC(=O)O)NC(=O)CNC(=O)CCC(=O)OCCOC(=O)CCC(=O)N2C(=O)C=CC2=O,,,,,,
698,130699,"4,7-Bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid",C1=CC(=C(C(=C1)Cl)S(=O)(=O)O)C2=CC(=NC3=C2C=CC4=C3N=C(C=C4C5=C(C(=CC=C5)Cl)S(=O)(=O)O)C(=O)O)C(=O)O,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
699,130700,ethyl (2S)-2-[[(2S)-2-[[(2S)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]propanoate,CCOC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)CC(=O)NO,,,,,,
700,130701,"7-((N-4-Aminobutyl)-N-ethyl)aminonaphthalene-1,2-dicarboxylic acid hydrazide",CCN(CCCCN)C1=CC2=C(C=C1)C=CC(=C2C(=O)NN)C(=O)NN,,,,,,
701,130702,"4-methyl-3-[4-(4-oxopyridin-1-yl)phenyl]-4,5-dihydro-1H-pyridazin-6-one",CC1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CC(=O)C=C3,,,,,,
702,130703,6-Chloro-2-phenylquinolin-4-ol,C1=CC=C(C=C1)C2=CC(=O)C3=C(N2)C=CC(=C3)Cl,,,,,,
703,130704,"(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2R)-3-[2,3-di(hexadecanoyloxy)propylsulfanyl]-2-(hexadecanoylamino)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoic acid",CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
704,130705,"6H-Indolo(2,3-b)quinoxaline-6-ethanamine, N,N,2,3-tetramethyl-",CC1=CC2=C(C=C1C)N=C3C(=N2)C4=CC=CC=C4N3CCN(C)C,,,,,,
705,130706,"(2,5-Dioxopyrrolidin-1-yl) 4-[1-(pyridin-2-yldisulfanyl)ethyl]benzoate",CC(C1=CC=C(C=C1)C(=O)ON2C(=O)CCC2=O)SSC3=CC=CC=N3,,,,,,
706,130707,"Dithiobis(ethylmethylamidoethylmethylaminomethyl-2,5,9-trimethylpsoralen)",CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)CN(C)CCN(C)C(=O)CCSSCCC(=O)N(C)CCN(C)CC4=C(OC5=C4C=C6C(=CC(=O)OC6=C5C)C)C)C,,,,,,
707,130708,Inmecarb,CC1=C(N(C2=C1C=C(C=C2)C(=O)OCCN(C)C)CC3=CC=CC=C3)C.Cl,,,,,,
708,130709,Eumaitenine,C[C@@H]1CC[C@@H]([C@@]2([C@@]13[C@@H]([C@@H](C([C@@H]2OC(=O)C4=COC=C4)OC(=O)C)C(O3)(C)C)OC(=O)C)C)OC(=O)C,,,,,,
709,130710,1-Octanoyl-2-acetylglycerol,CCCCCCCC(=O)OCC(CO)OC(=O)C,,,,,,
710,130711,4-[2-Bromo-1-(4-hydroxyphenyl)-2-phenylethyl]phenol,C1=CC=C(C=C1)C(C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)Br,,,,,,
711,130712,5'-Difluoromethylthio-5'-deoxyadenosine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C(C(F)F)S)O)O)N,,,,,,
712,130713,"5-Amino-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid",C1CC1N2C=C(C(=O)C3=C(C(=C(C(=C32)F)N4CCC(C4)N)F)N)C(=O)O,,,,,,
713,130714,"4-Amino-alpha,alpha-dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol",CC(C)(CN1C=NC2=C1C3=CC=CC=C3N=C2N)O,,,,,,
714,130715,N-Methyl-N-(1-acetoxy-2-oxopropyl)nitrosamine,CC(=O)C(N(C)N=O)OC(=O)C,,,,,,
715,130716,N-Succinimidyl-3-(tri-n-butylstannyl)benzoate,CCCC[Sn](CCCC)(CCCC)C1=CC=CC(=C1)C(=O)ON2C(=O)CCC2=O,,,,,,
716,130717,Sand-PR,C1C(C(=O)N(C1=O)OC(=O)CCSSCCNC(=O)C2=C(C=CC(=C2)N=[N+]=[N-])[N+](=O)[O-])S(=O)(=O)[O-].[Na+],,,,,,
717,130718,CID 130718,C1C(C(=O)N(C1=O)OC(=O)CCSSCCNC(=O)C2=C(C=CC(=C2)N[N+]#N)[N+](=O)[O-])S(=O)(=O)O,,,,,,
718,130719,CID 130719,C1=CC=C(C=C1)N=C(C(P(=O)(O)[O-])P(=O)(O)[O-])S.[Na+].[Na+],,,,,,
719,130720,CID 130720,C1=CC=C(C=C1)N=C(C(P(=O)(O)O)P(=O)(O)O)S,,,,,,
720,130721,CID 130721,CC1=NC(=O)C2=C(N1)C=CC(=C2)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
721,130722,CID 130722,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(CC#C)C3=CC(=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(F)(F)F,,,,,,
722,130723,(3S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-4-oxo-4-sulfooxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid,CCCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(=O)OS(=O)(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)NC(=O)[C@H](CC(=O)O)NC(=O)OC(C)(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
723,130724,[2-(Octadecoxymethyl)oxolan-2-yl]methyl 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCCCOCC1(CCCO1)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
724,130725,2-[Hydroxy-[[2-(octadecoxymethyl)oxolan-2-yl]methoxy]phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCOCC1(CCCO1)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
725,130726,"3-(Dimethylamino)propyl naphtho(2,1-b)thiophene-4-carboxylate",CN(C)CCCOC(=O)C1=CC2=CC=CC=C2C3=C1SC=C3,,,,,,
726,130727,"1-(3,5-Dichloro-2,6-dihydroxy-4-methoxyphenyl)pentan-1-one",CCCCC(=O)C1=C(C(=C(C(=C1O)Cl)OC)Cl)O,,,,,,
727,130728,CID 130728,C1=CN=C([N-]1)C=NCCCCN=CC2=NC=C[N-]2.[Cu+2],,,,,,
728,130729,1-(1H-imidazol-2-yl)-N-[4-(1H-imidazol-2-ylmethylideneamino)butyl]methanimine,C1=CN=C(N1)C=NCCCCN=CC2=NC=CN2,,,,,,
729,130730,Sdrnflrfamide,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N,,,,,,
730,130731,Talotrexin,C1=CC=C(C(=C1)C(=O)NCCC[C@@H](C(=O)O)NC(=O)C2=CC=C(C=C2)NCC3=CN=C4C(=N3)C(=NC(=N4)N)N)C(=O)O,"['Investigated for use/treatment in solid tumors, lung cancer, leukemia (unspecified), and leukemia (lymphoid).']",,,,,
731,130732,1-O-Octadecyl-2-O-methylglycerol-3-glucopyranoside,CCCCCCCCCCCCCCCCCCOCC(CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)OC,,,,,,
732,130733,4-(4-dihexadecylamino-styryl)-N-methylpyridinium iodide,CCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCC)C1=CC=C(C=C1)C=CC2=CC=[N+](C=C2)C.[I-],,,,,,
733,130734,"Pyridinium, 4-[2-[4-(dihexadecylamino)phenyl]ethenyl]-1-methyl-",CCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCC)C1=CC=C(C=C1)C=CC2=CC=[N+](C=C2)C,,,,,,
734,130735,2-Amino-3-methyl-5-phenylpyridine,CC1=CC(=CN=C1N)C2=CC=CC=C2,,,,,,
735,130736,"7-[4-(Dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienoic acid",CC(C=C(C)C=CC(=O)O)C(=O)C1=CC=C(C=C1)N(C)C,,,,,,
736,130737,"(4S,6R)-2-oxo-6-(sulfanylmethyl)-1,3-diazinane-4-carboxylic acid",C1[C@@H](NC(=O)N[C@@H]1C(=O)O)CS,,,,,,
737,130738,"3,26-Dihydroxycholest-8(14)-en-15-one",C[C@H](CCCC(C)CO)[C@H]1CC(=O)C2=C3CC[C@H]4C[C@H](CC[C@@]4([C@H]3CC[C@]12C)C)O,,,,,,
738,130739,"1-(2-Chloro-3,5-dimethoxyphenyl)-2-(4-fluorophenyl)-3-methyl-6-phenyl-4(1H)-pyridinone",CC1=C(N(C(=CC1=O)C2=CC=CC=C2)C3=C(C(=CC(=C3)OC)OC)Cl)C4=CC=C(C=C4)F,,,,,,
739,130740,6-Purinyl 6-deoxy-1-thioglucopyranoside,C[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)SC2=NC=NC3=C2NC=N3)O)O)O,,,,,,
740,130741,N-Nitrosodithiazine,C1N(CSCS1)N=O,,,,,,
741,130742,CID 130742,CC(=O)[NH2+][C@@H](CS1CC1)C(=O)OC.[O-]Cl(=O)(=O)=O,,,,,,
742,130743,CID 130743,CC(=O)N[C@@H](CS1CC1)C(=O)OC,,,,,,
743,130744,CID 130744,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)S)F)COP(=O)([O-])[O-])O,,,,,,
744,130745,CID 130745,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)S)F)COP(=O)(O)O)O,,,,,,
745,130746,"3,4-Dihydrodihydroxydibenz(a,j)anthracene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C5=C(C=C4)[C@@H]([C@H](C=C5)O)O,,,,,,
746,130747,"3,4-Dddba",CC1=C2C=CC3=CC=CC=C3C2=C(C4=C1C=CC5=C4C=C[C@@H]([C@H]5O)O)C,,,,,,
747,130748,CID 130748,C[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(NC2=O)(NOP(=O)(O)O)O)F)O,,,,,,
748,130749,"8,13-Epoxy-6-beta-(piperidinoacetoxy)-1-alpha,7-beta,9-alpha-trihydroxy-labd-14-en-11-one HCl",C[C@@]1(CC(=O)[C@@]2([C@]3([C@H](CCC([C@@H]3[C@@H]([C@@H]([C@]2(O1)C)O)OC(=O)CN4CCCCC4)(C)C)O)C)O)C=C.Cl,,,,,,
749,130750,"6beta-(Piperidinoacetyloxy)-1alpha,7beta,9-trihydroxy-8,13-epoxylabd-14-en-11-one",C[C@@]1(CC(=O)[C@@]2([C@]3([C@H](CCC([C@@H]3[C@@H]([C@@H]([C@]2(O1)C)O)OC(=O)CN4CCCCC4)(C)C)O)C)O)C=C,,,,,,
750,130751,"9,10-Dihydro-5,9,10-trihydroxybenzo(b)fluoranthene",C1=CC2=C3C(=C1)C4=C(C3=CC5=C2C=C[C@@H]([C@H]5O)O)C=CC(=C4)O,,,,,,
751,130752,"9,10-Dihydro-6,9,10-trihydroxybenzo(b)fluoranthene",C1=CC2=C3C(=C1)C4=C(C3=CC5=C2C=C[C@@H]([C@H]5O)O)C=C(C=C4)O,,,,,,
752,130753,CID 130753,C[C@H](CC(CC(C(F)(F)F)(C(F)(F)F)O)O)[C@H]1CCC2[C@@]1(CCCC2=CC=C3C[C@H](CC(C3=C)O)O)C,,,,,,
753,130754,5-(N-Hexadecanoyl)aminoeosin,CCCCCCCCCCCCCCCC(=O)NC1=CC2=C(C=C1)C3(C4=CC(=C(C(=C4OC5=C(C(=C(C=C53)Br)O)Br)Br)O)Br)OC2=O,,,,,,
754,130755,"3-(3-Hydroxy-4-methoxynaphthalen-1-yl)oxypropane-1,2-diol",COC1=C(C=C(C2=CC=CC=C21)OCC(CO)O)O,,,,,,
755,130756,"1-Chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol",CCCCCCCC1C(O1)CC#CC#CC(C(CCl)O)O,,,,,,
756,130757,"cis-(+)-4a,5,6,12b-Tetrahydro-4a,8-dihydroxy-3-methylbenz(a)anthracene-1,7,12(4H)-trione",CC1=CC(=O)[C@@H]2C3=C(CC[C@@]2(C1)O)C(=O)C4=C(C3=O)C=CC=C4O,,,,,,
757,130758,2-Methyl-6-propylellipticinium acetate,CCC[NH+]1C2C(=C3C=CN(C=C3C(=C2C4=CC=CC=C41)C)C)C.CC(=O)[O-],,,,,,
758,130759,"2,5,11-trimethyl-6-propyl-5aH-pyrido[4,3-b]carbazole",CCCN1C2C(=C3C=CN(C=C3C(=C2C4=CC=CC=C41)C)C)C,,,,,,
759,130760,Methyldeoxyspergualin,CO[C@@H](C(=O)NCCCCNCCCN)NC(=O)CCCCCCN=C(N)N,,,,,,
760,130761,"5-(2,2-Diphenylacetyl)-4-[(4-methoxy-3-methylphenyl)methyl]-1,4,6,7-tetrahydroimidazo[4,5-c]pyridine-6-carboxylic acid",CC1=C(C=CC(=C1)CC2C3=C(CC(N2C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)O)NC=N3)OC,,,,,,
761,130762,"4'-((2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid",CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C(=O)O)CO)Cl,,,,,,
762,130763,2-Amino-2-(4-iodophenyl)acetic acid,C1=CC(=CC=C1C(C(=O)O)N)I,,,,,,
763,130764,"2-Oxo-1,3-diazinane-4,6-dicarboxylic acid",C1C(NC(=O)NC1C(=O)O)C(=O)O,,,,,,
764,130765,"3-(4-hydroxy-3-iodophenyl)-N-[3-[(8-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-propylamino]propyl]propanamide",CCCN(CCCNC(=O)CCC1=CC(=C(C=C1)O)I)C2CCC3=C(C2)C(=CC=C3)OC,,,,,,
765,130766,Carbathymidine,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](C2)O)CO,,,,,,
766,130767,"2,5-Dioxopyrrolidin-1-YL 4-(pyren-1-YL)butanoate",C1CC(=O)N(C1=O)OC(=O)CCCC2=C3C=CC4=CC=CC5=C4C3=C(C=C5)C=C2,,,,,,
767,130768,CID 130768,CCCCCSCS(=O)C[C@H](CO)NC(=O)C=CC1=CNC(=O)NC1=O,,,,,,
768,130769,9-Hydroxybenfluron,CN(C)CCOC1=CC2=C(C3=C(C2=O)C=C(C=C3)O)C4=CC=CC=C41,,,,,,
769,130770,"1,3-Bis(4-amidinophenoxy)-2-(4-amidinophenoxymethyl)ethylpropane",CCC(C(COC1=CC=C(C=C1)C(=N)N)COC2=CC=C(C=C2)C(=N)N)OC3=CC=C(C=C3)C(=N)N,,,,,,
770,130771,CID 130771,C1=CC=C(C=C1)C(=NNC(=NCCCN)N)C(F)F,,,,,,
771,130772,4-(1-(Aminomethyl)-2-propynyl)phenol,C#CC(CN)C1=CC=C(C=C1)O,,,,,,
772,130773,"5-(4-(9-Fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxyphenoxy)valeric acid",COC1=CC(=CC(=C1CNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)OC)OCCCCC(=O)O,,,,,,
773,130774,Dercitin,CN1C=CC2=C3C1=C4C(=C(C3=NC5=CC=CC=C25)CCN(C)C)N=CS4,,,,,,
774,130775,Azepinomycin 3-ribofuranoside,C1C(NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
775,130776,N-Acetoxy-N-glycolyl-2-aminofluorene,CC(=O)ON(C1=CC2=C(C=C1)C3=CC=CC=C3C2)C(=O)CO,,,,,,
776,130777,CID 130777,CCCCC1CCC(C1)C(C=CC2C(CC(=O)C2CCCCCCC(=O)NC(CC(C)C)C(=O)N)O)O,,,,,,
777,130778,"18,19-Dihydroxycorticosterone",C1C[C@@H]([C@@]2([C@@H]1[C@@H]3CCC4=CC(=O)CC[C@@]4([C@H]3[C@H](C2)O)CO)CO)C(=O)CO,,,,,,
778,130779,7-Ethoxy-4-trifluoromethylcoumarin,CCOC1=CC2=C(C=C1)C(=CC(=O)O2)C(F)(F)F,,,,,['7-Ethoxy-4-trifluoromethylcoumarin has known human metabolites that include 7-Hydroxy-4-trifluoromethylcourmarin.'],
779,130780,Bis(4-hydroxyphenyl)(2-(phenoxysulfonyl)phenyl)methane,C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC=C2C(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,,,,,,
780,130781,CID 130781,CC(CCCC(C(C)(C)O)(F)F)C1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,,,,,,
781,130782,7-Chloro-4-nitrobenzofuran,C1=CC(=C2C(=C1[N+](=O)[O-])C=CO2)Cl,,,,,,
782,130783,2'-Methyl-2'-deoxycytidine,C[C@@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O,,,,,,
783,130784,CID 130784,C1[C@@H](CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
784,130785,3-(Pyridin-2-yldisulfanyl)propanehydrazide,C1=CC=NC(=C1)SSCCC(=O)NN,,,,,,
785,130786,"2,3-Dihydro-5-(4-(1-piperidinylmethyl)phenyl)imidazo(2,1-a)isoquinoline dihydrochloride",C1CCN(CC1)C2=CC=C(C=C2)C3=CC4=CC=CC=C4C5=NCCN35.Cl.Cl,,,,,,
786,130787,"5-(4-Piperidin-1-ylphenyl)-2,3-dihydroimidazo[2,1-a]isoquinoline",C1CCN(CC1)C2=CC=C(C=C2)C3=CC4=CC=CC=C4C5=NCCN35,,,,,,
787,130788,CID 130788,C(CC(=O)N[C@@](CS)(C(=C(C(=C([C@@](CS)(C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)Cl)Cl)Cl)Cl)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
788,130789,"1,4-(Bis-cystein-S-yl)-1,2,3,4-tetrachloro-1,3-butadiene",C([C@@H](C(=O)O)N)SC(=C(C(=C(SC[C@@H](C(=O)O)N)Cl)Cl)Cl)Cl,,,,,,
789,130790,CID 130790,C[C@@H](C1=C2C(=CC=C1)N=C3C(=N2)C=CC=C3C(=O)O)OC(=O)C(CO)(OC)OC,,,,,,
790,130791,"[(2R,3S,4R,5R)-5-[6-amino-8-(4-bromo-2,3-dioxobutyl)sulfanylpurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",C1=NC(=C2C(=N1)N(C(=N2)SCC(=O)C(=O)CBr)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
791,130792,"6-Methyl-4,5,5a,6,7,8-hexahydrothiazolo(4,5-f)quinolin-2-amine",CN1CCC=C2C1CCC3=C2N=C(S3)N,,,,,,
792,130793,"4,5-Dihydrothiazolo(4,5-f)quinolin-2-amine",C1CC2=C(C3=C1N=CC=C3)N=C(S2)N,,,,,,
793,130794,CID 130794,C#CCN(CC1=CC2=C(NC(=NC2=O)N)N=C1)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
794,130795,CID 130795,CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1NC4=NC5=C(N4[C@H]6C[C@@H]([C@H](O6)CO)O)NC(=NC5=O)N,,,,,,
795,130796,Picrocrocin,CC1=C(C(C[C@@H](C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)(C)C)C=O,,,,,,
796,130797,N-(2-Amidinoethyl)-5-imino-2-pyrrolidinecarboxamide,C1CC(=N[C@@H]1C(=O)NCCC(=N)N)N,,,,,,
797,130798,"3,12-Diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane",C1C[N+]2(CCN1)CC[N+]3(CCNCC3)CC2,,,,,,
798,130799,"Indeno[1,7-ab]pyrene",C1=CC2=C3C(=C1)C=CC4=C5C=CC6=C5C(=CC=C6)C(=C43)C=C2,,,,,,
799,130800,"7H-Pyrido[4,3-c]carbazole",C1=CC=C2C(=C1)C3=C(N2)C=CC4=C3C=NC=C4,,,,,,
800,130801,17H-cyclopenta[a]phenanthrene,C1C=CC2=C1C=CC3=C2C=CC4=CC=CC=C43,,,,,,
801,130802,"5H-Pyrido[4,3-b]indole",C1=CC=C2C(=C1)C3=C(N2)C=CN=C3,,,,,,
802,130803,3-Aminochrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C=C(C=C4)N,,,,,,
803,130804,2-Nonyl-4-hydroxyquinoline N-oxide,CCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1O,,,,,,
804,130805,5'-phosphoribosyl-N-formylglycinamide,C([C@@H]1[C@H]([C@H]([C@@H](O1)NC(=O)CNC=O)O)O)OP(=O)(O)O,,,,,,
805,130806,"Pregna-4,9(11)-diene-3,20-dione, 6-fluoro-17,21-dihydroxy-16-methyl-, (6alpha,16alpha)-",C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)CC[C@@]4(C3=CC[C@@]2([C@]1(C(=O)CO)O)C)C)F,,,,,,
806,130807,CID 130807,CC[C@H](C)[C@@H](C(=O)OOC[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(=O)NC2=O)C)N=[N+]=[N-])N,,,,,,
807,130808,CID 130808,COC1=C(C=CC(=C1)NS(=O)(=O)C)[N-]C2=C3C=CC(=CC3=NC4=CC=CC=C42)N[N+]#N,,,,,,
808,130809,CID 130809,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC(=CC3=NC4=CC=CC=C42)N[N+]#N,,,,,,
809,130810,4-[4-(4-Chlorophenyl)pyridin-1-ium-1-yl]-1-(2-fluorophenyl)butan-1-one,C1=CC=C(C(=C1)C(=O)CCC[N+]2=CC=C(C=C2)C3=CC=C(C=C3)Cl)F,,,,,,
810,130811,1-(3-Fluorophenyl)cyclohexanecarboxamide,C1CCC(CC1)(C2=CC(=CC=C2)F)C(=O)N,,,,,,
811,130812,CID 130812,C[C@H](C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F)N=C=O,,,,,,
812,130813,"N-(2-(3,4-Dimethoxyphenyl)ethyl)-N-(1,3,4,5-tetrahydro-7,8-dimethoxy-3-benzazepin-2-on-3-yl)-N,N-dimethylammonium iodide",C[N+](C)(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CCC3=CC(=C(C=C3)OC)OC.[I-],,,,,,
813,130814,"3-[(2,3,4,5-Tetrahydro-7,8-dimethoxy-2-oxo-1H-3-benzazepin)-3-yl]-N-[2-(3,4-dimethoxyphenyl)ethyl]-N,N-dimethyl-1-propanaminium",C[N+](C)(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CCC3=CC(=C(C=C3)OC)OC,,,,,,
814,130815,"trans-1,2-Dihydroxy-1,2-dihydrobenzo(b)naphtho(2,1-d)thiophene",C1=CC=C2C(=C1)C3=C(S2)C4=C(C=C[C@@H]([C@H]4O)O)C=C3,,,,,,
815,130816,Leucyl-aspartyl-valine,CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N,,,,,,
816,130817,"1-Ethyl-1,4 dihydro-7-methyl-4-oxo-1,8-naphthyridine dimer",CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C3=CC(=O)C4=C(N3CC)N=C(C=C4)C,,,,,,
817,130818,"5,7-Dinitroquinoxaline-2,3-dione",C1=C(C=C(C2=NC(=O)C(=O)N=C21)[N+](=O)[O-])[N+](=O)[O-],,,,,,
818,130819,"1-Methyl-4-benzyl-1,2,3,6-tetrahydropyridine",CN1CCC(=CC1)CC2=CC=CC=C2.Cl,,,,,,
819,130820,"4-Benzyl-1-methyl-1,2,3,6-tetrahydropyridine",CN1CCC(=CC1)CC2=CC=CC=C2,,,,,,
820,130821,"Phosphonic acid, (1-hydroxy-3-(1-pyrrolidinyl)propylidene)bis-, disodium salt",C1CCN(C1)CCC(O)(P(=O)(O)O)P(=O)([O-])[O-].[Na+].[Na+],,,,,,
821,130822,(1-Hydroxy-1-phosphono-3-pyrrolidin-1-ylpropyl)phosphonic acid,C1CCN(C1)CCC(O)(P(=O)(O)O)P(=O)(O)O,,,,,,
822,130823,"4-[3-(3,5-Bistrimethysilylphenyl)-3-oxo-1-propenyl]benzoic Acid",C[Si](C)(C)C1=CC(=CC(=C1)C(=O)C=CC2=CC=C(C=C2)C(=O)O)[Si](C)(C)C,,,,,,
823,130824,"4-[3-(3,5-Bistrimethylgermylphenyl)-3-oxo-1-propenyl]benzoic Acid",C[Ge](C)(C)C1=CC(=CC(=C1)C(=O)C=CC2=CC=C(C=C2)C(=O)O)[Ge](C)(C)C,,,,,,
824,130825,CID 130825,C1=NC2=C(N1CCF)C(=O)N=C(N2)N,,,,,,
825,130826,CID 130826,C1=CC(=CC=C1CCCC2=CN=C3C2=C(NC(=N3)N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
826,130827,"3H-Pyrrolo(3,2,1-ij)quinazolin-3-one, 5,6-dihydro-6-methyl-1-phenyl-",CC1CN2C3=C(C=CC=C13)C(=NC2=O)C4=CC=CC=C4,,,,,,
827,130828,"2,3,4,5-Tetrahydro-3-methyl-6-(phenylthio)-1H-3-benzazepine-7,8-diol",CN1CCC2=CC(=C(C(=C2CC1)SC3=CC=CC=C3)O)O,,,,,,
828,130829,O-Demethyltramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)O)O,,,"['Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,"['O-desmethyl-tramadol has known human metabolites that include (2S,3S,4S,5R,6S)-6-[3-[(1R,2R)-2-[(Dimethylazaniumyl)methyl]-1-hydroxycyclohexyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylate.']",
829,130830,Oxonorfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNC(=O)C3)F)C(=O)O,,,,,,
830,130831,"1,1',7,7'-Tetrakis(acetyloxy)-6,6'-dihydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-(2,2'-binaphthalene)-8,8'-dicarboxaldehyde",CC1=CC2=C(C(=C(C(=C2C(C)C)O)OC(=O)C)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)OC(=O)C)O)C(C)C)OC(=O)C)OC(=O)C,,,,,,
831,130832,Sila-rythmol,C[Si](C)(C1=CC=CC=C1)C2=CC(=C(C(=C2)CN3CCCCC3)O)CN4CCCCC4.Br.Br,,,,,,
832,130833,"4-[Dimethyl(phenyl)silyl]-2,6-bis(piperidin-1-ylmethyl)phenol",C[Si](C)(C1=CC=CC=C1)C2=CC(=C(C(=C2)CN3CCCCC3)O)CN4CCCCC4,,,,,,
833,130834,N-Acetyl-S-(1-phenyl-3-hydroxypropyl)cysteine,CC(=O)N[C@@H](CSC(CCO)C1=CC=CC=C1)C(=O)O,,,,,,
834,130835,N-Acetyl-S-(1-phenyl-2-carboxyethyl)cysteine,CC(=O)NC(CSC(CC(=O)O)C1=CC=CC=C1)C(=O)O,,,,,,
835,130836,"[(2S,3S,5S,10S,13S,16S,17R)-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-3-oxidanyl-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] ethanoate",CC(=O)O[C@H]1[C@H](CC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCCCC5)C)C)[N+]6(CCCCC6)C,,,,,,
836,130837,1-[3-(Trifluoromethyl)phenyl]butan-2-amine,CCC(CC1=CC(=CC=C1)C(F)(F)F)N,,,,,,
837,130838,"N-2,2,2-Trifluoroethyl-2-(3,4-dihydroxyphenyl)ethylamine",C1=CC(=C(C=C1CCNCC(F)(F)F)O)O.Br,,,,,,
838,130839,"1,2-Benzenediol, 4-(2-((2,2,2-trifluoroethyl)amino)ethyl)-",C1=CC(=C(C=C1CCNCC(F)(F)F)O)O,,,,,,
839,130840,"7-Bromo-5-(2-chloro-6-hydroxyphenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one",C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=C(C=CC=C3Cl)O,,,,,,
840,130841,2-Hydroxyethyl-dimethylsulfoxonium,C[S+](=O)(C)CCO,,,,,,
841,130842,N-Benzoylphenylalanyl-glycyl-proline,C1C[C@H](N(C1)C(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)C3=CC=CC=C3)C(=O)O,,,,,,
842,130843,"2-Phenylcyclohexyl N,N-diethylaminoethyl ether",CCN(CC)CCO[C@@H]1CCCC[C@@H]1C2=CC=CC=C2,,,,,,
843,130844,"3-Methyl-6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine",CN1CCC2=C(C(=C(C=C2C(C1)C3=CC=CC=C3)O)O)Cl,,,,,,
844,130845,"1-amino-3-[2-(5H-1,2-oxazol-2-ylmethoxy)phenoxy]propan-2-ol",C1C=CN(O1)COC2=CC=CC=C2OCC(CN)O,,,,,,
845,130846,Hbhsl,CC(CC(=O)NC1CCOC1=O)O,,,,,,
846,130847,benzyl (2S)-2-[[(2R)-2-[[(2S)-5-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoyl]amino]-3-(1-formylindol-3-yl)propanoyl]amino]-3-phenylpropanoate,CC(C)(C)OC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H](CC1=CN(C2=CC=CC=C21)C=O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)OCC4=CC=CC=C4,,,,,,
847,130848,"L-Phenylalaninamide, N-acetyl-L-threonyl-1-formyl-D-tryptophyl-N-methyl-N-(phenylmethyl)-",C[C@H]([C@@H](C(=O)N(C(=O)[C@@H](CC1=CN(C2=CC=CC=C21)C=O)N)C(=O)[C@H](CC3=CC=CC=C3)N(C)CC4=CC=CC=C4)NC(=O)C)O,,,,,,
848,130849,N-(2-((4-(9-Acridinylamino)phenyl)amino)-2-oxoethyl)-4-amino-1-methyl-1H-pyrrole-2-carboxamide,CN1C=C(C=C1C(=O)NCC(=O)NC2=CC=C(C=C2)NC3=C4C=CC=CC4=NC5=CC=CC=C53)N,,,,,,
849,130850,3-Methoxypropylgluconamide,COCCCNC(=O)[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
850,130851,"N-[(4S,7aS)-9-hydroxy-3-methyl-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-4a-yl]-2-bromoacetamide",CN1CCC23[C@H]4C(=O)CCC2([C@@H]1CC5=C3C(=C(C=C5)O)O4)NC(=O)CBr,,,,,,
851,130852,"1-Methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline",CC1(C2=CC=CC=C2CCN1)C3=CC=CC=C3.Cl,,,,,,
852,130853,"1-methyl-1-phenyl-3,4-dihydro-2H-isoquinoline",CC1(C2=CC=CC=C2CCN1)C3=CC=CC=C3,,,,,,
853,130854,2-Benzyl-5-cyano-4-oxopentanoic acid,C1=CC=C(C=C1)C[C@H](CC(=O)CC#N)C(=O)O,,,,,,
854,130855,"6H,8H-3,4-Dihydropyrimido(4,5-c)(1,2)oxazin-7-one",C1CONC2=C1C=NC(=O)N2,,,,,,
855,130856,"S-(4-Bromo-2,5-dihydroxyphenyl)-L-cysteine",C1=C(C(=CC(=C1SC[C@@H](C(=O)O)N)O)Br)O,,,,,,
856,130857,Carazostatin,CCCCCCCC1=C2C(=CC(=C1C)O)C3=CC=CC=C3N2,,,,,,
857,130858,AA-1 cation,C[N+](=C1C=CC(=C2C=C(SC(=C2)C3=CC=C(C=C3)N)C4=CC=C(C=C4)N)C=C1)C,,,,,,
858,130859,"2-Amino-1-(2-(3,6-dihydro-6-imino-2-oxo-1(2H)-pyrimidinyl)ethyl)-1,7-dihydro-6H-purin-6-one",C1=C(N(C(=O)N=C1)CCN2C(=O)C3=C(N=CN3)N=C2N)N,,,,,,
859,130860,"N-Acetyl-S-(3-bromo-2,5-dihydroxyphenyl)-L-cysteine",CC(=O)N[C@@H](CSC1=C(C(=CC(=C1)O)Br)O)C(=O)O,,,,,,
860,130861,2-Bromo-3-(N-acetylcystein-S-yl)hydroquinone,CC(=O)N[C@@H](CSC1=C(C=CC(=C1Br)O)O)C(=O)O,,,,,,
861,130862,2-Bromo-5-(N-acetylcystein-S-yl)hydroquinone,CC(=O)N[C@@H](CSC1=C(C=C(C(=C1)O)Br)O)C(=O)O,,,,,,
862,130863,2-((4-(Aminooxy)butyl)dithio)-3-nitropyridine monohydrochloride,C1=CC(=C(N=C1)SSCCCCON)[N+](=O)[O-].Cl,,,,,,
863,130864,1-(Aminooxy)-4-[(3-nitro-2-pyridyl)dithio]butane,C1=CC(=C(N=C1)SSCCCCON)[N+](=O)[O-],,,,,,
864,130865,1-(Aminooxy)-4-[(3-nitro-2-pyridyl)-dithio]but-2-ene,C1=CC(=C(N=C1)SSCC=CCON)[N+](=O)[O-],,,,,,
865,130866,"4-Hydroxyimino-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one",CC12C(C(=NO)CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)OC,,,,,,
866,130867,CID 130867,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@H]3CC4C(C[C@@H](C5[C@@]4(CC[C@@H]5C(=CCC=C(C)C)C)C)O)[C@@]6(C3C(C(CC6)O)(C)C)C)CO)O)O)O)O)O,,,,,,
867,130868,Agrimonolide-6-O-glucopyranoside,COC1=CC=C(C=C1)CC[C@H]2CC3=C(C(=CC(=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)C(=O)O2,,,,,,
868,130869,Di(triethyleneglycoltetradecylether) phosphate,CCCCCCCCCCCCCCOCCOCCOCCOP(=O)(O)OCCOCCOCCOCCCCCCCCCCCCCC,,,,,,
869,130870,"4,5,6,7-Tetrahydro-5-methylimidazo(4,5,1-jk)(1,4)benzodiazepin-2(1H)-one",CC1CN2C3=C(CN1)C=CC=C3NC2=O,,,,,,
870,130871,"Silanamine, 1,1-dimethyl-N,N-diphenyl-1-(2-propenyl)-",C[Si](C)(CC=C)N(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
871,130872,Fructose 3-phosphate,C([C@H]([C@H]([C@@H](C(=O)CO)OP(=O)(O)O)O)O)O,,,,,,
872,130873,"2-Acetamido-3-O-(3-acetamido-3,6-dideoxy-beta-glucopyranosyl)-2-deoxy-galactopyranose",C[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@H](C=O)NC(=O)C)[C@H]([C@@H](CO)O)O)O)NC(=O)C)O,,,,,,
873,130874,Dhptu,CC(CO)C(O)ON1C2=C(CCCC2)C(=O)NC1=O,,,,,,
874,130875,Et-Me-Deoxyamino-C,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)N)C2=NC5=C1C=C(C=C5)OC,,,,,,
875,130876,"Ergostane-3,15-diol",C[C@H](CC[C@H](C)C(C)C)[C@H]1C[C@@H]([C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
876,130877,CID 130877,CCCCCCOC(=O)C1=CC=CC=C1OC(C)C2=C(C=CC(=C2OC)O)C(=O)O,,,,,,
877,130878,CID 130878,CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N(C)C(=O)[C@H](CC(=O)O)N,,,,,,
878,130879,Cyclo(methyltauryl-phenylalanyl-proline),CN1CCS(=O)(=O)N[C@H](C(=O)N2CCC[C@@H]2C1=O)CC3=CC=CC=C3,,,,,,
879,130880,CID 130880,CCCCC[C@H](CC[C@@H]1[C@H](C[C@@H]2[C@H]1CC3=C(C2)C(=CC=C3)OCC(=O)[O-])O)O.[Na+],,,,,,
880,130881,Olmesartan medoxomil,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,,,"['Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)']",,,
881,130882,CID 130882,CCC1=C(S[C@](C1=O)(CC)C=C(C)C=C)O,,,,,,
882,130883,Desmethyletimizol,CCN1C=NC(=C1C(=O)NC)C(=O)N,,,,,,
883,130884,3-(3-Amino-1-fluoroprop-1-en-2-yl)phenol,C1=CC(=CC(=C1)O)C(=CF)CN,,,,,,
884,130885,(2-Acetyloxy-3-docosoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C,,,,,,
885,130886,2-[(2-Acetyloxy-3-docosoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C,,,,,,
886,130887,"2-[5-[(2,4-Dioxoimidazolidin-1-yl)iminomethyl]thiophen-2-yl]sulfanylbenzoic acid",C1C(=O)NC(=O)N1N=CC2=CC=C(S2)SC3=CC=CC=C3C(=O)O,,,,,,
887,130888,CID 130888,CC(C)OP(=S)(OC(C)C)[S-].C1=CC=C(C=C1)[SbH]C2=CC=CC=C2,,,,,,
888,130889,"Bis[(5-ethylpyridin-2-yl)methyl] 4-(2,3-dihydro-1,4-dioxin-5-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate",CCC1=CN=C(C=C1)COC(=O)C2=C(NC(=C(C2C3=COCCO3)C(=O)OCC4=NC=C(C=C4)CC)C)C,,,,,,
889,130890,Taurolipid C,CCCCCCCCCCCCCCCC(=O)OC(CCCC(CCCCC(C(CCCCC)O)O)O)C(C(=O)NCCS(=O)(=O)O)O,,,,,,
890,130891,Asarumin B,CC(C)[C@H](C(=O)OC)OC(=O)C1=CC=CC=C1,,,,,,
891,130892,CID 130892,CC(C)[C@H](C(=O)OC)OC(=O)C=CC1=CC=CC=C1,,,,,,
892,130893,CID 130893,CC1=C(C(CCC1)(C)CO)C=CC(=CC=CC(=CC(=O)O)C)C,,,,,,
893,130894,"L-Cysteine, N-acetyl-S-(2,2-dichloroethenyl)-",CC(=O)N[C@@H](CSC=C(Cl)Cl)C(=O)O,,,,,,
894,130895,"N1,N3-Bis(pentafluorobenzyl)-N7-(2-(pentafluorobenzyloxy)ethyl)xanthine",C1=CC(=C(C(=C1C(N2C3=C(C(=O)N(C2=O)C(C4=C(C(=C(C=C4)F)F)F)(F)F)N(C=N3)CCOC(C5=C(C(=C(C=C5)F)F)F)(F)F)(F)F)F)F)F,,,,,,
895,130896,N-(5-Fluorobenzothiazol-2-yl)-2-guanidinothiazole-4-carboxamide,C1=CC2=C(C=C1F)N=C(S2)NC(=O)C3=CSC(=N3)N=C(N)N,,,,,,
896,130897,"Phosphonium, ((4-formylphenyl)methyl)triphenyl-, chloride",C1=CC=C(C=C1)[P+](CC2=CC=C(C=C2)C=O)(C3=CC=CC=C3)C4=CC=CC=C4.[Cl-],,,,,,
897,130898,[(4-Formylphenyl)methyl]triphenylphosphonium,C1=CC=C(C=C1)[P+](CC2=CC=C(C=C2)C=O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
898,130899,CID 130899,CCCC1=CC(=O)N=C(N1)[SeH],,,,,,
899,130900,CID 130900,CC(=CCC1=C(C=CC(=C1)C2COC3=C(C2=O)C=CC(=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)OC(=O)C=CC5=CC=C(C=C5)O)OC)C,,,,,,
900,130901,Squamone,CCCCCCCCCCCCC(C1CCC(O1)C(CCCCCC(=O)CCCCC2CC(C(=O)O2)CC(=O)C)O)O,,,,,,
901,130902,CID 130902,CC(C)C[C@@H](C(=O)NCCCCNCC=NN)NC(=O)CCC(=O)O,,,,,,
902,130903,Bab-dota,C1CN(CCN(C(CN(CCN1CC(=O)O)CC(=O)O)CC2=CC=C(C=C2)NC(=O)CBr)CC(=O)O)CC(=O)O,,,,,,
903,130904,Ulipristal acetate,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,['Ulipristal acetate is indicated for one treatment course of pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.'],,"['Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)', 'Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)']",,,
904,130905,"Imidazo(1,2-a)pyridine-3-acetic acid, 8-(acetylamino)-5,6,7,8-tetrahydro-6,7-dihydroxy-5-(hydroxymethyl)-",CC(=O)NC1C(C(C(N2C1=NC=C2CC(=O)O)CO)O)O,,,,,,
905,130906,CID 130906,CC(C)C[C@@H](C(=O)N[C@@H](CSC)C(=O)O)NC(=O)OCCCCCN1C=NC2=C1NC=NC2=O,,,,,,
906,130907,2-Methoxy-N-n-propylnorapomorphine,CCCN1CCC2=C3[C@H]1CC4=C(C3=CC(=C2)OC)C(=C(C=C4)O)O,,,,,,
907,130908,"(2R,13S,21S)-22-(cyclopropylmethyl)-7-isothiocyanato-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaene-2,16-diol",C1CC1CN2CCC34[C@H]5C6=C(C[C@@]3([C@@H]2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C=CC(=C8)N=C=S,,,,,,
908,130909,Dabsyl-PC,CCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCCNS(=O)(=O)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N(C)C)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
909,130910,2-[[(2R)-2-decanoyloxy-3-[11-[[4-[[4-(dimethylamino)phenyl]diazenyl]phenyl]sulfonylamino]undecoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCCNS(=O)(=O)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N(C)C)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
910,130911,(3-Docosanoyloxy-2-dodecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC,,,,,,
911,130912,2-[(3-Docosanoyloxy-2-dodecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC,,,,,,
912,130913,N2-(N-(N-Acetyl-L-seryl)-L-alpha-aspartyl)-L-lysine,CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
913,130914,gamma-Tetrazole-methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC4=NNN=N4)C(=O)O,,,,,,
914,130915,Faveptv,CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)OCC2CO2)C(=O)N[C@@H](C(C)C)C(=O)OC)NC(=O)C(F)(F)F,,,,,,
915,130916,N-Acetylseryl-leucyl-asparaginyl(phenylalanyl-hydroxyethylamino-prolyl)isoleucyl-valyl methyl ester,CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)OC)NC(=O)[C@@H]1CCCN1C[C@@H]([C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)C)O,,,,,,
916,130917,"4-[(3,5-Ditert-butyl-4-hydroxyphenyl)methylidene]-2-methyloxazinan-3-one",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2CCON(C2=O)C,,,,,,
917,130918,Adatanserin,C1CN(CCN1CCNC(=O)C23CC4CC(C2)CC(C4)C3)C5=NC=CC=N5,,,,,,
918,130919,Auranthine,C1CC2=NC3=CC=CC=C3C(=O)N2C4=NC5=CC=CC=C5C(=O)NC41,,,,,,
919,130920,"5-(4,7-Dihydroxyhept-2-enylidene)-4-hydroxy-2-methylsulfanyl-4-(4-phenoxybutyl)cyclopent-2-en-1-one",CSC1=CC(C(=CC=CC(CCCO)O)C1=O)(CCCCOC2=CC=CC=C2)O,,,,,,
920,130921,CID 130921,C1=CC(=CC(=C1)[C@@H]([C@@H](C=CC=CCCCCCCCCC(F)(F)F)SCCC2=NNN=N2)O)C3=NNN=N3,,,,,,
921,130922,"3-Hydroxymethyl-2-methylimidazo(2,1-b)benzothiazole",CC1=C(N2C3=CC=CC=C3SC2=N1)CO,,,,,,
922,130923,6-Fluorohomovanillic acid,COC1=C(C=C(C(=C1)CC(=O)O)F)O,,,,,,
923,130924,4-Methoxyisomazole,COC1=C(C=CC(=C1)S(=O)C)C2=NC3=C(N2)C=CN=C3OC,,,,,,
924,130925,CID 130925,C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)OC)NC(=O)[C@H](C(C)C)NC(=O)C(C)(C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](C(C)C)NC(=O)OC(C)(C)C,,,,,,
925,130926,"7-Methoxycoumarin-3-carboxylyl-prolyl-leucyl-glycyl-prolyl-lysyl-2,4-dinitrophenyl",CC(C)C[C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](CCCCNC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C(=O)O)NC(=O)[C@@H]3CCCN3C(=O)C4=CC5=C(C=C(C=C5)OC)OC4=O,,,,,,
926,130927,CID 130927,CNC1=CC=CC=C1C(=O)[C@@]2(C[C@H](O[C@@H]2COP(=O)(O)OP(=O)(O)O)N3C=NC4=C3NC(=NC4=O)N)O,,,,,,
927,130928,"2-(4-Morpholino-6-propyl-1,3,5-triazin-2-yl)aminoethanol",CCCC1=NC(=NC(=N1)N2CCOCC2)NCCO,,,,,,
928,130929,2-Bromo-6-cystein-S-ylhydroquinone,C1=C(C=C(C(=C1SC[C@@H](C(=O)O)N)O)Br)O,,,,,,
929,130930,CID 130930,CN(CCCNC(=O)CC=CC1=CC=C(C=C1)N2C=CN=C2)CCC3=CC(=CC(=C3)OC)OC.Cl.Cl,,,,,,
930,130931,"N-[3-[2-(3,5-dimethoxyphenyl)ethyl-methylamino]propyl]-4-(4-imidazol-1-ylphenyl)but-3-enamide",CN(CCCNC(=O)CC=CC1=CC=C(C=C1)N2C=CN=C2)CCC3=CC(=CC(=C3)OC)OC,,,,,,
931,130932,alpha-Gliadin (43-49),C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=CC=C(C=C3)O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)O,,,,,,
932,130933,4-Propyl-5-(4-quinolinyl)-2(3H)-oxazolone,CCCC1=C(OC(=O)N1)C2=CC=NC3=CC=CC=C23,,,,,,
933,130934,"Acetamide, N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)-N-(phenylmethoxy)-, (3S-trans)-",CC(=O)N([C@@H]1[C@@H](C(OC2=C1C=C(C=C2)C#N)(C)C)O)OCC3=CC=CC=C3,,,,,,
934,130935,"4-(2,6-Dihydroxybenzoyl)-3-formyl-5-hydroxybenzoic acid",C1=CC(=C(C(=C1)O)C(=O)C2=C(C=C(C=C2O)C(=O)O)C=O)O,,,,,,
935,130936,2-(4-Hydroxyphenyl)-3-methyl-1-(6-(1-pyrrolidinyl)hexyl)indol-5-ol,CC1=C(N(C2=C1C=C(C=C2)O)CCCCCCN3CCCC3)C4=CC=C(C=C4)O,,,,,,
936,130937,"2-Amino-4,5-methanoadipate",C1C(C1C(=O)O)CC(C(=O)O)N,,,,,,
937,130938,N-4-Carboxybenzylglucamine dithiocarbamate,C1=CC(=CC=C1CN(C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)C(=S)S)C(=O)O,,,,,,
938,130939,Hydroxyglimepiride,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)CO)C,,,,,['Cyclohexylhydroymethylglimepiride is a known human metabolite of Glimepiride.'],
939,130940,1-((2-Azido-1-(hydroxymethyl)ethoxy)methyl)thymine,CC1=CN(C(=O)NC1=O)COC(CN=[N+]=[N-])CO,,,,,,
940,130941,CID 130941,CC1=C(C=CC(=C1)NN=C(N)N)N=NC(=N)S,,,,,,
941,130942,"2,3-Bis(hexanoylthio)propylphosphomethanol",CCCCCC(=O)SCC(CC(O)P(=O)(O)O)SC(=O)CCCCC,,,,,,
942,130943,"(endo-8-Methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1H-benzimidazole-1-carboxylate hydrochloride",CCN1C2=CC=CC=C2N(C1=O)C(=O)OC3CC4CCC(C3)N4C.Cl,,,,,,
943,130944,"3-Ethyl-2-oxo-2,3-dihydro-benzoimidazole-1-carboxylic acid 8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester; hydrochloride",CCN1C2=CC=CC=C2N(C1=O)C(=O)OC3CC4CCC(C3)N4C,,,,,,
944,130945,"(endo-N-8-Methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1H-benzimidazol-1-carboxamide",CCN1C2=CC=CC=C2N(C1=O)C(=O)NC3CC4CCC(C3)N4C.Cl,,,,,,
945,130946,"(endo-N-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1H-benzimidazol-1-carboxamide",CCN1C2=CC=CC=C2N(C1=O)C(=O)NC3CC4CCC(C3)N4C,,,,,,
946,130947,CID 130947,CCOC(=O)C1=CC=C(C=C1)N.C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.Cl.Cl,,,,,,
947,130948,"Tryptamine-4,5-dione",C1=CC(=O)C(=O)C2=C1NC=C2CCN,,,,,,
948,130949,Tyrosyl-arginyl-glycyl-4-nitrophenylalanyl-prolinamide,C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)[N+](=O)[O-])N)C(=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CC3=CC=C(C=C3)O)N,,,,,,
949,130950,5-Indolylmethylhydantoin,C1=CC=C2C(=C1)C=CN2CC3C(=O)NC(=O)N3,,,,,,
950,130951,N(5)-Piperazine-amiloride,C1CN(CCN1)C2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N,,,,,,
951,130952,3-Cyano-2-morpholino-5-(pyrid-4-yl)pyridine,C1COCCN1C2=C(C=C(C=N2)C3=CC=NC=C3)C#N,,,,,,
952,130953,"6,7-Dimethoxy-2-(2-trifluoromethylphenyl)-4H-thiochromene",COC1=C(C=C2C(=C1)CC=C(S2)C3=CC=CC=C3C(F)(F)F)OC,,,,,,
953,130954,methyl (1R)-3-(4-fluorophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate,COC(=O)C1[C@H]2CCC(N2)CC1C3=CC=C(C=C3)F,,,,,,
954,130955,4-Chloro-5-(((3-ethoxy-4-methoxyphenyl)methyl)amino)-3(2H)-pyridazinone,CCOC1=C(C=CC(=C1)CNC2=C(C(=O)NN=C2)Cl)OC,,,,,,
955,130956,Minodronic acid,C1=CC2=NC=C(N2C=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,"['Investigated for use/treatment in multiple myeloma, breast cancer, osteoporosis, and lung cancer.']",,,,,
956,130957,Zivulgarin,COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O,,,,,,
957,130958,CID 130958,C([C@@H]1[C@@H]([C@@H]([C@H](C(O1)(C=[N+]=[N-])C(=O)C2([C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)C=[N+]=[N-])O)O)O)O,,,,,,
958,130959,2-S-Thiuronium ethanesulfonate,C(CS(=O)(=O)O)S[14C](=N)N,,,,,,
959,130960,"9,10-Dihydroxy-9,10-dihydro-3-methylcholanthrene-2-one",CC1=C2C(=O)CC3=C2C(=CC4=C3C=CC5=C4C=CC(C5O)O)C=C1,,,,,,
960,130961,"N-(11-Undecanoic acid)-N,N'-bis(2-methyl-2-mercaptopropyl)ethylenediamine",CC(C)(CN(CCCCCCCCCCC(=O)O)CCNC(=O)C(C)(C)S)S.Cl.Cl,,,,,,
961,130962,11-[2-[(2-Methyl-2-sulfanylpropanoyl)amino]ethyl-(2-methyl-2-sulfanylpropyl)amino]undecanoic acid,CC(C)(CN(CCCCCCCCCCC(=O)O)CCNC(=O)C(C)(C)S)S,,,,,,
962,130963,3-[2-(Dimethylaminomethyl)phenyl]sulfanylphenol,CN(C)CC1=CC=CC=C1SC2=CC=CC(=C2)O,,,,,,
963,130964,Dads-E,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=C(C=C34)CN5CCNCC(SSC(C5)(C)C)(C)C)OC.Cl.Cl,,,,,,
964,130965,CID 130965,C[C@]12CC[C@H]3C(C1CCC2=O)CCC4=CC(=C(C=C34)CN5CCNCC(SSC(C5)(C)C)(C)C)OC,,,,,,
965,130966,"3H-Furo(4,3,2-de)indeno(4,5-h)-2-benzopyran-3,6(1H)-dione, 11-(acetyloxy)-6b,7,8,9,9a,10,11,11b-octahydro-9-hydroxy-1-(methoxymethyl)-9a,11b-dimethyl-",CC(=O)OC1CC2(C(CCC2O)C3=C1C4(C(OC(=O)C5=COC(=C54)C3=O)COC)C)C,,,,,,
966,130967,2-[2-Oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl]sulfanylethyl 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCCSCC(=O)NCCCOC4=CC=CC(=C4)CN5CCCCC5,,,,,,
967,130968,3-(4-Carboxymethoxy-3-(4-(4-phenylbutoxy)benzamido)phenyl)propionic acid,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=C(C=CC(=C3)CCC(=O)O)OCC(=O)O,,,,,,
968,130969,"2,3-Bis(tetradecanoylamino)propyl 2-(trimethylazaniumyl)ethyl phosphate",CCCCCCCCCCCCCC(=O)NCC(COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCC,,,,,,
969,130970,"O-[[2,3-Bis(myristoylamino)propyloxy]phosphonyl]choline",CCCCCCCCCCCCCC(=O)NCC(COP(=O)(O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCC,,,,,,
970,130971,"N-[(1S)-3-[[(2S)-3-methyl-1-[(3S,4R)-4-methyl-2,5-dioxopyrrolidin-3-yl]-1-oxobutan-2-yl]amino]-3-oxo-1-phenylpropyl]octa-2,4,6-trienamide",CC=CC=CC=CC(=O)N[C@@H](CC(=O)N[C@@H](C(C)C)C(=O)[C@@H]1[C@H](C(=O)NC1=O)C)C2=CC=CC=C2,,,,,,
971,130972,CID 130972,CN1[C@@H](C(=O)N[C@H](CC1=O)CCCN=C(N)N)CNNC=NC(=O)N,,,,,,
972,130973,Corchorusin D,C[C@]12CCC(C(C1CC[C@@]3(C2C=CC45[C@]3(C[C@H](C6([C@@H]4CC(CC6)(C)C)CO5)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O,,,,,,
973,130974,CID 130974,CN1[C@H](C(=O)N[C@H](CC1=O)CCCN=C(N)N)CNNC=NC(=O)N,,,,,,
974,130975,CID 130975,CC(=CCCC(C)(C=C)O)CCC(C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
975,130976,Phlorofucofuroeckol A,C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C3C5=C(C(=C4)O)OC6=C(O5)C(=CC(=C6OC7=CC(=CC(=C7)O)O)O)O)O)O)O,,,,,,
976,130977,CID 130977,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC=C(C=C5)O)CO)O)O)O)O)O,,,,,,
977,130978,Methyl 2-(4-(3-thienyl)phenyl)propionate,CC(C1=CC=C(C=C1)C2=CSC=C2)C(=O)OC,,,,,,
978,130979,"4-(1-Hydroxy-2-((2-(3,4,5-trimethoxyphenyl)ethyl)amino)ethyl)-1,2-benzenediol",COC1=CC(=CC(=C1OC)OC)CCNCC(C2=CC(=C(C=C2)O)O)O,,,,,,
979,130980,CID 130980,CC(C)CNC(CCCCCCCCCCCCCC1=CC=CC=C1)C(CO)C2=CC=CC=C2,,,,,,
980,130981,"2,3,4,5-Tetrahydro-8-(methylsulfonyl)-1H-3-benzazepin-7-ol",CS(=O)(=O)C1=C(C=C2CCNCCC2=C1)O,,,,,,
981,130982,"N-[[(5S)-2-oxo-3-(4-pyridin-4-ylphenyl)-1,3-oxazolidin-5-yl]methyl]acetamide",CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(C=C2)C3=CC=NC=C3,,,,,,
982,130983,"N,N-Diacetoxyethyl 9,10-dihydrolysergic acid amide",CC(=O)OCCN(CCOC(=O)C)C(=O)[C@@H]1CC2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
983,130984,CID 130984,CCC(CC)(CCCCC(C)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C)O,,,,,,
984,130985,"4,8-Dioxo-2-[(trimethylazaniumyl)methyl]oxocane-3-carboxylate",C[N+](C)(C)CC1C(C(=O)CCCC(=O)O1)C(=O)[O-],,,,,,
985,130986,"(3-Carboxy-4,8-dioxooxocan-2-yl)methyl-trimethylazanium",C[N+](C)(C)CC1C(C(=O)CCCC(=O)O1)C(=O)O,,,,,,
986,130987,N-Bromoacetylleucylglycine,CC(C)C[C@H](C(=O)NCC(=O)O)NC(=O)CBr,,,,,,
987,130988,"(3S,10R,13R,17R)-17-[(2R)-5-(3-hydroxy-2,4,4-trimethyl-1,3-oxazolidin-2-yl)pentan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol",C[C@H](CCCC1(N(C(CO1)(C)C)O)C)[C@H]2CCC3[C@@]2(CCC4C3CC=C5[C@@]4(CC[C@@H](C5)O)C)C,,,,,,
988,130989,Quin-MF,CC1=CC(=C(C=C1F)OCC2=NC3=C(C=CC=C3N(CC(=O)O)CC(=O)O)C=C2)N(CC(=O)O)CC(=O)O,,,,,,
989,130990,Minopafant,CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(CC1)C(=O)OC[C@H](COC(=O)N(CC2=CC=CC=[N+]2CC)C(=O)C3=CC=CC=C3OC)OC.[Cl-],,,,,,
990,130991,2-[2-Methoxybenzoyl[(R)-2-methoxy-3-[4-(N-stearylcarbamoyloxy)-piperidinocarbonyloxy]propoxycarbonyl]aminomethyl]-1-ethylpyridinium,CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(CC1)C(=O)OC[C@H](COC(=O)N(CC2=CC=CC=[N+]2CC)C(=O)C3=CC=CC=C3OC)OC,,,,,,
991,130992,"(9S)-10-benzyl-17-(cyclopropylmethyl)-4-hydroxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one",C1CC1CN2CCC34CC(=O)CCC3([C@@H]2CC5=C4C=C(C=C5)O)CC6=CC=CC=C6,,,,,,
992,130993,"Tetrahydrobenzo-4,6-dimethylangelicin",CC1=CC2=C(C3=C1OC4=C3CCCC4)OC(=O)C=C2C,,,,,,
993,130994,1-(3-Azido-3-deoxypentofuranosyl)-5-(2-carboxyethyl)-4-hydroxypyrimidin-2(1H)-one,C1=C(C(=O)NC(=O)N1[C@@H]2[C@@H]([C@@H]([C@H](O2)CO)N=[N+]=[N-])O)CCC(=O)O,,,,,,
994,130995,4'-Hydroxy Nimesulide,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=C(C=C2)O,,,,,,
995,130996,H-Lysyl-2-(2-nitrophenylsulfenyl)tryptophan methyl ester,COC(=O)[C@H](CC1=CN(C2=CC=CC=C21)SC3=CC=CC=C3[N+](=O)[O-])NC(=O)[C@H](CCCCN)N,,,,,,
996,130997,"(2S,3R,4R,14R)-2-Amino-3,4,14-trihydroxy-2-(hydroxymethyl)icosa-6,12-dienoic acid",CCCCCC[C@H](C=CCCCCC=CC[C@H]([C@@H]([C@@](CO)(C(=O)O)N)O)O)O,,,,,,
997,130998,2-[(4-Benzamidophenyl)sulfonylamino]acetic acid,C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)NCC(=O)O,,,,,,
998,130999,4-(Hydroxymethyl)-3-(1-hydroxy-4-methylhexyl)oxolan-2-one,CCC(C)CCC(C1C(COC1=O)CO)O,,,,,,
999,131000,"2(3H)-Furanone, dihydro-3-(1-hydroxyhexyl)-4-(hydroxymethyl)-",CCCCCC(C1C(COC1=O)CO)O,,,,,,
1000,131001,"3-(dipropylamino)-3,4-dihydro-2H-chromen-5-ol",CCCN(CCC)C1CC2=C(C=CC=C2OC1)O,,,,,,
1001,131002,Sauristolactam,CN1C2=CC3=CC=CC=C3C4=C2C(=CC(=C4OC)O)C1=O,,,,,,
1002,131003,4-(Hydroxymethyl)-3-(1-hydroxy-5-methylhexyl)oxolan-2-one,CC(C)CCCC(C1C(COC1=O)CO)O,,,,,,
1003,131004,4-O-(1-Carboxyethyl)rhamnose,C[C@@H]([C@@H]([C@H]([C@H](C=O)O)O)OC(C)C(=O)O)O,,,,,,
1004,131005,CID 131005,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC3=CC(=O)C=C4C3=C(C=C(O4)C5=CC=C(C=C5)O)O)CO)O)O)O,,,,,,
1005,131006,CID 131006,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC3=CC(=O)C=C4C3=C(C=C(O4)C5=CC=C(C=C5)O)O)COC(=O)C)O)O)O,,,,,,
1006,131007,Agatoxin 489,C1=CC=C2C(=C1)C(=CN2)CC(=O)NCCCN(CCCNCCCNCCCCNCCCN)O,,,,,,
1007,131008,Phzbaz,C1=CC(=CC=C1CCC(=O)C2=C(C=C(C(=C2O)CC3=CC=C(C=C3)N=[N+]=[N-])O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
1008,131009,Histamine dichloramine,C1=C(NC=N1)CCN(Cl)Cl,,,,,,
1009,131010,"[4-(4-methoxyphenyl)-2-oxo-1-(pyrrolidin-2-ylmethyl)-6-(trifluoromethyl)-4,5-dihydro-3H-1-benzazepin-3-yl] acetate",CC(=O)OC1C(CC2=C(C=CC=C2N(C1=O)CC3CCCN3)C(F)(F)F)C4=CC=C(C=C4)OC.Cl,,,,,,
1010,131011,CID 131011,CC(=O)OC1C(CC2=C(C=CC=C2N(C1=O)CC3CCCN3)C(F)(F)F)C4=CC=C(C=C4)OC,,,,,,
1011,131012,"4-Amino-N-(2,6-dimethylphenyl)-3,5-dimethylbenzamide",CC1=C(C(=CC=C1)C)NC(=O)C2=CC(=C(C(=C2)C)N)C,,,,,,
1012,131013,Methyl 5(6)-(4-methylpiperidin-1-yl)carbonylbenzimidazole-2-carbamate,CC1CCN(CC1)C(=O)C2=CC3=C(C=C2)N=C(N3)NC(=O)OC,,,,,,
1013,131014,Mifepristone methochloride,CC#C[C@]1(CCC2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)[N+](C)(C)C)C)O.[Cl-],,,,,,
1014,131015,CID 131015,CC#C[C@]1(CCC2[C@@]1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)[N+](C)(C)C)C)O,,,,,,
1015,131016,"(3R,7S,10R,11R)-10-[(2R,3R,4R,5S,6S)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3,11-diethyl-7-methyl-azacyclotetradecan-2-one",CC[C@@H]1CCCNC(=O)[C@@H](CCC[C@@H](CC[C@H]1O[C@H]2[C@@H]([C@@H]([C@@H]([C@@H](O2)C)O)N)O)C)CC,,,,,,
1016,131017,CID 131017,C[C@@H](C(=O)NC(=O)CN(C)[C@@H](CC1=CC=CC=C1)C(=O)CCl)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
1017,131018,Eriotriochin,CC(=CCC1=C2C(=C(C3=C1OC=C(C3=O)C4=CC=C(C=C4)O)O)CC(O2)C(C)(C)OCCO)C,,,,,,
1018,131019,14-(4-Nitrobenzoyloxy)yohimbine,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1[C@H]([C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)OC(=O)C6=CC=C(C=C6)[N+](=O)[O-])O,,,,,,
1019,131020,CID 131020,CC1=C(OC(=N1)C2=CC=C(C=C2)Cl)COC(C)(C)C(=O)[O-].[Na+],,,,,,
1020,131021,Lychnostatin 1,C[C@H]1CCC(=O)[C@](C[C@@H]([C@@H]2[C@@H]([C@H]1O)OC(=O)C2=C)OC(=O)C(=C)C)(C)OC(=O)C,,,,,,
1021,131022,4-Hydroxyhexanal,CCC(CCC=O)O,,,,,,
1022,131023,N-[2-[4-(3-Cyclohexyl-2-iminoimidazolidin-1-yl)sulfonylphenyl]ethyl]but-2-enamide,CC=CC(=O)NCCC1=CC=C(C=C1)S(=O)(=O)N2CCN(C2=N)C3CCCCC3,,,,,,
1023,131024,"1,1-Dimethyl-4-(2-quinolyl)piperazinium iodide",C[N+]1(CCN(CC1)C2=NC3=CC=CC=C3C=C2)C.[I-],,,,,,
1024,131025,"1,1-Dimethyl-4-(2-quinolyl)piperazinium",C[N+]1(CCN(CC1)C2=NC3=CC=CC=C3C=C2)C,,,,,,
1025,131026,"7-p-Sulfophenyl-3-dibenzothiophenesulfonic acid 5,5-dioxide, disodium salt",C1=CC(=CC=C1C2=CC3=C(C=C2)C4=C(S3(=O)=O)C=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
1026,131027,"5,5-Dioxo-7-(4-sulfophenyl)dibenzothiophene-3-sulfonic acid",C1=CC(=CC=C1C2=CC3=C(C=C2)C4=C(S3(=O)=O)C=C(C=C4)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1027,131028,Jietacin A,CC(C)CCCCCC(=O)CCCCCCCN=[N+](C=C)[O-],,,,,,
1028,131029,Prolyl-leucyl-psi(methylamino)glycinamide,CC(C)C[C@@H](CNCC(=O)N)NC(=O)[C@@H]1CCCN1.Cl,,,,,,
1029,131030,(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methylpentan-2-yl]pyrrolidine-2-carboxamide,CC(C)C[C@@H](CNCC(=O)N)NC(=O)[C@@H]1CCCN1,,,,,,
1030,131031,Prolyl-psi(methylamino)leucyl-glycinamide,CC(C)C[C@@H](C(=O)NCC(=O)N)NC[C@@H]1CCCN1.Cl.Cl,,,,,,
1031,131032,(2S)-N-(2-amino-2-oxoethyl)-4-methyl-2-[[(2S)-pyrrolidin-2-yl]methylamino]pentanamide,CC(C)C[C@@H](C(=O)NCC(=O)N)NC[C@@H]1CCCN1,,,,,,
1032,131033,Homopahutoxin,CCCCCCCCCCCCCC(CC(=O)OCC[N+](C)(C)C)OC(=O)CC.[Cl-],,,,,,
1033,131034,Trimethyl-[2-(3-propanoyloxyhexadecanoyloxy)ethyl]azanium,CCCCCCCCCCCCCC(CC(=O)OCC[N+](C)(C)C)OC(=O)CC,,,,,,
1034,131035,"(2S-(2R*,4R*,5R*))-N-(N-(6-Cyclohexyl-4-hydroxy-2-(1-methylethyl)-1-oxo-5-((N-(N-(1-(N2-(N2-((phenylmethoxy)carbonyl)-L-arginyl)-L-arginyl)-L-prolyl)-L-phenylalanyl)-L-valyl)amino)hexyl)-1-valyl)-L-tyrosine methyl ester",CC(C)[C@@H](C(=O)N[C@@H](CC1CCCCC1)[C@H](CC(C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)OC)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)OCC5=CC=CC=C5,,,,,,
1035,131036,CID 131036,CCCCCCCCCCCCCC=C[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)N)O,,,,,,
1036,131037,"16-[[(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyhexadecanoic acid",C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)OCCCCCCCCCCCCCCCC(=O)O)O)O,,,,,,
1037,131038,CID 131038,CCOC(=O)CP(=O)([C@@H](CC(C)C)N[C@@H](C(C)C)C(=O)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C)O,,,,,,
1038,131039,"(2aS,4aR)-2,2,4a,8-tetramethyl-2a,3,4,5,6,7-hexahydro-1H-cyclobuta[i]inden-8-ol",C[C@]12CCCC(C13CC([C@@H]3CC2)(C)C)(C)O,,,,,,
1039,131040,CID 131040,C[C@H](C(=O)NC(=O)[C@@H](C)NC(=O)OCC1=CC=CC=C1)N[C@@H](CC(C)C)P(=O)(O)O[C@@H](CC2=CC=CC=C2)C(=O)OC,,,,,,
1040,131041,"Hexyl 2,5-dichlorophenylphosphoroamidate",CCCCCCOP(=O)(NC1=C(C=CC(=C1)Cl)Cl)O,,,,,,
1041,131042,Isovaleryl-valyl-valyl-leucine phosphinate-3-phenyllactic acid methyl ester,CC(C)C[C@H](N[C@@H](C(C)C)C(=O)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C)P(=O)(O)O[C@@H](CC1=CC=CC=C1)C(=O)OC,,,,,,
1042,131043,"12-(4-Nitrobenzyl)-1,4,7,10-tetraazacyclotridecane-1,4,7,10-tetraacetic acid",C1CN(CCN(CC(CN(CCN1CC(=O)O)CC(=O)O)CC2=CC=C(C=C2)[N+](=O)[O-])CC(=O)O)CC(=O)O,,,,,,
1043,131044,CID 131044,CC(=CC1=CC=C(C=C1)CO)C2=CC3=C(CCCC3(C)C)C=C2,,,,,,
1044,131045,"12(4-Nitrobenzyl)-1,4,7,10-tetraazacyclotridecane-1,4,7-triacetic acid",C1CN(CCN(CCN(CC(CN1)CC2=CC=C(C=C2)[N+](=O)[O-])CC(=O)O)CC(=O)O)CC(=O)O,,,,,,
1045,131046,Methyl 4-O-beta-glucopyranosyl-2-O-alpha-rhamnopyranosyl-beta-galactopyranoside,C[C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2OC)CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O)O,,,,,,
1046,131047,Nitropeptin,CC(C)C[C@@H](C(=O)N[C@@H](C(CC(=O)O)[N+](=O)[O-])C(=O)O)N,,,,,,
1047,131048,LL-E-19085zeta,CC(C)CC(=O)OCC1(C(=O)OC2(N1C(=O)C3=C(C2)C=C4C=CC5=C(C4=C3)C(=O)C6=C(C5=O)OC7=CC(=C(C=C7C6=O)O)OC)C)C,,,,,,
1048,131049,CID 131049,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC2=C(OC3=C(C(=CC(=O)C3=C2O)O[C@@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)CO)O)O)O)CC=C(C)C)C5=CC=C(C=C5)OC)O)O[C@@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)COC(=O)C)O)O)O)O,,,,,,
1049,131050,Dimethyl(triphenylsilyloxy)arsane,C[As](C)O[Si](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1050,131051,CID 131051,C(C=CC(CF)(C(=O)O)N)N=C(N)N,,,,,,
1051,131052,CID 131052,C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@@H]2OC3=C(OC4=CC(=CC(=O)C4=C3O)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)CO)O)O)O)C6=CC=C(C=C6)O)CO)O)O)O)O)O,,,,,,
1052,131053,Citreamicin gamma,CC(=O)OCC1(C(=O)OC2(N1C(=O)C3=C(C2)C=C4C=CC5=C(C4=C3O)C(=O)C6=C(C5=O)OC7=CC(=C(C=C7C6=O)OC)OC)C)C,,,,,,
1053,131054,Ethyl 1-(1-(4-fluorophenyl)ethyl)-1H-imidazol-5-carboxylate hcl,CCOC(=O)C1=CN=CN1C(C)C2=CC=C(C=C2)F.Cl,,,,,,
1054,131055,Procaine isothiocyanate,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N=C=S,,,,,,
1055,131056,Aminodehydrochloramphenicol,C1=CC(=CC=C1C(=O)[C@@H](CO)NC(=O)C(Cl)Cl)N,,,,,,
1056,131057,Leuhistin,CC(C)C[C@@H]([C@](CC1=CN=CN1)(C(=O)O)O)N,,,,,,
1057,131058,"2-Amino-3-cyano-6-methyl-5-(3,4-dimethoxyphenyl)pyridine",CC1=C(C=C(C(=N1)N)C#N)C2=CC(=C(C=C2)OC)OC,,,,,,
1058,131059,2-Amino-3-cyano-6-ethyl-5-(4-pyridyl)pyridine,CCC1=C(C=C(C(=N1)N)C#N)C2=CC=NC=C2,,,,,,
1059,131060,CID 131060,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)C(CCCCC(=O)N(CC=CC3=CN(C(=O)NC3=O)[C@H]4C[C@@H]([C@H](O4)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)C(=O)CN)N.[NH4+].[NH4+].[NH4+].[NH4+],,,,,,
1060,131061,CID 131061,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)C(CCCCC(=O)N(CC=CC3=CN(C(=O)NC3=O)[C@H]4C[C@@H]([C@H](O4)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)C(=O)CN)N,,,,,,
1061,131062,"2,3,5,6-Tetrakis(methylsulfanyl)cyclohexa-2,5-diene-1,4-dione",CSC1=C(C(=O)C(=C(C1=O)SC)SC)SC,,,,,,
1062,131063,8-(3-Sulfophenyl)theophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3=CC(=CC=C3)S(=O)(=O)O,,,,,,
1063,131064,"5-(N-Carbobenzyloxyamino)-1,4-naphthoquinone",C1=CC=C(C=C1)COC(=O)NC2=CC=CC3=C2C(=O)C=CC3=O,,,,,,
1064,131065,N-Dodecylmonoaza-15-crown-5-N-oxide,CCCCCCCCCCCC[N+]1(CCOCCOCCOCCOCC1)[O-],,,,,,
1065,131066,alpha-N-Carboxy-beta-N-methylaminoalanine,CNC[C@@H](C(=O)O)NC(=O)O,,,,,,
1066,131067,3-(Carboxymethylamino)-L-alanine,CN(C[C@@H](C(=O)O)N)C(=O)O,,,,,,
1067,131068,4a-Fletoh,CCN1C2=C(C=C(C(=C2)C)C)N(C3=NC(=O)N(CC31O)C)C,,,,,,
1068,131069,"2-Butenoic acid,4-(6-methoxy-2-naphthalenyl)-4-oxo-, (2E)-",COC1=CC2=C(C=C1)C=C(C=C2)C(=O)C=CC(=O)O,,,,,,
1069,131070,Methyl 4-(6-methoxynaphthalene-2-yl)-4-oxo-2-butenoate,COC1=CC2=C(C=C1)C=C(C=C2)C(=O)C=CC(=O)OC,,,,,,
1070,131071,CID 131071,C[C@H](C(=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N)NCCCCNCCC(=O)NCCCCCNC(=O)[C@H](CC(=O)N)NC(=O)CC1=C(C=C(C=C1)O)O,,,,,,
1071,131072,Oxazofurin,C1=C(N=C(O1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,,,,,,
1072,131073,"2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol",CC(CC1=CC(=C(C=C1)Cl)Cl)(CO)N(C)C.Cl,,,,,,
1073,131074,Cericlamine,CC(CC1=CC(=C(C=C1)Cl)Cl)(CO)N(C)C,,,,,,
1074,131075,CID 131075,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4(C=CI)O)C,,,,,,
1075,131076,"(2S-cis)-3-(Acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-8-(2-thienylmethyl)-1,5-benzothiazepin-4(5H)-one monohydrochloride",CC(=O)O[C@@H]1[C@@H](SC2=C(C=CC(=C2)CC3=CC=CS3)N(C1=O)CCN(C)C)C4=CC=C(C=C4)OC.Cl,,,,,,
1076,131077,"[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-8-(thiophen-2-ylmethyl)-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate",CC(=O)O[C@@H]1[C@@H](SC2=C(C=CC(=C2)CC3=CC=CS3)N(C1=O)CCN(C)C)C4=CC=C(C=C4)OC,,,,,,
1077,131078,"4-(1,1-Dimethylethyl)cyclohexyl 4-pyridineacetate",CC(C)(C)C1CCC(CC1)OC(=O)CC2=CC=NC=C2,,,,,,
1078,131079,(E)-2-Chloro-3-(bromomethyl)oxirane,C(C1C(O1)Cl)Br,,,,,,
1079,131080,"1-(1-Chlorovinyl)-2,7-dimethoxynaphthalene",COC1=CC2=C(C=C1)C=CC(=C2C(=C)Cl)OC,,,,,,
1080,131081,Crigee ozonide,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC1OC(OO1)CCCCCCCC,,,,,,
1081,131082,"2-[[3-Hexadecanoyloxy-2-[8-(5-octyl-1,2,4-trioxolan-3-yl)octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC1OC(OO1)CCCCCCCC,,,,,,
1082,131083,KB-5492 (free base),COC1=CC=C(C=C1)OC(=O)CN2CCN(CC2)CC3=CC(=C(C(=C3)OC)OC)OC,,,,,,
1083,131084,Succinyl-phenylalanyl-leucyl-phenylalanine-4-methoxynaphthylamide,CC(C)C[C@@H](C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC2=C(C=CC3=CC=CC=C32)OC)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)CCC(=O)O,,,,,,
1084,131085,3-(oxiran-2-yl)-1H-indole,C1C(O1)C2=CNC3=CC=CC=C32,,,,,,
1085,131086,L-alpha-Aspartyl-L-tyrosyl-N-methyl-L-norleucylglycyl-L-tryptophyl-N-methyl-L-norleucyl-L-alpha-aspartyl-L-phenylalaninamide,CCCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N(C(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](CC(=O)O)N)C(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCC)NC)NC,,,,,,
1086,131087,CID 131087,CC1=NC=C(C(=O)N1)CN(C=O)C(=C(CCO)SS(=O)C(=C(C)N(CC2=CN=C(NC2=O)C)C=O)CCO)C,,,,,,
1087,131088,"[1,4-Bis(3,4,5-trimethoxybenzoyl)piperazin-2-yl]methyl 2,2-dimethylpropanoate",CC(C)(C)C(=O)OCC1CN(CCN1C(=O)C2=CC(=C(C(=C2)OC)OC)OC)C(=O)C3=CC(=C(C(=C3)OC)OC)OC,,,,,,
1088,131089,1-[2-(2-Phenylphenoxy)ethyl]-4-(3-phenylprop-2-enyl)piperazine,C1CN(CCN1CCOC2=CC=CC=C2C3=CC=CC=C3)CC=CC4=CC=CC=C4,,,,,,
1089,131090,CID 131090,CN(C)C(=O)C(=CC1=CC=C(C=C1)N)C2=CC=C(C=C2)Cl,,,,,,
1090,131091,"Substance P (6-11), arg(6)-trp(7,9)-Me-phe(8)-",CC1=CC=C(C=C1)C[C@@H](C(=O)N[C@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CCCN=C(N)N)N)N,,,,,,
1091,131092,"(2,5-dioxopyrrolidin-1-yl) 6-[[2-[[(3S,5R,8R,9S,10S,12R,13S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]acetyl]amino]hexanoate",C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4(C3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)OCC(=O)NCCCCCC(=O)ON6C(=O)CCC6=O,,,,,,
1092,131093,Pyroglutamyl-glutaminyl-glycyl-seryl-asparagine,C1CC(=O)N[C@@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O,,,,,,
1093,131094,Pyroglutamyl-glutamyl-glycyl-seryl-asparagine,C1CC(=O)N[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O,,,,,,
1094,131095,Pyro-glutamyl-glutamyl-glycyl-seryl-aspartic acid,C1CC(=O)N[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O,,,,,,
1095,131096,"(5S-trans)-N-(3-(4-(2-Aminoethyl)-2,6-dibromophenoxy)propyl)-7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-azaspiro(4,5)deca-2,6,8-triene-3-carboxamide",COC1=C([C@@H](C2(CC(=NO2)C(=O)NCCCOC3=C(C=C(C=C3Br)CCN)Br)C=C1Br)O)Br,,,,,,
1096,131097,"3-(4-((3,7-Dimethylocta-2,6-dien-1-yl)oxy)-3-methoxyphenyl)prop-2-en-1-ol",CC(=CCCC(=CCOC1=C(C=C(C=C1)C=CCO)OC)C)C,,,,,,
1097,131098,CID 131098,CCCCCCCC(=C1CC[C@@H]2CCC[C@@H]([C@H]2O1)SCC(=O)O)CCCCC(=O)C,,,,,,
1098,131099,"19,19-Difluoroandrost-4-en-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CCCC[C@]34C(F)F,,,,,,
1099,131100,"6-(5,6-Dimethoxybenzo(b)thien-2-yl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone",CC1CC(=O)NN=C1C2=CC3=CC(=C(C=C3S2)OC)OC,,,,,,
1100,131101,CID 131101,CCCCCCCCC=CCCCCCCCC(=O)C(CCCCCC=CCCCCCCCC)CC(=O)OC(C)COC(=O)CCC(=O)O,,,,,,
1101,131102,CID 131102,CC.CCCCN(CC)C1(CCCOC(=O)O1)N(CCCC)CCCC,,,,,,
1102,131103,CID 131103,CCCCN(CC)C1(CCCOC(=O)O1)N(CCCC)CCCC,,,,,,
1103,131104,CID 131104,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-])OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1104,131105,CID 131105,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)O,,,,,,
1105,131106,Cscomv,CC(C)[C@@H](C(=O)NC(=O)CN(C1CC2=CC=CC=C2C1)[C@@H](C(C)C)C(=O)C(F)(F)F)NC(=O)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC=C(C=C4)Cl,,,,,,
1106,131107,Ctbtp,C1CCC(CC1)NC(=O)C2CC3=C(CN2)SC4=CC=CC=C34.Cl,,,,,,
1107,131108,"1,2,3,4-Tetrahydro-N-cyclohexyl[1]benzothieno[2,3-c]pyridine-3-carboxamide",C1CCC(CC1)NC(=O)C2CC3=C(CN2)SC4=CC=CC=C34,,,,,,
1108,131109,1-Methylimidazole-2-carboxamide netropsin,CN1C=CN=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NCCCN(C)C)C)C,,,,,,
1109,131110,"7-(Dimethylamino)-8-methoxy-9-methyl-6,7,8,9-tetrahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-16-ol",C[C@@]12[C@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C)OC,,,,,,
1110,131111,CID 131111,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=CCN=C(C3=CC=C(C=C3)N[N+]#N)[O-])COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
1111,131112,CID 131112,C1[C@@H]([C@H](O[C@@H]1N2C=C(C(=O)NC2=O)C=CCNC(=O)C3=CC=C(C=C3)N[N+]#N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
1112,131113,Histidyl-aspartyl-glutamyl-leucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N,,,,,,
1113,131114,CID 131114,COC(=O)N=C(NC1=C(C=C(C=C1)C(F)(F)F)[N+](=O)[O-])S,,,,,,
1114,131115,CID 131115,CC(C)C1=CC=C2C(=C(C=C2S(=O)(=O)[O-])CCCCNS(=O)(=O)C3=CC=C(C=C3)Cl)C=C1.[Na+],,,,,,
1115,131116,KT2-962 free acid,CC(C)C1=CC=C2C(=C(C=C2S(=O)(=O)O)CCCCNS(=O)(=O)C3=CC=C(C=C3)Cl)C=C1,,,,,,
1116,131117,N-(1-(P-(5-Isoquinolinesulfonyl)benzyl)-2-(4-phenylpiperazinyl)ethyl)-5-isoquinolinesulfonamide,C1CN(CCN1CC(CC2=CC=C(C=C2)OS(=O)(=O)C3=CC=CC4=C3C=CN=C4)NS(=O)(=O)C5=CC=CC6=C5C=CN=C6)C7=CC=CC=C7,,,,,,
1117,131118,Mtech,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@@H](C4)OCCOCCOCCO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O)C)C,,,,,,
1118,131119,CID 131119,C1CC2=CC=CC=C2C(C3=CC=CC=C31)N4CCN(CC4)CC(COC5=CC=CC6=C5C=CC=N6)O,,,,,,
1119,131120,"[1,1'-Biphenyl]-2-carboxylicacid, 4'-[[2-(1-buten-1-yl)-4-chloro-5-formyl-1H-imidazol-1-yl]methyl]-",CCC=CC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C(=O)O)C=O)Cl,,,,,,
1120,131121,Neopentyl glycol diisooctanoate,CC(C)CCCCC(=O)OCC(C)(C)COC(=O)CCCCC(C)C,,,,,,
1121,131122,5-O-beta-Galactofuranosyl-galactofuranose,C([C@H]([C@H]1[C@@H]([C@H]([C@@H](O1)O[C@H](CO)[C@H]2[C@@H]([C@H]([C@H](O2)O)O)O)O)O)O)O,,,,,,
1122,131123,"(R)-3,4-Dihydro-2,2-dimethyl-4-((2-hydroxypropyl)imino)-7-pentyl-2H-1-benzothiopyran-5-ol",CCCCCC1=CC(=C2C(=NC[C@@H](C)O)CC(SC2=C1)(C)C)O,,,,,,
1123,131124,"3,9-Bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro(3,2-c)quinoline-6-one",CN(C)C(=O)OC1=CC2=C(C=C1)C3=C(C4=C(O3)C=C(C=C4)OC(=O)N(C)C)C(=O)N2,,,,,,
1124,131125,"3-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)-5-(1,1-dimethylethyl)imidazo(1,5-a)quinoxalin-4(5H)-one",CC(C)(C)N1C2=CC=CC=C2N3C=NC(=C3C1=O)C4=NOC(=N4)C5CC5,,,,,,
1125,131126,3-Amino-9-(diethylaminoethylthio)acridine,CCN(CC)CCSC1=C2C=CC(=CC2=NC3=CC=CC=C31)N,,,,,,
1126,131127,"2,6-Ditert-butyl-4-[(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylmethylsulfanyl]phenol",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SCSC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,,,,,
1127,131128,Methotrexate-alpha-arginine,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
1128,131129,2-Phenylethyl beta-primeveroside,C1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OCCC3=CC=CC=C3)O)O)O)O)O)O,,,,,,
1129,131130,N-(1-(2-Carboxy-4-phenylbutyl)cyclopentylcarbonyl)tryptophan,C1CCC(C1)(CC(CCC2=CC=CC=C2)C(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)O,,,,,,
1130,131131,(3R)-3-[[(2S)-6-amino-2-(methanesulfonamido)hexanoyl]amino]-4-[1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl]cyclopentyl]butanoic acid,CS(=O)(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)CC1(CCCC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O,,,,,,
1131,131132,"(3beta)-17-(Acetyloxy)-3-(alpha-L-arabinofuranosyloxy)pregna-4,6-dien-20-one",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=C[C@H](CC[C@]34C)O[C@H]5[C@@H]([C@H]([C@@H](O5)CO)O)O)C)OC(=O)C,,,,,,
1132,131133,Asp-pro-gln-tyr-ile-gln-ser-arg,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)N,,,,,,
1133,131134,Pentoxifylline mtpa,C[C@H](CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)OC(=O)[C@@](C3=CC=CC=C3)(C(F)(F)F)OC,,,,,,
1134,131135,"3-[3-(4-Azidophenyl)sulfonyl-1-[(4-hydroxy-3-iodophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid",CC(C)C1=CC2=C(C=C1)N(C(=C2S(=O)(=O)C3=CC=C(C=C3)N=[N+]=[N-])CC(C)(C)C(=O)O)CC4=CC(=C(C=C4)O)I,,,,,,
1135,131136,Arginyl-tyrosyl-aspartic acid,C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O,,,,,,
1136,131137,CID 131137,CC(C)CC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NC(=O)[C@H](CC2=CN=CN2)N[C@H](CC3CCCCC3)[C@H](CCCC4=CC=CC=N4)O,,,,,,
1137,131138,Sulfapen,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C.COC1=NN=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,
1138,131139,Gardan P,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)C(C)C.CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC,,,,,,
1139,131140,CID 131140,CC(=CC=C(C(F)(F)F)F)CS(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC.CC(=CCS(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC)C=C(C(F)(F)F)F,,,,,,
1140,131141,CID 131141,CC(=CC=C(C(F)(F)F)F)CS(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC,,,,,,
1141,131142,CID 131142,CC(=CCS(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC)C=C(C(F)(F)F)F,,,,,,
1142,131143,CID 131143,C[C@H]1CCCC=C[C@@H]2CCC[C@H]2[C@@H](C=CC(=O)O1)O,,,,,,
1143,131144,Methyl 2-hydroxy-5-methoxy-7-methyl-1-naphthalenecarboxylate,CC1=CC2=C(C=CC(=C2C(=O)OC)O)C(=C1)OC,,,,,,
1144,131145,"N-(9,10,10-trioxothioxanthen-3-yl)acetamide",CC(=O)NC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3S2(=O)=O,,,,,,
1145,131146,21-(Phenylseleno)progesterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)C[Se]C4=CC=CC=C4)CCC5=CC(=O)CC[C@]35C,,,,,,
1146,131147,"4-Amino-5-(2-aminopropyl)-1,2-benzenediol dihydrobromide",CC(CC1=CC(=C(C=C1N)O)O)N.Br.Br,,,,,,
1147,131148,"1,2-Benzenediol, 4-amino-5-(2-aminopropyl)-",CC(CC1=CC(=C(C=C1N)O)O)N,,,,,,
1148,131149,"[(2R,3R,4R,5R)-2-amino-4,5,6-trihydroxy-1-oxohexan-3-yl] hydrogen sulfate",C([C@H]([C@H]([C@@H]([C@H](C=O)N)OS(=O)(=O)O)O)O)O,,,,,,
1149,131150,1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine,CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
1150,131151,[O-(1-O-Myristoyl-2-O-stearoyl-L-glycero-3-phospho)choline]anion,CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
1151,131152,Diconal,CCC(=O)C(CCN1CCCCC1)(C2=CC=CC=C2)C3=CC=CC=C3.CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3.Cl.Cl,,,,,,
1152,131153,5-Fluoro-4-oxopentanoic acid,C(CC(=O)O)C(=O)CF,,,,,,
1153,131154,2-Phenyloxirane-2-carboxylic acid,C1C(O1)(C2=CC=CC=C2)C(=O)O,,,,,,
1154,131155,"1H-Azepinium, 1-(2-(decyloxy)-2-oxoethyl)-1-heptylhexahydro-, hydroxide",CCCCCCCCCCOC(=O)C[N+]1(CCCCCC1)CCCCCCC.[OH-],,,,,,
1155,131156,Decyl 2-(1-heptylazepan-1-ium-1-yl)acetate,CCCCCCCCCCOC(=O)C[N+]1(CCCCCC1)CCCCCCC,,,,,,
1156,131157,"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3',6'-dihydroxy-4',5'-diiodo-5-isothiocyanato-",C1=CC2=C(C=C1N=C=S)C(=O)OC23C4=C(C(=C(C=C4)O)I)OC5=C3C=CC(=C5I)O,,,,,,
1157,131158,"Benzenesulfonic acid, 3,5-diiodo-4-isothiocyanato-",C1=C(C=C(C(=C1I)N=C=S)I)S(=O)(=O)O,,,,,,
1158,131159,Dihydrokepone,C12C(=O)C3(C4C1(C5(C2(C3(C4(C5(Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1159,131160,"(2S)-2-amino-2-[(2,3-dihydroxyphenyl)methyl]-3-fluoropropanoic acid",C1=CC(=C(C(=C1)O)O)C[C@@](CF)(C(=O)O)N,,,,,,
1160,131161,"1,2,3-Propanetricarboxylic acid, 1-chloro-2-hydroxy-, (R*,R*)-(-)-",C(C(=O)O)[C@]([C@H](C(=O)O)Cl)(C(=O)O)O,,,,,,
1161,131162,Angoletin,CC1=C(C(=C(C(=C1O)C(=O)CCC2=CC=CC=C2)OC)C)O,,,,,,
1162,131163,"12-Hydroxyheptadeca-4,8,10-trienoic acid",CCCCCC(C=CC=CCCC=CCCC(=O)O)O,,,,,,
1163,131164,"Butanamide, N-cyclohexyl-N-(2-hydroxyethyl)-4-((1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)oxy)-",C1CCC(CC1)N(CCO)C(=O)CCCOC2=CC3=C(C=C2)NC(=O)CC3,,,,,,
1164,131165,N-(2-Benzoylphenyl)alanine,CC(C(=O)O)NC1=CC=CC=C1C(=O)C2=CC=CC=C2,,,,,,
1165,131166,2-(Pyridin-3-ylamino)propanoic acid,CC(C(=O)O)NC1=CN=CC=C1,,,,,,
1166,131167,1-(3-(p-Aminophenoxy)propyl)-4-(o-methoxyphenyl)piperazine dihydrochloride,COC1=CC=CC=C1N2CCN(CC2)CCCOC3=CC=C(C=C3)N.Cl.Cl,,,,,,
1167,131168,4-[3-[4-(2-Methoxyphenyl)piperazin-1-yl]propoxy]aniline,COC1=CC=CC=C1N2CCN(CC2)CCCOC3=CC=C(C=C3)N,,,,,,
1168,131169,CID 131169,C1=NC2=C(N1CCN)C(=O)N=C(N2)N,,,,,,
1169,131170,3-Chloro-1-carbacephem,C1CC(=C(N2[C@H]1[C@@H](C2=O)N)C(=O)O)Cl,,,,,,
1170,131171,(+/-)-Averufin,CC12CCCC(O1)C3=C(O2)C=C4C(=C3O)C(=O)C5=C(C4=O)C=C(C=C5O)O,,,,,,
1171,131172,1-Palmitoyl-2-linoleoyl PE,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC,,,,,,
1172,131173,"3-[5-[(3R,4S)-4-hydroxydithiolan-3-yl]-1-methylpyrrolidin-2-yl]dithiolan-4-ol",CN1C(CCC1C2C(CSS2)O)[C@@H]3[C@H](CSS3)O,,,,,,
1173,131174,2-(4-(2-Piperidinoethoxy)phenyl)-7-hydroxy-2H-1-benzopyran,C1CCN(CC1)CCOC2=CC=C(C=C2)C3C(=CC4=C(O3)C=C(C=C4)O)C5=CC=CC=C5,,,,,,
1174,131175,"6-((4-Imidazol-1-yl)phenyl)-4-phenyl-4,5-dihydro-2H-pyridazin-3-one",C1C(C(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3)C4=CC=CC=C4,,,,,,
1175,131176,Mag-fura-2-acetoxymethyl ester,CC(=O)OCOC(=O)CN(CC(=O)OCOC(=O)C)C1=C(C=C2C=C(OC2=C1)C3=NC=C(O3)C(=O)OCOC(=O)C)OCC(=O)OCOC(=O)C,,,,,,
1176,131177,"N-Succinimidyl-2,4-dimethoxy-3-(trimethylstannyl)benzoate",COC1=C(C(=C(C=C1)C(=O)ON2C(=O)CCC2=O)OC)[Sn](C)(C)C,,,,,,
1177,131178,Myristoyl-glycyl-seryl-seryl-lysine,CCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
1178,131179,CID 131179,CN1CCC23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@@H]3[C@@H](CC4)SSC6=NC=C(C=C6)[N+](=O)[O-],,,,,,
1179,131180,"2-(4-Chlorophenyl)-4,5-diphenyl-2-imidazoline hydrochloride",C1=CC=C(C=C1)[C@H]2[C@H](N=C(N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4.Cl,,,,,,
1180,131181,"(4R)-2-(4-Chlorophenyl)-4,5-dihydro-4alpha,5alpha-diphenyl-1H-imidazole",C1=CC=C(C=C1)[C@H]2[C@H](N=C(N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,,,,,,
1181,131182,9-Amino-20-camptothecin,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5N=C4C3=C2)N)O,,,,,,
1182,131183,"Propan-2-yl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-hydroxy-5-phenylpent-1-enyl)cyclopentyl]hept-5-enoate",CC(C)OC(=O)CCCC=CC[C@H]1[C@H](C[C@H]([C@@H]1C=CC(CCC2=CC=CC=C2)O)O)O,,,,,,
1183,131184,(+-)-4-Chloro-alpha-(4-chlorophenyl)-N-(2-hydroxybutyl)benzeneacetamide,CCC(CNC(=O)C(C1=CC=C(C=C1)Cl)C2=CC=C(C=C2)Cl)O,,,,,,
1184,131185,CID 131185,CC(C)OC(=O)CCCC=CC[C@H]1[C@H](C[C@H]([C@@H]1C=CC(=O)CCC2=CC=CC=C2)O)O,,,,,,
1185,131186,"N-(4-hydroxy-3,5-dimethylphenyl)-3,7-dimethylocta-2,6-dienamide",CC1=CC(=CC(=C1O)C)NC(=O)C=C(C)CCC=C(C)C,,,,,,
1186,131187,Pyrenylmethyl tributylphosphonium,CCCC[P+](CCCC)(CCCC)CC1=CC2=CC=CC3=C2C4=C(C=CC=C14)C=C3.[Br-],,,,,,
1187,131188,Tributyl(pyren-4-ylmethyl)phosphanium,CCCC[P+](CCCC)(CCCC)CC1=CC2=CC=CC3=C2C4=C(C=CC=C14)C=C3,,,,,,
1188,131189,"(3R)-3-hydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienamide",CC(=CC=CC=CCC1=CN=CO1)[C@H](C(C)(C)C(=O)N)O,,,,,,
1189,131190,"(2alpha,4alpha,4abeta,9abeta)-(+)-2,3,4,4a,9,9a-Hexahydro-6,8-dihydroxy-3,3,4a-trimethyl-7-(3-methyl-1-oxobutyl)-2,4-methano-1H-xanthene-5-carboxaldehyde",CC(C)CC(=O)C1=C(C(=C2C(=C1O)C[C@@H]3C[C@@H]4C[C@H]([C@@]3(O2)C)C4(C)C)C=O)O,,,,,,
1190,131191,Euglobal G 1,CC(C)CC(=O)C1=C2C(=C(C(=C1O)C=O)O)C[C@@H]3C[C@@H]4CC([C@@]3(O2)C)C4(C)C,,,,,,
1191,131192,CID 131192,C1=CC(=CC=C1CNC2=CC3=C(NC(=NC3=O)N)N=C2)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
1192,131193,CID 131193,C1[C@H](CNC2=C1C(=O)N=C(N2)N)NCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
1193,131194,Ngp-msh,CCCC[C@@H](C(=O)NC(=O)CNC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CC3=CC=CC=C3)NC(=O)[C@H](CC4C=NC=N4)NC(=O)[C@H](CCC(=O)N)NC5=CC=C(C=C5)O)NC(=O)C,,,,,,
1194,131195,3-(4-Chlorophenyl)tropane-2-carboxylic acid methyl ester,CN1[C@@H]2CCC1CC(C2C(=O)OC)C3=CC=C(C=C3)Cl,,,,,,
1195,131196,4-[5-[4-(N'-hydroxycarbamimidoyl)phenoxy]pentoxy]benzenecarboximidamide,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=NO)N,,,,,,
1196,131197,6-N-Benzoyl-5'-O-benzyl-2'-deoxyadenosine,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COCC5=CC=CC=C5)O,,,,,,
1197,131198,Esculentoside L,C[C@]1(CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(CC[C@@H]([C@@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)C)C)[C@H]2C1)C)C(=O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C(=O)OC,,,,,,
1198,131199,Rubiginone B1,C[C@@H]1C[C@@H](C2=C(C1)C=CC3=C2C(=O)C4=C(C3=O)C(=CC=C4)OC)O,,,,,,
1199,131200,N-(Phenylethylphosphonyl)-glycyl-prolyl-aminohexanoic acid,CCCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)CNP(=O)(CCC2=CC=CC=C2)O,,,,,,
1200,131201,"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-hexylcyclobutane-1-carboxylate",CCCCCCC1CC(C1)C(=O)O[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CCC5=CC(=O)CC[C@]45C)C,,,,,,
1201,131202,CID 131202,CC(C)([C@@H](C=C[C@H]1[C@@H]2CCC(=C[C@@H]2C[C@@H]1O)CCCCC(=O)O)O)OC3=CC=CC=C3,,,,,,
1202,131203,Aurobin,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O.CC(C)(CO)[C@H](C(=O)NCCCO)O.C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl.Cl,,,,,,
1203,131204,Dexpanthenol,CC(C)(CO)[C@H](C(=O)NCCCO)O,"['Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus.  Topical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy).']","['Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus.']",,"['Dexpanthenol is soluble in water and alcohol, although insoluble in fats and oil based substances. With the appropriate vehicle, Dexpanthenol is easily penetrated into the skin. Rate of penetration and absorption is reduced when Dexpanthenol is administered as an oil/water formula.', 'Milk of nursing mothers receiving a normal diet contains about 2 ug of pantothenic acid per mL. About 70% of an oral dose of pantothenic acid is excreted unchanged in urine and about 30% in feces.', 'Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A. Highest concentrations are found in the liver, adrenal glands, heart, and kidneys.', 'Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A. Highest concentrations are found in the liver, adrenal glands, heart, and kidneys. Milk of nursing mothers receiving a normal diet contains about 2 ug of pantothenic acid per mL. About 70% of an oral dose of pantothenic acid is excreted unchanged in urine and about 30% in feces.']","['Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.', 'Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.', 'Dexpanthenol is converted to pantothenic acid ... which then produces acetylcholine.']",['Half life have not been reported']
1204,131205,2-(4-(2-Pyrrolidinoethoxy)phenyl)-3-phenyl-2H-1-benzopyran,C1CCN(C1)CCOC2=CC=C(C=C2)C3C(=CC4=CC=CC=C4O3)C5=CC=CC=C5,,,,,,
1205,131206,CID 131206,C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N(C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(C)(C)N)[C@@](C)(CC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)OC(C)(C)C)C(=O)OC)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(C)(C)N,,,,,,
1206,131207,Bhdpa,C[C@]12CC([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)C(O)O)OC(=O)C4=CC=CC=C4)CCC5=CC(=O)C=C[C@]35C)O,,,,,,
1207,131208,"(8,8-Dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 5-hydroxy-4-phenylpentanoate iodide",C[N+]1(C2CCC1CC(C2)OC(=O)CCC(CO)C3=CC=CC=C3)C.[I-],,,,,,
1208,131209,"(8,8-Dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 5-hydroxy-4-phenylpentanoate",C[N+]1(C2CCC1CC(C2)OC(=O)CCC(CO)C3=CC=CC=C3)C,,,,,,
1209,131210,CID 131210,CC(=CCCC(=CCCC(=CCCC(=CC(=O)N[C@@H](CS)C(=O)OC)C)C)C)C,,,,,,
1210,131211,N-(3-Nitratopivaloyl)cysteine ethyl ester,CCOC(=O)[C@H](CS)NC(=O)C(C)(C)CO[N+](=O)[O-],,,,,,
1211,131212,2-Fluoro-N-n-propylnorapomorphine,CCCN1CCC2=C3[C@H]1CC4=C(C3=CC(=C2)F)C(=C(C=C4)O)O.Br,,,,,,
1212,131213,"2-Fluoro-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol",CCCN1CCC2=C3[C@H]1CC4=C(C3=CC(=C2)F)C(=C(C=C4)O)O,,,,,,
1213,131214,"1H-Indole-2-methanamine, 5-methoxy-N,1-dimethyl-N-2-propynyl-, monohydrochloride",CN1C2=C(C=C(C=C2)OC)C=C1CN(C)CC#C.Cl,,,,,,
1214,131215,(5-Methoxy-1-methyl-1H-indol-2-ylmethyl)-methyl-prop-2-ynyl-amine,CN1C2=C(C=C(C=C2)OC)C=C1CN(C)CC#C,,,,,,
1215,131216,2-(N-(2-Propynyl)aminomethyl)-1-methyl-5-methoxyindole,CN1C2=C(C=C(C=C2)OC)C=C1CNCC#C,,,,,,
1216,131217,CID 131217,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](C[C@H](C3)O)O)C,,,,,,
1217,131218,CID 131218,C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N(CC=C(C)CCC=C(C)CCC=C(C)C)[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N,,,,,,
1218,131219,Tnpcc,CCCCCC1CCC(CC1)C(=O)O[C@H]2CC[C@H]3[C@@]2(CC[C@H]4[C@H]3CCC5=CC(=O)CC[C@]45C)C,,,,,,
1219,131220,CID 131220,C1C[C@H]2C[C@H]1[C@@H]([C@H]2C=CCCCC(=O)O)CNS(=O)(=O)C3=CC=C(C=C3)Br,,,,,,
1220,131221,"[(1S,7S,8S,8aS)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-6-oxo-2,7,8,8a-tetrahydro-1H-naphthalen-1-yl] 2,2-dimethylbutanoate",CCC(C)(C)C(=O)O[C@H]1CC(=CC2=CC(=O)[C@H]([C@H]([C@H]12)CC[C@@H]3C[C@H](CC(=O)O3)O)C)C,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
1221,131222,Iodoethylspiperone,C1CN(CCC12C(=O)N(CN2C3=CC=CC=C3)CCI)CCCC(=O)C4=CC=C(C=C4)F,,,,,,
1222,131223,Seryl-lysyl-leucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N,,,,,,
1223,131224,N-(2-hydroxy-3-piperidin-1-ylpropoxy)pyridine-3-carboximidoyl chloride,C1CCN(CC1)CC(CON=C(C2=CN=CC=C2)Cl)O,,,,,,
1224,131225,Cholesteryl-3-iodobenzyl ether,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OCC5=CC(=CC=C5)I)C)C,,,,,,
1225,131226,"(3S,8S,9S,10R,13R,14S,17R)-3-[12-(3-iodophenyl)dodecoxy]-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OCCCCCCCCCCCCC5=CC(=CC=C5)I)C)C,,,,,,
1226,131227,CID 131227,CCOC(=O)N(C(=O)C)NC(=C1C(=O)C2=CC=CC=C2C1=O)C,,,,,,
1227,131228,Fpmpp,CCC(=O)OC1(CCN(CC1C)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=C3,,,,,,
1228,131229,Isopropyl 2-(4-(2-piperidinoethoxy)benzoyl)benzoate hydrochloride,CC(C)OC(=O)C1=CC=CC=C1C(=O)C2=CC=C(C=C2)OCCN3CCCCC3.Cl,,,,,,
1229,131230,Propan-2-yl 2-[4-(2-piperidin-1-ylethoxy)benzoyl]benzoate,CC(C)OC(=O)C1=CC=CC=C1C(=O)C2=CC=C(C=C2)OCCN3CCCCC3,,,,,,
1230,131231,Dhhbe,CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=C(C2=C(CCC(O2)(C)CC[N+](C)(C)C)C(=C1O)C)C,,,,,,
1231,131232,"2-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran)-2-yl]-N,N,N-trimethylethanaminium",CC1=C(C2=C(CCC(O2)(C)CC[N+](C)(C)C)C(=C1O)C)C,,,,,,
1232,131233,"1-[(2S,3R)-2-hydroxynonan-3-yl]imidazole-4-carboxamide",CCCCCC[C@H]([C@H](C)O)N1C=C(N=C1)C(=O)N,,,['Drugs that inhibit ADENOSINE DEAMINASE activity. (See all compounds classified as Adenosine Deaminase Inhibitors.)'],,,
1233,131234,"(7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2R,4S,6R)-4-hydroxy-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@@H]1C[C@@H](C[C@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)O,,,,,,
1234,131235,4-Methylluciferin,CC1=CC(=CC2=C1N=C(S2)C3=N[C@H](CS3)C(=O)O)O,,,,,,
1235,131236,CID 131236,C[C@H](CCCS(=O)(=O)[O-])[C@H]1CCC2[C@@]1(CCC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C.[Na+],,,,,,
1236,131237,"(4R)-4-[(3R,5S,7R,10S,13R,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentane-1-sulfonic acid",C[C@H](CCCS(=O)(=O)O)[C@H]1CCC2[C@@]1(CCC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
1237,131238,Secocubane-ccip,CC(C)NC(=O)C1(C2C3C1C4C3(C2C4Cl)C#N)Cl,,,,,,
1238,131239,"3,6-Dibenzylidene-1-methylpiperazine-2,5-dione",CN1C(=CC2=CC=CC=C2)C(=O)NC(=CC3=CC=CC=C3)C1=O,,,,,,
1239,131240,"N,N'-bis[2-(10-methoxy-7,7a-dihydropyrido[4,3-c]carbazol-7-ium-2-yl)ethyl]hexane-1,6-diamine",COC1=CC2=C3C(=CC=C4C3=CN(C=C4)CCNCCCCCCNCCN5C=CC6=CC=C7C(=C8C=C(C=CC8[NH2+]7)OC)C6=C5)[NH2+]C2C=C1,,,,,,
1240,131241,"N,N'-bis[2-(10-methoxy-7,7a-dihydropyrido[4,3-c]carbazol-2-yl)ethyl]hexane-1,6-diamine",COC1=CC2=C3C(=CC=C4C3=CN(C=C4)CCNCCCCCCNCCN5C=CC6=CC=C7C(=C8C=C(C=CC8N7)OC)C6=C5)NC2C=C1,,,,,,
1241,131242,"3,4-Dihydro-2-(2-dimethylaminoethyl)-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol",CC1=C(C2=C(CCC(O2)(C)CCN(C)C)C(=C1O)C)C.Cl,,,,,,
1242,131243,"2-(2-Dimethylaminoethyl)-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol",CC1=C(C2=C(CCC(O2)(C)CCN(C)C)C(=C1O)C)C,,,,,,
1243,131244,"4-((Carboxymethyl)amino)-5,7-dichloroquinoline-2-carboxylic acid",C1=C(C=C(C2=C1N=C(C=C2NCC(=O)O)C(=O)O)Cl)Cl,,,,,,
1244,131245,"4-((Carboxymethyl)oxy)-5,7-dichloroquinoline-2-carboxylic acid",C1=C(C=C(C2=C1N=C(C=C2OCC(=O)O)C(=O)O)Cl)Cl,,,,,,
1245,131246,CID 131246,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC=CCC=CCCCCCCCC,,,,,,
1246,131247,CID 131247,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCC=CCC=CCCCCCCCC,,,,,,
1247,131248,Benzyl beta-primeveroside,C1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OCC3=CC=CC=C3)O)O)O)O)O)O,,,,,,
1248,131249,1-(6-(1-Aziridinyl)hexyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol,CC1=C(N(C2=C1C=C(C=C2)O)CCCCCCN3CC3)C4=CC=C(C=C4)O,,,,,,
1249,131250,"methyl (3S,4S)-4-methoxy-2-(methoxymethylidene)-6-(4-methoxyphenyl)-3-methylhex-5-enoate",C[C@H]([C@H](C=CC1=CC=C(C=C1)OC)OC)C(=COC)C(=O)OC,,,,,,
1250,131251,Picumeterol,C1=CC=NC(=C1)CCOCCCCCCNC[C@@H](C2=CC(=C(C(=C2)Cl)N)Cl)O,,,,,,
1251,131252,"cis-N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)cyclohexylamine",CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@H]2N3CCCC3.Br.Br,,,,,,
1252,131253,"2-Azabutane, N-[[2-pyrrolidin-1-yl]cyclohexyl]-4-[3,4-dichlorophenyl]-",CN(CCC1=CC(=C(C=C1)Cl)Cl)C2CCCCC2N3CCCC3,,,,,,
1253,131254,"alpha-(2-(4-Aminophenyl)ethyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid",C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)O)C(CCC2=CC=C(C=C2)N)C(=O)O)CC(=O)O,,,,,,
1254,131255,2-(4-Morpholinyl)-4H-1-benzopyran-4-one,C1COCCN1C2=CC(=O)C3=CC=CC=C3O2,,,,,,
1255,131256,2-(4-Morpholinyl)-8-(3-pyridinylmethoxy)-4H-1-benzopyran-4-one,C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)OCC4=CN=CC=C4,,,,,,
1256,131257,8-Methyl-2-(4-morpholinyl)-7-(1-naphthalenylmethoxy)-4H-1-benzopyran-4-one,CC1=C(C=CC2=C1OC(=CC2=O)N3CCOCC3)OCC4=CC=CC5=CC=CC=C54,,,,,,
1257,131258,CID 131258,C[C@H]1C=C(C(=O)N(CC[C@H](CCC(=O)N1)O)N2CCCCCCNCC=CC2)NC(=O)[C@H]([C@@H](C)O)NC(=O)C=CC=CCCCCCC(C)C,,,,,,
1258,131259,CID 131259,C[C@H]1C=CC(=O)NCC[C@@H](C[C@@H](C(=O)N1)NC(=O)[C@H]([C@@H](C)O)NC(=O)C=CC=CCCCC(C)C)O,,,,,,
1259,131260,Aprophit,CCN(CC)CCOC(=O)C(C)(C1=CC=CC=C1)C2=CC=C(C=C2)N=C=S.C(=O)(C(=O)[O-])[O-],,,,,,
1260,131261,2-(Diethylamino)ethyl 2-(4-isothiocyanatophenyl)-2-phenylpropanoate,CCN(CC)CCOC(=O)C(C)(C1=CC=CC=C1)C2=CC=C(C=C2)N=C=S,,,,,,
1261,131262,((2-Azido-4-benzyl)phenoxy)-N-ethylmorpholine,C1COCCN1CCOC2=C(C=C(C=C2)CC3=CC=CC=C3)N=[N+]=[N-],,,,,,
1262,131263,"Indane-1,3-dione-2-imine-N-acetic acid",C1=CC=C2C(=C1)C(=O)C(=NCC(=O)O)C2=O,,,,,,
1263,131264,"4-[[3-Benzoyl-5-(3,7-dimethylocta-2,6-dienyl)-2,4,6-trihydroxyphenyl]methyl]-3,5-dihydroxy-6,6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one",CC(C)C(=O)C1=C(C(=C(C(C1=O)(C)C)O)CC2=C(C(=C(C(=C2O)CC=C(C)CCC=C(C)C)O)C(=O)C3=CC=CC=C3)O)O,,,,,,
1264,131265,"1-(3,4-Dihydroxyphenyl)-2-(3-(4-carbamylphenyl)-1-methylpropylamino)ethanol",CC(CCC1=CC=C(C=C1)C(=O)N)NCC(C2=CC(=C(C=C2)O)O)O,,,,,,
1265,131266,"4,4'-(4,4'-Biphenyldiylbis(sulfonylamino))bis(5-hydroxy-2,7-naphthalenedisulfonic acid)",C1=CC(=CC=C1C2=CC=C(C=C2)S(=O)(=O)NC3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C=C4O)S(=O)(=O)O)S(=O)(=O)NC5=C6C(=CC(=C5)S(=O)(=O)O)C=C(C=C6O)S(=O)(=O)O,,,,,,
1266,131267,2'-O-(N-Methylanthraniloyl)ATP,CNC1=CC=CC=C1C(=O)O[C@@H]2[C@@H]([C@H](O[C@H]2N3C=NC4=C(N=CN=C43)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
1267,131268,"8-(1-Piperazinyl)imidazo(1,2-a)pyrazine",C1CN(CCN1)C2=NC=CN3C2=NC=C3,,,,,,
1268,131269,"2-Amino-3-(3,5-dihydroxyphenyl)-1-propanol",C1=C(C=C(C=C1O)O)CC(CO)N,,,,,,
1269,131270,Flosequinoxan,CN1C=C(C(=O)C2=C1C=C(C=C2)F)S(=O)(=O)C,,,,,['Flosequinan sulfone is a known human metabolite of flosequinan.'],
1270,131271,"5,6-Dicl-amiloride",C1(=C(N=C(C(=N1)Cl)Cl)N)C(=O)N=C(N)N,,,,,,
1271,131272,Fluoro-p-chloroamphetamine,C1=CC(=CC=C1CC(CF)N)Cl,,,,,,
1272,131273,3-Heptadecadienyl pyrocatechol,CCCCCCCCCCCCCC=CC=CC1=C(C(=CC=C1)O)O,,,,,,
1273,131274,"10H-Phenothiazine-10-propanaminium, N-((benzoyloxy)methyl)-2-chloro-N,N-dimethyl-, chloride",C[N+](C)(CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl)COC(=O)C4=CC=CC=C4.[Cl-],,,,,,
1274,131275,Benzoyloxymethyl-[3-(2-chlorophenothiazin-10-yl)propyl]-dimethylazanium,C[N+](C)(CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl)COC(=O)C4=CC=CC=C4,,,,,,
1275,131276,"1-[(4-Hydroxy-5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione",C1C(=O)NC(=O)N1N=CC2=CC(=C(O2)[N+](=O)[O-])O,,,,,,
1276,131277,"(1S)-16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene;[(1R)-7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl]methanesulfonic acid",CC1(C2CC[C@@]1(C(=O)C2)CS(=O)(=O)O)C.COC1=C(C2=C(C[C@H]3C4=CC5=C(C=C4CCN3C2)OCO5)C=C1)OC,,,,,,
1277,131278,(1R)-(-)-10-Camphorsulfonic acid,CC1(C2CC[C@@]1(C(=O)C2)CS(=O)(=O)O)C,,,,,,
1278,131279,"1H-1,2,4-Triazole-1-ethanol, alpha,alpha-bis(4-fluorophenyl)-",C1=CC(=CC=C1C(CN2C=NC=N2)(C3=CC=C(C=C3)F)O)F,,,,,,
1279,131280,"1-(2,4-Dichlorophenyl)-1-(4-fluorophenyl)-2-(1,2,4-triazol-1-yl)ethanol",C1=CC(=CC=C1C(CN2C=NC=N2)(C3=C(C=C(C=C3)Cl)Cl)O)F,,,,,,
1280,131281,Ketoprofen glucuronide,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,['Ketoprofen glucuronide is a known human metabolite of Ketoprofen.'],
1281,131282,"4,4'-Bis(N-maleimido)benzophenone",C1=CC(=CC=C1C(=O)C2=CC=C(C=C2)N3C(=O)C=CC3=O)N4C(=O)C=CC4=O,,,,,,
1282,131283,"2H-Isoindol-2-amine, 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-1,3-dihydro-, monohydrochloride",C1CN=C(N1)NN2CC3=C(C2)C(=CC=C3)Cl.Cl,,,,,,
1283,131284,4-Chloro-2-(2-imidazolin-2-ylamino)isoindoline,C1CN=C(N1)NN2CC3=C(C2)C(=CC=C3)Cl,,,,,,
1284,131285,"4-[(3s,3Ar,5ar,6s,9as,9br)-3-hydroxy-3a,6-dimethyldodecahydro-1h-cyclopenta[a]naphthalen-6-yl]butan-2-one",CC(=O)CC[C@@]1(CCC[C@H]2[C@H]1CC[C@@]3([C@@H]2CC[C@@H]3O)C)C,,,,,,
1285,131286,1-(2-(Diphenylmethoxy)ethyl)-4-(3-(4-fluorophenyl)propyl)piperazine,C1CN(CCN1CCCC2=CC=C(C=C2)F)CCOC(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1286,131287,Quinacillin sulfone,CC1([C@@H](N2[C@H](S1(=O)=O)[C@@H](C2=O)NC(=O)C3=NC4=CC=CC=C4N=C3C(=O)O)C(=O)O)C,,,,,,
1287,131288,2-[4-[2-Hydroxy-3-(4-phenylbutan-2-ylamino)propoxy]phenyl]acetamide,CC(CCC1=CC=CC=C1)NCC(COC2=CC=C(C=C2)CC(=O)N)O,,,,,,
1288,131289,Benzophenone-4-iodoacetamide,C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)NC(=O)CI,,,,,,
1289,131290,Palmitoylhomocysteine,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCS)C(=O)O,,,,,,
1290,131291,"1h-Imidazole, 2-[(2,6-dichlorophenyl)thio]-4,5-dihydro-",C1CN=C(N1)SC2=C(C=CC=C2Cl)Cl,,,,,,
1291,131292,"1H-Imidazol-2-amine, N-(5-chloro-2-phenoxyphenyl)-4,5-dihydro-",C1CN=C(N1)NC2=C(C=CC(=C2)Cl)OC3=CC=CC=C3,,,,,,
1292,131293,Beserol,CC(=O)NC1=CC=C(C=C1)O.CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,,,,,,
1293,131294,Astra 2167,CCC(=O)O[C@](CC1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CN(C)C.CC(=O)OC1=CC=CC=C1C(=O)O.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O,,,,,,
1294,131295,"trans-(+-)-2,3,4,4a,7,8,12b,13-Octahydro-1H-6-thia-13a-azabenzo(f)naphth(1,2,3-cd)azulene",C1CCN2C[C@@H]3C4=CC=CC=C4CCC5=C3C(=CS5)[C@H]2C1,,,,,,
1295,131296,5-But-2-enoyl-4-methoxy-6-methylpyran-2-one,CC=CC(=O)C1=C(OC(=O)C=C1OC)C,,,,,,
1296,131297,"1,2,3,5,6,7,8,9-Octahydro(1)benzothieno(2,3-d)imidazo(1,2-a)pyrimidin-2-one hydrochloride",C1CCC2=C(C1)C3=C(S2)N=C4NC(=O)CN4C3.Cl,,,,,,
1297,131298,"5,6,7,8,9,11-Hexahydro[1]benzothieno[2,3-d]imidazo[1,2-a]pyrimidin-2(3H)-one",C1CCC2=C(C1)C3=C(S2)N=C4NC(=O)CN4C3,,,,,,
1298,131299,Boc-cys(npys)-OH,CC(C)(C)OC(=O)N[C@@H](CSSC1=C(C=CC=N1)[N+](=O)[O-])C(=O)O,,,,,,
1299,131300,CID 131300,CCCCCC(=NNN=O)C=CC=CC=O,,,,,,
1300,131301,Sulfacarbamide mixture with sulfadiazine and sulfamethazine,CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C.C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N.C1=CC(=CC=C1N)S(=O)(=O)NC(=O)N,,,,,,
1301,131302,Prisotinol,CC(C)NC(C)CC1=NC=C(C=C1)O,,,,,,
1302,131303,Propionylcarnitine-taurine amide,CCC(=O)O[C@H](CC(=O)NCCS(=O)(=O)[O-])C[N+](C)(C)C,,,,,,
1303,131304,trimethyl-[(2R)-4-oxo-2-propanoyloxy-4-(2-sulfoethylamino)butyl]azanium,CCC(=O)O[C@H](CC(=O)NCCS(=O)(=O)O)C[N+](C)(C)C,,,,,,
1304,131305,Tyrosyl-tryptophyl-alanyl-tryptophyl-phenylalaninamide,C[C@@H](C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CC6=CC=C(C=C6)O)N,,,,,,
1305,131306,2-Arg-5-leu-enkephalin,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
1306,131307,N-(2-Chloroethyl)-4-piperidinyl diphenylacetate,C1CN(CCC1OC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3)CCCl,,,,,,
1307,131308,"1-Ethynyl-2,7-dimethoxynaphthalene",COC1=CC2=C(C=C1)C=CC(=C2C#C)OC,,,,,,
1308,131309,"2-Methoxy-6-nonyl-1,4-benzoquinone",CCCCCCCCCC1=CC(=O)C=C(C1=O)OC,,,,,,
1309,131310,"4-[7-[5-[1,4-dihydroxy-4-[5-(1-hydroxytridecyl)oxolan-2-yl]butyl]oxolan-2-yl]-2-hydroxyheptyl]-2-methyl-2H-furan-5-one",CCCCCCCCCCCCC(C1CCC(O1)C(CCC(C2CCC(O2)CCCCCC(CC3=CC(OC3=O)C)O)O)O)O,,,,,,
1310,131311,"N-methyl-1-[1-[4-(trifluoromethyl)phenoxy]-2,3-dihydro-1H-inden-2-yl]methanamine;hydrochloride",CNCC1CC2=CC=CC=C2C1OC3=CC=C(C=C3)C(F)(F)F.Cl,,,,,,
1311,131312,1-(p-Trifluoromethylphenoxy)-2-(methylamino)methylindane,CNCC1CC2=CC=CC=C2C1OC3=CC=C(C=C3)C(F)(F)F,,,,,,
1312,131313,CID 131313,C1CN(CCC1C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)O)CCCOC4=CC=C(C=C4)C(=O)[O-].[Na+],,,,,,
1313,131314,4-[3-[4-[Bis(4-fluorophenyl)-hydroxymethyl]piperidin-1-yl]propoxy]benzoic acid,C1CN(CCC1C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)O)CCCOC4=CC=C(C=C4)C(=O)O,,,,,,
1314,131315,1-Butyl-5-hydroxy-2-methyl-N-(1-(2-phenylethyl)-4-piperidyl)indole-3-carboxamide hydrochloride,CCCCN1C(=C(C2=C1C=CC(=C2)O)C(=O)NC3CCN(CC3)CCC4=CC=CC=C4)C.Cl,,,,,,
1315,131316,1-butyl-5-hydroxy-2-methyl-N-(1-(2-phenylethyl)-4-piperidyl)indole-3-carboxamide,CCCCN1C(=C(C2=C1C=CC(=C2)O)C(=O)NC3CCN(CC3)CCC4=CC=CC=C4)C,,,,,,
1316,131317,CID 131317,C1C=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)C(=NO[C@H](C3=CC(=C(C=C3)O)O)C(=O)O)C4=CSC(=N4)N)C(=O)O,,,,,,
1317,131318,"[(4aR,8R,8aR)-2-phenyl-6-tributylstannyl-4,4a,8,8a-tetrahydropyrano[3,2-d][1,3]dioxin-8-yl]oxy-tert-butyl-dimethylsilane",CCCC[Sn](CCCC)(CCCC)C1=C[C@H]([C@H]2[C@H](O1)COC(O2)C3=CC=CC=C3)O[Si](C)(C)C(C)(C)C,,,,,,
1318,131319,N-[2-(N-formyl-p-chlorocinnamylamino)ethyl]-5-isoquinolinesulfonamide,C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCN(CC=CC3=CC=C(C=C3)Cl)C=O,,,,,,
1319,131320,1-Sulfooxymethylpyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)COS(=O)(=O)O,,,,,['1-Sulfooxymethylpyrene is a known human metabolite of 1-hydroxymethylpyrene.'],
1320,131321,CID 131321,C1CN(C[C@H]2[C@@H]1CNC3=C2C(=O)N=C(N3)N)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
1321,131322,4-Benzoyl(benzoyl)-1-amidofluorescein,C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)C(=O)NC3=CC4=C(C=C3)C5(C6=C(C=C(C=C6)O)OC7=C5C=CC(=C7)O)OC4=O,,,,,,
1322,131323,3'Anthraniloyl-2'-deoxy-adenosine-5'-triphosphate,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)OC(=O)C4=CC=CC=C4N,,,,,,
1323,131324,(2-Chloro-3-hexadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)Cl,,,,,,
1324,131325,"N,N,N-Trimethyl-2-[[(2-chloro-3-hexadecyloxypropyl)oxy](oxylato)phosphinyloxy]ethanaminium",CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)Cl,,,,,,
1325,131326,132-Ocdpc,CCCCCCCCCCCCCCCCOCC(CCl)OP(=O)([O-])OCC[N+](C)(C)C,,,,,,
1326,131327,2-[(1-Chloro-3-hexadecoxypropan-2-yl)oxy-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCOCC(CCl)OP(=O)(O)OCC[N+](C)(C)C,,,,,,
1327,131328,(3-Chloro-2-hexadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCOC(COP(=O)([O-])OCC[N+](C)(C)C)CCl,,,,,,
1328,131329,O-[[3-Chloro-2-(hexadecyloxy)propyloxy]phosphonyl]choline,CCCCCCCCCCCCCCCCOC(COP(=O)(O)OCC[N+](C)(C)C)CCl,,,,,,
1329,131330,CID 131330,C1C(C(C(C1O)CO)F)N2C=NC3=C2NC(=NC3=O)N,,,,,,
1330,131331,"3,16-Dihydroxyandrost-5-ene-17,19-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H](C2=O)O)CC=C4[C@@]3(CC[C@@H](C4)O)C=O,,,,,,
1331,131332,N-Acetyldopamine-sulfate,CC(=O)NCCC1=CC(=C(C=C1)O)O.OS(=O)(=O)O,,,,,,
1332,131333,Sulfosuccinimidyl-N-(3-(acetylthio)-3-methylbutyryl)-beta-alanine,CC(=O)SC(C)(C)CC(=O)N([C@@H](CC(=O)O)S(=O)(=O)O)N1C(=O)CCC1=O,,,,,,
1333,131334,"3-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]cyclohexa-2,4-diene-1-thione",C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=CC(=S)CC=C5)O)C)OC6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O,,,,,,
1334,131335,CID 131335,C(CCC(F)(F)F)CC=CCC=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)O)N,,,,,,
1335,131336,Botbo,C[C@]12CCC3=C([C@@H]1CCC2O)COC4=C3C=CC5=CC=CC=C54,,,,,,
1336,131337,"8-(Dicyclopropylmethyl)-1,3-dipropylxanthine",CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C(C3CC3)C4CC4,,,,,,
1337,131338,"N,N'-Bis(2-hydroxyethyl)-N'-acryloyl-1,3-diaminopropane",C=CC(=O)N(CCCNCCO)CCO,,,,,,
1338,131339,"4-(4-(4-(2-Pyrimidyl)-1-piperazinyl)butyl)-1,4-benzoxazepine-3,5(2H,4H)-dione",C1CN(CCN1CCCCN2C(=O)COC3=CC=CC=C3C2=O)C4=NC=CC=N4,,,,,,
1339,131340,Herierin III,CC1=C(C(=O)C=C(O1)CO)CO,,,,,,
1340,131341,Herierin IV,CC(C1=COC(=CC1=O)CO)O,,,,,,
1341,131342,"1H-Imidazole, 5-((2-chloro-6-methylphenyl)sulfonyl)-1-methyl-4-nitro-",CC1=C(C(=CC=C1)Cl)S(=O)(=O)C2=C(N=CN2C)[N+](=O)[O-],,,,,,
1342,131343,Isoleucyl-lysyl-valyl-alanyl-valine,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N,,,,,,
1343,131344,CID 131344,CN1C(=NN=N1)C(=C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C=C[C@@H](C[C@@H](CC(=O)[O-])O)O.[Na+],,,,,,
1344,131345,CID 131345,CN1C(=NN=N1)C(=C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C=C[C@@H](C[C@@H](CC(=O)O)O)O,,,,,,
1345,131346,"(2S,3R,4aS,6aR,6aS,6bR,9S,10S,12aR,14bS)-3,10-dihydroxy-9-(hydroxymethyl)-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-2-carboxylic acid",C[C@@]12CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(CC[C@@H]([C@]5(C)CO)O)C)C)[C@H]1C[C@]([C@@H](C2)O)(C)C(=O)O)C,,,,,,
1346,131347,"2-(4-(2-((3,5-Dichlorophenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid",CC(C)(C(=O)O)OC1=CC=C(C=C1)CC(=O)NC2=CC(=CC(=C2)Cl)Cl,,,,,,
1347,131348,Cornuside,COC(=O)C1=CO[C@@H]([C@H]([C@H]1CCOC(=O)C2=CC(=C(C(=C2)O)O)O)C=C)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
1348,131349,Pyrophen,CC(=O)N[C@@H](CC1=CC=CC=C1)C2=CC(=CC(=O)O2)OC,,,,,,
1349,131350,Saintopin,C1=C2C=C3C(=C(C2=C(C=C1O)O)O)C(=O)C4=C(C3=O)C=C(C=C4O)O,,,,,,
1350,131351,Buthionine sulfoximine ethyl ester,CCC(C)S(=N)(=O)CC[C@@H](C(=O)OCC)N,,,,,,
1351,131352,"(4R)-4-[(8R,9S,10S,13R,14S,17R)-3-Hydroxy-7-hydroxyimino-10,13-dimethyl-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=NO)CC4[C@@]3(CCC(C4)O)C)C,,,,,,
1352,131353,CID 131353,CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC(CO)(CO)N)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1353,131354,CID 131354,C1=CC(=CC=C1C[C@@H](C(=O)O)N=C(C2=C(C(=C(C(=C2F)F)N[N+]#N)F)F)[O-])O,,,,,,
1354,131355,CID 131355,C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)C2=C(C(=C(C(=C2F)F)N[N+]#N)F)F)O,,,,,,
1355,131356,CID 131356,C1CC(=O)N(C1=O)OC(=O)[C@H](CC2=CC=C(C=C2)O)N=C(C3=C(C(=C(C(=C3F)F)N[N+]#N)F)F)[O-],,,,,,
1356,131357,CID 131357,C1CC(=O)N(C1=O)OC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)C3=C(C(=C(C(=C3F)F)N[N+]#N)F)F,,,,,,
1357,131358,"Succinimidyl 2-(4-azido-2,3,5,6-tetrafluorophenyl)thiazole-4-carboxylate",C1CC(=O)N(C1=O)OC(=O)C2=CSC(=N2)C3=C(C(=C(C(=C3F)F)N=[N+]=[N-])F)F,,,,,,
1358,131359,CID 131359,CC(C)N(C(C)C)C(=O)[C@H]1CCC2[C@@]1(CCC3C2CCC4=C3C=CC(=C4)S(=O)(=O)[O-])C.[K+],,,,,,
1359,131360,"(13S,17S)-17-[di(propan-2-yl)carbamoyl]-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3-sulfonic acid",CC(C)N(C(C)C)C(=O)[C@H]1CCC2[C@@]1(CCC3C2CCC4=C3C=CC(=C4)S(=O)(=O)O)C,,,,,,
1360,131361,5-(N-Maleimido)-3-oxapentyl-(2-((3-carboxybenzoyl)thio)acetyl)glycyl-glycyl-glycinate,C1=CC(=CC(=C1)C(=O)SCC(=O)NCC(=O)NCC(=O)NCC(=O)OCCOCCN2C(=O)C=CC2=O)C(=O)O,,,,,,
1361,131362,N-(5-Maleimido-3-oxapentyl)(2-(3-carboxybenzoyl)thio)acetylglycyl-glycyl-glycinamide,C1=CC(=CC(=C1)C(=O)SCC(=O)NCC(=O)NCC(=O)NC(=O)CNCCOCCN2C(=O)C=CC2=O)C(=O)O,,,,,,
1362,131363,"1-(Aminocarbonyl)-6-(3-chlorophenyl)-1,2,3,6-tetrahydro-4-methyl-2-oxo-5-pyrimidinecarboxylic acid 1-methylethyl ester",CC1=C(C(N(C(=O)N1)C(=O)N)C2=CC(=CC=C2)Cl)C(=O)OC(C)C,,,,,,
1363,131364,"4-(8-Chloro-7-hydroxy-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-5-yl)benzaldehyde",CN1CCC2=CC(=C(C=C2C(C1)C3=CC=C(C=C3)C=O)O)Cl,,,,,,
1364,131365,CID 131365,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)O)O)O)NC(=NC2=O)N,,,,,,
1365,131366,4-(4-Azido-2-nitrophenyl)pyridoxamine,CC1=NC=C(C(=C1O)C(C2=C(C=C(C=C2)N=[N+]=[N-])[N+](=O)[O-])N)CO,,,,,,
1366,131367,"16-(3-Ethyloxiran-2-YL)hexadeca-5,8,11,14-tetraenoic acid",CCC1C(O1)CC=CCC=CCC=CCC=CCCCC(=O)O,,,,,,
1367,131368,"2,6-Dimethyl-5-(4,6-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-4-(3-nitrophenyl)-3-pyridinecarboxylic acid 2-[4-(diphenylmethyl)piperazino]ethyl ester",CC1CC(OP(=O)(O1)C2=C(C(=C(N=C2C)C)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5)C6=CC(=CC=C6)[N+](=O)[O-])C,,,,,,
1368,131369,2-Thiomorpholinoethylacrylamide,C=CC(=O)NCCN1CCOC(=S)C1,,,,,,
1369,131370,CID 131370,C[C@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)OC)NC(=O)CCC(=O)OC,,,,,,
1370,131371,CID 131371,CC(OC(C1=CC=CC=C1)(C2=CC=C(C=C2)OC)C3=CC=C(C=C3)OC)SC4=C(N=CC(=C4)[N+](=O)[O-])S,,,,,,
1371,131372,Lysyl-tyrosyl-serine acetate,CC(=O)O.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N)O,,,,,,
1372,131373,"L-Serine, L-lysyl-L-tyrosyl-",C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N)O,,,,,,
1373,131374,"6-(4-Methoxyphenyl)pyrrolo(2,1-d)(1,5)benzothiazepin-7(6H)-ol",COC1=CC=C(C=C1)[C@@H]2[C@@H](C3=CC=CN3C4=CC=CC=C4S2)O,,,,,,
1374,131375,"(2R)-2-amino-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenylsulfanyl)propanoic acid",CC(=CCCC(=CCCC(=CCCC(=CCSC[C@@H](C(=O)O)N)C)C)C)C,,,,,,
1375,131376,"1-(2-Hydroxy-3,3-dimethyl-6-nitro-1,2-dihydroinden-1-yl)pyridin-2-one",CC1(C(C(C2=C1C=CC(=C2)[N+](=O)[O-])N3C=CC=CC3=O)O)C,,,,,,
1376,131377,CID 131377,C[C@@H](C(=O)N[C@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C)O[C@@H]1[C@H](CNC([C@H]1O)CO)NC(=O)C.C(=O)(C(F)(F)F)O,,,,,,
1377,131378,CID 131378,C[C@@H](C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)[C@@H](C)O[C@@H]1[C@H](CNC([C@H]1O)CO)NC(=O)C,,,,,,
1378,131379,Cercosporamide,CC(=O)C1=C(C=C2[C@@](C1=O)(C3=C(C=C(C(=C3O2)C(=O)N)O)O)C)O,,,,,,
1379,131380,"9-acetyl-6,9,11-trihydroxy-7-[[5-hydroxy-2-(2-hydroxypropyl)-4,10-dimethyl-4,5,6,6a,7,8,10,10a-octahydropyrano[3,4-d][1,3,6]dioxazocin-8-yl]oxy]-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",CC1C2C(CC(O1)OC3CC(CC4=C3C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)OC)O)(C(=O)C)O)NC(C(OC(O2)CC(C)O)C)O,,,,,,
1380,131381,CID 131381,CC(C)(C)OC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N(C(=O)[C@H](CC3=CC=CC=C3)NC)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCNC(=O)C=CC4=CC=C(C=C4)O)N,,,,,,
1381,131382,"4-(N,N-Dimethylsulfamoyl)-7-hydrazino-benzofurazan",CN(C)S(=O)(=O)C1=CC=C(C2=NON=C12)NN,,,,,,
1382,131383,N-Stearoyl-seryl-proline ethyl ester,CCCCCCCCCCCCCCCCCC(=O)N[C@H](CO)C(=O)N1CCC[C@H]1C(=O)OCC,,,,,,
1383,131384,"2,3,6-Trimethylhept-5-en-1-ol",CC(CC=C(C)C)C(C)CO,,,,,,
1384,131385,CID 131385,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCNC1=CC=C(C2=NON=C12)[N+](=O)[O-],,,,,,
1385,131386,CID 131386,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCNC1=CC=C(C2=NON=C12)[N+](=O)[O-],,,,,,
1386,131387,Histidylprolyl-2-naphthylamide,C1C[C@H](N(C1)C2=CC3=CC=CC=C3C=C2)C(=O)NC(=O)[C@H](CC4=CN=CN4)N,,,,,,
1387,131388,6-Dmpcsl,CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC1(N(C(CO1)(C)C)[O])CCCCCCCC,,,,,,
1388,131389,CID 131389,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCC1(N(C(CO1)(C)C)[O])CCCCCCCC,,,,,,
1389,131390,6-(Difluoromethyl)tryptophan,C1=CC2=C(C=C1C(F)F)NC=C2C[C@@H](C(=O)O)N,,,,,,
1390,131391,1-Heptanoyl-2-heptanoylamino-2-deoxyglycero-3-phosphoglycol,CCCCCCC(=O)N[C@H](COC(=O)CCCCCC)COP(=O)(O)O,,,,,,
1391,131392,"1H-Imidazole-1-propanamine, N-(2-bromoethyl)-2-nitro-, monohydrobromide",C1=CN(C(=N1)[N+](=O)[O-])CCCNCCBr.Br,,,,,,
1392,131393,N-(2-bromoethyl)-3-(2-nitroimidazol-1-yl)propan-1-amine,C1=CN(C(=N1)[N+](=O)[O-])CCCNCCBr,,,,,,
1393,131394,"[(2R,3R,4R,5R)-4,6-dihydroxy-2-methyl-5-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] methyl sulfate",C[C@@H]1[C@@H]([C@@H]([C@H](C(O1)O[C@@H]2[C@H]([C@H]([C@H](OC2O)C)OS(=O)(=O)OC)O)O)O)O,,,,,,
1394,131395,Dgaca,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(C(C[C@H]3[C@H]2C(CC4[C@@]3(CCC(C4)C(=O)CC5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)O)C,,,,,,
1395,131396,"3-(4-(1-(6-Fluorobenzo(b)thiophen-3-yl)-4-piperazinyl)butyl)-2,5,5-trimethyl-4-thiazolidinone",CC1N(C(=O)C(S1)(C)C)CCCCN2CCN(CC2)C3=CSC4=C3C=CC(=C4)F,,,,,,
1396,131397,8a-Phenyldecahydroquinoline,C1CCC2(C(C1)CCCN2)C3=CC=CC=C3,,,,,,
1397,131398,CID 131398,CCOC12CCC(=O)[C@@]3(C14CCN([C@H]2CC5=C4C(=C(C=C5)O)O3)C)C,,,,,,
1398,131399,CID 131399,C1=CC(=CC=C1C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=C(C(=C(C(=C4F)F)N[N+]#N)F)F)[O-],,,,,,
1399,131400,CID 131400,C1=CC(=CC=C1C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=C(C(=C(C(=C4F)F)N[N+]#N)F)F)O,,,,,,
1400,131401,CID 131401,C1=CC(=CC=C1C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=CC=C(C=C4)N[N+]#N)[O-],,,,,,
1401,131402,CID 131402,C1=CC(=CC=C1C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=CC=C(C=C4)N[N+]#N)O,,,,,,
1402,131403,1-(3-(2-Hydroxy-3-(2-methylpropylamino)propoxy)-4-methyl-2-thienyl)-3-phenyl-1-propanone,CC1=CSC(=C1OCC(CNCC(C)C)O)C(=O)CCC2=CC=CC=C2,,,,,,
1403,131404,Methyl 2-O-galactopyranosyl-3-O-glucopyranosylglucopyranoside,COC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)OC2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O,,,,,,
1404,131405,Bis(acetoxymethyl)cromoglycate,CC(=O)OCOC(=O)C1=CC(=O)C2=C(O1)C=CC=C2OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)OCOC(=O)C)O,,,,,,
1405,131406,"(2R,3R,4R,5R,6S)-2-[2-[(9R,10R)-10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraenyl]-5,6-dimethoxy-3-methylpyridin-4-yl]oxy-6-methyloxane-3,4,5-triol",CC=C(C)[C@@H]([C@H](C)C=C(C)C=CCC(=CCC1=C(C(=C(C(=N1)OC)OC)O[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O)C)C)O,,,,,,
1406,131407,CID 131407,CC(C)(C1CC2=CC3=C(CC(=O)[C@H](O3)OC(=O)C=CC4=CC(=C(C=C4)O)OC)C=C2O1)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)[CH]O)O)O)O,,,,,,
1407,131408,N-1-Sulfooxy-2-benzoylaminofluorene,C1C2=CC=CC=C2C3=C1C(=C(C=C3)NC(=O)C4=CC=CC=C4)OS(=O)(=O)O,,,,,,
1408,131409,Imidodisuccinic acid,C(C(C(=O)O)NC(CC(=O)O)C(=O)O)C(=O)O,,,,,,
1409,131410,Umifenovir hydrochloride monohydrate,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3.O.Cl,,,,,,
1410,131411,Arbidol,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,"['Umifenovir is currently licensed in China and Russia for the prophylaxis and treatment of influenza and other respiratory viral infections. It has demonstrated activity against a number of viruses and has been investigated in the treatment of _Flavivirus_, Zika virus, foot-and-mouth disease, Lassa virus, Ebola virus, and herpes simplex. In addition, it has shown _in vitro_ activity against hepatitis B and C viruses, chikungunya virus, reovirus, Hantaan virus, and coxsackie virus B5.  Umifenovir is currently being investigated as a potential treatment and prophylactic agent for the prevention of COVID-19 caused by SARS-CoV-2 infections.']","['Umifenovir exerts its antiviral effects via both direct-acting virucidal activity and by inhibiting one (or several) stage(s) of the viral life cycle. Its broad-spectrum of activity covers both enveloped and non-enveloped RNA and DNA viruses. It is relatively well-tolerated and possesses a large therapeutic window - weight-based doses up to 100-fold greater than those used in humans failed to produce any pathological changes in test animals.  Umifenovir does not appear to result in significant viral resistance. Instances of umifenovir-resistant influenza virus demonstrated a single mutation in the HA2 subunit of influenza hemagglutinin, suggesting resistance is conferred by prevention of umifenovirs activity related to membrane fusion. The mechanism through which other viruses may become resistant to umifenovir requires further study.']",,"['Umifenovir is rapidly absorbed following oral administration, with an estimated T<sub>max</sub> between 0.65-1.8 hours. The C<sub>max</sub> has been estimated as 415 - 467 ng/mL and appears to increase linearly with dose, and the AUC<sub>0-inf</sub> following oral administration has been estimated to be approximately 2200 ng/mL/h.', 'The major route of elimination is via the feces. Approximately 40% of an ingested dose is excreted unchanged, of which 38.9% is excreted in the bile and 0.12% excreted through the kidneys. The total recovery of parent drug and metabolites in the urine accounts for less than 1% of an ingested dose.', 'Data regarding the volume of distribution of umifenovir are currently unavailable.', 'In a study involving healthy male Chinese volunteers, the oral clearance of umifenovir was found to be 99  34 L/h.']","['Umifenovir is highly metabolized in the body, primarily in hepatic and intestinal microsomess, with approximately 33 metabolites having been observed in human plasma, urine, and feces. The principal phase I metabolic pathways include sulfoxidation, N-demethylation, and hydroxylation, followed by phase II sulfate and glucuronide conjugation. In the urine, the major metabolites were sulfate and glucuronide conjugates, while the major species in the feces was unchanged parent drug (~40%) and the M10 metabolite (~3.0%). In the plasma, the principal metabolites are M6-1, M5, and M8 - of these, M6-1 appears of most importance given its high plasma exposure and long elimination half-life (~25h), making it a potentially important player in the safety and efficacy of umifenovir.  Enzymes involved in the metabolism of umifenovir include members of the cytochrome P450 family (primarily CYP3A4), flavin-containing monooxygenase (FMO) family, and UDP-glucuronosyltransferase (UGT) family (specifically UGT1A9 and UGT2B7).', 'Arbidol has known human metabolites that include (2S,3S,4S,5R)-6-[6-bromo-4-[(dimethylamino)methyl]-3-ethoxycarbonyl-1-methyl-2-(phenylsulfanylmethyl)indol-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.']","['The half-life of umifenovir following oral administration has been estimated to be between 17-21 hours. Serum half-lives of the M5, M6-1, and M8 metabolites were found to be 26.3  5.9, 25.0  5.4, and 25.7  8.8, respectively.']"
1411,131412,(Chloroacetyl)phosphonic acid,C(C(=O)P(=O)(O)O)Cl,,,,,,
1412,131413,CID 131413,C1CC2=CC=CC=C2C(C(=CC(=O)[O-])C1)O.[Na+],,,,,,
1413,131414,"2-(5-Hydroxy-5,7,8,9-tetrahydrobenzo[7]annulen-6-ylidene)acetic acid",C1CC2=CC=CC=C2C(C(=CC(=O)O)C1)O,,,['Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)'],,,
1414,131415,2-Dodecanoylamino-1-hexanolphosphocholine,CCCCCCCCCCCC(=O)NC(CCCC)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
1415,131416,N-[2-[[[[2-(Dodecanoylamino)hexyl]oxy]oxylatophosphinyl]oxy]ethyl]trimethylaminium,CCCCCCCCCCCC(=O)NC(CCCC)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
1416,131417,2-(Tetradecanoylamino)hexyl 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCC(=O)NC(CCCC)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
1417,131418,2-[Hydroxy-[2-(tetradecanoylamino)hexoxy]phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCC(=O)NC(CCCC)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
1418,131419,"3-Amino-2-(1,1'-biphenyl)-4-yl-6-fluoro-4-quinolinecarboxylic acid",C1=CC=C(C=C1)C2=CC=C(C=C2)C3=NC4=C(C=C(C=C4)F)C(=C3N)C(=O)O,,,,,,
1419,131420,Astraisoflavanin,COC1=C(C(=C(C=C1)[C@@H]2CC3=C(C=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC2)OC)O,,,,,,
1420,131421,Tyrosyl-cysteinyl(stbu)-glycyl-phenylalanyl-leucyl-threonyl(O-t-butyl),C[C@H]([C@@H](C(=O)OC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](CSC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O,,,,,,
1421,131422,"8-Chloro-5-(2,3-dihydro-1-benzofuran-7-yl)-7-(methoxymethoxy)-3-methyl-1,2,4,5-tetrahydro-3-benzazepine",CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC4=C3OCC4)OCOC)Cl,,,,,,
1422,131423,CID 131423,CCCCCC=CC=CC=CC(C(C)C(CC=CC1C(C=CC(=O)O1)O)OS(=O)(=O)[O-])O.[Na+],,,,,,
1423,131424,CID 131424,CCCCC/C=C/C=CC=CC(C(C)C(CC=CC1C(C=CC(=O)O1)O)OS(=O)(=O)O)O,,,,,,
1424,131425,7-Hexoxyquinoline,CCCCCCOC1=CC2=C(C=CC=N2)C=C1,,,,,,
1425,131426,"7-Phenyl-1,4,6-androstatriene-3,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)C(=CC4=CC(=O)C=C[C@]34C)C5=CC=CC=C5,,,,,,
1426,131427,"N-butyl-11-[(7R,8R,9S,13S,14S,16R,17R)-16-chloro-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-7-yl]-N-methylundecanamide",CCCCN(C)C(=O)CCCCCCCCCC[C@@H]1CC2=C(C=CC(=C2)O)[C@@H]3[C@@H]1[C@@H]4C[C@H]([C@@H]([C@]4(CC3)C)O)Cl,,,,,,
1427,131428,Bmd-eto,CCCCN(C)C(=O)CCCCCC#C[C@]1(CCC2[C@@]1(CCC3C2CCC4=C3C=CC(=C4)O)C)O,,,,,,
1428,131429,"2-Propenamide,3-[4-(2,5-dimethyl-1H-pyrrol-1-yl)phenyl]-N-hydroxy-N-methyl-, (2E)-",CC1=CC=C(N1C2=CC=C(C=C2)C=CC(=O)N(C)O)C,,,,,,
1429,131430,Glutamyl-arginyl-proline,C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O,,,,,,
1430,131431,N-Succinimidyl 8-((4'-fluorobenzyl)amino)suberate,C1CC(=O)N(C1=O)OC(=O)CCCCCCC(=O)NCC2=CC=C(C=C2)F,,,,,,
1431,131432,2-(2-Phenylethoxy)adenosine,C1=CC=C(C=C1)CCOC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,['Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Agonists.)'],,,
1432,131433,2-(2-(4-Methylphenyl)ethoxy)adenosine,CC1=CC=C(C=C1)CCOC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,,,,
1433,131434,N'-Acetyl-beta-lysine,CC(=O)NCCC[C@H](CC(=O)O)N,,,,,,
1434,131435,"But-2-enedioic acid;[4-(3-methyl-3-phenylbutyl)piperazin-1-yl]-(2-pyridin-3-yl-1,3-thiazolidin-4-yl)methanone",CC(C)(CCN1CCN(CC1)C(=O)C2CSC(N2)C3=CN=CC=C3)C4=CC=CC=C4.C(=CC(=O)O)C(=O)O,,,,,,
1435,131436,1-(3-Methyl-3-phenylbutyl)-4-[2-(3-pyridyl)thiazolidin-4-ylcarbonyl]piperazine,CC(C)(CCN1CCN(CC1)C(=O)C2CSC(N2)C3=CN=CC=C3)C4=CC=CC=C4,,,,,,
1436,131437,"1-(2-Hydroxy-2-phenylethyl)-3,5-diphenylpyrazole",C1=CC=C(C=C1)C2=CC(=NN2CC(C3=CC=CC=C3)O)C4=CC=CC=C4,,,,,,
1437,131438,"14,15-Secocholestane",CC[C@H]([C@H](C)CCCC(C)C)[C@]1(CC[C@H]2[C@H](C1)CC[C@@H]3[C@@]2(CCCC3)C)C,,,,,,
1438,131439,Didodecyl N-(alpha-trimethylammonioacetyl)glutamate,CCCCCCCCCCCCOC(=O)CC[C@H](C(=O)OCCCCCCCCCCCC)NC(=O)C[N+](C)(C)C.[Cl-],,,,,,
1439,131440,N-[(Trimethylaminio)acetyl]-D-glutamic acid didodecyl ester,CCCCCCCCCCCCOC(=O)CC[C@H](C(=O)OCCCCCCCCCCCC)NC(=O)C[N+](C)(C)C,,,,,,
1440,131441,"2,3,4-Tri-O-benzoylfucopyranosyl bromide",C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)Br)OC(=O)C2=CC=CC=C2)OC(=O)C3=CC=CC=C3)OC(=O)C4=CC=CC=C4,,,,,,
1441,131442,"3,4-Dihydro-2,2-dimethyl-4-(oxopiperidin-1-yl)-6-pentafluoroethyl-2H-1-benzopyran-3-ol",CC1([C@H]([C@@H](C2=C(O1)C=CC(=C2)C(C(F)(F)F)(F)F)N3CCCCC3=O)O)C,,,,,,
1442,131443,N-(3-Phenyl-n-propyl)-1-phenyl-2-aminopropane,C[C@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2.Cl,,,,,,
1443,131444,((R)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine,C[C@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2,,,,,,
1444,131445,CID 131445,CCCCCOC1=NC(=NC2=CC=CC=C21)N3CCN(CC3)CC=C.C(=CC(=O)O)C(=O)O,,,,,,
1445,131446,N(alpha)-Carbamoylmethionyl-leucyl-phenylalanine methyl ester,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)OC)NC(=O)[C@H](CCSC)NC(=O)N,,,,,,
1446,131447,"6-Cyano-5-methoxy-12-methylindolo(2,3-a)carbazole",CN1C2=CC=CC=C2C3=C(C(=C4C5=CC=CC=C5NC4=C31)C#N)OC,,,,,,
1447,131448,"5-Methoxy-11,12-dihydroindolo[2,3-a]carbazole-6-carbonitrile",COC1=C2C3=CC=CC=C3NC2=C4C(=C1C#N)C5=CC=CC=C5N4,,,,,,
1448,131449,"5-(Cyclopropylmethyl)-11-methoxy-5-methyl-5-azoniapentacyclo[12.5.0.01,6.02,17.08,13]nonadeca-8(13),9,11-triene",C[N+]1(CCC2C3CCC4C2(C1CC5=C4C=C(C=C5)OC)CC3)CC6CC6,,,,,,
1449,131450,2-(2-Cyclohexylethoxy)adenosine,C1CCC(CC1)CCOC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,,,,
1450,131451,2-(Diethylamino)-7-ethoxychromone,CCN(CC)C1=CC(=O)C2=C(O1)C=C(C=C2)OCC,,,,,,
1451,131452,4-Hydroxy-1-(1H-indol-3-ylcarbonyl)prolyl-N-(phenylmethyl)-N-methyl-tyrosineamide,CN(CC1=CC=CC=C1)[C@@H](CC2(CCC(C=C2)(O)O)C(=O)C3=CNC4=CC=CC=C43)C(=O)NC(=O)[C@@H]5CCCN5,,,,,,
1452,131453,1-Methoxy-6-(naphth-2-yl-methoxy)-1-(thiazol-2-yl)indan,COC1(CCC2=C1C=C(C=C2)OCC3=CC4=CC=CC=C4C=C3)C5=NC=CS5,,,,,,
1453,131454,CID 131454,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O[C@@H]2C[C@@H](C=C2)N3C=NC4=C3NC(=NC4=O)N)O)O)O,,,,,,
1454,131455,5-(4-Fluorophenyl)-1-propylpyrazolidin-3-one,CCCN1C(CC(=O)N1)C2=CC=C(C=C2)F,,,,,,
1455,131456,"2-[5-(4-methoxybenzoyl)-10-methyl-4H-pyrrolo[1,2-b][1,2,5]benzotriazepin-4-yl]acetic acid",CN1C2=CC=CC=C2N(C(C3=CC=CN31)CC(=O)O)C(=O)C4=CC=C(C=C4)OC,,,,,,
1456,131457,Pingbeinine,C[C@H]([C@H]1CC[C@@](CN1C)(C)O)[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C)O,,,,,,
1457,131458,Pingbeininoside,C[C@H]([C@H]1CCC(CN1C)(C)O)[C@H]2[C@@H](C[C@@H]3[C@@]2(CCC4[C@H]3CC=C5[C@@]4(CCC(C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O,,,,,,
1458,131459,"3-(3-Butylthio-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine",CCCCSC1=NSN=C1C2=CCCN(C2)C,,,,,,
1459,131460,Tazomeline,CCCCCCSC1=NSN=C1C2=CCCN(C2)C,,,,,,
1460,131461,CID 131461,C[C@@H](C1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C)OCCCCC(C)(C)O,,,,,,
1461,131462,"Octyl 5-(cyclopropylcarbamoyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3-carboxylate",CCCCCCCCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2[N+](=O)[O-])C(=O)NC3CC3)C)C,,,,,,
1462,131463,(2S)-2-[[(2R)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-(2-aminobutanoylamino)-5-decan-5-yloxy-4-methylsulfinyl-5-oxopentanoyl]amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]-3-phenylpropanoic acid,CCCCCC(CCCC)OC(=O)C(C[C@@H](C(=O)N[C@@H](CC1C=NC=N1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC)N)S(=O)C,,,,,,
1463,131464,[1-(2-Methoxyphenoxy)-3-sulfamoyloxypropan-2-yl] sulfamate,COC1=CC=CC=C1OCC(COS(=O)(=O)N)OS(=O)(=O)N,,,,,,
1464,131465,CID 131465,C1=CC=C2C(=C1)C(=O)C(=C(O2)[O-])NC(=O)C3=CC(=C(C=C3O)N[N+]#N)I,,,,,,
1465,131466,CID 131466,C1=CC=C2C(=C1)C(=O)C(=C(O2)O)NC(=O)C3=CC(=C(C=C3O)N[N+]#N)I,,,,,,
1466,131467,N-Dpb-thpo,C1CN(CC2=C1ONC2=O)CCC=C(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1467,131468,CID 131468,CO[C@H]1CC[C@@H]2N1C(=O)C3=CC(=C(C=C3N[C@H]2O)O)OC,,,,,,
1468,131469,Aspartyl-seryl-phenylalanyl-phenylalanyl-beta-alanyl-leucyl-methioninamide,CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CCNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N,,,,,,
1469,131470,"2-(2-(1-Phenyl-4-piperazynyl)ethyl)-1,2,3,4-tetrahydro-beta-carboline-1-spiro-4'-N'-benzylpiperidine",C1CN(C2(CCN(CC2)CC3=CC=CC=C3)C4=C1C5=CC=CC=C5N4)CCN6CCN(CC6)C7=CC=CC=C7,,,,,,
1470,131471,CID 131471,CC[C@H]1CC(C[C@H](C[C@H]([C@@H]([C@H]2C[C@H](C(O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H](C([C@@H](CC1=O)O)C)C(=C[C@@H]4CC[C@H](C(C4)OC)O)C)O)C)O)OC)C)C,,,,,,
1471,131472,CID 131472,CC(=CCOC1=C(C=C(C=C1)C=CC=C(C)C(=COC)C(=O)OC)OC[C@H]2C(O2)(C)C)C,,,,,,
1472,131473,CID 131473,CC1=NC2=CNC(=CN2C1=O)C3=CC=C(C=C3)OCCN=C(NC4=CC5=C(C=C4)C6(C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)[O-])OC5=O)S.[Na+],,,,,,
1473,131474,CID 131474,CC1=NC2=CNC(=CN2C1=O)C3=CC=C(C=C3)OCCN=C(NC4=CC5=C(C=C4)C6(C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)OC5=O)S,,,,,,
1474,131475,N-Chloroprocainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)NCl,,,,,,
1475,131476,CID 131476,COC1=C(C=C2C(=C1)C(=O)N3C(CCC3O)C(=O)N2)O,,,,,,
1476,131477,Prolyl-tyrosyl-glycinamide,C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)NCC(=O)N,,,,,,
1477,131478,CID 131478,CC1=C(NC(=C(C1=O)OC)OC)CC=C(C)CC=CC(=C[C@@H](C)[C@H](C(=CCO)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C,,,,,,
1478,131479,6-Trimethylsilylthio-9-trimethylsilylpurine,C[Si](C)(C)N1C=NC2=C1N=CN=C2S[Si](C)(C)C,,,,,,
1479,131480,CID 131480,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC(=C(C=C5)OC(=O)C)OC(=O)C)O)O)O)O)O)O,,,,,,
1480,131481,4-Trimethylaminopyridine,CNC1=C(C(=NC=C1)NC)NC,,,,,,
1481,131482,CID 131482,CC(=C1C(=O)CC(OC1=O)(C)C)NOC,,,,,,
1482,131483,1-Methyl-2-((4-aminophenyl)sulfonyl)amino-5-nitroimidazole,CN1C(=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N)[N+](=O)[O-],,,,,,
1483,131484,Astrachrysoside A,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](CO[C@H]2OC3CCC45CC46CC[C@@]7([C@H]([C@@H](C[C@]7(C6C[C@H](C5C3(C)C)O)C)O)[C@]8(CC[C@H](O8)C(C)(C)O)C)C)O)O)O)O)O,,,,,,
1484,131485,N-[3-(3-chloro-4-cyclohexylphenyl)prop-2-enyl]-N-ethylcyclohexanamine;hydrochloride,CCN(CC=CC1=CC(=C(C=C1)C2CCCCC2)Cl)C3CCCCC3.Cl,,,,,,
1485,131486,N-[3-(3-Chloro-4-cyclohexylphenyl)prop-2-en-1-yl]-N-ethylcyclohexanamine,CCN(CC=CC1=CC(=C(C=C1)C2CCCCC2)Cl)C3CCCCC3,,,,,,
1486,131487,"3-(tert-Butylamino)-1-(3,4-dihydroxy-6-fluorophenoxy)-2-propanol",CC(C)(C)NCC(COC1=C(C=C(C(=C1)O)O)F)O,,,,,,
1487,131488,"(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-3-[2-(1,5-dihydroxy-4-oxopyridin-2-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C=CC4=CC(=O)C(=CN4O)O)C(=O)O,,,,,,
1488,131489,5-Chloro-2'-deoxyuridine 5'(tetrahydrogen triphosphate),C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Cl)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
1489,131490,2-(4-(2-Hydroxy-3-(naphthalen-1-yloxy)propyl)piperazin-1-YL)phenol,C1CN(CCN1CC(COC2=CC=CC3=CC=CC=C32)O)C4=CC=CC=C4O,,,,,,
1490,131491,4-[4-(2-Hydroxy-3-naphthalen-1-yloxypropyl)piperazin-1-yl]-3-methoxyphenol,COC1=C(C=CC(=C1)O)N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,,,,,,
1491,131492,(3-Isocyanato-1-phenylbutyl)benzene,CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)N=C=O,,,,,,
1492,131493,N-(1-phenylpropyl)benzotriazol-1-amine,CCC(C1=CC=CC=C1)NN2C3=CC=CC=C3N=N2,,,,,,
1493,131494,N-Octamethylspermidine,C[N+](C)(C)CCCC[N+](C)(C)CCC[N+](C)(C)C,,,,,,
1494,131495,CID 131495,CCCCCCCCC[C@H]1[C@H](C2(CCCO2)NC(=N1)N)C(=O)OCCCCCCCN=C(N)N,,,,,,
1495,131496,CID 131496,C1=CN=CC=C1C2=C(NC3=NC(=O)NC3=C2)C(F)(F)F,,,,,,
1496,131497,Cyclic(3-1)-1-(carboxymethyl)prolyl-phenylalanyl-histidinamide,C1C[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CC3=CN(CC(=O)N2C1)C=N3)C(=O)O)CC4=CC=CC=C4,,,,,,
1497,131498,t-Butyloxycarbonyl-cyanoalanylproline benzyl ester,C[C@@H](C(=O)N1CCC([C@@]1(C#N)C(=O)OCC2=CC=CC=C2)C(=O)OC(C)(C)C)N,,,,,,
1498,131499,(2S)-N-[(2R)-1-(benzylamino)-3-methyl-1-oxobutan-2-yl]-N'-hydroxy-2-(2-methylpropyl)butanediamide,CC(C)C[C@@H](CC(=O)NO)C(=O)N[C@H](C(C)C)C(=O)NCC1=CC=CC=C1,,,,,,
1499,131500,"3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]propyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate",CN1CC2=C(N=CN2C3=C(C1=O)C=C(C=C3)F)C(=O)OCCCNC4=CC=C(C5=NON=C45)[N+](=O)[O-],,,,,,
1500,131501,"9-Fluoro-14-methylimino-10-(4-methylpiperazin-1-yl)-6-oxo-3-thia-13-azatetracyclo[9.2.1.04,13.07,12]tetradeca-1,4,7,9,11-pentaene-5-carboxylic acid",CN=C1C2=CSC3=C(C(=O)C4=CC(=C(C1=C4N23)N5CCN(CC5)C)F)C(=O)O,,,,,,
1501,131502,"2-Ethylhexyl 4-dimethylaminobenzoate; 1-(4-methoxyphenyl)-3-(4-tert-butylphenyl)propane-1,3-dione",CCCCC(CC)COC(=O)C1=CC=C(C=C1)N(C)C.CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC,,,['Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)'],,,
1502,131503,Loratadine/pseudoephedrine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1.C[C@@H]([C@H](C1=CC=CC=C1)O)NC,,,,,,
1503,131504,CID 131504,CCCCCCCCCCCC(=O)N[C@H](CCCC)COP(=O)([O-])OCCO.[Na+],,,,,,
1504,131505,Phosphonic acid 2-dodecanoylamino-hexyl ester propyl ester,CCCCCCCCCCCC(=O)N[C@H](CCCC)COP(=O)(O)OCCO,,,,,,
1505,131506,5-Iodo-2-aminoindane,C1C(CC2=C1C=CC(=C2)I)N,,,,,,
1506,131507,"N(2)-(N-(N-(9,10-Dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)glycyl)-L-histidyl)-L-lysine",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O)NCC(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
1507,131508,Dhq-ghk,C1=CC(=C2C(=C1NCC(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CCCCN)C(=O)O)C(=O)C4=C(C=CC(=C4C2=O)O)O)O,,,,,,
1508,131509,"5-[[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-3-(dimethylamino)-4-thiazolidinone",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N(CS2)N(C)C,,,,,,
1509,131510,"5-[(3,5-Ditert-butyl-4-hydroxyphenyl)methylidene]-3-(methylamino)-1,3-thiazolidin-4-one",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N(CS2)NC,,,,,,
1510,131511,Kapurimycin A1,CCCC1C(O1)(C)C2=CC(=O)C3=C(C=C4C=C5C(CCC(=O)C5=C(C4=C3O2)O)OC(=O)C)CC(=O)O,,,,,,
1511,131512,"1-hydroxy-10-methoxy-8-methyl-12-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxynaphtho[1,2-c]isochromen-6-one",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C3C(=C4C(=C2)C5=C(C=C(C=C5OC)C)C(=O)O4)C=CC=C3O)O)O)O,,,,,,
1512,131513,Acetaldoifosphamide,CC(=O)OC(CCOP(=O)(NCCCl)NCCCl)OC(=O)C,,,,,,
1513,131514,3-Propylproline,CCC[C@H]1CCN[C@@H]1C(=O)O,,,,,,
1514,131515,CID 131515,C1CCN(CC1)[C@@H]2CC[C@H]([C@@H]2CC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
1515,131516,3-Methyl-3-propan-2-yloxolan-2-one,CC(C)C1(CCOC1=O)C,,,,,,
1516,131517,"[(4S)-18-hydroxy-4-methyl-2,8-dioxo-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraen-16-yl] hydrogen sulfate",C[C@H]1CCCC(=O)CCCC=CC2=C(C(=CC(=C2)OS(=O)(=O)O)O)C(=O)O1,,,,,,
1517,131518,"2H-Imidazol-2-one, 1-benzoyl-5-(4-(4,5-dihydro-2-methyl-1H-imidazol-1-yl)benzoyl)-4-ethyl-1,3-dihydro-",CCC1=C(N(C(=O)N1)C(=O)C2=CC=CC=C2)C(=O)C3=CC=C(C=C3)N4CCN=C4C,,,,,,
1518,131519,"Diethyl 8,8-bis(mesyloxymethyl)dispiro(3.1.3.1)decane-2,3-dicarboxylate",CCOC(=O)C1CC2(C1C(=O)OCC)CC3(C2)CC(C3)(COS(=O)(=O)C)COS(=O)(=O)C,,,,,,
1519,131520,CID 131520,CCC(C)C(C(=O)NCC1=NC2=CC=CC=C2N1)NC(=O)[C@@H](CC=CC3=CC=CC=C3)C[C@@H]([C@H](CC4=CC=CC=C4)NC(=O)OC(C)(C)C)O,,,,,,
1520,131521,"2,2,6,6-Tetrakis(mesyloxymethyl)spiro-(3.3)heptane",CS(=O)(=O)OCC1(CC2(C1)CC(C2)(COS(=O)(=O)C)COS(=O)(=O)C)COS(=O)(=O)C,,,,,,
1521,131522,CID 131522,CC(=CCC1=C(C(=CC(=C1)C2=COC3=CC(=O)C=C(C3=C2O)OC)O)OC)C,,,,,,
1522,131523,CID 131523,CC(=CC(=O)O[C@H]1[C@@H]2[C@]3([C@@H]([C@H]([C@H]4C2(CO3)[C@H](C[C@@H]([C@H]4CC(=O)OC)C(=O)C)OC1=O)O)O)C(=O)OC)C(C)(C)OC(=O)C,,,,,,
1523,131524,CID 131524,CC(=CC(=O)OC1C2[C@]3([C@@H]([C@H](C4C2(CO3)C(CC(C4CC(=O)OC)C(=O)C)OC1=O)O)O)C(=O)OC)C(C)(C)O,,,,,,
1524,131525,Leiokinine A,CCCC1=C(C(=O)C2=CC=CC=C2N1C)OC,,,,,,
1525,131526,6-Methylspiro[4.5]dec-9-ene-10-carboxylic acid,CC1CCC=C(C12CCCC2)C(=O)O,,,,,,
1526,131527,4-(Hydroxymethyl)-3-[3-(3-methyloxiran-2-yl)prop-2-enoyl]oxolan-2-one,CC1C(O1)C=CC(=O)C2C(COC2=O)CO,,,,,,
1527,131528,"2,2-Dimethyl-4-hydroxy-4-androstene-3,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C(C(=O)C(C[C@]34C)(C)C)O,,,,,,
1528,131529,Exfoliazone,CC(=O)NC1=CC2=NC3=C(C=CC(=C3)CO)OC2=CC1=O,,,,,,
1529,131530,"2,4-Dibromoestra-1,3,5(10),6-tetraene-3,17-diol diacetate",CC(=O)OC1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=C(C(=C(C=C34)Br)OC(=O)C)Br)C,,,,,,
1530,131531,"(((Amino-2-ethoxy)-2-ethoxy)methyl)-2-(dichloro-2',3'-phenyl)-4-ethoxycarbonyl-3-methoxycarbonyl-5-methyl-6-dihydro-1,4-pyridine",CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)COCCOCCN.Cl,,,,,,
1531,131532,Olradipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)COCCOCCN,,,,,,
1532,131533,17-Ethoxycarbonyloxy-3-oxoandrost-4-ene-17-carbonitrile,CCOC(=O)OC1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C#N,,,,,,
1533,131534,Fluperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1534,131535,Fosamprenavir calcium,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2],"['Telzir in combination with low-dose ritonavir is indicated for the treatment of human-immunodeficiency-virus-type-1-infected adults, adolescents and children of six years and above in combination with other antiretroviral medicinal products.']",,"['Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)', 'Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)']",,,
1535,131536,Fosamprenavir,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,"['Indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission. The use of fosamprenavir is pending revision due to a potential association between the drug and myocardial infarction and dyslipidemia in HIV infected adults.']","['Fosamprenavir is hydrolyzed by cellular phosphatases to the antiretroviral protease inhibitor amprenavir. This hydrolysis allows for the slow release of amprenavir, reducing the number of pills a patient must take.']","['Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)', 'Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)']","['The absolute oral bioavailability of amprenavir after administration of fosamprenavir in humans has not been established. After administration of a single 1,400 mg dose in the fasted state, fosamprenavir oral suspension (50 mg/mL) and fosamprenavir tablets (700 mg) provided similar amprenavir exposures (AUC), however, the C<sub>max</sub> of amprenavir after administration of the suspension formulation was 14.5 % higher compared with the tablet.', 'Excretion of unchanged amprenavir in urine and feces is minimal. The renal elimination of unchanged amprenavir represents approximately 1% of the administered dose; therefore, renal impairment is not expected to significantly impact the elimination of amprenavir. Amprenavir, the active metabolite of fosamprenavir, is metabolized in the liver by the cytochrome P450 enzyme system.', 'Fosamprenavir is a prodrug that is rapidly hydrolyzed to amprenavir by enzymes in the gut epithelium as it is absorbed. After administration of a single dose of fosamprenavir to HIV-1-infected patients, the time to peak amprenavir concentration (Tmax) occurred between 1.5 and 4 hours (median 2.5 hours). The absolute oral bioavailability of amprenavir after administration of fosamprenavir in humans has not been established.', 'Administration of a single 1400 mg dose of fosamprenavir in the fed state compared with the fasted state was associated with no significant changes in amprenavir Cmax, Tmax or AUC.', 'The following are areas under the curve (AUC) values of amprenavir based on the drug therapy regimen administered: Fosamprenavir 1400 mg twice per day: 27.6 to 39.2 ug/hr/mL (median 33 ug/hr/mL; Fosamprenavir 1400 mg once per day plus ritonavir 200 mg once per day: 59.7 to 80.8 ug/hr/mL (median 69.4 ug/hr/mL);Fosamprenavir 700 mg twice per day plus ritonavir 100 mg twice per day: 69 to 90.6 ug/hr/mL (median 79.2 ug/hr/mL). Fosamprenavir may be taken with or without food.', 'Peak plasma concentration (Cmax): The following Cmax values of amprenavir based on the drug therapy regimen administered: Fosamprenavir 1400 mg once per day plus ritonavir 200 mg once per day: 6.32 to 8.28 ug/mL (median 7.24 ug/mL); Fosamprenavir 1400 mg twice per day: 4.06 to 5.72 ug/mL (median 4.82 ug/mL); Fosamprenavir 700 mg twice per day plus ritonavir 100 mg twice per day: 5.38 to 6.86 ug/mL (median 6.08 ug/mL)...', 'For more Absorption, Distribution and Excretion (Complete) data for FOSAMPRENAVIR (10 total), please visit the HSDB record page.']","['In the gut epithelium during absorption, fosamprenavir is rapidly and almost completely hydrolyzed to amprenavir and inorganic phosphate prior to reaching the systemic circulation. Amprenavir is metabolized in the liver by the cytochrome P450 3A4 (CYP3A4) enzyme system.', 'After oral administration, fosamprenavir is rapidly and almost completely hydrolyzed to amprenavir and inorganic phosphate prior to reaching the systemic circulation. This occurs in the gut epithelium during absorption. Amprenavir is metabolized in the liver by the cytochrome P450 and 3A4 (CYP3A4) enzyme system. The 2 major metabolites result from oxidation of the tetrahydrofuran and aniline moieties. Glucuronide conjugates of oxidized metabolites have been identified as minor metabolites in urine and feces.']","['The plasma elimination half-life of amprenavir (the active metabolite) is approximately 7.7 hours.', 'The plasma elimination half-life of amprenavir is approximately 7.7 hours.']"
1536,131537,Fosamprenavir sodium,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Na+].[Na+],,,"['Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)', 'Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)']",,,
1537,131538,2-(Hydroxy(phenyl)methyl)-2-methylcyclohexanone,CC1(CCCCC1=O)C(C2=CC=CC=C2)O,,,,,,
1538,131539,4-[4-(Dimethylamino)pyridin-1-ium-1-yl]butyl (2-ethoxy-3-hexadecoxypropyl) phosphate,CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCCCC[N+]1=CC=C(C=C1)N(C)C)OCC,,,,,,
1539,131540,4-[4-(Dimethylamino)pyridin-1-ium-1-yl]butyl (2-ethoxy-3-hexadecoxypropyl) hydrogen phosphate,CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCCCC[N+]1=CC=C(C=C1)N(C)C)OCC,,,,,,
1540,131541,"2-Carboxy-4-(carboxymethyl)-5,7-dichloro-1,2,3,4-tetrahydroquinoline",C1C(C2=C(C=C(C=C2Cl)Cl)NC1C(=O)O)CC(=O)O,,,,,,
1541,131542,4-Butyroxybenzenediazonium fluoroborate,[B-](F)(F)(F)F.CCCC(=O)OC1=CC=C(C=C1)[N+]#N,,,,,,
1542,131543,4-Butanoyloxybenzenediazonium,CCCC(=O)OC1=CC=C(C=C1)[N+]#N,,,,,,
1543,131544,Dumpda,CC1(CC2(C(N1O2)(C)C)NCC3=CN(C(=O)NC3=O)[C@H]4C[C@@H]([C@H](O4)CO)O)C,,,,,,
1544,131545,"1-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[[(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl)amino]methyl]pyrimidine-2,4-dione",CC1(CC(CC(N1O)(C)C)NCC2=CN(C(=O)NC2=O)[C@@H]3C[C@@H]([C@H](O3)CO)O)C,,,,,,
1545,131546,N-hydroxy-N-methyl-3-(2-methylsulfanylphenyl)prop-2-enamide,CN(C(=O)C=CC1=CC=CC=C1SC)O,,,,,,
1546,131547,3-Phenylpropionylcarnitine,C[N+](C)(C)CC(C(C(=O)CCC1=CC=CC=C1)C(=O)[O-])O,,,,,,
1547,131548,(3-Carboxy-2-hydroxy-4-oxo-6-phenylhexyl)-trimethylazanium,C[N+](C)(C)CC(C(C(=O)CCC1=CC=CC=C1)C(=O)O)O,,,,,,
1548,131549,"methyl (2S)-2-[[(2S,3S)-2-[[(2S)-1-[3-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-4-amino-4-oxobutanoyl]amino]-2-hydroxy-4-phenylbutyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoate",CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)OC)NC(=O)[C@@H]1CCCN1CC(C(CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)C)O,,,,,,
1549,131550,Tmphpg,CC1=CC(=C(C(=C1)[C@@H](C(=O)O)NCCCN[C@@H](C2=CC(=CC(=C2O)C)C)C(=O)O)O)C,,,,,,
1550,131551,Pentafluorobenzyl-4-aminobenzoate,C1=CC=C(C=C1)CC2=C(C(=C(C(=C2F)N(F)F)F)F)C(=O)[O-],,,,,,
1551,131552,"2-Benzyl-4-(difluoroamino)-3,5,6-trifluorobenzoic acid",C1=CC=C(C=C1)CC2=C(C(=C(C(=C2F)N(F)F)F)F)C(=O)O,,,,,,
1552,131553,"N-(3,4,5-Trimethoxybenzoyloxy)-3,4,5-trimethoxybenzamide",COC1=CC(=CC(=C1OC)OC)C(=O)NOC(=O)C2=CC(=C(C(=C2)OC)OC)OC,,,,,,
1553,131554,"4-[2-(3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinyl)ethyl]-3H-1,2,4-triazole-3,5(4H)-dione",CN1C2=CC(=C(C=C2N=C(C1=O)CCN3C(=O)N=NC3=O)OC)OC,,,,,,
1554,131555,CID 131555,CC(C1C2=CC(=C(C=C2CCN1C(C)(N3CCCCC3)O)OC)OC)C4=CC5=C(C=C4)C=C(C=C5)OC,,,,,,
1555,131556,Rufloxacinsulfoxide,CN1CCN(CC1)C2=C(C=C3C4=C2S(=O)CCN4C=C(C3=O)C(=O)O)F.Cl,,,,,,
1556,131557,Rufloxacin sulfoxide,CN1CCN(CC1)C2=C(C=C3C4=C2S(=O)CCN4C=C(C3=O)C(=O)O)F,,,,,,
1557,131558,15-Tetracosynoic acid,CCCCCCCCC#CCCCCCCCCCCCCCC(=O)O,,,,,,
1558,131559,"5-(Dipropylamino)-5,6-dihydro-4H-imidazo-(5,1ij)quinolin-2(1H)-one",CCCN(CCC)[C@@H]1CC2=C3C(=CC=C2)NC(=O)N3C1,,,,,,
1559,131560,Remifentanil Acid,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)O)C(=O)OC,,,,,,
1560,131561,CID 131561,CC(=O)C=C1CNC1=O,,,,,,
1561,131562,12-Doxyl-dmpc,CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCC[C@@]1(N(C(CO1)(C)C)[O])CC,,,,,,
1562,131563,CID 131563,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCC[C@@]1(N(C(CO1)(C)C)[O])CC,,,,,,
1563,131564,"1,10-Phenanthroline-valine palladium(II)",CC(C)[C@@H](C(=O)O)N.C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1.[Pd+2],,,,,,
1564,131565,CID 131565,CC(=CCCC(=CCCC=C(C)CCC=C(C)CCC1C(O1)(C)C)C)CCC[N+](C)(C)[O-],,,,,,
1565,131566,"4,8,11,11-Tetramethyl-3-oxobicyclo[5.3.1]undec-7-ene-4-carbaldehyde",CC1=C2CCC(C(=O)CC(C2(C)C)CC1)(C)C=O,,,,,,
1566,131567,(4-Fluorophenyl)-alpha-methyl-5-benzoxazole methylamine,CCNC1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F,,,,,,
1567,131568,"(9S,10R)-17-prop-2-enyl-17-thioniatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol",C=CC[S+]1CCC23CCCC[C@H]2[C@@H]1CC4=C3C=C(C=C4)O,,,,,,
1568,131569,Dihydroxerulin,CCCC#CC#CC=CC=CC=CC=C1C=CC(=O)O1,,,,,,
1569,131570,"5-Tetradeca-2,4,6,12-tetraen-8,10-diynylidenefuran-2-one",CC=CC#CC#CC=CC=CC=CC=C1C=CC(=O)O1,,,,,,
1570,131571,"2,8,10,12-Tetradecatetraene-4,6-diynoicacid, 14-(5-oxo-2(5H)-furanylidene)-, (2E,8E,10E,12E,14Z)-",C1=CC(=O)OC1=CC=CC=CC=CC#CC#CC=CC(=O)O,,,,,,
1571,131572,Pradimicin P,CC1=CC2=C(C3=C(C(C2O)O)C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC(=C5)O)O)O)C(=C1C(=O)N[C@H](C)C(=O)O)O,,,,,,
1572,131573,CID 131573,C[C@H](CN(C[C@@H](CC1=CC=C(C=C1)N)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O.Cl.Cl.Cl.Cl,,,,,,
1573,131574,2-[[(2R)-3-(4-aminophenyl)-2-[bis(carboxymethyl)amino]propyl]-[(2S)-2-[bis(carboxymethyl)amino]propyl]amino]acetic acid,C[C@@H](CN(C[C@@H](CC1=CC=C(C=C1)N)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
1574,131575,"5-methoxy-6-methyl-2,3-dihydro-1H-inden-2-amine",CC1=CC2=C(CC(C2)N)C=C1OC,,,,,,
1575,131576,2-Methoxy-4-(propylthio)aniline,CCCSC1=CC(=C(C=C1)N)OC,,,,,,
1576,131577,Acetylhistidyl-lysyl-aspartyl-methionyl-glutaminyl-leucyl-glycyl-arginine,CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CN=CN1)NC(=O)C,,,,,,
1577,131578,(2-Octadecyl-5-oxooxolan-2-yl)methyl 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCCCC1(CCC(=O)O1)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
1578,131579,2-[Hydroxy-[(2-octadecyl-5-oxooxolan-2-yl)methoxy]phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCC1(CCC(=O)O1)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
1579,131580,NH-Naftopidil,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=C(C4=CC=CC=C43)O)O,,,,,,
1580,131581,"2-Aziridinyl-1,4-naphthoquinon-5-yl 4-ethylbenzenesulfonate",CCC1=CC=C(C=C1)S(=O)(=O)OC2=CC=CC3=C2C(=O)C=C(C3=O)N4CC4,,,,,,
1581,131582,"2-Aziridinyl-1,4-naphthoquinon-5-yl 4-tert-butylbenzenesulfonate",CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)OC2=CC=CC3=C2C(=O)C=C(C3=O)N4CC4,,,,,,
1582,131583,6-Benzoylbenzothiazolin-2-one,C1=CC=C(C=C1)C(=O)C2=CC3=C(C=C2)NC(=O)S3,,,,,,
1583,131584,"1H-Purine-2,6-dione, 3,7-dihydro-8-(3-oxocyclopentyl)-1,3-dipropyl-",CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3CCC(=O)C3,,,['Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)'],,,
1584,131585,N-Methylbenperidol,CN1C2=CC=CC=C2N(C1=O)C3CCN(CC3)CCCC(=O)C4=CC=C(C=C4)F,,,,,,
1585,131586,EtdGp,C1[C@H](O[C@H]([C@@H]1O)N2C=NC3C24C=CN4C(NC3=O)N)COP(=O)(O)O,,,,,,
1586,131587,Succinimidyl 4-hydrazinobenzoate,C1CC(=O)N(C1=O)OC(=O)C2=CC=C(C=C2)NN,,,,,,
1587,131588,Aceratioside,C1CC2=C(C[C@H]1C(=O)O)C=C(C=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
1588,131589,Lyngbyatoxin B,CC(C)C1C(=O)NC(CC2=CNC3=C(C=CC(=C23)N1C)C(C)(CCC(C(=C)C)O)C=C)CO,,,,,,
1589,131590,2-[4-[[2-Butyl-6-(cyclohexylcarbamoylamino)benzimidazol-1-yl]methyl]phenyl]benzoic acid,CCCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2)NC(=O)NC5CCCCC5,,,,,,
1590,131591,CID 131591,COC1=CC=C(C=C1)C2=COC3=CC=CC(=O)C3=C2O,,,,,,
1591,131592,Ganoine,CC(C)CCN1C(=CC=C1C=O)CO,,,,,,
1592,131593,Zijinlongine,COC1=C2C(=CC3=C1OCO3)CCN4C2(CC5=C(C4)C6=C(C=C5)OCO6)CO,,,,,,
1593,131594,Ganoderpurine,CC(=O)CC(C)(C)N1C=NC2=C(N=CN=C21)N,,,,,,
1594,131595,1-(4-Aminobenzyl)-DTPA,C1=CC(=CC=C1CC(CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)N.Cl.Cl.Cl.Cl,,,,,,
1595,131596,2-[[3-(4-Aminophenyl)-2-[bis(carboxymethyl)amino]propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid,C1=CC(=CC=C1CC(CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)N,,,,,,
1596,131597,CID 131597,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC(=C(C=C2)O)O)C(=O)N[C@@]3([C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=CS5)C(=O)[O-])NC=O.[Na+],,,,,,
1597,131598,"(6R,7S)-7-[[2-(3,4-dihydroxyphenyl)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]acetyl]amino]-7-formamido-8-oxo-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC(=C(C=C2)O)O)C(=O)N[C@@]3([C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=CS5)C(=O)O)NC=O,,,,,,
1598,131599,"7-[3-[(4-Azido-3-iodophenyl)sulfonylamino]-6,6-dimethyl-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid",CC1(C2CC1C(C(C2)NS(=O)(=O)C3=CC(=C(C=C3)N=[N+]=[N-])I)CC=CCCCC(=O)O)C,,,,,,
1599,131600,CID 131600,C[C@H](CCCC(C)(C)O)[C@H]1CCC2[C@@]1(CCCC2=CC=C3C[C@H](CCC3=C)OCCCN=C4C=CC(=N[N+]#N)C=C4N(O)[O-])C,,,,,,
1600,131601,Ibrolipim,CCOP(=O)(CC1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)Br)C#N)OCC,,,"['Compounds that increase the enzymatic activity of LIPOPROTEIN LIPASE. Lipoprotein lipase activators have a potential role in the treatment of OBESITY by increasing LIPID METABOLISM. Note that substances that increase the synthesis of lipoprotein lipase are not included here. (See all compounds classified as Lipoprotein Lipase Activators.)', 'Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)']",,['Ibrolipim has known human metabolites that include [4-[(4-Bromo-2-cyanophenyl)carbamoyl]phenyl]methyl-ethoxyphosphinic acid.'],
1601,131602,"N,N'-(3,5-Dinitrobenzoyl)-1,2-diaminocyclohexane",C1CC[C@H]([C@@H](C1)NC(=O)C2=CC(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])NC(=O)C3=CC(=CC(=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
1602,131603,CID 131603,CCCC1NC2=C(C=CN=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C,,,,,,
1603,131604,Hexadecyl 6-(trimethylazaniumyl)hexyl phosphate,CCCCCCCCCCCCCCCCOP(=O)([O-])OCCCCCC[N+](C)(C)C,,,,,,
1604,131605,"Hexadecyl-N,N,N-trimethylhexanolamine",CCCCCCCCCCCCCCCCOP(=O)(O)OCCCCCC[N+](C)(C)C,,,,,,
1605,131606,Artilide,CCCCN(CCCC)CCC[C@H](C1=CC=C(C=C1)NS(=O)(=O)C)O,,,,,,
1606,131607,CID 131607,CC(=O)C1=C(C(=C2C(=C1)C(=C3C(=CC(=O)C(=C3C(=O)O)O)O2)O)C(=O)C)C4=COC5=CC(=O)C(=C(C5=C4O)C(=O)O)O,,,,,,
1607,131608,N-Cyano-N'-(2-phenylethyl)-3-pyridinecarboximidamide,C1=CC=C(C=C1)CCN=C(C2=CN=CC=C2)NC#N,,,,,,
1608,131609,"2,5-Bis((3-aminopropyl)amino)-N,N-dioctadecylpentanamide",CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)C(=O)C(CCCNCCCN)NCCCN,,,,,,
1609,131610,"12-(2-Hydroxy-5-methoxy-3-methylphenyl)-2,10-dimethyldodeca-2,10-diene-4,8-dione",CC1=CC(=CC(=C1O)CC=C(C)CC(=O)CCCC(=O)C=C(C)C)OC,,,,,,
1610,131611,"9,10-Difluorohexadecanoic acid",CCCCCCC(C(CCCCCCCC(=O)O)F)F,,,,,,
1611,131612,[hexadecoxy(hydroxy)phosphoryl] (2S)-2-amino-3-hydroxypropanoate,CCCCCCCCCCCCCCCCOP(=O)(O)OC(=O)[C@H](CO)N,,,,,,
1612,131613,Monooxyethylene trimethylolpropane tristearate,CCCCCCCCCCCCCCCCCC(=O)OCCOCC(CC)(COCCOC(=O)CCCCCCCCCCCCCCCCC)COCCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
1613,131614,CID 131614,C1=CC(=C(C=C1CNC2=NC(=O)C3=C(N2)N=CN3)Cl)Cl,,,,,,
1614,131615,beta-Hydroxyethylaprophen,CCN(CCO)CCOC(=O)C(C)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
1615,131616,CID 131616,CC1=CC2C(CCC(C2O)O)C(C1CCC(C)C(C(=CCC(C=CC(C)C(C=CCC(C(=CCC(CC3CCCN3C(=N)N)O)C)O)O)O)C)O)(C)C(=O)C4=C(NCC4=O)O,,,,,,
1616,131617,Dideaza-philanthotoxin-12,CCCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCCCCCCCCCCCCN,,,,,,
1617,131618,CID 131618,CC(=O)C=C1C2C(OC(=C2C(=O)C=C(O1)C=CC3=CC(=C(C=C3)O)O)O)C4=CC(=C(C=C4)O)O,,,,,,
1618,131619,"But-2-enedioic acid;3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-6,7,8,9-tetrahydropyrido[1,2-a][1,3,5]triazine-2,4-dione",C1CCN2C(=NC(=O)N(C2=O)CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F)C1.C(=CC(=O)O)C(=O)O,,,,,,
1619,131620,"3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2H-pyrido[1,2-a]-1,3,5-triazine-2,4(3H)-dione",C1CCN2C(=NC(=O)N(C2=O)CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F)C1,,,,,,
1620,131621,"8-Chloro-3-(3-fluoropropyl)-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol",C1CN(CC(C2=CC(=C(C=C21)Cl)O)C3=CC=CC=C3)CCCF,,,,,,
1621,131622,"ethyl 8-fluoro-5-(3-fluoropropyl)-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate",CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)CCCF,,,,,,
1622,131623,"3-fluoropropyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate",CN1CC2=C(N=CN2C3=C(C1=O)C=C(C=C3)F)C(=O)OCCCF,,,,,,
1623,131624,Methyl N-[(4-methylphenyl)sulfonyl]glycyl-3-[amino(imino)methyl]-D-phenylalaninate,CC1=CC=C(C=C1)S(=O)(=O)NCC(=O)N[C@@H](CC2=CC(=CC=C2)C(=N)N)C(=O)OC,,,,,,
1624,131625,N(alpha)-Tosyl-glycyl-3-amidinophenylalanine,CC1=CC=C(C=C1)S(=O)(=O)NCC(=O)N[C@@H](CC2=CC(=CC=C2)C(=N)N)C(=O)O,,,,,,
1625,131626,"4-Acetyl-1-((3,4-dichlorophenyl)acetyl)-2-((3-hydroxy-1-pyrrolidinyl)methyl)piperazine",CC(=O)N1CCN(C(C1)CN2CCC(C2)O)C(=O)CC3=CC(=C(C=C3)Cl)Cl,,,,,,
1626,131627,4-[[N-[(3-fluorophenyl)methyl]-4-(quinolin-2-ylmethoxy)anilino]methyl]benzoic acid,C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=C(C=C3)N(CC4=CC=C(C=C4)C(=O)O)CC5=CC(=CC=C5)F,,,,,,
1627,131628,CID 131628,CC(=C)C1CC(CCC1(C)C=C)C(=CC=CC(C)(C)O[C@@H]2[C@H]([C@@H]([C@@H](CO2)O)O)O)C,,,,,,
1628,131629,"(14-Amino-17,20-dicarbamoyl-11-methoxy-2-oxo-6,7,9,10-tetraoxa-3,8,13-triazatricyclo[13.6.2.016,21]tricosa-1(21),13,15,17,19,22-hexaen-5-yl) hydrogen carbonate",COC1CN=C(C2=C3C(=CC=C(C3=C(C=C2)C(=O)NCC(OONOO1)OC(=O)O)C(=O)N)C(=O)N)N,,,,,,
1629,131630,"6-(alpha-Phenylacetylpiperazinyl)phenyl-5-methyl-4,5-dihydro-3(2H)-pyridazinone",CC1CC(=O)NN=C1C2=CC=C(C=C2)N3CCN(CC3)C(=O)CC4=CC=CC=C4,,,,,,
1630,131631,"6H-Thiopyrano(3,2-d)pyrimidine, 2-(4-ethyl-1-piperazinyl)-7,8-dihydro-4-(1-pyrrolidinyl)-, 5,5-dioxide",CCN1CCN(CC1)C2=NC3=C(C(=N2)N4CCCC4)S(=O)(=O)CCC3,,,,,,
1631,131632,N-Methylglycyl-arginyl-glycyl-aspartyl-seryl-proline,CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O,,,,,,
1632,131633,Succinyl-isoleucyl-isoleucyl-tryptophyl-methylcoumarinamide,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC3=CC4=C(C=C3)C(=CC(=O)O4)C)NC(=O)CCC(=O)O,,,,,,
1633,131634,"11,15-Icosadienoic acid",CCCCC=CCCC=CCCCCCCCCCC(=O)O,,,,,,
1634,131635,"18-Methylicosa-5,9-dienoic acid",CCC(C)CCCCCCCC=CCCC=CCCCC(=O)O,,,,,,
1635,131636,"1-Benzyloxy-8,11,11-trimethyl-6-phenylthiobicyclo(5.3.1)undec-7-en-3-one",CC1=C2[C@H](CCC(=O)C[C@@](C2(C)C)(CC1)OCC3=CC=CC=C3)SC4=CC=CC=C4,,,,,,
1636,131637,CID 131637,CC1(C2CC1C(C(C2)NS(=O)(=O)C3=CC=C(C=C3)I)CC=CCCCC(=O)O)C,,,,,,
1637,131638,"Methyl 16-methyl-14-oxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,18-pentaene-12-carboxylate",CC1C2C(CC3C4=C(CC(N3C2=O)C(=O)OC)C5=CC=CC=C5N4)C=CO1,,,,,,
1638,131639,"3,3'-Azobis(benzeneacetic acid)",C1=CC(=CC(=C1)N=NC2=CC=CC(=C2)CC(=O)O)CC(=O)O,,,,,,
1639,131640,"1,3-Dimethyl-7-[2-[methyl(1-phenylpropan-2-yl)amino]ethyl]purine-2,6-dione",CC(CC1=CC=CC=C1)N(C)CCN2C=NC3=C2C(=O)N(C(=O)N3C)C,,,,,,
1640,131641,"1,2-Hmdddo",CC1(CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1(C)O)OC)OC)OC)OC)OC)OC)O,,,,,,
1641,131642,"4b,5,9b,10-Tetrahydroindeno[1,2-b]indole",C1C2C(C3=CC=CC=C31)NC4=CC=CC=C24,,,,,,
1642,131643,"[[4,7-Bis[[ethoxy(hydroxy)phosphoryl]-phosphonomethyl]-1,4,7-triazonan-1-yl]-[ethoxy(hydroxy)phosphoryl]methyl]phosphonic acid",CCOP(=O)(C(N1CCN(CCN(CC1)C(P(=O)(O)O)P(=O)(O)OCC)C(P(=O)(O)O)P(=O)(O)OCC)P(=O)(O)O)O,,,,,,
1643,131644,7-Desacetyl-7-(O-propionyl)hydroxyaminocarbonylforskolin,CCC(=O)ONC(=O)O[C@@H]1[C@@H]([C@H]2[C@@]([C@@H](CCC2(C)C)O)([C@]3([C@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,,,,,,
1644,131645,"8-[3-(tert-butylamino)-2-hydroxypropoxy]-4H-1,4-benzothiazin-3-one",CC(C)(C)NCC(COC1=CC=CC2=C1SCC(=O)N2)O,,,,,,
1645,131646,CID 131646,C1C(=NC2=C(N1)NC(=NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCCCN=C(NC4=CC5=C(C=C4)C6(C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)OC5=O)S)C(=O)O,,,,,,
1646,131647,N-(2-methylphenyl)-1-azabicyclo[2.2.2]octane-3-carboxamide,CC1=CC=CC=C1NC(=O)C2CN3CCC2CC3,,,,,,
1647,131648,CID 131648,C1=CC=C(C=C1)C[C@@H](C(=O)O)OC(=O)C(=CC2=CC=C(C=C2)N)NC(=O)C3=CC=CC=C3,,,,,,
1648,131649,CID 131649,C1=CC=C(C=C1)C[C@@H](C(=O)O)OC(=O)C(=CC2=CC=C(C=C2)N=NC3=CC=CC=C3)NC(=O)C4=CC=CC=C4,,,,,,
1649,131650,4-Methoxybenzyloxycarbonyl-asparaginyl-leucyl-glycine ethyl ester,CCOC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)OCC1=CC=C(C=C1)OC,,,,,,
1650,131651,CID 131651,CC(C)OC1=CC=CN2C1=NC(=C2C=C(C#N)C(=O)[O-])OC(C)C.[Na+],,,,,,
1651,131652,"2-Cyano-3-[2,8-di(propan-2-yloxy)imidazo[1,2-a]pyridin-3-yl]prop-2-enoic acid",CC(C)OC1=CC=CN2C1=NC(=C2C=C(C#N)C(=O)O)OC(C)C,,,,,,
1652,131653,2-(N-(2-Propynyl)-aminomethyl)-1-methyl-5-hydroxyindole,CN1C2=C(C=C(C=C2)O)C=C1CNCC#C,,,,,,
1653,131654,"2,5-dibutyl-4-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,2,4-triazol-3-one",CCCCC1=NN(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CCCC,,,,,,
1654,131655,"N,N-Dimethyl-2-(4-sec-butylphenoxy)ethylamine",CCC(C)C1=CC=C(C=C1)OCCN(C)C,,,,,,
1655,131656,"2,4-Dinitrophenylcysteinyl disulfide",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])N[C@@H](CSSCC(C(=O)O)NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])[14C](=O)O,,,,,,
1656,131657,4-[[(1S)-1-Carboxy-5-[hydroxy(3-phenylprop-2-enoyl)amino]pentyl]amino]-2-[2-[[(1S)-1-carboxy-5-[hydroxy(3-phenylprop-2-enoyl)amino]pentyl]amino]-2-oxoethyl]-2-hydroxy-4-oxobutanoic acid,C1=CC=C(C=C1)C=CC(=O)N(CCCC[C@@H](C(=O)O)NC(=O)CC(CC(=O)N[C@@H](CCCCN(C(=O)C=CC2=CC=CC=C2)O)C(=O)O)(C(=O)O)O)O,,,,,,
1657,131658,CID 131658,COC(=O)[C@H](CCCCN(C(=O)C=CC1=CC=CC=C1)O)NC(=O)CC(CC(=O)NC(CCCCN(C(=O)C=CC2=CC=CC=C2)O)C(=O)O)(C(=O)O)O,,,,,,
1658,131659,"3-Methoxy-7H-8-methyl-11-((3'-amino)propylamino)benzo(e)pyrido(4,3-b)indole",CC1=CN=C(C2=C1NC3=C2C4=C(C=C3)C=C(C=C4)OC)NCCCN,,,,,,
1659,131660,CID 131660,CCCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCNS(=O)(=O)C1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)O,,,,,,
1660,131661,CID 131661,CCCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)(O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCNS(=O)(=O)C1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)O,,,,,,
1661,131662,CID 131662,CCCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)C=CC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)O,,,,,,
1662,131663,CID 131663,CCCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)(O)OCC[N+](C)(C)C)NC(=O)C=CC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)O,,,,,,
1663,131664,Pagoclone,CC(C)CCC(=O)CC1C2=CC=CC=C2C(=O)N1C3=NC4=C(C=C3)C=CC(=N4)Cl,['For the potential treatment of panic and anxiety disorders.'],"['Pagoclone was originally developed as an anti-anxiety drug, but never commercialised. It is a partial agonist acting at GABAA receptors in the brain. In contrast to zopiclone, pagoclone produces anxiolytic effects with little or no sedative or amnestic actions at low doses.']",,,,
1664,131665,"2,6-Dimethoxyhydroquinone-3-mercaptoacetic acid",COC1=C(C(=C(C(=C1)O)SCC(=O)O)OC)O,,,,,,
1665,131666,"1-[2-[(4-chlorophenyl)methyl]cyclohexen-1-yl]-N,N-dimethylmethanamine",CN(C)CC1=C(CCCC1)CC2=CC=C(C=C2)Cl,,,,,,
1666,131667,"2-(Phenylazoxy)-1-methyl-6-phenylimidazo(4,5-b)pyridine",CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1[N+](=NC4=CC=CC=C4)[O-],,,,,,
1667,131668,CID 131668,C1CC(C(=O)C[C@@H]1C(=O)OC=CC(=O)CCC2=CN=CC=C2)(C3=CC=CC=C3)C4=CC5=CCOC5=C4,,,,,,
1668,131669,3-(((3-(7-Chloro-2-quinolinyl)methoxyphenyl)(2-(4-chloro-2-dimethylcarbamoylphenyl)ethyl)methyl)thio)propanoic acid,CN(C)C(=O)C1=C(C=CC(=C1)Cl)CCC(C2=CC(=CC=C2)OCC3=NC4=C(C=CC(=C4)Cl)C=C3)SCCC(=O)O,,,,,,
1669,131670,Serotonin-O-carboxymethyl-gly-tyr,C1=CC(=CC=C1C[C@@H](C(=O)N)NC(=O)CNC(=O)COC2=CC3=C(C=C2)NC=C3CCN)O,,,,,,
1670,131671,4-(3-Octadecan-4-ylphenyl)-4-oxobut-2-enoic acid,CCCCCCCCCCCCCCC(CCC)C1=CC(=CC=C1)C(=O)C=CC(=O)O,,,,,,
1671,131672,CID 131672,C1CC2=C(C=C1O)N=C3C2=C4C(=C5C3=NC6=C(CC(=O)C=C56)O)C=NC4=O,,,,,,
1672,131673,Vermixocin B,CC1=CC2=C(C(=C1)O)OC3=C(C(=C(C=C3)C(CC(C)C)OC(=O)C)OC)C(=O)OC2,,,,,,
1673,131674,Purpactin C,CC1=CC(=O)C2(C(=C1)C=O)C(=O)C3=C(O2)C=CC(=C3OC)C(CC(C)C)OC(=O)C,,,,,,
1674,131675,(S)-4-Benzyl-3-(but-2-enoyl)oxazolidin-2-one,CC=CC(=O)N1C(COC1=O)CC2=CC=CC=C2,,,,,,
1675,131676,"1,4-Bis(butylamino)benzo(g)phthalazine",CCCCNC1=NN=C(C2=CC3=CC=CC=C3C=C21)NCCCC,,,,,,
1676,131677,"N-(2,6-Bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea",CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)CN(C)C,,,,,,
1677,131678,Nevanimibe hydrochloride,CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)N(C)C.Cl,,,,,,
1678,131679,Nevanimibe,CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)N(C)C,,,,,,
1679,131680,CID 131680,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OC[C@@H]([C@@H]1C(=O)C(=C(O1)O)O)O)OC(=O)CCCCCCCCCCCCC,,,,,,
1680,131681,"Enkephalinamide, tyr(1)-psi-(methyleneoxy)-gly(2)-leu(5)-",CC(C)C[C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)COC[C@H](CC2=CC=C(C=C2)O)N,,,,,,
1681,131682,Safinamide,C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,['Safinamide is indicated as an add-on treatment to levodopa with or without other medicines for Parkinsons disease'],,,"['Rapid with peak plasma concentrations ranging from 2 to 4 h, total bioavailability is 95%. Food prolonged the rate and did not affect the extent of absorption of safinamide.', '76% renal, 1.5% faeces', '1.8 litres/kg', 'total oral clearance of plasma , which accounts for parent safinamide as well as metabolites, was on average only 17.53  2.71 ml/h  kg']","['The principal step is mediated by amidases which have not been identified, and produces safinamide acid. It is also metabolized to O-debenzylated safinamide and N-delkylated amine. The N-dealkylated amine is then oxidized to a carboxylic acid and finally glucuronidated. Dealkylation reactions are mediated by cytochrome P450s (CYPs), especially CYP3A4. Safinamide acid binds to organic anion transporter 3 (OAT3), but no clinical relevance of this interaction has been determined. Safinamide also binds to ABCG2 transiently. No other transporter affinities have been found in preliminary studies.']",['22 h']
1682,131683,1-Thio-alpha-tocopherol,CC1=C(C2=C(CC[C@@](S2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1OC(=O)C)C)C,,,,,,
1683,131684,Ramontoside,CO[C@H]1[C@@H](CO[C@H]([C@@H]1OC)OC2=C3COC(=O)C3=C(C4=CC(=C(C=C42)OC)OC)C5=CC6=C(C=C5)OCO6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O,,,,,,
1684,131685,Boc-glu-ofm,CC(C)(C)OC(=O)N[C@@H](CCC(=O)O)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
1685,131686,"5-[(3aS,5R,6R,6aS)-5-hydroxy-6-[(4S)-4-hydroxy-4-methyloct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentanoic acid",CCCC[C@@](C)(CC=C[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=C2)CCCCC(=O)O)O)O,,,,,,
1686,131687,(S)-N-(2-((4-((3-((3-Aminopropyl)amino)propyl)amino)butyl)amino)-1-methyl-2-oxoethyl)butanamide,CCCC(=O)N[C@@H](C)C(=O)NCCCCNCCCNCCCN,,,,,,
1687,131688,N-(4-Acetyl-1-piperazinyl)-4-fluorobenzenesulfonamide,CC(=O)N1CCN(CC1)NS(=O)(=O)C2=CC=C(C=C2)F,,,,,,
1688,131689,4-Amino-3-(2-thienyl)butanoic acid,C1=CSC(=C1)C(CC(=O)O)CN,,,,,,
1689,131690,"3-[1-But-2-en-2-yl-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid",CC=C(C)C1=CC(=C(C2=C1OC3=C(C(=CC(=C3CO)O)C(=CC(=O)O)C)C(=O)O2)C)OC,,,,,,
1690,131691,"3-(1-But-2-en-2-yl-10-formyl-9-hydroxy-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl)but-2-enoic acid",CC=C(C)C1=CC(=C(C2=C1OC3=C(C(=CC(=C3C=O)O)C(=CC(=O)O)C)C(=O)O2)C)OC,,,,,,
1691,131692,CID 131692,C1=CC=C2C(=C1)C(=O)C(=C(O2)O)CC3=CC=C(C=C3)N=[N+]=[N-],,,,,,
1692,131693,1-Cyclopropylisoguanosine,C1CC1N2C(=C3C(=NC2=O)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,,,,
1693,131694,"2,7-Dihydro-7-phenyl-2-(phenylmethyl)-5-propoxy-3H-imidazo(1,2-c)pyrazolo(4,3-e)pyrimidine",CCCOC1=NC2=C(C=NN2C3=CC=CC=C3)C4=NC(CN41)CC5=CC=CC=C5,,,,,,
1694,131695,1-(4-Fluorophenyl)-4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)butan-1-one,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=NC=C(C=N3)F,,,,,,
1695,131696,Disodium;(3S)-4-[2-[1-(4-fluorophenyl)-3-propan-2-ylindol-2-yl]ethynyl-oxidophosphoryl]-3-hydroxybutanoate,CC(C)C1=C(N(C2=CC=CC=C21)C3=CC=C(C=C3)F)C#CP(=O)(C[C@H](CC(=O)[O-])O)[O-].[Na+].[Na+],,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
1696,131697,"Butanoic acid, 4-(((1-(4-fluorophenyl)-3-(1-methylethyl)-1H-indol-2-yl)ethynyl)hydroxyphosphinyl)-3-hydroxy-, (3S)-",CC(C)C1=C(N(C2=CC=CC=C21)C3=CC=C(C=C3)F)C#CP(=O)(C[C@H](CC(=O)O)O)O,,,,,,
1697,131698,1-(4-Iodophenyl)-3-(1-adamantyl)guanidine,C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=C(C=C4)I,,,,,,
1698,131699,CID 131699,CCCCC\1=C(C(=NC(=O)O)C=C/C1=[N+](/[O-])\[O-])C,,,,,,
1699,131700,(3-Butyl-2-methyl-4-nitrophenyl)carbamic acid,CCCCC1=C(C=CC(=C1C)NC(=O)O)[N+](=O)[O-],,,,,,
1700,131701,"1-Cyano-2-(6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl)-3-(2-methylbutan-2-yl)guanidine",CCC(C)(C)NC(=NC1C(C(OC2=C1C=C(C=C2)C#N)(C)C)O)NC#N,,,,,,
1701,131702,"2-(p-(4,6-Diamino-1,3,5-triazin-2-ylamino)phenyl)-1,3,2-dithiarsepane-5,6-diol",C1C(C(CS[As](S1)C2=CC=C(C=C2)NC3=NC(=NC(=N3)N)N)O)O,,,,,,
1702,131703,N-[3-[[4-[formyl-[(2-methyl-6-oxo-1H-pyrimidin-5-yl)methyl]amino]-1-hydroxypentan-3-yl]disulfanyl]-5-hydroxypentan-2-yl]-N-[(2-methyl-6-oxo-1H-pyrimidin-5-yl)methyl]formamide,CC1=NC=C(C(=O)N1)CN(C=O)C(C)C(CCO)SSC(CCO)C(C)N(CC2=CN=C(NC2=O)C)C=O,,,,,,
1703,131704,"8-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one",C[C@@H]1[C@H]([C@H](C[C@H](O1)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=C(C=C4)O)O)OC)O)O,,,,,,
1704,131705,"(5alpha,17beta)-17-Benzoyl-4-azaandrost-1-en-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)C4=CC=CC=C4)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,,,['Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE. (See all compounds classified as 5-alpha Reductase Inhibitors.)'],,,
1705,131706,3-Ethyl-1-(6-hydroxy-6-methylheptyl)-7-propylxanthine,CCCN1C=NC2=C1C(=O)N(C(=O)N2CC)CCCCCC(C)(C)O,,,,,,
1706,131707,Benzyloxycarbonyl-prolyl-psi(CN4)-alanine benzyl ester,C[C@@H](C(=O)OCC1=CC=CC=C1)N2N=C(N=N2)[C@@H]3CCCN3C(=O)OCC4=CC=CC=C4,,,,,,
1707,131708,"N-(4-(2,3,4,6-Tetra-O-acetyl-D-glucopyranosyl)oxy)phenylmitomycin C",CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)NC5=CC=C(C=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
1708,131709,"(6aR,10aR)-3-(5-azidopentyl)-2-iodo-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol",CC1=CC[C@@H]2[C@@H](C1)C3=C(C=C(C(=C3O)I)CCCCCN=[N+]=[N-])OC2(C)C,,,,,,
1709,131710,(2S)-6-amino-2-[[2-amino-8-[[(1S)-5-amino-1-carboxypentyl]amino]-7-[[(2S)-3-carboxy-2-[[(2S)-5-[(2S)-3-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]butanoyl]amino]propanoyl]oxy-5-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoyl]amino]propanoyl]amino]-8-oxooctanoyl]amino]hexanoic acid,C1CC(=O)N[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)OC(=O)CC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NC(CCCCC(C(=O)N[C@@H](CCCCN)C(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]2CCC(=O)N2,,,,,,
1710,131711,CID 131711,CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)OC(C)C)O)O)OC(=O)CC,,,,,,
1711,131712,"2,6-Difluorophenyl-N-tert-butylnitrone",CC(C)(C)N(CC1=C(C=CC=C1F)F)[O],,,,,,
1712,131713,8-(Benzenesulfonamido)-7-(3-pyridinyl)octanoic acid,C1=CC=C(C=C1)S(=O)(=O)NCC(CCCCCC(=O)O)C2=CN=CC=C2,,,,,,
1713,131714,"Pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate",C[C@@]12CCCC1C3CC(C4=C(C3CC2)C=CC(=C4)OC)OS(=O)(=O)[O-].C1=CC=[NH+]C=C1,,,,,,
1714,131715,"[(13S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-6-yl] hydrogen sulfate",C[C@@]12CCCC1C3CC(C4=C(C3CC2)C=CC(=C4)OC)OS(=O)(=O)O,,,,,,
1715,131716,CID 131716,CC(=O)C1=CC=C(C=C1)[C@H]2C[C@]3([C@@H](CC[C@@]3(C=CCO)O)[C@H]4C2=C5CCC(=O)C=C5CC4)C,,,,,,
1716,131717,"(R,S)-8-((4-Chlorophenylsulfonyl)amino)-4-(3-(3-pyridinyl)propyl)octanoic acid",C1=CC(=CN=C1)CCCC(CCCCNS(=O)(=O)C2=CC=C(C=C2)Cl)CCC(=O)O,,,,,,
1717,131718,"1,3,4,5-Tetramethyl-2-((2-oxopropyl)thio)imidazolium",CC1=C([N+](=C(N1C)SCC(=O)C)C)C,,,,,,
1718,131719,"1,4-Epoxy-2-formamido-1,2,3,4-tetrahydro-8-trifluoromethylnaphthalene",C1C(C2C3=C(C1O2)C=CC=C3C(F)(F)F)NC=O,,,,,,
1719,131720,"3-(1,2,5,6-Tetrahydro-4-pyridyl)-5-n-propoxyindole",CCCOC1=CC2=C(C=C1)NC=C2C3=CCNCC3,,,,,,
1720,131721,CID 131721,C1=CC2=C(C(=CC3=C2C(=C1)C(=O)O3)CCN(CCCl)CCCl)O,,,,,,
1721,131722,Formyl-aminohexyl-leucyl-phenylalanyl-aminohexyl-tyrosyl-phenylalanine,CC(C)C[C@@H](C(=O)N(CCCCCCN(C(=O)[C@H](CC1=CC=C(C=C1)O)N)[C@@](CCCCCCNC=O)(CC2=CC=CC=C2)C(=O)O)C(=O)[C@H](CC3=CC=CC=C3)N)N,,,,,,
1722,131723,"3,9-Dihydro-3-((1,3-dihydroxy-2-propoxy)methyl)-6-methyl-9-oxo-5H-imidazol(1,2-a)purine",CC1=CN2C(=O)C3=C(N=C2N1)N(C=N3)COC(CO)CO,,,,,,
1723,131724,N-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-2-oxo-3-propan-2-ylbenzimidazole-1-carboxamide;hydrochloride,CC(C)N1C2=CC=CC=C2N(C1=O)C(=O)NC3CC4CCC(C3)N4C.Cl,,,,,,
1724,131725,BIMU8 hydrate,CC(C)N1C2=CC=CC=C2N(C1=O)C(=O)NC3CC4CCC(C3)N4C,,,,,,
1725,131726,Hexadecyl-dimethyl-octadec-9-enylazanium;chloride,CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCC=CCCCCCCCC.[Cl-],,,,,,
1726,131727,Hexadecyl-dimethyl-octadec-9-enylazanium,CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCC=CCCCCCCCC,,,,,,
1727,131728,CID 131728,CNCCOC1=CC=C(C=C1)CC2=CC=C(C=C2)OCCNC,,,,,,
1728,131729,"4-Methoxyphenyl-(5-methyl-6-(2-(4-morpholinyl)ethyl)-6H-thieno(2,3-b)pyrrol-4-yl)phenylmethanone",CC1=C(C2=C(N1CCN3CCOCC3)SC=C2)C(=O)C4=CC=C(C=C4)OC,,,,,,
1729,131730,7-(3-Oxocholest-4-en-2-yl)-5-oxa-4-oxoheptanoic acid,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)[C@@H](C[C@]34C)CCOC(=O)CCC(=O)O)C,,,,,,
1730,131731,"2(1H)-Pyridinone, 5-hydroxy-3,4-bis(hydroxymethyl)-6-methyl-",CC1=C(C(=C(C(=O)N1)CO)CO)O,,,,,,
1731,131732,"4,4'-Di(methacryloylamino)azobenzene",CC(=C)C(=O)NC1=CC=C(C=C1)N=NC2=CC=C(C=C2)NC(=O)C(=C)C,,,,,,
1732,131733,"alpha-Ethyl-3-(2-(ethyl(2-hydroxyethyl)amino)acetamido)-2,4,6-triiodohydrocinnamic acid",CCC(CC1=C(C(=C(C=C1I)I)NC(=O)CN(CC)CCO)I)C(=O)O,,,,,,
1733,131734,(2R)-2-[(2R)-Oxiranyl]-6-methyl-5-heptene-2-ol,CC(=CCC[C@](C)([C@H]1CO1)O)C,,,,,,
1734,131735,6-Chloro-6-deoxy-d-glucitol,C([C@@H]([C@H]([C@@H]([C@@H](CCl)O)O)O)O)O,,,,,,
1735,131736,"9-Chloro-7-(2-chlorophenyl)-5H-pyrimido(5,4-d)(2)benzazepine",C1C2=CN=CN=C2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4Cl,,,['Endogenous compounds and drugs that bind to and activate GABA-A RECEPTORS. (See all compounds classified as GABA-A Receptor Agonists.)'],,,
1736,131737,CID 131737,C1=CC=C(C=C1)C2=NC3=C(C=C2)C4=C(S3)C(=O)N=NN4,,,,,,
1737,131738,"3-(3-Hydroxy-1,2-oxazol-4-yl)alanine",C1=C(C(=O)NO1)CC(C(=O)O)N,,,,,,
1738,131739,"4-Pyridinecarboxylic acid, 1,2,3,6-tetrahydro-1-methyl-, propyl ester",CCCOC(=O)C1=CCN(CC1)C,,,,,,
1739,131740,Ethyl 2-bromo-2-(4-methoxyphenyl)acetate,CCOC(=O)C(C1=CC=C(C=C1)OC)Br,,,,,,
1740,131741,CID 131741,C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)Cl)C(=O)N[C@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
1741,131742,Thyroxine sulfate,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)OS(=O)(=O)O)I)I)C[C@@H](C(=O)O)N,,,,,,
1742,131743,[N'-methyl-N-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]carbamimidoyl]urea,CC1=C(N=CN1)CSCCNC(=NC)NC(=O)N,,,,,,
1743,131744,Hydroxymethylpentanone,CCCC(=O)CCO,,,,,,
1744,131745,"2-Propynoic acid, 2-naphthalenylmethyl ester",C#CC(=O)OCC1=CC2=CC=CC=C2C=C1,,,,,,
1745,131746,4-Amino-1-(6-chloro-2-pyridyl)-piperidine hydrochloride,C1CN(CCC1N)C2=NC(=CC=C2)Cl.Cl,,,,,,
1746,131747,1-(6-Chloropyridin-2-yl)piperidin-4-amine,C1CN(CCC1N)C2=NC(=CC=C2)Cl,,,,,,
1747,131748,p-Chloroisoprenaline,CC(C)NCC(C1=CC(=C(C=C1Cl)O)O)O,,,,,,
1748,131749,5-((1-Phenylcyclohexyl)amino)pentanal,C1CCC(CC1)(C2=CC=CC=C2)NCCCCC=O,,,,,,
1749,131750,3-Amino-4-fluorobutanoic acid,C(C(CF)N)C(=O)O,,,,,,
1750,131751,CID 131751,C1=CC(=CC=C1C(=NCC(=O)N[C@@H](CCCCN)C(=O)O)[O-])N[N+]#N,,,,,,
1751,131752,CID 131752,C1=CC(=CC=C1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N[N+]#N,,,,,,
1752,131753,"4-(4-Hydroxy-3-methylbut-2-enyl)-1,2-diphenylpyrazolidine-3,5-dione",CC(=CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)CO,,,,,,
1753,131754,1-(1-Phenylcyclohexyl)-4-phenyl-4-piperidinol,C1CCC(CC1)(C2=CC=CC=C2)N3CCC(CC3)(C4=CC=CC=C4)O,,,,,,
1754,131755,5-Hydroxyfenclofenac,C1=CC(=C(C=C1O)CC(=O)O)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
1755,131756,Chlorozil,CC[N+](C)(C)CCOC(=O)C(C1CCCC1)(C2=CC=CC=C2)O.[Cl-],,,,,,
1756,131757,"2-{[cyclopentyl(hydroxy)phenylacetyl]oxy}-N-ethyl-N,N-dimethylethanaminium",CC[N+](C)(C)CCOC(=O)C(C1CCCC1)(C2=CC=CC=C2)O,,,,,,
1757,131758,"L-Alanine, 3-((bromoacetyl)amino)-, monohydrobromide",C([C@@H](C(=O)O)N)NC(=O)CBr.Br,,,,,,
1758,131759,2-Amino-3-[(2-bromoacetyl)amino]propanoic acid,C(C(C(=O)O)N)NC(=O)CBr,,,,,,
1759,131760,4-Hydroxyisovaleric acid,CC(CC(=O)O)CO,,,,,,
1760,131761,"7-[(1R,2R,3R,5S)-2-(3-Fluorooct-1-enyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid",CCCCCC(C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O)F,,,,,,
1761,131762,"11-methyl-6H-pyrido[4,3-b]carbazole-5-carbaldehyde",CC1=C2C=NC=CC2=C(C3=C1C4=CC=CC=C4N3)C=O,,,,,,
1762,131763,"Piperidine, 4-(3-methoxy-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-",CN1CCC(=C2C3=CC=CC=C3C=CC4=C2C=C(C=C4)OC)CC1,,,,,,
1763,131764,"3-Benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6-methyl-",CC1CCN(CCC2=C1C=C(C=C2)O)CC3CC3,,,,,,
1764,131765,1-Isobutoxycarbonyl-4-methylpiperazine,C1CN(CCN1)C(=O)O.Cl,,,,,,
1765,131766,Piperazine-1-carboxylic acid,C1CN(CCN1)C(=O)O,,,,,,
1766,131767,1-(4-Thiazolyl)-3-cyano-1-propanone,C1=C(N=CS1)C(=O)CCC#N,,,,,,
1767,131768,"2-(4-Methoxy-2-(2-(methylsulfinyl)ethoxy)phenyl)-1H-imidazo(4,5-b)pyridine",COC1=CC(=C(C=C1)C2=NC3=C(N2)C=CC=N3)OCCS(=O)C,,,,,,
1768,131769,"4-(3-Amino-1h-1,2,4-triazol-5-yl)-n-ethylpyridin-2-amine",CCNC1=NC=CC(=C1)C2=NC(=NN2)N,,,,,,
1769,131770,CID 131770,C1=C(C=C(C(=C1O)O)O)C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,,
1770,131771,2-Nitrobenzyl acetate,CC(=O)OCC1=CC=CC=C1[N+](=O)[O-],,,,,,
1771,131772,2-Bromoacetoxybenzoic acid,C1=CC=C(C(=C1)C(=O)O)OC(=O)CBr,,,,,,
1772,131773,1-Methyl-2-methylsulfinyl-5-methoxycarbonylimidazole,CN1C(=CN=C1S(=O)C)C(=O)OC,,,,,,
1773,131774,Sulmazole sulfone,COC1=C(C=CC(=C1)S(=O)(=O)C)C2=NC3=C(N2)C=CC=N3,,,,,,
1774,131775,"1H-Imidazo(4,5-b)pyridine, 2-(2-methoxy-4-(methylthio)phenyl)-",COC1=C(C=CC(=C1)SC)C2=NC3=C(N2)C=CC=N3,,,,,,
1775,131776,CID 131776,CN1C(=C(NC2=NC=C(C=C2)O)O)C(=O)C3=CC=CC=C3S1(=O)=O,,,,,,
1776,131777,"4-[1-[(10R,13S,17S)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]ethylamino]-4-oxobutanoic acid",CC([C@H]1CCC2[C@@]1(CCC3C2CCC4=CC(=O)C=C[C@]34C)C)NC(=O)CCC(=O)O,,,,,,
1777,131778,CID 131778,C1CCC(CC1)CN2CCN(CC2)C(=O)CCCOC3=CC4=C(C=C3)NC5=NC(=O)NC5=C4,,,,,,
1778,131779,N-(2-Amino-1-(aminocarbonyl)-3-methylbutyl)histidine,CC(C)[C@@H]([C@@H](C(=O)N)N[C@@H](CC1=CN=CN1)C(=O)O)N,,,,,,
1779,131780,"4'-((2-Butyl-4-(hydroxymethyl)-5-chloro-1H-imidazolyl)methyl)-2',6'-dimethoxy(1,1'-biphenyl)-2-carboxylic acid",CCCCC1=NC(=C(N1CC2=CC(=C(C(=C2)OC)C3=CC=CC=C3C(=O)O)OC)Cl)CO,,,,,,
1780,131781,CID 131781,C1=C(NC=N1)C(CC(=O)O)S(C[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
1781,131782,"4'-((2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazolyl)methyl)-2',6'-dimethoxy(1,1'-biphenyl)-2-carboxylic acid",CCCCC1=NC(=C(N1CC2=CC(=C(C(=C2)OC)C3=CC=CC=C3C(=O)O)OC)CO)Cl,,,,,,
1782,131783,"Casomorphin, trp(3)-",C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N5CCC[C@H]5C(=O)NCC(=O)O,,,,,,
1783,131784,"N-Butyl-2-(5-(4-(3,17-dihydroxyestra-1,3,5(10)-trien-11-yl)phenoxy)pentylthio)-N-methylacetamide",CCCCN(C)C(=O)CSCCCCCOC1=CC=C(C=C1)[C@H]2C[C@@]3([C@H](CCC3C4C2C5=C(CC4)C=C(C=C5)O)O)C,,,,,,
1784,131785,"2',3',5'-Tris-O-(N-(2-n-propyl-n-pentanoyl)glycyl)-5-fluorouridine",CCCC(CCC)C(=O)NCC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)OC(=O)CNC(=O)C(CCC)CCC)OC(=O)CNC(=O)C(CCC)CCC,,,,,,
1785,131786,5-(Bis(2-chloroethyl)amino)-1-methylbenzimidazolyl-2-acetic acid methyl ester,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CC(=O)OC,,,,,,
1786,131787,2-[2-[Bis(carboxymethyl)amino]ethyl-[2-[[2-[[2-[[[2-[2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetyl]amino]methyl]-3-(4-isothiocyanatophenyl)propyl]amino]-2-oxoethyl]-(carboxymethyl)amino]ethyl]amino]acetic acid,C1=CC(=CC=C1CC(CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O)CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O)N=C=S,,,,,,
1787,131788,CID 131788,C[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)NC(=O)C1=CC=CC=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CN,,,,,,
1788,131789,Salmfamide 2,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CO)N)O,,,,,,
1789,131790,N-(3-Ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@@H]2[C@H](O2)C(=O)OCC,,,,,,
1790,131791,CID 131791,CC(C)C[C@@H](C([C@H](CC1CCCCC1)N[C@@H](C(=O)NC(=O)[C@H](CC2=CC=CC=C2)NS(=O)(=O)N3CCOCC3)C(=O)OC)O)O,,,,,,
1791,131792,1-(6-(N-(2-n-Propyl-n-pentanoyl)glycyl)amino-n-hexylcarbamoyl)-5-fluorouracil,CCCC(CCC)C(=O)NCC(=O)NCCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,,,,,,
1792,131793,N-hydroxy-N-[4-(3-phenoxyphenyl)but-3-en-2-yl]acetamide,CC(C=CC1=CC(=CC=C1)OC2=CC=CC=C2)N(C(=O)C)O,,,,,,
1793,131794,CID 131794,CCC(CC)(CC=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O,,,,,,
1794,131795,Epigeoside,C1[C@H]([C@@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O,,,,,,
1795,131796,"2,3-Dihydro-diimidazo(1,5-a-1',2'-C)quinazoline-5-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)",C1CC1C2=NC(=NO2)C3=C4N5CCN=C5C6=CC=CC=C6N4C=N3,,,,,,
1796,131797,"Diimidazo(1,5-a:1',2'-c)quinazoline, 12-chloro-5-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-2-methyl-, (S)-",CC1CN2C3=C(N=CN3C4=C(C2=N1)C(=CC=C4)Cl)C5=NOC(=N5)C6CC6,,,,,,
1797,131798,4-[(4-Cyanophenyl)-(tetrazol-2-yl)methyl]benzonitrile,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3N=CN=N3,,,,,,
1798,131799,CID 131799,CCC(CC)(CCCCC(C)C1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C)O,,,,,,
1799,131800,Chloro(dicyclohexylphenylphosphine)gold(I),C1CCC(CC1)P(C2CCCCC2)C3=CC=CC=C3Cl.[Au+],,,,,,
1800,131801,(2-Chlorophenyl)-dicyclohexylphosphane,C1CCC(CC1)P(C2CCCCC2)C3=CC=CC=C3Cl,,,,,,
1801,131802,Neohancoside A,CC(=CCCC(C)(C=C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H](CO2)O)O)O)O)O)O)C,,,,,,
1802,131803,"1,1'-Dipropyl-3,3,3',3'-tetramethylindocarbocyanine iodide",CCCN1C2=CC=CC=C2C(C1=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CCC)(C)C.[I-],,,,,,
1803,131804,"1-Propyl-2-[3-(1-propyl-3,3-dimethylindoline-2-ylidene)-1-propenyl]-3,3-dimethyl-3H-indole-1-ium",CCCN1C2=CC=CC=C2C(C1=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CCC)(C)C,,,,,,
1804,131805,CID 131805,C1=CC=C(C=C1)C=CC2C=C(C(=O)O2)C(=O)C[P+](C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5.[Br-],,,,,,
1805,131806,CID 131806,C1=CC=C(C=C1)C=CC2C=C(C(=O)O2)C(=O)C[P+](C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
1806,131807,3-(4-Nitrophenoxy)-2-(S-glutathionyl)-1-propanol,C1=CC(=CC=C1[N+](=O)[O-])OCC(CO)([C@](CS)(C(=O)O)NC(=O)CC[C@@H](C(=O)O)NC(=O)CN)O,,,,,,
1807,131808,"1-((2-(Dimethylamino)ethyl)amino)-4-((2-((hydroxyethyl)amino)ethyl)amino)-5,8-dihydroxy-9,10-anthracenedione",CN(C)CCNC1=C2C(=C(C=C1)NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
1808,131809,Formylmethionyl-leucyl-alpha-methyl(phenylalanine) methyl ester,CC(C)C[C@@H](C(=O)N(C=O)[C@@](C)(CC1=CC=CC=C1)C(=O)OC)NC(=O)[C@H](CCSC)N,,,,,,
1809,131810,CID 131810,CCCCC1(CCC2(CCC(C(O2)CC=C(C)C=CC(C(C)C=CC(=O)O)O)C)OC1C=CC(=CC(=O)O)C)OC(=O)CCC(=O)O,,,,,,
1810,131811,Quinuclidinyl-2-thienyl-4-bromobenzilate,C1CN2CCC1C(C2)OC(=O)C(C3=CC=C(C=C3)Br)(C4=CC=CS4)O,,,,,,
1811,131812,Benzyloxycarbonylcitrullyl-arginine 4-methylcoumarin-7-ylamide,CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CCCN=C(N)N)N(C(=O)[C@H](CCCNC(=O)N)N)C(=O)OCC3=CC=CC=C3,,,,,,
1812,131813,5-Propynyluracil,CC#CC1=CNC(=O)NC1=O,,,,,,
1813,131814,"3,4,5-Triphenyl-1H-pyrazole-1-nonanoic acid",C1=CC=C(C=C1)C2=C(N(N=C2C3=CC=CC=C3)CCCCCCCCC(=O)O)C4=CC=CC=C4,,,,,,
1814,131815,"Aspartyl-2,3-methanoproline propyl ester",CCCOC(=O)[C@]12CC1CCN2C(=O)[C@H](CC(=O)O)N,,,,,,
1815,131816,"3-Hydroxy-17-oxoestra-1,3,5(10)-trien-11-yl acetate",CC(=O)OC1C[C@]2(C(CCO2)C3C1C4=C(CC3)C=C(C=C4)O)C,,,,,,
1816,131817,"1,8-Naphthyridine-3-carboxaldehyde, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, monohydrochloride",C1CN(CC1N)C2=C(C=C3C(=O)C(=CN(C3=N2)C4=C(C=C(C=C4)F)F)C=O)F.Cl,,,,,,
1817,131818,"7-(3-Amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carbaldehyde",C1CN(CC1N)C2=C(C=C3C(=O)C(=CN(C3=N2)C4=C(C=C(C=C4)F)F)C=O)F,,,,,,
1818,131819,4-Iodophenylarsine oxide,C1=CC(=CC=C1[As]=O)I,,,,,,
1819,131820,3-((N-(Aminocarbonyl)-N-hydroxyamino)methyl)-6-phenoxychromene,C1C(=CC2=C(O1)C=CC(=C2)OC3=CC=CC=C3)CN(C(=O)N)O,,,,,,
1820,131821,CID 131821,C1=C(C=C(C(=C1Br)OCCCN)Br)CC(=C(NCCC2=CN=C(N2)N)O)N=O,,,,,,
1821,131822,2-Hexadecylamino-2-hydroxymethylnorbornene,CCCCCCCCCCCCCCCCNC1(CC2CC1C=C2)CO,,,,,,
1822,131823,"2-Hexadecylamino-2,3-bis(hydroxymethyl)norbornene",CCCCCCCCCCCCCCCCNC1(C2CCC(=C1CO)C2)CO,,,,,,
1823,131824,"3,6-Fluorescein diphosphate",C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)OP(=O)(O)O)OC5=C3C=CC(=C5)OP(=O)(O)O,,,,,,
1824,131825,"4-[2-Hydroxy-5-methyl-7-(3-methyl-12-oxo-1-oxacyclododeca-4,6,10-trien-2-yl)-4-oxooct-6-enyl]piperidine-2,6-dione",CC1C=CC=CCCC=CC(=O)OC1C(=CC(C)C(=O)CC(CC2CC(=O)NC(=O)C2)O)C,,,,,,
1825,131826,3-(2-Furylacryloyl)phenylalanylleucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC(=CC=C1)C(=O)C(=C)C2=CC=CO2)N,,,,,,
1826,131827,CID 131827,CC=C(C)[C@@H]([C@H](C)C=C(C)C=CCC(=CCC1=C(C(=C(C(=N1)OC)OC)O[C@H]2[C@H]([C@H]([C@H]([C@H](O2)C)O)O)O)C)C)O,,,,,,
1827,131828,Momorcharaside B,C[C@@H]([C@H]1CC[C@@]2([C@@]1(CC[C@]3(C2CC=C4[C@@H]3CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C)[C@@H]([C@H]([C@H](C(C)(C)O)O)O)O,,,,,,
1828,131829,"5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-1,2,3,4-tetrahydroquinoxalin-6-amine",C1CNC2=C(N1)C=CC(=C2Br)NC3=NCCN3,,,,,,
1829,131830,8-(2-Hydroxypropyl)adenosine,CC(CC1=NC2=C(N=CN=C2N1[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)O,,,,,,
1830,131831,N-[4-[(1-benzylpiperidin-4-yl)sulfamoyl]phenyl]-N-methyl-3-(4-methylsulfonylphenyl)prop-2-enamide,CN(C1=CC=C(C=C1)S(=O)(=O)NC2CCN(CC2)CC3=CC=CC=C3)C(=O)C=CC4=CC=C(C=C4)S(=O)(=O)C,,,,,,
1831,131832,"[(3S,4R)-4-methyl-2-[(4R,5R)-2,2,5-trimethyl-5-[2-[(6S)-5-methyl-2-oxo-6-[3-(phenylmethoxymethoxy)pentan-2-yl]-1,3-dioxan-4-yl]propyl]-1,3-dioxolan-4-yl]hex-5-en-3-yl] imidazole-1-carboxylate",CCC(C(C)[C@H]1C(C(OC(=O)O1)C(C)C[C@@]2([C@H](OC(O2)(C)C)C(C)[C@H]([C@H](C)C=C)OC(=O)N3C=CN=C3)C)C)OCOCC4=CC=CC=C4,,,,,,
1832,131833,CID 131833,CCCNC[C@]1(C[C@H]2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C7=C53)[C@]1(O2)C)CNC6=O)O,,,,,,
1833,131834,"11-(11-Amino-4,8-dihydroxyundec-1-enyl)-5,7,9,28,37,41,43-heptahydroxy-34-(1-hydroxy-4-methyloct-7-enyl)-27,29,40-trimethyl-12,45-dioxabicyclo[39.3.1]pentatetraconta-17,19,21,23,25,31,38-heptaene-13,30-dione",CC1C=CC=CC=CC=CC=CCCCC(=O)OC(CC(CC(CC(CCCC2CC(CC(O2)(C(C=CC(CCC(CC=CC(=O)C(C1O)C)C(CCC(C)CCC=C)O)O)C)O)O)O)O)O)C=CCC(CCCC(CCCN)O)O,,,,,,
1834,131835,Furaquinocin C,CC1C(C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)CCC=C(C)C,,,,,,
1835,131836,"4-hydroxy-3-(1-hydroxy-4-methylpent-3-enyl)-7-methoxy-2,3,8-trimethyl-2H-benzo[g][1]benzofuran-6,9-dione",CC1C(C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)C(CC=C(C)C)O,,,,,,
1836,131837,"4-hydroxy-3-(5-hydroxy-4-methylpenta-1,3-dienyl)-7-methoxy-2,3,8-trimethyl-2H-benzo[g][1]benzofuran-6,9-dione",CC1C(C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)C=CC=C(C)CO,,,,,,
1837,131838,"4-hydroxy-3-(5-hydroxy-4-methylpent-3-enyl)-7-methoxy-2,3,8-trimethyl-2H-benzo[g][1]benzofuran-6,9-dione",CC1C(C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)CCC=C(C)CO,,,,,,
1838,131839,Furaquinocin G,CC1C(C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)C4CC=C(C(O4)O)C,,,,,,
1839,131840,Furaquinocin H,CC1C(C2=C(C=C3C(=C2O1)C(=O)C(=C(C3=O)OC)C)O)(C)C(CC=C(CO)CO)O,,,,,,
1840,131841,Tibeglisene,CC1=CC=C(C=C1)S(=O)(=O)C(CC#CC2=CC=C(C=C2)Cl)C(=O)O,,,,,,
1841,131842,3-(2-Chlorobenzylamino)-2-benzhydrylquinuclidine,C1CN2CCC1C(C2C(C3=CC=CC=C3)C4=CC=CC=C4)NCC5=CC=CC=C5Cl,,,,,,
1842,131843,2-Hydroxy-2-(trifluoromethyl)octadec-4-enoic acid,CCCCCCCCCCCCCC=CCC(C(=O)O)(C(F)(F)F)O,,,,,,
1843,131844,Phenylalanyl-threonyl-arginyl-phenylalaninamide,C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N)N)O,,,,,,
1844,131845,CID 131845,C1CCN(CC1)CC2=CC=C(O2)CNCCN3CCNC3=C(C#N)C#N.C(=CC(=O)O)C(=O)O,,,,,,
1845,131846,"Propanedinitrile, 2-[1-[2-[[[5-(1-piperidinylmethyl)-2-furanyl]methyl]amino]ethyl]-2-imidazolidinylidene]-",C1CCN(CC1)CC2=CC=C(O2)CNCCN3CCNC3=C(C#N)C#N,,,,,,
1846,131847,4-((Methylsulfonyl)amino)-N-((4-phenylpiperazin-2-yl)methyl)benzamide,CS(=O)(=O)NC1=CC=C(C=C1)C(=O)NCC2CN(CCN2)C3=CC=CC=C3,,,,,,
1847,131848,Glycopril,CC(=O)SC[C@@H](CC1=CC2=C(C=C1)OCO2)C(=O)NCC(=O)OCC3=CC=CC=C3,,,,,,
1848,131849,"1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-((4-p-nitrobenzol)-1-piperazinyl)quinoline-3-carboxylic acid",CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C(=O)C4=CC=C(C=C4)[N+](=O)[O-])F)C(=O)O,,,,,,
1849,131850,"(S)-benzyl 2-((S)-2-(acetylthiomethyl)-3-(benzo[d][1,3]dioxol-5-yl)propanamido)propanoate",C[C@@H](C(=O)OCC1=CC=CC=C1)NC(=O)[C@](C)(CC2=CC3=C(C=C2)OCO3)SC(=O)C,,,,,,
1850,131851,"3b-hydroxy-3a,5,5-trimethyl-3-methylidene-4H-cyclopenta[a]pentalene-2,6-dione",CC1(CC2(C(=CC3=CC(=O)C(=C)C32C)C1=O)O)C,,,,,,
1851,131852,2-(Hexan-2-ylamino)acetamide,CCCCC(C)NCC(=O)N,,,,,,
1852,131853,"2,6-Bis(bis-(2-chloroethyl)amino)-4,8-dipiperidino-pyrimido(5,4-d)pyrimidine",C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCCl)CCCl)N(CCCl)CCCl,,,,,,
1853,131854,"[(2R,3S,4R,5R)-5-(6-amino-2-oxo-7H-purin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",C1=NC2=C(N1)C(=NC(=O)N2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
1854,131855,"3-(beta-Phenylethyl)-9-beta-methoxy-9alpha-(m-benzoyloxyphenyl)-3-azabicyclo(3,3,1)nonane",COC1(C2CCCC1CN(C2)CCC3=CC=CC=C3)C4=CC(=CC=C4)OC(=O)C5=CC=CC=C5,,,,,,
1855,131856,Fluoroclorgyline,CN(CCCOC1=C(C=C(C=C1)F)Cl)CC#C,,,,,,
1856,131857,"3-((2'-Carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3H-imidazo(4,5-b)pyridine",CC1=C2C(=NC=C1)N(C(=N2)C3CC3)CC4=CC=C(C=C4)C5=CC=CC=C5C(=O)O,,,['Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)'],,,
1857,131858,CID 131858,C1=CC(=CC=C1C(C2=CC=C(C=C2)O)C(C3=COC4=CC(=O)C=CC4=C3O)C(=O)O)O,,,,,,
1858,131859,CID 131859,CC1=NC(=O)C(=C(N1)NCC2=CC(=CN=C2)Br)Br.Br,,,,,,
1859,131860,CID 131860,CC1=NC(=O)C(=C(N1)NCC2=CC(=CN=C2)Br)Br,,,,,,
1860,131861,Momorcharaside A,C[C@@H]([C@H]1CC[C@@]2([C@@]1(CC[C@]3(C2CC=C4[C@@H]3CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O)O)O)O)O)C)C)C)[C@@H]([C@H]([C@H](C(C)(C)O)O)O)O,,,,,,
1861,131862,"2-[(2S,3S)-3-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylbutan-2-yl]oxyacetic acid",C[C@@H]([C@H](C)SC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)OCC(=O)O,,,,,,
1862,131863,"1,1-dioxo-3-phenylmethoxy-3,3a,4,7a-tetrahydro-2H-1-benzothiophen-5-one",C1C2C(CS(=O)(=O)C2C=CC1=O)OCC3=CC=CC=C3,,,,,,
1863,131864,Uridine triphosphopyridoxal,CC1=NC=C(C(=C1O)C=O)C(O)P(=O)(OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)OP(=O)(O)OP(=O)(O)O,,,,,,
1864,131865,Opochol,CCC([C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)OC5=C6C(=CCC5=O)OC7=CC=CC=C7N6,,,,,,
1865,131866,Armillaritin,CC1=CC(=CC(=C1C(=O)O[C@@H]2C[C@]3([C@@]2(C(=C[C@]4([C@@H]3CC(C4)(C)C)O)C=O)O)C)O)O,,,,,,
1866,131867,Armillarivin,CC1=CC(=CC(=C1C(=O)O[C@@H]2C[C@]3([C@@H]2C(=C[C@H]4[C@@H]3CC(C4)(C)C)C=O)C)O)O,,,,,,
1867,131868,"(4aR,6aR,6aS,6bR,10S,12aR,14bR)-10-[(2S,3R,4S,5S)-4-acetyloxy-3,5-dihydroxyoxan-2-yl]oxy-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-2,4a-dicarboxylic acid",CC(=O)O[C@H]1[C@H](CO[C@H]([C@@H]1O)O[C@H]2CC[C@@]3([C@H]4CC=C5[C@H]6CC(CC[C@@]6(CC[C@]5([C@@]4(CCC3C2(C)C)C)C)C(=O)O)(C)C(=O)O)C)O,,,,,,
1868,131869,"(5-(Nitro-2-furyl)-1,3,4-oxadiazol-2-ylthio)acethydrazide",C1=COC(=C1[N+](=O)[O-])C2=NN=C(O2)SCC(=O)NN,,,,,,
1869,131870,Pbdsng,CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)OC(=O)CCCCCCCCCCCCCCC,,,,,,
1870,131871,3-(2-Trifluoromethylbenzylamino)-2-benzhydrylquinuclidine,C1CN2CCC1[C@H]([C@H]2C(C3=CC=CC=C3)C4=CC=CC=C4)NCC5=CC=CC=C5C(F)(F)F,,,,,,
1871,131872,"(2R,6R)-2-methyl-4-oxo-6-[(10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7,11,12,15-pentaoxo-1,2,5,6,16,17-hexahydrocyclopenta[a]phenanthren-17-yl]heptanoic acid",C[C@H](CC(=O)C[C@@H](C)C(=O)O)[C@H]1CC(=O)[C@@]2([C@@]1(C(=O)C(=O)C3=C2C(=O)CC4[C@@]3(CCC(=O)C4(C)C)C)C)C,,,,,,
1872,131873,"Ethyl (+-)-alpha,alpha-diphenyl-gamma-((2-pyridinylmethoxy)methyl)-1-pyrrolidinebutanoate",CCOC(=O)C(CC(COCC1=CC=CC=N1)N2CCCC2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1873,131874,CID 131874,CCCC=CC=CC=C(C)[C@H]1[C@H]([C@@H]([C@@H](CO1)C)OC)OC(=O)CN,,,,,,
1874,131875,N-[3-(2-amino-1H-imidazol-5-yl)prop-2-enyl]-1H-pyrrole-2-carboxamide,C1=CNC(=C1)C(=O)NCC=CC2=CN=C(N2)N,,,,,,
1875,131876,6-Bromo-5-hydroxy-3-phenylisochroman,C1C(OCC2=C1C(=C(C=C2)Br)O)C3=CC=CC=C3,,,,,,
1876,131877,5-Nitro-2-(N-3-(4-azidophenyl)propylamino)benzoic acid,C1=CC(=CC=C1CCCNC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)O)N=[N+]=[N-],,,,,,
1877,131878,10-Propargyl-5-deazaaminopterin analog of folic acid,C#CCN(CC1=CC2=C(N=C(N=C2N=C1)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
1878,131879,10-Propargyl-5-methyl-5-deazaaminopterin analog of folic acid,CC1=C2C(=NC(=NC2=NC=C1CN(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)N,,,,,,
1879,131880,"2,3-Dibenzylthio-6-tert-butyl-4-benzoquinone",CC(C)(C)C1=CC(=O)C(=C(C1=O)SCC2=CC=CC=C2)SCC3=CC=CC=C3,,,,,,
1880,131881,2-(4-(Biscarboxymethyl)amino-3-(carboxymethoxy)phenyl)-1H-indole-6-carboxylic acid,C1=CC(=C(C=C1C2=CC3=C(N2)C=C(C=C3)C(=O)O)OCC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
1881,131882,Locoid C,CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)CO.CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl,,,,,,
1882,131883,"[(9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate",CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3C2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)CO,,,,,,
1883,131884,"10H-Benzo(4,5)cyclohepta(1,2-b)selenophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-",CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)[Se]C=C3)CC1,,,,,,
1884,131885,3'-Mercapto-3'-deoxythymidine-5'-triphosphate,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)S,,,,,,
1885,131886,"Acetamide, 2-((2-propylpentyl)amino)-",CCCC(CCC)CNCC(=O)N,,,,,,
1886,131887,"3-(((1,3-Benzoxazol-2-yl)methyl)amino)-5-ethyl-6-methylpyridin-2(1H)-one",CCC1=C(NC(=O)C(=C1)NCC2=NC3=CC=CC=C3O2)C,,,,,,
1887,131888,CID 131888,C[C@H]1C[C@H]([C@@H]([C@H](C1)C=C)C2=C(N(C=CC2=O)O)O)C,,,,,,
1888,131889,6-Propoxy-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester,CCCOC1=CC2=C(C=C1)NC3=CN=C(C(=C23)COC)C(=O)OCC,,,,,,
1889,131890,"(3R,7S,10R,11R)-10-[(2R,3R,4R,5S,6S)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3,7,11-triethyl-azacyclotetradecan-2-one",CC[C@H]1CCC[C@H](C(=O)NCCC[C@H]([C@@H](CC1)O[C@H]2[C@@H]([C@@H]([C@@H]([C@@H](O2)C)O)N)O)CC)CC,,,,,,
1890,131891,Monoterpenylmagnolol,CC1=C[C@@H]([C@H](CC1)C(C)C)C2=CC(=CC(=C2O)C3=C(C=CC(=C3)CC=C)O)CC=C,,,,,,
1891,131892,CID 131892,CC1=CC(=NN1C2=NNC(=C3C2=NC4=CC=CC=C43)NNC)C,,,,,,
1892,131893,Nmmpmpch,CC1=C(C(=NO1)C2=CC=CC(=C2NC)CC(C)C)C(=O)[O-],,,,,,
1893,131894,"5-Methyl-3-[2-(methylamino)-3-(2-methylpropyl)phenyl]-1,2-oxazole-4-carboxylic acid",CC1=C(C(=NO1)C2=CC=CC(=C2NC)CC(C)C)C(=O)O,,,,,,
1894,131895,"[(5R)-5-methyl-2-propan-2-ylcyclohexyl] (1R,2R,3S)-2-(morpholine-4-carbonyl)-3-phenylcyclopropane-1-carboxylate",C[C@@H]1CCC(C(C1)OC(=O)[C@@H]2[C@H]([C@H]2C(=O)N3CCOCC3)C4=CC=CC=C4)C(C)C,,,,,,
1895,131896,CID 131896,CCCCC(C)(C)C(=O)C=CC1=C(C(=O)C(C1)C(CC2=C(C(=O)CC2)CCCCCCC(=O)O)C(=O)C(C)(C)CCCC)CCCCCCC(=O)O,,,,,,
1896,131897,CID 131897,C[SeH](CC[C@@H](C(=O)O)N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=NC=NC(=C3N=C2N=[N+]=[N-])N)O)O,,,,,,
1897,131898,CID 131898,C1C[C@@H]2[C@H]([C@H]([C@H]1O2)CC3=CC=CC=C3CCC(=O)O)C=NNC(=O)NC4=CC=CC=C4,,,,,,
1898,131899,"1,3-dihydroxy-8-methoxy-3-methyl-2,4-dihydro-1H-benzo[a]anthracene-7,12-dione",CC1(CC(C2=C(C1)C=CC3=C2C(=O)C4=C(C3=O)C(=CC=C4)OC)O)O,,,,,,
1899,131900,Peimine,C[C@H]1CC[C@H]2[C@@]([C@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4C[C@@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)(C)O,,,,,,
1900,131901,"[(2S,3S,5S,10S,13S,16S,17R)-3-hydroxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-morpholin-4-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CC(=O)O[C@H]1[C@H](CC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCCC6)C,,,,,,
1901,131902,5-Cyclohexyl-6-methyluracil,CC1=C(C(=O)NC(=O)N1)C2CCCCC2,,,,,,
1902,131903,"(3S,5S)-7-[(1S,2R,3R,4S,6R,8S,8aR)-3,4,6-trihydroxy-2-methyl-8-(2-methylbutanoyloxy)-1,2,3,4,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid",CCC(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H]([C@H]([C@H]2O)O)C)CC[C@@H](C[C@@H](CC(=O)O)O)O)O,,,,,,
1903,131904,CID 131904,CC(C)C[C@@H]([C@@H]([C@@H](CC1CCCCC1)N[C@@H](CC2=CSC(=N2)N)C(=O)NC(=O)[C@H](CC3=CC=CC=C3)NS(=O)(=O)N4CCOCC4)O)O,,,,,,
1904,131905,S 14506 hydrochloride,COC1=CC2=C(C=CC=C2N3CCN(CC3)CCNC(=O)C4=CC=C(C=C4)F)C=C1.Cl,,,,,,
1905,131906,4-fluoro-N-[2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl]benzamide,COC1=CC2=C(C=CC=C2N3CCN(CC3)CCNC(=O)C4=CC=C(C=C4)F)C=C1,,,,,,
1906,131907,N-[2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl]thiophene-2-carboxamide,COC1=CC2=C(C=CC=C2N3CCN(CC3)CCNC(=O)C4=CC=CS4)C=C1,,,,,,
1907,131908,"[(1R,2R,3S,4R,5R,6S,8S,10R,11R,12R,15S)-3,4,6,11-Tetraacetyloxy-2,8-dihydroxy-1,15-dimethyl-9-methylidene-13-oxo-16-oxatetracyclo[10.5.0.02,15.05,10]heptadecan-5-yl]methyl benzoate",CC(=O)O[C@H]1C[C@@H](C(=C)[C@@H]2[C@@]1([C@H]([C@@H]([C@]3([C@@]4(CC(=O)[C@@H]([C@@H]2OC(=O)C)[C@@]3(CO4)C)C)O)OC(=O)C)OC(=O)C)COC(=O)C5=CC=CC=C5)O,,,,,,
1908,131909,N-Palmitoylpyrazinamide,CCCCCCCCCCCCCCCC(=O)NC1=NC=CN=C1,,,,,,
1909,131910,LupGG,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)C(=O)O,,,,,,
1910,131911,CID 131911,CC[C@H](C)[C@@H](C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)OC)NC(=O)OCC1=CC=CC=C1,,,,,,
1911,131912,"(1-(2,2-Dimethyl-6-nitro-2H-1-benzopyran-4-yl)-2(1H)-pyridinylidene)cyanamide",CC1(C=C(C2=C(O1)C=CC(=C2)[N+](=O)[O-])N3C=CC=CC3=NC#N)C,,,,,,
1912,131913,"2-Methyl-3-hydroxy-4-(3-(4-phenyl-1-piperazinyl)propyl)-3,4-dihydro-2H-1,5-benzoxathiepin-4-carboxylate hydrochloride",CC1C(C(SC2=CC=CC=C2O1)C(=O)OCCCN3CCN(CC3)C4=CC=CC=C4)O.Cl,,,,,,
1913,131914,"3-(4-phenylpiperazin-1-yl)propyl 3-hydroxy-2-methyl-3,4-dihydro-2H-1,5-benzoxathiepine-4-carboxylate",CC1C(C(SC2=CC=CC=C2O1)C(=O)OCCCN3CCN(CC3)C4=CC=CC=C4)O,,,,,,
1914,131915,CID 131915,CCCCCC=CCC(C(C=CC(CC=CCCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)N)O,,,,,,
1915,131916,N-Benzyloxycarbonyl-prolyl-alanine methyl ester,C[C@H](C(=O)OC)NC(=O)[C@@H]1CCCN1C(=O)OCC2=CC=CC=C2,,,,,,
1916,131917,Girodazole,C1=C(NC(=N1)N)[C@@H]([C@H](CN)Cl)O.Cl.Cl,,,,,,
1917,131918,"5,6-Dihydro-6-phenyl-2-n-propylimidazo(2,1-b)thiazole",CCCC1=CN2CC(N=C2S1)C3=CC=CC=C3,,,,,,
1918,131919,"Hexadecanoic acid, (6-(2,3-dimethyl-1-oxobutoxy)-1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-1,1,7,9-tetramethyl-11-oxo-10a-((1-oxododecyl)oxy)-1H-2,8a-methanocyclopenta(a)cyclopropa(e)cyclodecen-4-yl)methyl ester",CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(CC(C4(C2=O)C=C(C(C4(C1O)O)OC(=O)C(C)C(C)C)C)C)OC(=O)CCCCCCCCCCC)(C)C,,,,,,
1919,131920,Methyl 3-methyl-2-(2-oxo-3-propan-2-ylpiperazin-1-yl)butanoate,CC(C)C1C(=O)N(CCN1)C(C(C)C)C(=O)OC,,,,,,
1920,131921,methyl (2S)-2-[(3S)-3-benzyl-2-oxopiperazin-1-yl]-3-phenylpropanoate,COC(=O)[C@H](CC1=CC=CC=C1)N2CCN[C@H](C2=O)CC3=CC=CC=C3,,,,,,
1921,131922,3-Hydroxy-N-acetylanthranilic acid,CC(=O)NC1=C(C=CC=C1O)C(=O)O,,,,,,
1922,131923,"7-(3-Aminopyrrolidin-1-yl)-9-cyclopropyl-6,8-difluoro-[1,2]thiazolo[5,4-b]quinoline-3,4-dione",C1CC1N2C3=C(C(=C(C=C3C(=O)C4=C2SNC4=O)F)N5CCC(C5)N)F,,,,,,
1923,131924,CID 131924,CN(C)C1=CC=CC(C1)(N(C)C)N(CC(=O)O)C(=O)[C@H](CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
1924,131925,"2-(3-Methoxy-4-propoxy-5-(ethanolsulphonyl)phenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran",CCCOC1=C(C=C(C=C1S(=O)(=O)CCO)[C@@H]2CC[C@H](O2)C3=CC(=C(C(=C3)OC)OC)OC)OC,,,,,,
1925,131926,Dsgmg,CCCCCCCCCCCCCCCCCCOCC(C(=O)N(C)C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)OCCCCCCCCCCCCCCCCCC,,,,,,
1926,131927,DDP-225 free base anhydrous,CC1=CC2=C(N=C(N=C2S1)N3CCNCC3)C4=CC=CC=C4F,,,,,,
1927,131928,2-(Cyclopropylmethoxy)-N-{hydroxy[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)imino]methyl}benzene-1-carboximidic acid,CN1C2CCC1CC(C2)NC(=O)NC(=O)C3=CC=CC=C3OCC4CC4,,,,,,
1928,131929,4'-Carbamoylpyridoxamine 5'-phosphate,CC1=NC=C(C(=C1O)C(C(=O)N)N)COP(=O)(O)O,,,,,,
1929,131930,Glcnacbeta1-6GalNAc,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC[C@H]([C@@H]([C@@H]([C@H](C=O)NC(=O)C)O)O)O)CO)O)O,,,,,,
1930,131931,CID 131931,C1=NC2=NC=NC2=C(N1)S(C[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
1931,131932,CID 131932,CCCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)[N-]C=CC2.[Na+],,,,,,
1932,131933,"2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4,7-dihydroimidazo[4,5-b]pyridine",CCCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)NC=CC2,,,,,,
1933,131934,Justiciresinol,COC1=CC(=CC(=C1O)OC)C[C@H]2CO[C@@H]([C@H]2CO)C3=CC(=C(C=C3)O)OC,,,,,,
1934,131935,CID 131935,CCCC(=O)OC1C[C@@]([C@H]2C[C@H](C(=C2[C@H]3[C@]1([C@](C(=O)O3)(C)O)O)C)OC(=O)C(=CC)C)(C)OC(=O)C,,,,,,
1935,131936,"(S)Fluoro-6(morpholinyl-2-methoxy)-8-tetrahydro-1,2,3,4-quinoline",CS(=O)(=O)O.C1CC2=C(C(=CC(=C2)F)OC[C@@H]3CNCCO3)NC1,,,,,,
1936,131937,"6-Fluoro-1,2,3,4-tetrahydro-8-[[(S)-morpholin-2alpha-yl]methoxy]quinoline",C1CC2=C(C(=CC(=C2)F)OC[C@@H]3CNCCO3)NC1,,,,,,
1937,131938,Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic acid,C1C[C@H]2CN[C@@H](C[C@H]2C[C@H]1CP(=O)(O)O)C(=O)O,,,"['Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)', 'Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)']",,,
1938,131939,"2-[(4,5-Dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylidene]undecanoic acid",CCCCCCCCCC(=CC1=C(C(=O)C(=C(C1=O)OC)OC)C)C(=O)O,,,,,,
1939,131940,"(S)-N,N'-Didecyl-2-((4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)amino)pentanediamide",CCCCCCCCCCNC(=O)CC[C@@H](C(=O)NCCCCCCCCCC)NC(=O)C1=CC=C(C=C1)N(C)CC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
1940,131941,2-Acetamido-4-O-(2-acetamido-2-deoxygalactopyranosyl)-2-deoxyglucopyranose,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)NC(=O)C)O)CO)O)O,,,,,,
1941,131942,"2-[(3S,10S,13R,14R,17S)-3-hydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,17-octahydro-1H-cyclopenta[a]phenanthren-14-yl]acetic acid",C[C@H](CCCC(C)C)[C@H]1C=C[C@@]2([C@@]1(CCC3=C2CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)CC(=O)O,,,,,,
1942,131943,Cinatrin A,C=CCCCCCCCCC1C[C@]2(C(=O)O1)C([C@H](C(=O)O2)O)(C(=O)O)O,,,,,,
1943,131944,Cinatrin B,CCCCCCCCCCC1C[C@]2(C(=O)O1)C([C@H](C(=O)O2)O)(C(=O)O)O,,,,,,
1944,131945,Cinatrin C1,CCCCCCCCCCCCOC(=O)[C@@H]1[C@@H]([C@H](C(=O)O1)O)C(=O)OO,,,,,,
1945,131946,3-Carbonoperoxoyl-4-(1-hydroxydodecyl)-5-oxooxolane-2-carboxylic acid,CCCCCCCCCCCC(C1C(C(OC1=O)C(=O)O)C(=O)OO)O,,,,,,
1946,131947,"(2R,3R,4S)-3-carbonoperoxoyl-4-dodecyl-4-hydroxy-5-oxooxolane-2-carboxylic acid",CCCCCCCCCCCC[C@@]1([C@@H]([C@@H](OC1=O)C(=O)O)C(=O)OO)O,,,,,,
1947,131948,"(2R)-3-[(4a,8,12a,12b-tetrahydroxy-3-methyl-1,7,12-trioxo-5,6-dihydro-4H-benzo[a]anthracen-6a-yl)sulfanyl]-2-acetamidopropanoic acid",CC1=CC(=O)C2(C(C1)(CCC3(C2(C(=O)C4=C(C3=O)C(=CC=C4)O)O)SC[C@@H](C(=O)O)NC(=O)C)O)O,,,,,,
1948,131949,"(2R)-3-[(4a,6,8,12a,12b-pentahydroxy-3-methyl-1,7,12-trioxo-5,6-dihydro-4H-benzo[a]anthracen-6a-yl)sulfanyl]-2-acetamidopropanoic acid",CC1=CC(=O)C2(C(C1)(CC(C3(C2(C(=O)C4=C(C3=O)C(=CC=C4)O)O)SC[C@@H](C(=O)O)NC(=O)C)O)O)O,,,,,,
1949,131950,"[(1S,2S,4S,5R)-9,9-Dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate;bromide",C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-],,,,,,
1950,131951,"[(1S,2S,4S,5R)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate",C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,,,,,,
1951,131952,3-Hydroxy-15-keto-chol-8(14)-en-24-oic acid,C[C@H](CCC(=O)O)[C@H]1CC(=O)C2=C3CCC4CC(CC[C@@]4([C@H]3CC[C@]12C)C)O,,,,,,
1952,131953,CID 131953,C1=C(N=C2C(=N1)NC(=NC2=O)N)C=CC(COP(=O)(O)O)O,,,,,,
1953,131954,"4-(3-Chlorobenzamido)-5-(3,3-dimethylbutylamino)-5-oxopentanoic acid",CC(C)(C)CCNC(=O)[C@@H](CCC(=O)O)NC(=O)C1=CC(=CC=C1)Cl,,,,,,
1954,131955,CID 131955,C[C+]1CCC2CN(C1)C3=CC=CC=C23,,,,,,
1955,131956,[2-[1-(2-Acetyloxypropyl)pyrrol-2-yl]-2-oxoethyl] acetate,CC(CN1C=CC=C1C(=O)COC(=O)C)OC(=O)C,,,,,,
1956,131957,"7-[4-(5-cyclohexylpenta-2,4-dienoylamino)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl]-N-(2-hydroxy-5-oxocyclopenten-1-yl)hepta-2,4,6-trienamide",C1CCC(CC1)C=CC=CC(=O)NC2=CC(C3C(C2=O)O3)(C=CC=CC=CC(=O)NC4=C(CCC4=O)O)O,,,,,,
1957,131958,N-Formylmethionyl-dipropylglycyl-phenylalanine methyl ester,CCC[C@](C(C1=CC=CC=C1)C(=O)[C@H](CCSC)NC=O)(C(=O)OC)N(CCC)C(=O)CN,,,,,,
1958,131959,"Fluoromethyl 17-ethoxycarbonyloxy-11-hydroxyandrosta-1,4-dien-3-one-17-carboxylate",CCOC(=O)OC1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCF,,,,,,
1959,131960,"4,5-Diphenyl-2-oxazolenonanoic acid",C1=CC=C(C=C1)C2=C(OC(=N2)CCCCCCCCC(=O)O)C3=CC=CC=C3,,,,,,
1960,131961,"2-(3-(2-(4,5-Diphenyl-2-oxazolyl)ethyl)phenoxy)acetic acid",C1=CC=C(C=C1)C2=C(OC(=N2)CCC3=CC(=CC=C3)OCC(=O)O)C4=CC=CC=C4,,,,,,
1961,131962,"2,9-Dimethyl-3a,4,9,9a-tetrahydrofuro(2,3-b)-quinoxaline-3-carboxylic acid",CC1=C(C2=C(O1)N(C3=CC=CC=C3N2)C)C(=O)OC4CC5CCC4(C5(C)C)C,,,,,,
1962,131963,"8-((4-Azidophenyl)methoxy)-1,2,3-trimethylimidazo(1,2-a)pyridinium",CC1=C([N+](=C2N1C=CC=C2OCC3=CC=C(C=C3)N=[N+]=[N-])C)C,,,,,,
1963,131964,3-(2-Nitrophenylmethyl)-2-thiazolidinone,C1CSC(=O)N1CC2=CC=CC=C2[N+](=O)[O-],,,,,,
1964,131965,N-(2(S)-(Acetylthiomethyl)-3-(2-methylphenyl)-1-oxopropyl)-L-methionine ethyl ester,CCOC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=CC=C1C)CSC(=O)C,,,,,,
1965,131966,"3,5-Dioxa-8-aza-4-phosphahexacosan-1-aminium, 4-hydroxy-7-(methoxymethyl)-N,N,N,8-tetramethyl-, hydroxide, inner salt, 4-oxide",CCCCCCCCCCCCCCCCCCN(C)C(COC)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
1966,131967,2-[Hydroxy-[3-methoxy-2-[methyl(octadecyl)amino]propoxy]phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCN(C)C(COC)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
1967,131968,"3,5-Dioxa-9-aza-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N,9-tetramethyl-, hydroxide, inner salt, 4-oxide",CCCCCCCCCCCCCCCCCCN(C)CC(COP(=O)([O-])OCC[N+](C)(C)C)OC,,,,,,
1968,131969,2-[Hydroxy-[2-methoxy-3-[methyl(octadecyl)amino]propoxy]phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCN(C)CC(COP(=O)(O)OCC[N+](C)(C)C)OC,,,,,,
1969,131970,[2-(Methylcarbamoyloxy)-3-[methyl(octadecyl)amino]propyl] 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCCCN(C)CC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)NC,,,,,,
1970,131971,2-[Hydroxy-[2-(methylcarbamoyloxy)-3-[methyl(octadecyl)amino]propoxy]phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCN(C)CC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)NC,,,,,,
1971,131972,[1-Methoxy-3-[methyl(octadecyl)amino]propan-2-yl] 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCCCCN(C)CC(COC)OP(=O)([O-])OCC[N+](C)(C)C,,,,,,
1972,131973,2-[Hydroxy-[1-methoxy-3-[methyl(octadecyl)amino]propan-2-yl]oxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCN(C)CC(COC)OP(=O)(O)OCC[N+](C)(C)C,,,,,,
1973,131974,"2-(3,4-Dihydro-2,2-dimethyl-6-nitro-2H-1,4-benzoxazin-4-yl)pyridine N-oxide",CC1(CN(C2=C(O1)C=CC(=C2)[N+](=O)[O-])C3=CC=CC=[N+]3[O-])C,,,['Chemical agents that increase the permeability of CELL MEMBRANES to POTASSIUM ions. (See all compounds classified as Potassium Ionophores.)'],,,
1974,131975,6-Benzoyl-12-methyl-13-oxo-9(12)-9(12)-dihomo-18-podocarpanol,C[C@@]12CC[C@@]3(C1)[C@H](C[C@@H]([C@H]4[C@]3(CCC[C@@]4(C)CO)C)OC(=O)C5=CC=CC=C5)CC2=O,,,['Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)'],,,
1975,131976,"[10-hydroxy-5-(10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl)-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-4-yl] acetate",CC1CC2=C(C3=C(C(=CC(=C3)OC)OC)C(=C2CO1)O)C4=C5C(C(OCC5=C(C6=C4C=C(C=C6OC)OC)O)C)OC(=O)C,,,,,,
1976,131977,4-(1-methyltetrazol-5-yl)sulfanyl-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]butanamide,CN1C(=NN=N1)SCCCC(=O)NCCCOC2=CC=CC(=C2)CN3CCCCC3.Cl,,,,,,
1977,131978,N-[3-[3-(Piperidinomethyl)phenoxy]propyl]-4-[(1-methyl-1H-tetrazol-5-yl)thio]butyramide,CN1C(=NN=N1)SCCCC(=O)NCCCOC2=CC=CC(=C2)CN3CCCCC3,,,,,,
1978,131979,Dimyristoylphosphatidylinositol,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OC1[C@H]([C@H](C([C@H]([C@@H]1O)O)O)O)O)OC(=O)CCCCCCCCCCCCC,,,,,,
1979,131980,1-Hydroxycarvedilol O-glucuronide,COC1=CC=CC=C1OCCNC[C@H](COC2=C3C4=CC=CC=C4NC3=C(C=C2)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O)O,,,,,,
1980,131981,8-Hydroxycarvedilol O-glucuronide,COC1=CC=CC=C1OCCNC[C@H](COC2=CC=CC3=C2C4=C(N3)C(=CC=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O)O,,,,,,
1981,131982,"3-[1-Benzyl-3-(3,3-dimethylbutanoyl)-5-(quinolin-2-ylmethoxy)indol-2-yl]-2,2-dimethylpropanoic acid",CC(C)(C)CC(=O)C1=C(N(C2=C1C=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC(C)(C)C(=O)O,,,,,,
1982,131983,N-Bromoacetyl-2-iodo-5-methoxytryptamine,COC1=CC2=C(C=C1)NC(=C2CCNC(=O)CBr)I,,,,,,
1983,131984,14-Debromoaraplysillin I,COC1=C([C@@H](C2(CC(=NO2)C(=O)NCCCOC3=C(C=C(C=C3)CCN)Br)C=C1Br)O)Br,,,,,,
1984,131985,"5-[(2S)-2-(methylamino)propyl]benzene-1,2,4-triol",C[C@@H](CC1=CC(=C(C=C1O)O)O)NC,,,,,,
1985,131986,1-Cyclobutyl-7-(dimethylamino)-1-hydroxy-1-phenyl-5-heptyn-2-one,CN(C)CC#CCCC(=O)C(C1CCC1)(C2=CC=CC=C2)O.Cl,,,,,,
1986,131987,1-Cyclobutyl-7-(dimethylamino)-1-hydroxy-1-phenylhept-5-yn-2-one,CN(C)CC#CCCC(=O)C(C1CCC1)(C2=CC=CC=C2)O,,,,,,
1987,131988,"3,5-Dichloro-N-(2-chloro-4-isothiocyanatophenyl)salicylamide",C1=CC(=C(C=C1N=C=S)Cl)NC(=O)C2=C(C(=CC(=C2)Cl)Cl)O,,,,,,
1988,131989,2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile,C1=CN=CC=C1C2=CNC(=O)C(=C2)C#N,,,,,,
1989,131990,"10-(4-Methylpiperazin-1-yl)pyrido(4,3-b)(1,4)benzothiazepine",CN1CCN(CC1)C2=NC3=C(C=CN=C3)SC4=CC=CC=C42,,,,,,
1990,131991,"4-(sec-Butyl{[1-(2-chlorophenyl)-3-isoquinolinyl]carbonyl}amino)-N,N,N-trimethyl-1-butanaminium iodide",CCC(C)N(CCCC[N+](C)(C)C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl.[I-],,,,,,
1991,131992,4-[[[1-(2-Chlorophenyl)isoquinolin-3-yl]carbonyl](1-methylpropyl)amino]butyltrimethylaminium,CCC(C)N(CCCC[N+](C)(C)C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl,,,,,,
1992,131993,N-Nor-3-(4'-iodophenyl)tropane-2-carboxylic acid methyl ester,COC(=O)C1[C@H]2CCC(N2)CC1C3=CC=C(C=C3)I,,,,,,
1993,131994,10'-Desmethoxystreptonigrin,CC1=C(C(=C(N=C1C(=O)O)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)N)OC)N)C4=C(C(=CC=C4)OC)O,,,,,,
1994,131995,EtNBS,CCNC1=CC2=C(C3=CC=CC=C31)N=C4C=CC(=[N+](CC)CC)C=C4S2.[Cl-],,,,,,
1995,131996,Diethyl-[5-(ethylamino)benzo[a]phenothiazin-9-ylidene]azanium,CCNC1=CC2=C(C3=CC=CC=C31)N=C4C=CC(=[N+](CC)CC)C=C4S2,,,,,,
1996,131997,CID 131997,CCNC1=CC2=C(C3=CC=CC=C31)NC4=C([SeH+]2)C=C(C=C4)N(CC)CC.[Cl-],,,,,,
1997,131998,"5-N,9-N,9-N-triethyl-12H-benzo[a]phenoselenazine-5,9-diamine",CCNC1=CC2=C(C3=CC=CC=C31)NC4=C([Se]2)C=C(C=C4)N(CC)CC,,,,,,
1998,131999,N-(2-Aminoethyl)-5-iodo-2-pyridinecarboxamide monohydrochloride,C1=CC(=NC=C1I)C(=O)NCCN.Cl,,,,,,
1999,132000,N-(2-Aminoethyl)-5-iodo-2-pyridinecarboxamide,C1=CC(=NC=C1I)C(=O)NCCN,,,,,,
2000,132001,"Methanesulfonamide, N-(4-((1-(2-(4-fluorophenyl)-2-oxoethyl)-4-piperidinyl)carbonyl)phenyl)-, monohydrochloride",CS(=O)(=O)NC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)C3=CC=C(C=C3)F.Cl,,,,,,
2001,132002,N-[4-[1-[2-(4-fluorophenyl)-2-oxoethyl]piperidine-4-carbonyl]phenyl]methanesulfonamide,CS(=O)(=O)NC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)C3=CC=C(C=C3)F,,,,,,
2002,132003,"5-[2,3-dihydroxypropanoyl(2,3-dihydroxypropyl)amino]-1-N-(2-hydroxyethyl)-3-N-(hydroxymethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide",C(CO)NC(=O)C1=C(C(=C(C(=C1I)N(CC(CO)O)C(=O)C(CO)O)I)C(=O)NCO)I,,,,,,
2003,132004,"2,3-dihydro-1H-indol-5-yl N,N-dimethylcarbamate",CN(C)C(=O)OC1=CC2=C(C=C1)NCC2,,,,,,
2004,132005,delta-Ava-pro(9)-substance P (7-11),CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H]1CCCN1C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CCCCN,,,,,,
2005,132006,"4-((2-(7-Chloro-2-phenyl-2H-pyrazolo(4,3-c)quinolin-4-yl)ethyl)amino)benzonitrile",C1=CC=C(C=C1)N2C=C3C(=NC4=C(C3=N2)C=CC(=C4)Cl)CCNC5=CC=C(C=C5)C#N,,,,,,
2006,132007,N-Methyl-N-(1-(4-phenoxybutyl)-3-pyrrolidinyl)-2-benzothiazolamine,CN(C1=CN(C=C1)CCCCOC2=CC=CC=C2)C3=NC4=CC=CC=C4S3,,,,,,
2007,132008,CID 132008,C(CC(=O)N[C@@H](CSS(C[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)CC(=O)C(=O)CBr)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
2008,132009,"(10R,11S,14S)-7-Methoxy-10,11,15,15-tetramethyl-2-oxatetracyclo[8.8.0.01,14.03,8]octadeca-3,5,7-trien-4-ol",C[C@H]1CC[C@H]2C(CCCC23[C@@]1(CC4=C(C=CC(=C4O3)O)OC)C)(C)C,,,,,,
2009,132010,(2S)-2-[[(2S)-1-[6-amino-2-[[(1R)-1-amino-2-hydroxypropyl]carbamoyl]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid,CC([C@H](N)NC(=O)C(CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)O,,,,,,
2010,132011,4-N-(3-Methoxypropyl)-N-pentylcarbamoyl-5-(2-naphthylsulfonyl)pentanoic acid,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)CS(=O)(=O)C1=CC2=CC=CC=C2C=C1.C(C[C@@H](C(=O)O)N)CN=C(N)N,,,,,,
2011,132012,(4R)-4-[N-(3-Methoxypropyl)-N-pentylcarbamyl]-5-(2-naphthalenylsulfonyl)pentanoic acid,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)CS(=O)(=O)C1=CC2=CC=CC=C2C=C1,,,,,,
2012,132013,"(3S)-3-amino-4-[[(2S,5S,8S)-8-[(1-aminocyclohexanecarbonyl)amino]-3-hydroxy-5-(3-methylbutylcarbamoyl)-7-oxo-1,9-diphenyl-6-propan-2-ylnonan-2-yl]amino]-4-oxobutanoic acid;hydrochloride",CC(C)CCNC(=O)[C@@H](CC([C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N)O)C(C(C)C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)C3(CCCCC3)N.Cl,,,,,,
2013,132014,CID 132014,CC(C)CCNC(=O)[C@H](CC([C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N)O)C(C(C)C)C(=O)C(CC2=CC=CC=C2)NC(=O)C3(CCCCC3)N,,,,,,
2014,132015,Okicenone,CC1=CC(=CC2=CC3=C(C(=O)CCC3O)C(=C12)O)O,,,,,,
2015,132016,Fluvirucin A1,CC[C@H]1CCC[C@H](CC[C@@H]([C@H](C(=O)NCCC1)C)O[C@H]2[C@@H]([C@@H]([C@@H]([C@@H](O2)C)O)N)O)C,,,,,,
2016,132017,CID 132017,CC1=CC2=CC(=O)C=C(C2=C3C1=C(C=C(O3)O)O)O,,,,,,
2017,132018,"2,6-Diamino-3,4-dimethyl-7-oxopyrano(4,3-g)benzimidazole",CC1=CC2=C(C(=O)OC=C2C3=C1N(C(=N3)N)C)N,,,,,,
2018,132019,Soladulcoside A,C[C@@H]1C[C@@H](C2([C@H]([C@H]3[C@@H](O2)[C@@H]([C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)O)C)OC1=O)O,,,,,,
2019,132020,Nbd-tpa,C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)COC(=O)C)O)C)O)OC(=O)C)OC(=O)CCCCCCCCCCCN(C)C5=CC=C(C6=NON=C56)[N+](=O)[O-],,,,,,
2020,132021,"Ergostan-3,24-diol",C[C@H](CC[C@](C)(C(C)C)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CCC(C4)O)C)C,,,,,,
2021,132022,"1,3-Dimethyl-7-[4-(2-nitroimidazol-1-yl)butyl]purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCCN3C=CN=C3[N+](=O)[O-],,,,,,
2022,132023,3-(N-Butyrylamino)benzamide,CCCC(=O)NC1=CC=CC(=C1)C(=O)N,,,,,,
2023,132024,Cytoblastin,CC(C)C1C(=O)NC(CC2=CNC3=C(C=CC(=C23)N1C)C(C4=CNC5=CC=CC=C54)C(CO)O)CO,,,,,,
2024,132025,Naphthgeranine A,CC1=C[C@@H]2[C@H](CC1)C(OC3=C2C(=O)C4=C(C3=O)C(=CC(=C4)OC)OC)(C)C,,,,,,
2025,132026,Naphthgeranine B,CC1([C@H]2CCC(=C[C@H]2C3=C(O1)C(=O)C4=C(C3=O)C=C(C=C4O)O)CO)C,,,,,,
2026,132027,Naphthgeranine C,CC1([C@H]2C[C@@H](C(=C[C@H]2C3=C(O1)C(=O)C4=C(C3=O)C=C(C=C4O)O)CO)O)C,,,,,,
2027,132028,Naphthgeranine E,CC1(C2=C(C=C(C(=C2)O)CO)C3=C(O1)C(=O)C4=C(C3=O)C=C(C=C4O)O)C,,,,,,
2028,132029,Atramycin A,C[C@H]1CC2=CC(=C3C(=C2C(=O)C1)C(=O)C4=C(C3=O)C(=CC=C4)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)O)O)O)O,,,,,,
2029,132030,Atramycin B,C[C@H]1CC2=C(C(=O)C1)C3=C(C=C2)C(=O)C4=C(C3=O)C=CC=C4O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)O)O)O,,,,,,
2030,132031,"1-[2,4,6-trihydroxy-3-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]phenyl]dodecan-1-one",CCCCCCCCCCCC(=O)C1=C(C=C(C(=C1O)C2CC(OC3=C2C=CC(=C3)O)C4=CC=C(C=C4)O)O)O,,,,,,
2031,132032,"8,11-Dihydroxy-4-(2-hydroxyethyl)-6-(2-(2-hydroxyethylamino)ethylamino)-1,2,3,4-tetrahydronaphtho[2,3-f]quinoxaline-7,12-dione",C1CN(C2=C(N1)C3=C(C(=C2)NCCNCCO)C(=O)C4=C(C=CC(=C4C3=O)O)O)CCO,,,,,,
2032,132033,CID 132033,C[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N,,,,,,
2033,132034,"1,6,8-Trihydroxy-3-methylanthraquinone 1-O-rhamnosyl(1-2)glucoside",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=CC4=C3C(=O)C5=C(C4=O)C=C(C=C5O)O)C)CO)O)O)O)O)O,,,,,,
2034,132035,Fulicin,CC(C)[C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N,,,,,,
2035,132036,Vidalol A,C1=C(C(=C(C(=C1O)O)Br)Br)CC2=C(C(=C(C=C2O)O)Br)O,,,,,,
2036,132037,Vidalol B,C1=C(C(=C(C(=C1O)O)Br)Br)CC2=C(C(=C(C(=C2O)Br)O)CC3=CC(=C(C(=C3Br)Br)O)O)O,,,,,,
2037,132038,"(1R,2R)-2-(2,6-dimethoxy-4-prop-1-enylphenoxy)-1-(3,4,5-trimethoxyphenyl)propan-1-ol",CC=CC1=CC(=C(C(=C1)OC)O[C@H](C)[C@@H](C2=CC(=C(C(=C2)OC)OC)OC)O)OC,,,,,,
2038,132039,Docosyl-triethylenetetraminepentaacetic acid,CCCCCCCCCCCCN(CCN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,,,,,,
2039,132040,4-(3-Amino-2-oxoazetidinonyl-1)methylbenzoic acid,CC1=C(C=CC(=C1)N2C(=O)C(C2=O)N)C(=O)O,,,['Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)'],,,
2040,132041,(2S)-6-[3-[(2-bromoacetyl)amino]propanoylamino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)CCNC(=O)CBr)C(=O)O,,,,,,
2041,132042,CID 132042,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)O)N,,,,,,
2042,132043,Tdfpeht,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@@H]([C@H](O2)CCP(=O)([O-])[O-])F.[Na+].[Na+],,,,,,
2043,132044,"2-[(2R,3S,5S)-3-fluoro-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]ethylphosphonic acid",CC1=CN(C(=O)NC1=O)[C@@H]2C[C@@H]([C@H](O2)CCP(=O)(O)O)F,,,,,,
2044,132045,CID 132045,C[C@@](CC=C[C@H]1[C@@H](CC(=O)[C@@H]1CCC=CCCC(=O)OC)O)(C=CC2=CCCC2)O,,,,,,
2045,132046,CID 132046,CC1=C(OOC(C1=O)(C)CCCCCC(C)CCCCC2=CC=C(C=C2)O)O,,,,,,
2046,132047,CID 132047,C1=C(C2=C(N1)NC(=NC2=O)N)C(=O)NCCC(=N)N,,,,,,
2047,132048,CID 132048,C1=C(C2=C(N1)NC(=NC2=O)N)C(=O)NCCCN,,,,,,
2048,132049,"Ergoline-8-carboxamide, N-(2-hydroxycyclopentyl)-6-methyl-1-(1-methylethyl)-, (8beta(1S,2R))-",CC(C)N1C=C2C[C@@H]3C(C[C@H](CN3C)C(=O)N[C@H]4CCC[C@H]4O)C5=C2C1=CC=C5,,,,,,
2049,132050,CID 132050,C1=CC=C2C(=C1)C(=CC=N2)[NH+](N3C=[N+](C4=C3C(=O)N=C(N4)N)[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O)[O-])[O-],,,,,,
2050,132051,CID 132051,C1=CC=C2C(=C1)C(=CC=N2)N(N3C=[N+](C4=C3C(=O)N=C(N4)N)[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O)O)[O-],,,,,,
2051,132052,3-Phenyllactyl-phenylalanyl-lysyl-alaninamide,C[C@@H](C(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)O,,,,,,
2052,132053,Acetylthreonyl-leucyl-asparaginyl-phenylalanine,C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)C)O,,,,,,
2053,132054,"2-Acetamido-1,5-naphthalenedisulfonate",CC(=O)NC1=C(C2=C(C=C1)C(=CC=C2)S(=O)(=O)[O-])S(=O)(=O)[O-],,,,,,
2054,132055,"2-(Acetylamino)naphthalene-1,5-disulfonic acid",CC(=O)NC1=C(C2=C(C=C1)C(=CC=C2)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2055,132056,Tyrosyl-glycyl-prolyl-leucyl-phenylalanyl-proline,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
2056,132057,Tyrosyl-valyl-prolyl-glycyl-phenylalanyl-proline,CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
2057,132058,Tyrosyl-glycyl-prolyl-glycyl-phenylalanyl-proline,C1C[C@H](N(C1)C(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N4CCC[C@H]4C(=O)O,,,,,,
2058,132059,"N-(4-((5-(3-(2-Aminoethyl)-1H-indol-5-yl)-1,2,4-oxadiazol-3-yl)methyl)phenyl)methanesulfonamide",CS(=O)(=O)NC1=CC=C(C=C1)CC2=NOC(=N2)C3=CC4=C(C=C3)NC=C4CCN,,,,,,
2059,132060,Hpmpc3A,C1[C@@H](OCP(=O)(O1)O)CN2C=NC3=C2C=CN=C3N,,,,,,
2060,132061,"(8S,13S,14S)-13-methyl-10-(2-methylsulfanylethyl)-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-3,17-dione",C[C@]12CC=C3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CCC43CCSC,,,,,,
2061,132062,17-Fluoro-3-methylheptadecanoic acid,CC(CCCCCCCCCCCCCCF)CC(=O)O,,,,,,
2062,132063,"Cholecytokinin (26-33), N-methylnorleucyl(28-31)-4-nitrophenylalaninamide(33)-",CCCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N(C(=O)[C@H](CC3=CC=C(C=C3)[N+](=O)[O-])NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CC(=O)O)N)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCC)NC)NC,,,,,,
2063,132064,1-Hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol,CCCCCCCCCCCCCCCC(=O)OCC(COCC(F)(F)F)OP(=O)(O)OC,,,,,,
2064,132065,"(2S)-2-[[4-(1,3-diamino-7,8,9,10-tetrahydropyrimido[4,5-c]isoquinolin-8-yl)benzoyl]amino]pentanedioic acid",C1CC2=C3C(=NC(=NC3=NC=C2CC1C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)N,,,,,,
2065,132066,"cis-((2,6-Dimethyl-1-piperidinyl)nitrosoamino)acetonitrile",C[C@@H]1CCC[C@@H](N1N(CC#N)N=O)C,,,,,,
2066,132067,Rhapontisterone,CC(C)[C@H](C[C@H]([C@@](C)([C@H]1CCC2([C@@]1(C[C@H]([C@H]3C2=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)O)C)O)O)O)O,,,,,,
2067,132068,Gnetifolin A,COC1=C(C=C(C=C1O)C2=C(C3=C(O2)C=CC(=C3)O)OC)O,,,,,,
2068,132069,"4-[(2,5-Dihydroxyphenyl)methylamino]benzamide",C1=CC(=CC=C1C(=O)N)NCC2=C(C=CC(=C2)O)O,,,,,,
2069,132070,L-N-(N-Hydroxy-2-isobutylsuccinamoyl)seryl-L-valine,CC(C)CC(CC(=O)NO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)O,,,,,,
2070,132071,CID 132071,C1CC2C(N2C1)(CCCCCCC3(C4N3CCC4)C5=CC(=C(C=C5)O)O)C6=CC(=C(C=C6)O)O,,,,,,
2071,132072,2-(3-(tert-Butylamino)-2-hydroxypropoxy)-4-methoxybenzanilide,CC(C)(C)NCC(COC1=C(C=CC(=C1)OC)C(=O)NC2=CC=CC=C2)O.Cl,,,,,,
2072,132073,2-[3-(tert-butylamino)-2-hydroxypropoxy]-4-methoxy-N-phenylbenzamide,CC(C)(C)NCC(COC1=C(C=CC(=C1)OC)C(=O)NC2=CC=CC=C2)O,,,,,,
2073,132074,CID 132074,C1=CC=C(C(=C1)C=CC2=NC3=C(C=C(C=C3C=C2)F)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
2074,132075,"2-[3-[[5-(Dimethylamino)naphthalen-1-yl]sulfonylamino]propoxy]-4-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalene-2-carbonyl)amino]benzoic acid",CC1(CCC(C2=C1C=CC(=C2)C(=O)NC3=CC(=C(C=C3)C(=O)O)OCCCNS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C)(C)C)C,,,,,,
2075,132076,Annomutacin,CCCCCCCCCCCCC(C1CCC(O1)C(CCCCCCC(CCCCCC(CC2=CC(OC2=O)C)O)O)O)O,,,,,,
2076,132077,Deutzicoside A,C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(C[C@H]([C@@]5([C@@H]4CC(CC5)(C)C)C(=O)O)O)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@H](CO6)O[C@H]7[C@@H]([C@H]([C@H](CO7)O)O)O)O)O,,,,,,
2077,132078,CID 132078,C[C@H]1C(=O)C(=O)N[C@H](C(=O)NCCC[C@@H](C(=O)N1)NC(=O)C=CCCC(C)C)CC(C)C,,,,,,
2078,132079,"6-methyl-N-[7-methyl-3-(2-methylpropyl)-2,5,6,9-tetraoxo-1,4,8-triazacyclotridec-10-yl]oct-2-enamide",CCC(C)CCC=CC(=O)NC1CCCNC(=O)C(NC(=O)C(=O)C(NC1=O)C)CC(C)C,,,,,,
2079,132080,Hexanolamino PAF C-16,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCCCCCC[N+](C)(C)C)OC(=O)C,,,,,,
2080,132081,6-[[(2R)-2-acetyloxy-3-hexadecoxypropoxy]-hydroxyphosphoryl]oxyhexyl-trimethylazanium,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCCCCCC[N+](C)(C)C)OC(=O)C,,,,,,
2081,132082,"(5R,9R,10S,13R,14R,17R)-17-[(2R,5S)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,4,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC[C@@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC[C@H]4[C@@]3(CCC(=O)C4)C)C)C(C)C,,,,,,
2082,132083,"1H-Cyclohept(ghi)perylene-6,11-dione, 3-acetyl-5,12-dihydroxy-4,8,9,13-tetramethoxy-2-methyl-, (+-)-",CC1=C2C3=C4C(=C(C(C(=O)C5=C4C6=C(C3=C(C(=C2C(=O)C)OC)O)C(=O)CC(=C6C(=C5)OC)OC)O)OC)C1,,,,,,
2083,132084,CID 132084,CCCCC=CCC(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)O,,,,,,
2084,132085,"5H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 1,11-dibromo-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-",CO[C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O)C2CC3=C(C=C2Br)N=C4C3=C5C(=CN=C5Br)C6=C4N=C7C6=CC(=O)CC7=O)CO,,,,,,
2085,132086,N(alpha)-(4-Toluenesulfonyl)-4-guanidinophenylalanylpiperidine,CC1=CC=C(C=C1)S(=O)(=O)NC(CC2=CC=C(C=C2)N=C(N)N)C(=O)N3CCCCC3,,,,,,
2086,132087,"Tris(2,4-dibromo-6-methylphenyl) propane-1,2,3-tricarboxylate",CC1=CC(=CC(=C1OC(=O)CC(CC(=O)OC2=C(C=C(C=C2C)Br)Br)C(=O)OC3=C(C=C(C=C3C)Br)Br)Br)Br,,,,,,
2087,132088,"1-[[2,7-bis[(2S,6R)-2,6-dimethylmorpholin-4-yl]-6-phenylpteridin-4-yl]-(2-hydroxyethyl)amino]-2-methylpropan-2-ol",C[C@@H]1CN(C[C@@H](O1)C)C2=NC3=C(C(=NC(=N3)N4C[C@H](O[C@H](C4)C)C)N(CCO)CC(C)(C)O)N=C2C5=CC=CC=C5,,,,,,
2088,132089,4-Ethoxycarbamoylthio-6-guanidinocaproate phosphate,CCONC(=O)SC(CCC(=O)[O-])CCN=C(N)N.OP(=O)(O)O,,,,,,
2089,132090,6-(Diaminomethylideneamino)-4-(ethoxycarbamoylsulfanyl)hexanoic acid,CCONC(=O)SC(CCC(=O)O)CCN=C(N)N,,,,,,
2090,132091,CID 132091,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC1=C2C=COC2=C(C=C1)[N+](=O)[O-])O)O)O,,,,,,
2091,132092,"4,5-Dihydro-4-(4-methoxyphenyl)-6-(trifluoromethyl)-1H-benzazepin-2,3-dione",COC1=CC=C(C=C1)C2=C(C(=O)NC3=CC=CC(=C3C2)C(F)(F)F)O,,,,,,
2092,132093,2-Butyllysergamide,CCCCC1=C2C[C@@H]3C(=C[C@H](CN3C)C(=O)N)C4=C2C(=CC=C4)N1,,,,,,
2093,132094,CID 132094,CC(=C)C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)OCC(=O)C(C)(C)C,,,,,,
2094,132095,CID 132095,CC1=C(OC(=O)O1)COC(=O)C2=C(CS[C@H]3N2C(=O)[C@H]3NC(=O)C(=NOC)C4=CSC(=N4)N)C(=C)C,,,,,,
2095,132096,CID 132096,C1CCCC(CC1)NC2=C(C=NC=C2)S(=O)(=O)NC(=NC3CCCCC3)S,,,,,,
2096,132097,CID 132097,CCCCCCC1CCC2(C1CCCCCCC(=O)[O-])C(=O)NC(=O)N2.[Na+],,,,,,
2097,132098,"7-(7-Hexyl-2,4-dioxo-1,3-diazaspiro[4.4]nonan-6-yl)heptanoic acid",CCCCCCC1CCC2(C1CCCCCCC(=O)O)C(=O)NC(=O)N2,,,,,,
2098,132099,"[[(2R,3S)-5-[3-[5-[6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoylamino]pentyl]-4-aminopyrazolo[3,4-d]pyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",C1[C@@H]([C@H](OC1N2C3=NC=NC(=C3C(=N2)CCCCCNC(=O)CCCCCNC(=O)CCCC[C@H]4[C@@H]5[C@H](CS4)NC(=O)N5)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
2099,132100,"[(1R,2S,3S,4R,5R,6S)-2,3,4,5,6-pentahydroxy-2-naphthalen-1-ylcyclohexyl] dihydrogen phosphate",C1=CC=C2C(=C1)C=CC=C2[C@@]3([C@H]([C@@H]([C@H]([C@@H]([C@H]3OP(=O)(O)O)O)O)O)O)O,,,,,,
2100,132101,N-Methyl-N-2-(methylsulfinyl)ethylpropionic acid amide,CCN(C)C(=O)C(C)S(=O)C,,,,,,
2101,132102,CID 132102,C1=CC=C(C=C1)CCCN=C(S)SC[C@@H](C(=O)O)N,,,,,,
2102,132103,CID 132103,COC1=CC[N-]C2=C1CCCCC2S(=O)C3=NC4=CC=CC=C4N3.[Na+],,,,,,
2103,132104,"9-(1H-benzimidazol-2-ylsulfinyl)-4-methoxy-2,5,6,7,8,9-hexahydro-1H-cyclohepta[b]pyridine",COC1=CCNC2=C1CCCCC2S(=O)C3=NC4=CC=CC=C4N3,,,,,,
2104,132105,N-(4-(Phenyloxy-3-(methyl-(2-quinolinylmethyl)amino)propoxy)phenyl)methanesulfonamide,CN(CC1=NC2=CC=CC=C2C=C1)C(CCOC3=CC=C(C=C3)NS(=O)(=O)C)OC4=CC=CC=C4,,,,,,
2105,132106,2-(2-Aminopropyl)-5-iodothiophene,CC(CC1=CC=C(S1)I)N,,,,,,
2106,132107,N-Isopropyl-2-(2-aminopropyl)-5-iodothiophene,CC(C)NC(C)CC1=CC=C(S1)[131I],,,,,,
2107,132108,1-Methylspermidine,CC(CCNCCCCN)N,,,,,,
2108,132109,"N,N-dimethyl-2-(10H-phenothiazin-2-yloxy)ethanamine",CN(C)CCOC1=CC2=C(C=C1)SC3=CC=CC=C3N2,,,,,,
2109,132110,4-(1-(1-Naphthyl)ethyl)imidazole,CC(C1=CC=CC2=CC=CC=C21)C3=CN=CN3.Cl,,,['Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)'],,,
2110,132111,5-(1-naphthalen-1-ylethyl)-1H-imidazole,CC(C1=CC=CC2=CC=CC=C21)C3=CN=CN3,,,['Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)'],,,
2111,132112,"7,12,23-Trihydroxy-26,28-epoxy-16,23-cyclolanost-8-ene-3,11,15,26-tetrone",C[C@@H]1C[C@@]2(C[C@H](C(=O)OCC3(C4C[C@H](C5=C([C@]4(CCC3=O)C)C(=O)[C@H]([C@@]6(C1[C@@H]2C(=O)[C@@]56C)C)O)O)C)C)O,,,,,,
2112,132113,"3,7,12,23-Tetrahydroxy-26,28-epoxy-16,23-cyclolanost-8-ene-11,15,26-trione",C[C@@H]1C[C@@]2(C[C@H](C(=O)OCC3([C@H](CC[C@]4(C3C[C@H](C5=C4C(=O)[C@H]([C@@]6(C1[C@@H]2C(=O)[C@@]56C)C)O)O)C)O)C)C)O,,,,,,
2113,132114,((N-Acetyl-N-(((2-(octadecyloxy)tetrahydrofuran-4-yl)methoxy)carbonyl)amino)methyl)-1-ethylpyridinium chloride,CCCCCCCCCCCCCCCCCCOC1CC(CO1)COC(=O)N(CC2=CC=CC=[N+]2CC)C(=O)C.[Cl-],,,,,,
2114,132115,2-{[Acetyl-(5-octadecyloxy-tetrahydro-furan-3-ylmethoxycarbonyl)-amino]-methyl}-1-ethyl-pyridinium; chloride,CCCCCCCCCCCCCCCCCCOC1CC(CO1)COC(=O)N(CC2=CC=CC=[N+]2CC)C(=O)C,,,,,,
2115,132116,1-Fluoroglucopyranosyl fluoride,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)(F)F)O)O)O)O,,,,,,
2116,132117,Benzoyl-alanyl-thioglycolic acid,C[C@@H](C(=O)C(C(=O)C1=CC=CC=C1)(C(=O)[O-])S)N,,,,,,
2117,132118,(4S)-4-amino-2-benzoyl-3-oxo-2-sulfanylpentanoic acid,C[C@@H](C(=O)C(C(=O)C1=CC=CC=C1)(C(=O)O)S)N,,,,,,
2118,132119,CID 132119,C1=CC(=C(C=C1C2=CNC=C3C2=CC=C(C3=O)O)O)O.Cl,,,,,,
2119,132120,CID 132120,C1=CC(=C(C=C1C2=CNC=C3C2=CC=C(C3=O)O)O)O,,,,,,
2120,132121,N-(4-Carbamimidoylbenzoyl)-Beta-Alanyl-L-Alpha-Aspartyl-L-Phenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCNC(=O)C2=CC=C(C=C2)C(=N)N,,,,,,
2121,132122,Desamino-tyrosyl-phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-argininamide,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CCC4=CC=C(C=C4)O,,,,,,
2122,132123,CID 132123,C1=CC(=CC=C1C(=O)O)NC(=O)CCN2C=NC3=C2NC=NC3=O,,,,,,
2123,132124,N-(3-Fluoropropyl)paroxetine,C1CN(C[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4)CCCF,,,,,,
2124,132125,"1-((2-Thiazolin-2-yl)amino)acetyl-4-(1,3-dithiol-2-ylidene)-2,3,4,5-tetrahydro-1H-1-benzazepin-3,5-dione hydrochloride",C1CSC(=N1)NCC(=O)N2CC(=O)C(=C3SC=CS3)C(=O)C4=CC=CC=C42.Cl,,,,,,
2125,132126,"1-[[(2-Thiazolin-2-yl)amino]acetyl]-4-(1,3-dithiol-2-ylidene)-1H-1-benzazepine-3,5(2H,4H)-dione",C1CSC(=N1)NCC(=O)N2CC(=O)C(=C3SC=CS3)C(=O)C4=CC=CC=C42,,,,,,
2126,132127,Symadex,CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=C(C2=O)C=C(C=C4)O,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)']",,,
2127,132128,"5-((2-(Diethylamino)ethyl)amino)-8-hydroxy-1-methyl-6H-imidazo(4,5,1-de)acidin-6-one",CCN(CC)CCNC1=C2C3=C(C=C1)N=C(N3C4=C(C2=O)C=C(C=C4)O)C,,,,,,
2128,132129,CID 132129,CC1=C(SC(=N1)N2NC(=N[NH+]2C3=CC=C(C=C3)S(=O)(=O)[O-])C4=CC(=CC=C4)OCC(=O)O)C,,,,,,
2129,132130,"3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazole",CC1=C(SC(=N1)N2NC(=NN2C3=CC=C(C=C3)S(=O)(=O)O)C4=CC(=CC=C4)OCC(=O)O)C,,,,,,
2130,132131,Drummondin D,CC(=CCC1(C(=C(C(=C(C1=O)C(=O)C)O)CC2=C(C(=C3C(=C2O)C=CC(O3)(C)C)C(=O)C)O)O)C)C,,,,,,
2131,132132,Isodrummondin D,CC(=CCC1(C(=C(C(=C(C1=O)C(=O)C)O)CC2=C3C(=C(C(=C2O)C(=O)C)O)C=CC(O3)(C)C)O)C)C,,,,,,
2132,132133,Drummondin E,CC(=CCC1(C(=C(C(=C(C1=O)C(=O)C)O)CC2=C(C=C(C(=C2O)C(=O)C)O)OCC=C(C)C)O)C)C,,,,,,
2133,132134,3-(2-Pyridyldithio)propionylarginylmonoiodotyrosine,CCC(=O)[C@](CC1=CC(=C(C=C1)O)SSC2=CC=CC=N2)(C(=O)O)N(C(=O)[C@H](CCCN=C(N)N)N)I,,,,,,
2134,132135,3-Maleimidopropionylarginylmonoiodotyrosine,C1=CC(=CC=C1C[C@@](C(=O)CCN2C(=O)C=CC2=O)(C(=O)O)N(C(=O)[C@H](CCCN=C(N)N)N)I)O,,,,,,
2135,132136,14-Fluoro-6-thiaheptadecanoic acid,CCCC(CCCCCCCSCCCCC(=O)O)F,,,,,,
2136,132137,Tyrosyl-arginyl-phenylalanyl-beta-alaninamide,C1=CC=C(C=C1)C[C@@H](C(=O)NCCC(=O)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
2137,132138,CID 132138,CS(=O)(=O)NC(=O)CCC=C=CCC1C(C(CC1=O)O)C=CC(COC2=CC=CC=C2)O,,,,,,
2138,132139,CID 132139,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2.C1=C2C(=NC=NC2=O)NN1,,,,,,
2139,132140,Aserbine,C1=CC=C(C=C1)C(=O)O.C1=CC=C(C(=C1)C(=O)O)O.C(C(C(=O)O)O)C(=O)O,,,,,,
2140,132141,Pharodoran,CCCOC(=O)C1=CC=CC=C1O.CC(=O)OC1=CC=CC=C1C(=O)O.COC(=O)C1=CC=CC=C1O,,,,,,
2141,132142,"2,3-Bis(3-indolylmethyl)indole",C1=CC=C2C(=C1)C(=CN2)CC3=C(NC4=CC=CC=C43)CC5=CNC6=CC=CC=C65,,,,,,
2142,132143,CID 132143,C[C@@H]1CC(=O)[C@@H]([C@H]1C=C[C@H](COC2=CC=CC=C2)O)CC=C=CCCC(=O)OC,,,,,,
2143,132144,2'-Chloroetoposide,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7Cl)OC)O)OC)O)O,,,,,,
2144,132145,CID 132145,C1=CC(=NC2=NC(=NC(=N2)NC3=CC4=CC(=CC(=C4C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-])Cl)C=C5C1=CC(=C(C5=O)N=NC6=C(C=C(C=C6)N(O)O)[N+](=O)[O-])S(=O)(=O)[O-].[K+].[K+].[K+],,,,,,
2145,132146,CID 132146,C1=CC(=NC2=NC(=NC(=N2)NC3=CC4=CC(=CC(=C4C=C3)S(=O)(=O)O)S(=O)(=O)O)Cl)C=C5C1=CC(=C(C5=O)N=NC6=C(C=C(C=C6)N(O)O)[N+](=O)[O-])S(=O)(=O)O,,,,,,
2146,132147,"4-Thiazolidinecarboxylic acid, 3-(1-oxo-2-((2-thienylcarbonyl)thio)propyl)-",CC(C(=O)N1CSCC1C(=O)O)SC(=O)C2=CC=CS2,,,,,,
2147,132148,CID 132148,C[C@H](C=C[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CCC3(C2=CCC4[C@@]3(CC(C(C4)O)O)C)O)C,,,,,,
2148,132149,2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5-(trifluoromethyl)imidazol-4-ol,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)O)C(F)(F)F,,,,,,
2149,132150,5-Lipoxygenase-In-1,CCN1C(=S)N(C(=O)C1(C)C)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)O,,,,,,
2150,132151,N(6)-(4-(Piperazinylsulfonyl)benzyl)-6-aminobenz(cd)indol-2(1H)-one,CCN(CC1=CC=C(C=C1)S(=O)(=O)N2CCNCC2)C3=C4C=CC=C5C4=C(C=C3)NC5=O,,,,,,
2151,132152,"3-(2-Mercaptoethyl)quinazoline-2,4(1H,3H)-dione",C1=CC=C2C(=C1)C(=O)N(C(=O)N2)CCS,,,,,,
2152,132153,"17-Amino-19-hydroxy-18-(2-propylpentanoyl)pentatriacontane-16,20-dione",CCCCCCCCCCCCCCCC(=O)C(C(C(C(=O)CCCCCCCCCCCCCCC)O)C(=O)C(CCC)CCC)N,,,,,,
2153,132154,2-[[2-[2-[[2-[Bis(carboxymethyl)amino]-2-oxoethyl]-(2-tetradecanoyloxyethyl)amino]ethyl-(2-hydroxyethyl)amino]acetyl]-(carboxymethyl)amino]acetic acid,CCCCCCCCCCCCCC(=O)OCCN(CCN(CCO)CC(=O)N(CC(=O)O)CC(=O)O)CC(=O)N(CC(=O)O)CC(=O)O,,,,,,
2154,132155,Vanidil,COC1=C(C=C(C(=C1)C(=O)O)[N+](=O)[O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],,,,,,
2155,132156,"N,N-Diethyl-4-(3-(2,3,6,7-tetrahydro-1,3,7-trimethyl-2,6-dioxo-1H-purin-8-yl)propyl)-1-piperazinecarboxamide monohydrochloride",CCN(CC)C(=O)N1CCN(CC1)CCCC2=NC3=C(N2C)C(=O)N(C(=O)N3C)C.Cl,,,,,,
2156,132157,Stacofylline,CCN(CC)C(=O)N1CCN(CC1)CCCC2=NC3=C(N2C)C(=O)N(C(=O)N3C)C,,,,,,
2157,132158,2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]methylamino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetic acid,C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)CN[C@@H](CC3=CC=CC=C3)C(=O)N4CCC[C@H]4C(=O)NCC(=O)O,,,,,,
2158,132159,tert-Butyloxycarbonyl-1-alanine 4-methylumbelliferyl ester,CC1=CC(=O)OC2=C1C=CC(=C2)OC(=O)[C@H](C)NC(=O)OC(C)(C)C,,,,,,
2159,132160,4-(methanesulfonamido)-N-methyl-N-[2-[methyl-(1-methylbenzimidazol-2-yl)amino]ethyl]benzenesulfonamide,CN1C2=CC=CC=C2N=C1N(C)CCN(C)S(=O)(=O)C3=CC=C(C=C3)NS(=O)(=O)C,,,,,,
2160,132161,CID 132161,CCC(C)C(=O)O[C@H]1C[C@@H](CC2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O.[Na+],,,,,,
2161,132162,"(3R,5R)-7-[(1S,2S,6R,8S,8aS)-6-hydroxy-2-methyl-8-(2-methylbutanoyloxy)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid",CCC(C)C(=O)O[C@H]1C[C@@H](CC2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,,,,,,
2162,132163,5(6)-1(2H)-Phthalazinonyl-4(1H)-benzimidazole-2-carbamate methyl ester,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C3=NNC(=O)C4=CC=CC=C43,,,,,,
2163,132164,"4-Amino-N-(1-azabicyclo(2.2.2)oct-3-yl)-5-chloro-2,3-dihydrobenzo(b)-furan-7-carboxamide",C1CN2CCC1[C@H](C2)NC(=O)C3=CC(=C(C4=C3OCC4)N)Cl,,,,,,
2164,132165,CID 132165,CCCC[C@@H](C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C)N[C@H](CC2CCCCC2)C(C[C@@H](C(C)C)C(=O)NCCCC)O,,,,,,
2165,132166,5-(Aminomethyl)fluorescein,C1=CC2=C(C=C1CN)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,,,,,,
2166,132167,6-(Aminomethyl)fluorescein,C1=CC2=C(C=C1CN)C3(C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O)OC2=O,,,,,,
2167,132168,CID 132168,CCC(C)C1C(=O)N[C@@H](CC2=CNC3=C(C=CC(=C23)N1C)C(C)(C)C=C)CO,,,,,,
2168,132169,[1-Naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-yl] dodecanoate,CCCCCCCCCCCC(=O)OC(CNC(C)C)COC1=CC=CC2=CC=CC=C21,,,,,,
2169,132170,2-Phosphonooxybut-2-enedioic acid,C(=C(C(=O)O)OP(=O)(O)O)C(=O)O,,,,,,
2170,132171,CID 132171,CCCC=C[C@H]([C@H](CO)[N+](C)(C)C)O,,,,,,
2171,132172,3-(1-Oxo-2-phosphonoethyl)-2-piperidinecarboxylic acid,C1CC(C(NC1)C(=O)O)C(=O)CP(=O)(O)O,,,,,,
2172,132173,CID 132173,CC(C)C[C@@H]([C@H]([C@H](CC1CCCCC1)NC(=O)C(CC2=CSC=N2)NC(=O)[C@@H](CC3=CC=CC=C3)CS(=O)(=O)N4CCN(CC4)C)O)O,,,,,,
2173,132174,4-Chlorophenylmethoxybenzyl ketoxime,C1=CC=C(C=C1)C(C(=NO)C(C2=CC=CC=C2)OCC3=CC=C(C=C3)Cl)OCC4=CC=C(C=C4)Cl,,,,,,
2174,132175,"1,3,5-Trihydroxy-24-methylenecholestan-6-one",C[C@H](CCC(=C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)C4([C@@]3(C(CC(C4)O)O)C)O)C,,,,,,
2175,132176,"2-[2-[(1R,2S)-2-Dimethylamino-1-hydroxy-1-(2-methoxy-5-tert-butylphenyl)propyl]phenoxy]acetamide",C[C@@H]([C@@](C1=CC=CC=C1OCC(=O)N)(C2=C(C=CC(=C2)C(C)(C)C)OC)O)N(C)C,,,,,,
2176,132177,Thp-ergostenone,CC(=C(C)CCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)OC5CCCCO5)C)C)C,,,,,,
2177,132178,"3-Amino-1,4a-dihydro-4a,8-dimethyl-2H-phenoxazin-2-one",CC1=CC2=C(C=C1)OC3(C=C(C(=O)CC3=N2)N)C,,,,,,
2178,132179,"4(N-(5-ethyl-1-thia-3,4-diazol-2-yl)sulfophenylamino)-5-methoxy-1,2-benzoquinone",CCC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)NC3=CC(=O)C(=O)C=C3OC,,,,,,
2179,132180,5-(Dibenzylamino)-2-[2-[4-(dibenzylamino)-2-sulfophenyl]ethenyl]benzenesulfonic acid,C1=CC=C(C=C1)CN(CC2=CC=CC=C2)C3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N(CC5=CC=CC=C5)CC6=CC=CC=C6)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2180,132181,2-Methyloctadecyl paf,CCCCCCCCCCCCCCCCC(C)COCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C,,,,,,
2181,132182,2-[[2-Acetyloxy-3-(2-methyloctadecoxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCC(C)COCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C,,,,,,
2182,132183,3-((2-Aminoethyl)carbamoyl)psoralen,C1=COC2=CC3=C(C=C21)C=C(C(=O)O3)C(=O)NCCN,,,,,,
2183,132184,2-amino-N-(2-nitrophenyl)acetamide,C1=CC=C(C(=C1)NC(=O)CN)[N+](=O)[O-],,,,,,
2184,132185,CID 132185,C[C@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CN=CN4)N,,,,,,
2185,132186,"20,29-Epoxy-3-oxolupan-30,21alpha-olide",C[C@@]12CC[C@@]3([C@@H]([C@H]1[C@H]4C(C2)OC(=O)C45CO5)CC[C@H]6[C@]3(CC[C@@H]7[C@@]6(CCC(=O)C7(C)C)C)C)C,,,,,,
2186,132187,Ochraceolide C,C[C@@]12CC[C@@]3([C@@H]([C@H]1[C@H]4C(C2)OC(=O)C4=C)CC[C@H]5[C@]3(CC(=O)[C@@H]6[C@@]5(CCC(=O)C6(C)C)C)C)C,,,,,,
2187,132188,2-(Bromoethanoyloxy)-2-phenylethanoic acid,C1=CC=C(C=C1)C(C(=O)O)OC(=O)CBr,,,,,,
2188,132189,CID 132189,C1C(C(C1N2C=NC3=C2NC(=NC3=O)N)CO)CO,,,,,,
2189,132190,"1-(4-Bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone",C1=CC=C(C=C1)C2C(N(NC2=O)C(=O)NC3=CC=C(C=C3)Br)C4=CC=CC=C4,,,,,,
2190,132191,"3-[2-(6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)-1-hydroxyethyl]pyrrolidine-2,5-dione",CC1(C2CC(C(=C)C(C2(CC(C1Cl)Cl)C)CC(C3CC(=O)NC3=O)O)O)C,,,,,,
2191,132192,CID 132192,CC(=C)[C@@H]1CCC23C[C@@H]4C([C@]4(C2)C)C[C@@H]3[C@H]1CCC(=O)OC,,,,,,
2192,132193,Antho-riamide I,CC[C@H](C)[C@@H](C(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)O,,,,,,
2193,132194,Tyrosyl-arginyl-isoleucinamide,CC[C@H](C)[C@@H](C(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N,,,,,,
2194,132195,CID 132195,CC1CCC(=C(CO)CO)C(C1(C)CCC=C(C)CCC=C(CCC(C(C)(C)O)O)CO)CCCO,,,,,,
2195,132196,8-Thiocyano-adenosine triphosphate,C1=NC(=C2C(=N1)N(C(=N2)SC#N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
2196,132197,CID 132197,C[C@@H]1[C@@H](C[C@@H]2[C@H]1[C@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OC(=O)C=CC4=CC(=C(C=C4)O)O,,,,,,
2197,132198,CID 132198,CC1=C(O[C@@H]2[C@H]1[C@]3(CCC4C(C3C2)CCC5[C@@]4(CCC(C5)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)C)CCC(C)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O,,,,,,
2198,132199,"N-(1-azabicyclo[2.2.2]octan-3-yl)-6-oxo-5,11-dihydrobenzo[c][1]benzazepine-11-carboxamide",C1CN2CCC1C(C2)NC(=O)C3C4=CC=CC=C4C(=O)NC5=CC=CC=C35,,,,,,
2199,132200,Cui xing ning,CC1(CN(C2=C1C=C(C=C2)OC(=O)N(C)C)C)C.Cl,,,,,,
2200,132201,"N,N-Dimethylcarbamic acid 2,3-dihydro-1,3,3-trimethylindol-5-yl ester",CC1(CN(C2=C1C=C(C=C2)OC(=O)N(C)C)C)C,,,,,,
2201,132202,4-[[(1R)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobut-2-enoic acid,C[C@@](CC1=CNC2=CC=CC=C21)(C(=O)NC[C@@H](C3=CC=CC=C3)NC(=O)C=CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6,,,,,,
2202,132203,7-Hydroxy Quetiapine,C1CN(CCN1CCOCCO)C2=NC3=C(C=C(C=C3)O)SC4=CC=CC=C42,,,,,['7-Hydroxy Quetiapine is a known human metabolite of quetiapine.'],
2203,132204,CID 132204,C1CC(CN(C1)C2=NC(=NC3=C2OC(CC3)S(=O)=O)N4CCNCC4)O,,,,,,
2204,132205,CID 132205,C1C(C(=CC2=C1C3=C4C(=C5C6=CC(=O)CC(=C6N=C5C3=N2)O)C=NC4=O)O)[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O,,,,,,
2205,132206,Marinostatin D,C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C)N)O,,,,,,
2206,132207,CID 132207,CCCC[C@@H](C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OC(C)(C)C)N[C@H](CC2CCCCC2)[C@@H](CNCC3=CC=CC=C3)O,,,,,,
2207,132208,4-(N-Carboxymethyl-N-methylamino)-tempo,CC1(CC(CC(N1[O])(C)C)N(C)CC(=O)O)C,,,,,,
2208,132209,4-(N-Carboxydecyl-N-methylamino)-tempo,CC1(CC(CC(N1[O])(C)C)N(C)CCCCCCCCCCC(=O)O)C,,,,,,
2209,132210,4-Hmdm-territrem B,C[C@]12CC[C@@]3([C@@](C=CC(=O)[C@]3([C@@]1(CC4=C(O2)C=C(OC4=O)C5=CC(=C(C(=C5)OC)OC)OC)O)C)(C)CO)O,,,,,,
2210,132211,Pyrene-PI,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)CCCCOP(=O)(O)OC5[C@H]([C@H](C([C@H]([C@@H]5O)O)O)O)O,,,,,,
2211,132212,CID 132212,CCOC(=O)[C@H](CS)NC(=O)C(C)(C)CO[N+](=O)[O-].C[C@@H](C(=O)O)NC(=O)C,,,,,,
2212,132213,N-Acetyl-D-alanine,C[C@H](C(=O)O)NC(=O)C,,,,,,
2213,132214,"4-[[3-[(2-cyclohexyl-2-hydroxyethylidene)amino]-1-ethyl-2-oxo-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]imidazol-5-yl]sulfanyl]butanoic acid",CCN1C2CC(CC2N(C1=O)N=CC(C3CCCCC3)O)SCCCC(=O)O,,,,,,
2214,132215,CID 132215,CC(=CCC1=C(C(=CC(=C1)C2=CC(=C3C(=CC(=O)C=C3O2)O)O)O)O)C,,,,,,
2215,132216,CID 132216,C1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC3=C(OC4=C(C(=O)C=C5C4=C3C(=C2O)OC5=O)O)O)O)O)O,,,,,,
2216,132217,CID 132217,CC[NH+]1C(N(C2=CC3=CC=CC=C3C=C21)CC)C=CC=C4C(C5=CC=CC=C5N4C)(C)C.[Cl-],,,,,,
2217,132218,"1,3-diethyl-2-[3-(1,3,3-trimethylindol-2-ylidene)prop-1-enyl]-2H-benzo[f]benzimidazole",CCN1C(N(C2=CC3=CC=CC=C3C=C21)CC)C=CC=C4C(C5=CC=CC=C5N4C)(C)C,,,,,,
2218,132219,CID 132219,CC=C(C)[C@H]([C@@H](C)C=C(C)C=CCC(=CCC1=C(C(=O)C(=C(N1O)OC)OC)C)C)OC,,,,,,
2219,132220,"5,7,9,11-Tetramethyl-14-(3,5,7-trihydroxy-4,6-dimethylnonan-2-yl)-1-oxacyclotetradec-11-ene-2,4-dione",CCC(C(C)C(C(C)C(C(C)C1CC=C(CC(CC(CC(C(=O)CC(=O)O1)C)C)C)C)O)O)O,,,,,,
2220,132221,"2,2-Difluorocitric acid",C(C(=O)O)C(C(=O)O)(C(C(=O)O)(F)F)O,,,,,,
2221,132222,2-((N-(1-(1H-Imidazol-4-yl)-2-propyl)imino)phenylmethyl)phenol,CC(CC1=CN=CN1)N=C(C2=CC=CC=C2)C3=CC=CC=C3O,,,,,,
2222,132223,"5-Hydroxy-4,6,7-trimethyl-2,3-dihydrobenzofuran-2-acetic acid",CC1=C(C2=C(CC(O2)CC(=O)O)C(=C1O)C)C,,,,,,
2223,132224,"4-(3,4-Dihydroxyphenyl)-7-hydroxy-8-methyl-1,2,3,4-tetrahydroisoquinoline",CC1=C(C=CC2=C1CNCC2C3=CC(=C(C=C3)O)O)O,,,,,,
2224,132225,propan-2-yl 4-cyclohexyl-2-hydroxy-3-[2-[[2-(3-oxo-1H-isoindol-2-yl)-3-phenylpropanoyl]amino]pentanoylamino]butanoate,CCCC(C(=O)NC(CC1CCCCC1)C(C(=O)OC(C)C)O)NC(=O)C(CC2=CC=CC=C2)N3CC4=CC=CC=C4C3=O,,,,,,
2225,132226,N-Methyl-3-bromophenylsuccinimide,CN1C(=O)CC(C1=O)C2=CC(=CC=C2)Br,,,,,,
2226,132227,Norursocholic acid,C[C@H](CC(=O)O)[C@H]1CCC2[C@@]1(CCC3C2CC[C@H]4[C@@]3(CC(C(C4)(O)O)O)C)C,,,,,,
2227,132228,Quilostigmine,C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)N4CCC5=CC=CC=C5C4)C)C,,,,,,
2228,132229,"4-(N,N-Dimethylsulfamoyl)-7-piperazino-benzofurazan",CN(C)S(=O)(=O)C1=CC=C(C2=NON=C12)N3CCNCC3,,,,,,
2229,132230,CID 132230,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N=C(S2)N.CS(=O)(=O)O,,,,,,
2230,132231,"5-[[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-2-imino-4-thiazolidinone",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N=C(S2)N,,,,,,
2231,132232,"5-(1-Azabicyclo[2.2.1]heptan-3-yl)-3-cyclopropyl-1,2,4-oxadiazole",C1CC1C2=NOC(=N2)C3CN4CCC3C4,,,,,,
2232,132233,"3,7-Dimethyl-10-(3-(4-aminomethyl-5-hydroxy-6-methyl-3-pyridyl)propyl)-3,7,10-triazatricyclo(3.3.3.0(1,5))undecane",CC1=NC=C(C(=C1O)CN)CCCN2CC34CN(CC3(C2)CN(C4)C)C,,,,,,
2233,132234,"N,N'-Dimethylisopropylmalonamide",CC(C)N(C)C(=O)CC(=O)NC,,,,,,
2234,132235,Ibdpa,CC(C)C(NC(=O)C(C)(C)C)NC(=O)C(C)(C)C,,,,,,
2235,132236,N-[carboxy-[(2S)-pyrrolidine-2-carbonyl]amino]-2-methyl-N-[(1R)-1-(propan-2-ylamino)ethyl]propan-2-amine oxide,C[C@H](NC(C)C)[N+](C(C)(C)C)(N(C(=O)[C@@H]1CCCN1)C(=O)O)[O-],,,,,,
2236,132237,"N-(4-Azido-2,3,5,6-tetrafluorobenzyl)-6-maleimidohexanamide",C1=CC(=O)N(C1=O)CCCCCC(=O)NCC2=C(C(=C(C(=C2F)F)N=[N+]=[N-])F)F,,,,,,
2237,132238,"6-Chloro-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-5-methylimidazo(1,5-a)quinoxalin-4(5H)-one",CN1C2=C(C=CC=C2Cl)N3C=NC(=C3C1=O)C4=NOC(=N4)C5CC5,,,,,,
2238,132239,CID 132239,C[C@H](C=C[C@H](C)C(C)C)[C@@H]1CCC2=C3[C@H](CC[C@]12C(=O)O)[C@]4(CC[C@@H](C[C@@]45[C@@H]([C@@H]3O)O5)OC(=O)C(C)(C)N)C,,,,,,
2239,132240,"2-(3-(4-(2-Quinolyl))-1-piperazinyl)propyl-1,2,4-triazolo(4,3-a)pyridin-3(2H)-one",C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=NC5=CC=CC=C5C=C4,,,,,,
2240,132241,"6-Chloro-1-(2,5-dimethoxy-4-propylbenzyl)-7-hydroxy-2-methyl-1,2,3,4-tetrahydroisoquinoline",CCCC1=CC(=C(C=C1OC)C[C@H]2C3=CC(=C(C=C3CCN2C)Cl)O)OC,,,,,,
2241,132242,"1,2-Dihydro-5,9-dimethyl-3,4-epoxy-1,2,3,4-tetrahydrochrysene",CC1=CC2=C(C=C1)C=C(C3=C2C=CC4=C3[C@H]5[C@H](O5)[C@@H]([C@H]4O)O)C,,,,,,
2242,132243,Hatomarubigin B,C[C@H]1CC2=C(C(=O)C1)C3=C(C=C2)C(=O)C4=C(C=CC(=C4C3=O)O)OC,,,,,,
2243,132244,Hatomarubigin C,C[C@@H]1C[C@@H](C2=C(C1)C=CC3=C2C(=O)C4=C(C=CC(=C4C3=O)OC)O)O,,,,,,
2244,132245,7-Bromo-N-(2-imidazolidinylidene)-1H-indazol-6-amine,C1CN=C(N1)NC2=C(C3=C(C=C2)C=NN3)Br,,,,,,
2245,132246,"N-(4-(1-((2,4-Diamino-5-methylpyrido(2,3-d)pyrimidin-6-yl)methyl)propyl)benzoyl)-L-glutamic acid",CCC(CC1=CN=C2C(=C1C)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
2246,132247,"4-(Hydroxymethyl)-1,8-dimethyl-12-propan-2-yltricyclo[9.3.0.03,7]tetradec-10-ene-6,8-diol",CC(C)C1CCC2(C1=CCC(C3C(CC(C3C2)CO)O)(C)O)C,,,,,,
2247,132248,Hatomarubigin A,C[C@H]1CC2=CC(=C3C(=C2C(=O)C1)C(=O)C4=C(C3=O)C(=CC=C4)OC)O,,,,,,
2248,132249,"Sulfosuccinimidyl-2-(7-azido-4-methylcoumarin-3-acetamido)ethyl-1,3'-dithiopropionate",CC1=C(C(=O)OC2=C1C=CC(=C2)N=[N+]=[N-])CC(=O)NCCSSCCC(=O)ON3C(=O)CC(C3=O)S(=O)(=O)[O-].[Na+],,,,,,
2249,132250,CID 132250,CC1=C(C(=O)OC2=C1C=CC(=C2)N[N+]#N)CC(=O)NCCSSCCC(=O)ON3C(=O)CC(C3=O)S(=O)(=O)O,,,,,,
2250,132251,"1,2-Dihydroxy-5,7-dimethyl-3,4-epoxy-1,2,3,4-tetrahydrochrysene",CC1=C2C=C(C3=C(C2=CC=C1)C=CC4=C3C5C(O5)C(C4O)O)C,,,,,,
2251,132252,"3-[(3,4-Dichlorophenyl)methylamino]propyl-(diethoxymethyl)phosphinic acid",CCOC(OCC)P(=O)(CCCNCC1=CC(=C(C=C1)Cl)Cl)O,,,,,,
2252,132253,CID 132253,C[C@@H]1CCC=C([C@]1(C)CCC(=CCCC(=CCS(=O)(=O)CCN=C(N)N)CO)C)C,,,,,,
2253,132254,Enkleine,COC1=CC2=C(C3=C(C=C2C=C1)C(=O)NC=C3OC)O,,,,,,
2254,132255,CID 132255,CCCCCCCCCCCCCC(=O)C(C(CO)O)(C(=O)CCCCCCCCCCCCC)O.CC1=CN(C(=O)NC1=O)[C@@H]2CC[C@H](O2)COP(=O)(O)OP(=O)(O)O,,,,,,
2255,132256,CID 132256,CC1=CN(C(=O)NC1=O)[C@@H]2CC[C@H](O2)COP(=O)(O)OP(=O)(O)O,,,,,,
2256,132257,"15-(1,2-Dihydroxyethyl)-15-hydroxynonacosane-14,16-dione",CCCCCCCCCCCCCC(=O)C(C(CO)O)(C(=O)CCCCCCCCCCCCC)O,,,,,,
2257,132258,"[(1R,2R,3R,8R,10R,14S)-2,5,10-Triacetyloxy-8,12,15,15-tetramethyl-4-methylidene-14-tricyclo[9.3.1.03,8]pentadec-11-enyl] (2R,3S)-3-hydroxy-2-methylbutanoate",CC1=C2[C@@H](C[C@]3(CCC(C(=C)[C@@H]3[C@H]([C@H](C2(C)C)[C@H](C1)OC(=O)[C@H](C)[C@H](C)O)OC(=O)C)OC(=O)C)C)OC(=O)C,,,,,,
2258,132259,"Methyl 2-methyl-4-(3,4-(methylenedioxy)phenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate",CC1=C(C(C2=C(N1)CCCC2=O)C3=CC4=C(C=C3)OCO4)C(=O)OC,,,,,,
2259,132260,Piv-his-pro-phe-leu(OH)leu-tyr-tyr-ser-NH2,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N)NC(C(CC(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CN=CN5)NC(=O)C(C)(C)C)O,,,,,,
2260,132261,(3-Amino-2-hydroxy-4-(para-azidophenyl)-butanoyl)leucine,CC(C)C[C@@H](C(=O)O)NC(=O)C(C(CC1=CC=C(C=C1)N=[N+]=[N-])N)O,,,,,,
2261,132262,"2-[4-[(2S,4S,5S)-4-hydroxy-2-[[(1S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl]-5-[(2-methylpropan-2-yl)oxycarbonylamino]-6-phenylhexyl]phenoxy]acetic acid",CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC2=CC=C(C=C2)OCC(=O)O)C(=O)N[C@@H]3C(CC4=CC=CC=C34)O)O,,,,,,
2262,132263,Triptonoditerpenic acid,CC1=C(CCC2(C1CCC3=C(C(=C(C=C32)OC)C(C)C)O)C)C(=O)O,,,,,,
2263,132264,Isorupestonic acid,C[C@H]1CC[C@H](CC2=CC(=O)C[C@H]12)C(=C)C(=O)O,,,,,,
2264,132265,"Cholest-14-ene-3,16-diol",C[C@H](CCCC(C)C)[C@H]1[C@@H](C=C2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
2265,132266,Cyclazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,,,['Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)'],,,
2266,132267,CID 132267,CC=C(C)C1=CC(=C(C2=C1C(=O)OC3=C(O2)C(=CC(=C3C)O)C(=CC)C)C)O,,,,,,
2267,132268,2-N-Carboxamidinonormianserin,C1CN2C(CN1C(=N)N)C3=CC=CC=C3CC4=CC=CC=C42.Cl,,,,,,
2268,132269,"2,5-Diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene-5-carboximidamide",C1CN2C(CN1C(=N)N)C3=CC=CC=C3CC4=CC=CC=C42,,,,,,
2269,132270,"Thieno(3,2-c)pyridinium, 5-((2-chlorophenyl)methyl)-2-(2,2-dimethyl-1-oxopropoxy)-4,5,6,7-tetrahydro-5-hydroxy-",CC(C)(C)C(=O)OC1=CC2=C(S1)CC[N+](C2)(CC3=CC=CC=C3Cl)O,,,,,,
2270,132271,2-Ethoxy-3-(2-((5-methyl-2-phenyloxazol-4-yl)methyl)benzofuran-5-yl)propionic acid,CCOC(CC1=CC2=C(C=C1)OC(=C2)CC3=C(OC(=N3)C4=CC=CC=C4)C)C(=O)O,,,,,,
2271,132272,"24-Ethylcholest-14-ene-3,16-diol",CC[C@@H](CC[C@@H](C)[C@H]1[C@@H](C=C2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)O)C(C)C,,,,,,
2272,132273,"Octyl 3,6-di-O-(alpha-D-mannopyranosyl)-beta-D-mannopyranoside",CCCCCCCCO[C@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
2273,132274,CID 132274,CC=CN1C(NC2=C(C1=O)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
2274,132275,"20-Hex-2-enyl-9,10-dihydroxy-7,15-dimethyl-1-azacycloicosa-3,5,7,11,13,15,17-heptaen-2-one",CCCC=CCC1CC=CC=C(C=CC=CC(C(C=C(C=CC=CC(=O)N1)C)O)O)C,,,,,,
2275,132276,8-Acetyl-2-(dipropylamino)tetralin,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)C(=O)C,,,,,,
2276,132277,S-(3-Oxopropyl)-N-acetylcysteine,CC(=O)N[C@@H](CSCCC=O)C(=O)O,,,,,,
2277,132278,Esculentagenin,C[C@]1(CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CCC5[C@@]4(C[C@@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@H]2C1)C)C(=O)O)C(=O)OC,,,,,,
2278,132279,4-Carboxymethylphenylalanine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)CC(=O)O,,,,,,
2279,132280,"23-Methyltetracosa-5,9-dienoic acid",CC(C)CCCCCCCCCCCCC=CCCC=CCCCC(=O)O,,,,,,
2280,132281,Esculentoside M,C[C@]1(CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CCC5[C@@]4(C[C@@H]([C@@H]([C@@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C)C)[C@H]2C1)C)C(=O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C(=O)OC,,,,,,
2281,132282,(R)-2-(3-Mercapto-2(S)-methyl-1-oxopropoxy)-3-(methylthio)propanoic acid,C[C@H](CS)C(=O)O[C@@H](CSC)C(=O)O,,,,,,
2282,132283,alpha-((2-((4-Carboxyphenyl)amino)-2-oxo-1-(phenylmethyl)ethyl)amino)benzenebutanoic acid,C1=CC=C(C=C1)CCC(C(=O)O)NC(CC2=CC=CC=C2)C(=O)NC3=CC=C(C=C3)C(=O)O,,,,,,
2283,132284,CID 132284,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CC3=C(C=C2)NN=NC3=O,,,,,,
2284,132285,3-Hydroxy-N-(2'-biphenyl)-2-naphthalenecarboxamide phosphate,C1=CC=C(C=C1)C2=CC=CC=C2NC(=O)C3=CC4=CC=CC=C4C=C3OP(=O)(O)O,,,,,,
2285,132286,Lactosylphenyl-trolox,CC1=C(C2=C(CCC(O2)(C)C(=O)NC3=CC=C(C=C3)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O)O)C(=C1O)C)C,,,,,,
2286,132287,2-Nitroimidazole-1-methylacetohydroxamate,CONC(=O)CN1C=CN=C1[N+](=O)[O-],,,,,,
2287,132288,N-[3-(2-nitroimidazol-1-yl)propyl]acridin-9-amine,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCN4C=CN=C4[N+](=O)[O-],,,,,,
2288,132289,Glycyl-arginyl-glycyl-aspartyl-seryl-tyrosine,C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O,,,,,,
2289,132290,"(2-Methoxycarbonyl-3-tetradecoxyphenyl) [3-[(5-methyl-1,3-thiazol-3-ium-3-yl)methyl]phenyl] phosphate",CCCCCCCCCCCCCCOC1=C(C(=CC=C1)OP(=O)([O-])OC2=CC=CC(=C2)C[N+]3=CSC(=C3)C)C(=O)OC,,,,,,
2290,132291,Phosphoric acid hydrogen [2-methoxycarbonyl-3-tetradecyloxyphenyl][3-[(5-methylthiazolium-3-yl)methyl]phenyl] ester,CCCCCCCCCCCCCCOC1=C(C(=CC=C1)OP(=O)(O)OC2=CC=CC(=C2)C[N+]3=CSC(=C3)C)C(=O)OC,,,,,,
2291,132292,N-[(4-fluorophenyl)methyl]-2-(2-nitroimidazol-1-yl)acetamide,C1=CC(=CC=C1CNC(=O)CN2C=CN=C2[N+](=O)[O-])F,,,,,,
2292,132293,N-(1-Azido-5-naphthalenesulfonyl)galactosamine,C1=CC2=C(C=CC=C2S(=O)(=O)N[C@@H](C=O)[C@H]([C@H]([C@@H](CO)O)O)O)C(=C1)N=[N+]=[N-],,,,,,
2293,132294,N-Acetyl-S-(4-(((hexahydro-2-(2-(2-(hydroxyamino)-2-oxoethyl)-1-oxoheptyl)-3-pyridazinyl)carbonyl)amino)-5-methyl-3-oxoheptyl)-L-cysteine,CCCCCC(CC(=O)NO)C(=O)N1C(CCCN1)C(=O)NC(C(C)CC)C(=O)CCSC[C@@H](C(=O)O)NC(=O)C,,,['Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)'],,,
2294,132295,CID 132295,C[C@@H]1[C@@H]2C(=CCO)C(=O)N2C(=C1SCC3=CC=CC=N3)C(=O)O,,,,,,
2295,132296,"3-[2-Methyl-1-[[2-[2-[2-(oxidoamino)-2-oxoethyl]hexanoyl]diazinane-3-carbonyl]amino]butyl]-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-9-ium-5-carboxylic acid",CCCCC(CC(=O)N[O-])C(=O)N1C(CCCN1)C(=O)NC(C2=CC=[N+]3N2C(CCC3)C(=O)O)C(C)CC,,,['Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)'],,,
2296,132297,"2,2-Diethyl-4-oxo-4-[3-[2-(4-propan-2-yl-1,3-thiazol-2-yl)ethenyl]anilino]butanoic acid",CCC(CC)(CC(=O)NC1=CC=CC(=C1)C=CC2=NC(=CS2)C(C)C)C(=O)O,,,,,,
2297,132298,Xochitloldione,CC1=CC2=C(C=C3[C@@H](CC2=O)C(C=CC3=O)(C)C)C=C1O,,,,,,
2298,132299,Ecofembenpa,CCOC(=O)COC1=CC(=CC2=C1C3=C(CCN(C3)CC(=O)NC)C(O2)(C)C)C(C)CCCC4=CC=C(C=C4)F,,,,,,
2299,132300,Lysyl-valyl-aspartyl-leucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)N,,,,,,
2300,132301,Tagdmu,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1O[C@H]2[C@@H]([C@@H](C(O[C@@H]2C(=O)O)OC3=CC=C(C=C3)NC(=O)C(F)(F)F)NC(=O)C)O)CO)O)O,,,,,,
2301,132302,"4-[2-(Hydroxymethyl)pyrimidin-4-YL]-N,N-dimethylpiperazine-1-sulfonamide",CN(C)S(=O)(=O)N1CCN(CC1)C2=NC(=NC=C2)CO,,,,,,
2302,132303,Osutidine,CNCC1=CC=C(O1)CSCCNC(=NCC(C2=CC=C(C=C2)O)O)NS(=O)(=O)C,,,,,,
2303,132304,Methyl (+-)-(4-(2-((2-hydroxy-3-phenoxypropyl)amino)ethoxy)phenoxy)acetate,COC(=O)COC1=CC=C(C=C1)OCCNCC(COC2=CC=CC=C2)O.Cl,,,,,,
2304,132305,(-)-Methyl 4-[2-(2-hydroxy-3-phenoxypropylamino)ethoxy]phenoxyacetate,COC(=O)COC1=CC=C(C=C1)OCCNCC(COC2=CC=CC=C2)O,,,,,,
2305,132306,6-[[3-Fluoro-5-(4-methoxyoxan-4-yl)phenoxy]methyl]-1-methylquinolin-2-one,CN1C2=C(C=CC1=O)C=C(C=C2)COC3=CC(=CC(=C3)C4(CCOCC4)OC)F,,,,,,
2306,132307,"N,N-dipropyl-5,6,7,8-tetrahydroindolizin-7-amine",CCCN(CCC)C1CCN2C=CC=C2C1,,,,,,
2307,132308,5-3-(Dimethylamino)propoxycarbonyl-7-oxo-7H-benzo(c)fluorene dihydrochloride,CN(C)CCCOC(=O)C1=CC2=C(C3=CC=CC=C31)C4=CC=CC=C4C2=O.Cl.Cl,,,,,,
2308,132309,3-(Dimethylamino)propyl 7-oxobenzo[c]fluorene-5-carboxylate,CN(C)CCCOC(=O)C1=CC2=C(C3=CC=CC=C31)C4=CC=CC=C4C2=O,,,,,,
2309,132310,"3,6-Bis(dimethylamino)-10-(6-(4-nitrobenzoyloxy)hexyl)acridinium chloride",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=[N+]2CCCCCCOC(=O)C4=CC=C(C=C4)[N+](=O)[O-])N(C)C.[Cl-],,,,,,
2310,132311,"6-[3,6-Bis(dimethylamino)acridin-10-ium-10-yl]hexyl 4-nitrobenzoate",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=[N+]2CCCCCCOC(=O)C4=CC=C(C=C4)[N+](=O)[O-])N(C)C,,,,,,
2311,132312,CID 132312,CCCCC1N=C(C(=C[O-])N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)Cl.[K+],,,,,,
2312,132313,"2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,2-dihydroimidazole-4-carbaldehyde",CCCCC1NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C=O)Cl,,,,,,
2313,132314,9-((6-(4-Nitrobenzoyloxy)hexyl)amino)acridine,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCOC(=O)C4=CC=C(C=C4)[N+](=O)[O-].O.Cl,,,,,,
2314,132315,6-(Acridin-9-ylamino)hexyl 4-nitrobenzoate,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCOC(=O)C4=CC=C(C=C4)[N+](=O)[O-],,,,,,
2315,132316,"(3R,4R)-2,2-difluoro-3-hydroxy-N,6-dimethyl-4-[[(2S)-3-methyl-1-[[(2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]-1-oxobutan-2-yl]amino]heptanamide",CC(C)C[C@H]([C@H](C(C(=O)NC)(F)F)O)N[C@@H](C(C)C)C(=O)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C,,,,,,
2316,132317,"(4S)-2,2-difluoro-N,6-dimethyl-4-[[(2S)-3-methyl-1-[[(2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]-1-oxobutan-2-yl]amino]-3-oxoheptanamide",CC(C)C[C@@H](C(=O)C(C(=O)NC)(F)F)N[C@@H](C(C)C)C(=O)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C,,,,,,
2317,132318,but-2-enedioic acid;N-ethyl-N-[[4-fluoro-2-(4-fluorophenyl)phenyl]methoxy]-2-phenylethanamine,CCN(CCC1=CC=CC=C1)OCC2=C(C=C(C=C2)F)C3=CC=C(C=C3)F.C(=CC(=O)O)C(=O)O,,,,,,
2318,132319,N-ethyl-N-[[4-fluoro-2-(4-fluorophenyl)phenyl]methoxy]-2-phenylethanamine,CCN(CCC1=CC=CC=C1)OCC2=C(C=C(C=C2)F)C3=CC=C(C=C3)F,,,,,,
2319,132320,Cicletanine sulfate,CC1=NC=C2C(OCC2=C1OS(=O)(=O)O)C3=CC=C(C=C3)Cl,,,,,,
2320,132321,2-[2-(2-amino-2-oxoethyl)heptanoyl]-1-hydroxy-N-(3-methyl-5-oxoheptan-4-yl)diazinane-3-carboxamide,CCCCCC(CC(=O)N)C(=O)N1C(CCCN1O)C(=O)NC(C(C)CC)C(=O)CC,,,['Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)'],,,
2321,132322,"3,4-Dihydro-4-oxo-5,6-dimethyl-3-((5,7-difluorobenzothiazol-2-yl)methyl)-1-pyridazineacetic acid",CC1=C(N(NC(C1=O)CC2=NC3=C(S2)C(=CC(=C3)F)F)CC(=O)O)C,,,,,,
2322,132323,"3,4-Dihydro-4-oxo-5,6-cyclohexano-3-((5-(trifluoromethyl)benzothiazol-2-yl)methyl)-1-pyridazineacetic acid",C1CCC2=C(C1)C(=NN(C2=O)CC3=NC4=C(S3)C=CC(=C4)C(F)(F)F)CC(=O)O,,,,,,
2323,132324,"N,N'-Bis(2-bromoethyl)phosphorodiamidic acid",C(CBr)NP(=O)(NCCBr)O,,,,,,
2324,132325,"3,3-Dichloro-4-(alpha-chlorobenzyl)-1-methyl-5-phenyl-2-pyrrolidinone",CN1[C@@H](C(C(C1=O)(Cl)Cl)[C@H](C2=CC=CC=C2)Cl)C3=CC=CC=C3,,,,,,
2325,132326,"N-(1-Methyl-4-(3-methylbenzyl)hexahydro-1H-1,4-diazepin-6-yl)-1H-indazole-3-carboxamide dihydrochloride",CC1=CC(=CC=C1)CN2CCN(C[C@H](C2)NC(=O)C3=NNC4=CC=CC=C43)C.Cl.Cl,,,,,,
2326,132327,"N-[(6R)-1-methyl-4-[(3-methylphenyl)methyl]-1,4-diazepan-6-yl]-1H-indazole-3-carboxamide",CC1=CC(=CC=C1)CN2CCN(C[C@H](C2)NC(=O)C3=NNC4=CC=CC=C43)C,,,,,,
2327,132328,CID 132328,CCC(CC=CC1=CC=CC=C1)(C2=CC=C(C=C2)Cl)N(C)C.Cl,,,,,,
2328,132329,"3-(4-chlorophenyl)-N,N-dimethyl-6-phenylhex-5-en-3-amine",CCC(CC=CC1=CC=CC=C1)(C2=CC=C(C=C2)Cl)N(C)C,,,,,,
2329,132330,Yiyeliangwanoside IV,CC(=O)O[C@@H]1[C@H]([C@@H](CO[C@H]1O[C@H]2CC[C@@]3([C@H]4CC=C5[C@H]6CC(CC[C@@]6(CC[C@]5([C@@]4(CCC3C2(C)C)C)C)C(=O)O)(C)C(=O)O)C)O)O,,,,,,
2330,132331,"1,1-bis[3-(4-fluorophenyl)propyl]-2-[3-(1H-imidazol-5-yl)propyl]guanidine",C1=CC(=CC=C1CCCN(CCCC2=CC=C(C=C2)F)C(=NCCCC3=CN=CN3)N)F,,,,,,
2331,132332,6-[2-[5-(4-Fluorophenyl)-3-propan-2-yl-1-pyridin-2-ylpyrazol-4-yl]ethenyl]-4-hydroxyoxan-2-one,CC(C)C1=NN(C(=C1C=CC2CC(CC(=O)O2)O)C3=CC=C(C=C3)F)C4=CC=CC=N4,,,,,,
2332,132333,"2-[dimethylamino(fluoro)phosphoryl]oxy-N,N-dimethylethanamine",CN(C)CCOP(=O)(N(C)C)F,,,,,,
2333,132334,CID 132334,CC(C)C1=NN(C(=C1C=C[C@@H]2C[C@H](CC(=O)O2)O)C3=CC=C(C=C3)F)C4=NC=CN=C4,,,,,,
2334,132335,CID 132335,C1=CC(=C2C(=CC=C3C2=C1C(=O)OC3=O)C(=O)[O-])C(=O)O.O.[Na+],,,,,,
2335,132336,"1,4,5,8-Naphthalenetetracarboxylic acid 1,8-monoanhydride",C1=CC(=C2C(=CC=C3C2=C1C(=O)OC3=O)C(=O)O)C(=O)O,,,,,,
2336,132337,4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride,COC1=CC(=C(C=C1C(=O)NC[C@@H]2CCN3[C@H]2CCC3)Cl)N,,,,,,
2337,132338,"6-(2,4-Dichlorophenyl)-2,3,4-trihydroxyhexanesulfonic acid",C1=CC(=C(C=C1Cl)Cl)CCC(C(C(CS(=O)(=O)O)O)O)O,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
2338,132339,CID 132339,C1=CC(=C(C=C1Cl)Cl)CC[C@H](C[C@H](COP(=O)(O)O)O)O,,,,,,
2339,132340,"(3R,5S)-7-[4-(4-fluorophenyl)-1-oxo-2-propan-2-ylisoquinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid",CC(C)N1C(=C(C2=CC=CC=C2C1=O)C3=CC=C(C=C3)F)C=C[C@H](C[C@H](CC(=O)O)O)O,,,,,,
2340,132341,"3,4-Dichloro-N-methyl-N-(3-methylene-2-oxo-8-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-7-yl)benzeneacetamide",CN(C1CC2(CCC1N3CCCC3)CC(=C)C(=O)O2)C(=O)CC4=CC(=C(C=C4)Cl)Cl,,,,,,
2341,132342,CID 132342,[Li+].COC1=CC=C(C=C1)CCCCCCCCOC2=C(N=C(C=C2)CS(=O)C3=CC=CC(=C3)N)C=CC(=O)[O-],,,,,,
2342,132343,3-[6-[(3-Aminophenyl)sulfinylmethyl]-3-[8-(4-methoxyphenyl)octoxy]pyridin-2-yl]prop-2-enoic acid,COC1=CC=C(C=C1)CCCCCCCCOC2=C(N=C(C=C2)CS(=O)C3=CC=CC(=C3)N)C=CC(=O)O,,,,,,
2343,132344,CID 132344,C[C@H](C(=O)N[C@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N)NC(=O)C,,,,,,
2344,132345,"Ethanone, 1-(4-(dipropylamino)-1,3,4,5-tetrahydrobenz(cd)indol-6-yl)-, (R)-",CCCN(CCC)[C@H]1CC2=CNC3=C2C(=C(C=C3)C(=O)C)C1,,,,,,
2345,132346,CID 132346,C1CCC(C1)(CC2=CC=C(C=C2)CC(=O)[O-])CNS(=O)(=O)C3=CC=C(C=C3)Cl.[Na+],,,,,,
2346,132347,2-[4-[[1-[[(4-chlorophenyl)sulfonylamino]methyl]cyclopentyl]methyl]phenyl]acetic Acid,C1CCC(C1)(CC2=CC=C(C=C2)CC(=O)O)CNS(=O)(=O)C3=CC=C(C=C3)Cl,,,,,,
2347,132348,2-(3-Cyclopentyl-1-propyn-1-yl)adenosine,C1CCC(C1)CC#CC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,,,,
2348,132349,"(8S,9S,10R,11S,13S,14S,17S)-17-(3-fluoroprop-1-ynyl)-11,17-dihydroxy-6,10,13-trimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one",CC1=C[C@H]2[C@@H]3CC[C@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C#CCF)O,,,,,,
2349,132350,1-Butyl-4-(4-dimethylaminophenyl)-3-(4-trifluoromethylphenoxymethyl)piperidine dihydrochloride,CCCCN1CC[C@@H]([C@H](C1)COC2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)N(C)C.Cl.Cl,,,,,,
2350,132351,"4-[(3R,4S)-1-butyl-3-[[4-(trifluoromethyl)phenoxy]methyl]piperidin-4-yl]-N,N-dimethylaniline",CCCCN1CC[C@@H]([C@H](C1)COC2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)N(C)C,,,,,,
2351,132352,Lysyl-arginyl-arginyltryptophyl-lysyl-lysine,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N,,,,,,
2352,132353,Lysyl-arginyl-arginyl-phenylalanyl-lysyl-lysine,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N,,,,,,
2353,132354,CID 132354,CC=CC=CC=C(C)C1C(C(C(CO1)C)OC)OC(=O)CN[C@H]2[C@H]([C@H]([C@@H]([C@@H](O2)CO)O)O)O,,,,,,
2354,132355,CID 132355,C1CN(CCC1CC2=CC=CC=C2)CCSC3C4=CC=CC=C4COC5=C3C=C(C=C5)C(=O)[O-].[Na+],,,,,,
2355,132356,"11-[2-(4-Benzylpiperidin-1-yl)ethylsulfanyl]-6,11-dihydrobenzo[c][1]benzoxepine-2-carboxylic acid",C1CN(CCC1CC2=CC=CC=C2)CCSC3C4=CC=CC=C4COC5=C3C=C(C=C5)C(=O)O,,,,,,
2356,132357,1-(2-Aminohexyldisulfanyl)hexan-2-amine,CCCC[C@@H](CSSC[C@H](CCCC)N)N,,,,,,
2357,132358,Tyromycin A,CC1=C(C(=O)OC1=O)CCCCCCCCCCCCCCCCC2=C(C(=O)OC2=O)C,,,,,,
2358,132359,Cyclohexylmethyl 1-[2-(4-azidophenyl)-2-oxoethyl]-1-methylpiperidin-1-ium-4-carboxylate,C[N+]1(CCC(CC1)C(=O)OCC2CCCCC2)CC(=O)C3=CC=C(C=C3)N=[N+]=[N-],,,,,,
2359,132360,CID 132360,C[N+]1(CCC(CC1)C(=O)OCC2CCCCC2)CC(=O)C3=CC=C(C=C3)N[N+]#N,,,,,,
2360,132361,CID 132361,C1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCCN)C(=O)O,,,,,,
2361,132362,n-Butyl 2-imidazolyl disulfide,CCCCSSC1=NC=CN1,,,,,,
2362,132363,CID 132363,CC(C)N1C(=O)C(=O)N=C1N=C(N)NC2=CC(=C(C=C2)Cl)Cl,,,,,,
2363,132364,CID 132364,CC(C)C[C@@H](C(=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C=CC(=O)O)N[C@H](CCCN=C(N)N)C=O,,,,,,
2364,132365,Gloeosteretriol,C[C@@H]1[C@H](C[C@]2([C@@]1([C@@H]3CC(C[C@@]3(C2)O)(C)C)C)O)O,,,,,,
2365,132366,2-[[2-[2-[[2-[Bis(carboxymethyl)amino]-2-oxoethyl]-(2-tetradecanoyloxyethyl)amino]ethyl-(2-tetradecanoyloxyethyl)amino]acetyl]-(carboxymethyl)amino]acetic acid,CCCCCCCCCCCCCC(=O)OCCN(CCN(CCOC(=O)CCCCCCCCCCCCC)CC(=O)N(CC(=O)O)CC(=O)O)CC(=O)N(CC(=O)O)CC(=O)O,,,,,,
2366,132367,6-Propylchromone-2-carboxylic acid,CCCC1=CC2=C(C=C1)OC(=CC2=O)C(=O)O,,,,,,
2367,132368,"2-amino-4-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1,3-thiazole-5-carbonitrile;but-2-enedioic acid",CN1CCC(=CC1)C2=C(SC(=N2)N)C#N.C(=CC(=O)O)C(=O)O,,,,,,
2368,132369,"2-Amino-4-[(1-methyl-1,2,3,6-tetrahydropyridin)-4-yl]thiazole-5-carbonitrile",CN1CCC(=CC1)C2=C(SC(=N2)N)C#N,,,,,,
2369,132370,CID 132370,CN1CCC=C(C1)C2=C(SC(=N2)N)Cl.C(=CC(=O)O)C(=O)O,,,,,,
2370,132371,"5-Chloro-4-[(1-methyl-1,2,5,6-tetrahydropyridin)-3-yl]thiazol-2-amine",CN1CCC=C(C1)C2=C(SC(=N2)N)Cl,,,,,,
2371,132372,CID 132372,CCCC[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H]2CCCN2C(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)C6=CC=CC=C6,,,,,,
2372,132373,Benzyoxybenzyloxybenzylacyclouridine monophosphate,C1=CC=C(C=C1)COC2=CC=C(C=C2)COC3=CC=CC(=C3)CC4=CN(C(=O)NC4=O)COCCOP(=O)(O)O,,,,,,
2373,132374,4'-Azido-3'-iodophenylethyl 3-(4-chlorophenyl)-tropane-2-carboxylate,CN1C2CCC1C(C(C2)C3=CC=C(C=C3)Cl)C(=O)OCCC4=CC(=C(C=C4)N=[N+]=[N-])I,,,,,,
2374,132375,Disodium monofluorophosphate-calcium carbonate,C(=O)([O-])[O-].[O-]P(=O)([O-])F.[Na+].[Na+].[Ca+2],,,,,,
2375,132376,Russuphelin A,COC1=CC(=C(C(=C1)OC2=C(C=C(C=C2Cl)O)Cl)OC)OC3=C(C=C(C=C3Cl)O)Cl,,,,,,
2376,132377,"Urea, N-butyl-N'-(2-(3-(5-ethyl-4-phenyl-1H-imidazol-1-yl)propoxy)-6-methylphenyl)-",CCCCNC(=O)NC1=C(C=CC=C1OCCCN2C=NC(=C2CC)C3=CC=CC=C3)C,,,,,,
2377,132378,O-Tnp-ump,C1=CN(C(=O)NC1=O)[C@H]2[C@H]3[C@@H]([C@H](O2)COP(=O)(O)O)OC4(O3)C(C=C(C=C4[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
2378,132379,4-(2-(Methyl(2-phenylethyl)amino)-2-oxoethyl)-8-(phenylmethoxy)-2-naphthalenecarboxylic acid,CN(CCC1=CC=CC=C1)C(=O)CC2=C3C=CC=C(C3=CC(=C2)C(=O)O)OCC4=CC=CC=C4,,,,,,
2379,132380,"Glycinamide, D-alanyl-L-glutaminyl-L-tyrosyl-L-phenylalanyl-L-arginyl-L-tryptophyl-, acetate",C[C@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NOC(=O)C)N,,,,,,
2380,132381,N-[2-(diacetylamino)-3-(4-isocyanatophenyl)propyl]-N-[2-(diacetylamino)propyl]acetamide,CC(CN(CC(CC1=CC=C(C=C1)N=C=O)N(C(=O)C)C(=O)C)C(=O)C)N(C(=O)C)C(=O)C,,,,,,
2381,132382,4-Thioanisyl-2-biphenylyl-3-hydroxypropionic acid,CSC1=CC=C(C=C1)OC(=O)C(CO)C2=CC=CC=C2C3=CC=CC=C3,,,,,,
2382,132383,6-Fluoro-7-(4-hydroxyphenyl)-1-cyclopropyl-4-quinolone-3-carboxylic acid,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)C4=CC=C(C=C4)O)F)C(=O)O,,,,,,
2383,132384,"2-(4,5-Dihydro-1H-imidazol-2-yl)-1,2,4,5-tetrahydro-2-propylpyrrolo(3,2,1-HI)indole hcl",CCCC1(CC2=CC=CC3=C2N1CC3)C4=NCCN4.Cl,,,,,,
2384,132385,4-Bromomethyl-3-nitrobenzoic acid succinimide ester,C1CC(=O)NC1=O.C1=CC(=C(C=C1C(=O)O)[N+](=O)[O-])CBr,,,,,,
2385,132386,4-(Bromomethyl)-3-nitrobenzoic acid,C1=CC(=C(C=C1C(=O)O)[N+](=O)[O-])CBr,,,,,,
2386,132387,2-(N-Propyl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)amino)pyridine-3-carboxylic acid,CCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=C(C=CC=N4)C(=O)O,,,['Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)'],,,
2387,132388,Esculentoside I,C[C@]1(CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CCC5[C@@]4(C[C@@H]([C@@H]([C@@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C)C)[C@H]2C1)C)C(=O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C(=O)OC,,,,,,
2388,132389,"Thiazolo(4,5-f)quinolin-2-amine",C1=CC2=C(C=CC3=C2N=C(S3)N)N=C1,,,,,,
2389,132390,"N-(3,5-Dichloro-4-hydroxyphenyl)succinimide",C1CC(=O)N(C1=O)C2=CC(=C(C(=C2)Cl)O)Cl,,,,,,
2390,132391,"N-(3,5-Dichloro-4-hydroxyphenyl)succinamic acid",C1=C(C=C(C(=C1Cl)O)Cl)NC(=O)CCC(=O)O,,,,,,
2391,132392,"2-Hydroxy-3-(8-phenylocta-1,3,5,7-tetraenyl)-2H-furan-5-one",C1=CC=C(C=C1)C=CC=CC=CC=CC2=CC(=O)OC2O,,,,,,
2392,132393,4-Trifluoromethylphenyl-2-biphenylyl-3-hydroxypropionic acid,C1=CC=C(C=C1)C2=CC=CC=C2C(C(C3=CC=C(C=C3)C(F)(F)F)O)C(=O)O,,,,,,
2393,132394,CID 132394,CON=C(C1=C(SC(=N1)N)Cl)C(=O)N[C@@H]2[C@H]3N(C2=O)C(=C(CS3)C[N+]4=CN5C=CC=CC5=C4)C(=O)[O-],,,,,,
2394,132395,CID 132395,CON=C(C1=C(SC(=N1)N)Cl)C(=O)N[C@@H]2[C@H]3N(C2=O)C(=C(CS3)C[N+]4=CN5C=CC=CC5=C4)C(=O)O,,,,,,
2395,132396,CID 132396,CC1=NC2=NC(=NN2C(=C1)SCC3=C(N4[C@@H]([C@@H](C4=O)NC(=O)C(=NOC(C)(C)C(=O)NNC(=O)C5=CC(=C(C=C5)O)O)C6=CSC(=N6)N)SC3)C(=O)[O-])C(=O)N.[Na+],,,,,,
2396,132397,CID 132397,CC1=NC2=NC(=NN2C(=C1)SCC3=C(N4[C@@H]([C@@H](C4=O)NC(=O)C(=NOC(C)(C)C(=O)NNC(=O)C5=CC(=C(C=C5)O)O)C6=CSC(=N6)N)SC3)C(=O)O)C(=O)N,,,,,,
2397,132398,CID 132398,C[C@@H](C(=O)N[C@@H](CC1C=NC=N1)C(=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@@H](C)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)N)N,,,,,,
2398,132399,CID 132399,C[C@H]([C@@H](C(N=[N+]=[N-])O)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC4=CC=CC=C4)N)O,,,,,,
2399,132400,"Carbamic acid, (1-(cyclohexylmethyl)-2-hydroxy-5-methyl-4-(((2-methyl-1-(((2-(2-pyridinyl)ethyl)amino)carbonyl)butyl)amino)carbonyl)hexyl)-, 1,1-dimethylethyl ester, (1S-(1R*,2R*,4S*(1R*,2R*)))-",CCC(C)C(C(=O)NCCC1=CC=CC=N1)NC(=O)[C@H](C[C@@H]([C@H](CC2CCCCC2)NC(=O)OC(C)(C)C)O)C(C)C,,,,,,
2400,132401,CID 132401,C1C[C@@H]2C[C@H](C1)OC3=C2C=C(C[C@@]3(C4CN5CCC4CC5)C(=O)N)Cl,,,,,,
2401,132402,"alpha,alpha,alpha Trifluoro-N-methyl-N-(2-pyrrolidinylcyclohexyl)-4-toluamide",CC1=CC=C(C=C1)S(=O)(=O)O.CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)C3=CC=C(C=C3)C(F)(F)F,,,,,,
2402,132403,N-Methyl-N-[2alpha-(1-pyrrolidinyl)cyclohexan-1beta-yl]-4-(trifluoromethyl)benzamide,CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)C3=CC=C(C=C3)C(F)(F)F,,,,,,
2403,132404,"2-[[4-[[2-Butyl-6-[methylcarbamoyl(pentyl)amino]benzimidazol-1-yl]methyl]phenyl]carbamoyl]-3,6-dichlorobenzoic acid",CCCCCN(C1=CC2=C(C=C1)N=C(N2CC3=CC=C(C=C3)NC(=O)C4=C(C=CC(=C4C(=O)O)Cl)Cl)CCCC)C(=O)NC,,,,,,
2404,132405,"Nonylene-1,9-bis(5-dithio-2-nitrobenzoic acid)",C1=CC(=C(C=C1SSCCCCCCCCCSSC2=CC(=C(C=C2)[N+](=O)[O-])C(=O)O)C(=O)O)[N+](=O)[O-],,,,,,
2405,132406,CID 132406,C1C[C@@H]2[C@H]([C@H]([C@H]1O2)CC=CCCC(=O)O)C=NNC(=O)NC3=CC=CC=C3,,,,,,
2406,132407,CID 132407,C1C[C@@H]2[C@H]([C@H]([C@H]1O2)CC=CCCC(=O)O)C=NNC(=O)NC3=CC=C(C=C3)Cl,,,,,,
2407,132408,3-(6-Amino-9h-purin-9-yl)-cyclopentanol,C1C[C@H](C[C@H]1N2C=NC3=C(N=CN=C32)N)O,,,,,,
2408,132409,Thiodeacylaprophen,CCN(CC)CCSC(C)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
2409,132410,CID 132410,CC(=CC(=O)OC1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(CC[C@H]34)OC(=O)C)C)C#C)OC(=O)C,,,,,,
2410,132411,Cizolirtine citrate,CN1C(=CC=N1)C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
2411,132412,Cizolirtine,CN1C(=CC=N1)C(C2=CC=CC=C2)OCCN(C)C,,,,,,
2412,132413,N-Acetylleucylprolinamide,CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N)NC(=O)C,,,,,,
2413,132414,Octylmethane-tri-(2-oxabutanoic acid),CCCCCCCCC(CCOC(=O)O)(CCOC(=O)O)CCOC(=O)O,,,,,,
2414,132415,Rubilactone,COC(=O)C1=C(C2=CC=CC=C2C3=C1C=CC(=O)O3)O,,,,,,
2415,132416,delta(3)-Cefotiam,CN(C)CCN1C(=NN=N1)SCC2=CSC3C(C(=O)N3C2C(=O)O)NC(=O)CC4=CSC(=N4)N,,,,,,
2416,132417,"2,4,6-Cycloheptatrien-1-one, 7-((4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)methyl)-2-((2-hydroxyethyl)amino)-4-(1-methylethyl)-",CC(C)C1=CC=C(C(=O)C(=C1)NCCO)CN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,,,,,
2417,132418,Tris(dicyclohexylphenylphosphine)gold(I),C1CCC(CC1)P(C2CCCCC2)C3=CC=CC=C3.C1CCC(CC1)P(C2CCCCC2)C3=CC=CC=C3.C1CCC(CC1)P(C2CCCCC2)C3=CC=CC=C3.[Au+],,,,,,
2418,132419,Homocysteinylpropachlor,CC(C)N(C1=CC=CC=C1)C(=O)CSCC[C@@H](C(=O)O)NC(=O)C,,,,,,
2419,132420,"8-Chloro-7-hydroxy-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine",CC(=O)O.CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC4=C3OCC4)O)Cl,,,,,,
2420,132421,Odapipam,CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC4=C3OCC4)O)Cl,,,,,,
2421,132422,Glyantrypine,C1C2=NC3=CC=CC=C3C(=O)N2C(C(=O)N1)CC4=CNC5=CC=CC=C54,,,,,,
2422,132423,Cycloviracin B1,CC(CCCCCC(CCCCCCCCCCCCCC1CC(=O)OCC2C(C(C(C(O2)OC(CC(=O)OCC3C(C(C(C(O1)O3)O)O)O)CCCCCCCCCCCCCCCC(CCCCCC(C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)OC)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)OC)O)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)OC)O,,,,,,
2423,132424,"[(1S,2R,3S,4R)-1-acetyloxy-5-cyano-3,7-dihydroxy-3-methyl-4-(2-methylpropanoyloxy)-6,11-dioxo-2,4-dihydro-1H-benzo[b]carbazol-2-yl] 2-methylpropanoate",CC(C)C(=O)O[C@@H]1[C@H](C2=C([C@H]([C@]1(C)O)OC(=O)C(C)C)N(C3=C2C(=O)C4=C(C3=O)C(=CC=C4)O)C#N)OC(=O)C,,,,,,
2424,132425,"2,2-Dimethyl-7-(3-(3-phenylpropyl)-2-thienyl)heptanoic acid",CC(C)(CCCCCC1=C(C=CS1)CCCC2=CC=CC=C2)C(=O)O,,,,,,
2425,132426,"2,4,7-Triamino-6-(N,N-dimethylaminomethyl)pteridine",CN(C)CC1=C(N=C2C(=N1)C(=NC(=N2)N)N)N,,,,,,
2426,132427,"2,4,7-Triamino-6-(2-(N,N-dimethylamino)ethyl)pteridine",CN(C)CCC1=C(N=C2C(=N1)C(=NC(=N2)N)N)N,,,,,,
2427,132428,"2,4,7-Triamino-6-(3-(N,N-dimethylamino)propyl)pteridine",CN(C)CCCC1=C(N=C2C(=N1)C(=NC(=N2)N)N)N,,,,,,
2428,132429,"N-((N,N-Dimethylamino)ethyl)-5-(N,N-bis(2-chloroethyl)amino)-2,4-dinitrobenzamide",CN(C)CCNC(=O)C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])N(CCCl)CCCl,,,,,,
2429,132430,Halomon,CC(C)([C@@H](CC[C@@](CBr)(C(=C)Cl)Cl)Br)Cl,,,,,,
2430,132431,"1,6-Dioxa-2-azaspiro(4.6)undeca-2,7,9-triene-3-carboxamide, 8,10-dibromo-N-(3-(2,6-dibromo-4-(1-hydroxy-2-(methylamino)ethyl)phenoxy)propyl)-4-hydroxy-9-methoxy-",CNCC(C1=CC(=C(C(=C1)Br)OCCCNC(=O)C2=NOC3(C2O)CC(=C(C(=CO3)Br)OC)Br)Br)O,,,,,,
2431,132432,CID 132432,CC1([C@@H](N2[C@H](S1)C(=CC=CC=O)C2=O)C(=O)OCOC(=O)C(C)(C)C)C,,,,,,
2432,132433,"8-[5-hydroxy-4-(hydroxymethyl)-1,3-dioxan-2-yl]-3-methyl-7-(2-oxopropyl)-1-propyl-1H-benzo[g]isochromene-6,9-dione",CCCC1C2=CC3=C(C=C2C=C(O1)C)C(=O)C(=C(C3=O)C4OCC(C(O4)CO)O)CC(=O)C,,,,,,
2433,132434,CID 132434,C[C@@H]1C(=O)N=C2N1CC3=C(N2)C=CC(=C3C)Br,,,,,,
2434,132435,"1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-3-(2-propenyl)-",C=CCN1CCC2=C(C(=C(C=C2C(C1)C3=CC=C(C=C3)O)O)O)Cl,,,,,,
2435,132436,"1-[2-(4-Ethyl-2,3-dioxopiperazin-1-yl)ethyl]-3-methylurea",CCN1CCN(C(=O)C1=O)CCNC(=O)NC,,,,,,
2436,132437,tert-Butyloxycarbonyl-prolyl-aminosuccinyl-glycyl-alanine methyl ester,C[C@@H](C(=O)OC)N(C(=O)CN1C(=O)CCC1=O)N(C(=O)[C@@H]2CCCN2)C(=O)OC(C)(C)C,,,,,,
2437,132438,Trimesoyl tris(methyl phosphate),COP(=O)([O-])OC(=O)C1=CC(=CC(=C1)C(=O)OP(=O)([O-])OC)C(=O)OP(=O)([O-])OC.[Na+].[Na+].[Na+],,,,,,
2438,132439,"Tris[hydroxy(methoxy)phosphoryl] benzene-1,3,5-tricarboxylate",COP(=O)(O)OC(=O)C1=CC(=CC(=C1)C(=O)OP(=O)(O)OC)C(=O)OP(=O)(O)OC,,,,,,
2439,132440,"Hexanamide, N-(2,6-dimethylphenyl)-5-hydroxy-",CC1=C(C(=CC=C1)C)NC(=O)CCCC(C)O,,,,,,
2440,132441,Fonturacetam,C1C(CN(C1=O)CC(=O)N)C2=CC=CC=C2,,,,,,
2441,132442,"9,10-Dibromohexadecanoic acid",CCCCCCC(C(CCCCCCCC(=O)O)Br)Br,,,,,,
2442,132443,2-Hydroxy-3-(4-iodophenyl)-1-(4-phenylpiperidinyl)propane,C1CN(CCC1C2=CC=CC=C2)CC(CC3=CC=C(C=C3)I)O,,,,,,
2443,132444,7-Cbnceph mustard,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CCCC(=O)O)C(=O)O)COC(=O)NC3=CC=C(C=C3)N(CCCl)CCCl,,,,,,
2444,132445,7-(1-Benzylpyridinium-4-yl)amino-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)ceph-3-em-4-carboxylate,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC4=CC=[N+](C=C4)CC5=CC=CC=C5)SC2)C(=O)[O-],,,,,,
2445,132446,"(6R,7R)-7-[(1-benzylpyridin-1-ium-4-yl)amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC4=CC=[N+](C=C4)CC5=CC=CC=C5)SC2)C(=O)O,,,,,,
2446,132447,"2-(3,4-dichlorophenyl)-N-[(1R,2R)-5-methoxy-2-pyrrolidin-1-yl-1,2,3,4-tetrahydronaphthalen-1-yl]-N-methylacetamide",CN([C@H]1[C@@H](CCC2=C1C=CC=C2OC)N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl,,,,,,
2447,132448,Northienamycin,C1[C@@H]2[C@H](C(=O)N2C(=C1SCCN)C(=O)O)CO,,,,,,
2448,132449,[1-(4-Hydroxyphenoxy)-1-phosphonoethyl]phosphonic acid,CC(OC1=CC=C(C=C1)O)(P(=O)(O)O)P(=O)(O)O,,,,,,
2449,132450,Silabolin,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O[Si](C)(C)C)CCC4=CC(=O)CC[C@H]34,,,,,,
2450,132451,CID 132451,CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC=C(C=C2)Cl)C3=CC=CC=C3,,,,,,
2451,132452,Glutamyl-lysyl-valyl-isoleucyl-serine,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)N,,,,,,
2452,132453,"D-Mannitol, mixt. with 1,2,3-propanetriol",C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O.C(C(CO)O)O,,,,,,
2453,132454,2-((2-Methoxy-5-chlorophenyl)azo)-1H-imidazole,COC1=C(C=C(C=C1)Cl)N=NC2=NC=CN2,,,,,,
2454,132455,Cdc2 peptide (9-19),CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CCCCN)N,,,,,,
2455,132456,Unii-4bbs3A53GJ,C(C(C(=O)[O-])O)C(=O)[O-].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Ca+2].[Ca+2].[Ca+2].[Ca+2],,,,,,
2456,132457,Leucyl-seryl-prolyl-phenylalanyl-prolyl-phenylalanyl-aspartyl-leucine,CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N,,,,,,
2457,132458,9-(2-(2-Nitro-1-imidazolyl)ethylamino)acridine,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCN4C=CN=C4[N+](=O)[O-].Cl,,,,,,
2458,132459,"9-Acridinamine, N-[2-(2-nitro-1H-imidazol-1-yl)ethyl]-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCN4C=CN=C4[N+](=O)[O-],,,,,,
2459,132460,"S-(2-(N,N-Diisopropylamino)ethyl)isothiourea",CC(C)N(CCSC(=N)N)C(C)C,,,,,,
2460,132461,CID 132461,C1=CC=C(C=C1)C[C@H](C(=O)N[C@H](CC(=O)O)O)N[C@@H](CCC2=CC=C(C=C2)O)C(=O)O,,,,,,
2461,132462,CID 132462,C(CC(=O)N[C@@H](CSS(C[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C(C(Cl)Br)(F)F)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
2462,132463,N(alpha)-(4-Aminobutyryl)cystathionine,C(CC(=O)N[C@@H](CCSC[C@@H](C(=O)O)N)C(=O)O)CN,,,,,,
2463,132464,"2H-Imidazol-2-one, 1,3-dihydro-4-(4-methoxybenzoyl)-5-methyl-",CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)OC,,,,,,
2464,132465,P-Hydroxyhippuryl-his-leu-OH,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)CNC(=O)C2=CC=C(C=C2)O,,,,,,
2465,132466,"8-Benzylthio-4-morpholino-2-piperazino-pyrimido(5,4-d)pyrimidine",C1CN(CCN1)C2=NC3=C(C(=N2)N4CCOCC4)N=CN=C3SCC5=CC=CC=C5,,,,,,
2466,132467,"3,7-Bis-(4-trifluoromethylphenyl)-1,5,3,7-dioxadiazocane",C1N(COCN(CO1)C2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)C(F)(F)F,,,,,,
2467,132468,"2-(4-Hydroxyphenyl)-1,2-dihydro-3h-pyrazolo[4,3-c]quinolin-3-one",C1=CC=C2C(=C1)C3=C(C=N2)C(=O)N(N3)C4=CC=C(C=C4)O,,,,,,
2468,132469,omega-N-Hydroxymethylarginine,C(C[C@@H](C(=O)O)N)CN=CNNCO,,,,,,
2469,132470,"1,2,3,4,4a,5,6,7,8,8a-Decahydroquinoline-5-carboxylic acid;hydrochloride",C1CC(C2CCCNC2C1)C(=O)O.Cl,,,,,,
2470,132471,"1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline-5-carboxylic Acid",C1CC(C2CCCNC2C1)C(=O)O,,,,,,
2471,132472,"1,2,3,4-Tetrahydro-2-(3-mercapto-1-oxopropyl)-3-isoquinolinecarboxylic acid",C1C(N(CC2=CC=CC=C21)C(=O)CCS)C(=O)O,,,,,,
2472,132473,"3-[4-(3,7-Dimethylocta-2,6-dienoxy)-3,5-dimethoxyphenyl]prop-2-en-1-ol",CC(=CCCC(=CCOC1=C(C=C(C=C1OC)C=CCO)OC)C)C,,,,,,
2473,132474,1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylprop-2-enyl)piperazine;methanesulfonic acid,CS(=O)(=O)O.CS(=O)(=O)O.C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CC=CC4=CC=CC=C4,,,,,,
2474,132475,1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylprop-2-enyl)piperazine,C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CC=CC4=CC=CC=C4,,,,,,
2475,132476,(2S)-2-amino-5-[[(2S)-2-[[(3R)-3-methoxy-2-oxo-1-sulfoazetidin-3-yl]amino]propanoyl]amino]-5-oxopentanoic acid,C[C@@H](C(=O)NC(=O)CC[C@@H](C(=O)O)N)N[C@]1(CN(C1=O)S(=O)(=O)O)OC,,,,,,
2476,132477,(2-Decanoyloxy-3-decanoylsulfanylpropyl) 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCC(=O)OC(COP(=O)([O-])OCC[N+](C)(C)C)CSC(=O)CCCCCCCCC,,,,,,
2477,132478,2-[(2-Decanoyloxy-3-decanoylsulfanylpropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCC(=O)OC(COP(=O)(O)OCC[N+](C)(C)C)CSC(=O)CCCCCCCCC,,,,,,
2478,132479,"1-(4-(5-Amino-6-chloro-2-pyridyl)aminobenzyl)-4-benzyl-2,3-dioxopiperazine",C1CN(C(=O)C(=O)N1CC2=CC=CC=C2)CC3=CC=C(C=C3)NC4=NC(=C(C=C4)N)Cl,,,,,,
2479,132480,CID 132480,C1CN(CN2C1CNC3=C2C(=O)N=C(N3)N)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)O.C(=O)O,,,,,,
2480,132481,CID 132481,C1CN(CN2C1CNC3=C2C(=O)N=C(N3)N)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
2481,132482,N-(1-butylpiperidin-4-yl)pyridine-4-carboxamide,CCCCN1CCC(CC1)NC(=O)C2=CC=NC=C2,,,,,,
2482,132483,"3,17-Dihydroxyandrostan-11-one",C[C@]12CCC(CC1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4O)C)O,,,,,,
2483,132484,4-(1-Methylpiperidine-4-carbonyl)benzenesulfonamide,CN1CCC(CC1)C(=O)C2=CC=C(C=C2)S(=O)(=O)N,,,,,,
2484,132485,"(3S,4S,5R)-2-(6-aminopurin-9-yl)-5-[(2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl)oxymethyl]oxolane-3,4-diol",C1COP(=O)(OC1)OC[C@@H]2[C@H]([C@@H](C(O2)N3C=NC4=C(N=CN=C43)N)O)O,,,,,,
2485,132486,CID 132486,C[C@]1([C@H]([C@H]2[C@@H]([C@H](CC(=O)C2=C(O1)O)O)O)N)C(Cl)Cl,,,,,,
2486,132487,"1-[2-[4-[(2,3-Dihydro-5-methoxy-2alpha-phenyl-1H-inden)-1beta-yl]phenoxy]ethyl]pyrrolidine",COC1=CC2=C(C=C1)[C@H]([C@@H](C2)C3=CC=CC=C3)C4=CC=C(C=C4)OCCN5CCCC5,,,,,,
2487,132488,5-(4-Carboxyphenyl)azo-2-hydroxybenzeneacetic acid,C1=CC(=CC=C1C(=O)O)N=NC2=CC(=C(C=C2)O)CC(=O)O,,,,,,
2488,132489,"L-Prolinamide, 5-oxo-L-prolyl-L-norvalyl-",CCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N)NC(=O)[C@@H]2CCC(=O)N2,,,,,,
2489,132490,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1,3-dimethylbutyl)-",CC(C)CC(C)C1C(=O)NC(=O)NC1=O,,,,,,
2490,132491,CID 132491,COCC(CN1C=CN=C1N=[N+](C2=NC=CN2CC(COC)O)[O-])O,,,,,,
2491,132492,CID 132492,COCC(CN1C=CN=C1N=NC2=NC=CN2CC(COC)O)O,,,,,,
2492,132493,"N,N,N',N'-Tetrakis(2-hydroxy-3,5-dimethylbenzyl)ethylenediamine",CC1=CC(=C(C(=C1)CN(CCN(CC2=CC(=CC(=C2O)C)C)CC3=CC(=CC(=C3O)C)C)CC4=CC(=CC(=C4O)C)C)O)C,,,,,,
2493,132494,CID 132494,C[C@H]1[C@H](C(=O)N1S(=O)(=O)O)NC(=O)C(=NOCC2=C(NC3=CC(=O)C(=O)C=C3N2)C(=O)O)C4=CSC(=N4)N,,,,,,
2494,132495,CID 132495,C(CC(=O)O)[C@@H](C(=O)OC(=O)[C@H](CSC(=CCl)Cl)N)N,,,,,,
2495,132496,"N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide",CCCCCCN(CCCCCC)C(=O)CC1=C(NC2=CC=CC=C21)C3=CC=C(C=C3)F,,,,,,
2496,132497,"2,4,7-Triamino-6-(4-methanesulfonamidophenyl)pteridine",CS(=O)(=O)NC1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,,,,,,
2497,132498,"Pyrano(2,3-c)pyrazol-6(2H)-one, 2-((3-methoxyphenyl)methyl)-3,4-dimethyl-",COC1=CC=CC(=C1)CN2CC3=C(N2)OC(=O)C=C3,,,,,,
2498,132499,1-[1-(2-Chlorophenyl)-2-(dimethylamino)ethyl]cyclohexan-1-ol,CN(C)CC(C1=CC=CC=C1Cl)C2(CCCCC2)O,,,,,,
2499,132500,4-Nitrophenyl myo-inositol-1-phosphate,C1=CC(=CC=C1[N+](=O)[O-])OP(=O)(O)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@@H]2[O-])O)O)O)O.[NH4+],,,,,,
2500,132501,CID 132501,C1=CC(=CC=C1[N+](=O)[O-])OP(=O)(O)OC2[C@H]([C@H](C(C([C@@H]2O)O)O)O)O,,,,,,
2501,132502,CID 132502,CC1=CC(=O)C[C@@]([C@H]2[C@@H](C[C@]([C@@H]2C(=O)[C@@H](CC1)C(C)C)(C)O)O)(C)O,,,,,,
2502,132503,CID 132503,CC(C)CC(C1=C2C(=C3C=CC(=CC3=N2)Br)C=CN1)N,,,,,,
2503,132504,11-Ketofistularin 3,COC1=C(C(C2(CC(=NO2)C(=O)NCC(C3=CC(=C(C(=C3)Br)OCC(=O)CNC(=O)C4=NOC5(C4)C=C(C(=C(C5O)Br)OC)Br)Br)O)C=C1Br)O)Br,,,,,,
2504,132505,CID 132505,CN1CCN(CC1)C2=NC3=C(C=C2)NC(=N3)C4=CC=C5C(=NC(=N5)C6=CC=C(C=C6)OC)N4,,,,,,
2505,132506,"(1R,2S,4S,8R)-1-Methyl-2-(6-methylhept-5-en-2-yl)-5-oxatricyclo[6.3.1.04,12]dodecane-6,9-dione",CC(CCC=C(C)C)[C@@H]1C[C@H]2C3[C@@]1(CCC(=O)[C@@H]3CC(=O)O2)C,,,,,,
2506,132507,CID 132507,C1CCN(C1)C(=O)[C@H]([C@@H](C2=CC(=C(C=C2)O)O)O)NCCCC3=CC=C(C=C3)F.Br,,,,,,
2507,132508,CID 132508,C1CCN(C1)C(=O)C([C@@H](C2=CC(=C(C=C2)O)O)O)NCCCC3=CC=C(C=C3)F,,,,,,
2508,132509,CID 132509,CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1NC4=NC5=C(N4[C@H]6C[C@@H]([C@H](O6)CO)O)NC(=NC5=O)N,,,,,,
2509,132510,"20-(3-Hydroxy-3-methylbutoxy)pregna-5,7-diene-1,3-diol",CC([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(C(CC(C4)O)O)C)C)OCCC(C)(C)O,,,,,,
2510,132511,CID 132511,C[C@H]1CC[C@@]2([C@H]([C@]1(C)CCC(=CC[NH+]3CN(C4=NC=NC(=C43)N)C)C)CCC=C2COC(=O)C5=CC(=CN5)Br)C,,,,,,
2511,132512,"[(4aS,5R,6S,8aR)-5-[5-(6-amino-9-methyl-8H-purin-7-yl)-3-methylpent-3-enyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 4-bromo-1H-pyrrole-2-carboxylate",C[C@H]1CC[C@@]2([C@H]([C@]1(C)CCC(=CCN3CN(C4=NC=NC(=C43)N)C)C)CCC=C2COC(=O)C5=CC(=CN5)Br)C,,,,,,
2512,132513,5-Methyl-17-fluoroheptadecanoic acid,CC(CCCCCCCCCCCCF)CCCC(=O)O,,,,,,
2513,132514,Clausine F,CC(=CCC1=C2C3=CC=CC=C3NC2=C(C=C1C(=O)OC)O)C,,,,,,
2514,132515,"2-(Benzyl(phenyl)amino)ethyl-1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1-(2-morpholinoethyl)-4-(3-nitrophenyl)-3-pyridine carboxylate",CC1=C(C(C(=C(N1CCN2CCOCC2)C)P3(=O)OCC(CO3)(C)C)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OCCN(CC5=CC=CC=C5)C6=CC=CC=C6.Cl.Cl,,,,,,
2515,132516,"2,6-Dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1-(2-morpholinoethyl)-4-(3-nitrophenyl)-1,4-dihydro-3-pyridinecarboxylic acid 2-(benzylphenylamino)ethyl ester",CC1=C(C(C(=C(N1CCN2CCOCC2)C)P3(=O)OCC(CO3)(C)C)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OCCN(CC5=CC=CC=C5)C6=CC=CC=C6,,,,,,
2516,132517,CID 132517,CCN(CC)CCCCC1CCN(CC1)CC(=O)C2C=CC=C3C24C=CC=CN4CC(=O)CN3,,,,,,
2517,132518,"2-Methoxy-5-hydroxymethylcyclopentane-1,3,4-triol",COC1C(C(C(C1O)O)CO)O,,,,,,
2518,132519,Ilomastat,CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NC,,,,,,
2519,132520,CID 132520,CC1=C(C([N+](C(=N1)S)(C2CCN(CC2)CC3=CC=C(C=C3)F)C(=O)O)C4=CC=CC=C4C(F)(F)F)C(=O)OC(C)C,,,,,,
2520,132521,"1,6-Dihydroxy-2-methoxyanthraquinone",COC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=CC(=C3)O)O,,,,,,
2521,132522,"1-(Benzo(b)thiophen-5-yl)-2-(2-(N,N-diethylamino)ethoxy)ethanol hydrochloride",CCN(CC)CCOC[C@@H](C1=CC2=C(C=C1)SC=C2)O.Cl,,,,,,
2522,132523,(R)-1-(Benzo[b]thiophen-5-yl)-2-[2-(diethylamino)ethoxy]ethanol,CCN(CC)CCOC[C@@H](C1=CC2=C(C=C1)SC=C2)O,,,,,,
2523,132524,Triptoquinone A,CC1=C(CC[C@]2([C@H]1CCC3=C2C(=O)C=C(C3=O)C(C)C)C)C(=O)O,,,,,,
2524,132525,"5-Carboxy-2',7'-dichlorofluorescein",C1=CC2=C(C=C1C(=O)O)C(=O)OC23C4=CC(=C(C=C4OC5=CC(=C(C=C35)Cl)O)O)Cl,,,,,,
2525,132526,Tdpdp-onsu,C1CC(=O)N(C1=O)OC(=O)C(C(C2=CC(=CC=C2)C3(N=N3)C(F)(F)F)O)O,,,,,,
2526,132527,CID 132527,CC=CC=CC(=O)OCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OCCCCCCCCCCOC(=O)C=CC=CC,,,,,,
2527,132528,CID 132528,CC=CC=CC(=O)OCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OCCCCCCCCCCOC(=O)C=CC=CC,,,,,,
2528,132529,"2,3-Bis(tricosa-10,12-diynoxy)propyl 2-(trimethylazaniumyl)ethyl phosphate",CCCCCCCCCCC#CC#CCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OCCCCCCCCCC#CC#CCCCCCCCCCC,,,,,,
2529,132530,"2-[2,3-Bis(tricosa-10,12-diynoxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCC#CC#CCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OCCCCCCCCCC#CC#CCCCCCCCCCC,,,,,,
2530,132531,CID 132531,CC(C)N(C(C)C)[P@](OCCC#N)O[C@@H](CNC(=O)CCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC,,,,,,
2531,132532,"[(2S)-2,3-bis(tricosa-10,12-diynoxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate",CCCCCCCCCCC#CC#CCCCCCCCCCOC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OCCCCCCCCCC#CC#CCCCCCCCCCC,,,,,,
2532,132533,"2-[[(2S)-2,3-bis(tricosa-10,12-diynoxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCC#CC#CCCCCCCCCCOC[C@@H](COP(=O)(O)OCC[N+](C)(C)C)OCCCCCCCCCC#CC#CCCCCCCCCCC,,,,,,
2533,132534,N-Ethoxycarbonyl-7-oxostaurosporine,CCOC(=O)N(C)[C@@H]1C[C@H]2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C7=C53)[C@]([C@H]1OC)(O2)C)C(=O)NC6=O,,,,,,
2534,132535,"(1R,5R,9S)-9-(2-hydroxypropan-2-yl)-2,6-dimethylidenecyclodecane-1,5-diol",CC(C)([C@H]1CCC(=C)[C@@H](CCC(=C)[C@@H](C1)O)O)O,,,,,,
2535,132536,CID 132536,C1CN(CCN1CC=CC2=CC=CC=C2)C3C4=C(C=C(C=C4)F)OCC5=CC=CC=C35.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
2536,132537,"1-(3-Fluoro-6,11-dihydrobenzo[c][1]benzoxepin-11-yl)-4-(3-phenylprop-2-enyl)piperazine",C1CN(CCN1CC=CC2=CC=CC=C2)C3C4=C(C=C(C=C4)F)OCC5=CC=CC=C35,,,,,,
2537,132538,Imperialine 3-beta-D-glucoside,C[C@H]1CC[C@H]2[C@@]([C@@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4CC(=O)[C@@H]6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)(C)O,,,,,,
2538,132539,CID 132539,CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OC(=O)N(CCCl)CCCl)C3=CC=CC=C3,,,,,,
2539,132540,CID 132540,CCCNCC(C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O)O,,,,,,
2540,132541,"6,7-Dimethoxy-2-methylquinoxaline",CC1=NC2=CC(=C(C=C2N=C1)OC)OC,,,,,,
2541,132542,"[5-methyl-3-oxo-4-(4,5,7-trifluoro-1,3-benzothiazol-2-yl)-3,4-dihydro-2H-1,4-benzothiazin-2-yl]acetic acid",CC1=C2C(=CC=C1)SC(C(=O)N2C3=NC4=C(C(=CC(=C4S3)F)F)F)CC(=O)O,,,,,,
2542,132543,"2,6-Bis(1,1-dimethylethyl)-4-((3,7,11-trimethyldodecyl)thio)phenol",CC(C)CCCC(C)CCCC(C)CCSC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,,,,,,
2543,132544,N-((4-Cycloheptylaminopyrid-3-yl)sulfonyl)-N'-(cycloheptyl)urea,C1CCCC(CC1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC3CCCCCC3,,,,,,
2544,132545,2-Chloro-4-nitrophenylmaltoside,C1=CC(=C(C=C1[N+](=O)[O-])Cl)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,,,,,,
2545,132546,"7,8-Dihydroxyoctadec-9-enoic acid",CCCCCCCCC=CC(C(CCCCCC(=O)O)O)O,,,,,,
2546,132547,19-Hydroperoxy-20-hydroxyarachidic acid,C(CCCCCCCCC(CO)OO)CCCCCCCCC(=O)O,,,,,,
2547,132548,N-(2-aminoethyl)-N-[2-[3-(4-chlorophenyl)prop-2-enylamino]ethyl]isoquinoline-5-sulfonamide,C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)N(CCN)CCNCC=CC3=CC=C(C=C3)Cl,,,,,,
2548,132549,CID 132549,CCCCCCCCC=CCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,,,,,,
2549,132550,2-[Docos-13-enoxy(hydroxy)phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCC=CCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C,,,,,,
2550,132551,"1,5-Bis(3,4-dimethoxyphenyl)tetrahydropyran",COC1=C(C=C(C=C1)C2CCCC(O2)C3=CC(=C(C=C3)OC)OC)OC,,,,,,
2551,132552,N-Methyl-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indole-5-methanesulfonamide,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2C[C@H]3CCCN3C,,,,,,
2552,132553,N-Methyl-N-(2-pentyl)propargylamine,CCCC(C)N(C)CC#C,,,,,,
2553,132554,N-2-Hexyl-N-methylpropargylamine,CCCCC(C)N(C)CC#C,,,,,,
2554,132555,"2-Aminohexylamino-4-ethylamino-6-isopropylamino-1,3,5-triazine",CCNC1=NC(=NC(=N1)NC(C)C)NCCCCCCN,,,,,,
2555,132556,Bis(2-nitro-4-sulfophenyl) hexanedioate,C1=CC(=C(C=C1S(=O)(=O)O)[N+](=O)[O-])OC(=O)CCCCC(=O)OC2=C(C=C(C=C2)S(=O)(=O)O)[N+](=O)[O-],,,,,,
2556,132557,"3-[Dimethyl-[3-[4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinolin-1-ium-1-yl]propyl]azaniumyl]propyl-dimethyl-[3-[4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinolin-1-ium-1-yl]propyl]azanium;tetraiodide",CN1C2=CC=CC=C2SC1=CC3=CC=[N+](C4=CC=CC=C34)CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+]5=CC=C(C6=CC=CC=C65)C=C7N(C8=CC=CC=C8S7)C.[I-].[I-].[I-].[I-],,,,,,
2557,132558,"3-[Dimethyl-[3-[4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinolin-1-ium-1-yl]propyl]azaniumyl]propyl-dimethyl-[3-[4-[(3-methyl-1,3-benzothiazol-2-ylidene)methyl]quinolin-1-ium-1-yl]propyl]azanium",CN1C2=CC=CC=C2SC1=CC3=CC=[N+](C4=CC=CC=C34)CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+]5=CC=C(C6=CC=CC=C65)C=C7N(C8=CC=CC=C8S7)C,,,,,,
2558,132559,Neoalsogenin A,C[C@]12CC[C@@H]([C@H]1[C@@H](C[C@H]3[C@H]2CCC4[C@@]3(CCC(C4(C)C)O)C)O)[C@@]5(CC(C(O5)C(C)(C)O)O)C,,,,,,
2559,132560,"3-Methyl-3,4-epoxybutyl diphosphate",CC1(CO1)CCOP(=O)(O)OP(=O)(O)O,,,,,,
2560,132561,CID 132561,C[C@@H]([C@@H](C1=CN=C2C(=N1)C(=O)N=C(N2)NCCCN)O)O,,,,,,
2561,132562,"2-Ethyl-4-((2'-(1H-1,2,3,4-tetrazol-5-yl)biphenyl-4-yl)methoxy)quinoline hydrochloride",CCC1=NC2=CC=CC=C2C(=C1)OCC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,,,,,,
2562,132563,Cynanester A,CCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@@H]4[C@H]5[C@@H](CC[C@@]5(CC[C@]4([C@@]3(CC[C@H]2C1(C)C)C)C)C)C(=C)C)C,,,,,,
2563,132564,"1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano(3,2-e)indole",CN1C=C(C2=C1C=CC3=C2CCCO3)CCN,,,,,,
2564,132565,"6,7-Dimethoxy-1-(3,4-dimethoxyphenyl)-3-hydroxymethyl-3,4-dihydroisoquinoline",COC1=CC(=CC(=C1)C2=N[C@@H](CC3=CC(=C(C=C32)OC)OC)CO)OC,,,,,,
2565,132566,CID 132566,C1=CC(=C(C=C1CCC(=O)O)C(=NCC(=O)O)CCC(=NCC(=O)O)C2=C(C=CC(=C2)CCC(=O)O)O)O,,,,,,
2566,132567,Curculigoside B,COC1=CC=CC(=C1C(=O)OCC2=C(C=CC(=C2)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
2567,132568,Curculigine C,CC1=C(C(=C(C(=C1Cl)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O)O)O)Cl)OC)Cl,,,,,,
2568,132569,"methyl (1S,2R,4aS,8aR)-2-[(2R)-2-hydroxybutyl]-3-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylate",CC[C@H](C[C@@H]1[C@H]([C@@H]2CCCC[C@@H]2C=C1C)C(=O)OC)O,,,,,,
2569,132570,"9,11-Sthceo",C[C@H](CCCC(C)C)[C@H]1CCC([C@]1(C)CCO)C2=CC(C3CC(CC[C@@]3(C2=O)C)O)O,,,,,,
2570,132571,"9,11-Symco",C[C@H](CCC(=C)C(C)C)[C@H]1CCC([C@]1(C)CCO)C2=CC(C3CC(CC[C@@]3(C2=O)C)O)O,,,,,,
2571,132572,3-Deoxy-2-octulosonate-4-phosphate,C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)OP(=O)(O)O)C(=O)C(=O)O,,,,,,
2572,132573,"[1-[(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-2-pyridin-1-ium-1-ylethyl]phosphonic acid",C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CCC(C4)C(C[N+]5=CC=CC=C5)P(=O)(O)O)C)C,,,,,,
2573,132574,CID 132574,C1=CC=NC(=C1)SSCCC(=O)NCCCCN=C(C2=CC=C(C=C2)N[N+]#N)[O-],,,,,,
2574,132575,CID 132575,C1=CC=NC(=C1)SSCCC(=O)NCCCCNC(=O)C2=CC=C(C=C2)N[N+]#N,,,,,,
2575,132576,CID 132576,CC1C=C(C(C(C1(C2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3C)C)C(=O)O)OC)C)OC)C)C(=O)[O-])O)(C)CC4=C(C=C(C(=C4O)C(=O)OC5=C(C(=C(C(=C5C)C)C(=O)OC6=C(C(=C(C(=C6C)C)C(=O)O)OC)C)OC)C)C)O)O,,,,,,
2576,132577,CID 132577,CC1C=C(C(C(C1(C2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3C)C)C(=O)O)OC)C)OC)C)C(=O)O)O)(C)CC4=C(C=C(C(=C4O)C(=O)OC5=C(C(=C(C(=C5C)C)C(=O)OC6=C(C(=C(C(=C6C)C)C(=O)O)OC)C)OC)C)C)O)O,,,,,,
2577,132578,Methyl 4-O-alpha-D-mannopyranosyl-beta-D-mannopyranoside,CO[C@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
2578,132579,"5-Amino-10-dimethylamino-2-(2-furanyl)-(1,2,4)triazolo(1,5-c)quinazoline-bis mesylate",CN(C)C1=CC=CC2=C1C3=NC(=NN3C(=N2)N)C4=CC=CO4.CS(=O)(=O)O.CS(=O)(=O)O,,,,,,
2579,132580,"2-(furan-2-yl)-10-N,10-N-dimethyl-[1,2,4]triazolo[1,5-c]quinazoline-5,10-diamine",CN(C)C1=CC=CC2=C1C3=NC(=NN3C(=N2)N)C4=CC=CO4,,,,,,
2580,132581,"4-(3,4,4-Trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile",CC1(C(=O)N(C(=S)N1C)C2=CC(=C(C=C2)C#N)C(F)(F)F)C,,,,,,
2581,132582,(4S)-4-amino-6-methylhept-2-enoic acid,CC(C)C[C@@H](C=CC(=O)O)N,,,,,,
2582,132583,4-Cdpca,CCC1(C(N(C1=O)C(=O)NCC2=CC=CC=C2)OC3=CC=C(C=C3)C(=O)O)CC,,,,,,
2583,132584,"1,4-Dimethoxy-2-methyl-5-(2-nitroprop-1-enyl)benzene",CC1=CC(=C(C=C1OC)C=C(C)[N+](=O)[O-])OC,,,,,,
2584,132585,CID 132585,CC(=CCCC(=CCCC(=CCO[C@H]1[C@H]([C@@H]([C@@H](CO1)O[C@H]2[C@H]([C@@H]([C@@H](CO2)O)O)OC(=O)C)OC(=O)C)OC(=O)C)C)C)C,,,,,,
2585,132586,CID 132586,CC(C)C[C@H](C(=O)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)NC(CC2=CC=CC=C2)C=O,,,,,,
2586,132587,CID 132587,C[C@@H](C(=O)N[C@H](CCC(=O)N)C(=O)N[C@@H](CCCCN=C(NC1=CC(=C(C=C1)C2=C3C=CC(=O)C=C3OC4=C2C=CC(=C4)O)C(=O)O)S)C(=O)O)NC(=O)C(C)O[C@@H]5[C@H]([C@H](O[C@@H]([C@H]5O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)NC(=O)C)CO)O)NC(=O)C,,,,,,
2587,132588,2'-Aminoethylphosphoryl(-6)-N-acetylglucosamine,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)COP(=O)(O)OCCN)O)O,,,,,,
2588,132589,"3-Isoquinolinecarboxamide, 1-(5-(((3',6'-dihydroxy-3-oxospiro(isobenzofuran-1(3H),9'-(9H)xanthen)-5-yl)carbonyl)amino)-2-fluorophenyl)-N-methyl-N-(1-methylpropyl)-",CCC(C)N(C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=C(C=CC(=C3)NC(=O)C4=CC5=C(C=C4)C6(C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)OC5=O)F,,,,,,
2589,132590,4-Bromo-6-nitroquipazine,C1CN(CCN1)C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)Br,,,,,,
2590,132591,Mhmocac,COC(=O)N1CCC2=CC3=C(C=C2C4C1=CC(=O)C4)OCO3,,,,,,
2591,132592,Tpch2NHPPG,C1C[C@H](N(C1)CC(CC2=CC=CC=C2)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC4=CC=C(C=C4)O)N)C(=O)NCC(=O)O,,,,,,
2592,132593,CID 132593,COC1=CC(=O)C2=C(C3=C(C=CC(=C3OC2=C1)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)O,,,,,,
2593,132594,Uralenneoside,C1[C@H]([C@@H]([C@H]([C@@H](O1)OC(=O)C2=CC(=C(C=C2)O)O)O)O)O,,,,,,
2594,132595,Httod-BK,C1CC[C@H]2[C@@H](C1)C[C@@H](N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)N[C@@H](CC5=CC=CS5)C(=O)N(C(=O)CNC(=O)[C@@H]6C[C@@H](CN6)O)C(=O)[C@@H]7CCCN7C(=O)[C@H](CCCN=C(N)N)N)C(=O)O,,,,,,
2595,132596,"Tetralithium 1,4,5,8-naphthalenetetracarboxylate",[Li+].[Li+].[Li+].[Li+].C1=CC(=C2C(=CC=C(C2=C1C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-],,,,,,
2596,132597,"Pyrano(2,3-c)pyrazol-6(2H)-one, 3,4-dimethyl-2-(2-thienylmethyl)-",CC1=CC(=O)OC2=NN(C(=C12)C)CC3=CC=CS3,,,,,,
2597,132598,"1H-Pyrido(4,3-b)indole, 2,3,4,5-tetrahydro-8-methoxy-2-(phenylmethyl)-, monohydrochloride",COC1=CC2=C(C=C1)NC3=C2CN(CC3)CC4=CC=CC=C4.Cl,,,,,,
2598,132599,"2-Benzyl-8-methoxy-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indole",COC1=CC2=C(C=C1)NC3=C2CN(CC3)CC4=CC=CC=C4,,,,,,
2599,132600,"5H-Cyclooct(b)indole, 6,7,8,9,10,11-hexahydro-5-(3-(4-(2-methylphenyl)-1-piperazinyl)propyl)-, dihydrochloride",CC1=CC=CC=C1N2CCN(CC2)CCCN3C4=C(CCCCCC4)C5=CC=CC=C53.Cl.Cl,,,,,,
2600,132601,"5-[3-[4-(2-Methylphenyl)piperazin-1-yl]propyl]-6,7,8,9,10,11-hexahydrocycloocta[b]indole",CC1=CC=CC=C1N2CCN(CC2)CCCN3C4=C(CCCCCC4)C5=CC=CC=C53,,,,,,
2601,132602,Tmc-aea,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@@H](C4)C(=O)NCC[N+](C)(C)C)C)C.[I-],,,,,,
2602,132603,"2-[[(3S,10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carbonyl]amino]ethyl-trimethylazanium",C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@@H](C4)C(=O)NCC[N+](C)(C)C)C)C,,,,,,
2603,132604,CID 132604,C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CN=CN3)N)O,,,,,,
2604,132605,Arginyl-glycyl-aspartyl-tryptophan,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N,,,,,,
2605,132606,CID 132606,C[C@H](CCC=C(C)C(=O)OC)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
2606,132607,"3-((4-Azidophenyl)sulfonyl)-2-((4-iodophenyl)methyl)-alpha,alpha-dimethyl-5-(2-quinolinylmethoxy)-1H-indole-2-propanoic acid",CC(C)(CC1=C(C2=C(N1CC3=CC=C(C=C3)I)C=CC(=C2)OCC4=NC5=CC=CC=C5C=C4)S(=O)(=O)C6=CC=C(C=C6)N=[N+]=[N-])C(=O)O,,,,,,
2607,132608,Distel,CC1=C2C=CN=C(C2=C(C3=C1NC4=C3C=C(C=C4)OC)C)NCCCNC(=O)C5=CC(=CN5C)NC(=O)C6=CC(=CN6C)NC(=O)C7=CC(=CN7C)NC=O,,,,,,
2608,132609,Acodpr-PC,CCCCCCCCCCCCCCCCCCOCC(CP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C,,,,,,
2609,132610,2-[(2-Acetyloxy-3-octadecoxypropyl)-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCOCC(CP(=O)(O)OCC[N+](C)(C)C)OC(=O)C,,,,,,
2610,132611,(2-Methoxy-3-octadecoxypropyl)-[2-(trimethylazaniumyl)ethoxy]phosphinate,CCCCCCCCCCCCCCCCCCOCC(CP(=O)([O-])OCC[N+](C)(C)C)OC,,,,,,
2611,132612,2-[Hydroxy-(2-methoxy-3-octadecoxypropyl)phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCCOCC(CP(=O)(O)OCC[N+](C)(C)C)OC,,,,,,
2612,132613,2-O-(6-O-glycero-manno-Heptopyranosyl-glucopyranosyl)glucopyranose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)[C@@H](CO)O)O)O)O)O)O)O)O)O)O,,,,,,
2613,132614,4'-Amidinophenyl-4-chloroanthranilic acid,C1=CC(=CC=C1C(=N)N)NC2=C(C=CC(=C2)Cl)C(=O)O,,,,,,
2614,132615,Adipostatin B,CC(C)CCCCCCCCCCCCC1=CC(=CC(=C1)O)O,,,,,,
2615,132616,"6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-((1-carboxy-3-(4-hydroxyphenyl)propyl)amino)octahydro-10-oxo-, (1S-(1alpha,9alpha(R*)))-",C1C[C@@H](C(=O)N2[C@@H](CCCN2C1)C(=O)O)N[C@@H](CCC3=CC=C(C=C3)O)C(=O)O,,,,,,
2616,132617,N-Bromoacetyl-phenylalanyl-leucyl-glutamyl-glutamyl-leucyl-tyrosine,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CBr,,,,,,
2617,132618,1-Benzyl-4-(2-(4-(benzoylamino)phthalimido)ethyl)piperidine monohydrochloride,C1CN(CCC1CCN2C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)C4=CC=CC=C4)CC5=CC=CC=C5.Cl,,,,,,
2618,132619,1-Benzyl-4-(2-(4-(benzoylamino)phthalimido)ethyl)piperidine,C1CN(CCC1CCN2C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)C4=CC=CC=C4)CC5=CC=CC=C5,,,,,,
2619,132620,"6-(N,S-Dimethyl-N'-cyanoisothioureidomethyl)-6,11-dihydro-5H-dibenz(b,e)azepine",CN(CC1C2=CC=CC=C2CC3=CC=CC=C3N1)C(=NC#N)SC.Cl,,,,,,
2620,132621,"methyl N'-cyano-N-(6,11-dihydro-5H-benzo[c][1]benzazepin-6-ylmethyl)-N-methylcarbamimidothioate",CN(CC1C2=CC=CC=C2CC3=CC=CC=C3N1)C(=NC#N)SC,,,,,,
2621,132622,3-Fluoropropanesulfonate,C(CF)CS(=O)(=O)[O-],,,,,,
2622,132623,3-Fluoropropane-1-sulfonic acid,C(CF)CS(=O)(=O)O,,,,,,
2623,132624,2-[(Cyclo-hexylmethylene)hydrazino] adenosine,C1CCC(CC1)C=NNC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,,,,,,
2624,132625,17alpha-Acetoxy-3beta-((beta-D-glucopyranosyl)oxy)-6alpha-methylpregn-4-en-20-one,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=C[C@H](CC4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C,,,,,,
2625,132626,Cholecystokinin-J,CCCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(=O)O)C(=O)OCCC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)OS(=O)(=O)O)NC(=O)OC(C)(C)C,,,,,,
2626,132627,CID 132627,CC1=C(C(=CC2=C1C3=C(C(=O)CCCC3=O)C(=O)O2)C(=O)[C@H](C)N)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](C)N,,,,,,
2627,132628,"9-(Methoxymethyl)-2,2,5a-trimethyloctahydro-2H-3,9a-methano-1-benzoxepine",C[C@]12CCC[C@@H](C13C[C@@H](CC2)C(O3)(C)C)COC,,,,,,
2628,132629,2-(Diphenylmethyl)-N-((2-iodophenyl)methyl)-3-quinuclidinamine,C1CN2CCC1[C@H]([C@H]2C(C3=CC=CC=C3)C4=CC=CC=C4)NCC5=CC=CC=C5I,,,,,,
2629,132630,"5-(2,3,5-Trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate",CCS(=O)(=O)O.C1=C(C=C(C(=C1C2=CN=C(N=C2N)N)Cl)Cl)Cl,,,,,,
2630,132631,"5-(2,3,5-Trichlorophenyl)pyrimidine-2,4-diamine",C1=C(C=C(C(=C1C2=CN=C(N=C2N)N)Cl)Cl)Cl,,,,,,
2631,132632,Tyrosyl-prolyl-tryptophyl-glycinamide,C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N,,,,,,
2632,132633,CID 132633,CCOC(=O)N[C@@H](CC(C)C)C(=O)NC(=O)[C@@H](CC(C)C)N[C@H](CC1CCCCC1)C([C@H](C(C)C)O)O,,,,,,
2633,132634,"(3S,5R)-7-[4,5-bis(4-fluorophenyl)-2-propan-2-ylimidazol-1-yl]-3,5-dihydroxyhept-6-enoic acid",CC(C)C1=NC(=C(N1C=C[C@@H](C[C@@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)F,,,,,,
2634,132635,"[2,2-dimethylpropanoyloxymethoxy-[[(2S,5R)-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxymethyl 2,2-dimethylpropanoate",CC(C)(C)C(=O)OCOP(=O)(OC[C@@H]1CC[C@@H](O1)N2C=CC(=O)NC2=O)OCOC(=O)C(C)(C)C,,,,,,
2635,132636,CID 132636,CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N,,,,,,
2636,132637,"3-Hydroxycholest-8(14),24-dien-15-one",C[C@H](CCC=C(C)C)[C@H]1CC(=O)C2=C3CC[C@H]4C[C@H](CC[C@@]4([C@H]3CC[C@]12C)C)O,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
2637,132638,Phenylalanyl-arginyl-valyl-phenylalanine,CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=CC=C2)N,,,,,,
2638,132639,4-(Bis(2-chloroethyl)amino)-L-phenylalanine 2-((1-oxohexadecyl)oxy)-1-(((1-oxohexadecyl)oxy)methyl)ethyl ester,CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)[C@H](CC1=CC=C(C=C1)N(CCCl)CCCl)N,,,,,,
2639,132640,3-Phenyl-5-(2-(1-pyrrolidinylmethyl)butyryl)isoxazole hydrochloride,CCC(CN1CCCC1)C(=O)C2=CC(=NO2)C3=CC=CC=C3.Cl,,,,,,
2640,132641,3-Phenyl-5-[2-(pyrrolizinomethyl)butyryl]isoxazole,CCC(CN1CCCC1)C(=O)C2=CC(=NO2)C3=CC=CC=C3,,,,,,
2641,132642,"2,6-Ditert-butyl-4-[3-(3,5-ditert-butyl-4-hydroxyphenoxy)propoxy]phenol",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)OCCCOC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,,,,,
2642,132643,"9-((3-Methoxyphenyl)amino)-7-methyl-1H-pyrazolo(3,4-f)quinoline",CC1=CC(=C2C(=N1)C=CC3=C2NN=C3)NC4=CC(=CC=C4)OC.Cl,,,,,,
2643,132644,"7-Methyl-9-[[3-methoxyphenyl]amino]-1H-pyrazolo[3,4-f]quinoline",CC1=CC(=C2C(=N1)C=CC3=C2NN=C3)NC4=CC(=CC=C4)OC,,,,,,
2644,132645,CID 132645,C[C@@H](C(=O)N[C@H](C)C(=O)N1CCC[C@H]1C(=O)C2(C(=O)CCC2=O)N(C(C)C)C(=O)OC3=CC=C(C=C3)[N+](=O)[O-])N,,,,,,
2645,132646,Idpm-C5MI,CC1(OC2C(CC(C2O1)C3=CC(=O)NC3=O)COC(=O)C(C)(C)C)C,,,,,,
2646,132647,2-(N-Bis(2-pyrenylethyl)methylamino)ethanol,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)CCC(CCC5=C6C=CC7=CC=CC8=C7C6=C(C=C8)C=C5)NCCO,,,,,,
2647,132648,"N,N'-1,4-Butanediylbis(N-(3-(((1,6-dihydro-1-hydroxy-6-oxo-2-pyridinyl)carbonyl)amino)propyl)-1,6-dihydro-1-hydroxy-6-oxo-2-pyridinecarboxamide",C1=CC(=O)N(C(=C1)C(=O)NCCCN(CCCCN(CCCNC(=O)C2=CC=CC(=O)N2O)C(=O)C3=CC=CC(=O)N3O)C(=O)C4=CC=CC(=O)N4O)O,,,,,,
2648,132649,CID 132649,CC1=NC=C(C(=O)N1)CN(C=O)C(=C(CCOC(=O)C2=CN=CC=C2)SSC(=C(C)N(CC3=CN=C(NC3=O)C)C=O)CCOC(=O)C4=CN=CC=C4)C,,,,,,
2649,132650,Methyl 7-[3-hydroxy-2-(3-hydroxy-3-methyl-4-phenoxybut-1-ynyl)-5-oxocyclopentyl]heptanoate,CC(COC1=CC=CC=C1)(C#CC2C(CC(=O)C2CCCCCCC(=O)OC)O)O,,,,,,
2650,132651,"3,7-Diamino-2-hydroxyheptanoyl-leucyl-proline",CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)NC(=O)C([C@@H](CCCCN)N)O,,,,,,
2651,132652,3-Pivaloylepinephrine,CC(C)(C)C(=O)OC1=C(C=CC(=C1)[C@H](CNC)O)O,,,,,,
2652,132653,"1,2,3-Tristriphenylethylaminopropane",C1=CC=C(C=C1)C(CNCC(CNCC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)NCC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)(C8=CC=CC=C8)C9=CC=CC=C9,,,,,,
2653,132654,CID 132654,CC(C)(C)C1=CC=C(C=C1)NC2=CC3=C(C=C2)C=C(C=C3)S(=O)(=O)[O-].[Na+],,,,,,
2654,132655,"2-Naphthalenesulfonic acid, 6-[[4-(1,1-dimethylethyl)phenyl]amino]-",CC(C)(C)C1=CC=C(C=C1)NC2=CC3=C(C=C2)C=C(C=C3)S(=O)(=O)O,,,,,,
2655,132656,Adenosine 3'-phosphate phenyl ester,C1=CC=C(C=C1)OP(=O)(O)O[C@@H]2[C@H](O[C@H]([C@@H]2O)N3C=NC4=C(N=CN=C43)N)CO,,,,,,
2656,132657,CID 132657,C1CN2CCC1C(C2)C3=CN=CC(=N3)Cl.C(=CC(=O)O)C(=O)O,,,,,,
2657,132658,3-(6-Chloropyrazin-2-YL)quinuclidine,C1CN2CCC1C(C2)C3=CN=CC(=N3)Cl,,,,,,
2658,132659,4-Chloro-2-(2-hydroxy-3-morpholinopropyl)-5-phenyl-4-isoxazolin-3-one,C1COCCN1C[C@H](CN2C(=O)C(=C(O2)C3=CC=CC=C3)Cl)O.Cl,,,,,,
2659,132660,CS-722 (Free base),C1COCCN1C[C@H](CN2C(=O)C(=C(O2)C3=CC=CC=C3)Cl)O,,,,,,
2660,132661,Seryl-lysyl-prolyl-tyrosyl-methionyl-arginyl-phenylalaninamide,CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N,,,,,,
2661,132662,Aphepds,CC(=O)N[C@H](CC1=CC=CC=C1)C(=O)OCCSSC2=CC=CC=N2,,,,,,
2662,132663,Adenosine kinase inhibitor GP515,C1=NC(=C2C(=N1)N(N=C2Br)[C@H]3[C@@H]([C@@H]([C@H](O3)CN)O)O)N,,,,,,
2663,132664,"3,11,17-Trioxoandrostane-5-carbonitrile",C[C@]12CCC(=O)C[C@@]1(CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4=O)C)C#N,,,,,,
2664,132665,CID 132665,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)(O)O)O)CC=CNC(=O)CBr,,,,,,
2665,132666,CID 132666,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3C2)N)C(=O)OC)C)C)O)O)O.Cl,,,,,,
2666,132667,"methyl (3S,8R,9S,10S,13R,14S,17S)-14-amino-10,13-dimethyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-17-carboxylate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3C2)N)C(=O)OC)C)C)O)O)O,,,,,,
2667,132668,Methyldichlorobenzene sulfonate,COS(=O)(=O)C1=C(C=CC(=C1)Cl)Cl,,,,,,
2668,132669,"1,2-Ethanediamine, N'-(10-(4-chlorophenyl)-3-((4-chlorophenyl)amino)-2(10H)-phenazinylidene)-N,N-diethyl-",CCN(CC)CCN=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,,,,,,
2669,132670,2-Amino-4-picoline palladium chloride,CC1=CC(=NC=C1)N.CC1=CC(=NC=C1)N.[Cl-].[Cl-].[Pd+2],,,,,,
2670,132671,"1-Naphthalenesulfonamide, N-(8-aminooctyl)-5-(dimethylamino)-",CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCCCCCCN,,,,,,
2671,132672,1-(2-(Bis(4-fluorophenyl)methoxy)ethyl)-4-(3-(4-fluorophenyl)propyl)piperazine dimethanesulfonate,CS(=O)(=O)O.CS(=O)(=O)O.C1CN(CCN1CCCC2=CC=C(C=C2)F)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,,,,,
2672,132673,1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-[3-(4-fluorophenyl)propyl]piperazine,C1CN(CCN1CCCC2=CC=C(C=C2)F)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,,,,,
2673,132674,CID 132674,C1=CC=C(C(=C1)C(=NCC(=O)NN)[O-])N[N+]#N,,,,,,
2674,132675,CID 132675,C1=CC=C(C(=C1)C(=O)NCC(=O)NN)N[N+]#N,,,,,,
2675,132676,1-[[1-(4-azido-3-iodophenyl)-2-methylpropan-2-yl]amino]-3-(1H-indol-4-yloxy)propan-2-ol,CC(C)(CC1=CC(=C(C=C1)N=[N+]=[N-])I)NCC(COC2=CC=CC3=C2C=CN3)O,,,,,,
2676,132677,Zomebazam,CC1=NN(C2=C1N(C(=O)CC(=O)N2C)C3=CC=CC=C3)C,,,,,,
2677,132678,[2-Methoxy-4-(2-nitroethenyl)phenyl] propanoate,CCC(=O)OC1=C(C=C(C=C1)C=C[N+](=O)[O-])OC,,,,,,
2678,132679,Diacetylspermine,CC(=O)NCCCNCCCCNCCCNC(=O)C.Cl.Cl,,,,,,
2679,132680,"N1,N12-Diacetylspermine",CC(=O)NCCCNCCCCNCCCNC(=O)C,,,,,,
2680,132681,"Isoquinolinium, 3-(1,3-benzodioxol-5-yl)-6,7-dimethoxy-2-methyl-, chloride",C[N+]1=CC2=CC(=C(C=C2C=C1C3=CC4=C(C=C3)OCO4)OC)OC.[Cl-],,,,,,
2681,132682,"3-(1,3-Benzodioxol-5-yl)-6,7-dimethoxy-2-methylisoquinolin-2-ium",C[N+]1=CC2=CC(=C(C=C2C=C1C3=CC4=C(C=C3)OCO4)OC)OC,,,,,,
2682,132683,CID 132683,CCCCCCC(C(C)O)N1C=NC(=C1C=C)CN,,,,,,
2683,132684,CID 132684,CC1C(=O)N(C(=NN=C2N(C(=O)C(S2)OP(=O)([O-])OC)C)S1)CC(=C)C.[Na+],,,,,,
2684,132685,"Phosphoric acid, monomethyl mono(3-methyl-2-((5-methyl-3-(2-methyl-2-propenyl)-4-oxo-2-thiazolidinylidene)hydrazono)-4-oxo-5-thiazolidinyl) ester",CC1C(=O)N(C(=NN=C2N(C(=O)C(S2)OP(=O)(O)OC)C)S1)CC(=C)C,,,,,,
2685,132686,CID 132686,CN=C(NN=C1N(C(=O)CS1)CC=C)S,,,,,,
2686,132687,"7-[(1S,2R,3S,4R)-3-(3-hydroxy-4-phenylpent-1-enyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid",CC(C1=CC=CC=C1)C(C=C[C@@H]2[C@H]3CC[C@@H]([C@@H]2CC=CCCCC(=O)O)O3)O,,,,,,
2687,132688,"4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-(2-(2-methylpropoxy)ethoxy)phenoxy)propyl)amino)ethyl)-",CC(C)COCCOC1=CC=C(C=C1)OCC(CNCCNC(=O)N2CCOCC2)O,,,,,,
2688,132689,CID 132689,CCCCCCCC[C@@H](C=CC=CC=C[C@@H](CCCC(=O)O)O)O,,,,,,
2689,132690,"2-Hydroxy-6-oxo-6-(4'-chlorophenyl)-hexa-2,4-dienoate",C1=CC(=CC=C1C(=CC=CC(=O)C(=O)O)O)Cl,,,,,,
2690,132691,CID 132691,C=CC=C1CCC(O1)C2=NCCN2,,,,,,
2691,132692,Dppd-phos 2-oxide,C=CCP1(=O)OC(CC(O1)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
2692,132693,"4-Piperidinemethanol, 1-(2-(2,6-dimethylphenoxy)ethyl)-alpha,alpha-bis(4-fluorophenyl)-",CC1=C(C(=CC=C1)C)OCCN2CCC(CC2)C(C3=CC=C(C=C3)F)(C4=CC=C(C=C4)F)O,,,,,,
2693,132694,"[(2S,3R,4S,5R)-2-[(2S,3R,4S,5S)-3-acetyloxy-2-[[(3R,8S,9R,10R,13S,14R,16R,17S)-3,17-dihydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxyoxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate",C[C@H](C(=O)CCC(C)C)[C@]1([C@@H](C[C@H]2[C@@]1(CC[C@@H]3[C@@H]2CC=C4[C@@]3(CC[C@H](C4)O)C)C)O[C@H]5[C@@H]([C@H]([C@H](CO5)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)OC(=O)C7=CC=C(C=C7)OC)OC(=O)C)O,,,,,,
2694,132695,Alanyl-phosphothreonyl-phosphotyrosyl-seryl-alanine,C[C@H]([C@@H](C(=O)[C@](C(C(=O)[C@H](C)N)P(=O)(O)O)(C(=O)O)N(C(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)P(=O)(O)O)N)O,,,,,,
2695,132696,CID 132696,C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](C)N)O,,,,,,
2696,132697,8-Methyl-8-azabicyclo(3.2.1)oct-3-yl 2-(n-propyloxy)-4-quinolinecarboxylate,CCCOC1=NC2=CC=CC=C2C(=C1)C(=O)OC3CC4CCC(C3)N4C,,,,,,
2697,132698,9-Hydroxy-9-pivaloylfluorene,CC(C)(C)C(=O)C1(C2=CC=CC=C2C3=CC=CC=C31)O,,,,,,
2698,132699,CID 132699,CCC1C=CC(=O)OC1C=CC(CCN)(C(CC(C=CC=CC2CCCC(C2)OC(=O)CCCCC(C)CC)O)OP(=O)(O)O)O,,,,,,
2699,132700,"3,4-Dihydroxy-5-(1,2,3,4,5-pentahydroxy-6,20-dimethylhenicosa-8,10,14,16-tetraenyl)oxolan-2-one",CC(C)CCC=CC=CCCC=CC=CCC(C)C(C(C(C(C(C1C(C(C(=O)O1)O)O)O)O)O)O)O,,,,,,
2700,132701,"N-(5,6'-dihydroxyspiro[3H-furan-2,2'-4,8-dioxatricyclo[5.1.0.03,5]octane]-4-yl)-4,6-dimethyldodeca-2,4-dienamide",CCCCCCC(C)C=C(C)C=CC(=O)NC1=C(OC2(C1)C3C(O3)C(C4C2O4)O)O,,,,,,
2701,132702,"N-[5,6'-dihydroxy-6'-(2-oxopropyl)spiro[3H-furan-2,2'-4,8-dioxatricyclo[5.1.0.03,5]octane]-4-yl]-4,6-dimethyldodeca-2,4-dienamide",CCCCCCC(C)C=C(C)C=CC(=O)NC1=C(OC2(C1)C3C(O3)C(C4C2O4)(CC(=O)C)O)O,,,,,,
2702,132703,N-Benzyl-4-hydroxymethylaniline,C1=CC=C(C=C1)CNC2=CC=C(C=C2)CO,,,,,,
2703,132704,"Octadeca-6,8,10,12-tetraenoic acid",CCCCCC=CC=CC=CC=CCCCCC(=O)O,,,,,,
2704,132705,CID 132705,C[C@@]12[C@@H]([C@@H]([C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)O)OC,,,,,,
2705,132706,Forasartan,CCCCC1=NN(C(=N1)CCCC)CC2=CN=C(C=C2)C3=CC=CC=C3C4=NNN=N4,['For the treatment of hypertension.'],"['Forasartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. By inhibiting angiotensin II receptors, this drug leads to a decrease in sodium reabsorption (which decreases water content of blood) and a decrease in vasoconstriction. Combined, this has the effect of lowering blood pressure.']",,,,
2706,132707,Thrombin receptor peptide sfllrnp,CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)N,,,,,,
2707,132708,"Benzenepropanoic acid, 4-hydroxy-alpha-(2-((3-(hydroxyamino)-3-oxo-1-(phenylmethyl)propyl)amino)-2-oxoethyl)-3-iodo-",C1=CC=C(C=C1)CC(CC(=O)NO)NC(=O)CC(CC2=CC(=C(C=C2)O)I)C(=O)O,,,,,,
2708,132709,(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-methylamino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pentanediamide,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)N(C)C(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
2709,132710,CID 132710,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)NCCN=C(C3=C(C(=C(C(=C3F)F)N[N+]#N)F)F)[O-])COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
2710,132711,CID 132711,C1[C@@H]([C@H](O[C@@H]1N2C=CC(=NC2=O)NCCNC(=O)C3=C(C(=C(C(=C3F)F)N[N+]#N)F)F)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
2711,132712,"Pentanamide, N-(3-(1-(2-(8-chloro-5,6-dihydro-6-oxo-11H-pyrido(2,3-b)(1,4)benzodiazepin-11-yl)-2-oxoethyl)-4-piperidinyl)propyl)-N-ethyl-2,2-dimethyl-",CCCC(C)(C)C(=O)N(CC)CCCC1CCN(CC1)CC(=O)N2C3=C(C=C(C=C3)Cl)C(=O)NC4=C2N=CC=C4,,,,,,
2712,132713,"O-(11-(5-Cholesten-3-yloxy)3,6,9-trioxaundecyl) O-(2-(galactopyranosyloxy)ethyl) phosphorothioate",C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@H](C4)OCCOCCOCCOCCOP(=S)(O)OCCO[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)C)C,,,,,,
2713,132714,"6,14-Dihydroxy-6-(hydroxymethyl)-5-methyl-5,6,7,8-tetrahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacene-13,15(14H)-dione",C[C@@]12[C@](C[C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(=O)N(C6=O)O)(CO)O,,,,,,
2714,132715,3-(2-(Benzoxazol-2-yl)-ethyl)-5-(1-hydroxyethyl)-6-methylpyridin-2(1H)-one,CC1=C(C=C(C(=O)N1)CCC2=NC3=CC=CC=C3O2)C(C)O,,,,,,
2715,132716,(2S)-2-amino-5-[[(2R)-3-[[(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-3-[[2-(4-amino-3-oxobutoxy)-2-oxoethyl]amino]-3-oxopropyl]disulfanyl]-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,C(CC(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)OCCC(=O)CN)NC(=O)CC[C@@H](C(=O)O)N)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
2716,132717,"alpha,alpha'-Bis(3-(N-benzyl-N-methylcarbamoyl)piperidinol)-4-xylene",CN(CC1=CC=CC=C1)C(=O)[C@@H]2CCCN(C2)CC3=CC=C(C=C3)CN4CCC[C@H](C4)C(=O)N(C)CC5=CC=CC=C5,,,,,,
2717,132718,Metacytofilin,CC(C)C[C@@]1(C(=O)N[C@](C(=O)O1)(CC2=CC=CC=C2)O)NC,,,,,,
2718,132719,"2-Amino-3,4,5-trihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid",CCCCCCC(=O)CCCCCCC=CC(C(C(C(CO)(C(=O)O)N)O)O)O,,,,,,
2719,132720,"2-Amino-3,4,5-trihydroxy-2-methyl-14-oxoicos-6-enoic acid",CCCCCCC(=O)CCCCCCC=CC(C(C(C(C)(C(=O)O)N)O)O)O,,,,,,
2720,132721,"stereoisomer of 3-[2-Hydroxy-7-[tetrahydro-5-(1,4,5-trihydroxy-8-heneicosen-1-yl)-2-furanyl]heptyl]-5-methyl-2(5H)-furanone",CCCCCCCCCCCCC=CCCC(C(CCC(C1CCC(O1)CCCCCC(CC2=CC(OC2=O)C)O)O)O)O,,,,,,
2721,132722,2-Trimethylsilyl-1-propanol,CC(CO)[Si](C)(C)C,,,,,,
2722,132723,"(8R,9S,10R,13S,14S)-17-hydroxy-17-(2-iodoethynyl)-10,13-dimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one",C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4(C#CI)O)C,,,,,,
2723,132724,CID 132724,C[C@@H]([C@@H](C(=O)O)N)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2724,132725,O-(2-O-Mannopyranosyl-mannopyranosyl)serine,C([C@@H]1[C@H]([C@@H]([C@@H](C(O1)O[C@H]2[C@H]([C@@H]([C@H](OC2OC[C@@H](C(=O)O)N)CO)O)O)O)O)O)O,,,,,,
2725,132726,cis-4-(3-Carboxyprop-1-yl)piperidine-2-carboxylic acid,C1CN[C@H](C[C@H]1CCCC(=O)O)C(=O)O,,,,,,
2726,132727,CID 132727,C1[C@@H](O[C@@H](O1)CO)N2C=NC3=C2NC(=NC3=O)N,,,,,,
2727,132728,Leucyl-prolyl-prolyl-glycyl-prolyl-leucyl-prolyl-arginyl-prolinamide,CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCN=C(N)N)C(=O)N5CCC[C@H]5C(=O)N)N,,,,,,
2728,132729,"1H-Imidazo(4,5-c)pyridine-6-carboxylic acid, 1-((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-",C1C(N(CC2=C1N(C=N2)CC3COC4=CC=CC=C4O3)C(=O)C(C5=CC=CC=C5)C6=CC=CC=C6)C(=O)O,,,,,,
2729,132730,CID 132730,CCOC(=O)N1CC[C@H]([C@@H]1C2(CC2)S(=O)C3=CC=C(C=C3)C)OC(=O)OCC,,,,,,
2730,132731,Periconin B,CC(CC(C1(C(C1C(=O)NC(CC(=O)O)C(=O)NC2CCC(NC2=O)CN)C(C(=O)O)Cl)Cl)Cl)O,,,,,,
2731,132732,Peritoxin A,CC(CC(C1(C(C1C(=O)NC(CC(=O)O)C(=O)NC2C(CC(CNC2=O)N)O)C(C(=O)O)Cl)Cl)Cl)O,,,,,,
2732,132733,CID 132733,COC1=CC=CC2=C3C4=C(C=C21)N(C(=O)C4=CC5=C3OCO5)[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)COC(=O)C=CC7=CC=C(C=C7)O)O)O)O,,,,,,
2733,132734,CID 132734,CC1=NC2=C(N1OC(CCO)O)NC(=NC2=O)N,,,,,,
2734,132735,N-(2-(4-Hydroxy-3-iodophenyl)ethyl)-4-chloro-2-propyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)imidazole-5-carboxamide,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)NCCC5=CC(=C(C=C5)O)I)Cl,,,,,,
2735,132736,CID 132736,C[C@H](CCC(=O)N[C@H](C)C(=O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3([C@@H](C[C@H](C4)O)O)C)O)O)C,,,,,,
2736,132737,CID 132737,CCCCCCCCCCCCCCCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@H](C)C(=O)O,,,,,,
2737,132738,CID 132738,C[C@H](C(=CF)C1=C(C=C(C(=C1)C(=O)O)O)F)N,,,,,,
2738,132739,"[(2R,3S,4S,5R,6S)-6-[(2R,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13R,14S,15R,17S)-17-acetyl-14,15-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate",CC(=O)[C@H]1C[C@H]([C@]2([C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)COC(=O)C=CC7=CC(=C(C(=C7)OC)O)OC)O)O)O)C)C)O)O,,,,,,
2739,132740,CID 132740,CC(=O)N1CC[N+](C(C1)SSC2CN(CC[N+]2(C)C)C(=O)C)(C)C,,,,,,
2740,132741,CID 132741,C1=CC=C(C=C1)CC(CS)C(=O)NCCCCCCN=C(NC2=CC3=C(C=C2)C4(C5=C(C=C(C=C5)O)OC6=C4C=CC(=C6)O)OC3=O)S,,,,,,
2741,132742,CID 132742,CC1=CC2=C(C=C1CN(CC#C)C3=CC(=C(C=C3)C(=O)N[C@@H](CCC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)F)C(=O)N=C(N2)C,,,,,,
2742,132743,CID 132743,C[C@@H]1C[C@H]2[C@H](C2(C)C)CC1=NOCC(CNC(C)C)O,,,,,,
2743,132744,"(3R,5R)-7-[(1S,2R,3R,8S,8aR)-3-hydroxy-2-methyl-8-(2-methylbutanoyloxy)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid",CCC(C)C(=O)O[C@H]1CC=CC2=C[C@@H]([C@@H]([C@@H]([C@@H]12)CC[C@H](C[C@H](CC(=O)O)O)O)C)O,,,,,,
2744,132745,N-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methyl-4-(oxirane-2-carbonylamino)pyrrole-2-carboxamide,CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NCCC(=N)N)C)C)NC(=O)C4CO4,,,,,,
2745,132746,"Icosa-10,15-dienoic acid",CCCCC=CCCCC=CCCCCCCCCC(=O)O,,,,,,
2746,132747,CID 132747,COC1=C(C=C(C=C1)C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O,,,,,,
2747,132748,"8-Chloro-dibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid 2-[1-oxo-3-(4-pyridinyl)propyl]hydrazide monohydrochloride",C1C2=CC=CC=C2OC3=C(N1C(=O)NNC(=O)CCC4=CC=NC=C4)C=C(C=C3)Cl.Cl,,,,,,
2748,132749,"3-chloro-N'-(3-pyridin-4-ylpropanoyl)-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide",C1C2=CC=CC=C2OC3=C(N1C(=O)NNC(=O)CCC4=CC=NC=C4)C=C(C=C3)Cl,,,,,,
2749,132750,CID 132750,C[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC3C(CCC4[C@@]3(CCC(C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H](O5)COC(=O)C)O)O)C)[C@@]6(C2[C@H](CC6)[C@@]7(CC[C@@H](O7)C(C)(C)O)C)C)O)O)O,,,,,,
2750,132751,3-(4-Iodophenyl)tropan-2beta-carboxylic acid phenyl ester,CN1[C@@H]2CCC1CC(C2C(=O)OC3=CC=CC=C3)C4=CC=C(C=C4)I,,,,,,
2751,132752,CID 132752,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CO)N,,,,,,
2752,132753,3-Carbamoyl-1-(3-chloro-4-hydroxyphenyl)-5-methoxypyrazole,COC1=CC(=NN1C2=CC(=C(C=C2)O)Cl)C(=O)N,,,,,,
2753,132754,(E)-2-[(amino)-phenylmethylene]-benzo[b]thiophen-3(2H)-one,C1=CC=C(C=C1)C(=N)C2=C(C3=CC=CC=C3S2)O,,,,,,
2754,132755,Ppmipa,C[C@@H](C(=O)NC(=O)[C@@H]1CCCN1C(=O)C(C)(C)C)N(C)C(C)C,,,,,,
2755,132756,2-(N-Iodoacetylaminoethyl)thioadenine,CC(=O)N(CCSC1=NC(=C2C(=N1)N=CN2)N)I,,,,,,
2756,132757,CID 132757,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)CNC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCCCN)N,,,,,,
2757,132758,"(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S,3S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-3-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoic acid",CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)N)N,,,,,,
2758,132759,Proglobeflowery acid,CC(=CCC1=C(C(=CC(=C1)C(=O)O)OC)O)C,,,,,,
2759,132760,Pivaloyloxymethyl 7-phenylacetamido-3-vinyl-3-cephem-4-carboxylate,CC(C)(C)C(=O)OCOC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)CC3=CC=CC=C3)C=C,,,,,,
2760,132761,2-Taehm,CCCCCCCCCCCCCCCCOC[C@H](CCP(=O)([O-])OCC[N+](C)(C)C)OC,,,,,,
2761,132762,"N,N,N-Trimethyl-2-[[(S)-4-(hexadecyloxy)-3-methoxybutyl]phosphonyloxy]ethanaminium",CCCCCCCCCCCCCCCCOC[C@H](CCP(=O)(O)OCC[N+](C)(C)C)OC,,,,,,
2762,132763,1-O-Hexadecyl-2-hydroxypropane-3-phosphonocholine,CCCCCCCCCCCCCCCCOP(=O)(C(CO)[N+](C)(C)C)OCC(C)O,,,,,,
2763,132764,CID 132764,CC1(CO1)C2CC3=C4C(=C(C5=CC=CC=C5N4C)O)C(=O)C=C3O2,,,,,,
2764,132765,CID 132765,CCCCCC1C(CC=CCC=CCC=CCCCC(=O)O1)I,,,,,,
2765,132766,"15-(1-Iodohexyl)-1-oxacyclopentadeca-6,9,12-trien-2-one",CCCCCC(C1CC=CCC=CCC=CCCCC(=O)O1)I,,,,,,
2766,132767,"3-Propyl-1H-pyrazolo(2,3-b)isoquinolin-9-one",CCCC1=CNN2C1=CC3=CC=CC=C3C2=O,,,,,,
2767,132768,"Pyridinium, 1-methyl-3-((3-((4-(((4-(((1-methylpyridinium-3-yl)amino)carbonyl)phenyl)amino)carbonyl)benzoyl)amino)benzoyl)amino)-",C[N+]1=CC=CC(=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(=O)NC4=CC=CC(=C4)C(=O)NC5=C[N+](=CC=C5)C,,,,,,
2768,132769,CID 132769,CC(=O)[C@@H]([C@H]([C@H]([C@@H](CO)O)O)O)[N-]S(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C,,,,,,
2769,132770,"5-(dimethylamino)-N-[(3R,4R,5R,6R)-4,5,6,7-tetrahydroxy-2-oxoheptan-3-yl]naphthalene-1-sulfonamide",CC(=O)[C@@H]([C@H]([C@H]([C@@H](CO)O)O)O)NS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C,,,,,,
2770,132771,Isothiobarbamin,CCN(CC)CCSC1=NC(=C(C(=O)N1)C(C)C)O.Cl,,,,,,
2771,132772,2-(2-Diethylamino-ethylsulfanyl)-6-hydroxy-5-isopropyl-3H-pyrimidin-4-one,CCN(CC)CCSC1=NC(=C(C(=O)N1)C(C)C)O,,,,,,
2772,132773,"2-Naphthalenol, 5-(((2-(1,1'-biphenyl)-4-ylethyl)methylamino)methyl)-5,6,7,8-tetrahydro-",CN(CCC1=CC=C(C=C1)C2=CC=CC=C2)CC3CCCC4=C3C=CC(=C4)O,,,,,,
2773,132774,2-[(2-Amino-7h-purin-6-yl)oxy]ethanol,C1=NC2=C(N1)C(=NC(=N2)N)OCCO,,,,,,
2774,132775,"4-(2-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-(1,3)dithiolan-2-yl)benzoic acid",CC1(CCC(C2=C1C=CC(=C2)C3(SCCS3)C4=CC=C(C=C4)C(=O)O)(C)C)C,,,,,,
2775,132776,N-Desmethyldauricine,CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5)OC)OC)O)OC)OC,,,,,,
2776,132777,octadecyl-(2-(N-methylpiperidino)ethyl)phosphate,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+]1(CCCCC1)C,,,,,,
2777,132778,2-(1-Methylpiperidin-1-ium-1-yl)ethyl octadecyl hydrogen phosphate,CCCCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+]1(CCCCC1)C,,,,,,
2778,132779,CID 132779,C(C(=O)C(=C([C]=O)Cl)Cl)C(=O)[O-],,,,,,
2779,132780,CID 132780,C(C(=O)C(=C([C]=O)Cl)Cl)C(=O)O,,,,,,
2780,132781,"7-(2-Aminomethylmorpholino)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid",C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)F)N4CCOC(C4)CN)F)C(=O)O,,,,,,
2781,132782,CID 132782,CNCC(=O)OC(COCCCCCCCCCCCCN)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
2782,132783,CID 132783,CNCC(=O)OC(COCCCCCCCCCCCCN)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
2783,132784,N-(2-(Bis(4-fluorophenyl)methylthio)ethyl)-N-methyl-N-(2-phenyl)ethylamine,CN(CCC1=CC(=CC=C1)C(F)(F)F)CCSC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F,,,,,,
2784,132785,N-Dansylmethionyl-leucyl-phenylalanine,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)NS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C,,,,,,
2785,132786,"1,5,14-Tris(2,3-dihydroxybenzoyl)-10-(1-hydroxy-2-pyridon-6-oyl)-1,5,10,14-tetraazatetradecane",C1=CC(=C(C(=C1)O)O)C(=O)NCCCN(CCCCN(CCCNC(=O)C2=C(C(=CC=C2)O)O)C(=O)C3=CC=CC(=O)N3O)C(=O)C4=C(C(=CC=C4)O)O,,,,,,
2786,132787,4-(Benzodioxan-5-yl)-1-(indan-2-yl)piperazine,C1CN(CCN1C2CC3=CC=CC=C3C2)C4=C5C(=CC=C4)OCCO5,,,,,,
2787,132788,1-(3-Chloro-4-hydroxyphenyl)-5-methoxy-3-(N-methylcarbamoyl)pyrazole,CNC(=O)C1=NN(C(=C1)OC)C2=CC(=C(C=C2)O)Cl,,,,,,
2788,132789,CID 132789,C#CCOC1CN2CCC1CC2.C(=CC(=O)O)C(=O)O,,,,,,
2789,132790,3-(2-Propinyloxy)-quinuclidine,C#CCOC1CN2CCC1CC2,,,,,,
2790,132791,"1-(2-Fluoro-4-iodo-2,4-dideoxyxylopyranosyl)-2-nitroimidazole",C1[C@H]([C@@H]([C@H](C(O1)N2C=CN=C2[N+](=O)[O-])F)O)I,,,,,,
2791,132792,"(3aR,9bS)-3-propyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indole-9-carboxamide",CCCN1CC[C@@H]2[C@H]1CCC3=C2C(=CC=C3)C(=O)N,,,,,,
2792,132793,Limptar,CN1C=NC2=C1C(=O)NC(=O)N2C.CN1C=NC2=C1C(=O)NC(=O)N2C.COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3[C@@H](C4)C=C)O.COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3[C@@H](C4)C=C)O.C(CN)N.C(CN)N.OS(=O)(=O)O,,,,,,
2793,132794,"[(2S,4R,6S)-6-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol",COC1=CC2=C(C=CN=C2C=C1)C([C@@H]3C[C@@H]4CCN3[C@@H](C4)C=C)O,,,,,,
2794,132795,Methyl laminarabioside,CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
2795,132796,Trisuccin,C1=CC=C(C=C1)CONC(=O)CCC(CCC(=O)NOCC2=CC=CC=C2)(CCC(=O)NOCC3=CC=CC=C3)NC(=O)CCC(=O)O,,,,,,
2796,132797,"1,3,4,5-Tetrahydrobenzo[cd]indol-4-amine",C1C(CC2=CNC3=CC=CC1=C23)N,,,,,,
2797,132798,"6-[(2S,4S,5R)-2-[2-(4-methyl-2-nitrophenoxy)propan-2-yl]-4-pyridin-3-yl-1,3-dioxan-5-yl]hex-4-enoic acid",CC1=CC(=C(C=C1)OC(C)(C)[C@H]2OC[C@H]([C@H](O2)C3=CN=CC=C3)CC=CCCC(=O)O)[N+](=O)[O-],,,,,,
2798,132799,CID 132799,C1=CC2=C(C=C1Cl)C(=O)N=C(N2)C3=C(C=CC(=C3)Cl)OP(=O)(O)O,,,,,,
2799,132800,"Thiazolo(3,2-c)(1,2,3)triazolo(4,5-e)pyrimidine",C1=CSC2=C3C(=NN=N3)N=CN21,,,,,,
2800,132801,"1,2-Di-O-dodecyl-3-O-(glucopyranosyl)glycerol",CCCCCCCCCCCC(=O)OCC(CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)OC(=O)CCCCCCCCCCC,,,,,,
2801,132802,"N-(4-Chloro-2-(trifluoromethyl)phenyl)-4,5-dihydro-1H-pyrazole-2-amine",C1CN(N=C1N)C2=CC(=C(C=C2)Cl)C(F)(F)F,,,,,,
2802,132803,"calcium (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoate",C1CC1C2=NC3=CC=CC=C3C(=C2C=C[C@H](C[C@H](CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=C[C@H](C[C@H](CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],,,,,,
2803,132804,CID 132804,C1CC1C2=NC3=CC=CC=C3C(=C2C=C[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F,,,,,,
2804,132805,"3-aminopropyl N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]carbamate",C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)OCCCN)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,,,,,,
2805,132806,3-Benzoyl-N-beta-ethoxyisopropyl-2-methylindole,CCOCC(C)N1C(=C(C2=CC=CC=C21)C(=O)C3=CC=CC=C3)C,,,,,,
2806,132807,CID 132807,C1CN(C=CN(C(CN1CC(=O)O)CC2=CC=C(C=C2)N=C=S)CC(=O)O)CC(=O)O,,,,,,
2807,132808,"4-Amino-6,7-dimethoxy-2-(4-(4-(4-aminophenyl)butanoyl)-1-piperazinyl)quinazoline",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)CCCC4=CC=C(C=C4)N)N)OC,,,,,,
2808,132809,CID 132809,C1=CC(=O)C2=C(OC(=CC2=C1)C3=CC(=C(C=C3)O)O)O,,,,,,
2809,132810,CID 132810,C1=CC(=C(C=C1C2=CC3=CC(=O)C=C(C3=C(O2)O)O)O)O,,,,,,
2810,132811,"3-[(3,4-Dihydroxyphenyl)methylidene]-7-hydroxy-2-benzofuran-1-one",C1=CC2=C(C(=C1)O)C(=O)OC2=CC3=CC(=C(C=C3)O)O,,,,,,
2811,132812,3-(N-(2-(((Diphenylphosphono)methyl)amino)-3-(4-biphenylyl)propionyl)amino)propionic acid,C1=CC=C(C=C1)C2=CC=C(C=C2)C[C@@H](C(=O)NCCC(=O)O)NCP(=O)(OC3=CC=CC=C3)OC4=CC=CC=C4,,,,,,
2812,132813,Diammine platinum(II) dilactate,CC(C(=O)[O-])O.CC(C(=O)[O-])O.N.N.[Pt+2],,,,,,
2813,132814,((4-(4-Amidinophenoxy)butanoyl)aspartyl)valine,CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCOC1=CC=C(C=C1)C(=N)N,,,,,,
2814,132815,"Seminalplasmin, lys(13)-",CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4,,,,,,
2815,132816,"Kauran-18-oic acid, 15-oxo-, methyl ester, (4alpha)-",C[C@@H]1[C@H]2CC[C@H]3[C@@]4(CCC[C@@]([C@H]4CCC3(C2)C1=O)(C)C(=O)OC)C,,,,,,
2816,132817,Urauchimycin B,CC1C(C(C(=O)OC(C(C(=O)O1)NC(=O)C2=C(C(=CC=C2)NC=O)O)C)CCC(C)C)O,,,,,,
2817,132818,[6-(6-Amino-8-bromopurin-9-yl)-3-hexylmorpholin-2-yl]methanol,CCCCCCC1C(OC(CN1)N2C3=NC=NC(=C3N=C2Br)N)CO,,,,,,
2818,132819,Valyl-leucyl-lysyl-4-aminomethylcoumarin,CC(C)C[C@@H](C(=O)NC(=O)[C@H](CCCCN)NCC1=CC(=O)OC2=CC=CC=C21)NC(=O)[C@@H](C(C)C)N,,,,,,
2819,132820,"[37-Acetyloxy-11-(7-chloro-4-hydroxy-2-methylideneocta-5,7-dienyl)-10,14,15,17,27,43-hexahydroxy-31-methoxy-18,36,38,43,47-pentamethyl-39-methylidene-7,35-dioxo-8,12,45,46,48,49,50-heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-en-3-yl] acetate",CC1C2CCCC=CC3CC(CC4(C3C)CC(CC(O4)CC(=O)C(C(C(C(=C)CC5CC(CC6(O5)CC(CC(O6)CC(=O)OC7C(C(OC(O7)C(C(O2)(CC1O)O)O)CC(=C)CC(C=CC(=C)Cl)O)O)OC(=O)C)(C)O)C)OC(=O)C)C)OC)O,,,,,,
2820,132821,"9-(4-(1,2-Dihydroxyethyl)cyclopent-2-en-1-yl)-9H-adenine",C1C(C=CC1N2C=NC3=C(N=CN=C32)N)C(CO)O,,,,,,
2821,132822,Boc-phe-leu-phe-leu-phe,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)OC(C)(C)C,,,,,,
2822,132823,"3H-Pyrido(3,2,1-kl)phenoxazine-2-carboxylic acid, 6-(2-amino-1-pyrrolidinyl)-5-fluoro-3-oxo-, monohydrochloride, (+-)-",C1CC(N(C1)C2=C(C=C3C4=C2OC5=CC=CC=C5N4C=C(C3=O)C(=O)O)F)N.Cl,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)'],,,
2823,132824,"10-(2-Aminopyrrolidin-1-yl)-11-fluoro-14-oxo-8-oxa-1-azatetracyclo[7.7.1.02,7.013,17]heptadeca-2,4,6,9(17),10,12,15-heptaene-15-carboxylic acid",C1CC(N(C1)C2=C(C=C3C4=C2OC5=CC=CC=C5N4C=C(C3=O)C(=O)O)F)N,,,,,,
2824,132825,"3H-Pyrido(3,2,1-kl)phenoxazine-2-carboxylic acid, 6-(2-((2-amino-1-oxopentyl)amino)-1-pyrrolidinyl)-5-fluoro-3-oxo-, monohydrochloride",CCCC(C(=O)NC1CCCN1C2=C(C=C3C4=C2OC5=CC=CC=C5N4C=C(C3=O)C(=O)O)F)N.Cl,,,,,,
2825,132826,"6-[2-[(2-Amino-1-oxopentyl)amino]-1-pyrrolidinyl]-5-fluoro-3-oxo-3H-pyrido[3,2,1-kl]phenoxazine-2-carboxylic acid",CCCC(C(=O)NC1CCCN1C2=C(C=C3C4=C2OC5=CC=CC=C5N4C=C(C3=O)C(=O)O)F)N,,,,,,
2826,132827,"7-(2-Amino-2-phenylacetamido)-3-(1H-1,2,3-triazol-4-yl)methylthiomethyl-3-cephem-4-carboxylic acid",C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)CSCC4=NNN=C4,,,,,,
2827,132828,2-Chloro-n-(ethoxymethyl)-n-[2-methyl-6-(trifluoromethyl)phenyl]acetamide,CCOCN(C1=C(C=CC=C1C(F)(F)F)C)C(=O)CCl,,,,,,
2828,132829,"WURCS=2.0/2,2,1/[a1122h-1x_1-5][a2122h-1x_1-5_2*NCC/3=O]/1-2/a2-b1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1O[C@H]2[C@H]([C@@H]([C@H](OC2O)CO)O)O)CO)O)O,,,,,,
2829,132830,"7-[3-Iodoprop-2-enyl(propyl)amino]-5,6,7,8-tetrahydronaphthalen-2-ol",CCCN(CC=CI)C1CCC2=C(C1)C=C(C=C2)O,,,,,,
2830,132831,3-Hydroxyguanfacine,C1=CC(=C(C(=C1O)Cl)CC(=O)N=C(N)N)Cl,,,,,,
2831,132832,"1,4-Bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone",COC1=CC=C(C=C1)[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)OC)CCCC4=CC=CC=C4,,,,,,
2832,132833,4-(Aminomethyl)-1-phenylpyrrolidin-2-one,C1C(CN(C1=O)C2=CC=CC=C2)CN,,,,,,
2833,132834,4-(Aminomethyl)-1-(4-methoxyphenyl)pyrrolidin-2-one,COC1=CC=C(C=C1)N2CC(CC2=O)CN,,,,,,
2834,132835,"Acetic acid, (4-(3-(aminomethyl)-4-hydroxybenzoyl)-2,3-dichlorophenoxy)-, ethyl ester",CCOC(=O)COC1=C(C(=C(C=C1)C(=O)C2=CC(=C(C=C2)O)CN)Cl)Cl,,,,,,
2835,132836,trans-2-(4-(1-Hydroxyhexyl)phenyl)-5-oxocyclopentaneheptanoic acid,CCCCCC(C1=CC=C(C=C1)[C@H]2CCC(=O)[C@@H]2CCCCCCC(=O)O)O,,,,,,
2836,132837,"3,5-Bis(trifluoromethyl)benzyl N-acetyltryptophan",CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,,,,,,
2837,132838,"(2S)-2-[[(2S,3S)-2-[[(2S)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@@H](CC1=CC=CC=C1)CC(=O)NO,,,,,,
2838,132839,"2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline",C1CN(CC2=CC=CC=C21)CC3CN=C(NO3)C4=CC=CC=C4,,,,,,
2839,132840,Ripisartan,CCCC1=C(C2=NC(=O)NN2C(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,,,,,,
2840,132841,CID 132841,C1=C(C2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC(=NC2=O)N)C(=N)N,,,,,,
2841,132842,5-Formylcytidine,C1=C(C(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C=O,,,,,,
2842,132843,2-[2-Amino-3-(4-chlorobenzoyl)phenyl]acetamide,C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Cl)N)CC(=O)N,,,,,,
2843,132844,"2,3-Dihydro-7-methyl-9-phenyl-1H-pyrazolo(1,2-a)indazolium",CC1=CC2=C(C=C1)N3CCC[N+]3=C2C4=CC=CC=C4.O.[Br-],,,,,,
2844,132845,"7-methyl-5-phenyl-2,3-dihydro-1H-pyrazolo[1,2-a]indazol-4-ium",CC1=CC2=C(C=C1)N3CCC[N+]3=C2C4=CC=CC=C4,,,,,,
2845,132846,"(2S,3S)-3-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine",C1C[C@@H]([C@@H](NC1)C2=CC=CC=C2)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,,,['Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)'],,,
2846,132847,8-(3-(4-Phenyl-1-piperazinyl)propoxy)-7-methoxycoumarin,COC1=C(C2=C(C=C1)C=CC(=O)O2)OCCCN3CCN(CC3)C4=CC=CC=C4,,,,,,
2847,132848,3-Chloroacetyl-3-demethylthiocolchicine,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)OC(=O)CCl,,,,,,
2848,132849,"[(7S)-7-acetamido-1,3-dimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-2-yl] 2-chloroacetate",CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC(=O)CCl)OC,,,,,,
2849,132850,CID 132850,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)Br)Br.[Na+],,,,,,
2850,132851,"(3R,5R)-7-[3,4-dibromo-2-(4-fluorophenyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid",CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)Br)Br,,,,,,
2851,132852,Bucromarone,CCCCN(CCCC)CCCOC1=C(C=C(C=C1C)C(=O)C2=CC(=O)C3=CC=CC=C3O2)C,,,,,,
2852,132853,Alanyl-phosphoseryl-phosphotyrosyl-seryl-alanine,C[C@@H](C(=O)C([C@@](C(=O)[C@H](CO)N)(C(=O)O)N(C(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)P(=O)(O)O)P(=O)(O)O)N,,,,,,
2853,132854,"(2R)-5-amino-2-[[(2S)-2-[2-[(2S,3R,4R,5S,6R)-3-(hexadecanoylamino)-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoyl]amino]-5-oxopentanoic acid",CCCCCCCCCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)OC(C)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)N)C(=O)O,,,,,,
2854,132855,"1,3-Bis(3-deoxyglucopyranose-3-yloxy)-2-propyl-4-benzoylbenzoate",C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)C(=O)OC(CO[C@H]([C@H](C=O)O)[C@@H]([C@@H](CO)O)O)CO[C@H]([C@H](C=O)O)[C@@H]([C@@H](CO)O)O,,,,,,
2855,132856,"L-Cysteine, N-acetyl-S-(2-hydroxycyclohexyl)-, methyl ester",CC(=O)N[C@@H](CSC1CCCCC1O)C(=O)OC,,,,,,
2856,132857,"L-368,899 (unspecified endo/exo stereochemistry)",CC1=CC=CC=C1N2CCN(CC2)S(=O)(=O)C[C@@]34CC[C@@H](C3(C)C)CC4NC(=O)[C@H](CCS(=O)(=O)C)N,,,,,,
2857,132858,5-(Bromomethyl)fluorescein,C1=CC2=C(C=C1CBr)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,,,,,,
2858,132859,1-Methyl-4-(((1-methyl-4-((3-((methylsulfonyl)oxy)-1-oxopropyl)amino)-1H-pyrrol-2-yl)carbonyl)amino)-N-propyl-1H-pyrrole-2-carboxamide,CCCNC(=O)C1=CC(=CN1C)NC(=O)C2=CC(=CN2C)NC(=O)CCOS(=O)(=O)C,,,,,,
2859,132860,2-(9-Anthroyloxy)stearic acid,CCCCCCCCCCCCCCCCC(C(=O)O)OC(=O)C1=C2C=CC=CC2=CC3=CC=CC=C31,,,,,,
2860,132861,N5-(Imino(methylamino)methyl)-L-ornithine bis(4-((4-hydroxyphenyl)azo)benzenesulfonate),CN=C(N)NCCC[C@@H](C(=O)O)N.C1=CC(=CC=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)O.C1=CC(=CC=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)O,,,,,,
2861,132862,Tilarginine,CN=C(N)NCCC[C@@H](C(=O)O)N,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
2862,132863,Val-arg-lys-arg-thr-arg-leu-leu-arg,C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N)O,,,,,,
2863,132864,"2-(N,N-Dimethylaminomethyl)-2,3,7,8-tetrahydro-1H-quino(1,8-ab)(1)benzazepine",CN(C)CC1CC2=CC=CC3=C2N(C1)C4=CC=CC=C4CC3,,,,,,
2864,132865,"(2S,5R,6R)-6-[hydroxy(phenyl)methyl]-3,3-dimethyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2[C@H](S1(=O)=O)[C@@H](C2=O)C(C3=CC=CC=C3)O)C(=O)O)C,,,,,,
2865,132866,1-Methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol,CN1CCC(CC1)(C2=CC=CN2C)O,,,,,,
2866,132867,CID 132867,CCCCCC[C@@H](C#C[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)O)C2)O)O,,,,,,
2867,132868,"Benzeneethanamine, N-butyl-4-chloro-alpha,alpha-dimethyl-",CCCCNC(C)(C)CC1=CC=C(C=C1)Cl,,,,,,
2868,132869,Threonyl-lysyl-glutaminyl-glutamyl-leucyl-glutamic acid,C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O,,,,,,
2869,132870,Lysyl-arginyl-arginyl-(1-naphthyl-alanyl)-lysyl-lysine,C1=CC=C2C(=C1)C=CC=C2C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N,,,,,,
2870,132871,O-Mannopyranosylthreonine,C[C@H]([C@@H](C(=O)O)N)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
2871,132872,3-(4-Chlorophenyl)glutamic acid,C1=CC(=CC=C1C(CC(=O)O)[C@@H](C(=O)O)N)Cl,,,,,,
2872,132873,O-Mannopyranosylserine,C([C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)OC[C@@H](C(=O)O)N)O)O)O)O,,,,,,
2873,132874,"4-(2-Bromo-4,5-dimethoxyphenyl)octahydro-2H-quinolizin-2-one",COC1=C(C=C(C(=C1)C2CC(=O)CC3N2CCCC3)Br)OC,,,,,,
2874,132875,"3-Chloro-2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl)benzo(b)thiophene",C1=CC=C2C(=C1)C(=C(S2)C3=NNC(=O)O3)Cl,,,,,,
2875,132876,"5-(Benzo[d]oxazol-2-yl)-1,3,4-oxadiazol-2-ol",C1=CC=C2C(=C1)N=C(O2)C3=NNC(=O)O3,,,,,,
2876,132877,3-Cyclohexyl-3-hydroxy-3-phenylpropanoic acid,C1CCC(CC1)C(CC(=O)O)(C2=CC=CC=C2)O,,,,,,
2877,132878,N-(Carboxymethyl)-N-(phosphonomethyl)-5-aminoshikimate-3-phosphate,C1[C@H]([C@@H]([C@@H](C=C1C(=O)O)OP(=O)(O)O)O)N(CC(=O)O)CP(=O)(O)O,,,,,,
2878,132879,Neuropeptide DF2,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,,,,,,
2879,132880,"5-(1-Methyl-1h-benzimidazol-2-yl)-1,3,4-oxadiazol-2-ol",CN1C2=CC=CC=C2N=C1C3=NNC(=O)O3,,,,,,
2880,132881,CID 132881,COC(=O)C[C@@H]1C[C@H](NC1=O)COC2=CC=C(C=C2)C3=CC=C(C=C3)C(=NC(=O)OC)N,,,,,,
2881,132882,1-Isopropyl-2-[[1-isopropylquinolin-4(1H)-ylidene]methyl]quinolinium,CC(C)N1C(=CC2=CC=[N+](C3=CC=CC=C23)C(C)C)C=CC4=CC=CC=C41,,,,,,
2882,132883,S-Methylcaptopril,C[C@H](CSC)C(=O)N1CCC[C@H]1C(=O)O,,,,,,
2883,132884,"1-(2-Deoxy-2-fluoropentofuranosyl)-4-imino-5-methyl-1,4-dihydropyrimidin-2-ol",CC1=CN(C(=O)N=C1N)[C@@H]2[C@H]([C@@H]([C@H](O2)CO)O)F,,,,,,
2884,132885,CID 132885,C1=C(C=C(C(=C1N(O)O)C(=O)N=O)Cl)Cl,,,,,,
2885,132886,"(3R,5S,7R,8R,9S,10S,12S,13R,14S,17S)-17-[(2R)-5,6-dihydroxyheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol",C[C@H](CCC(C(C)O)O)[C@@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
2886,132887,FTase Inhibitor I,CC(C)[C@@H](CN[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)O)NC[C@H](CS)N,,,,,,
2887,132888,"2-[3-(2,6-Dimethylpiperazin-1-yl)phenyl]-2-phenylpentanamide",CCCC(C1=CC=CC=C1)(C2=CC(=CC=C2)N3C(CNCC3C)C)C(=O)N,,,,,,
2888,132889,CID 132889,CCN1CCCCC1CC(C2CCCCC2)C3CCCCC3.C(=CC(=O)O)C(=O)O,,,,,,
2889,132890,"1,1-Dicyclohexyl-2-(1-ethylpiperidin-2-yl)ethane",CCN1CCCCC1CC(C2CCCCC2)C3CCCCC3,,,,,,
2890,132891,"3-((4-(2-Methoxyphenyl)piperazin-1-yl)methyl)-2,3-dihydroimidazo(1,2-c)quinazolin-5(6H)-one",COC1=CC=CC=C1N2CCN(CC2)CC3CNC4=C5C=CC=CC5=NC(=O)N34,,,,,,
2891,132892,Iodoazidophenoxymethylimidazoline,C1CN=C(N1)C(N=[N+]=[N-])(OC2=CC=CC=C2)I,,,,,,
2892,132893,"N-{N-[4-(Morpholine-4-carbonyl)benzoyl]valyl}-1-(5,5,6,6,6-pentafluoro-2-methyl-4-oxohexan-3-yl)pyrrolidine-2-carboximidic acid",CC(C)[C@@H](C(=O)NC(=O)[C@@H]1CCCN1C(C(C)C)C(=O)C(C(F)(F)F)(F)F)NC(=O)C2=CC=C(C=C2)C(=O)N3CCOCC3,,,,,,
2893,132894,"Pyridinium, 1-(2-(diethylamino)ethyl)-, bromide, hydrobromide",CCN(CC)CC[N+]1=CC=CC=C1.Br.[Br-],,,,,,
2894,132895,"N,N-diethyl-2-pyridin-1-ium-1-ylethanamine",CCN(CC)CC[N+]1=CC=CC=C1,,,,,,
2895,132896,"1,2-Dipropyl-1,2-bis(3'-hydroxyphenyl)ethane",CCC[C@H](C1=CC(=CC=C1)O)[C@@H](CCC)C2=CC(=CC=C2)O,,,,,,
2896,132897,"6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((2,4,5-trimethoxyphenyl)methyl)-, hydrochloride",COC1=CC(=C(C=C1CC2C3=CC(=C(C=C3CCN2)O)O)OC)OC.Cl,,,,,,
2897,132898,"1-[(2,4,5-Trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol",COC1=CC(=C(C=C1CC2C3=CC(=C(C=C3CCN2)O)O)OC)OC,,,,,,
2898,132899,H-Tyr-D-Ala-Phe-Gly-OH,C[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
2899,132900,"Uridine, 5'-(((2-((1-oxodecyl)amino)-3-phenylpropoxy)carbonyl)sulfamate)",CCCCCCCCCC(=O)NC(CC1=CC=CC=C1)COC(=O)NS(=O)(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O,,,,,,
2900,132901,Tyrosyl-alanyl-phenylalanyl-glycinamide,C[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
2901,132902,Immunocorticotropin,CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O)N,,,,,,
2902,132903,Procainamide methacrylamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C(=C)C,,,,,,
2903,132904,"5,8-Dihydroxy-3-methyl-4-(9H)-naphtho(2,3-c)furanone",CC1=C2C(=CO1)CC3=C(C=CC(=C3C2=O)O)O,,,,,,
2904,132905,1-(4-Nitrophenyl)prop-2-yn-1-ol,C#CC(C1=CC=C(C=C1)[N+](=O)[O-])O,,,,,,
2905,132906,"[6'-Acetyloxy-5-[3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propylcarbamoyl]-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl] acetate",CC(=O)OC1=CC2=C(C=C1)C3(C4=C(C=C(C=C4)C(=O)NCCCN5C=C(C6=CC=CC=C65)C7=C(C(=O)NC7=O)C8=CN(C9=CC=CC=C98)C)C(=O)O3)C1=C(O2)C=C(C=C1)OC(=O)C,,,,,,
2906,132907,9-Hydroxy-alpha-naphthoflavone,C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=C(C=CC(=C4)O)C=C3,,,,,,
2907,132908,N-Methyl-N-((4-(1-methyl-1-phenylethyl)phenyl)methyl)-1-naphthalenemethanamine hydrochloride,CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)CN(C)CC3=CC=CC4=CC=CC=C43.Cl,,,,,,
2908,132909,Sdz-sba-586,CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)CN(C)CC3=CC=CC4=CC=CC=C43,,,,,,
2909,132910,Flupyrsulfuron,COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=C(C=CC(=N2)C(F)(F)F)C(=O)O)OC,,,,,,
2910,132911,"3,5-Diethyl-3'-isopropylthyronine",CCC1=CC(=CC(=C1OC2=CC(=C(C=C2)O)C(C)C)CC)CC(C(=O)O)N,,,,,,
2911,132912,"Phenol, 3-(1,3,4-trimethyl-4-piperidinyl)-, hydrochloride, cis-(+/-)-",C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C.Cl,,,,,,
2912,132913,"3-(1,3,4-Trimethyl-piperidin-4-yl)-phenol",C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C,,,,,,
2913,132914,"N-[11-(3,9-dihydroxy-11,17-dimethoxy-4,4-dimethyl-7-oxo-6,20-dioxa-21-azabicyclo[16.2.1]henicosa-1(21),12,14,18-tetraen-5-yl)-4,10-dimethoxy-5,9-dimethyl-6-oxoundec-1-enyl]-N-methylformamide",CC(CCC(=O)C(C)C(CC=CN(C)C=O)OC)C(CC1C(C(CC2=NC(=CO2)C(CC=CC=CC(CC(CC(=O)O1)O)OC)OC)O)(C)C)OC,,,,,,
2914,132915,CID 132915,CCC(=C(CC)C1=CC(=C(C=C1)O)OC)C2=CC(=C(C=C2)O)OC,,,,,,
2915,132916,Pranazepide,C1CN2C(=O)[C@H](N=C(C3=CC=CC1=C32)C4=CC=CC=C4F)NC(=O)C5=CC6=CC=CC=C6N5,,,,,,
2916,132917,3-(2-((5-Methyl-2-phenyloxazol-4-yl)methyl)benzofuran-5-yl)-2-(propylsulfanyl)propionic acid,CCCSC(CC1=CC2=C(C=C1)OC(=C2)CC3=C(OC(=N3)C4=CC=CC=C4)C)C(=O)O,,,,,,
2917,132918,CID 132918,C1=C2C=C(C(=O)C=C2OC(=C1NC=O)O)O,,,,,,
2918,132919,"2,3-Dihydro-1-(3-mercapto-2-methyl-1-oxopropyl)-1H-indoline-2-carboxylic acid",C[C@H](CS)C(=O)N1[C@@H](CC2=CC=CC=C21)C(=O)O,,,,,,
2919,132920,"(4R)-N-(2-aminoethyl)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide",C[C@H](CCC(=O)NCCN)[C@@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
2920,132921,"(4R)-N-(2-aminoethyl)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamide",C[C@H](CCC(=O)NCCN)[C@@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
2921,132922,1-Cyclohexyl-3-hydroxy-6-methyl-2-(N(alpha)-methyl-N(alpha)-(2-(N-methyl-N-(2-(N-methyl-N-morpholinocarbonylamino)ethyl)aminocarbonyloxy)-3-phenylpropionyl)histidyl)aminoheptane hydrochloride,CC(C)CCC(C(CC1CCCCC1)NC(=O)[C@H](CC2=CN=CN2)N(C)C(=O)C(CC3=CC=CC=C3)OC(=O)N(C)CCN(C)C(=O)N4CCOCC4)O.Cl,,,,,,
2922,132923,[1-[[(2S)-1-[(1-cyclohexyl-3-hydroxy-6-methylheptan-2-yl)amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-methylamino]-1-oxo-3-phenylpropan-2-yl] N-methyl-N-[2-[methyl(morpholine-4-carbonyl)amino]ethyl]carbamate,CC(C)CCC(C(CC1CCCCC1)NC(=O)[C@H](CC2=CN=CN2)N(C)C(=O)C(CC3=CC=CC=C3)OC(=O)N(C)CCN(C)C(=O)N4CCOCC4)O,,,,,,
2923,132924,N-(2-Dimethylaminoethyl)-2-anisamide,CN(C)CCNC(=O)C1=CC=CC=C1OC,,,,,,
2924,132925,"3beta,11alpha,15beta-Trihydroxy-5-pregnen-20-one",CC(=O)[C@H]1C[C@H]([C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)O)C)O,,,,,,
2925,132926,3-(4-Hydroxynaphthalen-1-yl)prop-2-enoic acid,C1=CC=C2C(=C1)C(=CC=C2O)C=CC(=O)O,,,,,,
2926,132927,((4-((2-((Bis(cyclohexylamino)methylene)amino)-3-(2-naphthyl)-1-oxopropyl)amino)phenyl)methyl)tributylphosphonium chloride monohydrochloride,CCCC[P+](CCCC)(CCCC)CC1=CC=C(C=C1)NC(=O)[C@H](CC2=CC3=CC=CC=C3C=C2)NC(=NC4CCCCC4)NC5CCCCC5.[Cl-],,,,,,
2927,132928,"2-(N'',N''''-Dicyclohexyl-guanidino)-3-naphthalen-2-yl-N-[4-(tributyl-lambda*5*-phosphanylmethyl)-phenyl]-propionamide; chloride",CCCC[P+](CCCC)(CCCC)CC1=CC=C(C=C1)NC(=O)[C@H](CC2=CC3=CC=CC=C3C=C2)NC(=NC4CCCCC4)NC5CCCCC5,,,,,,
2928,132929,Allotrap,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
2929,132930,(3S)-4-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carbonyl]amino]-4-oxo-3-(2-propylpentanoylamino)butanoic acid,CCCC(CCC)C(=O)N[C@@H](CC(=O)O)C(=O)NC(=O)[C@@H]1CCCN1[C@@H](CCCN=C(N)N)C=O,,,,,,
2930,132931,"3,4-Dihydro-3-methyl-6-nitro-2H-1,3-benzoxazin-2-one",CN1CC2=C(C=CC(=C2)[N+](=O)[O-])OC1=O,,,,,,
2931,132932,3-(Difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole,COC1=CC=C(C=C1)N2C(=CC(=N2)C(F)F)C3=CC=C(C=C3)S(=O)C,,,,,,
2932,132933,Zinquin,CC1=CC=C(C=C1)S(=O)(=O)NC2=C3C(=CC(=C2)OCC(=O)O)C=CC(=N3)C,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)', 'Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)']",,,
2933,132934,"13-Hydroxyicosa-2,4,6,8-tetraenoic acid",CCCCCCCC(CCCC=CC=CC=CC=CC(=O)O)O,,,,,,
2934,132935,4-amino-5-chloro-2-ethoxy-N-(morpholin-2-ylmethyl)benzamide,CCOC1=CC(=C(C=C1C(=O)NCC2CNCCO2)Cl)N,,,,,,
2935,132936,Benzyloxycarbonylleucyl-leucyl-leucyl-4-methyl-coumaryl-7-amide,CC1=CC(=O)OC2=C1C=CC(=C2)N[C@@H](CC(C)C)C(=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC3=CC=CC=C3,,,,,,
2936,132937,Iodoproxyfan,C1=CC(=CC=C1COCCCC2=CN=CN2)I,,,,,,
2937,132938,"Trimethyl-[3-[4-[(3-methyl-1,3-benzoxazol-2-ylidene)methyl]quinolin-1-ium-1-yl]propyl]azanium;diiodide",CN1C2=CC=CC=C2OC1=CC3=CC=[N+](C4=CC=CC=C34)CCC[N+](C)(C)C.[I-].[I-],,,,,,
2938,132939,"Oxazole yellow, >=98% (HPLC)",CN1C2=CC=CC=C2OC1=CC3=CC=[N+](C4=CC=CC=C34)CCC[N+](C)(C)C,,,,,,
2939,132940,"3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-5,6-dimethoxysalicylamide",CCN1CCCC1CNC(=O)C2=C(C(=CC(=C2O)Br)OC)OC,,,,,,
2940,132941,"N-[3,4-dihydroxy-16-methyl-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]-2-hydroxytetracosanamide",CCCCCCCCCCCCCCCCCCCCCCC(C(=O)NC(CO[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)C(C(CCCCCCCCCCCC(C)CC)O)O)O,,,,,,
2941,132942,Bullatalicin,CCCCCCCCCCC(C1CCC(O1)C(CCC(C2CCC(O2)CCCCCCCC(CC3=CC(OC3=O)C)O)O)O)O,,,,,,
2942,132943,"Hexahydro-5,6-bis(hydroxy)-1,3-bis((4-(hydroxymethyl)phenyl)methyl)-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one",C1=CC=C(C=C1)C[C@H]2[C@H]([C@@H]([C@@H](N(C(=O)N2CC3=CC=C(C=C3)CO)CC4=CC=C(C=C4)CO)CC5=CC=CC=C5)O)O,,,,,,
2943,132944,Selligueain A,C1[C@@H]([C@H](OC2=C1C(=CC(=C2[C@@H]3[C@H]([C@H](OC4=C3C(=CC5=C4[C@H]6C([C@@](O5)(OC7=CC(=CC(=C67)O)O)C8=CC=C(C=C8)O)O)O)C9=CC=C(C=C9)O)O)O)O)C1=CC=C(C=C1)O)O,,,,,,
2944,132945,CID 132945,CC(C)C(C)NC1=NS(=O)(=O)C2=C(N1)C=CN=C2,,,,,,
2945,132946,"7,9,10-trimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine",CC(C)CC1CCC2C3=CC(=C(C=C3C(CN2C1)OC)OC)OC,,,,,,
2946,132947,Tripitramine,CN(CCCCCCCCN(C)CCCCCCN(CC(=O)N1C2=CC=CC=C2C(=O)NC3=C1N=CC=C3)CC(=O)N4C5=CC=CC=C5C(=O)NC6=C4N=CC=C6)CCCCCCNCC(=O)N7C8=CC=CC=C8C(=O)NC9=C7N=CC=C9,,,,,,
2947,132948,CID 132948,CC1=CC=C(C=C1)N=C(NNC(=O)C)S,,,,,,
2948,132949,CID 132949,CC(=CCCC(=CCO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@H](CO2)O)O)O)O)O)O)C)C,,,,,,
2949,132950,"4-[(4-Methylsulfanylcyclohexa-2,4-dien-1-yl)methyl]-5-(trifluoromethyl)pyrazol-3-one",CSC1=CCC(C=C1)CC2=C(N=NC2=O)C(F)(F)F,,,,,,
2950,132951,CID 132951,C1=CC=C(C=C1)N(CC(=O)OC(=O)CC[C@@H](C(=O)N)N)C(=O)[C@H](CSCC2=CC=C(C=C2)Cl)N,,,,,,
2951,132952,Hemorphin 7,C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CC=C(C=C5)O)N)O,,,,,,
2952,132953,Diepoxin sigma,C1=CC2=C3C(=C1)OC4([C@H]5[C@H](O5)C(=O)C67C4(O6)C(=O)C=C[C@@H]7O)OC3=CC=C2,,,,,,
2953,132954,"N,N-dimethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine",CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3,,,,,,
2954,132955,"5-Propylamino-5,6-dihydro-4H-imidazo(4,5,1-ij)quinolin-2(1H)-one",CCCN[C@@H]1CC2=C3C(=CC=C2)NC(=O)N3C1,,,,,,
2955,132956,Sialokinin I,C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC(=O)N)N)O,,,,,,
2956,132957,Sialokinin II,C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC(=O)O)N)O,,,,,,
2957,132958,"1-Methyl-8-((morpholin-2-yl)methoxy)-1,2,3,4-tetrahydroquinoline monomethane sulfonate",CN1CCCC2=C1C(=CC=C2)OC[C@@H]3CNCCO3.CS(=O)(=O)O,,,,,,
2958,132959,"Dabelotine, (S)-",CN1CCCC2=C1C(=CC=C2)OC[C@@H]3CNCCO3,,,,,,
2959,132960,"N-Benzyloxycarbonyl-3-amino-5-carboxy-2-oxopent-1-yl 2,6-dichlorobenzoate",C1=CC=C(C=C1)COC(=O)N[C@@H](CCC(=O)O)C(=O)COC(=O)C2=C(C=CC=C2Cl)Cl,,,,,,
2960,132961,Dapitant,C[C@@H](C1=CC=CC=C1OC)C(=O)N2C[C@@H]3[C@H](C2)C(CC[C@]3(C4=CC=CC=C4OC)O)(C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
2961,132962,"(3S,5S,9R,10S,13R,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6,7,7,7-tetrafluoro-6-(trifluoromethyl)heptan-2-yl]-1,2,3,4,5,6,7,9,11,12,16,17-dodecahydrocyclopenta[a]phenanthren-15-one",C[C@H](CCCC(C(F)(F)F)(C(F)(F)F)F)[C@H]1CC(=O)C2=C3CC[C@H]4C[C@H](CC[C@@]4([C@H]3CC[C@]12C)C)O,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
2962,132963,"5-((2,3-Dihydro-1-indolyl)carbonyl)-4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride",C1CC2=C(C[C@@H]1C(=O)N3CCC4=CC=CC=C43)NC=N2.Cl,,,,,,
2963,132964,"2,3-dihydroindol-1-yl(4,5,6,7-tetrahydro-3H-benzimidazol-5-yl)methanone",C1CC2=C(CC1C(=O)N3CCC4=CC=CC=C43)NC=N2,,,,,,
2964,132965,2-Iodohexadecan-1-ol,CCCCCCCCCCCCCCC(CO)I,,,,,,
2965,132966,(3-(1-((3-(Cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid,CC(C1=CC(=CC=C1)C(=O)O)NCC(CP(=O)(CC2CCCCC2)O)O,,,,,,
2966,132967,"N-(1-Carboxy-ethyl)-alpha-(2-phenyl-ethyl)glycine-leucine, N-phenylamide",CC(C)C[C@@H](C(=O)NC1=CC=CC=C1)NC(=O)[C@H](CCC2=CC=CC=C2)NC(C)C(=O)O,,,,,,
2967,132968,(S)-2-Biphenyl-4-yl-1-(1H-tetrazol-5-yl)ethylaminomethyl phosphonic acid,C1=CC=C(C=C1)C2=CC=C(C=C2)C[C@@H](C3=NNN=N3)NCP(=O)(O)O,,,,,,
2968,132969,(3S)-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[[2-[[(2S)-4-methylsulfanyl-2-[[2-(4-sulfooxyphenyl)acetyl]amino]butanoyl]amino]acetyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[[(2S)-2-(methylamino)-3-phenylpropanoyl]amino]-4-oxobutanoic acid,CN[C@@H](CC1=CC=CC=C1)C(=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)CC4=CC=C(C=C4)OS(=O)(=O)O,,,,,,
2969,132970,"17-(3-Pyridyl)-5,16-androstadien-3beta-acetate",CC(=O)O[C@H]1CC[C@@]2(C3CC[C@]4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,,,"['Compounds that bind to and inhibit enzymes involved in the synthesis of STEROIDS. (See all compounds classified as Steroid Synthesis Inhibitors.)', 'Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
2970,132971,Abiraterone,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O,"['Used in combination with prednisone for the treatment of metastatic, castration-resistant prostate cancer.']","['Abiraterone is associated with decreases in PSA levels, tumor shrinkage (as evaluated by RECIST criteria), radiographic regression of bone metastases and improvement in pain. Levels of adrenocorticotropic hormones increased up to 6-fold but this can be suppressed by dexamethasone.']",,"['Abiraterone itself is poorly absorbed and is susceptible to hydrolysis by esterases. The salt form, abiraterone acetate, is a prodrug which has a much higher oral bioavailability and is also esterase resistant. Peak drug concentrations of abiraterone were reached in 1.5 - 4 hours. Abiraterone acetate was rapidly and completely deacetylated into abiraterone-the parent salt form was not detectable in early pharmacokinetic studies. Food and high fat meals increases absorption 4.4-fold.', 'Excreted via feces (~88%) and urine (~5%)', 'Vdss= 19,669  13,358 L']","['Abiraterone acetate is hydrolyzed into active metabolite abiraterone via esterases. CYP3A4 and SULT2A1 further metabolizes abiraterone into two inactive metabolites called abiraterone sulfate and N-oxide abiraterone sulfate.', 'Abiraterone has known human metabolites that include abiraterone sulfate.']",['Terminal elimination half-life = 5-14 hours']
2971,132972,Casomokinin L,CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CC=C(C=C5)O)N,,,,,,
2972,132973,CID 132973,CN(C)CC(=O)NC(=C1C(=O)[C@H]([C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C1=O)O)O)O)N(C)C)N(C)C)O,,,,,,
2973,132974,Alinastine,CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C,,,,,,
2974,132975,"(R)-2-Hydroxy-2-[(S)-2-hydroxy-8-(2,4-dichlorophenyl)octyl]butanedioic acid",C1=CC(=C(C=C1Cl)Cl)CCCCCC[C@@H](C[C@@](CC(=O)O)(C(=O)O)O)O,,,,,,
2975,132976,Nitrofenac,C1=CC=C(C(=C1)CC(=O)OCCCCO[N+](=O)[O-])NC2=C(C=CC=C2Cl)Cl,,,,,,
2976,132977,"1,3-Naphthalenedisulfonic acid, 7,7'-(carbonylbis(imino(1-methyl-1H-pyrrole-4,2-diyl)carbonylimino(1-methyl-1H-pyrrole-4,2-diyl)carbonylimino))bis-, tetrasodium salt",CN1C=C(C=C1C(=O)NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C4=CC(=CN4C)NC(=O)NC5=CN(C(=C5)C(=O)NC6=CN(C(=C6)C(=O)NC7=CC8=C(C=C(C=C8C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])C)C.[Na+].[Na+].[Na+].[Na+],,,,,,
2977,132978,"7-[[4-[[4-[[5-[[5-[(6,8-Disulfo-2-naphthyl)carbamoyl]-1-methyl-pyrrol-3-yl]carbamoyl]-1-methyl-pyrrol-3-yl]carbamoylamino]-1-methyl-pyrrole-2-carbonyl]amino]-1-methyl-pyrrole-2-carbonyl]amino]naphthalene-1,3-disulfonic acid",CN1C=C(C=C1C(=O)NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CN4C)NC(=O)NC5=CN(C(=C5)C(=O)NC6=CN(C(=C6)C(=O)NC7=CC8=C(C=C(C=C8C=C7)S(=O)(=O)O)S(=O)(=O)O)C)C,,,,,,
2978,132979,Pibrozelesin,CC1=C(C2=C3[C@@H](CN(C3=CC(=C2N1)OC(=O)N4CCN(CC4)C)C(=O)C5=CC6=CC(=C(C(=C6N5)OC)OC)OC)CBr)C(=O)OC,,,"['Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)', 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)']",,,
2979,132980,"1-[(3R)-5-(3-azabicyclo[3.2.2]nonan-3-yl)-1-methyl-2-oxo-3H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea",CC1=CC(=CC=C1)NC(=O)N[C@H]2C(=O)N(C3=CC=CC=C3C(=N2)N4CC5CCC(C4)CC5)C,,,,,,
2980,132981,"4-(3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile",CC1(C(=O)N(C(=O)N1CCCCO)C2=CC(=C(C=C2)C#N)C(F)(F)F)C,,,,,,
2981,132982,1-(4-(5-Maleimidopentyl)aminobenzyl)ethylenediaminetetraacetic acid,C1=CC(=CC=C1CC(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)NCCCCCN2C(=O)C=CC2=O,,,,,,
2982,132983,"3,7-Diazabicyclo(3.3.1)nonane, 3-(4-(1H-imidazol-1-yl)benzoyl)-7-(1-methylethyl)-, perchlorate",CC(C)N1CC2CC(C1)CN(C2)C(=O)C3=CC=C(C=C3)N4C=CN=C4.OCl(=O)(=O)=O,,,,,,
2983,132984,"[4-(1H-Imidazol-1-yl)phenyl](7-isopropyl-3,7-diazabicyclo[3.3.1]nonan-3-yl)methanone",CC(C)N1CC2CC(C1)CN(C2)C(=O)C3=CC=C(C=C3)N4C=CN=C4,,,,,,
2984,132985,"N,N,N',N'-Tetramethyl-N,N'-bis(3-(4-oxo-2-phenyl-3,4-dihydro-2H-quinazolin-1-yl)propyl)-N,N'-hexane-1,6-diylbisammonium dibromide",C[N+](C)(CCCCCC[N+](C)(C)CCCN1C(NC(=O)C2=CC=CC=C21)C3=CC=CC=C3)CCCN4C(NC(=O)C5=CC=CC=C54)C6=CC=CC=C6.[Br-].[Br-],,,,,,
2985,132986,"6-[Dimethyl-[3-(4-oxo-2-phenyl-2,3-dihydroquinazolin-1-yl)propyl]azaniumyl]hexyl-dimethyl-[3-(4-oxo-2-phenyl-2,3-dihydroquinazolin-1-yl)propyl]azanium",C[N+](C)(CCCCCC[N+](C)(C)CCCN1C(NC(=O)C2=CC=CC=C21)C3=CC=CC=C3)CCCN4C(NC(=O)C5=CC=CC=C54)C6=CC=CC=C6,,,,,,
2986,132987,Pyroglutamyl-glutamyl-aspartyl-aminobutyryl-lysine,C1CC(=O)N[C@@H]1C(=O)OC(=O)CC[C@@H](C(=O)N(CCCC(=O)N[C@@H](CCCCN)C(=O)O)C(=O)[C@H](CC(=O)O)N)N,,,,,,
2987,132988,"1,3,4,5-Tetrahydro-7,8-dimethoxy-3-((1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl)methyl)-2H-3-benzazepin-2-one hydrochloride",COC1=C(C=C(C=C1)CCN2CCC[C@H](C2)CN3CCC4=CC(=C(C=C4CC3=O)OC)OC)OC.Cl,,,,,,
2988,132989,"3-[[(3R)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one",COC1=C(C=C(C=C1)CCN2CCC[C@H](C2)CN3CCC4=CC(=C(C=C4CC3=O)OC)OC)OC,,,,,,
2989,132990,"2-[3-(2,4-Difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-1,2,4-triazol-3-one",CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3C(=O)N(C=N3)C4=CC=C(C=C4)OCC(C(F)F)(F)F,,,,,,
2990,132991,N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan,CC(C)C[C@@H](C(=O)N[C@H](CC1=CN(C2=CC=CC=C21)C)C(=O)N[C@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)N4CCCCCC4,,,,,,
2991,132992,"(22RS-N-1,1,1-Trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C4=CC=CC=C4)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,,,['Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE. (See all compounds classified as 5-alpha Reductase Inhibitors.)'],,,
2992,132993,"3-hydroxy-N-[3-[8-(6-hydroxy-3,5-dimethylhept-4-enyl)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]propyl]-4-[[2-[6-(2-hydroxypent-3-enyl)-4-methyloxan-2-yl]acetyl]amino]-2-methylbutanamide",CC=CC(CC1CC(CC(O1)CC(=O)NCC(C(C)C(=O)NCCCC2C(CCC3(O2)CCCC(O3)CCC(C)C=C(C)C(C)O)C)O)C)O,,,,,,
2993,132994,"3-[4(1,2-Diphenyl-but-1-enyl)-phenyl]-acrylic acid",CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)C=CC(=O)O)C3=CC=CC=C3,,,,,,
2994,132995,N-(1-benzylpiperidin-4-yl)-4-iodobenzamide,C1CN(CCC1NC(=O)C2=CC=C(C=C2)I)CC3=CC=CC=C3,,,,,,
2995,132996,CID 132996,C[C@@H](C1=CC=CC=C1)[C@H](CS)C(=O)N[C@H](C)C(=O)O,,,,,,
2996,132997,4-amino-N-[1-[3-(4-fluorophenyl)propyl]-4-methylpiperidin-4-yl]-5-iodo-2-methoxybenzamide,CC1(CCN(CC1)CCCC2=CC=C(C=C2)F)NC(=O)C3=CC(=C(C=C3OC)N)I,,,,,,
2997,132998,"1-Ethyl-6-((3-fluoro-5-(4-methoxy-3,4,5,6-tetrahydro-2H-pyran-4-yl)phenoxy)methyl)-2-quinolone",CCN1C2=C(C=CC1=O)C=C(C=C2)COC3=CC(=CC(=C3)C4(CCOCC4)OC)F,,,,,,
2998,132999,Ivabradine,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)C[C@H]3CC4=CC(=C(C=C34)OC)OC,"['Ivabradine is indicated by the FDA to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction 35%, who are in sinus rhythm with resting heart rate 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use. It is also indicated for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy for pediatric patients 6 months of age or more.']","[""The funny channels (If) open during repolarization and close during depolarization, making ivabradine's activity dependent on heart rate or the closing and opening of the channels. Therefore ivabradine exhibits use-dependence and is more pharmacologically active at higher heart rates. Ivabradine exhibits a linear dose-dependent heart-rate lowering activity (bradycardic effect) until a maximum dose of 30-40mg. At higher doses, the concentration of ivabradine tends to plateau, reducing risk of serious sinus bradycardia.  It has been shown that the metabolite of ivabradine lowers heart rate as well, contributing to ivabradine's overall effect.""]","['Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)']","[""It is recommended to take ivabradine with food to reduce variability in systemic exposure. Administration with food slows absorption by 1 hour, but increases systemic absorption by 20-30%. Ivabradine's oral bioavailability is about 40%."", 'Metabolites are equally excreted in feces and urine.', '~100 L.', 'Total clearance is about 400ml/min; renal clearance about 70ml/min. About 4% is excreted unchanged in urine.']","[""Ivabradine is extensively metabolized by oxidation in the gut and liver by cytochrome P450 3A4 enzyme. Its active metabolite, N-desmethylated derivative, is also metabolized by CYP 3A4. Ivabradine's affinity for CYP 3A4 is low, making it unlikely to affect the metabolism of other drugs; however potent inhibitors or inducers of CYP 3A4 may affect ivabradine's plasma concentration and pharmacodynamic effects and should not be co-administered.""]",['2 hours.']
2999,133000,Embusartan,CCCCC1=CC(=CC(=O)N1CC2=C(C=C(C=C2)C3=CC=CC=C3C4=NNN=N4)F)C(=O)OC,,,,,,
3000,133001,4-(3-(Benzotriazol-1-yl)propyl)-1-(2-methoxyphenyl)piperazine,COC1=CC=CC=C1N2CCN(CC2)CCCN3C4=CC=CC=C4N=N3,,,,,,
3001,133002,PG 9 Cpd,CC(C1=CC=C(C=C1)Br)C(=O)OC2CC3CCC(C2)N3C,,,,,,
3002,133003,Dbd-cocl,CN(C)S(=O)(=O)C1=CC=C(C2=NON=C12)N(C)CC(=O)Cl,,,,,,
3003,133004,Aspartyl-tyrosyl-phenylalanyl-glycyl-tryptophyl-(N-methyl)norleucyl-aspartyl-phenylalaninamide,CCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NC(=O)CNC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](CC(=O)O)N)NC(=O)[C@H](CC4=CN(C5=CC=CC=C54)C)N,,,,,,
3004,133005,"Methyl 2,11-bis[(ethylsulfanyl)methyl]-15-hydroxy-8-methyl-5,6,7,8-tetrahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacene-7-carboperoxoate",CCSCC1=CC2=C(C=C1)N3[C@@H]4C[C@@H]([C@](O4)(N5C6=C(C=C(C=C6)CSCC)C7=C8CNC(=O)C8=C2C3=C75)C)C(=O)OOC,"[""Investigated for use/treatment in asthma and parkinson's disease.""]",,,,,
3005,133006,Phthalmustine,C1=CC=C2C(=C1)C(=O)N(C2=O)CCN(CCCl)CCCl,,,,,,
3006,133007,"(2,11,12,13,15,16-Hexachloro-14-hydroxytetracos-1-enyl) hydrogen sulfate",CCCCCCCCC(C(C(C(C(C(CCCCCCCCC(=COS(=O)(=O)O)Cl)Cl)Cl)Cl)O)Cl)Cl,,,,,,
3007,133008,5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole,CC1=C(ON=C1C2CCN(CC2)CCC3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
3008,133009,"5,6,7,8-Tetrahydro-3-(5-methoxy-1,3,4-oxadiazol-2-yl)-6-(phenylmethyl)-1,6-naphthyridin-2(1H)-one",COC1=NN=C(O1)C2=CC3=C(CCN(C3)CC4=CC=CC=C4)NC2=O,,,,,,
3009,133010,"N-(3-(2,3-Dihydroxybenzamido)propyl)-1,3-bis(2-(2-hydroxyphenyl)-5-methyl-2-oxazoline-4-carboxamido)propane",C[C@@H]1[C@H](N=C(O1)C2=CC=CC=C2O)C(=O)N(CCCNC(=O)C3C(OC(=N3)C4=CC=CC=C4O)C)CCCNC(=O)C5=C(C(=CC=C5)O)O,,,,,,
3010,133011,alpha-Conotoxin imi,C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CN,,,,,,
3011,133012,Fscpx,CCCN1C(=O)C2=C(N=C(N2)C3CCCC3)N(C1=O)CCCOC(=O)C4=CC=C(C=C4)S(=O)(=O)F,,,,,,
3012,133013,7-Iodobenzovesamicol,C1CN(CCC1C2=CC=CC=C2)[C@@H]3CC4=C(C[C@@H]3O)C=C(C=C4)I,,,,,,
3013,133014,3-Amino-3-methylthiolan-2-one,CC1(CCSC1=O)N,,,,,,
3014,133015,"5-((4-(4-(Diisobutylamino)butyl)-1-phenyl)acetyl)-10,11-dihydro-5H-dibenzo(b,e)(1,4)diazepin-11-one",CC(C)CN(CCCCC1=CC=C(C=C1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=CC=CC=C42)CC(C)C,,,,,,
3015,133016,Rupatadine trihydrochloride,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2.Cl.Cl.Cl,,,,,,
3016,133017,Rupatadine,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2,['For the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis and perennial allergic rhinitis in patients 2 years of age and older. Also used for the symptomatic relief of chronic spontaneous urticaria in patients 2 years of age and older.'],"['Rupatadine is an anti allergenic and acts to reduce allergic symptoms like urticaria, rhinorrhea, sneezing and itching.']",,"['Rupatidine is rapidly absorbed with a Tmax of 1 h. Administration with a high fat meal increases exposure by 23% and increases Tmax to 2 h.', 'The apparent volume of distribution is 9799 L.', 'Systemic clearance is 1556.2 L/h in young adults and 798.2 L/h in geriatric patients.']","['Rupatadine is metabolized by oxidation mediated primarily by CYP3A4. CYP2C9, CYP2C19, and CYP2D6 are also involved to a lesser extent. The metabolites desloratidine and hydroxylated forms of desloratidine retain some activity as H1 receptor antagonists.', 'Rupatadine has known human metabolites that include Desloratadine.']","['The half life of elimination is 15.9 h in children 2-5 years old, 12.3 h in children 6-11 years old, 5.9 h in adults, and 8.7 h in geriatric patients.']"
3017,133018,CID 133018,C[C@H](C(=O)N[C@H](C)C(=O)NC(=O)[C@@H]1CCCN1C(CC2=CC=CC=C2)C(=O)CCl)NC(=O)CCC(=O)O,,,,,,
3018,133019,7-Aminocholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(C=C4[C@@]3(CC[C@@H](C4)O)C)N)C,,,,,,
3019,133020,"[7-Hydroxy-6-methyl-2-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)tetradeca-8,10,12-trien-5-yl] dihydrogen phosphate",CC=CC=CC=CC(C(C)C(CCC(C)C1C(C=CC(=O)O1)C)OP(=O)(O)O)O,,,,,,
3020,133021,Licofelone,CC1(CC2=C(C(=C(N2C1)CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)C,['For the management of osteoarthritis.'],['Licofelone belongs to a novel class of dual-acting anti-inflammatory drugs called COX/LO inhibitors. This group of drugs simultaneously inhibits the enzymes cyclooxygenase (COX) and 5-lipoxygenase (LO).'],"['Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)', 'Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)', 'Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)', 'Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)']",,"['Licofelone has known human metabolites that include (2S,3S,4S,5R)-6-[2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid, Licofelone M2, and Licofelone M4.']",
3021,133022,4-(((3beta)-Cholest-5-en-3-yl)oxy)butanoic acid,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC=C4[C@@]3(CC[C@@H](C4)OCCCC(=O)O)C)C,,,,,,
3022,133023,"1-((3,4-Dichlorophenyl)acetyl)-2-((3-hydroxy-1-pyrrolidinyl)methyl)-4,4-dimethylpiperidine",CC1(CCN(C(C1)CN2CCC(C2)O)C(=O)CC3=CC(=C(C=C3)Cl)Cl)C,,,,,,
3023,133024,"2-(7-Methyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo(2,3-d)pyrimidin-6-yl)phenol",CN1C(=CC2=C1N=C(N=C2N3CCCC3)N4CCCC4)C5=CC=CC=C5O,,,,,,
3024,133025,1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3-nitro-1H-pyrrole,C1[C@@H]([C@H](O[C@@H]1N2C=CC(=C2)[N+](=O)[O-])CO)O,,,,,,
3025,133026,"Benzo(a)naphthacene-2-carboxylic acid, 5,6,8,13-tetrahydro-8,13-dioxo-3-(2-hydroxypropyl)-7-methoxy-1,6,9,14-tetrahydroxy-",CC(CC1=C(C(=C2C(=C1)CC(C3=C2C(=C4C(=C3OC)C(=O)C5=C(C4=O)C=CC=C5O)O)O)O)C(=O)O)O,,,,,,
3026,133027,"4,5-Bis(phenylamino)-1H-isoindole-1,3(2H)-dione",C1=CC=C(C=C1)NC2=C(C3=C(C=C2)C(=O)NC3=O)NC4=CC=CC=C4,,,['Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)'],,,
3027,133028,2-(4-(2-Piperidinoethoxy)phenyl)-3-(4-methoxyphenyl)-2H-benzopyran,COC1=CC=C(C=C1)C2=CC3=CC=CC=C3OC2C4=CC=C(C=C4)OCCN5CCCCC5,,,,,,
3028,133029,CID 133029,CCCCCCC(=O)CCCCCCC=CCC[C@@H]([C@@](CO)(C(=O)O)N)O,,,,,,
3029,133030,"1-(Phosphonooxy)-2,4-pentanedione",CC(=O)CC(=O)COP(=O)(O)O,,,,,,
3030,133031,"3-((2'-(Benzoylaminosulfonyl)biphenyl-4-yl)methyl)-2-ethyl-5,7-dimethyl-3H-imidazo(4,5-b)pyridine",CCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC(=O)C5=CC=CC=C5)N=C(C=C2C)C,,,,,,
3031,133032,5-Ethyl-3-[[2-fluoro-4-[2-(3-methylbutoxycarbonylsulfamoyl)phenyl]phenyl]methyl]-2-propylimidazole-4-carboxylic acid,CCCC1=NC(=C(N1CC2=C(C=C(C=C2)C3=CC=CC=C3S(=O)(=O)NC(=O)OCCC(C)C)F)C(=O)O)CC,,,,,,
3032,133033,Leucokinin 2,C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)N)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CC(=O)N)N,,,,,,
3033,133034,Indomethacin triethylene ester,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCCOCCOCCO,,,,,,
3034,133035,"3-(1-Pyrrolidinylmethyl)-4-(5,6-dichloro-1-indancarbonyl)-tetrahydro-1,4-thiazine hydrochloride",C1CCN(C1)C[C@@H]2CSCCN2C(=O)[C@H]3CCC4=CC(=C(C=C34)Cl)Cl.Cl,,,,,,
3035,133036,R-84760 free base,C1CCN(C1)C[C@@H]2CSCCN2C(=O)[C@H]3CCC4=CC(=C(C=C34)Cl)Cl,,,,,,
3036,133037,2-[[6-[6-[6-[[Bis(carboxymethyl)amino]methyl]pyridin-2-yl]-4-(3-isothiocyanato-4-methoxyphenyl)pyridin-2-yl]pyridin-2-yl]methyl-(carboxymethyl)amino]acetic acid,COC1=C(C=C(C=C1)C2=CC(=NC(=C2)C3=CC=CC(=N3)CN(CC(=O)O)CC(=O)O)C4=CC=CC(=N4)CN(CC(=O)O)CC(=O)O)N=C=S,,,,,,
3037,133038,1-(9H-Carbazol-4-yloxy)-3-((1-(fluoromethyl)ethyl)amino)-2-propanol,CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O,,,,,,
3038,133039,"N-[(1S,2S,3R)-1-[(alpha-D-Galactopyranosyl)methyl]-2,3-dihydroxyheptadecyl]hexacosaneamide",CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](C[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)[C@@H]([C@@H](CCCCCCCCCCCCCC)O)O,,,,,,
3039,133040,1-(Saligenin cyclic phospho)-9-biotinyldiaminononane,C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCCCCCCCCNP3(=O)OCC4=CC=CC=C4O3)NC(=O)N2,,,,,,
3040,133041,(N-(2-(4-Hydroxyphenyl)ethyl)glycyl)-(N-(4-biphenylyl)glycyl)-N-(2-phenylethyl)glycinamide,C1=CC=C(C=C1)CCN(CCC2=CC=C(C=C2)O)CC(=O)N(C(=O)CN)C(=O)CNC3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
3041,133042,"Glycinamide, N-(2,2-diphenylethyl)glycyl-N-(1,3-benzodioxol-5-ylmethyl)glycyl-N2-(2-(4-hydroxyphenyl)ethyl)-",C1OC2=C(O1)C=C(C=C2)CN(CCC3=CC=C(C=C3)O)[C@@H](C(=O)CN)C(=O)N(CC(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)CN,,,,,,
3042,133043,N(4)-Octadecyl-1-arabinofuranosylcytosine,CCCCCCCCCCCCCCCCCCNC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
3043,133044,(+-)-3-(2-Phenylethyl)-alpha-((propylamino)methyl)-2-benzofuranmethanol,CCCNCC(C1=C(C2=CC=CC=C2O1)CCC3=CC=CC=C3)O,,,,,,
3044,133045,(2S)-2-amino-5-[[(2R)-2-amino-3-[2-[bis[bis(2-chloroethyl)amino]phosphoryloxy]ethylsulfonyl]propanoyl]-[(R)-carboxy(phenyl)methyl]amino]-5-oxopentanoic acid,C1=CC=C(C=C1)[C@H](C(=O)O)N(C(=O)CC[C@@H](C(=O)O)N)C(=O)[C@H](CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)N,,,,,,
3045,133046,"1-(tert-Butylamino)-3-(2-((3-methoxy-1,2,4-oxadiazol-5-yl)methoxy)phenoxy)propan-2-ol hydrochloride",CC(C)(C)NCC(COC1=CC=CC=C1OCC2=NC(=NO2)OC)O.Cl,,,,,,
3046,133047,Zoleprodolol,CC(C)(C)NCC(COC1=CC=CC=C1OCC2=NC(=NO2)OC)O,,,,,,
3047,133048,"3,14-Octadecadien-1-ol, 2-amino-",CCCC=CCCCCCCCCCC=CC(CO)N,,,,,,
3048,133049,"6-tert-Butyl-2,3-epoxy-1,4-benzoquinone",CC(C)(C)C1=C[C@H]([C@@H]2[C@H](C1=O)O2)O,,,,,,
3049,133050,Maleimidoethyl 3-(tri-n-butylstannyl)hippurate,CCCC[Sn](CCCC)(CCCC)C1=CC=CC(=C1)C(=O)NCC(=O)OCCN2C(=O)C=CC2=O,,,,,,
3050,133051,"benzyl N-[(4S)-8-amino-9-(ethylamino)-2-methyl-5,9-dioxononan-4-yl]carbamate",CCNC(=O)C(CCC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)N,,,,,,
3051,133052,4-Nitro-2-(3-phenylpropylamino)benzoate,C1=CC=C(C=C1)CCCNC2=C(C=CC(=C2)[N+](=O)[O-])C(=O)[O-],,,,,,
3052,133053,4-Nitro-2-(3-phenylpropylamino)benzoic acid,C1=CC=C(C=C1)CCCNC2=C(C=CC(=C2)[N+](=O)[O-])C(=O)O,,,,,,
3053,133054,"3-Benzylidene-6-[[4-[2-(dimethylamino)ethoxy]phenyl]methylidene]piperazine-2,5-dione",CN(C)CCOC1=CC=C(C=C1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,,,,,,
3054,133055,Hapalosin,CCCCCCC[C@@H]1[C@@H](C(=O)O[C@H](C(=O)N([C@H]([C@@H](CC(=O)O1)O)CC2=CC=CC=C2)C)C(C)C)C,,,,,,
3055,133056,"7-[3-Iodoprop-2-enyl(propyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol",CCCN(CC=CI)C1CCC2=C(C1)C(=CC=C2)O,,,,,,
3056,133057,1-(4-Fluoro-3-iodobenzyl)guanidine,C1=CC(=C(C=C1CN=C(N)N)I)F,,,,,,
3057,133058,N-(3-(Trifluoromethyl)phenyl)-N'-(2-hydroxy-5-chlorophenyl)urea,C1=CC(=CC(=C1)NC(=O)NC2=C(C=CC(=C2)Cl)O)C(F)(F)F,,,,,,
3058,133059,"1-Azabicyclo(2.2.1)heptan-3-one, O-(3-(3-methoxyphenyl)-2-propynyl)oxime ethanedioate",COC1=CC=CC(=C1)C#CCON=C2CN3CCC2C3.C(=O)(C(=O)O)O,,,,,,
3059,133060,N-[3-(3-methoxyphenyl)prop-2-ynoxy]-1-azabicyclo[2.2.1]heptan-3-imine,COC1=CC=CC(=C1)C#CCON=C2CN3CCC2C3,,,,,,
3060,133061,CID 133061,C(CCC=CCC=CCC=CCC=CCCCC(=O)O)CC[18F],,,,,,
3061,133062,"(2S)-2-[[(4S,5S)-5-acetamido-6-cyclohexyl-4-hydroxy-2-propan-2-ylhexanoyl]amino]-N-[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pentanediamide",CC(C)C(C[C@@H]([C@H](CC1CCCCC1)NC(=O)C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N,,,,,,
3062,133063,8-(((Trifluoromethyl)sulfonyl)oxy)-2-(n-propylamino)tetralin,CCCN[C@@H]1CCC2=C(C1)C(=CC=C2)OS(=O)(=O)C(F)(F)F,,,,,,
3063,133064,N-Methylphenylalanyl-prolyl-arginine,CN[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
3064,133065,2alpha-(2'-Cyclopentyl-2'-ethoxy-2'-phenylethoxy)tropane,CN1C2CCC1C(CC2)OCC(C3CCCC3)(C4=CC=CC=C4)O,,,,,,
3065,133066,2-[4-(3-Iodophenyl)piperidin-1-yl]cyclohexan-1-ol,C1CCC(C(C1)N2CCC(CC2)C3=CC(=CC=C3)I)O,,,,,,
3066,133067,Thnla-1,C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCN4C=CN=C4[N+](=O)[O-].Cl,,,,,,
3067,133068,"N-[3-(2-nitroimidazol-1-yl)propyl]-1,2,3,4-tetrahydroacridin-9-amine",C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCN4C=CN=C4[N+](=O)[O-],,,,,,
3068,133069,3-Quinuclidinyl tropate,C1CN2CCC1C(C2)OC(=O)C(CO)C3=CC=CC=C3,,,,,,
3069,133070,"5-Methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4-dione",CN1C(=O)C2CC1(C3=CC=CC=C3NC2=O)C4=CC=CC=C4,,,,,,
3070,133071,"N-cis-2,6-Dimethylpiperidinocarbonyl-2-cyclopropylglycyl-2-bromotryptophanyl-norleucine",CCCC[C@@H](C(=O)O)N(C(=O)[C@H](CC1=C(NC2=CC=CC=C21)Br)NC(=O)N3[C@@H](CCC[C@@H]3C)C)C(=O)[C@H](C4CC4)N,,,['Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)'],,,
3071,133072,Muricatocin B,CCCCCCCCCCCCC(C1CCC(O1)C(CCC(CC(CCCCCC(CC2=CC(OC2=O)C)O)O)O)O)O,,,,,,
3072,133073,"5-[2-[1-[1-[3-(2-hydroxypropan-2-yl)phenoxy]propan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",CC(COC1=CC=CC(=C1)C(C)(C)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,,,,,,
3073,133074,3-Quinuclidinyl 4-fluoromethylbenzilate,C1CN2CCC1C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=C(C=C4)CF)O,,,,,,
3074,133075,RS 67506 hydrochloride,COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CCNS(=O)(=O)C)Cl)N.Cl,,,,,,
3075,133076,N-[2-[4-[3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxopropyl]piperidin-1-yl]ethyl]methanesulfonamide,COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CCNS(=O)(=O)C)Cl)N,,,,,,
3076,133077,"((4-(3-(4-Fluoro-alpha-hydroxybenzyl)-4-hydroxyphenoxy)-3,5-dimethylphenyl)amino)oxoacetate",CC1=CC(=CC(=C1OC2=CC(=C(C=C2)O)C(C3=CC=C(C=C3)F)O)C)NC(=O)C(=O)O,,,,,,
3077,133078,Sonepiprazole mesylate,CS(=O)(=O)O.C1CO[C@H](C2=CC=CC=C21)CCN3CCN(CC3)C4=CC=C(C=C4)S(=O)(=O)N,,,,,,
3078,133079,Sonepiprazole,C1CO[C@H](C2=CC=CC=C21)CCN3CCN(CC3)C4=CC=C(C=C4)S(=O)(=O)N,,,,,,
3079,133080,but-2-enedioic acid;1-[3-[3-[4-(5-methoxypyrimidin-4-yl)piperazin-1-yl]propyl]-1H-indol-5-yl]-N-methylmethanesulfonamide,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC.C(=CC(=O)O)C(=O)O,,,,,,
3080,133081,Avitriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC,,,,,,
3081,133082,CID 133082,CC1=C(C=CC(=C1)NC(=C(C#N)C(=O)C2CC2)O)C(F)(F)F,,,,,,
3082,133083,1-(3-(4-Benzhydryl-1-piperazinyl)propyl)-3-(1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid,C1CN(CCN1CCCN2C=C(C3=C2C=C(C=C3)C(=O)O)CN4C=CN=C4)C(C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
3083,133084,N-(10-Azido-1-methyldecyl)-4-quinazolinamine,C1=CC=C2C(=C1)C(=NC(=N2)N)CCCCCCCCCCCN=[N+]=[N-],,,,,,
3084,133085,4-(4-(3-(Trifluoromethyl)-3H-diazirin-3-yl)phenethoxy)quinazoline,C1=CC=C2C(=C1)C=NC(=N2)OCCC3=CC=C(C=C3)C4(N=N4)C(F)(F)F,,,,,,
3085,133086,(2-(2-(2-((2-Bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid,C(COCCOCCOCC(=O)O)NC(=O)CBr,,,,,,
3086,133087,"1-Butyl-3-(6,7-dimethoxy-2-naphthylsulfonyl)amino-3-(3-guanidinopropyl)-2-pyrrolidinone hydrochloride",CCCCN1CCC(C1=O)(CCCN=C(N)N)NS(=O)(=O)C2=CC3=CC(=C(C=C3C=C2)OC)OC.Cl,,,,,,
3087,133088,"2-[3-[1-Butyl-3-[(6,7-dimethoxynaphthalen-2-yl)sulfonylamino]-2-oxopyrrolidin-3-yl]propyl]guanidine",CCCCN1CCC(C1=O)(CCCN=C(N)N)NS(=O)(=O)C2=CC3=CC(=C(C=C3C=C2)OC)OC,,,,,,
3088,133089,CID 133089,CCC[C@]1(CC(=O)C(=C(O1)O)[C@@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4,,,,,,
3089,133090,N-(alpha-Ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide,CCC(C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)O,"['Investigated for use/treatment in schizophrenia and schizoaffective disorders, irritable bowel syndrome (IBS), and chronic obstructive pulmonary disease (COPD).']",,,,,
3090,133091,"3-Benzylidene-6-[[4-[2-(dimethylamino)ethylsulfanyl]phenyl]methylidene]piperazine-2,5-dione",CN(C)CCSC1=CC=C(C=C1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,,,,,,
3091,133092,CID 133092,C[C@@H]1C(=O)N=C(C(O1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)S,,,,,,
3092,133093,"6,7-Dimethoxy-3-cyano-3,4-dihydrocarbostyril",COC1=C(C=C2C(=C1)CC(C(=O)N2)C#N)OC,,,,,,
3093,133094,CID 133094,CN(CC=CC1=CC=C(C=C1)Cl)CC2=CC=CC=C2N(CCN)S(=O)(=O)C3=CC(=C(C=C3Cl)Cl)Cl,,,,,,
3094,133095,"Estra-1(10),2,4-triene-2,3,14,15,16,17-hexol",C[C@]12CC[C@H]3[C@H](C1(C(C(C2O)O)O)O)CCC4=CC(=C(C=C34)O)O,,,,,,
3095,133096,"2-Cyclopropyl-5-ethyl-7-methoxy-imidazo(1,2-a)pyrimidine methanesulfonate",CCC1=CN2C=C(N=C2N=C1OC)C3CC3.CS(=O)(=O)O,,,,,,
3096,133097,"2-Cyclopropyl-6-ethyl-7-methoxyimidazo[1,2-a]pyrimidine",CCC1=CN2C=C(N=C2N=C1OC)C3CC3,,,,,,
3097,133098,Gamma-CEHC,CC1=C(C=C2CCC(OC2=C1C)(C)CCC(=O)O)O,,,,,,
3098,133099,5-Hydroxy-2-iodotyrosine,C1=C(C(=CC(=C1O)O)I)C[C@@H](C(=O)O)N,,,,,,
3099,133100,"3,5-Diamino-4-hydroxybenzoic acid dihydrochloride",C1=C(C=C(C(=C1N)O)N)C(=O)O.Cl.Cl,,,,,,
3100,133101,"3,5-Diamino-4-hydroxybenzoic acid",C1=C(C=C(C(=C1N)O)N)C(=O)O,,,,,,
3101,133102,(2S)-1-[(S)-benzamido-benzyl-methylazaniumyl]-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutan-2-olate,CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)[C@H](C[N@+](C)(CC2=CC=CC=C2)NC(=O)C3=CC=CC=C3)[O-],,,,,,
3102,133103,(S)-benzamido-benzyl-[(2S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutyl]-methylazanium,CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)[C@H](C[N@+](C)(CC2=CC=CC=C2)NC(=O)C3=CC=CC=C3)O,,,,,,
3103,133104,"1-(4-Methanesulfonamidophenoxy)-3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol, benzoic acid salt",CN(CCC1=CC(=C(C=C1)Cl)Cl)CC(COC2=CC=C(C=C2)NS(=O)(=O)C)O.C1=CC=C(C=C1)C(=O)O,,,,,,
3104,133105,But-2-enedioic acid;3-ethynyl-5-(1-methylpyrrolidin-2-yl)pyridine,CN1CCCC1C2=CN=CC(=C2)C#C.C(=CC(=O)O)C(=O)O,,,,,,
3105,133106,3-Ethynyl-5-(1-methyl-2-pyrrolidinyl)pyridine,CN1CCCC1C2=CN=CC(=C2)C#C,,,,,,
3106,133107,3-Ethoxy-N-methyl-N-(1-(phenylmethyl)-4-piperidinyl)-2-pyridinylamine,CCOC1=C(N=CC=C1)N(C)C2CCN(CC2)CC3=CC=CC=C3,,,,,,
3107,133108,"4-(3-((1,1-Dimethyl-3-iodopropenyl)amino)-2-hydroxypropoxy)carbazole",CC(=C(CI)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O)C,,,,,,
3108,133109,"2-Amino-4-(3,5-diacetylphenyl)amino-6-methylpyrimidine",CC1=CC(=NC(=N1)N)NC2=CC(=CC(=C2)C(=O)C)C(=O)C,,,,,,
3109,133110,2-Amino-4-(3-acetylphenyl)amino-6-methylpyrimidine,CC1=CC(=NC(=N1)N)NC2=CC=CC(=C2)C(=O)C,,,,,,
3110,133111,2-(Thiocyanatomethyl)-5-(benzyloxy)-4H-pyran-4-one,C1=CC=C(C=C1)COC2=COC(=CC2=O)CSC#N,,,,,,
3111,133112,5-Fluoro-3-(1-(2-(1-methyl-1H-pyrazol-4-yl)ethyl)-4-piperidinyl)-1H-indole,CN1C=C(C=N1)CCN2CCC(CC2)C3=CNC4=C3C=C(C=C4)F,,,['Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)'],,,
3112,133113,"N-benzyl-3-(4-chlorophenyl)-N-(1,5-dipyridin-4-ylpentan-3-yl)propanamide;methanesulfonic acid;[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]methanesulfonic acid",CN(CS(=O)(=O)O)C(=O)C(=O)C1=CC(=C(C(=C1)OC)OC)OC.CS(=O)(=O)O.C1=CC=C(C=C1)CN(C(CCC2=CC=NC=C2)CCC3=CC=NC=C3)C(=O)CCC4=CC=C(C=C4)Cl,,,,,,
3113,133114,"[Methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]methanesulfonic acid",CN(CS(=O)(=O)O)C(=O)C(=O)C1=CC(=C(C(=C1)OC)OC)OC,,,,,,
3114,133115,"N-benzyl-3-(4-chlorophenyl)-N-(1,5-dipyridin-4-ylpentan-3-yl)propanamide",C1=CC=C(C=C1)CN(C(CCC2=CC=NC=C2)CCC3=CC=NC=C3)C(=O)CCC4=CC=C(C=C4)Cl,,,,,,
3115,133116,"Androst-5-en-4,7,17-trione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)C(=O)C=C4[C@@]3(CCCC4=O)C,,,,,,
3116,133117,Mtsac cpd,CN(C)CCNC(=O)OCCSS(=O)(=O)C,,,,,,
3117,133118,3-Hydroxycholestan-27-al,C[C@H](CCCC(C)C=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
3118,133119,Bhcec,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CCC3([C@H]2[C@@H](C[C@@H]4[C@@]3(CC[C@@H](C4)OC(=O)C)C)OS(=O)(=O)C)C#N)C,,,,,,
3119,133120,"1-[(3S,8S,9S,10R,13S,14S,17S)-3-(diethylamino)-3-ethoxy-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanol;2,5-dimethylbenzenesulfonic acid",CCN(CC)[C@@]1(CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4C(C)O)C)C)OCC.CC1=CC(=C(C=C1)C)S(=O)(=O)O,,,,,,
3120,133121,"1-[(3S,8S,9S,10R,13S,14S,17S)-3-(diethylamino)-3-ethoxy-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanol",CCN(CC)[C@@]1(CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4C(C)O)C)C)OCC,,,,,,
3121,133122,CID 133122,C[C@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)C=CC2=CC=CO2,,,,,,
3122,133123,"4-[[(2S,3R,5R,9R,10R,13R,17S)-3,14-dihydroxy-10,13-dimethyl-6-oxo-17-[(2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-2-yl]oxy]-4-oxobutanoic acid",C[C@]12CC[C@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)OC(=O)CCC(=O)O)C)C1(CC[C@@H]2[C@](C)([C@@H](CCC(C)(C)O)O)O)O,,,,,,
3123,133124,Whitfield's ointment,C1=CC=C(C=C1)C(=O)O.C1=CC=C(C(=C1)C(=O)O)O,,,,,,
3124,133125,"4-Oxo-4-((5-sulfamoyl-1,3,4-thiadiazol-2-yl)amino)butanoic acid",C(CC(=O)O)C(=O)NC1=NN=C(S1)S(=O)(=O)N,,,,,,
3125,133126,"(4S,5aR)-2,5a-dimethyl-4-sulfanyl-4,5,6,7,10,11-hexahydro-[1]benzofuro[4,5-h]isochromen-6-ol",CC1=CC2=C(O1)CCC3=C2[C@H](C[C@@]4(C3=COCC4O)C)S,,,,,,
3126,133127,"(5aS,6S)-5a-methyl-4,5,6,7,10,11-hexahydro-[1]benzothiolo[4,5-h]isothiochromen-6-ol",C[C@]12CCC3=C(C1=CSC[C@H]2O)CCC4=C3C=CS4,,,,,,
3127,133128,5'-(4-Fluorosulfonylbenzoyl)adenosine hydrochloride,C1=CC(=CC=C1C(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)S(=O)(=O)F.Cl,,,"['Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)']",,,
3128,133129,5'-(Sulfonylbenzoyl)adenosine,C1=CC(=CC=C1C(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)S(=O)(=O)F,,,,,,
3129,133130,"Enkephalin, ala(2)-val(5)-",C[C@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
3130,133131,Cairomycin A,CC(C)[C@H]1C(=O)N[C@H](C(=O)N1)CC(=O)O,,,,,,
3131,133132,"3-Aminopropyl(icosa-5,8,11,14-tetraenoxy)phosphinic acid",CCCCCC=CCC=CCC=CCC=CCCCCOP(=O)(CCCN)O,,,,,,
3132,133133,CID 133133,C1CCC(CC1)C(CCN2C(C(=O)NC2=O)CC=CCCC(=O)O)O,,,,,,
3133,133134,"Enkephalin, ala(2)-valnh2(5)-",C[C@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
3134,133135,Gma-rppo,C1=CN2C(=O)C3=C(N=C2N=C1)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
3135,133136,Valpinax,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3.[Br-],,,,,,
3136,133137,"4(5)-(2,6-Dimethylbenzyl)imidazole",CC1=C(C(=CC=C1)C)CC2=CN=CN2,,,,,,
3137,133138,"Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-((4-azido-2-nitrobenzoyl)oxy)ethyl)-4-methyl-, bromide, monohydrobromide",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)C3=C(C=C(C=C3)N=[N+]=[N-])[N+](=O)[O-].Br.[Br-],,,,,,
3138,133139,CID 133139,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)C3=C(C=C(C=C3)N[N+]#N)[N+](=O)[O-],,,,,,
3139,133140,Travocort,CCCCC(=O)OCC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C.C1=CC(=C(C(=C1)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],,,,,,
3140,133141,"[2-[(6S,8S,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] pentanoate",CCCCC(=O)OCC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C,,,,,,
3141,133142,"3-{[(2-Amino-3,5-dibromophenyl)methyl](cyclohexyl)amino}-1,1,1-trifluoropropan-2-one",C1CCC(CC1)N(CC2=C(C(=CC(=C2)Br)Br)N)CC(=O)C(F)(F)F,,,,,,
3142,133143,"2-(3,4-Dichlorophenoxy)-5-nitrobenzonitrile",C1=CC(=C(C=C1[N+](=O)[O-])C#N)OC2=CC(=C(C=C2)Cl)Cl,,,,,,
3143,133144,"6-(Dipropylamino)-6,7,8,9-tetrahydro-5h-benzo[7]annulen-1-ol",CCCN(CCC)C1CCCC2=C(C1)C=CC=C2O,,,,,,
3144,133145,Yakuchinone-A,COC1=C(C=CC(=C1)CCC(=O)CCCCC2=CC=CC=C2)O,,,,,,
3145,133146,"12-Hydroxy-3-oxo-1,4-pregnadiene-20-carboxylic acid",C[C@@H]([C@H]1CC[C@@H]2[C@@]1([C@@H](C[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)O,,,,,,
3146,133147,Tabac,CC(=O)NC1=C(C=C(C(=C1I)C(=O)OCCOC(=O)NC2CCCCC2)I)I,,,,,,
3147,133148,"1H-Indole-1-carboxamide, N,N'-1,11-undecanediylbis(2,3-dihydro-2-methyl-",CC1CC2=CC=CC=C2N1C(=O)NCCCCCCCCCCCNC(=O)N3C(CC4=CC=CC=C43)C,,,,,,
3148,133149,4-Nitrophenyl 2-azidobenzoate,C1=CC=C(C(=C1)C(=O)OC2=CC=C(C=C2)[N+](=O)[O-])N=[N+]=[N-],,,,,,
3149,133150,CID 133150,C1=CC=C(C(=C1)C(=O)OC2=CC=C(C=C2)[N+](=O)[O-])N[N+]#N,,,,,,
3150,133151,2-Hydroxyaklavinone,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC(=C4)O)O)O)O)O,,,,,,
3151,133152,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(4-hydroxyphenyl)-1-methyl-",CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=C(C=C2)O,,,,,['4-hydroxymephobarbital is a known human metabolite of (s)-mephobarbital.'],
3152,133153,Sulfanizolone,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N.C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,,,,,,
3153,133154,"Carbamic acid, (2-((2,5-dioxo-1-pyrrolidinyl)oxy)-1-((4-hydroxy-3-iodophenyl)methyl)-2-oxoethyl)-, 1,1-dimethylethyl ester, (S)-",CC(C)(C)OC(=O)N[C@@H](CC1=CC(=C(C=C1)O)I)C(=O)ON2C(=O)CCC2=O,,,,,,
3154,133155,"Thiazolo(5,4-f)quinolinecarboxylic acid",C1=CC2=C(C3=C1N=CC(=C3)C(=O)O)SC=N2,,,,,,
3155,133156,"3-(Cyclopentyloxy)-19-norpregna-3,5-dien-20-yn-17-yl acetate--6-methyl-3,20-dioxopregna-4,6-dien-17-yl acetate (1/1)",CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C.CC(=O)OC1(CCC2[C@@]1(CCC3C2CC=C4[C@@H]3CCC(=C4)OC5CCCC5)C)C#C,,,,,,
3156,133157,"[(10R,13S)-3-cyclopentyloxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CC(=O)OC1(CCC2[C@@]1(CCC3C2CC=C4[C@@H]3CCC(=C4)OC5CCCC5)C)C#C,,,,,,
3157,133158,N-Acetyl-3-hydroxyprocainamide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1)NC(=O)C)O,,,,,,
3158,133159,CID 133159,C1=CC(=O)C=C2C1=CC(=C(O2)O)C(=O)NCCO,,,,,,
3159,133160,"5,8,14-Eicosatrienoic acid",CCCCCC=CCCCCC=CCC=CCCCC(=O)O,,,,,,
3160,133161,Gusanlung B,COC1=C(C2=C(C[C@H]3C4=CC5=C(C=C4CCN3C2=O)OCO5)C=C1)OC,,,,,,
3161,133162,"Dihydrocodeine bitartrate, aspirin and caffeine",CCOC1=CC=C(C=C1)NC(=O)C.CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.CC(=O)OC1=CC=CC=C1C(=O)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C.Cl,,,,,,
3162,133163,Dotpo,CC1(CC(=CC(=O)C=[N+]=[N-])CC(N1[O])(C)C)C,,,,,,
3163,133164,CID 133164,CC1(CC(=CC(=C[N+]#N)O)CC(N1[O])(C)C)C,,,,,,
3164,133165,CID 133165,CC1(C=C(C(N1[O])(C)C)C=CC(=C[N+]#N)[O-])C,,,,,,
3165,133166,CID 133166,CC1(C=C(C(N1[O])(C)C)C=CC(=C[N+]#N)O)C,,,,,,
3166,133167,"17,18-Dibromooctadecanoic acid",C(CCCCCCCC(CBr)Br)CCCCCCCC(=O)O,,,,,,
3167,133168,"Butanoic acid, 2-amino-4-(methylsulfonyl)-, hydrazide, (S)-",CS(=O)(=O)CC[C@@H](C(=O)NN)N,,,,,,
3168,133169,"1,3,5-Benzenetriol, mixt. with 1,3,5-trimethoxybenzene",COC1=CC(=CC(=C1)OC)OC.C1=C(C=C(C=C1O)O)O,,,,,,
3169,133170,beta-Galactosylumbelliferone theophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CCCNC(=O)C3=CC4=C(C=C(C=C4)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)OC3=O,,,,,,
3170,133171,5-Phenyl-5-(4-aminobutyl)barbituric acid,C1=CC=C(C=C1)C2(C(=O)NC(=O)NC2=O)CCCCN,,,,,,
3171,133172,CID 133172,CC=C(C)C(=O)OC1C2=C(C(=CC=C2)OC(=O)NC)OC1(C)C,,,,,,
3172,133173,"3-Methyl-4-hydroxy-1-(N,N-dimethylaminomethyl)cyclopent-2-ene",CC1=C[C@@H](C[C@@H]1O)C[N+](C)(C)C.[I-],,,,,,
3173,133174,CID 133174,CC1=C[C@@H](CC1O)C[N+](C)(C)C,,,,,,
3174,133175,"2-Cyclopentene-1-methanaminium, N,N,N,3-tetramethyl-4-oxo-, iodide",CC1=CC(CC1=O)C[N+](C)(C)C.[I-],,,,,,
3175,133176,Trimethyl-[(3-methyl-4-oxocyclopent-2-en-1-yl)methyl]azanium,CC1=CC(CC1=O)C[N+](C)(C)C,,,,,,
3176,133177,N-5-Carboxypentyl-1-deoxynojirimycin,C1[C@@H]([C@H]([C@@H]([C@H](N1CCCCCC(=O)O)CO)O)O)O,,,,,,
3177,133178,"2,4,6-Triiodobenzene-1,3,5-tricarboxylic acid",C1(=C(C(=C(C(=C1I)C(=O)O)I)C(=O)O)I)C(=O)O,,,,,,
3178,133179,"(+-)-2-(Acetylamino)-N,N,4-trimethylpentanamide",CC(C)CC(C(=O)N(C)C)NC(=O)C,,,,,,
3179,133180,"2-[4-[4-(2,6,6-Trimethylcyclohexen-1-yl)but-3-en-2-ylidene]cyclohept-2-en-1-ylidene]acetaldehyde",CC1=C(C(CCC1)(C)C)C=CC(=C2CCCC(=CC=O)C=C2)C,,,,,,
3180,133181,CID 133181,C1=NC(=C2C(=NC(=N2)N[N+]#N)[N-]1)N,,,,,,
3181,133182,CID 133182,C1=NC(=C2C(=N1)N=C(N2)N[N+]#N)N,,,,,,
3182,133183,Estradiol mixture with estriol and estrone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O.C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O.C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O,,,,,,
3183,133184,"(8R,9S,13S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H]3[C@H](C1CCC2=O)CCC4=C3C=CC(=C4)O,,,,,"['Estrone has known human metabolites that include 15alpha-hydroxy-estrone, 16alpha-hydroxy-estrone, 16beta-hydroxy-estrone, 2-hydroxyestrone, 4-hydroxyestrone, 6alpha-hydroxy-estrone, 6beta-estrone, and 7alpha-hydroxy-estrone.']",
3184,133185,1-Amino-3-[3-(4-hydroxy-2-iodophenyl)propanoylamino]urea,C1=CC(=C(C=C1O)I)CCC(=O)NNC(=O)NN,,,,,,
3185,133186,"(2S,3S,4S,5R,6S)-6-[2-(carboxymethylcarbamoyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",C1=CC=C(C(=C1)C(=O)NCC(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
3186,133187,"4,4-Dimethyl-14a-formyl-5a-cholesta-8,24-dien-3b-ol",C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C=O,,,,,,
3187,133188,"(1R,7R,9R,10R,14R)-12,12-Dimethyl-11,13,15-trioxa-2,4-diazatetracyclo[7.5.1.02,7.010,14]pentadecane-3,5-dione",CC1(O[C@@H]2[C@H]3C[C@@H]4CC(=O)NC(=O)N4[C@@H]([C@@H]2O1)O3)C,,,,,,
3188,133189,Phe-pro-arg,C1C[C@H](N(C1)C(=O)[C@@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
3189,133190,"2-Ethyl-5-(2-phenylethenyl)-1,3-benzenediol",CCC1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O,,,,,,
3190,133191,"1,3-Benzenediol, 2-(1-methylethyl)-5-(2-phenylethenyl)-",CC(C)C1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O,,,,,,
3191,133192,"(2S)-2-amino-3-[4-(3,5-diiodo-4-sulfooxyphenoxy)-3-iodophenyl]propanoic acid",C1=CC(=C(C=C1C[C@@H](C(=O)O)N)I)OC2=CC(=C(C(=C2)I)OS(=O)(=O)O)I,,,,,,
3192,133193,CID 133193,C1=NC2=C(N1COCCN)NC(=NC2=O)N,,,,,,
3193,133194,Prolyl-phenylalanyl-N-heptylargininamide,CCCCCCCN[C@@H](CCCN=C(N)N)C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H]2CCCN2,,,,,,
3194,133195,"1-Dodecyl 2,3-ditetradecyloxypropionate",CCCCCCCCCCCCCCOCC(C(=O)OCCCCCCCCCCCC)OCCCCCCCCCCCCCC,,,,,,
3195,133196,alpha-Methoxyiminopyrazineacetonitrile,CON=C(C#N)C1=NC=CN=C1,,,,,,
3196,133197,CID 133197,C1[C@H]([C@@H]([C@H](C1=O)CC=CCCCC(=O)CO)C=CC(COC2=CC=CC=C2)O)O,,,,,,
3197,133198,"2,9-Dibromobenzanthrone",C1=CC2=CC(=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)Br)Br,,,,,,
3198,133199,CID 133199,C(CCNC(=O)CCS[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)C[C@@H](C(=O)N[C@@H](CCCCNC(=O)CCS[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)O)NC(=O)CCS[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
3199,133200,Methyl N-succinimidoxyacetate,COC(=O)CON1C(=O)CCC1=O,,,,,,
3200,133201,"Benzenesulfonamide, 5-(2-amino-1-hydroxyethyl)-2-chloro-",C1=CC(=C(C=C1C(CN)O)S(=O)(=O)N)Cl,,,,,,
3201,133202,"Octadecanoic acid, 4-methyl-2-oxo-2H-1-benzopyran-7-yl ester",CCCCCCCCCCCCCCCCCC(=O)OC1=CC2=C(C=C1)C(=CC(=O)O2)C,,,,,,
3202,133203,CID 133203,CCCCCCC(CC=CCCCCCCCC(=O)O)OC(CCCCCC)CC=CCCCCCCCC(=O)O,,,,,,
3203,133204,Hydroxyethylclavam,C1[C@H]2N(C1=O)C[C@@H](O2)CCO,,,,,,
3204,133205,CID 133205,C1N(C2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)NC(=NC2=O)N)CCCCCC(=O)O,,,,,,
3205,133206,CID 133206,CC1(O[C@@H]2[C@H](O[C@H]([C@@H]2O1)N3CN(C4=C3NC(=NC4=O)N)C)COP(=O)(O)OP(=O)(O)O)CCC(=O)O,,,,,,
3206,133207,5-Tridecylpyrazole-3-carboxylic acid,CCCCCCCCCCCCCC1=CC(=NN1)C(=O)O,,,,,,
3207,133208,"(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-(5-methyl-2-propan-2-ylcyclohexyl)oxyoxane-2-carboxylic acid",CC1CCC(C(C1)O[C@@H]2[C@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)O)O)O)C(C)C,,,,,,
3208,133209,CID 133209,C1=CC2=C(C=C1N[N+]#N)C(=C[N-]2)CC(=O)O,,,,,,
3209,133210,CID 133210,C1=CC2=C(C=C1N[N+]#N)C(=CN2)CC(=O)O,,,,,,
3210,133211,"(4R,7S,10S,13S,16S,19R)-10-(4-aminobutyl)-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@H](CC5=CC=CC=C5)N)C(=O)N)O,,,,,,
3211,133212,"(2r,3r,6r,7r)-7-[(5-Amino-5-carboxypentanoyl)amino]-3-hydroxy-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic acid",C[C@@]1(CS[C@@H]2[C@@H](C(=O)N2[C@H]1C(=O)O)NC(=O)CCCC(C(=O)O)N)O,,,,,,
3212,133213,2C12-Glu-ph-C2-N+,CCCCCCCCCCCCOC(=O)CC[C@@H](C(=O)OCCCCCCCCCCCC)NC(=O)C1=CC=C(C=C1)OCC[N+](C)(C)C.[Br-],,,,,,
3213,133214,"2-[4-[[(2S)-1,5-didodecoxy-1,5-dioxopentan-2-yl]carbamoyl]phenoxy]ethyl-trimethylazanium",CCCCCCCCCCCCOC(=O)CC[C@@H](C(=O)OCCCCCCCCCCCC)NC(=O)C1=CC=C(C=C1)OCC[N+](C)(C)C,,,,,,
3214,133215,CID 133215,CC(C(=NN=C(N)S)C=NN=C(N)S)N1C(=O)C2=CC=CC=C2C1=O,,,,,,
3215,133216,6-Acetoxy-4-methylhexanal,C[C@H](CCC=O)CCOC(=O)C,,,,,,
3216,133217,"{[(8xi,9xi,14xi)-3,17-Dioxoandrost-4-en-19-yl]oxy}acetic acid",C[C@]12CCC3C(C1CCC2=O)CCC4=CC(=O)CC[C@]34COCC(=O)O,,,,,,
3217,133218,Cyclic leucine enkephalin,CC(C)C[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)CCCCN)CCCCN,,,,,,
3218,133219,4-Azidophlorhizin,C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)N=[N+]=[N-],,,,,,
3219,133220,S-(3-Nitro-2-pyridinesulfenyl)cysteine,C1=CC(=C(N=C1)SSC[C@@H](C(=O)O)N)[N+](=O)[O-],,,,,,
3220,133221,"(3bR,9bS)-6-hydroxy-9b-methyl-7-(propan-2-yl)-3,3b,4,9b,10,11-hexahydrophenanthro[1,2-c]furan-1,5-dione",CC(C)C1=C(C2=C(C=C1)[C@@]3(CCC4=C([C@H]3CC2=O)COC4=O)C)O,,,,,,
3221,133222,Ferene,C1=CC=NC(=C1)C2=NC(=C(N=N2)C3=CC=C(O3)S(=O)(=O)[O-])C4=CC=C(O4)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3222,133223,"5-[3-Pyridin-2-yl-6-(5-sulfofuran-2-yl)-1,2,4-triazin-5-yl]furan-2-sulfonic acid",C1=CC=NC(=C1)C2=NC(=C(N=N2)C3=CC=C(O3)S(=O)(=O)O)C4=CC=C(O4)S(=O)(=O)O,,,,,,
3223,133224,"14,15-Dihydroxyicosa-5,8,11-trienoic acid",CCCCCC(C(CC=CCC=CCC=CCCCC(=O)O)O)O,,,,,,
3224,133225,"11,12-Dihydroxyicosa-5,8,14-trienoic acid",CCCCCC=CCC(C(CC=CCC=CCCCC(=O)O)O)O,,,,,,
3225,133226,19(R)-Hete,CC(CCCC=CCC=CCC=CCC=CCCCC(=O)O)O,,,,,,
3226,133227,CID 133227,C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)C=CBr,,,,,,
3227,133228,CID 133228,C[C@@H](C(=O)NCC(=O)N(C(=O)[C@H](CC1=CC=C(C=C1)F)N)C(=O)[C@H](C2=CC=CC=C2)N)NC(=O)[C@H](CC3=CC=C(C=C3)O)N.CC(=O)O,,,,,,
3228,133229,CID 133229,C[C@@H](C(=O)NCC(=O)N(C(=O)[C@H](CC1=CC=C(C=C1)F)N)C(=O)[C@H](C2=CC=CC=C2)N)NC(=O)[C@H](CC3=CC=C(C=C3)O)N,,,,,,
3229,133230,"4-Methylamino-alpha,2-dimethylphenethylamine",CC1=C(C=CC(=C1)NC)C[C@H](C)N,,,,,,
3230,133231,"3,7,11,15,19-Pentamethyl-eicosa-2,6,10,14,18-pentaen-1-ol",CC(=CCCC(=CCCC(=CCCC(=CCCC(=CCO)C)C)C)C)C,,,,,,
3231,133232,"[(6S,8S,10S,11S,13S,14S,16S)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-17-methylsulfanylcarbonyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)OC1([C@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SC,,,,,,
3232,133233,4-Nitrophenyl 2-O-alpha-D-galactopyranosyl-alpha-D-mannopyranoside,C1=CC(=CC=C1[N+](=O)[O-])O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O,,,,,,
3233,133234,4-Nitrophenyl 2-O-alpha-D-glucopyranosyl-alpha-D-mannopyranoside,C1=CC(=CC=C1[N+](=O)[O-])O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
3234,133235,"13-Hydroxy-14,15-epoxy-5,8,11-eicosatrienoic acid",CCCCCC1C(O1)C(C=CCC=CCC=CCCCC(=O)O)O,,,,,,
3235,133236,"11,14,15-Trihydroxyicosa-5,8,12-trienoic acid",CCCCCC(C(C=CC(CC=CCC=CCCCC(=O)O)O)O)O,,,,,,
3236,133237,N-(4-Chlorobenzyl)phenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NCC2=CC=C(C=C2)Cl,,,,,,
3237,133238,Cui xing an,CN(C)CCOC1=CC(=CC=C1)OC(=O)N(C)C,,,,,,
3238,133239,Nitroso-5-methyloxazolidone,CC1CN(C(=O)O1)N=O,,,,,,
3239,133240,"N-[(2S,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]propanamide",CCC(=O)N[C@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
3240,133241,CID 133241,C[C@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])CCl.[K+],,,,,,
3241,133242,"(2S,3S,5R)-3-(chloromethyl)-3-methyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",C[C@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CCl,,,,,,
3242,133243,CID 133243,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCCN3CC3)C4=CC=CC=C4,,,,,,
3243,133244,CID 133244,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCC3=C(N4[C@@H]([C@@H](C4=O)NC(=O)CC5=CC=CS5)SC3)C(=O)[O-].[Na+],,,,,,
3244,133245,"(6R,7R)-3-[[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]methyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCC3=C(N4[C@@H]([C@@H](C4=O)NC(=O)CC5=CC=CS5)SC3)C(=O)O,,,,,,
3245,133246,CID 133246,C[C@@H]([C@@H]([C@H]1CN=C2C(=N1)C(=O)N=C(N2)N)O)O,,,,,,
3246,133247,CID 133247,C1=C(C(=NC(=N1)S)N)N.O.O.Cl.Cl,,,,,,
3247,133248,CID 133248,C1=C(C(=NC(=N1)S)N)N,,,,,,
3248,133249,N-Demethylfleroxacin,C1CN(CCN1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F,,,,,,
3249,133250,CID 133250,COC1=C(C=C2CC(CC2=C1)C(=NO)N)OC.Cl,,,,,,
3250,133251,"2,3-Dihydro-N-hydroxy-5,6-dimethoxy-1H-indene-2-carboxamidine",COC1=C(C=C2CC(CC2=C1)C(=NO)N)OC,,,,,,
3251,133252,Madgpm,CC(=O)N[C@@H]1C[C@@H]([C@H](O[C@@H]1OP(=O)(O)OC)C(O)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
3252,133253,CID 133253,CCCCC[C@@H](C=C[C@H]1[C@@H](CC2=C1C=C(N2C3=CC=CC=C3)CCCCC(=O)OC)O)O,,,,,,
3253,133254,"(2S,4S,4aS,6R,8aR)-4-[4-(1,1-Dimethyl-heptyl)-2-hydroxy-phenyl]-6-hydroxymethyl-decahydro-naphthalen-2-ol",CCCCCCC(C)(C)C1=CC(=C(C=C1)[C@H]2C[C@H](C[C@@H]3[C@@H]2C[C@@H](CC3)CO)O)O,,,,,,
3254,133255,"1,1'-Biphenyl, 2,3,3',4,4',5,6-heptabromo-",C1=CC(=C(C=C1C2=C(C(=C(C(=C2Br)Br)Br)Br)Br)Br)Br,,,,,,
3255,133256,"1,2,3-Propanetriol, mixt. with sulfinylbis(methane)",CS(=O)C.C(C(CO)O)O,,,,,,
3256,133257,"(3aS,4S,7R,7aR)-7-hydroxy-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-2,3,3a,4,6,7-hexahydroindene-1,5-dione",CC1=C(C=C(C=C1)O)CC[C@H]2[C@@H]3CCC(=O)[C@]3([C@@H](CC2=O)O)C,,,,,,
3257,133258,5-Bromo-2-((2-thienylmethyl)sulfinyl)pyrimidine,C1=CSC(=C1)CS(=O)C2=NC=C(C=N2)Br,,,,,,
3258,133259,"10-((2,3-Dimethyl-1-oxopentyl)amino)-4-oxo-4H-pyrimido(1,2-c)quinazoline-3-carboxylic acid",CCC(C)C(C)C(=O)NC1=CC2=C(C=C1)N=CN3C2=NC=C(C3=O)C(=O)O,,,,,,
3259,133260,"(4R,6R)-6-[2-[(1R,2R,8R,8aS)-8-[(4-fluorophenyl)methoxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl]-4-hydroxyoxan-2-one",C[C@@H]1C=CC2=CC(C[C@H]([C@H]2[C@@H]1CC[C@@H]3C[C@H](CC(=O)O3)O)OCC4=CC=C(C=C4)F)C,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
3260,133261,CID 133261,CCC=CCC=CCC=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)O)N,,,,,,
3261,133262,"2-Propanol, 1-((1-(4-azidophenyl)-1-methylethyl)amino)-3-(9H-carbazol-4-yloxy)-",CC(C)(C1=CC=C(C=C1)N=[N+]=[N-])NCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,,,,,,
3262,133263,6-Bromopenicillanic acid S-sulfoxide,CC1([C@@H](N2[C@H](S1=O)[C@H](C2=O)Br)C(=O)O)C,,,,,,
3263,133264,Risarestat,CCCCCOC1=C(C=C(C=C1)C2C(=O)NC(=O)S2)OCC,,,,,,
3264,133265,CID 133265,CC(=O)N[C@]1(CN(C1=O)S(=O)(=O)[O-])OC.[K+],,,,,,
3265,133266,(3R)-3-acetamido-3-methoxy-2-oxoazetidine-1-sulfonic acid,CC(=O)N[C@]1(CN(C1=O)S(=O)(=O)O)OC,,,,,,
3266,133267,10-Hydroxydec-8-enoic acid,C(CCCC(=O)O)CCC=CCO,,,,,,
3267,133268,Calcium specific chelator,CC1=CC(=C(C=C1)N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C)OCCOC2=CC=CC=C2N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C,,,,,,
3268,133269,CID 133269,CCCCC[C@@H]1[C@H](O1)C(=O)C=CCCCCCCCC(=O)O,,,,,,
3269,133270,"7-[(1R,2R,3R,5S)-5-Hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-3-methoxycyclopentyl]hept-5-enoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)OC)O,,,,,,
3270,133271,"7-[(1R,2R,3R,5S)-3-Hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-methoxycyclopentyl]hept-5-enoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)OC)O)O,,,,,,
3271,133272,CID 133272,CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]2[C@@H]1CC(=CCCCC(=O)O)O2)OC)O,,,,,,
3272,133273,CID 133273,CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]2[C@@H]1CC(=CCCCC(=O)O)O2)O)OC,,,,,,
3273,133274,Pyrrolomycin B,C1=C(C=C(C(=C1CC2=C(C(=C(N2)Cl)Cl)[N+](=O)[O-])O)Cl)Cl,,,,,,
3274,133275,Pyrrolomycin A,C1=C(C(=C(N1)Cl)Cl)[N+](=O)[O-],,,,,,
3275,133276,Murametide,C[C@@H](C(=O)N[C@H](CCC(=O)N)C(=O)OC)NC(=O)C(C)O[C@@H]1[C@H]([C@H](O[C@@H]([C@H]1O)CO)O)NC(=O)C,,,,,,
3276,133277,3-Hydroxyphencyclidine,C1CCC(CC1)(C2=CC(=CC=C2)O)N3CCCCC3,,,,,,
3277,133278,2-(2-Acetamido-2-deoxyglucose-3-O-yl)hexanoyl-alanyl-isoglutamine,CCCOC(=O)[C@@H](CCC(=O)N)NC(=O)[C@H](C)NC(=O)C(C)O[C@@H]1[C@H]([C@H](O[C@@H]([C@H]1O)CO)O)NC(=O)C,,,,,,
3278,133279,13-[(Phosphonooxy)methyl]hexacosanedioic acid,C(CCCCCCC(=O)O)CCCCCC(CCCCCCCCCCCC(=O)O)COP(=O)(O)O,,,,,,
3279,133280,Veprisinium,CC(C)([C@@H]1CC2=C(C3=C(C(=C(C=C3)OC)OC)[N+](=C2O1)C)OC)O,,,,,,
3280,133281,"4-[4-[5-(1,3-dibutyl-2,4,6-trioxo-1,3-diazinan-5-ylidene)penta-1,3-dienyl]-3-methyl-5-oxo-4H-pyrazol-1-yl]benzenesulfonic acid",CCCCN1C(=O)C(=CC=CC=CC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)O)C)C(=O)N(C1=O)CCCC,,,,,,
3281,133282,"Propanenitrile, 2-((4-((2-hydroxy-3-(2-nitro-1H-imidazol-1-yl)propyl)amino)-2,2,6,6-tetramethyl-1-piperidinyl)oxy)-2-methyl-, dihydrochloride",CC1(CC(CC(N1OC(C)(C)C#N)(C)C)NCC(CN2C=CN=C2[N+](=O)[O-])O)C.Cl.Cl,,,,,,
3282,133283,"2-[4-[[2-Hydroxy-3-(2-nitroimidazol-1-yl)propyl]amino]-2,2,6,6-tetramethylpiperidin-1-yl]oxy-2-methylpropanenitrile",CC1(CC(CC(N1OC(C)(C)C#N)(C)C)NCC(CN2C=CN=C2[N+](=O)[O-])O)C,,,,,,
3283,133284,CID 133284,C1=CC(=CC=C1C2C(=O)C(=C(O2)O)O)Cl,,,,,,
3284,133285,"Phenol, 4-(2-chloro-1-(4-(2-(diethylamino)ethoxy)phenyl)-2-phenylethenyl)-",CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=C(C=C3)O,,,,,,
3285,133286,N-[3-cyano-4-[2-hydroxy-3-(2-methylbut-3-yn-2-ylamino)propoxy]phenyl]-2-methylprop-2-enamide,CC(=C)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C#C)O)C#N,,,,,,
3286,133287,CID 133287,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC.CN(C)CCCC1=CC=CC=N1.C1=CC(=CC=C1OC(=O)C=CC(=O)O)Cl.Cl,,,,,,
3287,133288,(2-Pyridyl)-3-dimethylaminopropane,CN(C)CCCC1=CC=CC=N1,,,,,,
3288,133289,CID 133289,C1=CC(=CC=C1OC(=O)C=CC(=O)O)Cl,,,,,,
3289,133290,17beta-Bromoacetylamino-4-androsten-3-one,C[C@]12CCC3C(C1CC[C@@H]2NC(=O)CBr)CCC4=CC(=O)CC[C@]34C,,,,,,
3290,133291,"3-(3-Acetyl-4-hydroxyphenyl)-1,1-diethylurea",CCN(CC)C(=O)NC1=CC(=C(C=C1)O)C(=O)C,,,,,,
3291,133292,"3-Imidazo(2,1-b)benzothiazol-2-ylphenol",C1=CC=C2C(=C1)N3C=C(N=C3S2)C4=CC(=CC=C4)O,,,,,,
3292,133293,CID 133293,CCO[C@H]1[C@]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O)(C4=CC(=C(C=C4)O)O)O,,,,,,
3293,133294,"8-(3-Dimethylamino-propoxy)-1,3,7-trimethyl-3,7-dihydro-purine-2,6-dione",CN1C2=C(N=C1OCCCN(C)C)N(C(=O)N(C2=O)C)C,,,,,,
3294,133295,5-Hydroxy-3-mercapto-4-methoxybenzoic acid,COC1=C(C=C(C=C1S)C(=O)O)O,,,['Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)'],,,
3295,133296,4-Chloro-gamma-hydroxybenzenebutanoic acid,C1=CC(=CC=C1C(CCC(=O)O)O)Cl,,,,,,
3296,133297,"1,3-Propanediamine, N,N-dimethyl-N'-(5-nitro-4-quinolinyl)-",CN(C)CCCNC1=C2C(=NC=C1)C=CC=C2[N+](=O)[O-],,,,,,
3297,133298,alpha-(Dimethylaminomethyl)-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol,CCC1=NOC(=C1C2=C(C3=CC=CC=C3N2)C(CN(C)C)O)C,,,,,,
3298,133299,Pyridine pentaamineruthenium(III),C1=CC=NC=C1.N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Ru+3],,,,,,
3299,133300,4-(1-Methyl-2-piperidinyl)-1(2H)-phthalazinone hydrochloride,CN1CCCCC1C2=NNC(=O)C3=CC=CC=C32.Cl,,,,,,
3300,133301,4-(1-methylpiperidin-2-yl)-2H-phthalazin-1-one,CN1CCCCC1C2=NNC(=O)C3=CC=CC=C32,,,,,,
3301,133302,CID 133302,CCOC(=O)C=C(C)NCC1=C(C(=CC(=C1)C(C)(C)C)Cl)O,,,,,,
3302,133303,2-{[2-(Acetyloxy)benzoyl]oxy}-3-phenylpropanoic acid,CC(=O)OC1=CC=CC=C1C(=O)OC(CC2=CC=CC=C2)C(=O)O,,,,,,
3303,133304,beta-Endorphin 2-9,C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CN)O,,,,,,
3304,133305,"4(5)-2-(2,6-Dimethylphenyl)ethylimidazole",CC1=C(C(=CC=C1)C)CCC2=CN=CN2,,,,,,
3305,133306,"Thiazolium, 5-(2-(((2-(aminocarbonyl)phenoxy)hydroxyphosphinyl)oxy)ethyl)-3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-, bromide",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OC3=CC=CC=C3C(=O)N.[Br-],,,,,,
3306,133307,"2-[3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl (2-carbamoylphenyl) hydrogen phosphate",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OC3=CC=CC=C3C(=O)N,,,,,,
3307,133308,Maleimidomethyl-3-maleimido propionate,C1=CC(=O)N(C1=O)CCC(=O)OCN2C(=O)C=CC2=O,,,,,,
3308,133309,"4alpha,23,24-Trimethyl-5alpha-cholestan-3beta-ol",C[C@H]1[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@]2(CC[C@@H]1O)C)C)[C@H](C)CC(C)C(C)C(C)C,,,,,,
3309,133310,"4-Hydroxy-6-[2-(8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl]oxan-2-one",CC1CC(C2C(C(C=CC2=C1)C)CCC3CC(CC(=O)O3)O)O,,,,,,
3310,133311,CID 133311,CCCCN1C(=O)C(=CC=CC=C2C=CN(C3=CC=CC=C23)CCCCS(=O)(=O)[O-])SC1=S.[Na+],,,,,,
3311,133312,CID 133312,CCCCN1C(=O)C(=CC=CC=C2C=CN(C3=CC=CC=C23)CCCCS(=O)(=O)O)SC1=S,,,,,,
3312,133313,"3-Heptyl-2-[3-(3-heptyl-1,3-benzoxazol-2(3H)-ylidene)prop-1-en-1-yl]-3H-1,3-benzoxazol-1-ium",CCCCCCCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)CCCCCCC,,,,,,
3313,133314,5-Carboxyfluorescein diacetate,CC(=O)OC1=CC2=C(C=C1)C3(C4=C(C=C(C=C4)C(=O)O)C(=O)O3)C5=C(O2)C=C(C=C5)OC(=O)C,,,,,,
3314,133315,"N-[4-[(4-methoxy-1,2,5-thiadiazol-3-yl)sulfamoyl]phenyl]acetamide",CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=NSN=C2OC,,,,,,
3315,133316,"(2r)-2,3-Bis[(4,4-difluorotetradecanoyl)oxy]propyl 2-(trimethylammonio)ethyl phosphate",CCCCCCCCCCC(CCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC(CCCCCCCCCC)(F)F)(F)F,,,,,,
3316,133317,"2-[[(2R)-2,3-bis(4,4-difluorotetradecanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCC(CCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCC(CCCCCCCCCC)(F)F)(F)F,,,,,,
3317,133318,5-Fluorouridine diphosphate glucose,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)C([C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OP(=O)(O)OP(=O)(O)O)O)O)F,,,,,,
3318,133319,N-4-Methoxyphenylretinamide,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)OC)C)C,,,,,,
3319,133320,"[(2R,4S)-1,2-dimethyl-4-phenylpiperidin-4-yl] propanoate",CCC(=O)O[C@]1(CCN([C@@H](C1)C)C)C2=CC=CC=C2,,,,,,
3320,133321,Isotheoline,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)OC)O)O)OC.CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)O)OC)O)OC,,,,,,
3321,133322,Bracteoline,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)O)OC)O)OC,,,,,,
3322,133323,(+)-Isoboldine,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)OC)O)O)OC,,,,,,
3323,133324,"3,7-Dihydroxy-2-(1,4-benzodioxan-6-yl)chroman-4-one",C1COC2=C(O1)C=CC(=C2)[C@H]3[C@@H](C(=O)C4=C(O3)C=C(C=C4)O)O,,,,,,
3324,133325,"3,7-Dihydroxy-2-((2,3-diphenyl)-1,4-benzdioxan-6-yl)chroman-4-one",C1=CC=C(C=C1)C2C(OC3=C(O2)C=CC(=C3)C4C(C(=O)C5=C(O4)C=C(C=C5)O)O)C6=CC=CC=C6,,,,,,
3325,133326,Moroxybrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl.C1COCCN1C(=N)N=C(N)N,,,,,,
3326,133327,Elsinore pill,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC.CN1C=NC2=C1C(=O)N(C(=O)N2C)C,,,,,,
3327,133328,"sodium;(2R,3R,4S,5S,6R)-2-[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;7-hydroxy-10-oxidophenoxazin-10-ium-3-one;azide",C1=CC2=C(C=C1O)OC3=CC(=O)C=CC3=[N+]2[O-].C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.[N-]=[N+]=[N-].[Na+],,,,,,
3328,133329,CID 133329,C(C1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@]2([C@H]([C@@H](C(O2)CO)O)O)CO)O)O)O)O,,,,,,
3329,133330,CID 133330,CCCC(C)(C)C[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
3330,133331,CID 133331,CCCC(C)(C)CC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
3331,133332,"5-(2-fluoroethenyl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=CF)CO)O,,,,,,
3332,133333,CID 133333,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)N)O)NC(=NC2=O)N,,,,,,
3333,133334,N-(1H-Tetrazol-5-yl)-4-methyl-6-(4-(methylamino)phenyl)-2-pyridinecarboxamide,CC1=CC(=NC(=C1)C(=O)NC2=NNN=N2)C3=CC=C(C=C3)NC,,,,,,
3334,133335,"2-(4-(1-Azacyclooctylcarbonyl)piperidin-1-yl)-4-amino-6,7-dimethoxyquinazoline hcl",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCC(CC3)C(=O)N4CCCCCCC4)N)OC.Cl,,,,,,
3335,133336,"[1-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperidin-4-yl]-(azocan-1-yl)methanone",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCC(CC3)C(=O)N4CCCCCCC4)N)OC,,,,,,
3336,133337,"2-Vinyl-4H-1,3-dithiine",C=CC1SCC=CS1,,,,,,
3337,133338,"N,N,N',N'-Tetrakis(2-fluoro-2,2-dinitroethyl)oxamide",C(C([N+](=O)[O-])([N+](=O)[O-])F)N(CC([N+](=O)[O-])([N+](=O)[O-])F)C(=O)C(=O)N(CC([N+](=O)[O-])([N+](=O)[O-])F)CC([N+](=O)[O-])([N+](=O)[O-])F,,,,,,
3338,133339,Succinylacetone pyrrole,CC1=C(C(=CN1)CCC(=O)O)C(=O)CCC(=O)O,,,,,,
3339,133340,Propylinium,C1=CC=C2C(=C1)C=CC=[N+]2CCC[N+]3=CC=CC4=CC=CC=C43,,,,,,
3340,133341,"2,5,7,8-Tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chlorochroman",CC1=C(C(=C(C2=C1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)Cl)C,,,,,,
3341,133342,Prototapen,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,,,,,,
3342,133343,2-Hydroxypropanoic acid;2-(trimethylazaniumyl)acetate;urea,CC(C(=O)O)O.C[N+](C)(C)CC(=O)[O-].C(=O)(N)N,,,,,,
3343,133344,Calmurid-HC,CC(C(=O)O)O.C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O.C[N+](C)(C)CC(=O)[O-].C(=O)(N)N,,,,,,
3344,133345,1-Acetyl-2-methyl-2-formylhydrazine,CC(=O)NN(C)C=O,,,,,,
3345,133346,1-(4-Methyl-3-nitrobenzoyl)piperazine,CC1=C(C=C(C=C1)C(=O)N2CCNCC2)[N+](=O)[O-],,,,,,
3346,133347,CID 133347,CCC1=CC=C(C=C1)C(=O)CSS(=O)(=O)[O-].[Na+],,,,,,
3347,133348,1-Ethyl-4-(2-sulfosulfanylacetyl)benzene,CCC1=CC=C(C=C1)C(=O)CSS(=O)(=O)O,,,,,,
3348,133349,N-Methylpiperidin-4-yl propionate,CCC(=O)OC1CCN(CC1)C,,,,,,
3349,133350,"1,2-Dimethyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile",CC1=C(C=C(C(=O)N1C)C#N)C2=CC=NC=C2,,,,,,
3350,133351,"2-Methyl-3,4'-bipyridin-6(1H)-one",CC1=C(C=CC(=O)N1)C2=CC=NC=C2,,,,,,
3351,133352,4-[(2-aminoacetyl)-[(2S)-1-(4-methyl-2-oxochromen-7-yl)pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid,CC1=CC(=O)OC2=C1C=CC(=C2)N3CCC[C@H]3C(=O)N(C(=O)CCC(=O)O)C(=O)CN,,,,,,
3352,133353,"3-(2-Ethylhex-2-enyl)oxolane-2,5-dione",CCCC=C(CC)CC1CC(=O)OC1=O,,,,,,
3353,133354,"N4-(5-(4-Fluorophenoxy)-6-methoxy-4-methyl-8-quinolinyl)-1,4-pentanediamine",CC1=C2C(=C(C=C(C2=NC=C1)NC(C)CCCN)OC)OC3=CC=C(C=C3)F,,,,,,
3354,133355,4-Acetoxy-6-decyloxy-7-isopropoxy-3-methoxycarbonylquinoline,CCCCCCCCCCOC1=C(C=C2C(=C1)C(=C(C=N2)C(=O)OC)OC(=O)C)OC(C)C,,,,,,
3355,133356,"2-N-[6-methoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,2-diamine",CCCC(CN)NC1=CC(=C(C2=C(C=CN=C12)C)OC3=CC=CC(=C3)C(F)(F)F)OC,,,,,,
3356,133357,"(S)-3-[(4-carboxymethylthiazol-2-yl)imino]-1,5,10,10a-tetrahydrothiazolo[3,4-b]-isoquinoline",C1[C@H]2CSC(=NC3=NC(=CS3)CC(=O)O)N2CC4=CC=CC=C41,,,,,,
3357,133358,Centa,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CS3)C(=O)O)CSC4=CC(=C(C=C4)[N+](=O)[O-])C(=O)O,,,,,,
3358,133359,5-Acetamido-6-hydroxynaphthalene-2-sulphonic acid,CC(=O)NC1=C(C=CC2=C1C=CC(=C2)S(=O)(=O)O)O,,,,,,
3359,133360,5-Methyl-3-isoxazolepropionic acid,CC1=CC(=NO1)CCC(=O)O,,,,,,
3360,133361,"(2s,3s)-3-Amino-2-methyl-4-oxoazetidine-1-sulfonic acid",C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)N,,,,,,
3361,133362,"7-chloro-3-(2,4-dichlorophenyl)-1-[3-(dimethylamino)propylamino]-2,3,4,10-tetrahydro-1H-acridin-9-one",CN(C)CCCNC1CC(CC2=C1C(=O)C3=C(N2)C=CC(=C3)Cl)C4=C(C=C(C=C4)Cl)Cl,,,,,,
3362,133363,1-Cyclohexyl-4-(1-phenyl-5-tetrazolyl)thio-1-butanone,C1CCC(CC1)C(=O)CCCSC2=NN=NN2C3=CC=CC=C3,,,,,,
3363,133364,4-[2-(1h-Indol-3-yl)ethyl]piperidin-2-one,C1CNC(=O)CC1CCC2=CNC3=CC=CC=C32,,,,,,
3364,133365,4-Nitrophenyl-6-sulfo-2-acetamido-2-deoxyglucose,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=CC=C(C=C2)[N+](=O)[O-])COS(=O)(=O)O)O)O,,,,,,
3365,133366,"17-(Acetyloxy)-6,16-bis(methylene)pregn-4-ene-3,20-dione",CC(=O)[C@]1(C(=C)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=C)C4=CC(=O)CC[C@]34C)C)OC(=O)C,,,,,,
3366,133367,2-(2-Bicyclo[2.2.1]heptanylidene)ethanamine,C1CC2CC1CC2=CCN,,,,,,
3367,133368,2-(2-Bicyclo[2.2.1]heptanylidene)acetamide,C1CC2CC1CC2=CC(=O)N,,,,,,
3368,133369,"(2S)-2-[(2S,3R,4R)-5-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetic acid",CC(C)(C(=O)OC1[C@@H]([C@H]([C@H](O1)[C@@H](C(=O)O)O)O)O)OC2=CC=C(C=C2)Cl,,,,,,
3369,133370,"Butyl 3-[5-(benzyloxy)-1-oxo-2,3-dihydro-1h-inden-2-yl]propanoate",CCCCOC(=O)CCC1CC2=C(C1=O)C=CC(=C2)OCC3=CC=CC=C3,,,,,,
3370,133371,Ciladopa,COC1=C(C=C(C=C1)[C@@H](CN2CCN(CC2)C3=CC=CC=CC3=O)O)OC,,,,,,
3371,133372,10-Hydroxyoctadec-2-enoic acid,CCCCCCCCC(CCCCCCC=CC(=O)O)O,,,,,,
3372,133373,6-Gpaaq,C1=CC=C(C=C1)C[C@@H](C(=O)NC2=CC3=C(C=C2)N=CC=C3)NC(=O)CCCC(=O)O,,,,,,
3373,133374,"[(2R)-2,3-bis(4-pyren-4-ylbutanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate",C[N+](C)(C)CCOP(=O)([O-])OC[C@@H](COC(=O)CCCC1=CC2=CC=CC3=C2C4=C(C=CC=C14)C=C3)OC(=O)CCCC5=CC6=CC=CC7=C6C8=C(C=CC=C58)C=C7,,,,,,
3374,133375,"2-[[(2R)-2,3-bis(4-pyren-4-ylbutanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",C[N+](C)(C)CCOP(=O)(O)OC[C@@H](COC(=O)CCCC1=CC2=CC=CC3=C2C4=C(C=CC=C14)C=C3)OC(=O)CCCC5=CC6=CC=CC7=C6C8=C(C=CC=C58)C=C7,,,,,,
3375,133376,CID 133376,CCCCCC=CCC=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)C,,,,,,
3376,133377,"3-Bromo-1,2-epoxycyclohexane",C1C[C@@H]2[C@@H](O2)[C@@H](C1)Br,,,,,,
3377,133378,"L-Glucose, 3-(acetylamino)-3,6-dideoxy-",C[C@@H]([C@@H]([C@H]([C@@H](C=O)O)NC(=O)C)O)O,,,,,,
3378,133379,2-(3-Hydroxy-2-(3-hydroxypicolinamido)phenyl)benzo[d]oxazole-4-carboxylic acid,C1=CC(=C(C(=C1)O)NC(=O)C2=C(C=CC=N2)O)C3=NC4=C(C=CC=C4O3)C(=O)O,,,,,,
3379,133380,"3,4-Bis-(m-hydroxyphenyl)-hex-3-ene",CCC(=C(CC)C1=CC(=CC=C1)O)C2=CC(=CC=C2)O,,,,,,
3380,133381,Norstephalagine,COC1=C2C(=C3C4=CC=CC=C4C[C@@H]5C3=C1CCN5)OCO2,,,,,,
3381,133382,CID 133382,CCCC=CC=CC=CC(=O)OC12CC(C3(C(C1C2(C)C)C=C(CC4(C3C=C(C4=O)C)O)CO)O)C,,,,,,
3382,133383,N-Isovalerylglutamic acid,CC(C)CC(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
3383,133384,"Dibenzo(b,def)chrysene-1,2-diol, 1,2-dihydro-",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC6=C5C=CC(C6O)O)C=C3,,,,,,
3384,133385,"3,4-Dihydrodibenzo(a,i)pyrene-3,4-diol",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CC6=C(C=CC(C6O)O)C(=C54)C=C3,,,,,,
3385,133386,Defucogilvocarcin V,COC1=CC(=CC2=C1C3=CC(=C4C(=C3OC2=O)C=CC=C4O)OC)C=C,,,,,,
3386,133387,CID 133387,C1=CC=C2C(=C1)C=CC=C2NC3=NC4=C(N3)C(=O)N=C(N4)N,,,,,,
3387,133388,Tetraacetyl A 33853,CC(=O)N(C1=C(C=CC=C1OC(=O)C)C2=NC3=C(C=CC=C3O2)C(=O)O)C(=O)C4=C(C=CC=N4)OC(=O)C,,,,,,
3388,133389,"[(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl 4-diazo-3,5-diiodocyclohexa-1,5-diene-1-carboxylate",C1=C(C=C(C(=[N+]=[N-])C1I)I)C(=O)OC[C@@]2([C@H]([C@@H]([C@H](O2)CO)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
3389,133390,1-(n-Decyl)-3-pyrazolidinone,CCCCCCCCCCN1CCC(=O)N1,,,,,,
3390,133391,CID 133391,C1=CC(=C(C(=C1)Cl)NN=C(CN2C=CN=C2)C3=CC=C(S3)Cl)Cl.Cl,,,,,,
3391,133392,CID 133392,C1=CC(=C(C(=C1)Cl)NN=C(CN2C=CN=C2)C3=CC=C(S3)Cl)Cl,,,,,,
3392,133393,7-Benzylcysteinyl-4-methylcoumarinylamide,CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@@H](CSCC3=CC=CC=C3)N,,,,,,
3393,133394,3-Hydroxypropylpentanoic acid ethyl ester,CCCC(C(CC)O)C(=O)OCC,,,,,,
3394,133395,"3-[1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]prop-2-enenitrile",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=CC#N)CO)O,,,,,,
3395,133396,"[(13S,16R,17R)-3,16-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-methylazanium;4-hydroxy-4-oxobut-2-enoate",C[C@]12CCC3C(C1C[C@H]([C@@H]2[NH2+]C)O)CCC4=C3C=CC(=C4)O.C(=CC(=O)[O-])C(=O)O,,,,,,
3396,133397,CID 133397,C[C@]12CCC3C(C1CC(C2NC)O)CCC4=C3C=CC(=C4)O,,,,,,
3397,133398,N-Formyl-methionyl-leucyl-phenylalanyl-phenylalanine,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CCSC)NC=O,,,,,,
3398,133399,"6,6'-Diselenobis-(3-nitrobenzoic acid)",C1=CC(=C(C=C1[N+](=O)[O-])C(=O)O)[Se][Se]C2=C(C=C(C=C2)[N+](=O)[O-])C(=O)O,,,,,,
3399,133400,Dyphylline nicotinate,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(COC(=O)C3=CN=CC=C3)O,,,,,,
3400,133401,"(2S,3S,4S,5R)-6-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",CC(C)(C(=O)OC1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O)OC2=CC=C(C=C2)Cl,,,,,"['(2S,3S,4S,5R)-6-[2-(4-Chlorophenoxy)-2-methylpropanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid is a known human metabolite of Clofibric acid.']",
3401,133402,S-(2-carboxypropyl)-Cysteamine,CC(CSCCN)C(=O)O,,,,,,
3402,133403,"Methyl 3-((2,3-dihydroxy-4-((3-imino-3-methoxypropyl)amino)-4-oxobutanoyl)amino)propanimidoate",COC(=N)CCNC(=O)C(C(C(=O)NCCC(=N)OC)O)O,,,,,,
3403,133404,"3-O,4-O-Dibenzoylisoproterenol",CC(C)NCC(C1=CC(=C(C=C1)OC(=O)C2=CC=CC=C2)OC(=O)C3=CC=CC=C3)O.Br,,,,,,
3404,133405,[2-Benzoyloxy-4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl] benzoate,CC(C)NCC(C1=CC(=C(C=C1)OC(=O)C2=CC=CC=C2)OC(=O)C3=CC=CC=C3)O,,,,,,
3405,133406,"[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-[(3S,4S,5S,6R)-6-[(1S)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]methyl] phosphono hydrogen phosphate",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C(C4[C@H]([C@H]([C@@H]([C@H](O4)[C@H](CO)O)O)O)O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
3406,133407,"2,8-Dinitroimipramine",CN(C)CCCN1C2=C(CCC3=C1C=CC(=C3)[N+](=O)[O-])C=C(C=C2)[N+](=O)[O-],,,,,,
3407,133408,Cycloalkannin,CC1(CCC(O1)C2=CC(=O)C3=C(C=CC(=C3C2=O)O)O)C,,,,,,
3408,133409,Cycloalkannin leucoacetate,CC(=O)OC1=C2C(=CC(=C(C2=C(C=C1)OC(=O)C)OC(=O)C)C3CCC(O3)(C)C)OC(=O)C,,,,,,
3409,133410,Acebutolol azide,CC(C)NCC(COC1=C(C=C(C=C1)N=[N+]=[N-])C(=O)C)O,,,,,,
3410,133411,"1-Hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione",C1=CC2=C(C(=C1)O)C(=O)C3=C(C=CC(=C3C2=O)NCCNCCO)NCCNCCO,,,,,,
3411,133412,1-(4-Hydroxybenzyl)pyrazole,C1=CN(N=C1)CC2=CC=C(C=C2)O,,,,,,
3412,133413,"N,N-Bis(alpha-iodoacetyl)-2,2'-dithiobis(ethylamine)",C(CSSCCNC(=O)CI)NC(=O)CI,,,,,,
3413,133414,3'-O-(3-(2-Nitro-4-azidophenyl)propionyl)adenosine triphosphate,C1=CC(=C(C=C1N=[N+]=[N-])[N+](=O)[O-])CCC(=O)O[C@@H]2[C@H](O[C@H]([C@@H]2O)N3C=NC4=C(N=CN=C43)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O,,,,,,
3414,133415,CID 133415,CCCCC[C@@H](C#C[C@@H]1[C@H]2CC(=CCCCC(=O)O)O[C@@H]2C([C@H]1O)(F)F)O,,,,,,
3415,133416,CID 133416,C1=C(SN=N1)C=NOC2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
3416,133417,"2-[4-(1,2-Diphenylbut-1-enyl)phenoxy]ethanamine",CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN)C3=CC=CC=C3,,,,,,
3417,133418,CID 133418,CC1=NC=CN1P(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3NC(=NC4=O)N)O)O,,,,,,
3418,133419,CID 133419,C1=CC(=CC=C1C=CC(=O)NCCCCN)O.Cl,,,,,,
3419,133420,N-(4-aminobutyl)-3-(4-hydroxyphenyl)prop-2-enamide,C1=CC(=CC=C1C=CC(=O)NCCCCN)O,,,,,,
3420,133421,[4-(3-Amino-3-iminoprop-1-enyl)phenyl] 4-(diaminomethylideneamino)benzoate;methanesulfonic acid,CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C=CC(=N)N)OC(=O)C2=CC=C(C=C2)N=C(N)N,,,,,,
3421,133422,4-(beta-Amidinoethenyl)phenyl 4-guanidinobenzoate,C1=CC(=CC=C1C=CC(=N)N)OC(=O)C2=CC=C(C=C2)N=C(N)N,,,,,,
3422,133423,4-Amidino-2-benzoylphenyl 4-guanidinobenzoate dimethanesulfonate,CS(=O)(=O)O.CS(=O)(=O)O.C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2)C(=N)N)OC(=O)C3=CC=C(C=C3)N=C(N)N,,,,,,
3423,133424,(2-Benzoyl-4-carbamimidoylphenyl) 4-(diaminomethylideneamino)benzoate,C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2)C(=N)N)OC(=O)C3=CC=C(C=C3)N=C(N)N,,,,,,
3424,133425,Methylbenzopyrene,CC1=C2C3=CC=CC=C3C4=CC=CC5=C4C2=C(C=C1)C=C5,,,,,,
3425,133426,"{2-[18-(2,5-Dioxopyrrolidin-1-yl)-18-oxooctadecan-3-yl]-4,4-dimethyl-1,3-oxazolidin-3-yl}oxidanyl",CCC(CCCCCCCCCCCCCCC(=O)N1C(=O)CCC1=O)C2N(C(CO2)(C)C)[O],,,,,,
3426,133427,"(2-(3,4-Dihydroxyphenyl)-2-oxoethyl)dimethylsulfonium",C[S+](C)CC(=O)C1=CC(=C(C=C1)O)O,,,,,,
3427,133428,"(2-(3,4-Dihydroxyphenyl)ethyl)dimethylsulfonium",C[S+](C)CCC1=CC(=C(C=C1)O)O,,,,,,
3428,133429,3-[(2-Phenylethyl)amino]alanine,C1=CC=C(C=C1)CCNCC(C(=O)O)N,,,,,,
3429,133430,"1,4-Pentanediamine, N4-((5,8-dimethoxy-2,4-dimethyl-6-quinolinyl)methyl)-N1,N1-diethyl-",CCN(CC)CCCC(C)NCC1=CC(=C2C(=C1OC)C(=CC(=N2)C)C)OC,,,,,,
3430,133431,"Dibenz(a,e)aceanthrylene-12,13-diol, 12,13-dihydro",C1=CC=C2C(=C1)C=C3C4=C(C=CC(C4O)O)C=C5C3=C2C6=CC=CC=C65,,,,,,
3431,133432,"Dibenz(a,e)aceanthrylene-3,4-diol, 3,4-dihydro",C1=CC=C2C(=C1)C=C3C4=CC=CC=C4C5=C6C(C(C=CC6=CC2=C35)O)O,,,,,,
3432,133433,"3-tert-Butyl-4,5-dihydroxyanisole",CC(C)(C)C1=C(C(=CC(=C1)OC)O)O,,,,,,
3433,133434,Bis(4-methyl-2-oxochromen-7-yl) phosphono phosphate,CC1=CC(=O)OC2=C1C=CC(=C2)OP(=O)(OC3=CC4=C(C=C3)C(=CC(=O)O4)C)OP(=O)(O)O,,,,,,
3434,133435,"Theophylline, 8-benzyl-7-(2-((2-hydroxyethyl)amino)ethyl)-",CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)CC3=CC=CC=C3)CCNCCO,,,,,,
3435,133436,"1H-Purine-2,6-dione, 7-(2-(ethylamino)ethyl)-3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-",CCNCCN1C(=NC2=C1C(=O)N(C(=O)N2C)C)CC3=CC=CC=C3,,,,,,
3436,133437,"1H-Purine-2,6-dione, 7-(2-aminoethyl)-3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-",CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)CC3=CC=CC=C3)CCN,,,,,,
3437,133438,"2,5-Pyrrolidinedione, 1-((4-nitrophenyl)methyl)-",C1CC(=O)N(C1=O)CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
3438,133439,"1,4-Dihydro-2,6-dimethyl-4-(3-methylphenyl)-3,5-pyridinedicarboxylic acid dimethyl ester",CC1=CC(=CC=C1)C2C(=C(NC(=C2C(=O)OC)C)C)C(=O)OC,,,,,,
3439,133440,N-(gamma-Maleimidobutyryloxy)succinimide,C1CC(=O)N(C1=O)OC(=O)CCCN2C(=O)C=CC2=O,,,,,,
3440,133441,(Z)-(4-dodecoxyphenyl)methylidene-oxido-tert-butyl-azanium,CCCCCCCCCCCCOC1=CC=C(C=C1)C=[N+](C(C)(C)C)[O-],,,,,,
3441,133442,"N,N-Dimethylalanylbenzocaine",CCOC(=O)C1=CC=C(C=C1)NC(=O)CCN(C)C.Cl,,,,,,
3442,133443,Ethyl 4-[3-(dimethylamino)propanoylamino]benzoate,CCOC(=O)C1=CC=C(C=C1)NC(=O)CCN(C)C,,,,,,
3443,133444,CID 133444,CC=CC1=CC(=C(C=C1)OC)OC.CC=CC1=CC(=C(C=C1OC)OC)OC,,,,,,
3444,133445,"1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-beta-D-glucopyranose",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC(=O)C)N=[N+]=[N-])OC(=O)C)OC(=O)C,,,,,,
3445,133446,"1-Piperidinyloxy, 2,2,6,6-tetramethyl-4-[[(1e)-phenylmethylene]amino]-",CC1(CC(CC(N1[O])(C)C)N=CC2=CC=CC=C2)C,,,,,,
3446,133447,Bismark Brown,C1=CC(=C(C(=C1)N=NC2=CC=C(C=C2)N)N)N,,,,,,
3447,133448,"1-Methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine",CN1CCC(=CC1)C2=CC=CS2,,,,,,
3448,133449,[3-Hexadecanoyloxy-2-[8-(3-octyloxiran-2-yl)octanoyloxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC1C(O1)CCCCCCCC,,,,,,
3449,133450,2-[[3-Hexadecanoyloxy-2-[8-(3-octyloxiran-2-yl)octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC1C(O1)CCCCCCCC,,,,,,
3450,133451,Ses-ppc,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC[C@@H]1[C@@H](O1)CCCCCCCC,,,,,,
3451,133452,"2-[hydroxy-[(2R)-3-octadecanoyloxy-2-[8-[(2R,3S)-3-octyloxiran-2-yl]octanoyloxy]propoxy]phosphoryl]oxyethyl-trimethylazanium",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCC[C@@H]1[C@@H](O1)CCCCCCCC,,,,,,
3452,133453,"benzhydryl (6R,7R)-3,4-dimethylidene-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate",C=C1C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1=C)C(=O)OC(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
3453,133454,Panasinsanol A,C[C@]12CCC[C@@](C13CC([C@@H]3CC2)(C)C)(C)O,,,,,,
3454,133455,"3b,15b,17a-Trihydroxy-Pregnenone",CC(=O)[C@]1(C[C@H]([C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O)O,,,,,,
3455,133456,"Acetamide, N-(acetyloxy)-N-(7-ethyl-9H-fluoren-2-yl)-",CCC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)N(C(=O)C)OC(=O)C,,,,,,
3456,133457,"3,15,17-Trihydroxypregnan-20-one",CC(=O)[C@]1(C[C@H]([C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C)O)O,,,,,,
3457,133458,5-Bromoethynyl-2'-deoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C#CBr)CO)O,,,,,,
3458,133459,Pafbg,C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2OC3=CC=CC=C3)CO)O)O)O)O)O,,,,,,
3459,133460,"2-Amino-5,8-dimethoxy-6-methyl-1,2-dihydronaphthalene",CC1=CC(=C2CC(C=CC2=C1OC)N)OC,,,,,,
3460,133461,3-Amino-6-methyl-5-phenyl-2(1H)-pyridinone,CC1=C(C=C(C(=O)N1)N)C2=CC=CC=C2,,,,,,
3461,133462,Lysine-methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
3462,133463,Lysine butyrate,CCCC(=O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
3463,133464,"L-Ornithine, N2-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCCN)C(=O)O,,,,,,
3464,133465,CID 133465,CC(=CCC[C@](C)([C@@H]1CC[C@@]2(C1[C@@H](CC3C2C[C@H](C4[C@]3(CCC(C4(C)C)O)C)O[C@@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)CO)O)O)O[C@@H]6[C@@H]([C@@H]([C@@H](CO6)O)O)O)O)C)O[C@@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)CO)O)O)O)C,,,,,,
3465,133466,"Carbamic acid, (5-amino-1,2-dihydro-3-((methylphenylamino)methyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)CN(C)C3=CC=CC=C3)N,,,,,,
3466,133467,"5,7'-Dimethyl-4,4',10,10',11,11',12,12'-octaoxo-7,7'-bi(2-thia-1,3-diazatricyclo[6.2.1.13,6]dodecane)-7-carboxylate",CC1C2C(=O)N(C1=O)SN3C(=O)CC(C3=O)C2(C(=O)[O-])C4(C5CC(=O)N(C5=O)SN6C(=O)CC4C6=O)C,,,,,,
3467,133468,"5-Methyl-7-(7-methyl-4,10,11,12-tetraoxo-2-thia-1,3-diazatricyclo[6.2.1.13,6]dodecan-7-yl)-4,10,11,12-tetraoxo-2-thia-1,3-diazatricyclo[6.2.1.13,6]dodecane-7-carboxylic acid",CC1C2C(=O)N(C1=O)SN3C(=O)CC(C3=O)C2(C(=O)O)C4(C5CC(=O)N(C5=O)SN6C(=O)CC4C6=O)C,,,,,,
3468,133469,Gly-gly-arg,C(C[C@@H](C(=O)O)NC(=O)CNC(=O)CN)CN=C(N)N,,,,,,
3469,133470,4-(Acetylamino)benzylphosphonate,CC(=O)NC1=CC=C(C=C1)CP(=O)(O)O,,,,,,
3470,133471,"(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenedioic acid",C(CCC(=O)O)CC=CC[C@H](C=CC=CC=C[C@H](CCCC(=O)O)O)O,,,,,,
3471,133472,"Benzoic acid, 2-(acetyloxy)-5-((3-carboxy-1-oxopropyl)amino)-",CC(=O)OC1=C(C=C(C=C1)NC(=O)CCC(=O)O)C(=O)O,,,,,,
3472,133473,Methyl 4-O-alpha-D-galactopyranosyl-beta-D-Galactopyranoside,CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
3473,133474,Globotriose,C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](OC([C@@H]([C@H]3O)O)O)CO)CO)O)O)O)O,,,,,,
3474,133475,Paeoniflorigenone,C[C@@]12CC(=O)[C@H]3C[C@@]1(O[C@@H]([C@@H]3COC(=O)C4=CC=CC=C4)O2)O,,,,,,
3475,133476,"Piperidine, 1-(3-(4-(aminoiminomethyl)phenyl)-2-((4-methylphenyl)sulfonylamino)-1-oxopropyl)-",CC1=CC=C(C=C1)S(=O)(=O)NC(CC2=CC=C(C=C2)C(=N)N)C(=O)N3CCCCC3,,,,,,
3476,133477,CID 133477,C1=CC2=CC=C1C2(N=NC3(C4=CC=C3C=C4)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
3477,133478,"6-Benzyl-5h-dibenzo[d,f][1,3]diazepine",C1=CC=C(C=C1)CC2=NC3=CC=CC=C3C4=CC=CC=C4N2,,,,,,
3478,133479,"1,2,5-Naphthalenetriol, 6-(cyclobutylamino)-5,6,7,8-tetrahydro-",C1CC(C1)NC2CCC3=C(C2O)C=CC(=C3O)O,,,,,,
3479,133480,CID 133480,C[C@H](CC=CC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C,,,,,,
3480,133481,CID 133481,C[C@H](CC(C(C(C)(C)O)O)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C,,,,,,
3481,133482,Chloroacetyliodotyramine,C1=CC(=CC=C1CCN(C(=O)CCl)I)O,,,,,,
3482,133483,2-Bromo-1-(pyren-1-yl)ethanone,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)C(=O)CBr,,,,,,
3483,133484,"2-[[6-[Bis(carboxymethyl)amino]-1,4-dioxocan-6-yl]-(carboxymethyl)amino]acetic acid",C1COCCOCC1(N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
3484,133485,1-Amino-2-ethylcyclopropanecarboxylic acid,CCC1CC1(C(=O)O)N,,,,,,
3485,133486,N-prop-2-ynyl-3-trimethylsilylpropan-1-amine,C[Si](C)(C)CCCNCC#C,,,,,,
3486,133487,N-(p-Di(2-chloroethyl)aminophenylbutyryl)-p-aminobenzoic acid,C1=CC(=CC=C1CCCC(=O)NC2=CC=C(C=C2)C(=O)O)N(CCCl)CCCl,,,,,,
3487,133488,(4-(((6-Aminohexyl)amino)carbonyl)-3-nitrophenyl)boronic acid,B(C1=CC(=C(C=C1)C(=O)NCCCCCCN)[N+](=O)[O-])(O)O,,,,,,
3488,133489,15-(4-Bromophenyl)pentadecanoic acid,C1=CC(=CC=C1CCCCCCCCCCCCCCC(=O)O)Br,,,,,,
3489,133490,Dimethyl-[2-(oxolan-2-yl)ethyl]sulfanium;2-methylbenzenesulfonic acid,CC1=CC=CC=C1S(=O)(=O)O.C[S+](C)CCC1CCCO1,,,,,,
3490,133491,Dimethyl[2-[(tetrahydrofuran)-2-yl]ethyl]sulfonium,C[S+](C)CCC1CCCO1,,,,,,
3491,133492,"2-Bromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undec-8-en-3-one",CC1=C(C[C@@]2(CC1)C(=C)CC(=O)[C@H](C2(C)C)Br)Cl,,,,,,
3492,133493,CID 133493,CCC(=C)[C@H](C)C=C[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
3493,133494,"5alpha-Ergostane-3beta,5,6beta,7beta-tetrol",C[C@H](CC[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H]([C@H]([C@@]4([C@@]3(CC[C@@H](C4)O)C)O)O)O)C,,,,,,
3494,133495,CID 133495,C[C@H](C=C[C@H](C)C(=C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
3495,133496,"O-(3-(Trimethylammonium)phenyl)-1,3,2-dioxaphosphorinane 2-oxide",C[N+](C)(C)C1=CC=CC(C1=O)OP2OCCCO2.[I-],,,,,,
3496,133497,"[5-(1,3,2-Dioxaphosphinan-2-yloxy)-6-oxocyclohexa-1,3-dien-1-yl]-trimethylazanium",C[N+](C)(C)C1=CC=CC(C1=O)OP2OCCCO2,,,,,,
3497,133498,6-Chloromercuricholesterol,C[C@H](CCCC(C)C)[C@H]1CCC2[C@@]1(CCC3C2CC(=C4[C@@]3(CC[C@@H](C4)O)C)[Hg]Cl)C,,,,,,
3498,133499,C8-SL-ATP,CC1(CCC(C(N1[O])(C)C)NC2=NC3=C(N=CN=C3N2[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N)C,,,,,,
3499,133500,CID 133500,C1[C@@H](C(=O)N1S(=O)(=O)[O-])NC(=O)CC2=CC=CC=C2.[K+],,,,,,
3500,133501,"1-Azetidinesulfonic acid, 2-oxo-3-[(phenylacetyl)amino]-, (3S)-",C1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)CC2=CC=CC=C2,,,,,,
3501,133502,"(1R,2S)-1-N,1-N,2-N,2-N-tetrakis(2-methylpropyl)cyclohexane-1,2-dicarboxamide",CC(C)CN(CC(C)C)C(=O)[C@@H]1CCCC[C@@H]1C(=O)N(CC(C)C)CC(C)C,,,,,,
3502,133503,1-(Malonylamino)cyclopropanecarboxylic acid,C1CC1(C(=O)O)NC(=O)CC(=O)O,,,,,,
3503,133504,Schinifoline,CCCCCCCC1=CC(=O)C2=CC=CC=C2N1C,,,,,,
3504,133505,"2,8-Dihydroxy-3-ethoxymethyl-1-methoxyanthraquinone",CCOCC1=CC2=C(C(=C1O)OC)C(=O)C3=C(C2=O)C=CC=C3O,,,,,,
3505,133506,3-Ethoxymethyl-2-hydroxy-1-methoxyanthraquinone,CCOCC1=CC2=C(C(=C1O)OC)C(=O)C3=CC=CC=C3C2=O,,,,,,
3506,133507,10-Methyl-10-deazaaminopterin,CC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
3507,133508,"10,10-Dimethyl-10-deazaaminopterin",CC(C)(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
3508,133509,4-(Ethoxymethylene)-2-(2-furanyl)-5(4H)-oxazolone,CCOC=C1C(=O)OC(=N1)C2=CC=CO2,,,,,,
3509,133510,"4-(Ethoxymethylidene)-2-prop-1-enyl-1,3-oxazol-5-one",CCOC=C1C(=O)OC(=N1)C=CC,,,,,,
3510,133511,Cortisol-21-hemisuccinate-aminobutylisoluminol,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)NCCCCNC5=CC6=C(C=C5)C(=O)NNC6=O)O)C)O,,,,,,
3511,133512,Cortisol-21-hemisuccinate-aminobutylethylisoluminol,CCN(CCCCNC(=O)CCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O)C5=CC6=C(C=C5)C(=O)NNC6=O,,,,,,
3512,133513,"Enkephalin-leu, sulfonated",CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)OS(=O)(=O)O)N,,,,,,
3513,133514,CID 133514,C(CS(=O)(=O)[O-])N(Cl)Cl.[Na+],,,,,,
3514,133515,"Ethanesulfonic acid, 2-(dichloroamino)-",C(CS(=O)(=O)O)N(Cl)Cl,,,,,,
3515,133516,CID 133516,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=CBr)CO)N,,,,,,
3516,133517,"4-amino-1-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-methyl-1,3,5-triazin-2-one",CC1=NC(=NC(=O)N1[C@@H]2C[C@@H]([C@H](O2)CO)O)N,,,,,,
3517,133518,"3,5-Dimethylstyrene oxide",CC1=CC(=CC(=C1)C2CO2)C,,,,,,
3518,133519,Ethyl-10-iododecanoate,CCOC(=O)CCCCCCCCCI,,,,,,
3519,133520,1H-Imidazole-2-carboxamide,C1=CN=C(N1)C(=O)N,,,,,,
3520,133521,CID 133521,C1=NC2=C(N1COCC(=O)O)NC(=NC2=O)N,,,,,,
3521,133522,CID 133522,C(COCN1C2=C(C(=O)N=C(N2)N)NC1=O)O,,,,,,
3522,133523,Nbd-chol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)NCCOCCOCCNC5=CC=C(C6=NON=C56)[N+](=O)[O-])C)C,,,,,,
3523,133524,But-2-enedioic acid;1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]pyrrolidin-2-one,CN1CCN(CC1)C(=O)CN2CCCC2=O.C(=CC(=O)O)C(=O)O,,,,,,
3524,133525,1-Methyl-4-((2-oxo-1-pyrrolidinyl)acetyl)piperazine,CN1CCN(CC1)C(=O)CN2CCCC2=O,,,,,,
3525,133526,"5-Methyl-[1,2,4]triazolo[4,3-A]quinoxaline-1,4(2H,5H)-dione",CN1C2=CC=CC=C2N3C(=NNC3=O)C1=O,,,,,,
3526,133527,"7-Chloro-5-propyl-1,2,4-triazolo(4,3-a)quinoxaline-1,4(2H,5H)-dione",CCCN1C2=C(C=CC(=C2)Cl)N3C(=NNC3=O)C1=O,,,,,,
3527,133528,"3,9,13-Trioxa-6-azapentadecan-15-amide, N-(2-ethoxyethyl)-N,6-diheptyl-11,11-dimethyl-7-oxo-",CCCCCCCN(CCOCC)C(=O)COCC(C)(C)COCC(=O)N(CCCCCCC)CCOCC,,,,,,
3528,133529,3beta-Hydroxy-16alpha-fluoro-5alpha-androstan-17-one,C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@H](C4=O)F)C)O,,,,,,
3529,133530,"2-(3alpha,7beta-Dihydroxy-24-nor-5beta-cholanyl)-4,4-dimethyl-2-oxazoline",CC[C@@H](C)[C@H]1CCC2[C@@]1(CCC3C2[C@H](C[C@H]4[C@@]3(CC[C@@](C4)(C5=NC(CO5)(C)C)O)C)O)C,,,,,,
3530,133531,"sodium (6R,7R)-7-((1-benzylpyridin-1-ium-4-yl)amino)-3-(((5-((carboxylatomethyl)thio)-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC3=CC=[N+](C=C3)CC4=CC=CC=C4)C(=O)[O-])CSC5=NN=C(S5)SCC(=O)[O-].[Na+],,,,,,
3531,133532,"4-[[(6R,7R)-2-Carboxylato-3-[[[5-[(carboxymethyl)thio]-1,3,4-thiadiazol-2-yl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]amino]-1-(phenylmethyl)pyridinium",C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC3=CC=[N+](C=C3)CC4=CC=CC=C4)C(=O)O)CSC5=NN=C(S5)SCC(=O)O,,,,,,
3532,133533,Dansyl-glycyl-nitrophenylalanyl-proline,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCC(=O)N[C@@H](CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)N4CCC[C@H]4C(=O)O,,,,,,
3533,133534,Castasterone,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)[C@@H]4[C@@]3(C[C@H]([C@H](C4)O)O)C)C)[C@H]([C@@H]([C@@H](C)C(C)C)O)O,,,,,,
3534,133535,[3-Octadec-9-enoyloxy-2-(4-pyren-1-ylbutanoyloxy)propyl] octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
3535,133536,"1-Octylpiperidine-2,6-dione",CCCCCCCCN1C(=O)CCCC1=O,,,,,,
3536,133537,"5H-Dibenz(b,f)azepine-5-propanamine, 2-azido-10,11-dihydro-N,N-dimethyl-",CN(C)CCCN1C2=C(CCC3=CC=CC=C31)C=C(C=C2)N=[N+]=[N-],,,,,,
3537,133538,"3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine",CC1=CC(=CC=C1)C2CN(CCC3=C(C(=C(C=C23)O)O)Cl)C,,,,,,
3538,133539,"4-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-2H-1,5-methano-1,4-benzodiazocin-9-amine",C1CC1CN2CCN3CC2CC4=C3C=C(C=C4)N,,,,,,
3539,133540,1-Dtpgpu,C1=NC2=C(N1)C(=NC=N2)S[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)N)O)O)O,,,,,,
3540,133541,(2S)-N-[2-[[(2R)-2-amino-3-methylbutanoyl]amino]acetyl]-5-(diaminomethylideneamino)-2-(4-nitroanilino)pentanamide,CC(C)[C@H](C(=O)NCC(=O)NC(=O)[C@H](CCCN=C(N)N)NC1=CC=C(C=C1)[N+](=O)[O-])N,,,,,,
3541,133542,24-Ketolanosterol,C[C@H](CCC(=O)C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CCC4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C,,,['Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)'],,,
3542,133543,"2,5-Cyclohexadiene-1,4-dione, 2-(12-hydroxy-5,10-dodecadiynyl)-5,6-dimethoxy-3-methyl-",CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCC#CCCCC#CCO,,,,,,
3543,133544,Phosphorylleucylphenylalanine,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NP(=O)(O)O,,,,,,
3544,133545,"Phenol, 4-((5-(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinyl)amino)-",CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)O,,,,,,
3545,133546,"(2S,3S,4S,5R,6S)-6-[5-(4-chlorophenyl)-3-propan-2-yliminophenazin-2-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,,,,,,
3546,133547,4'-Hydroxymethohexital,CC(C#CC(C)O)C1(C(=O)NC(=O)N(C1=O)C)CC=C,,,,,,
3547,133548,"n-[4-Chloro-3-(4-chlorobenzoyl)phenyl]-2-hydroxy-3,5-diiodobenzamide",C1=CC(=CC=C1C(=O)C2=C(C=CC(=C2)NC(=O)C3=C(C(=CC(=C3)I)I)O)Cl)Cl,,,,,,
3548,133549,CID 133549,CSCC[C@H](C(=O)O)NC1([C@H]([C@@H]([C@H](O1)CO)O)O)CO,,,,,,
3549,133550,"1-Propanone, 1-(3-((4-azidophenyl)methyl)-2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)-",C1=CC(=CC=C1CCC(=O)C2=C(C=C(C(=C2O)CC3=CC=C(C=C3)N=[N+]=[N-])O)O)O,,,,,,
3550,133551,"(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid",CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)C=CC6=CC(=C(C=C6)O)O)C)C(=O)O,,,,,,
3551,133552,3-Hydroxyphenyl-3H-diazirine,C1=CC(=CC(=C1)O)C2N=N2,,,,,,
3552,133553,(Hexadecanoylsulfanyl)acetic acid,CCCCCCCCCCCCCCCC(=O)SCC(=O)O,,,,,,
3553,133554,2-Methyl-4-(2-methyl-1H-imidazol-4-yl)pyridine,CC1=NC=CC(=C1)C2=CN=C(N2)C,,,,,,
3554,133555,Hmtdo,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)C=CC34SC,,,,,,
3555,133556,Methylsulfonylnorleucyl-glycyl-arginine-4-nitroanilide,CCCC[C@H](C(=O)NCC(=O)NC(=O)[C@H](CCCN=C(N)N)NC1=CC=C(C=C1)[N+](=O)[O-])NS(=O)(=O)C,,,,,,
3556,133557,"(8S,9S,10R,14S,17S)-17-acetyl-10-methyl-13-prop-2-ynyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)[C@H]1CC[C@@H]2C1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)CC#C,,,,,,
3557,133558,"(8S,9S,10R,14S,17S)-17-(2-hydroxyacetyl)-10-methyl-13-prop-2-ynyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CCC4([C@H]3CC[C@@H]4C(=O)CO)CC#C,,,,,,
3558,133559,Dmobcpa,COC1=C(C=C(C=C1)C[C@H]2CCC[C@H]2N)OC,,,,,,
3559,133560,3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acid,C1CC(C(=O)N(C1)CC(=O)O)CS,,,,,,
3560,133561,Haloquinone,CC1=C(C=C2C3=C(C(=CC=C3)O)C(=O)C(=O)C2=C1O)C(=O)C,,,,,,
3561,133562,Siphonoside,C1C(=CC(=O)O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
3562,133563,"2-[[1-(2-amino-1,3-thiazol-4-yl)-2-oxo-2-[[(3S)-2-oxo-1-sulfoazetidin-3-yl]amino]ethylidene]amino]oxy-2-methylpropanoic acid",CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2CN(C2=O)S(=O)(=O)O,,,,,,
3563,133564,"Acetamide, N-(4-((3-aminopropyl)amino)butyl)-2,2-dihydroxy-, dihydrochloride",C(CCNC(=O)C(O)O)CNCCCN.Cl.Cl,,,,,,
3564,133565,"N-[4-(3-aminopropylamino)butyl]-2,2-dihydroxyacetamide",C(CCNC(=O)C(O)O)CNCCCN,,,,,,
3565,133566,"1,2-dimethyl-1H-Imidazol-5-amine",CC1=NC=C(N1C)N,,,,,,
3566,133567,"Benzeneacetic acid, 4-(2,3-dihydro-3-oxo-1H-indazol-1-yl)-",C1=CC=C2C(=C1)C(=O)NN2C3=CC=C(C=C3)CC(=O)O,,,,,,
3567,133568,2-[4-(3-oxo-2H-indazol-1-yl)phenyl]propanoic acid,CC(C1=CC=C(C=C1)N2C3=CC=CC=C3C(=O)N2)C(=O)O,,,,,,
3568,133569,16-Iodo-9 hexadecenoic acid,C(CCCC=CCCCCCCI)CCCC(=O)O,,,,,,
3569,133570,"4-[(2R,3R,4R,5S)-3,4-dihydroxy-5-[(1R)-1-hydroxyethyl]oxolan-2-yl]-8-ethyl-1-hydroxy-10,12-dimethoxynaphtho[1,2-c]isochromen-6-one",CCC1=CC2=C(C(=C1)OC)C3=C(C4=C(C=CC(=C4C(=C3)OC)O)[C@@H]5[C@@H]([C@H]([C@@H](O5)[C@@H](C)O)O)O)OC2=O,,,,,,
3570,133571,Threonyl-lysyl-prolyl-arginyl-threonyl-lysyl-prolyl-arginine,C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O,,,,,,
3571,133572,2-Propylisonicotinamide,CCCC1=NC=CC(=C1)C(=O)N,,,,,,
3572,133573,"1,4-Phthalazinedione, 6-((2-aminoethyl)ethylamino)-2,3-dihydro-",CCN(CCN)C1=CC2=C(C=C1)C(=O)NNC2=O,,,,,,
3573,133574,N-(3-Methylphenyl)-N'-cyanobenzamidine,CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)NC#N,,,,,,
3574,133575,Isobornyl bromoacetate,CC1(C2CCC1(C(C2)OC(=O)CBr)C)C,,,,,,
3575,133576,Leucine thiorphan,CC(C)C[C@@H](C(=O)O)NC(=O)C(CC1=CC=CC=C1)CS,,,,,,
3576,133577,N-Desethyloxybutynin,CCNCC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,,,,,,
3577,133578,CID 133578,C[C@H](C(=O)N[C@@H](COC(=O)[C@H]1C(S[C@@H](N1)CNC(=O)CC2=CC=CC=C2)(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@H](C(C)C)C(=O)O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(C)C)N,,,,,,
3578,133579,Octamethylene bis(methanethiosulfonate),CS(=O)(=S)OCCCCCCCCOS(=O)(=S)C,,,,,,
3579,133580,Dotriacolide,CC(CCCCCCCC1CC(CCCCCCCCCCCC(CC(CCCCCCCCCCCC=CC(=O)O1)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O,,,['Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)'],,,
3580,133581,2-Methylthio-N-isopropylacetanilide,CC(C)N(C1=CC=CC=C1)C(=O)CSC,,,,,,
3581,133582,(2-Octadec-9-enoyloxy-3-tetradecylsulfinylpropyl) octadec-9-enoate,CCCCCCCCCCCCCCS(=O)CC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
3582,133583,Pdspc,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC1CC1CCCCCCCC,,,,,,
3583,133584,2-[[3-Hexadecanoyloxy-2-[8-(2-octylcyclopropyl)octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC1CC1CCCCCCCC,,,,,,
3584,133585,Aaa-bppa,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C[C@@H]4[C@H](O[C@H]([C@@]4(O)OP(=O)(N)OC[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=NC7=C(N=CN=C76)N)O)O)N8C=NC9=C(N=CN=C98)N)COP(=O)(N)O)O)O)N,,,,,,
3585,133586,Succinimidyl 2-naphthoxyacetate,C1CC(=O)N(C1=O)OC(=O)COC2=CC3=CC=CC=C3C=C2,,,,,,
3586,133587,CID 133587,CCCCCCCCCCCC1=CC(=O)C=C(O1)O,,,,,,
3587,133588,"2-Thiazolecarboxylic acid, 4,5-dihydro-",C1CSC(=N1)C(=O)O,,,,,,
3588,133589,Oxo[(2-sulfanylethyl)amino]acetic acid,C(CS)NC(=O)C(=O)O,,,,,,
3589,133590,Ethyl alpha-D-fructofuranoside,CCO[C@@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO,,,,,,
3590,133591,"(5R,6R)-3-(3-aminopropylsulfanyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid",C[C@H]([C@H]1[C@@H]2N(C1=O)C(=C(S2)SCCCN)C(=O)O)O,,,,,,
3591,133592,"(2S)-N-[(2S)-5-amino-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]-2-[[(2R)-pyrrolidine-2-carbonyl]amino]pentanediamide",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]6CCCN6,,,,,,
3592,133593,3-Quinuclidinyl p-azidobenzilate,C1CN2CCC1C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=C(C=C4)N=[N+]=[N-])O,,,,,,
3593,133594,N-Methyl-4-piperidyl p-azidobenzilate,CN1CCC(CC1)OC(=O)C(C2=CC=CC=C2)(C3=CC=C(C=C3)N=[N+]=[N-])O,,,,,,
3594,133595,N-(2-(4-Hydroxyphenyl)glycyl)-3-oxoalanine,C1=CC(=CC=C1[C@@H](C(=O)N[C@@H](C=O)C(=O)O)N)O,,,,,,
3595,133596,(2S)-1-[4-[4-[bis(2-chloroethyl)amino]phenyl]butanoyl]pyrrolidine-2-carboxylic acid,C1C[C@H](N(C1)C(=O)CCCC2=CC=C(C=C2)N(CCCl)CCCl)C(=O)O,,,,,,
3596,133597,"1-(4-Oxo-3,4-dihydropyridinium-1-yl)-3,5,8,11-tetraoxa-4-phosphatricosan-4-olate",CCCCCCCCCCCCOCCOCCOP([O-])OCC[N+]1=CCC(=O)C=C1,,,,,,
3597,133598,2-(2-dodecoxyethoxy)ethyl 2-(4-oxo-3H-pyridin-1-ium-1-yl)ethyl hydrogen phosphite,CCCCCCCCCCCCOCCOCCOP(O)OCC[N+]1=CCC(=O)C=C1,,,,,,
3598,133599,"Urea, N-(2-chloroethyl)-N'-(2-(5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-(methylthio)ethyl)-N-nitroso-",CSC(CNC(=O)N(CCCl)N=O)N1C=C(C(=O)NC1=O)F,,,,,,
3599,133600,"N-Succinyl-4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl",CC1(CC(CC(N1[O])(C)C)N2C(=O)CCC2=O)C,,,,,,
3600,133601,"1-(6-Chloro-4-hydroxyimino-2,3-dihydroquinolin-1-yl)propan-1-one",CCC(=O)N1CCC(=NO)C2=C1C=CC(=C2)Cl,,,,,,
3601,133602,"Furo(3,2-c)pyridine, 6-methyl-4-(1-piperazinyl)-",CC1=CC2=C(C=CO2)C(=N1)N3CCNCC3,,,,,,
3602,133603,"ethyl 3-(2-chlorophenyl)-5,7-dimethyl-2,4-dioxo-1H-quinazoline-6-carboxylate",CCOC(=O)C1=C(C2=C(C=C1C)NC(=O)N(C2=O)C3=CC=CC=C3Cl)C,,,,,,
3603,133604,Lysyl-prolyl-glycyl-glutamyl-prolyl-glycyl-prolyl-lysine,C1C[C@H](N(C1)C(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)N)C(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
3604,133605,"2-Amino-1,2-dihydronaphthalene",C1C(C=CC2=CC=CC=C21)N,,,,,,
3605,133606,N-Carboxymethyl-phenylalanylleucine,CC(C)C[C@H](C(=O)O)NC(=O)[C@@H](CC1=CC=CC=C1)NCC(=O)O,,,,,,
3606,133607,CID 133607,CC1=C(C(CCC1)(C)C)C=CC(C)OC(=O)CBr,,,,,,
3607,133608,CID 133608,CC1=C(C(CCC1)(C)C)C=CC(=CCOC(=O)CBr)C,,,,,,
3608,133609,"[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] 2-bromoacetate",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)CBr)C)C,,,,,,
3609,133610,CID 133610,CC[C@H](C)[C@@H](C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N,,,,,,
3610,133611,"9H-Purine-9-ethanol, beta-hexyl-alpha-methyl-, (R*,S*)-(+-)-",CCCCCC[C@@H]([C@@H](C)O)N1C=NC2=CN=CN=C21,,,,,,
3611,133612,"1,6-Dihydro-6-(hydroxymethyl)-9-(2-hydroxy-3-nonyl)purine",CCCC[C@@H](C)[N+]1(C=NC2=C1NC=N[C@H]2CO)C[C@H](C)O,,,['Drugs that inhibit ADENOSINE DEAMINASE activity. (See all compounds classified as Adenosine Deaminase Inhibitors.)'],,,
3612,133613,4-[(Dimethylamino)methyl]-1-(3-hydroxyphenyl)non-1-en-3-one,CCCCCC(CN(C)C)C(=O)C=CC1=CC(=CC=C1)O,,,,,,
3613,133614,8-Chloro-tetrahydroisoquinoline-7-sulfonamide,C1CNCC2=C1C=CC(=C2Cl)S(=O)(=O)N,,,,,,
3614,133615,CID 133615,CCCC[C@@H](C(=O)NC(=O)[C@@H](CC(C)C)N[C@@H](CC1=CC=CC=C1)C(=O)CCl)NC=O,,,,,,
3615,133616,"(2S,3R,4R)-2-amino-3-hydroxy-4-methyloct-6-enoic acid",CC=CC[C@@H](C)[C@H]([C@@H](C(=O)O)N)O,,,,,,
3616,133617,2-[3-[(3-Carbamimidoylphenoxy)methyl]-4-(1-carboxy-1-hydroxyethyl)cyclohexyl]-2-hydroxypropanoic acid;3-(cyclohexylmethoxy)benzenecarboximidamide,CC(C1CCC(C(C1)COC2=CC=CC(=C2)C(=N)N)C(C)(C(=O)O)O)(C(=O)O)O.C1CCC(CC1)COC2=CC=CC(=C2)C(=N)N,,,,,,
3617,133618,2-[3-[(3-Carbamimidoylphenoxy)methyl]-4-(1-carboxy-1-hydroxyethyl)cyclohexyl]-2-hydroxypropanoic acid,CC(C1CCC(C(C1)COC2=CC=CC(=C2)C(=N)N)C(C)(C(=O)O)O)(C(=O)O)O,,,,,,
3618,133619,3-(Cyclohexylmethoxy)benzenecarboximidamide,C1CCC(CC1)COC2=CC=CC(=C2)C(=N)N,,,,,,
3619,133620,3-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)O)O,,,,,,
3620,133621,Imiloxan,CCN1C=CN=C1CC2COC3=CC=CC=C3O2,,,,,,
3621,133622,"1,4-Butanediol diisethionate",C(CCOS(=O)(=O)CCO)COS(=O)(=O)CCO,,,,,,
3622,133623,"1-Piperazineheptanoic acid, 4-(2-methoxyphenyl)-, ethyl ester",CCOC(=O)CCCCCCN1CCN(CC1)C2=CC=CC=C2OC,,,,,,
3623,133624,"1-(2,4,6-Triisopropylbenzenesulfonyl)-5-(pyridin-2-yl)tetrazolide",CC(C)C1=CC(=C(C(=C1)C(C)C)S(=O)(=O)N2C(=NN=N2)C3=CC=CC=N3)C(C)C,,,,,,
3624,133625,"3-(3,5-Dibromophenyl)-1-methylpyrrolidine-2,5-dione",CN1C(=O)CC(C1=O)C2=CC(=CC(=C2)Br)Br,,,,,,
3625,133626,Penstemonoside,C[C@H]1C[C@@H]([C@@H]2[C@H]1[C@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
3626,133627,Pedicularioside,C[C@H]1C[C@@H]([C@@]2([C@H]1[C@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,,,,,,
3627,133628,"(1-Oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)methanethiosulfonate",CC1(C=C(C(N1[O])(C)C)CSS(=O)(=O)C)C,,,,,,
3628,133629,3-Bromobut-2-en-2-yl 2-phenylacetate,CC(=C(C)Br)OC(=O)CC1=CC=CC=C1,,,,,,
3629,133630,5-Bromo-4-oxo-2-phenylhexanoic acid,CC(C(=O)CC(C1=CC=CC=C1)C(=O)O)Br,,,,,,
3630,133631,1-Stearyl-2-stearoylaminodeoxyphosphatidylcholine,CCCCCCCCCCCCCCCCCC(=O)N[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C,,,,,,
3631,133632,2-[hydroxy-[(2R)-2-(octadecanoylamino)-3-octadecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCCC(=O)N[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OCC[N+](C)(C)C,,,,,,
3632,133633,3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CC3=CNC4=CC=CC=C43,,,"['Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)']",,,
3633,133634,1-(gamma-Chloropropyl)-2-chloromethylpiperidine,C1CCN(C(C1)CCl)CCCCl,,,,,,
3634,133635,"9-Oxaergoline, 6-ethyl-",CCN1CCOC2[C@H]1CC3=CNC4=CC=CC2=C34,,,,,,
3635,133636,"Tetracosa-2,4,6,8,10,12-hexaenoic acid",CCCCCCCCCCCC=CC=CC=CC=CC=CC=CC(=O)O,,,,,,
3636,133637,Metakelfin,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl.COC1=NN=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,
3637,133638,"3-Pyridinecarboxamide, 2-chloro-N-(tetrahydro-2-oxo-3-thienyl)-",C1CSC(=O)C1NC(=O)C2=C(N=CC=C2)Cl,,,,,,
3638,133639,"3-Pyridinecarboxamide, 1,6-dihydro-6-oxo-N-(tetrahydro-2-oxo-3-thienyl)-",C1CSC(=O)C1NC(=O)C2=CNC(=O)C=C2,,,,,,
3639,133640,Mdz-glucuronide,C1C2=CN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4F)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,,,,,,
3640,133641,"Diaziridine, 3-(4-chlorophenyl)-1,2-dimethyl-",CN1C(N1C)C2=CC=C(C=C2)Cl,,,,,,
3641,133642,(-)-MDO-NPA HCl,CCCN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C5=C(C=C4)OCO5,,,,,,
3642,133643,"N-(2,2,2-Trifluoroethoxycarbonyl)imidazole",C1=CN(C=N1)C(=O)OCC(F)(F)F,,,,,,
3643,133644,Tetracosapentenoic acid,CCCCCCCCCCCCCC=CC=CC=CC=CC=CC(=O)O,,,,,,
3644,133645,(S)-1-(2-Methyl-1-oxo-3-((phenylmethyl)thio)propyl)-L-proline,C[C@H](CSCC1=CC=CC=C1)C(=O)N2CCC[C@H]2C(=O)O,,,,,,
3645,133646,"1,2-Di-O-tetradecyl-3-O-(glucopyranosyl)glycerol",CCCCCCCCCCCCCCO[C@@]1([C@@H]([C@H](O[C@@H]([C@@]1(O)OCCCCCCCCCCCCCC)OCCC)CO)O)O,,,,,,
3646,133647,CID 133647,C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](C)NC(=O)[C@H](CO)N,,,,,,
3647,133648,"(5-Amino-3,4-dihydro-2H-pyrrol-2-ylidene)bisphosphonic acid",C1CC(N=C1N)(P(=O)(O)O)P(=O)(O)O,,,,,,
3648,133649,19-Oic-deoxycorticosterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)CCC4=CC(=O)CC[C@]34C(=O)O,,,,,,
3649,133650,N-(2-cyclohexyl-2-phenylethyl)cyclohexanamine,C1CCC(CC1)C(CNC2CCCCC2)C3=CC=CC=C3,,,,,,
3650,133651,"2H-Pyran-2-one, 6-(2-(4-(1,1-dimethylethyl)phenyl)ethyl)tetrahydro-4-hydroxy-, trans-",CC(C)(C)C1=CC=C(C=C1)CC[C@@H]2C[C@H](CC(=O)O2)O,,,,,,
3651,133652,4-Hydroxytetradec-2-enal,CCCCCCCCCCC(C=CC=O)O,,,,,,
3652,133653,"Androst-4-ene-3beta,17beta-diol dienanthate",CCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@@H]4OC(=O)CCCCCC)C)C,,,,,,
3653,133654,"Benzamide, N,N-bis(3-(9-acridinylamino)propyl)-4-azido-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCN(CCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)C(=O)C7=CC=C(C=C7)N=[N+]=[N-],,,,,,
3654,133655,CID 133655,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCN(CCCNC4=C5C=CC=CC5=NC6=CC=CC=C64)C(=O)C7=CC=C(C=C7)N[N+]#N,,,,,,
3655,133656,Socketol,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,,,,,,
3656,133657,"methyl (1R,2R)-2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate",CC[C@]1(CC(=O)C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)O,,,,,,
3657,133658,"1,4-Pentanediamine, N4-(5-(hexyloxy)-6-methoxy-4-methyl-8-quinolinyl)-",CCCCCCOC1=C(C=C(C2=NC=CC(=C12)C)NC(C)CCCN)OC,,,,,,
3658,133659,Steroid U,CC1=C2CC[C@H]3[C@H]([C@@H]2CC1=O)CC[C@H]4[C@@]3(CC[C@H](C4)O)C,,,,,,
3659,133660,Adcpp,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCC4)CCC5=C[C@H](CC[C@]35C)OC(=O)CCC6CCCC6,,,,,,
3660,133661,1-Pyrenebutyltrimethylammonium,C[N+](C)(C)CCCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
3661,133662,alpha-Monofluoromethyltyrosine methyl ester,COC(=O)[C@@](CC1=CC=C(C=C1)O)(CF)N,,,,,,
3662,133663,"1H-Indole-5-carboxylic acid, 2-octadecyl-",CCCCCCCCCCCCCCCCCCC1=CC2=C(N1)C=CC(=C2)C(=O)O,,,,,,
3663,133664,"Ammonium 7-chloro-2,1,3-benzoxadiazole-4-sulfonate",C1=C(C2=NON=C2C(=C1)Cl)S(=O)(=O)[O-].[NH4+],,,,,,
3664,133665,7-Chloro-4-benzofurazansulfonic acid,C1=C(C2=NON=C2C(=C1)Cl)S(=O)(=O)O,,,,,,
3665,133666,CID 133666,C[C@H](C(=O)NCC(=O)NCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)N=[N+]=[N-])N,,,,,,
3666,133667,"3,6,7,8-Tetramethyl-4-(2-methylpropyl)-6h-pyrrolo[3,2-f]indolizine-2-carboxylic acid",CC1C(=C(C2=CC3=NC(=C(C3=C(N12)CC(C)C)C)C(=O)O)C)C,,,,,,
3667,133668,Phenylalanyl-prolyl-alanine,C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CC=CC=C2)N,,,,,,
3668,133669,"Cyclohexanone, 2-amino-2-(2-chlorophenyl)-6-hydroxy-",C1CC(C(=O)C(C1)(C2=CC=CC=C2Cl)N)O,,,,,,
3669,133670,"Cyclohexanone, 2-(2-chlorophenyl)-6-hydroxy-2-(methylamino)-",CNC1(CCCC(C1=O)O)C2=CC=CC=C2Cl,,,,,,
3670,133671,CID 133671,CCCCC(C)(C)[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)C)OC(=O)C,,,,,,
3671,133672,Acetoxyvalerensre,CC1CCC(C2=C(CC(C12)OC(=O)C)C)C=C(C)C(=O)O,,,,,,
3672,133673,"3-(2,4,5,6,7,7a-Hexahydro-1-hydroxy-3,7-dimethyl-1H-inden-4-yl)-2-methyl-2-propenoic acid",CC1CCC(C2=C(CC(C12)O)C)C=C(C)C(=O)O,,,,,,
3673,133674,PAESe,C1=CC=C(C=C1)[Se]CCN,,,,,,
3674,133675,2-Hydroxy-2-methyllevulinic acid,CC(=O)CC(C)(C(=O)O)O,,,,,,
3675,133676,CID 133676,CC1=C(C2=CC=CC=C2N(C1=O)CC3=CC(=C(C=C3)Cl)Cl)CC(=O)[O-].[Na+],,,,,,
3676,133677,"2-[1-[(3,4-Dichlorophenyl)methyl]-3-methyl-2-oxoquinolin-4-yl]acetic acid",CC1=C(C2=CC=CC=C2N(C1=O)CC3=CC(=C(C=C3)Cl)Cl)CC(=O)O,,,,,,
3677,133678,"2-[3-(2,4-Dinitroanilino)propanimidoyloxy]ethanesulfonic acid",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NCCC(=N)OCCS(=O)(=O)O,,,,,,
3678,133679,"N-Aminomethylmorpholine 3,3-diethyl-2,4-pyridinedione",CCC1(C(=O)C=CN(C1=O)CNN2CCOCC2)CC,,,,,,
3679,133680,"2,4(1H,3H)-Pyridinedione, 3,3-diethyl-1-((1-piperazinylamino)methyl)-",CCC1(C(=O)C=CN(C1=O)CNN2CCNCC2)CC,,,,,,
3680,133681,[(2R)-3-[2-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]ethoxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C)OC(=O)CCCCCCCCCCCCCCC,,,,,,
3681,133682,CID 133682,CCC=CCC=CCCC=CC=CC(=O)NCC(C)C,,,,,,
3682,133683,"Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-2,2,2-trifluoro-",CN1C(=NC(=O)C(F)(F)F)SC(=N1)S(=O)(=O)N,,,,,,
3683,133684,(R)-alpha-Amino-2-benzothiazolepropanoic acid,C1=CC=C2C(=C1)N=C(S2)C[C@H](C(=O)O)N,,,,,,
3684,133685,3-(2-Benzimidazolyl)alanine,C1=CC=C2C(=C1)NC(=N2)C[C@H](C(=O)O)N,,,,,,
3685,133686,"(1S,10R,12S,21R,22S,23S,24R)-4,8,12,22,24-pentahydroxy-10-methoxy-1,12-dimethyl-23-(methylamino)-20,25-dioxahexacyclo[19.3.1.02,19.05,18.07,16.09,14]pentacosa-2,4,7(16),8,14,18-hexaene-6,17-dione",C[C@]1(C[C@H](C2=C(C3=C(C=C2C1)C(=O)C4=C5C(=CC(=C4C3=O)O)[C@]6([C@@H]([C@@H]([C@@H]([C@H](O5)O6)O)NC)O)C)O)OC)O,,,,,,
3686,133687,CID 133687,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C)C(CCC(C)(C)O)O,,,,,,
3687,133688,"4-(2-(Dimethylamino)ethylaminocarbonyl)phenyl 1,2,3,4-tetrahydro-1-naphthoate hydrochloride",CN(C)CCNC(=O)C1=CC=C(C=C1)OC(=O)C2CCCC3=CC=CC=C23.Cl,,,,,,
3688,133689,"[4-[2-(Dimethylamino)ethylcarbamoyl]phenyl] 1,2,3,4-tetrahydronaphthalene-1-carboxylate",CN(C)CCNC(=O)C1=CC=C(C=C1)OC(=O)C2CCCC3=CC=CC=C23,,,,,,
3689,133690,"3,3-Didemethylpiperacillin",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](CS4)C(=O)O,,,,,,
3690,133691,Bz-Leu-ala-arg-NE,C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)OC1=CC=CC2=CC=CC=C21)NC(=O)[C@H](CC(C)C)NC(=O)C3=CC=CC=C3,,,,,,
3691,133692,"Butanamide, 4-amino-N-hydroxy-",C(CC(=O)NO)CN,,,,,,
3692,133693,"1-(1,1-Dioxothiolan-2-yl)-5-fluoropyrimidine-2,4-dione",C1CC(S(=O)(=O)C1)N2C=C(C(=O)NC2=O)F,,,,,,
3693,133694,Isovaleryl-valyl-3-oxo-4-amino-6-methylheptanoyl-alanyl-isoamylamide,C[C@@H](C(=O)N(CCC(C)C)C(=O)C(C(=O)CC(C)C)C(=O)C(CC(C)CC(=O)[C@H](C(C)C)N)N)N,,,,,,
3694,133695,"(R)-4-(2-(Dimethylamino)-1-hydroxyethyl)-1,2-phenylene 2,2-dimethylpropanoate",CC(C)(C)C(=O)OC1=C(C=C(C=C1)[C@H](CN(C)C)O)OC(=O)C(C)(C)C,,,,,,
3695,133696,2-Amino-2'-deoxyadenosine 5'-(tetrahydrogen triphosphate),C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)N)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
3696,133697,CID 133697,C[C@H](CC(CC(C)(CO)O)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C,,,,,,
3697,133698,(2S)-2-[[(2R)-2-amino-3-methylbutanoyl]amino]-N-[(2S)-5-(diaminomethylideneamino)-2-[(4-methoxynaphthalen-2-yl)amino]pentanoyl]-4-methylpentanamide,CC(C)C[C@@H](C(=O)NC(=O)[C@H](CCCN=C(N)N)NC1=CC2=CC=CC=C2C(=C1)OC)NC(=O)[C@@H](C(C)C)N,,,,,,
3698,133699,[(2R)-1-octadecoxy-3-phosphonooxypropan-2-yl] acetate,CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)O)OC(=O)C,,,,,,
3699,133700,CID 133700,C1=CC2=C(C=C1N[N+]#N)[N-]C=C2C[C@@H](C(=O)O)N,,,,,,
3700,133701,CID 133701,C1=CC2=C(C=C1N[N+]#N)NC=C2C[C@@H](C(=O)O)N,,,,,,
3701,133702,CID 133702,C1=CC2=C(C=C[N-]2)C=C1N[N+]#N,,,,,,
3702,133703,CID 133703,C1=CC2=C(C=CN2)C=C1N[N+]#N,,,,,,
3703,133704,CID 133704,CC1(C=CC2=C3C(=C(C4=C(N3C)C(=C(C=C4)O)OC)O)C(=O)C=C2O1)C,,,,,,
3704,133705,3-Iodo-4-aminophentermine,CC(C)(CC1=CC(=C(C=C1)N)I)N,,,,,,
3705,133706,"2-[2-(Diethylamino)ethyl]-5,11-dimethylpyrido[4,3-b]carbazol-9-ol",CCN(CC)CCN1C=CC2=C(C3=NC4=C(C3=C(C2=C1)C)C=C(C=C4)O)C,,,,,,
3706,133707,"1,2,5-trimethyl-6H-pyrido[4,3-b]carbazol-2-ium-9-ol;acetate",CC1=C2C=C[N+](=C(C2=CC3=C1NC4=C3C=C(C=C4)O)C)C.CC(=O)[O-],,,,,,
3707,133708,"9-Hydroxy-1,2,5-trimethyl-6H-pyrido[4,3-b]carbazol-2-ium",CC1=C2C=C[N+](=C(C2=CC3=C1NC4=C3C=C(C=C4)O)C)C,,,,,,
3708,133709,"(2S,3R,4S,5R)-2-[(2R,3R,4S,5S,6R)-2-[[(6S,10R,12S,13R,14R,17R)-3,12-dihydroxy-17-[(2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol",C[C@]1(CC[C@H](O1)C(C)(C)O)[C@@H]2CC[C@]3([C@@]2([C@H](CC4C3C[C@@H](C5[C@@]4(CCC(C5(C)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O)C)C,,,,,,
3709,133710,Isoxepac glucuronide,C1C2=CC=CC=C2C(=O)C3=C(O1)C=CC(=C3)CC(=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,,
3710,133711,"Acridine, 3,6-bis(2-(1-piperidinyl)ethoxy)-, trihydrochloride",C1CCN(CC1)CCOC2=CC3=C(C=C2)C=C4C=CC(=CC4=N3)OCCN5CCCCC5.Cl.Cl.Cl,,,,,,
3711,133712,"Acridine, 3,6-bis(2-(1-piperidinyl)ethoxy)-",C1CCN(CC1)CCOC2=CC3=C(C=C2)C=C4C=CC(=CC4=N3)OCCN5CCCCC5,,,,,,
3712,133713,4-Hydroxypenbutolol,CC(C)(C)NC[C@@H](COC1=C(C=C(C=C1)O)C2CCCC2)O,,,,,,
3713,133714,4-Nitrophenyl methyl(4-trifluoromethylphenyl)phosphinate,CP(=O)(C1=CC=C(C=C1)C(F)(F)F)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
3714,133715,"8-Ethylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one",CC=C1CC2C=NC3=CC=CC=C3C(=O)N2C1,,,,,,
3715,133716,CID 133716,CC(=CC(=O)N(CCC[C@@H](C(=O)OCCC(=CC(=O)N(CCCC1C(=O)N[C@@H](C(=O)N1)CCCN(C(=O)C)O)O)C)NC(=O)C)O)CCO,,,,,,
3716,133717,"5,6-Epoxycamphor",C[C@]12[C@@H]3[C@@H](O3)[C@@H](C1(C)C)CC2=O,,,,,,
3717,133718,CID 133718,CCCCCCCCCCCCCC=C[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)NS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C)O,,,,,,
3718,133719,"[(1R,2R,3R,4R)-4-(6-aminopurin-9-yl)-2,3-dihydroxycyclopentyl]methyl 2-methoxyacetate",COCC(=O)OC[C@H]1C[C@H]([C@H]([C@@H]1O)O)N2C=NC3=C(N=CN=C32)N,,,,,,
3719,133720,4-Hydroxy-N-(3-diethylaminopropyl)benzamide,CCN(CC)CCCNC(=O)C1=CC=C(C=C1)O,,,,,,
3720,133721,2-Bromohippuric acid,C1=CC=C(C(=C1)C(=O)NCC(=O)O)Br,,,,,,
3721,133722,CID 133722,CCN(CC)CC(C(=O)OCCC1=C([N+](=CS1)CC2=CN=C(N=C2N=O)C)C)(Cl)Cl.[Cl-],,,,,,
3722,133723,CID 133723,CCN(CC)CC(C(=O)OCCC1=C([N+](=CS1)CC2=CN=C(N=C2N=O)C)C)(Cl)Cl,,,,,,
3723,133724,N-Palmitoyltryptophan n-hexyl ester,CCCCCCCCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)OCCCCCC,,,,,,
3724,133725,"1-Naphthalenesulfonic acid, 5-(dimethylamino)-, 1-(((1-methylethyl)amino)methyl)-2-(1-naphthalenyloxy)ethyl ester",CC(C)NCC(COC1=CC=CC2=CC=CC=C21)OS(=O)(=O)C3=CC=CC4=C3C=CC=C4N(C)C,,,,,,
3725,133726,"(1S)-4beta-(6-Amino-3-carba-9H-purine-9-yl)-2alpha,3alpha-dihydroxycyclopentane-1beta-methanol",C1[C@H]([C@@H]([C@@H]([C@H]1N2C=NC3=C2C=CN=C3N)O)O)CO,,,,,,
3726,133727,2-(5-Bromo-2-pyridylazo)-5-(N-n-propyl-N-3-sulfopropylamino)phenol,CCCN(CCCS(=O)(=O)O)C1=CC(=C(C=C1)N=NC2=NC=C(C=C2)Br)O,,,,,,
3727,133728,4-Hydroxyequilenin,C[C@]12CCC3=C([C@@H]1CCC2=O)C=CC4=C3C=CC(=C4O)O,,,,,,
3728,133729,"Estra-1,3,5(10),7-tetraen-17-one, 3,4-dihydroxy-",C[C@]12CC[C@H]3C(=CCC4=C3C=CC(=C4O)O)[C@@H]1CCC2=O,,,,,,
3729,133730,Flupropadine,CC(C)(C)C1CCN(CC1)CC#CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F,,,,,,
3730,133731,"N-(6-(2,4-Difluorophenoxy)-2,3-dihydro-1H-inden-5-yl)methanesulfonamide",CS(=O)(=O)NC1=C(C=C2CCCC2=C1)OC3=C(C=C(C=C3)F)F,,,,,,
3731,133732,"N-(3,4-Dimethyl-5-isoxazolyl)-4-amino-1,2-naphthoquinone",CC1=C(ON=C1C)NC2=CC(=O)C(=O)C3=CC=CC=C32,,,,,,
3732,133733,"4-(3,4-Dimethylisoxazole-5-ylimino)-2-(3,4-dimethylisoxazole-5-ylamino)naphthalene-1(4H)-one",CC1=C(ON=C1C)NC2=CC(=NC3=C(C(=NO3)C)C)C4=CC=CC=C4C2=O,,,,,,
3733,133734,2-(4-Methyl-5-isoxazolylamino)-4-(4-methyl-5-isoxazolylimino)naphthalen-1(4H)-one,CC1=C(ON=C1)NC2=CC(=NC3=C(C=NO3)C)C4=CC=CC=C4C2=O,,,,,,
3734,133735,2-(5-Methoxy-3-indolyl)-3-aminopropanol,COC1=CC2=C(C=C1)NC=C2C(CN)CO,,,,,,
3735,133736,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, ethyl 2-(phenylthio)ethyl ester",CCOC(=O)C1=C(NC(=C(C1C)C(=O)OCCSC2=CC=CC=C2)C)C,,,,,,
3736,133737,Acetyldipeptide A2,CC(=O)NCCC1=NC(=CS1)C2=NC(=CS2)C(=O)NCCC[S+](C)C,,,,,,
3737,133738,CID 133738,C1=C(C2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC(=NC2=O)N)C(=O)O,,,,,,
3738,133739,CID 133739,CCCCCCCCCCCCCCCCCCCCCCCC(C(CCCCCCCCCCCCCCCCCCCCCC)C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)OC(C)CN[C@@H](C)C(=O)N[C@H](CCC(=O)N)C(=O)O)O,,,,,,
3739,133740,CID 133740,COC(=O)C1[C@H]2CCC(N2[O])CC1OC(=O)C3=CC=CC=C3,,,,,,
3740,133741,4-(2-Di-n-propylaminoethyl)-7-hydroxy-2-(3H)indolone,CCCN(CCC)CCC1=C2CC(=O)NC2=C(C=C1)O,,,,,"['4-[2-(Dipropylamino)ethyl]-7-hydroxy-1,3-dihydro-2h-indol-2-one is a known human metabolite of ropinirole.']",
3741,133742,CID 133742,C[C@H](C(=O)N[C@H](CCC(=O)N)C(=O)O)NC(=O)C(C)O[C@@H]1[C@H]([C@H](O[C@@H]([C@H]1O)CO)O)N,,,,,,
3742,133743,3-Aminotyramine,C1=CC(=C(C=C1CCN)N)O,,,,,,
3743,133744,"N-4-(2,3-Bis(bis(carboxymethyl)amino)propyl)phenyl bromoacetamide",C1=CC(=CC=C1C[C@@H](CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)NC(=O)CBr,,,,,,
3744,133745,"(6S)-3,6,10-trimethyl-6,7,8,11-tetrahydro-4H-cyclodeca[b]furan-5-one",C[C@H]1CCC=C(CC2=C(CC1=O)C(=CO2)C)C,,,,,,
3745,133746,2'-Deoxy-3-methylpseudouridine,CN1C(=O)C(=CNC1=O)[C@@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
3746,133747,"Phthalic acid, ethyl 2-methylphenyl ester",CCOC(=O)C1=CC=CC=C1C(=O)OC2=CC=CC=C2C,,,,,,
3747,133748,"3-{[2-Amino-1-(4-azido-2-nitrophenyl)ethyl]disulfanyl}-1-(propanoyloxy)pyrrolidine-2,5-dione",CCC(=O)ON1C(=O)CC(C1=O)SSC(CN)C2=C(C=C(C=C2)N=[N+]=[N-])[N+](=O)[O-],,,,,,
3748,133749,"7-Chloro-N,N,3-trimethyl-2-benzofurancarboxamide",CC1=C(OC2=C1C=CC=C2Cl)C(=O)N(C)C,,,,,,
3749,133750,"Carbamic acid, dimethyl-, 3-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-5-hydroxyphenyl ester",CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)O)O,,,,,,
3750,133751,4-Ureidooxycyclophosphamide,C1COP(=O)(NC1ONC(=O)N)N(CCCl)CCCl,,,,,,
3751,133752,CID 133752,C[C@@H](C(=O)NCC(=O)NC(=O)[C@H](CC1=CC=C(C=C1)[N+](=O)[O-])N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
3752,133753,Methyl 4-amino-5-ethyl-3-thiophenecarboxylate,CCC1=C(C(=CS1)C(=O)OC)N,,,,,,
3753,133754,5-Bromosalicyl-4'-chloroanilide O-beta-D-xylopyranoside triacetate,CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@H]1OC(=O)C)OC(=O)C)OC2=C(C=C(C=C2)Br)C(=O)NC3=CC=C(C=C3)Cl,,,,,,
3754,133755,4-(3-Phenylprop-2-enyl)piperazine-1-carboximidamide,C1CN(CCN1CC=CC2=CC=CC=C2)C(=N)N,,,,,,
3755,133756,Swainsonine N-oxide,C1C[C@H]([C@@H]2[C@@H]([C@@H](C[N+]2(C1)[O-])O)O)O,,,,,,
3756,133757,Kahweol palmitate,CCCCCCCCCCCCCCCC(=O)OCC1(CC23CC[C@@H]4C5=C(C=CC4(C2CCC1C3)C)OC=C5)O,,,,,,
3757,133758,"(7-Hydroxy-10b-methyl-3b,4,5,6,7,8,9,10,10a,10b,11,12-dodecahydro-5a,8-methanocyclohepta[5,6]naphtho[2,1-b]furan-7-yl)methyl hexadecanoate",CCCCCCCCCCCCCCCC(=O)OC[C@@]1(C[C@]23CC[C@@H]4C5=C(CC[C@]4([C@@H]2CC[C@@H]1C3)C)OC=C5)O,,,,,,
3758,133759,"L-Histidine, 1-(2-hydroxypropyl)-",CC(CN1C=C(N=C1)C[C@@H](C(=O)O)N)O,,,,,,
3759,133760,Tosglyproargnan,CC1=CC=C(C=C1)S(=O)(=O)[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(=O)[C@H](CCCN=C(N)N)NC3=CC=C(C=C3)[N+](=O)[O-])N,,,,,,
3760,133761,Methylsulfanyl 2-(3-phenylpropanoylamino)acetate,CSOC(=O)CNC(=O)CCC1=CC=CC=C1,,,,,,
3761,133762,5-(4-Iodophenyl)-5-(nonyltellanyl)pentanoic acid,CCCCCCCCC[Te]C(CCCC(=O)O)C1=CC=C(C=C1)I,,,,,,
3762,133763,"(2S,5R,6R)-6-[[2-[[(3,4-dihydroxybenzoyl)-(3-hydroxypropyl)carbamoyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N(CCCO)C(=O)C4=CC(=C(C=C4)O)O)C(=O)O)C,,,,,,
3763,133764,"1,3-Didecanoyl-2-(6-(5-fluorouracil-1-yl)carbonylamino)glyceride",CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCNC(=O)N1C=C(C(=O)NC1=O)F,,,,,,
3764,133765,"2-(3,7-Dimethylocta-2,6-dienyl)-5-hydroxy-6-[hydroxy(phenyl)methylidene]-2,4-bis(3-methylbut-2-enyl)cyclohex-4-ene-1,3-dione",CC(=CCCC(=CCC1(C(=O)C(=C(C(=C(C2=CC=CC=C2)O)C1=O)O)CC=C(C)C)CC=C(C)C)C)C,,,,,,
3765,133766,Neotriptophenolide,CC(C)C1=CC(=C2C(=C1OC)CC[C@@H]3[C@@]2(CCC4=C3COC4=O)C)O,,,,,,
3766,133767,CID 133767,CCCCCC(C=CC1C(C(CC(O1)O)O)CC=CCCCCCC(=O)O)O,,,,,,
3767,133768,CID 133768,CCCC[C@](C)(CC=C[C@H]1[C@@H](CC(=O)[C@@H]1CC=CC=CCC(=O)OC)O)O,,,,,,
3768,133769,Sandoz L1 32-468,CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CC3(C2=O)CCCCC3)O,,,,,,
3769,133770,CID 133770,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=S)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
3770,133771,CID 133771,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(OCC[N+](C)(C)C)S)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
3771,133772,"(8R,9S,10R,13S,14S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,15,17-triol",C[C@]12CCC(CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C(CC4O)O)C)O,,,,,,
3772,133773,5-[5-Hydroxy-6-(3-hydroxyoct-1-en-1-yl)-3a-methylhexahydropentalen-2(1H)-ylidene]pentanoic acid,CCCCCC(C=CC1C2CC(=CCCCC(=O)O)CC2(CC1O)C)O,,,,,,
3773,133774,Tripynadine,C1CCN(C1)CC2=CC(=CC(=C2O)CN3CCCC3)NC4=C5C(=NC6=C4C=CC(=C6)Cl)C=CC(=N5)N7CCCC7,,,,,,
3774,133775,"1-[2,4-dihydroxy-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl]-3-hydroxy-3-(4-hydroxyphenyl)propan-1-one",C1=CC(=CC=C1C(CC(=O)C2=C(C(=C(C=C2)O)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O,,,,,,
3775,133776,"Icosa-7,11,14-trienoic acid",CCCCCC=CCC=CCCC=CCCCCCC(=O)O,,,,,,
3776,133777,Dichlorophenyl-bis-triazolylpropanol,C1=CC(=C(C=C1Cl)Cl)C(CN2C=NC=N2)(CN3C=NC=N3)O,,,,,,
3777,133778,"Propanoic acid, 2-hydroxy-3-(4-hydroxyphenoxy)-",C1=CC(=CC=C1O)OCC(C(=O)O)O,,,,,,
3778,133779,"(3,5-Dichloro-2-hydroxyphenyl)(4,5-dichloro-1H-pyrrol-2-yl)methanone",C1=C(C=C(C(=C1C(=O)C2=CC(=C(N2)Cl)Cl)O)Cl)Cl,,,,,,
3779,133780,Pyrrolomycin D,C1=C(C=C(C(=C1C(=O)C2=C(C(=C(N2)Cl)Cl)Cl)O)Cl)Cl,,,,,,
3780,133781,N-Benzyloxycarbonylpyroglutamyl diazomethyl ketone,C1CC(=O)N([C@@H]1C(=O)C=[N+]=[N-])C(=O)OCC2=CC=CC=C2,,,,,,
3781,133782,CID 133782,C1CC(=O)N([C@@H]1C(=C[N+]#N)O)C(=O)OCC2=CC=CC=C2,,,,,,
3782,133783,Bisbromoacetyl hexestrol,CCC(C1=CC=C(C=C1)OC(=O)CBr)C(CC)C2=CC=C(C=C2)OC(=O)CBr,,,,,,
3783,133784,CID 133784,CCCCCCCCCCC(C)(C)CC(=O)C1=CC=C(C=C1)S(=O)(=O)[O-].[Na+],,,,,,
3784,133785,"4-(3,3-Dimethyltridecanoyl)benzenesulfonic acid",CCCCCCCCCCC(C)(C)CC(=O)C1=CC=C(C=C1)S(=O)(=O)O,,,,,,
3785,133786,CID 133786,CCCCC[C@@H]1[C@H](O1)C=CC=CC=CCC=CCCCC(=O)O,,,,,,
3786,133787,"(3S,8R,9S,10S,13R,14S,17R)-17-(2,10-dimethylundecan-6-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol",CC(C)CCCC(CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
3787,133788,2-Dadmt,CC1=C(C2=C(C=C1)[C@]([C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C2O)O)O)C(=O)C)N)(C)O)O,,,,,,
3788,133789,"5,6-Dihydroxyicosa-8,11,14-trienoic acid",CCCCCC=CCC=CCC=CCC(C(CCCC(=O)O)O)O,,,,,,
3789,133790,1-Pyrenebutyrylcarnitine,C[N+](C)(C)CC(CC(=O)[O-])OC(=O)CCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
3790,133791,[3-Carboxy-2-(4-pyren-1-ylbutanoyloxy)propyl]-trimethylazanium,C[N+](C)(C)CC(CC(=O)O)OC(=O)CCCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
3791,133792,CID 133792,CC(C)NC[C@@H](COC1=CC=C(C=C1)OS(=O)(=O)O)[O-].[K+],,,,,,
3792,133793,(S)-4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl hydrogen sulfate,CC(C)NC[C@@H](COC1=CC=C(C=C1)OS(=O)(=O)O)O,,,,,,
3793,133794,"2,3-Dihydro-1,4-benzodioxine-6,7-diamine",C1COC2=C(O1)C=C(C(=C2)N)N,,,,,,
3794,133795,Trimethyl-[[3-[3-[(trimethylammonio)methyl]phenyl]azophenyl]methyl]ammonium,C[N+](C)(C)CC1=CC(=CC=C1)N=NC2=CC=CC(=C2)C[N+](C)(C)C,,,,,,
3795,133796,Acetoxymethylphenylnitrosamine,CC(=O)OCN(C1=CC=CC=C1)N=O,,,,,,
3796,133797,"L-Argininamide, N-((1,1-dimethylethoxy)carbonyl)-L-norleucyl-L-glutaminyl-L-leucylglycyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-",CCCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(=O)[C@H](CCCN=C(N)N)NC1=CC2=C(C=C1)C(=CC(=O)O2)C)NC(=O)OC(C)(C)C,,,,,,
3797,133798,CID 133798,C1=NC2=C(N=CN(C2=N1)[C@@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)S,,,,,,
3798,133799,3-Bromoacetoxyestrone,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OC(=O)[14CH2]Br,,,,,,
3799,133800,"2-[[8-[6-(Hydroxymethyl)-2,6-dimethyl-3-oxocyclohexen-1-yl]-2,6-dimethylocta-5,7-dienoyl]amino]ethanesulfonic acid",CC1=C(C(CCC1=O)(C)CO)C=CC(=CCCC(C)C(=O)NCCS(=O)(=O)O)C,,,,,,
3800,133801,(2S)-2-[[2-chloroethyl(nitroso)carbamoyl]amino]-3-methylbutanamide,CC(C)[C@@H](C(=O)N)NC(=O)N(CCCl)N=O,,,,,,
3801,133802,"1,2-Benzenediol, 4-(2-(propylamino)propyl)-",CCCNC(C)CC1=CC(=C(C=C1)O)O,,,,,,
3802,133803,"5-Fluoropent-2-ene-1,4-diamine",C(C=CC(CF)N)N,,,,,,
3803,133804,"2,5-Diamino-2-(fluoromethyl)pent-3-enoic acid",C(C=CC(CF)(C(=O)O)N)N,,,,,,
3804,133805,tert-Butoxycarbonyl-beta-phenacyl-aspartyl-phenylalanineamide,CC(C)(C)OC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)C2=CC=CC=C2,,,,,,
3805,133806,Isoscutellarein 6-galactoside,C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)O)O)[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
3806,133807,CID 133807,C[C@H](C(=O)NCC(=O)NC(=O)[C@@H](CC1=CC=CC=C1)N(C)[C@@H](CCS(=O)C)CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N=C(N)N,,,,,,
3807,133808,Cfech-androst,CCOC(=O)OC1([C@@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)OCCl,,,,,,
3808,133809,"5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one",C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O)O,,,,,,
3809,133810,"[2,2,6,6-Tetramethyl-4-(4-hydroxy-4-oxobutyrylamino)-1-piperidinyloxy]radical",CC1(CC(CC(N1[O])(C)C)NC(=O)CCC(=O)O)C,,,,,,
3810,133811,6-Nitrocholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=C4[C@@]3(CC[C@@H](C4)O)C)[N+](=O)[O-])C,,,,,,
3811,133812,CID 133812,CC(C)(C)OC(=O)N[C@@H](CCC(=O)N)C(=O)NC(=O)[C@@H](CC1=CC=CC=C1)N[C@@H](CCCCN)C=O,,,,,,
3812,133813,Butyloxycarbonyl-glutaminyl-leucyl-lysinal,CC(C)C[C@@H](C(=O)NC(=O)[C@H](CCC(=O)N)NC(=O)OC(C)(C)C)N[C@@H](CCCCN)C=O,,,,,,
3813,133814,"4-Chloro-3',6'-dimethyl-2,2'-iminodibenzoate",CC1=C(C(=C(C=C1)C)NC2=C(C=CC(=C2)Cl)C(=O)O)C(=O)O,,,,,,
3814,133815,Ethyl 2-(4-azidophenoxy)-2-methylpropanoate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)N=[N+]=[N-],,,,,,
3815,133816,"N-[(2S,11bR)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]-N-methylpropane-1-sulfonamide;hydrochloride",CCCS(=O)(=O)N(C)[C@H]1CCN2CCC3=CC=CC=C3[C@H]2C1.Cl,,,,,,
3816,133817,CID 133817,CCCS(=O)(=O)N(C)[C@H]1CCN2CCC3=CC=CC=C3C2C1,,,,,,
3817,133818,"N-[(2S,11bR)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]-N-methylmethanesulfonamide",CN([C@H]1CCN2CCC3=CC=CC=C3[C@H]2C1)S(=O)(=O)C,,,,,,
3818,133819,"N-[(2S,11bR)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]-N-methylbutane-1-sulfonamide;hydrochloride",CCCCS(=O)(=O)N(C)[C@H]1CCN2CCC3=CC=CC=C3[C@H]2C1.Cl,,,,,,
3819,133820,"N-[(2S,11bR)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]-N-methylbutane-1-sulfonamide hydrochloride",CCCCS(=O)(=O)N(C)[C@H]1CCN2CCC3=CC=CC=C3[C@H]2C1,,,,,,
3820,133821,"[(1S)-1-[(2R,5R)-5-[(2R)-5-[(1R)-1-hydroxy-13-[(2S)-2-methyl-5-oxo-2H-furan-4-yl]tridecyl]oxolan-2-yl]oxolan-2-yl]undecyl] acetate",CCCCCCCCCC[C@@H]([C@H]1CC[C@@H](O1)[C@H]2CCC(O2)[C@@H](CCCCCCCCCCCCC3=C[C@@H](OC3=O)C)O)OC(=O)C,,,,,,
3821,133822,N-Methoxycarbonylphenylalanylglycine 4-nitrophenyl ester,COC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
3822,133823,CID 133823,CC(C)(C)OC(=O)N[C@H](CC1=CC=CC=C1)C(=O)NC(=O)[C@@H](CC2=CC=CC=C2)N[C@@H](CCCCN)C=O,,,,,,
3823,133824,Monoanilinogossypol,CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=NC3=CC=CC=C3)C(=C1C4=C(C5=C(C=C4C)C(=C(C(=C5C=O)O)O)C(C)C)O)O,,,,,,
3824,133825,4-Chloro-2-hydroxyphenylacetic acid,C1=CC(=C(C=C1Cl)O)CC(=O)O,,,,,,
3825,133826,Rotraxate hydrochloride,C1CC(CCC1CN)C(=O)C2=CC=C(C=C2)CCC(=O)O.Cl,,,,,,
3826,133827,CID 133827,C[C@H](CC(=O)CC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](C[C@H](C3=C)O)O)C,,,,,,
3827,133828,CID 133828,C[C@H](CC(=O)CC(C)(CO)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](C[C@H](C3=C)O)O)C,,,,,,
3828,133829,CID 133829,C1=CC(=CC=C1C(=O)NCC(=O)[O-])N=NC2=CC(=C(C=C2)O)C(=O)[O-].[Na+].[Na+],,,,,,
3829,133830,"(1s,2r)-1-Amino-2-phenylcyclopropanecarboxylic acid",C1[C@@H]([C@@]1(C(=O)O)N)C2=CC=CC=C2,,,,,,
3830,133831,1-(4-Fluorophenyl)-4-(4-isoquinolin-3-ylpiperazin-1-yl)butan-1-one hydrochloride,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC4=CC=CC=C4C=N3.Cl,,,,,,
3831,133832,Cinuperone,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC4=CC=CC=C4C=N3,,,,,,
3832,133833,H-Glu-Glu-Glu-Glu-Tyr-Met-Pro-Met-Gly-OH,CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N,,,,,,
3833,133834,CID 133834,CC(C)(CN=C(C1=CC=C(C=C1)N[N+]#N)[O-])NCC(COC2=CC=CC3=C2C(=C(N3)C#N)I)O,,,,,,
3834,133835,CID 133835,CC(C)(CNC(=O)C1=CC=C(C=C1)N[N+]#N)NCC(COC2=CC=CC3=C2C(=C(N3)C#N)I)O,,,,,,
3835,133836,(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid,CC(C)C[C@@H](CN[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)[C@@H](CC5=CN=CN5)N,,,,,,
3836,133837,Icyp-azide-1,CC(C)(CN=C(C1=CC=C(C=C1)N=[N+]=[N-])N)NCC(COC2=CC=CC3=C2C(=C(N3)C#N)I)O,,,,,,
3837,133838,7-Methoxy-3-acridinamine,COC1=CC2=C(C=C1)N=C3C=C(C=CC3=C2)N,,,,,,
3838,133839,"(5R,6R)-7-oxo-3-sulfo-6-[(1R)-1-sulfooxyethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid",C[C@H]([C@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)S(=O)(=O)O)OS(=O)(=O)O,,,,,,
3839,133840,"11,12,15-Trihydroxyicosa-5,8,13-trienoic acid",CCCCCC(C=CC(C(CC=CCC=CCCCC(=O)O)O)O)O,,,,,,
3840,133841,5-{[N-(2-Amino-1-hydroxy-3-sulfanylpropylidene)glycyl]imino}-5-hydroxynorvaline,C(CC(=O)NC(=O)CNC(=O)[C@H](CS)N)[C@@H](C(=O)O)N,,,,,,
3841,133842,3-Oxo-3-[(1-phenyl-3-sulfanylpropan-2-yl)amino]propanoic acid,C1=CC=C(C=C1)CC(CS)NC(=O)CC(=O)O,,,,,,
3842,133843,2-Bromoethyl carbamimidothioate,C(CBr)SC(=N)N,,,,,,
3843,133844,"(6R,8S,10S,11S,13S,14S,16R)-9-fluoro-6,11,16-trihydroxy-10,13,16-trimethyl-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthrene-3,17-dione",C[C@]12C[C@@H](C3([C@H]([C@@H]1C[C@@](C2=O)(C)O)C[C@H](C4=CC(=O)C=C[C@@]43C)O)F)O,,,,,,
3844,133845,6-Guanidinohexanesulfonic acid,C(CCCS(=O)(=O)O)CCN=C(N)N,,,,,,
3845,133846,CID 133846,C[C@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(=O)[C@H](C(C)C)NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)CCC(=O)O,,,,,,
3846,133847,"3-hydroxy-2-methyl-3-(3,7,11,15-tetramethylhexadecyl)-2H-naphthalene-1,4-dione",CC1C(=O)C2=CC=CC=C2C(=O)C1(CCC(C)CCCC(C)CCCC(C)CCCC(C)C)O,,,,,,
3847,133848,"Ethyl 3-(2-chlorophenyl)-5,7-dimethyl-2-(methylcarbamoyloxymethyl)-4-oxoquinazoline-6-carboxylate",CCOC(=O)C1=C(C2=C(C=C1C)N=C(N(C2=O)C3=CC=CC=C3Cl)COC(=O)NC)C,,,,,,
3848,133849,Abeorphine,CCC[C@H]1C2=CC=CC3=C2[C@H](N1CC)CC4=C3C(=C(C=C4)O)O,,,,,,
3849,133850,4'-Hydroxybutobarbitone,CCC1(C(=O)NC(=O)NC1=O)CCCCO,,,,,,
3850,133851,"6-(4,6-Dichlorotriazinyl)aminofluorescein",C1=CC2=C(C=C1NC3=NC(=NC(=N3)Cl)Cl)C4(C5=C(C=C(C=C5)O)OC6=C4C=CC(=C6)O)OC2=O,,,,,,
3851,133852,CID 133852,CCCCCCCCC(=C(CCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=C(CCCCCCCC)Br)Br)Br)Br,,,,,,
3852,133853,CID 133853,CCCCCCCCC(=C(CCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=C(CCCCCCCC)Br)Br)Br)Br,,,,,,
3853,133854,"D-Glucopyranuronic acid, 2,3-diamino-2,3-dideoxy-",[C@@H]1([C@@H]([C@H](OC([C@@H]1N)O)C(=O)O)O)N,,,,,,
3854,133855,"[(2S,3R)-6-hydroxy-6-methyl-2-[(2S,3R,5R,9R,10R,13R,17R)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]heptan-3-yl] dihydrogen phosphate",C[C@@H]([C@H]1CCC2([C@@]1(CC[C@H]3C2=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C)O)[C@@H](CCC(C)(C)O)OP(=O)(O)O,,,,,,
3855,133856,"[(2S,3R)-2-[(3S,5R,9R,10R,13R,17R)-3,14-dihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-6-methylheptan-3-yl] dihydrogen phosphate",C[C@@H]([C@H]1CCC2([C@@]1(CC[C@H]3C2=CC(=O)[C@H]4[C@@]3(CC[C@@H](C4)O)C)C)O)[C@@H](CCC(C)(C)O)OP(=O)(O)O,,,,,,
3856,133857,"10beta-Hydroxy-4-estrene-3,17-dione formate",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CCC34OC=O,,,,,,
3857,133858,CID 133858,C(CC(=O)N[C@@H](CSS(C[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)CC(CC(C(=O)O)N)C(=O)O)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
3858,133859,CID 133859,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CC=CC=CC=CCC,,,,,,
3859,133860,CID 133860,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CC=CC=C/C=C/CC,,,,,,
3860,133861,"2-Amino-6,7-diacetoxy-1,2,3,4-tetrahydronaphthalene",CC(=O)OC1=C(C=C2CC(CCC2=C1)N)OC(=O)C.Cl,,,,,,
3861,133862,"(3-Acetyloxy-6-amino-5,6,7,8-tetrahydronaphthalen-2-yl) acetate",CC(=O)OC1=C(C=C2CC(CCC2=C1)N)OC(=O)C,,,,,,
3862,133863,alpha-Lactylthiamine,CC1=C(SC(=[N+]1CC2=CN=C(N=C2N)C)C(C)(C(=O)[O-])O)CCO,,,,,,
3863,133864,"2-[3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-2-yl]-2-hydroxypropanoic acid",CC1=C(SC(=[N+]1CC2=CN=C(N=C2N)C)C(C)(C(=O)O)O)CCO,,,,,,
3864,133865,"Propanamide, N-phenyl-N-(1-(2-phenylethyl)-3-(2-propenyl)-4-piperidinyl)-, monohydrochloride, cis-",CCC(=O)N([C@@H]1CCN(C[C@@H]1CC=C)CCC2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
3865,133866,3-Allylfentanyl,CCC(=O)N([C@@H]1CCN(C[C@@H]1CC=C)CCC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3866,133867,Liconeolignan,CC(=CCC1=C(C=CC(=C1)C2=C(C3=CC(=C(C=C3O2)OC)OC)O)O)C,,,,,,
3867,133868,"4-[2-[(4aS,5R,6R,8aS)-6-hydroxy-5,8a-dimethyl-2-methylidene-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-2H-furan-5-one",C[C@@]12CC[C@H]([C@@]([C@H]1CCC(=C)C2CCC3=CCOC3=O)(C)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
3868,133869,CID 133869,C[C@@]12CC[C@H]([C@@]([C@H]1CCC(=C)C2CC=C3[C@@H](COC3=O)O)(C)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
3869,133870,8-Nitroellipticine,CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=CC(=C4)[N+](=O)[O-])C,,,,,,
3870,133871,CID 133871,C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)NCCN[C@@H](CC(C)C)C(=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
3871,133872,Glycyl-histidyl-arginine,C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)CN,,,,,,
3872,133873,Chloramine hemisuccinate,CC(C)(COC(=O)CCC(=O)O)N(Cl)Cl,,,,,,
3873,133874,(2-(2-(4-(Diphenylmethylene)-1-piperidinyl)ethoxy)ethoxy)acetic acid hydrochloride,C1CN(CCC1=C(C2=CC=CC=C2)C3=CC=CC=C3)CCOCCOCC(=O)O.Cl,,,,,,
3874,133875,Pibaxizine,C1CN(CCC1=C(C2=CC=CC=C2)C3=CC=CC=C3)CCOCCOCC(=O)O,,,,,,
3875,133876,Cuminyl hydroperoxide,CC(C)C1=CC=CC=C1COO,,,,,,
3876,133877,4-(Acetylamino)phenyl 1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetate,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)OC3=CC=C(C=C3)NC(=O)C,,,,,,
3877,133878,CID 133878,C[C@H](CCC(=CCO)C(C)C)[C@H]1C[C@H]([C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2C(=O)C=C4[C@@]3(CC[C@@H](C4)O)C)O)C)O,,,,,,
3878,133879,H-His-Pro-Phe-His-Leu-Val-Ile-His-OH,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CN=CN5)N,,,,,,
3879,133880,2-(2-Methoxyphenoxy)ethyl 2-(acetyloxy)benzoate,CC(=O)OC1=CC=CC=C1C(=O)OCCOC2=CC=CC=C2OC,,,,,,
3880,133881,"3-[2,3-Dihydro-2,2-dimethylbenzofuran-7-yl]-5-methoxy-1,3,4-oxadiazol-2(3H)-one",CC1(CC2=C(O1)C(=CC=C2)N3C(=O)OC(=N3)OC)C,,,,,,
3881,133882,"Acetamide, 2-phenoxy-N-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-, monomethanesulfonate",CS(=O)(=O)O.C1CN(CCN1CCNC(=O)COC2=CC=CC=C2)C3=CC=CC(=C3)C(F)(F)F,,,,,,
3882,133883,N-[2-[4-[3-(Trifluoromethyl)phenyl]piperazin-1-yl]ethyl]phenoxyacetamide,C1CN(CCN1CCNC(=O)COC2=CC=CC=C2)C3=CC=CC(=C3)C(F)(F)F,,,,,,
3883,133884,"3,7,12,25-Tetrahydroxycholestan-24-one",C[C@H](CCC(=O)C(C)(C)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
3884,133885,Prolyl-phenylalanyl-prolyl-glycine,C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N3CCC[C@H]3C(=O)NCC(=O)O,,,,,,
3885,133886,5-Cyano-2-(trifluoromethyl)-1H-imidazole-4-carboxamide,C(#N)C1=C(NC(=N1)C(F)(F)F)C(=O)N,,,,,,
3886,133887,2-(2-Naphthylmethyl)benzimidazole,C1=CC=C2C=C(C=CC2=C1)CC3=NC4=CC=CC=C4N3,,,,,,
3887,133888,"1,3-Di-(p-amidinophenoxy)-2,2-bis-(p-amidinophenoxymethyl)-propane",C1=CC(=CC=C1C(=N)N)OCC(COC2=CC=C(C=C2)C(=N)N)(COC3=CC=C(C=C3)C(=N)N)COC4=CC=C(C=C4)C(=N)N,,,,,,
3888,133889,Lysine-iodoacetylmethotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCCCNC(=O)CI)C(=O)O,,,"['Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Folic Acid Antagonists.)']",,,
3889,133890,Dazoxiben glucuronide,C1=CC(=CC=C1C(=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)OCCN3C=CN=C3,,,,,,
3890,133891,Anticonvulsant 7903; Chlocibutamine,CCC(C)NC(=O)C=CC1=CC(=C(C=C1)Cl)Cl,,,,,,
3891,133892,Antibiotic 79002,CCN1C2=CC=CC=C2C(=C1O)C3=NC4=CC=CC=C4C3=O,,,,,,
3892,133893,"Methanediamine, 1,1-di-2-pyridinyl-N,N'-di-8-quinolinyl-",C1=CC=NC(=C1)C(C2=CC=CC=N2)(NC3=CC=CC4=C3N=CC=C4)NC5=CC=CC6=C5N=CC=C6,,,,,,
3893,133894,"2-Hydroxy-5-methoxy-3-pentadec-10-enylcyclohexa-2,5-diene-1,4-dione",CCCCC=CCCCCCCCCCC1=C(C(=O)C=C(C1=O)OC)O,,,,,,
3894,133895,1-[2-Hydroxy-3-(2-nitroimidazol-1-yl)propyl]piperidin-3-ol,C1CC(CN(C1)CC(CN2C=CN=C2[N+](=O)[O-])O)O,,,,,,
3895,133896,3'-Hydroxyhexestrol,CC[C@H](C1=CC=C(C=C1)O)[C@@H](CC)C2=CC(=C(C=C2)O)O,,,,,,
3896,133897,Allylfluorescein,C=CCC1=C2C(=CC=C1)C3(C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O)OC2=O,,,,,,
3897,133898,(2S)-2-amino-4-[[(2S)-1-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid,CSCC[C@@H](C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C[C@@H](C(=O)O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N,,,,,,
3898,133899,CID 133899,CCCCCCCCC(CNC1CC2CC(C1CC=CCCCC(=O)O)C2(C)C)O,,,,,,
3899,133900,"5-Heptenoic acid, 7-(3-((3-((4-ethylphenyl)thio)-2-hydroxypropyl)amino)-6,6-dimethylbicyclo(3.1.1)hept-2-yl)-",CCC1=CC=C(C=C1)SCC(CNC2CC3CC(C2CC=CCCCC(=O)O)C3(C)C)O,,,,,,
3900,133901,4-Aminobenzylcarazolol,CC(C)(CC1=CC=C(C=C1)N)NCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,,,,,,
3901,133902,7-Anilinocoumarin-4-acetic acid,C1=CC=C(C=C1)NC2=CC3=C(C=C2)C(=CC(=O)O3)CC(=O)O,,,,,,
3902,133903,7-Anilino-4-methylcoumarin-3-acetic acid,CC1=C(C(=O)OC2=C1C=CC(=C2)NC3=CC=CC=C3)CC(=O)O,,,,,,
3903,133904,"Piperidine, 1-(1-phenylcyclohexyl)-, 1-oxide",C1CCC(CC1)(C2=CC=CC=C2)[N+]3(CCCCC3)[O-],,,,,,
3904,133905,Desmethylofloxacin,CN1CCN(CC1)C2=C(C=C3C4=C2OCCN4C=C(C3=O)C(=O)O)F,,,,,,
3905,133906,Thiobenzyl N-heptafluorobutyrylanthranilate,C1=CC=C(C=C1)CSC(=O)C2=CC=CC=C2NC(=O)C(C(C(F)(F)F)(F)F)(F)F,,,,,,
3906,133907,2-Trifluoroacetamidobenzenesulfonyl fluoride,C1=CC=C(C(=C1)NC(=O)C(F)(F)F)S(=O)(=O)F,,,,,,
3907,133908,CID 133908,CC(C)[C@@H]1CCC(=C[C@H]1C=C(CO)C(=O)O)CO,,,,,,
3908,133909,"1-Hydroxy-2,5-dioxopyrrolidine-3-sulfonic acid",C1C(C(=O)N(C1=O)O)S(=O)(=O)O,,,,,,
3909,133910,15-Hydroxyeicosatrienoic acid,CCCCCC(CCCCCCCC=CC=CC=CC(=O)O)O,,,,,,
3910,133911,delta-9-Tetrahydrocannabinol dichloroethyl carbamoyl ester,CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)OC(=O)N(CCCl)CCCl,,,,,,
3911,133912,Michefucscalide,CC(=O)O[C@H]1CC(=C)[C@@H]2CC[C@]([C@@H]2[C@@H]3[C@@H]1C(=C)C(=O)O3)(C)O,,,,,,
3912,133913,Isodiazinon,CCOP(=O)(OCC)SC1=NC(=NC(=C1)C)C(C)C,,,,,,
3913,133914,Butyryl trihexyl citrate,CCCCCCOC(=O)CC(CC(=O)OCCCCCC)(C(=O)OCCCCCC)OC(=O)CCC,,,,,,
3914,133915,Leucinal,CC(C)C[C@@H](C=O)N,,,,,,
3915,133916,Antibiotic OA 6129C,CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCNC(=O)CCNC(=O)C(C(C)(C)CO)O)OS(=O)(=O)O,,,,,,
3916,133917,Dptpc,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=S)([O-])OCC[N+](CC)(CC)CC)OC(=O)CCCCCCCCCCCCCCC,,,,,,
3917,133918,"2-[[(2R)-2,3-di(hexadecanoyloxy)propoxy]-hydroxyphosphinothioyl]oxyethyl-triethylazanium",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=S)(O)OCC[N+](CC)(CC)CC)OC(=O)CCCCCCCCCCCCCCC,,,,,,
3918,133919,(2S)-N-[2-[(2-aminoacetyl)amino]acetyl]-3-(4-hydroxyphenyl)-2-(methylamino)propanamide,CN[C@@H](CC1=CC=C(C=C1)O)C(=O)NC(=O)CNC(=O)CN,,,,,,
3919,133920,n-Octyl-beta-D-maltopyranoside,CCCCCCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O,,,,,,
3920,133921,2-[(4-Bromobenzyl)oxy]acetic acid,C1=CC(=CC=C1COCC(=O)O)Br,,,,,,
3921,133922,2-(3-Amino-5-oxofuran-2-ylidene)acetaldehyde,C1=C(C(=CC=O)OC1=O)N,,,,,,
3922,133923,"[3-(1,3-Dimethyl-2,6-dioxopurin-7-yl)-2-hydroxypropyl] 4-phenylmethoxybenzoate",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(COC(=O)C3=CC=C(C=C3)OCC4=CC=CC=C4)O,,,,,,
3923,133924,CID 133924,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=C(C4=CSC(=N4)N)N=O)O)SC2)C(=O)O,,,,,,
3924,133925,"4-N,N-Diacetylaminobenzo(a)pyrene",CC(=O)N(C1=CC2=CC3=CC=CC=C3C4=C2C5=C(C=CC=C15)C=C4)C(=O)C,,,,,,
3925,133926,CID 133926,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=C(C=C3)O)NC(=O)NC4=CN=C(NC4=O)NC5=CC=C(C=C5)S(=O)(=O)N)C(=O)[O-])C.[Na+],,,,,,
3926,133927,"(2S,5R,6R)-6-[[2-(4-hydroxyphenyl)-2-[[6-oxo-2-(4-sulfamoylanilino)-1H-pyrimidin-5-yl]carbamoylamino]acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=C(C=C3)O)NC(=O)NC4=CN=C(NC4=O)NC5=CC=C(C=C5)S(=O)(=O)N)C(=O)O)C,,,,,,
3927,133928,Antibiotic OA 6129B(sub 1),CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCNC(=O)CCNC(=O)C(C(C)(C)CO)O)O,,,,,,
3928,133929,"12-N,N-Diacetylaminobenzo(a)pyrene",CC(=O)N(C1=CC2=C3C(=CC4=CC=CC=C42)C=CC5=C3C1=CC=C5)C(=O)C,,,,,,
3929,133930,"5-[2-Hydroxy-5-oxo-4-(4,6,8-trimethylnona-2,7-dienoylamino)-7-oxabicyclo[4.1.0]hept-3-en-2-yl]pentanoic acid",CC(CC(C)C=C(C)C)C=CC(=O)NC1=CC(C2C(C1=O)O2)(CCCCC(=O)O)O,,,,,,
3930,133931,5-Isothiocyanato-1-naphthalene azide,C1=CC2=C(C=CC=C2N=[N+]=[N-])C(=C1)N=C=S,,,,,,
3931,133932,Tyrosyl-5-aminovalerylphenylalanylmethionine,CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CCCCNC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
3932,133933,CID 133933,CC1(CC(=NN=C(N)S)CC(=NN=C(N)S)C1)C.Cl,,,,,,
3933,133934,CID 133934,CC1(CC(=NN=C(N)S)CC(=NN=C(N)S)C1)C,,,,,,
3934,133935,"7-(2-Oxo-2-phenylethyl)-6-phenyl-3,5,6,7-tetrahydro-2h-imidazo[2,1-b][1,3]thiazol-4-ium bromide",C1CSC2=[N+]1CC(N2CC(=O)C3=CC=CC=C3)C4=CC=CC=C4.[Br-],,,,,,
3935,133936,"1-Phenyl-2-(6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-4-ium-7-yl)ethanone",C1CSC2=[N+]1CC(N2CC(=O)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3936,133937,CID 133937,CCCCCCCCCCCCCC=C[C@@H]([C@@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)NS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C)O,,,,,,
3937,133938,"1,1-Diethoxy-3-(1-naphthoxy)-2-propanol",CCOC(C(COC1=CC=CC2=CC=CC=C21)O)OCC,,,,,,
3938,133939,Dansyl-phenylalanyl-leucyl-arginine,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C,,,,,,
3939,133940,O(6)-Butylguanosine,CCCCOC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
3940,133941,"2-butoxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-4-one",CCCCOC1=NC(=O)C(=CN1[C@H]2C[C@@H]([C@H](O2)CO)O)C,,,,,,
3941,133942,Penta-O-ethylquercetin,CCOC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OCC)OCC)OCC)OCC,,,,,,
3942,133943,"(2S,3aS,4R,6R,7R,7aR)-6,7-dihydroxy-4-(hydroxymethyl)-2-methyl-4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2-carboxylic acid",C[C@]1(O[C@H]2[C@H](O[C@H]([C@@H]([C@H]2O1)O)O)CO)C(=O)O,,,,,,
3943,133944,Cppac,COC1=CC=C(C=C1)NP(=O)(OC2=CC=CC=C2Cl)Cl,,,,,,
3944,133945,Epoxyagroclavine-1,C[C@@]12CN([C@@H]3CC4=CNC5=CC=CC(=C45)[C@@H]3[C@@H]1O2)C,,,,,,
3945,133946,4-Caprylamidophenol,CCCCCCCC(=O)NC1=CC=C(C=C1)O,,,,,,
3946,133947,4-Nitrobenzyl selenosulfuric acid,C1=CC(=CC=C1C[Se]S(=O)(=O)O)[N+](=O)[O-],,,,,,
3947,133948,Benzylselenium sulfuric acid,C1=CC=C(C=C1)C[Se]S(=O)(=O)O,,,,,,
3948,133949,"2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-ylmethyl)benzonitrile;methyl hydrogen sulfate",COS(=O)(=O)O.C1CN(CC2=C1SC=C2)CC3=CC=CC=C3C#N,,,,,,
3949,133950,"Benzonitrile, 2-((4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)methyl)-",C1CN(CC2=C1SC=C2)CC3=CC=CC=C3C#N,,,,,,
3950,133951,Baycuten SD,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4.C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)CN=[N+]=[N-])O)[N+](=O)[O-],,,,,,
3951,133952,"2-azido-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide",C1=CC(=CC=C1C(C(CO)NC(=O)CN=[N+]=[N-])O)[N+](=O)[O-],,,,,,
3952,133953,Bvlgaa,CCN1C2=C(C=C(C=C2)N[C@@H](CCCN=C(N)N)C(=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)OC(C)(C)C)C3=CC=CC=C31,,,,,,
3953,133954,N-Benzoylarginine-3-amino-9-ethylcarbazole,CCN1C2=C(C=C(C=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C3=CC=CC=C3)C4=CC=CC=C41,,,,,,
3954,133955,3-Otp-cyclophosphamide,CC1(CC(CC(N1[O])(C)C)N2CCCOP2(=O)N(CCCl)CCCl)C,,,,,,
3955,133956,"2-[(4R)-4-[(5S,7R,10S,12S,13R,17R)-2,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentyl]pentanedioic acid",C[C@H](CCCC(CCC(=O)O)C(=O)O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC(CC4)O)C)O)O)C,,,,,,
3956,133957,N-2-Mdmn,CNCC1=NC(=CS1)CSCCNC(=C[N+](=O)[O-])NC,,,,,,
3957,133958,2-Acetoxycyclobutyltrimethylammonium,CC(=O)O[C@H]1CC[C@H]1[N+](C)(C)C.[I-],,,,,,
3958,133959,(2-Acetyloxycyclobutyl)-trimethylazanium,CC(=O)OC1CCC1[N+](C)(C)C,,,,,,
3959,133960,"Galactose 4,6-pyruvate acetal",C[C@]1(OC[C@@H]2[C@H](O1)[C@@H]([C@H]([C@H](O2)O)O)O)C(=O)O,,,,,,
3960,133961,CID 133961,C1C[C@@H]2C[C@@H]1[C@H]([C@@H]2C=NNC(=O)NC3=CC=CC=C3)CC=CCCCC(=O)O,,,,,,
3961,133962,Imidazole oxoglurate,C1=CN=CN1.C(CC(=O)O)C(=O)C(=O)O,,,,,,
3962,133963,"2-[6-Chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-n-propylacetamide",CCCNC(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,,,,,,
3963,133964,CID 133964,C([C@@H]([C@@H]1C(=O)C(=C(O1)[O-])O)O)O.[Fe+3],,,,,,
3964,133965,Bis(4-cyanophenyl)imidazo-1-yl-methane hemisuccinate salt,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=CN=C3.C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=CN=C3.C(CC(=O)O)C(=O)O,,,,,,
3965,133966,4-[(4-Cyanophenyl)-imidazol-1-ylmethyl]benzonitrile,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=CN=C3,,,,,,
3966,133967,Fluasterone,C[C@]12CCCCC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@H](C4=O)F)C,"['Investigated for use/treatment in psoriasis and psoriatic disorders, hyperlipidemia, metabolic disease, cancer/tumors (unspecified), and obesity.']",,,,,
3967,133968,3-Carboxy-2-methylene-4-nonanolide,CCCCC[C@H]1[C@@H](C(=C)C(=O)O1)C(=O)O,,,,,,
3968,133969,"8-chloro-5-(4-chlorophenyl)-5H-indeno[1,2-d]pyrimidine",C1=CC(=CC=C1C2C3=C(C=C(C=C3)Cl)C4=NC=NC=C24)Cl,,,,,,
3969,133970,Dicyclidol,C1CCC(CC1)C(CN2CCCCC2)(C3CCCCC3)O,,,,,,
3970,133971,Bisucaberin,C1CCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CC1)O)O,,,,,,
3971,133972,Zn(II) Aetiopurpurin,CCC1=C(C2=CC3=NC(=CC4=C(C(=C([N-]4)C5=CC(=C([O-])OCC)C6(C5=NC(=CC1=N2)C6C)CC)C)CC)C(=C3CC)C)C.[Zn+2],,,,,,
3972,133973,"methyl (2R,8S)-8-chloro-4-hydroxy-7-methyl-1-oxo-6-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-3,7,8,9-tetrahydro-2H-pyrrolo[3,2-f]quinoline-2-carboxylate",CC1[C@H](CC2=C3C(=O)[C@@H](NC3=C(C=C2N1C(=O)C4=CC5=CC(=C(C(=C5N4)OC)OC)OC)O)C(=O)OC)Cl,,,,,,
3973,133974,Ccris 6861,CC(=O)N1C2C1C3(C(C4=C(C=C(C=C4OC(=O)C)C=O)N(C2)O3)COC(=O)N)OC(=O)C,,,,,,
3974,133975,CID 133975,C#CCN(CC1=CC2=C(C=C1)NC(=NC2=O)C(F)(F)F)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
3975,133976,N-Acetylneuraminyl cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[C@@]5(C[C@@H]([C@H]([C@@H](O5)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)C)C,,,,,,
3976,133977,"5-Ethenyl-9-hydroxy-5,12-dimethyl-10-oxapentacyclo[7.7.1.01,15.02,7.012,17]heptadec-6-ene-8,11-dione",CC1(CCC2C(=C1)C(=O)C3(C4C25CC5CCC4(C(=O)O3)C)O)C=C,,,,,,
3977,133978,CID 133978,C1CN1CCOC2=CC=C(C=C2)C(=C(C3=CC=CC=C3)[125I])C4=CC=CC=C4,,,,,,
3978,133979,"Diamminecyclobutane-1,1-dicarboxylatodihydroxyplatinum(IV)",C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[OH-].[OH-].[Pt+4],,,,,,
3979,133980,"1,8-Di-(2-imidazoyl)-2,7-diazoctadiene-1,7-(N,N',N'',N''')-Cu(II)diperchlorate",C1=CN=C(N1)C=NCCCCN=CC2=NC=CN2.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[Cu+2],,,,,,
3980,133981,CID 133981,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)C=C(CC(=O)O)C(=O)O)O,,,,,,
3981,133982,"5,11-Dimethyl-5H-quinindoline",CC1=C2C3=CC=CC=C3N=C2N(C4=CC=CC=C14)C,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)'],,,
3982,133983,Ravidomycin N-oxide,C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C2=C3C(=C(C=C2)O)C(=CC4=C3OC(=O)C5=C4C(=CC(=C5)C=C)OC)OC)O)[N+](C)(C)[O-])OC(=O)C,,,,,,
3983,133984,"(4alpha,10alpha)-4,19-Cyclo-A-dihomoandrost-4b-ene-4a,17-dione",CC12CCC3C(C1CCC2=O)CCC4=CC(=O)C5CCCC34C5,,,,,,
3984,133985,"(4S,7S,12bR)-7-[[(2S)-2-acetylsulfanyl-3-phenylpropanoyl]amino]-6-oxo-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid",CC(=O)S[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]2CC3=CC=CC=C3[C@H]4CCC[C@H](N4C2=O)C(=O)O,,,['A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both NEUTRAL ENDOPEPTIDASE and ANGIOTENSIN CONVERTING ENZYME. They increase the availability of NATRIURETIC PEPTIDES and BRADYKININ and inhibit production of ANGIOTENSIN II. (See all compounds classified as Vasopeptidase Inhibitors.)'],,,
3985,133986,"(4S,7S,12bR)-6-oxo-7-[[(2S)-3-phenyl-2-sulfanylpropanoyl]amino]-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid",C1C[C@@H]2C3=CC=CC=C3C[C@@H](C(=O)N2[C@@H](C1)C(=O)O)NC(=O)[C@H](CC4=CC=CC=C4)S,,,,,,
3986,133987,Quinato(chda)Pt,C1CCC(C(C1)N)N.C1C(C(C(CC1(C(=O)[O-])[O-])O)O)O.[Pt+2],,,,,,
3987,133988,"2-phenyl-3H-1,3,2-benzoxazaphosphinin-4-one",C1=CC=C(C=C1)P2NC(=O)C3=CC=CC=C3O2,,,,,,
3988,133989,CID 133989,C1C2CN(CC2C3=C(N1)NC(=NC3=O)N)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
3989,133990,"3-amino-5-[1-cyano-2-(3,4-dihydroxyphenyl)ethenyl]-1H-pyrazole-4-carbonitrile",C1=CC(=C(C=C1C=C(C#N)C2=C(C(=NN2)N)C#N)O)O,,,,,,
3990,133991,"4-(2,5-dioxopyrrol-1-yl)-N-[3-[3-(trifluoromethyl)diazirin-3-yl]phenyl]butanamide",C1=CC(=CC(=C1)NC(=O)CCCN2C(=O)C=CC2=O)C3(N=N3)C(F)(F)F,,,,,,
3991,133992,CID 133992,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)N=C2S)F)CO)O,,,,,,
3992,133993,"Platinum(2+) chloride--N~2~,N~4~-diethylpentane-2,4-diamine (1/2/1)",CCNC(C)CC(C)NCC.[Cl-].[Cl-].[Pt+2],,,,,,
3993,133994,"2-N,4-N-diethylpentane-2,4-diamine",CCNC(C)CC(C)NCC,,,,,,
3994,133995,5-(Aziridin-1-yl)-2-nitro-4-nitrosobenzamide,C1CN1C2=C(C=C(C(=C2)C(=O)N)[N+](=O)[O-])N=O,,,,,,
3995,133996,Patulin hemiglutarate,C1C=C2C(=CC(=O)O2)C(O1)OC(=O)CCCC(=O)O,,,,,,
3996,133997,5-Methoxydehydropodophyllotoxin,COC1=CC(=CC(=C1OC)OC)C2=C3C(=C(C4=C(C5=C(C=C24)OCO5)OC)O)COC3=O,,,,,,
3997,133998,"3-(2-(Dimethylamino)ethoxy)-1-hydroxybenzo(b)naphtho(2,3-d)furan-6,11-dione",CN(C)CCOC1=CC(=C2C(=C1)OC3=C2C(=O)C4=CC=CC=C4C3=O)O,,,,,,
3998,133999,"N-((Hexahydro-1H-pyrrolizin-1-yl)methyl)-6-chloroimidazo(1,2-a)pyridine-8-carboxamide hydrochloride",C1C[C@H]2[C@@H](CCN2C1)CNC(=O)C3=CC(=CN4C3=NC=C4)Cl,,,,,,
3999,134000,"N(1)-Ethyl-N(11)-propargyl-4,8-diazaundecane-1,11-diamine",CCNCCCNCCCNCCCNCC#C.Br.Br.Br.Br,,,,,,
4000,134001,"N-ethyl-N'-[3-[3-(prop-2-ynylamino)propylamino]propyl]propane-1,3-diamine",CCNCCCNCCCNCCCNCC#C,,,,,,
4001,134002,"2,3-Dimethoxy-N-(1-(4-fluorobenzyl)piperidin-4-yl)benzamide",COC1=CC=CC(=C1OC)C(=O)NC2CCN(CC2)CC3=CC=C(C=C3)F,,,,,,
4002,134003,CID 134003,C1CSC2=NC(=C(N21)CSCCN=C(NC34CC5CC(C3)CC(C5)C4)S)Cl,,,,,,
4003,134004,"4-amino-1-[(3S,4S,5R)-3-(fluoromethyl)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C1=CN(C(=O)N=C1N)C2[C@H]([C@@H]([C@H](O2)CO)O)CF,,,,,,
4004,134005,"4-amino-1-[(3S,4S,5R)-4-hydroxy-3,5-bis(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C1=CN(C(=O)N=C1N)C2[C@H]([C@@H]([C@H](O2)CO)O)CO,,,,,,
4005,134006,2-Benzamido-4-(isothiocyanatomethyl)thiazole,C1=CC=C(C=C1)C(=O)NC2=NC(=CS2)CN=C=S,,,,,,
4006,134007,"(1R,2R,4aS,10aR)-1,7-bis(hydroxymethyl)-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-2,6-diol",C[C@]12CC[C@H]([C@@]([C@@H]1CCC3=CC(=C(C=C23)O)CO)(C)CO)O,,,,,,
4007,134008,Methyl 4-(isothiocyanatomethyl)thiazole-2-carbamate,COC(=O)NC1=NC(=CS1)CN=C=S,,,,,,
4008,134009,"3,6-Dimethyl-2,5-diaziridinylhydroquinone",CC1=C(C(=C(C(=C1O)N2CC2)C)O)N3CC3,,,,,,
4009,134010,2-Amino-(6-amidobiotinyl)pyridine,C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NC3=CC=CC(=N3)N)NC(=O)N2,,,,,,
4010,134011,Ptcl4(neutral red)2,[H+].[H+].CC1=CC2=NC3=C(C=C(C=C3)N(C)C)N=C2C=C1N.CC1=CC2=NC3=C(C=C(C=C3)N(C)C)N=C2C=C1N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2],,,,,,
4011,134012,2-Hydroxy-2-methyl-3(2H)-benzoxazolepropanesulfonic acid,CC1(N(C2=CC=CC=C2O1)CCCS(=O)(=O)O)O,,,,,,
4012,134013,Merocil,CCCCN1C(=O)C(C(=O)N(C1=S)CCCC)(O)OC,,,,,,
4013,134014,Merodantoin,CCCCN1C(=O)C(=O)N(C1=S)CCCC,,,,,,
4014,134015,3-Trimethylsilylbenzylguanidine,C[Si](C)(C)C1=CC=CC(=C1)CN=C(N)N,,,,,,
4015,134016,CID 134016,CSC=C[C@@H](C(=O)O)N,,,,,,
4016,134017,Supprescin A,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1OC[C@@H](C(=O)OC(=O)CNC(=O)[C@H](CO)N)N)CO)O)O,,,,,,
4017,134018,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,"['Febuxostat is indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of [allopurinol], who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. It is not recommended for the treatment of asymptomatic hyperuricemia or secondary hyperuricemia.']","['Febuxostat is a novel, selective xanthine oxidase/dehydrogenase inhibitor that works by decreasing serum uric acid in a dose-dependent manner. In healthy subjects, febuxostat decreased the mean serum uric acid and serum xanthine concentrations, as well as the total urinary uric acid excretion. Febuxostat at daily doses of 40-80 mg reduced the 24-hour mean serum uric acid concentrations by 40 to 55%. Closely related to the drug-induced reduction of serum uric acid levels and mobilization of urate crystals in tissue deposits, febuxostat is associated with gout flares.   Unlike [allopurinol] and [oxypurinol], febuxostat has no inhibitory actions against other enzymes involved in purine and pyrimidine synthesis and metabolism, because it does not structurally resemble purines or pyrimidines.']","['Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)']","['After oral administration, about 85% of febuxostat is absorbed rapidly. T<sub>max</sub> ranges from 1 to 1.5 hours. Following once-daily oral administration, C<sub>max</sub> was approximately 1.6  0.6 mcg/mL at a dose of 40 mg febuxostat and 2.6  1.7 mcg/mL at a dose of 80 mg febuxostat.  A high-fat meal decreased C<sub>max</sub> by 49% and AUC by 18%, but there were no clinically significant changes in the ability of febuxostat to decrease serum uric acid concentrations.', 'Febuxostat is eliminated via both hepatic and renal pathways. Following oral administration of 80 mg radiolabeled febuxostat, approximately 49% of the dose was recovered in the urine. In urine, about 3% of the recovered dose accounted for unchanged febuxostat, 30% accounted for the acyl glucuronide metabolite, 13% accounted for oxidative metabolites and their conjugates, and 3% accounted for unidentified metabolites.  Approximately 45% of the total dose was recovered in the feces, where 12% of the dose accounted for the unchanged parent drug. About 1% accounted for the acyl glucuronide metabolite, 25% accounted for oxidative metabolites and their conjugates, and 7% accounted for unidentified metabolites.', 'The apparent steady-state volume of distribution (V<sub>ss</sub>/F) of febuxostat ranges from 29 to 75 L, indicating a low to medium volume of distribution.', 'Following oral administration of single doses of 10 to 240 mg, the mean apparent total clearance ranged from 10 to 12 L/h.']","['Febuxostat is metabolized in the liver by UDP-glucuronosyltransferase (UGT) and Cytochrome P450 (CYP) enzymes, with the relative contribution of each enzyme isoform in the metabolism of febuxostat not fully elucidated. UGT1A1, UGT1A3, UGT1A9, and UGT2B7 mediate conjugation of febuxostat, which approximately accounts for 2244% of the metabolism of the total dose administered, to produce the acyl-glucuronide metabolite. CYP1A2, CYP2C8, CYP2C9, and non-P450 enzymes are responsible for the oxidation reaction, which accounts for 2-8% of the metabolism of the dose. Oxidation reaction produces 67M-1, 67M-2, and 67M-4, which are pharmacologically active metabolites. 67M-1, 67M-2, and 67M-4 can further undergo glucuronidation and sulfation. Hydroxy metabolites are present in human plasma at much lower concentrations than the parent drug.']",['The apparent mean terminal elimination half-life of approximately 5 to 8 hours.']
4018,134019,Pixantrone,C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN,"[""Currently in Phase III investigation for treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma in patients who have failed two prior lines of therapy. Presently, no standard therapy exists for patients with relapsed or refractory NHL. [2] After first line therapy has been initiated, most patients have received their lifetime limit of doxorubicin and further use of anthracyclines may potentially lead to anthracycline-induced congestive heart failure (CHF). Pixantrone is an attractive alternative as a second line agent, due to its lack of cardiac toxicity. [2]   The phase III trial, PIX-R, is ongoing and will compare pixantrone multidrug therapy with an equivalent regimen in patients with diffuse large B-cell lymphoma (the most common type of NHL).  Previous study results have also suggested the possibility that pixantrone may be safe and effective in doxorubicin naive patients. In myocardial strips which are doxorubicin naive, pixantrone is taken up to a higher degree than in myocardial strips which are doxorubicin exposed, and once absorbed exhibits redox inactivity. [3]   Pixantrone dimaleate has also been investigated as a treatment for acute myelogenous leukemia, diffuse large B-cell lymphoma, follicular lymphoma, metastatic breast cancer, low grade small lymphocytic lymphomas and general metastatic cancers.""]","['Pixantrone has a wide range of antitumor activity, especially in terms of treating leukemias and lymphomas [3].   Pixantrone lacks cardio-toxic effects. It has postulated that his is because of its redox inactivity and lack and inhibition of doxorubicinol formation in human myocardium. [3]']",['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)'],"['Intravenous administration results in a rapid distribution followed by a slow elimination. [2] In ex vivo myocardial strips, pixantrone is taken up to a higher degree than mitoxantrone. In myocardial strips which are doxorubicin naive pixantrone displays higher uptake than in DOX-loaded myocardial strips. DOX clearance causes membrane effects which may be responsible for this observation. DOX clearance involves rapid passive diffusion through one side of the membrane followed by ""flip flop"" reorientation of the lipid bilayer. This disorganization of lipids is believed to impair membrane penetration by pixantrone. [3]', 'Fecally and renally excreted. Urinary elimination of unchanged drug is less than 10%. [2]', '9.7-29.7 L/kg. [2]', 'Plasma clearance is 0.75 - 1.31 L/h/kg. [2]']",['Pixantrone does not form secondary alcohol metabolites. [2] Pixantrone hydrolyzes extensively to CT-45886 which is believed to inhibit doxol formation by displacing DOX from the active site of reductases. CT4889 and CT-45890 are also formed.[3]'],['Half life is 12 hours. [2]']
4019,134020,"1-N-(1,3-Dihydroxy-2-propoxymethyl)-6-(tert-butyl)-5,6,7,8-tetrahydro-2,4-quinazolinedione",CC(C)(C)C1CCC2=C(C1)C(=O)NC(=O)N2COC(CO)CO,,,,,,
4020,134021,Glycerol 2-phosphoglycerol,C(C(CO)OP(=O)(O)OCC(CO)O)O,,,,,,
4021,134022,N-Succinimidyl 4-hydroxy-3-iodobenzoate,C1CC(=O)N(C1=O)OC(=O)C2=CC(=C(C=C2)O)[131I],,,,,,
4022,134023,Cl-Dach-ida-Pt,CN(CC(=O)[O-])CC(=O)[O-].C1CCC(C(C1)N)N.[Cl-].[Cl-].[Pt+4],,,,,,
4023,134024,Tetracenomycin A2,CC1=C(C(=CC2=CC3=C(C(=C12)O)C(=O)C4=C(C3=O)C=C(C=C4O)OC)OC)C(=O)OC,,,,,,
4024,134025,Sergeolide,C[C@H]1[C@@H]2C[C@@H]3[C@@]45CO[C@@]([C@@H]4[C@H](C(=O)O3)OC(=O)C)([C@H]([C@@H]([C@@H]5[C@]2(C=C6C1=CC(=O)O6)C)O)O)C(=O)OC,,,,,,
4025,134026,"4-(5,6-Dihydro(1,2,4)triazolo(5,1-a)isoquinolin-2-yl)-1,2-benzenediol",C1CN2C(=NC(=N2)C3=CC(=C(C=C3)O)O)C4=CC=CC=C41,,,,,,
4026,134027,"(S)-5,6-Dihydro-2-(3-hydroxyphenyl)-(1,2,4)triazolo(5,1-a)isoquinolin-6-ol",C1[C@H](C2=CC=CC=C2C3=NC(=NN31)C4=CC(=CC=C4)O)O,,,,,,
4027,134028,Methyl (5-Hydroxy-6(propylsulfonyl)-1h-benzimidazol-2-yl)carbamate,CCCS(=O)(=O)C1=C(C=C2C(=C1)NC(=N2)NC(=O)OC)O,,,,,,
4028,134029,"1H-Benzimidazol-2-amine, 1-methyl-6-(propylsulfonyl)-",CCCS(=O)(=O)C1=CC2=C(C=C1)N=C(N2C)N,,,,,,
4029,134030,5-(propylthio)-1H-benzimidazol-2-amine,CCCSC1=CC2=C(C=C1)N=C(N2)N,,,,,,
4030,134031,Albendazole-gamma-hydroxysulphone,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)(=O)CCCO,,,,,,
4031,134032,"Propan-2-yl 2-chloro-5-(1,3-dioxo-1,3,4,5,6,7-hexahydro-2h-isoindol-2-yl)-4-fluorobenzoate",CC(C)OC(=O)C1=CC(=C(C=C1Cl)F)N2C(=O)C3=C(C2=O)CCCC3,,,,,,
4032,134033,"1H-1,2,4-Triazole-1-ethanol, alpha-(4-chlorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-",C1=CC(=CC=C1C(CN2C=NC=N2)(CN3C=NC=N3)O)Cl,,,,,,
4033,134034,"2-(4-Fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol",C1=CC(=CC=C1C(CN2C=NC=N2)(CN3C=NC=N3)O)F,,,,,,
4034,134035,"beta-D-Glucopyranuronic acid, 1-(1,1'-biphenyl)-4-carboxylate",C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,,,,
4035,134036,"1,2-Dichloro-3-(4-nitrophenoxy)benzene",C1=CC(=C(C(=C1)Cl)Cl)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
4036,134037,(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpentan-2-yl]amino]-5-oxopentanoic acid,CCC([C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)S,,,,,,
4037,134038,"(2S,3R,4R,5R)-(214C)hexane-1,2,3,4,5,6-hexol",C([C@H]([C@H]([C@@H]([14C@H](CO)O)O)O)O)O,,,,,,
4038,134039,L-Serine-1-13C,C([C@@H]([13C](=O)O)N)O,,,,,,
4039,134040,CID 134040,C1=CC=C(C=C1)CC(C(=O)[O-])O.[Na+],,,,,,
4040,134041,"Carbamic acid, (5-((4-hydroxyphenyl)sulfonyl)-1H-benzimidazol-2-yl)-, methyl ester",COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)(=O)C3=CC=C(C=C3)O,,,,,,
4041,134042,Methyl (5-((4-hydroxyphenyl)sulfinyl)-1H-benzo[d]imidazol-2-yl)carbamate,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=C(C=C3)O,,,,,,
4042,134043,2-Hydroxy-5-((1S)-1-hydroxy-2-(((1S)-1-methyl-3-phenylpropyl)amino)ethyl)benzamide,C[C@@H](CCC1=CC=CC=C1)NC[C@H](C2=CC(=C(C=C2)O)C(=O)N)O,,,,,,
4043,134044,Dilevalol,C[C@H](CCC1=CC=CC=C1)NC[C@@H](C2=CC(=C(C=C2)O)C(=O)N)O,,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)', 'Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)', 'Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)']",,,
4044,134045,"(S,R)-labetolol",C[C@H](CCC1=CC=CC=C1)NC[C@H](C2=CC(=C(C=C2)O)C(=O)N)O,,,,,,
4045,134046,Bcahcs,[H+].[H+].C(CCl)NCCCl.C(CCl)NCCCl.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Sn+4],,,,,,
4046,134047,"3-((alpha-Carboxy-4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenethyl)carbamoyl)-2,2,5,5-tetramethyl-3-pyrrolin-1-yloxy",CC1(C=C(C(N1[O])(C)C)C(=O)N[C@@H](CC2=CC(=C(C(=C2)I)OC3=CC(=C(C=C3)O)I)I)C(=O)O)C,,,,,,
4047,134048,4-OOH-Dechlorocyclophosphamide,CCN(CCCl)P1(=O)NC(CCO1)OO,,,,,,
4048,134049,Albendazole-beta-hydroxysulphone,CC(CS(=O)(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC)O,,,,,,
4049,134050,"Benz(f)isoquinoline-1-carboxylic acid, 3,4-dihydro-, ethyl ester",CCOC(=O)C1=CNCC2=C1C3=CC=CC=C3C=C2,,,,,,
4050,134051,"Carbamothioic acid, cyclohexylethyl-",CCN(C1CCCCC1)C(=O)S,,,,,,
4051,134052,Alinidine hydrobromide,C=CCN(C1=C(C=CC=C1Cl)Cl)C2=NCCN2.Br,,,,,,
4052,134053,CID 134053,CCNC(=O)C1=CC=C(C=C1)C=C(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,,,,,,
4053,134054,CID 134054,CC(=CC1=CC=C(C=C1)COC)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,,,,,,
4054,134055,1-(4-Methoxyphenyl)-2-[(4-methoxyphenyl)methylidene]butan-1-one,CCC(=CC1=CC=C(C=C1)OC)C(=O)C2=CC=C(C=C2)OC,,,,,,
4055,134056,"1-Butanone, 1-(4-methoxyphenyl)-2-((4-methoxyphenyl)methyl)-",CCC(CC1=CC=C(C=C1)OC)C(=O)C2=CC=C(C=C2)OC,,,,,,
4056,134057,beta-Ethyl-4-methoxy-alpha-(4-methoxyphenyl)-benzenepropanol,CCC(CC1=CC=C(C=C1)OC)C(C2=CC=C(C=C2)OC)O,,,,,,
4057,134058,"1-Iodo-3-aminomethyl-5,6,7,8-tetrahydro-2-naphthol",C1CCC2=C(C(=C(C=C2C1)CN)O)I,,,,,,
4058,134059,"N-[(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide",CC1=C(C(=O)NC(=O)N1)C=CC(=O)N[C@H](CO)[C@@H](C2=CC=C(C=C2)[N+](=O)[O-])O,,,,,,
4059,134060,"Pyridine, 2-(methyldithio)-3-nitro-",CSSC1=C(C=CC=N1)[N+](=O)[O-],,,,,,
4060,134061,Cervinomycin A2,CC12CC3=C(C(=C4C(=C3)C=CC5=C4C(=O)C6=C(C5=O)OC7=CC(=C(C=C7C6=O)OC)OC)O)C(=O)N1CCO2,,,,,,
4061,134062,"exo-3,6-endo-Epoxy-4,5-epoxyhexahydrophthalic anhydride",[C@@H]12[C@@H]([C@H]3[C@H]4[C@@H]([C@@H]1O3)O4)C(=O)OC2=O,,,,,,
4062,134063,Methyl-2beta-ethoxy-2alpha-hydroxy-11alpha-(3-methylbutyl-amino)-5alpha-androstane-17beta carboxylate,CCO[C@@]1(CC[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(C[C@H]([C@@H]3[C@]2(C1)C)NCCC(C)C)C)C(=O)OC)O,,,,,,
4063,134064,"2-N,N-Di-n-propylamino-4,7-dimethoxyindan",CCCN(CCC)C1CC2=C(C=CC(=C2C1)OC)OC,,,,,,
4064,134065,CID 134065,C1[C@@H]([C@H](O[C@H]1N2C3=C(C(=O)N=C(N3)N)N=C2NC4=CC=C(C=C4)C5=CC=C(C=C5)N)CO)O,,,,,,
4065,134066,(17xi)-17-Hydroxy-3-oxopregn-4-en-20-yn-19-yl acetate,CC(=O)OC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4(C#C)O)C,,,,,,
4066,134067,"Bromobenzene-2,3-dihydrodiol",C1=CC(C(C(=C1)Br)O)O,,,,,,
4067,134068,"3-Phenoxybenzyl 3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate",CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,,,,,,
4068,134069,CID 134069,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C.[C@@H]1([C@@H]([C@H](O[C@H]([C@@H]1O)O)C(=O)O)O)O,,,,,,
4069,134070,"(1R,3S)-5-[2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylenecyclohexane-1,3-diol",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,,,,,,
4070,134071,Mezolidon,CC1C(=O)NC(S1)C2=CC(=C(C=C2)OC)OC,,,,,,
4071,134072,CID 134072,CC=C(C1=CC=C(C=C1)OC(=O)C)[C@@]2([C@H](O2)C)C3=CC=C(C=C3)OC(=O)C,,,,,,
4072,134073,[4-[3-[3-(4-Acetyloxyphenyl)-3-methyloxiran-2-yl]-2-methyloxiran-2-yl]phenyl] acetate,CC(=O)OC1=CC=C(C=C1)C2(C(O2)C3C(O3)(C)C4=CC=C(C=C4)OC(=O)C)C,,,,,,
4073,134074,2-Hydroxyethyl-2-hydroxydodecyldimethylammonium,CCCCCCCCCCCC[N+](C)(C)CC(O)O.[Cl-],,,,,,
4074,134075,"2,2-Dihydroxyethyl-dodecyl-dimethylazanium",CCCCCCCCCCCC[N+](C)(C)CC(O)O,,,,,,
4075,134076,"P,P-Dimethyl-N-(4-nitrophenyl)phosphinic amide",CP(=O)(C)NC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
4076,134077,"N,N,N',N'-Tetramethyl-N''-(4-nitrophenyl)phosphoric triamide",CN(C)P(=O)(NC1=CC=C(C=C1)[N+](=O)[O-])N(C)C,,,,,,
4077,134078,"6,10-Dimethylbenzo[a]pyrene",CC1=C2C3=C4C(=C(C2=CC=C1)C)C=CC5=C4C(=CC=C5)C=C3,,,,,,
4078,134079,2'-Deoxy-6-diethylcarbamyloxyguanosine,CCN(CC)C(=O)OC1=NC(=NC2=C1N=CN2[C@H]3C[C@@H]([C@H](O3)CO)O)N,,,,,,
4079,134080,Bhaap,CC(C)(C)OC(=O)N1C[C@H](C[C@H]1C(=O)N(C(=O)C(C)(C)N)C(=O)C(C)(C)NC(CC2=CC=CC=C2)CO)O,,,,,,
4080,134081,"(3R,4S,5R)-2-(hydroxymethyl)-2-pentoxyoxane-3,4,5-triol",CCCCCOC1([C@@H]([C@H]([C@@H](CO1)O)O)O)CO,,,,,,
4081,134082,"Glycine, N-(ethoxyacetyl)-",CCOCC(=O)NCC(=O)O,,,,,,
4082,134083,"[4-Cyano-5-methyl-4-(3,4,5-trimethoxyphenyl)hexyl]-[2-(3,4-dimethoxyphenyl)ethyl]-dimethylazanium",CC(C)C(CCC[N+](C)(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC,,,,,,
4083,134084,"4-(4'-Bromo(1,1'-biphenyl)-4-yl)-2,4-dioxobutanoic acid",C1=CC(=CC=C1C2=CC=C(C=C2)Br)C(=O)CC(=O)C(=O)O,,,,,,
4084,134085,7-Oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,C1C=C(N2C1CC2=O)C(=O)O,,,,,,
4085,134086,"3-Nitrobenzothiazolo(3,2-a)quinolinium",C1=CC=C2C(=C1)[N+]3=C(S2)C=CC4=C3C=CC(=C4)[N+](=O)[O-],,,,,,
4086,134087,Cbmida,C1=CC(=C(C(=C1CN(CC(=O)O)CC(=O)O)O)O)CN(CC(=O)O)CC(=O)O,,,,,,
4087,134088,O-Isopropylguanosine,CC(C)OC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
4088,134089,"N-(3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)acetamide",CC(=O)NC1=CC2=C(C=C1)C3(C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O)OC2=O,,,,,,
4089,134090,Pyroglutamyl-histidyl-alanine,C[C@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]2CCC(=O)N2,,,,,,
4090,134091,"2-(2,3,6-Trichlorophenylimino)imidazolidine",C1CN=C(N1)NC2=C(C=CC(=C2Cl)Cl)Cl,,,,,,
4091,134092,"3,4-Dihydroxyphthalic acid",C1=CC(=C(C(=C1C(=O)O)C(=O)O)O)O,,,,,,
4092,134093,Pyroglutamyl-3-methylhistidyl-glycine,CN1C=NC=C1C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@@H]2CCC(=O)N2,,,,,,
4093,134094,"Benzene, (((2-chloro-1,1,2-trifluoroethyl)thio)methyl)-",C1=CC=C(C=C1)CSC(C(F)Cl)(F)F,,,,,,
4094,134095,2'-Oxoquinidinone,COC1=CC2=C(C=C1)NC(=O)C=C2C(=O)C3CC4CCN3CC4C=C,,,,,,
4095,134096,Piroxafos,CN1C(=C(C2=CC=CC=C2S1(=O)=O)OP(=O)(O)O)C(=O)NC3=CC=CC=N3,,,,,,
4096,134097,Arg-Lys-Arg-Ala-Arg-Lys-Glu,C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
4097,134098,"2-(2,3-Dichloro-6-methylphenylimino)imidazolidine",CC1=C(C(=C(C=C1)Cl)Cl)NC2=NCCN2,,,,,,
4098,134099,"1,2-Ethanediol, 1-(2-hydroxyphenyl)-",C1=CC=C(C(=C1)C(CO)O)O,,,,,,
4099,134100,16-Iodostanolone,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@H]([C@@H]4O)I)C,,,,,,
4100,134101,4-Azido-3-iodophenylalanine,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)I)N=[N+]=[N-],,,,,,
4101,134102,Mopyridone,C1CNC(=O)N(C1)CN2CCOCC2,,,,,,
4102,134103,Glycyrrhetinyl-glycine conjugate,C[C@]12CC[C@@](C[C@@H]1C3=CC(=O)C4[C@]5(CC[C@@H](C(C5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)NCC(=O)[O-].C[C@]12CC[C@@](C[C@@H]1C3=CC(=O)C4[C@]5(CC[C@@H](C(C5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)NCC(=O)[O-].[Ca+2],,,,,,
4103,134104,"2-[[(2R,4aS,6aS,6bR,10S,12aS,14bS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carbonyl]amino]acetic acid",C[C@]12CC[C@@](C[C@@H]1C3=CC(=O)C4[C@]5(CC[C@@H](C(C5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)NCC(=O)O,,,,,,
4104,134105,Passicapsin,C[C@@H]1[C@@H]([C@H](C[C@H](O1)O[C@H]2C[C@](C=C2)(C#N)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,,,,,,
4105,134106,3-(2-Acetamidoethenylsulfanyl)-7-oxo-6-propan-2-yl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,CC(C)C1C2CC(=C(N2C1=O)C(=O)O)SC=CNC(=O)C,,,,,,
4106,134107,2-(Acetylamino)-2-deoxy-L-galacturonic acid,CC(=O)N[C@H](C=O)[C@@H]([C@@H]([C@H](C(=O)O)O)O)O,,,,,,
4107,134108,"3,4-Bis(3',4'-dimethoxyphenyl)-3-hexene",CCC(=C(CC)C1=CC(=C(C=C1)OC)OC)C2=CC(=C(C=C2)OC)OC,,,,,,
4108,134109,CID 134109,CCCCCC=CCC=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)S(=O)(=O)C[C@@H](C(=O)NCC(=O)O)N,,,,,,
4109,134110,Pingpeimine B,C[C@H]1CC[C@H]2[C@@]([C@@H]3[C@H](CC4([C@@H]5C[C@@H]([C@H]6C[C@H](CC[C@@]6([C@H]5CC4([C@@H]3CN2C1)O)C)O)O)O)O)(C)O,,,,,,
4110,134111,"1-((2-Hydroxyethoxy)methyl)-5-(3-(benzyloxy)benzyl)pyrimidine-2,4(1H,3H)-dione",C1=CC=C(C=C1)COC2=CC=CC(=C2)CC3=CN(C(=O)NC3=O)COCCO,,,,,,
4111,134112,5-(3-(4-(4-Fluorophenyl)-1-piperazinyl)propoxy)indan,C1CC2=C(C1)C=C(C=C2)OCCCN3CCN(CC3)C4=CC=C(C=C4)F,,,,,,
4112,134113,CID 134113,C[C@@H](C(=O)N[C@H](C)C(=O)N[C@@H](CCCCN)C(=O)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](CC1=CC=C(C=C1)[N+](=O)[O-])N)NC(=O)C,,,,,,
4113,134114,Acetyl-asparaginyl-prolyl-methyltyrosinamide,CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)N)N,,,,,,
4114,134115,CID 134115,CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@H]2C(=O)N(C)C(=O)[C@H](CC(=O)O)N,,,,,,
4115,134116,CID 134116,COC1=CC(=O)C2=C(C3=C(C(=C(C(=C3OC2=C1)OC)OC)OC)O)O,,,,,,
4116,134117,"1-[3-(1,3-Benzodioxol-5-yloxy)propyl]-4-phenylpiperazine",C1CN(CCN1CCCOC2=CC3=C(C=C2)OCO3)C4=CC=CC=C4,,,,,,
4117,134118,N-beta-Cyclohexylpropionyl-L-tyrosine,C1CCC(CC1)CCC(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O,,,,,,
4118,134119,"N,N'-Dicyclopropylmethylpiperazine",C1CC1CN2CCN(CC2)CC3CC3.Cl.Cl,,,,,,
4119,134120,Ino-2628CZ,C1CC1CN2CCN(CC2)CC3CC3,,,,,,
4120,134121,"2,3-Dihydroxy-1,10b-epoxy-1,2,3-trihydrofluoranthene",C1=CC=C2C(=C1)C3=C4C25C(O5)C(C(C4=CC=C3)O)O,,,,,,
4121,134122,N-(9-Fluorenylmethoxycarbonyloxy)succinimide,C1CC(=O)N(C1=O)OC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24,,,,,,
4122,134123,CID 134123,CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(C4=C(C=CC(=C4S3)N(C)C)O)O)C(=O)[C@@]2(C(=O)C(=C(N)O)C1=O)O,,,,,,
4123,134124,"6-Methoxy-2,2-dimethyl-4H-1,3-benzodioxin-4-one",CC1(OC2=C(C=C(C=C2)OC)C(=O)O1)C,,,,,,
4124,134125,"3,3-Bis(trifluoromethyl)bicyclo(2.2.1)heptane-2,2-dicarbonitrile",C1CC2CC1C(C2(C(F)(F)F)C(F)(F)F)(C#N)C#N,,,,,,
4125,134126,"1-(4-Carboxy-2-methylpentanoyl)-2,3-dihydro-1h-indole-2-carboxylic acid",CC(CC(C)C(=O)O)C(=O)N1C(CC2=CC=CC=C21)C(=O)O,,,,,,
4126,134127,Theophylline-7-acetylaminobutanol,CCC(CO)NC(=O)CN1C=NC2=C1C(=O)N(C(=O)N2C)C,,,,,,
4127,134128,Carbocysteine-lysine,C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CSCC(=O)O)N,,,,,,
4128,134129,"D-Mannuronic acid, 2,3-bis(acetylamino)-2,3-dideoxy-",CC(=O)N[C@H](C=O)[C@H]([C@@H]([C@@H](C(=O)O)O)O)NC(=O)C,,,,,,
4129,134130,"1-Piperidinepropanol, 4-(3-hydroxyphenyl)-3,4-dimethyl-alpha-phenyl-",CC1CN(CCC1(C)C2=CC(=CC=C2)O)CCC(C3=CC=CC=C3)O,,,,,,
4130,134131,"3-(3,4-Dimethyl-1-phenethyl-piperidin-4-yl)-phenol",C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)CCC3=CC=CC=C3,,,,,,
4131,134132,4-[[5-(6-ethoxy-3-methyl-6-oxohex-2-enyl)-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-4-yl]oxycarbonylamino]benzoic acid,CCOC(=O)CCC(=CCC1=C(C(=C2COC(=O)C2=C1OC(=O)NC3=CC=C(C=C3)C(=O)O)C)OC)C,,,,,,
4132,134133,Diazoketone methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)C=[N+]=[N-])C(=O)O,,,,,,
4133,134134,CID 134134,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=C[N+]#N)O)C(=O)O,,,,,,
4134,134135,"(2S,3S)-3-[(4R,5S)-1-acetyl-5-formyl-2-methyl-4,5-dihydroimidazol-4-yl]-2,3-dihydroxypropanoic acid",CC1=N[C@H]([C@H](N1C(=O)C)C=O)[C@@H]([C@@H](C(=O)O)O)O,,,,,,
4135,134136,"17-(Cyclopropylmethyl)-3-hydroxy-6-oxo-4,5-epoxymorphinan-14-yl chloroacetate",C1CC1CN2CCC34[C@H]5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)OC(=O)CCl,,,,,,
4136,134137,"4H-1-Benzothiopyran-4-one, 2,3-dihydro-3-methylene-, 1,1-dioxide",C=C1CS(=O)(=O)C2=CC=CC=C2C1=O,,,,,,
4137,134138,CID 134138,COC(=O)CCCCCS[C@@H]1[C@H]([C@@H](CC1=O)O)C=CC(C2CCCCC2)O,,,,,,
4138,134139,CID 134139,CCCCCC(C=C[C@H]1[C@@H](CC(=O)[C@@H]1CCCSCCC(=O)O)O)O,,,,,,
4139,134140,"1-Piperazineethanol, 4-(3-(7-azido-2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-",C1CN(CCN1CCCN2C3=C(C=C(C=C3)N=[N+]=[N-])SC4=C2C=C(C=C4)C(F)(F)F)CCO,,,,,,
4140,134141,10-[3-[4-(2-Chloroethyl)-1-piperazinyl]propyl]-2-(trifluoromethyl)phenothiazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCCl,,,,,,
4141,134142,CID 134142,CCCCCC=CC[C@@H](C=CC=CC=C[C@@H](CCCC(=O)N(C)C)O)O,,,,,,
4142,134143,"Tetradecanoic acid, 1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta(a)cyclopropa(e)cyclodecen-6-yl ester",CCCCCCCCCCCCCC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)O)O)C,,,,,,
4143,134144,CID 134144,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC(=C(C=C5)O)O)CO)O)O)O)O)O,,,,,,
4144,134145,beta-Hydroxy-5-methoxytryptamine,COC1=CC2=C(C=C1)NC=C2C(CN)O,,,,,,
4145,134146,"1-Diazo-4,8,12-trimethyltrideca-3,7,11-trien-2-one",CC(=CCCC(=CCCC(=CC(=O)C=[N+]=[N-])C)C)C,,,,,,
4146,134147,CID 134147,CC(=CCCC(=CCCC(=CC(=C[N+]#N)O)C)C)C,,,,,,
4147,134148,Tfmsapas,CC1([C@@H](N2[C@H](S1(=O)=O)[C@@H](C2=O)NS(=O)(=O)C(F)(F)F)C(=O)O)C,,,['Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)'],,,
4148,134149,CID 134149,CCCC[C@@H](C)CC(C=C[C@H]1[C@@H](CC(=O)[C@@H]1SCCCCCC(=O)OC)O)O,,,,,,
4149,134150,6-Dimethylamino-2'-deoxyguanosine,CN(C)C1=NC(=NC2=C1N=CN2[C@H]3C[C@@H]([C@H](O3)CO)O)N,,,,,,
4150,134151,Ipomeanol 4-glucuronide,CC(CCC(=O)C1=COC=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
4151,134152,"4-(4'-(((3,4-Dihydro-3-hydroxy-2H-1,5-benzodioxepin-3-yl)methyl)thio)(1,1'-biphenyl)-4-yl)-2,4-dioxobutanoic acid",C1C(COC2=CC=CC=C2O1)(CSC3=CC=C(C=C3)C4=CC=C(C=C4)C(=O)CC(=O)C(=O)O)O,,,,,,
4152,134153,"6-((2-(3,4-Dihydroxyphenyl)-2-hydroxyethyl)amino)-N-(4-(trifluoromethyl)phenyl)heptanamide",CC(CCCCC(=O)NC1=CC=C(C=C1)C(F)(F)F)NCC(C2=CC(=C(C=C2)O)O)O,,,,,,
4153,134154,L-T3 Pal,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)NC(=O)C(=[N+]=[N-])C(F)(F)F)I)I)O,,,,,,
4154,134155,CID 134155,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)NC(=C(C(F)(F)F)[N+]#N)O)I)I)O,,,,,,
4155,134156,CID 134156,CC(=O)NC=CC1=CC(=C(C=C1)O)O,,,,,,
4156,134157,(2R-cis)-N-(2-Methyl-4-oxo-3-oxetanyl)actamide,C[C@@H]1[C@@H](C(=O)O1)NC(=O)C,,,,,,
4157,134158,"(1)Benzopyrano(4,3-b)(1,5)benzodiazepine, 6,6a,7,8,13,13a-hexahydro-3,4-dimethoxy-10,11-dimethyl-",CC1=CC2=C(C=C1C)NC3C(CN2)COC4=C3C=CC(=C4OC)OC,,,,,,
4158,134159,"[(1S,2R,6S,7S,8S)-4-[3-(Dimethylamino)propyl]-3,5-dioxo-4-azatricyclo[5.2.1.02,6]decan-8-yl] 1H-indole-3-carboxylate;hydrochloride",CN(C)CCCN1C(=O)[C@@H]2[C@H]3C[C@@H]([C@@H]2C1=O)[C@H](C3)OC(=O)C4=CNC5=CC=CC=C54.Cl,,,,,,
4159,134160,"[(1S,2R,6S,7S,8S)-4-[3-(dimethylamino)propyl]-3,5-dioxo-4-azatricyclo[5.2.1.02,6]decan-8-yl] 1H-indole-3-carboxylate",CN(C)CCCN1C(=O)[C@@H]2[C@H]3C[C@@H]([C@@H]2C1=O)[C@H](C3)OC(=O)C4=CNC5=CC=CC=C54,,,,,,
4160,134161,2-Amino-6-trifluoromethylbenzonorbornene,C1[C@H]2C[C@H]([C@@H]1C3=C2C=C(C=C3)C(F)(F)F)N,,,,,,
4161,134162,Isodityrosine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)OC2=C(C=CC(=C2)CC(C(=O)O)N)O,,,,,,
4162,134163,CID 134163,C[C@H](C[C@H]1C[C@@](C(O1)O)(C)O)[C@H]2CC[C@@H]3[C@@]2(CCCC3=CC=C4C[C@@H](CCC4=C)O)C,,,,,,
4163,134164,Slcnu,CC1(CC(CC(N1[O])(C)C)NC(=O)N(CCCl)N=O)C,,,,,,
4164,134165,"Phenanthro(1,2-b)furan-10,11-dione, 6,7,8,9-tetrahydro-7-hydroxy-1-methyl-6-methylene-",CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCC(C4=C)O,,,,,,
4165,134166,5-Benzamido-2-methyl-4-oxo-6-phenylhexanoylproline,C[C@H](CC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CC=CC=C2)C(=O)N3CCC[C@H]3C(=O)O,,,,,,
4166,134167,"(2S,5R)-3,3-dimethyl-7-oxo-6-(2-oxopropylidene)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC(=O)C=C1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)O,,,,,,
4167,134168,"5-Methyl-1-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid",CC1=CSC2=C1C(=O)N=C(N2CC(C)C)C(=O)O,,,,,,
4168,134169,CID 134169,C1=CC=C2C(=C1)C=CC(=C2O)N=NC(=N)S,,,,,,
4169,134170,Chloromethylketone methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)CCl)C(=O)O,,,,,,
4170,134171,(2R)-N-[2-[[(2S)-5-(diaminomethylideneamino)-2-(4-nitroanilino)pentanoyl]amino]-2-oxoethyl]-2-(methanesulfonamido)-4-methylpentanamide,CC(C)C[C@H](C(=O)NCC(=O)NC(=O)[C@H](CCCN=C(N)N)NC1=CC=C(C=C1)[N+](=O)[O-])NS(=O)(=O)C,,,,,,
4171,134172,CID 134172,C(C1=NC(=O)NN1)N,,,,,,
4172,134173,"2,5-Dinitrobenzimidazole",C1=CC2=C(C=C1[N+](=O)[O-])NC(=N2)[N+](=O)[O-],,,,,,
4173,134174,Cholesterol iopanoate,CCC(CC1=C(C=C(C=C1I)I)I)C(=O)ON[C@]2(CC[C@@]3(C4CC[C@@]5([C@H](CCC5C4CC=C3C2)[C@H](C)CCCC(C)C)C)C)O,,,,,,
4174,134175,"Iodo-2,3-bis(4-hydroxyphenyl)pentane",CCC(C1=CC=C(C=C1)O)C(CI)C2=CC=C(C=C2)O,,,,,,
4175,134176,N-[4-(1H-imidazol-5-yl)phenyl]-N'-methylmethanimidamide,CN=CNC1=CC=C(C=C1)C2=CN=CN2,,,,,,
4176,134177,N-(Ethyl-2-diazomalonyl)thyroxine,CCOC(=O)C(=[N+]=[N-])C(=O)N[C@@H](CC1=CC(=C(C(=C1)I)OC2=CC(=C(C(=C2)I)O)I)I)C(=O)O,,,,,,
4177,134178,CID 134178,CCOC(=C(C(=O)N[C@@H](CC1=CC(=C(C(=C1)I)OC2=CC(=C(C(=C2)I)O)I)I)C(=O)O)[N+]#N)O,,,,,,
4178,134179,N-(tert-butyl)-N'-[4-(1H-imidazol-4-yl)phenyl]imidoformamide,CC(C)(C)N=CNC1=CC=C(C=C1)C2=CN=CN2,,,,,,
4179,134180,4-[1-Bromo-2-(4-hydroxyphenyl)pentan-3-yl]phenol,CCC(C1=CC=C(C=C1)O)C(CBr)C2=CC=C(C=C2)O,,,,,,
4180,134181,"5-Nitro-2-furyl-alpha,beta-dibromopropionamide",C1=C(OC(=C1)[N+](=O)[O-])C(C(C(=O)N)Br)Br,,,,,,
4181,134182,but-2-enedioic acid;1-(4-chlorophenyl)sulfanyl-N-methylpropan-2-amine,CC(CSC1=CC=C(C=C1)Cl)NC.C(=CC(=O)O)C(=O)O,,,,,,
4182,134183,1-(4-chlorophenyl)sulfanyl-N-methylpropan-2-amine,CC(CSC1=CC=C(C=C1)Cl)NC,,,,,,
4183,134184,Saphenamycin,CC1=C(C(=CC=C1)O)C(=O)OC(C)C2=C3C(=CC=C2)N=C4C(=N3)C=CC=C4C(=O)O,,,,,,
4184,134185,(2s)-2-Amino-4-sulfamoylbutanoic acid,C(CS(=O)(=O)N)[C@@H](C(=O)O)N,,,,,,
4185,134186,7-Hydroxyolivacine,CC1=C2C=CNC(=C2C=C3C1=NC4=C3C=CC=C4O)C,,,,,,
4186,134187,4-Bromomisonidazole,COCC(CN1C=C(N=C1[N+](=O)[O-])Br)O,,,,,,
4187,134188,CID 134188,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O)OC(=O)CCCCCCCCCCCCCCC.[Na+],,,,,,
4188,134189,"[(2R)-3-[[(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate",CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O)OC(=O)CCCCCCCCCCCCCCC,,,,,,
4189,134190,CID 134190,CN(CCCl)C1=CC=C(C=C1)C(=O)N.C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)NC(=NC2=O)N,,,,,,
4190,134191,4-[2-Chloroethyl(methyl)amino]benzamide,CN(CCCl)C1=CC=C(C=C1)C(=O)N,,,,,,
4191,134192,4-(9-Acridinylamino)-N-(lysylglycyl)aniline,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)NCC(=O)NC(=O)[C@H](CCCCN)N,,,,,,
4192,134193,"4-(2-Tetradeca-1,3,5,8-tetraenylcyclopropyl)butanoic acid",CCCCCC=CCC=CC=CC=CC1CC1CCCC(=O)O,,,,,,
4193,134194,Ara-cdp-distearin,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O)OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
4194,134195,CID 134195,CC(=O)C(C(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O)O,,,,,,
4195,134196,"ethyl N-(5-amino-2-methyl-3-phenyl-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamate",CCOC(=O)NC1=NC(=C2C(=C1)NC(C(=N2)C3=CC=CC=C3)C)N,,,,,,
4196,134197,2-Hydroxy-5-(4-carboxybenzenesulfonyloxy)benzene sulfonic acid,C1=CC(=CC=C1C(=O)O)S(=O)(=O)OC2=CC(=C(C=C2)O)S(=O)(=O)O,,,,,,
4197,134198,4-(2-Bromoethyl)-2-phenylmorpholin-2-ol,C1COC(CN1CCBr)(C2=CC=CC=C2)O,,,,,,
4198,134199,"1-Fluoro-2,3-bis(4-hydroxyphenyl)pentane",CC[C@H](C1=CC=C(C=C1)O)[C@@H](CF)C2=CC=C(C=C2)O,,,,,,
4199,134200,Adenosine 6-N-phosphoramidate,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NOP(=O)(N)O,,,,,,
4200,134201,alpha-Monofluoromethylputrescine,C(C(CF)N)N,,,['Substances and drugs that inhibit or block the activity of ORNITHINE DECARBOXYLASE. (See all compounds classified as Ornithine Decarboxylase Inhibitors.)'],,,
4201,134202,"5-Chloro-3-(3,7-dimethylocta-2,6-dienyl)-2,4-dihydroxy-6-methylbenzaldehyde",CC1=C(C(=C(C(=C1Cl)O)CC=C(C)CCC=C(C)C)O)C=O,,,,,,
4202,134203,"4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenol",COC1=C(C=CC(=C1)CC2COC(C2CO)C3=CC(=C(C=C3)O)OC)O,,,,,,
4203,134204,Mercaptoacetyl-Phe-Leu,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CS,,,,,,
4204,134205,N~2~-Phosphono-L-Leucinamide,CC(C)C[C@@H](C(=O)N)NP(=O)(O)O,,,,,,
4205,134206,Armillarin,CC1=CC(=CC(=C1C(=O)O[C@@H]2C[C@]3([C@@]2(C(=C[C@H]4[C@@H]3CC(C4)(C)C)C=O)O)C)O)OC,,,,,,
4206,134207,"N-Nitrosobis(2,2,3,3,4,4,4-heptafluorobutyl)amine",C(C(C(C(F)(F)F)(F)F)(F)F)N(CC(C(C(F)(F)F)(F)F)(F)F)N=O,,,,,,
4207,134208,CID 134208,COC(=O)C=CC(=O)N[C@H]1CCC2(C3CC4=C5C2([C@@H]1OC5=C(C=C4)O)CCN3CC6CC6)O,,,,,,
4208,134209,CID 134209,CCOC(=O)[C@H](CCC1=CC=CC=C1)[N+]2([C@@H](CC3=CC=CC=C32)C(=O)[O-])C(=O)[C@H](C)N.[Na+],,,,,,
4209,134210,CID 134210,CCOC(=O)C(CCC1=CC=CC=C1)[N+]2(C(CC3=CC=CC=C32)C(=O)O)C(=O)C(C)N,,,,,,
4210,134211,CID 134211,CC1=NC=C(C(=C1O)C=NOC(=O)C)COP(=O)(O)O,,,,,,
4211,134212,"N-methyl-N-[2-[2-[2-[methyl-[(2,5,9-trimethyl-7-oxofuro[3,2-g]chromen-3-yl)methyl]amino]ethoxy]ethoxy]ethyl]-3-(pyridin-2-yldisulfanyl)propanamide",CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)CN(C)CCOCCOCCN(C)C(=O)CCSSC4=CC=CC=N4)C,,,,,,
4212,134213,Methyl(methylthio)acetimidate,CC(C(=O)N)SC,,,,,,
4213,134214,CID 134214,C[C@H](CC(=O)CC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C,,,,,,
4214,134215,"2,3-Bis(hexadecyloxy)propyl 4-O-beta-D-glucopyranosyl-beta-D-Glucopyranoside",CCCCCCCCCCCCCCCCOCC(CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)OCCCCCCCCCCCCCCCC,,,,,,
4215,134216,"beta-D-Xylopyranoside, 4-(hydroxy(4-nitrophenyl)methyl)phenyl",C1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC=C(C=C2)C(C3=CC=C(C=C3)[N+](=O)[O-])O)O)O)O,,,,,,
4216,134217,CID 134217,CC(=CC=O)C=CC=C(C)C=CC1=CC(=CC=C1)C2N=N2,,,,,,
4217,134218,Methyl 6-amino-6-deoxy-beta-D-Galactopyranoside,CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CN)O)O)O,,,,,,
4218,134219,CID 134219,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=CBr)COP(=O)([O-])[O-])O,,,,,,
4219,134220,"[(2R,3S,5R)-5-[5-(2-bromoethenyl)-2,4-dioxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=CBr)COP(=O)(O)O)O,,,,,,
4220,134221,CID 134221,CC1[C@@]2(CCN([C@]1(CC3=C2C=C(C=C3)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCSC)C(=O)N)C)C,,,,,,
4221,134222,"5H-Dibenz(b,f)azepin-1-ol, 7-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-",CN(C)CCCN1C2=C(CCC3=C1C=C(C=C3)Cl)C(=CC=C2)O,,,,,['8-hydroxy-clomipramine is a known human metabolite of clomipramine.'],
4222,134223,CID 134223,CN(C)C1=CC=C(C=C1)C=C/C=N/O,,,,,,
4223,134224,"2-Acetyl-3-phenyl-tetrahydro-1,2,4-oxadiazine-5-one",CC(=O)N1C(NC(=O)CO1)C2=CC=CC=C2,,,,,,
4224,134225,2-[1-(Piperidin-1-yl)cyclohexyl]phenol,C1CCC(CC1)(C2=CC=CC=C2O)N3CCCCC3,,,,,,
4225,134226,2-[(3-Chloro-1-phenylpropyl)amino]ethyl acetate,CC(=O)OCCNC(CCCl)C1=CC=CC=C1,,,,,,
4226,134227,2-Oxoticlopidine,C1CN(CC2=CC(=O)SC21)CC3=CC=CC=C3Cl,,,,,,
4227,134228,DN-isobutylamide,CC(C)CNC(=O)CCC(C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N)O,,,,,,
4228,134229,"3-Pyridinecarboxamide, N-(2-bromoethyl)-",C1=CC(=CN=C1)C(=O)NCCBr,,,,,,
4229,134230,N-[2-(Acetoxy)ethyl]-3-pyridinecarboxamide,CC(=O)OCCNC(=O)C1=CN=CC=C1,,,,,,
4230,134231,Leucyl-leucyl-4-azido-2-nitrophenylalanine,CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=C(C=C(C=C1)N=[N+]=[N-])[N+](=O)[O-])C(=O)O)N,,,,,,
4231,134232,"1,4-Methanoazulene-9-carboxaldehyde, decahydro-8-(hydroxymethyl)-4,8-dimethyl-",CC1(CCCC2(C3C1C(C2C=O)CC3)C)CO,,,,,,
4232,134233,BrAnd,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)OC(=O)CBr,,,,,,
4233,134234,6-Hydroxy-2-methylxanthen-9-spiro-1'-isobenzofuran-3'-one,CC1=CC2=C(C=C1)OC3=C(C24C5=CC=CC=C5C(=O)O4)C=CC(=C3)O,,,,,,
4234,134235,"10-Hydroxyundeca-2,4,6,8-tetraynamide",CC(C#CC#CC#CC#CC(=O)N)O,,,,,,
4235,134236,Thtdtyal,CC(C#CC#CC#CC#CC1C(CC(=O)O1)O)O,,,,,,
4236,134237,"7-Hydroxymethylbenz(a)anthracene-3,4-dihydrodiol",C1=CC=C2C(=C1)C=C3C4=C(C=CC3=C2CO)[C@@H]([C@H](C=C4)O)O,,,,,,
4237,134238,N-(Leucyl)-o-aminobenzenesulfonate,CC(C)C[C@@H](C(=O)NC1=CC=CC=C1S(=O)(=O)O)N,,,,,,
4238,134239,N-11-(4-Iodophenylsulfonamide)undecanoic acid,C1=CC(=CC=C1S(=O)(=O)NCCCCCCCCCCC(=O)O)I,,,,,,
4239,134240,N-12-(4-Iodophenylsulfonamide)dodecanoic acid,C1=CC(=CC=C1S(=O)(=O)NCCCCCCCCCCCC(=O)O)I,,,,,,
4240,134241,"2,3,6,7-Tetrahydroxycholanoic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(C(C4[C@@]3(CC(C(C4)O)O)C)O)O)C,,,,,,
4241,134242,CID 134242,CCCCC[C@@H](C(=O)N[C@H]1C=CC(=O)[C@@H]1CC=CCCCC(=O)O)O,,,,,,
4242,134243,CID 134243,C1[C@@H]([C@@H]([C@H]([C@@H]1O)NC(=O)[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)CC=CCCCC(=O)O)O,,,,,,
4243,134244,CID 134244,C1[C@@H]([C@@H]([C@H]([C@@H]1O)NC(=O)[C@@H](COC2=CC=C(C=C2)F)O)CC=CCCCC(=O)O)O,,,,,,
4244,134245,CID 134245,CC1=C(C=C(C=C1)OC[C@H](C(=O)N[C@H]2[C@@H](C[C@@H]([C@@H]2CC=CCCCC(=O)O)O)O)O)C,,,,,,
4245,134246,CID 134246,C1[C@@H]([C@@H]([C@H]([C@@H]1O)NC(=O)[C@@H](COC2=CC=CC(=C2)C(F)(F)F)O)CC=CCCCC(=O)O)O,,,,,,
4246,134247,CID 134247,CCCCC[C@H](C(=O)N[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O)O,,,,,,
4247,134248,"1-Naphthalenamine, 2-chloro-N-phenyl-",C1=CC=C(C=C1)NC2=C(C=CC3=CC=CC=C32)Cl,,,,,,
4248,134249,Deacetylmuldamine,C[C@H]1CC[C@@H](NC1)[C@@H](C)[C@H]2[C@@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C)O,,,,,,
4249,134250,o-Carboxybenzoyl-glutamic acid imide,C1CC(=O)N(C(=O)C1N)C(=O)C2=CC=CC=C2C(=O)O,,,,,,
4250,134251,CID 134251,CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)OC)O[C@@H]3C(=NOCC(=O)O)CC4.O,,,,,,
4251,134252,CID 134252,CN1CC[C@]23[C@@H]4C1CC5=C2C(=C(C=C5)OC)O[C@@H]3C(=NOCC(=O)O)CC4,,,,,,
4252,134253,"s-Triazole, 5-(m-methoxyphenyl)-3-(o-tolyl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)OC,,,,,,
4253,134254,"Benzenamine, N,N-dimethyl-4-(5-(2-methylphenyl)-1H-1,2,4-triazol-3-yl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC=C(C=C3)N(C)C,,,,,,
4254,134255,"s-Triazole, 5-(o-chlorophenyl)-3-(o-tolyl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC=CC=C3Cl,,,,,,
4255,134256,"s-Triazole, 5-(o-methoxyphenyl)-3-(o-tolyl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC=CC=C3OC,,,,,,
4256,134257,"s-Triazole, 5-(m-chlorophenyl)-3-(o-tolyl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)Cl,,,,,,
4257,134258,"s-Triazole, 3-(o-tolyl)-5-(alpha,alpha,alpha-trifluoro-m-tolyl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)C(F)(F)F,,,,,,
4258,134259,5-(Phenylsulfinyl)-1H-benzimidazol-2-amine,C1=CC=C(C=C1)S(=O)C2=CC3=C(C=C2)N=C(N3)N,,,,,,
4259,134260,CID 134260,CCCC(=CCC)C(=O)[O-].[Na+],,,,,,
4260,134261,"2-[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenylidene]cyclopentane-1,3-dione",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=C2C(=O)CCC2=O)C)C,,,,,,
4261,134262,CID 134262,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=C[14C](=O)O)C)C,,,,,,
4262,134263,CID 134263,[3H]C(=CC(=CC(=O)O)C)C(=C(C)C=CC1=C(CCCC1(C)C)C)[3H],,,,,,
4263,134264,Lac Dye,CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
4264,134265,"Pyrimidine, 2,4-diamino-5-phenyl-6-propyl-",CCCC1=C(C(=NC(=N1)N)N)C2=CC=CC=C2,,,,,,
4265,134266,"Pyrimidine, 6-butyl-2,4-diamino-5-phenyl-",CCCCC1=C(C(=NC(=N1)N)N)C2=CC=CC=C2,,,,,,
4266,134267,"Leucine, trifluoro-",CC(C)C[C@@](C(=O)O)(N(F)F)F,,,,,,
4267,134268,CID 134268,CCCCCC(=NO)O[C@@]1(CCC2[C@@]1(CCC3C2CCC4=CC(=O)CC[C@H]34)C)C#C,,,,,,
4268,134269,CID 134269,C1[C@H]([C@](OC2=CC(=CC(=C21)O)O)(C3=CC(=C(C=C3)O)O)S(=O)(=O)[O-])O.[Na+],,,,,,
4269,134270,"(2S,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydrochromene-2-sulfonic acid",C1[C@H]([C@](OC2=CC(=CC(=C21)O)O)(C3=CC(=C(C=C3)O)O)S(=O)(=O)O)O,,,,,,
4270,134271,"1-Propene, 1,1-dichloro-2-methyl-",CC(=C(Cl)Cl)C,,,,,,
4271,134272,CID 134272,CCCC1C(O1)CCC(=CCCC(=CC(=O)OC)C)CC,,,,,,
4272,134273,"Pyrrolidine, 1-(2-(p-(2-phenylnaphtho(2,1-b)furan-1-yl)phenoxy)ethyl)-, hydrochloride",C1CCN(C1)CCOC2=CC=C(C=C2)C3=C(OC4=C3C5=CC=CC=C5C=C4)C6=CC=CC=C6.Cl,,,,,,
4273,134274,"1-(2-(p-(2-Phenylnaphtho(2,1-b)furan-1-yl)phenoxy)ethyl)pyrrolidine",C1CCN(C1)CCOC2=CC=C(C=C2)C3=C(OC4=C3C5=CC=CC=C5C=C4)C6=CC=CC=C6,,,,,,
4274,134275,Triacetonamine tosilate,CC1=CC=C(C=C1)S(=O)(=O)O.CC1(CC(=O)CC(N1)(C)C)C,,,,,,
4275,134276,CID 134276,[Li+].C(C(C(C(C(F)(F)S(=O)(=O)[O-])(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
4276,134277,"Potassium;1-methyl-7-[2-(5-nitrofuran-2-yl)ethenyl]-4-oxo-1,8-naphthyridine-3-carboxylate",CN1C=C(C(=O)C2=C1N=C(C=C2)C=CC3=CC=C(O3)[N+](=O)[O-])C(=O)[O-].[K+],,,,,,
4277,134278,"1-Methyl-7-[2-(5-nitrofuran-2-yl)ethenyl]-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",CN1C=C(C(=O)C2=C1N=C(C=C2)C=CC3=CC=C(O3)[N+](=O)[O-])C(=O)O,,,,,,
4278,134279,Pteroside B,C[C@@H]1CC2=C(C1=O)C(=C(C(=C2)C)CCO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C,,,,,,
4279,134280,N-Phthaloylglutamic acid imide,C1CC(=O)NC(=O)[C@H]1NC(=O)C2=CC=CC=C2C(=O)O,,,,,,
4280,134281,"Acetic acid, (2,2-diphenylethoxy)-, 3-(diethylamino)propyl ester, hydrochloride",CCN(CC)CCCOC(=O)COCC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,,,,,,
4281,134282,"3-(Diethylamino)propyl 2-(2,2-diphenylethoxy)acetate",CCN(CC)CCCOC(=O)COCC(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
4282,134283,Phthaloyl isoglutamine,C1=CC=C(C(=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)N)C(=O)O,,,,,,
4283,134284,"Acetamidine, 2-anilino-N-(2-(m-chlorophenoxy)propyl)-, monohydrochloride",CC(CN=C(CNC1=CC=CC=C1)N)OC2=CC(=CC=C2)Cl.O.Cl,,,,,,
4284,134285,2-anilino-N'-[2-(3-chlorophenoxy)propyl]ethanimidamide,CC(CN=C(CNC1=CC=CC=C1)N)OC2=CC(=CC=C2)Cl,,,,,,
4285,134286,"2,5-Dichloro-4-methoxyphenoxyacetic acid",COC1=CC(=C(C=C1Cl)OCC(=O)O)Cl,,,,,,
4286,134287,2-Ethyl-5-methylbenzimidazole,CCC1=NC2=C(N1)C=C(C=C2)C,,,,,,
4287,134288,Arg-tyr-leu-gly-tyr-leu,CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
4288,134289,Cyclo(N-methyltyrosylarginyl),CN1[C@H](C(=O)N[C@H](C1=O)CCCN=C(N)N)CC2=CC=C(C=C2)O,,,,,,
4289,134290,"7-[2-[(1-Carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid",CC(C(=O)N1CC2(CC1C(=O)O)SCCS2)NC(CCC3=CC=CC=C3)C(=O)O,,,,,,
4290,134291,6-Keto-28-homobrassinolide,CC[C@@H]([C@H]([C@@H]([C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)[C@@H]4[C@@]3(C[C@H]([C@H](C4)O)O)C)C)O)O)C(C)C,,,,,,
4291,134292,"Cyclohexanepropanaminium, beta-hydroxy-N,N-dimethyl-N-(1-methylethyl)-1-phenoxy-, chloride",CC(C)[N+](C)(C)CC(CC1(CCCCC1)OC2=CC=CC=C2)O.[Cl-],,,,,,
4292,134293,[2-Hydroxy-3-(1-phenoxycyclohexyl)propyl]-dimethyl-propan-2-ylazanium,CC(C)[N+](C)(C)CC(CC1(CCCCC1)OC2=CC=CC=C2)O,,,,,,
4293,134294,"10H-Phenothiazine-2-sulfonamide, 10-(1-azabicyclo(2.2.2)oct-3-yl)-N-methyl-",CNS(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2C4CN5CCC4CC5,,,,,,
4294,134295,"5-Hydroxy-N-(2-piperidinylmethyl)-2-(2,2,2-trifluoroethoxy)benzamide",C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)O)OCC(F)(F)F,,,,,,
4295,134296,3-Pentadec-10-enylbrenzcatechin,CCCCC=CCCCCCCCCCC1=C(C(=CC=C1)O)O,,,,,,
4296,134297,CID 134297,C1=CC=C(C=C1)C2=CC(=NC3=CC=C(C=C3)N(O)O)C=CC2=NC(=O)S,,,,,,
4297,134298,CID 134298,C1=CC(=NCCC2=CN=CN2)C(=CC1=N[N+]#N)N(O)[O-],,,,,,
4298,134299,"2-Amino-6,7-dihydroxybenzonorbornene",C1[C@H]2C[C@H]([C@@H]1C3=CC(=C(C=C23)O)O)N,,,,,,
4299,134300,Melochinine,CC1=C(C(=O)C=C(N1)CCCCCCCCCC[C@@H](C)O)OC,,,,,,
4300,134301,"4-{[1,3-Bis(hexadecanoyloxy)propan-2-yl]oxy}-4-oxobutanoic acid",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC(=O)O,,,,,,
4301,134302,"(5R,6R)-3-(acetyloxymethyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid",C[C@H]([C@H]1[C@@H]2N(C1=O)C(=C(S2)COC(=O)C)C(=O)O)O,,,,,,
4302,134303,Benzyl (S)-[4-[(aminocarbonyl)amino]-1-[[(4-nitrophenyl)amino]carbonyl]butyl]carbamate,C1=CC=C(C=C1)COC(=O)N[C@@H](CCCNC(=O)N)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
4303,134304,Benzyloxycarbonylglycyl-phenylalanyl-citrulline 4-nitroanilide,C1=CC=C(C=C1)C[C@@H](C(=O)NC(=O)[C@H](CCCNC(=O)N)NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)CNC(=O)OCC3=CC=CC=C3,,,,,,
4304,134305,2-Apaeps,CC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCSSC2=CC=CC=N2,,,,,,
4305,134306,Pbtcps,C[S+](C)CCCNC(=O)C1=CSC(=N1)C2=CSC(=N2)C3=CC=CC=C3.[I-],,,,,,
4306,134307,"Dimethyl-[3-[[2-(2-phenyl-1,3-thiazol-4-yl)-1,3-thiazole-4-carbonyl]amino]propyl]sulfanium",C[S+](C)CCCNC(=O)C1=CSC(=N1)C2=CSC(=N2)C3=CC=CC=C3,,,,,,
4307,134308,"3-{[(2,3-Dihydroxypropoxy)(hydroxy)phosphoryl]oxy}-2-(pentadecanoyloxy)propyl pentadecanoate",CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCCCCCCCC,,,,,,
4308,134309,N-Benzyloxycarbonylphenylalanyl-citrulline 4-nitroanilide,C1=CC=C(C=C1)C[C@@H](C(=O)NC(=O)[C@H](CCCNC(=O)N)NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)OCC3=CC=CC=C3,,,,,,
4309,134310,4-Hydroxymethyl-3-methoxyphenoxyacetic acid,COC1=C(C=CC(=C1)OCC(=O)O)CO,,,,,,
4310,134311,N-Formylaminoglutethimide,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)NC=O,,,,,,
4311,134312,Bapps,C1CC(=O)N(C1=O)OC(=O)CCC2=CC=C(C=C2)OC(=O)CCCCCNC(=O)CCCC[C@H]3[C@@H]4[C@H](CS3)NC(=O)N4,,,,,,
4312,134313,N-trans-Feruloylmethoxytyramine; trans-Feruloylmethoxytyramine; trans-N-Feruloyl-3-O-methyldopamine,COC1=C(C=CC(=C1)CCNC(=O)C=CC2=CC(=C(C=C2)O)OC)O,,,,,,
4313,134314,Fluorescein mono-p-guanidinobenzoate,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)OC(=O)C6=CC=C(C=C6)N=C(N)N.Cl,,,,,,
4314,134315,"(6'-Hydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) 4-(diaminomethylideneamino)benzoate",C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)OC(=O)C6=CC=C(C=C6)N=C(N)N,,,,,,
4315,134316,1-[3-(Trifluoromethyl)phenyl]pentan-2-amine,CCCC(CC1=CC(=CC=C1)C(F)(F)F)N,,,,,,
4316,134317,"Morpholine, 4,4'-(selenodi-2,1-ethanediyl)bis-",C1COCCN1CC[Se]CCN2CCOCC2,,,,,,
4317,134318,Di-beta-(piperidinoethyl)selenide,C1CCN(CC1)CC[Se]CCN2CCCCC2,,,,,,
4318,134319,"1,4-Diacetoxy-2,3-dicyanobenzene",CC(=O)OC1=C(C(=C(C=C1)OC(=O)C)C#N)C#N,,,,,,
4319,134320,"3,5,9,13,17-Pentahydroxy-20-(hydroxymethyl)-16,18,22,24,26-pentamethyloctacosa-6,10,14,18,20-pentaenoic acid",CCC(C)CC(C)CC(C)C=C(CO)C=C(C)C(C(C)C=CC(CC=CC(CC=CC(CC(CC(=O)O)O)O)O)O)O,,,,,,
4320,134321,"4-Hydroxy-6-[4,8,12-trihydroxy-15-(hydroxymethyl)-11,13,17,19,21-pentamethyltricosa-1,5,9,13,15-pentaenyl]oxan-2-one",CCC(C)CC(C)CC(C)C=C(CO)C=C(C)C(C(C)C=CC(CC=CC(CC=CC1CC(CC(=O)O1)O)O)O)O,,,,,,
4321,134322,"2,4,6-Quinazolinetriamine, N6-((4-chlorophenyl)methyl)-N6-methyl-",CN(CC1=CC=C(C=C1)Cl)C2=CC3=C(C=C2)N=C(N=C3N)N,,,,,,
4322,134323,"7-[(1R,2R,3R)-3-hydroxy-2-[(3R,4R)-3-hydroxy-4-methoxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoic acid",CCCC[C@](C)([C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O)OC,,,,,,
4323,134324,Thiamine indole-3-propionate,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)CCC3=CNC4=CC=CC=C43.[Cl-],,,,,,
4324,134325,"2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl 3-(1H-indol-3-yl)propanoate",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOC(=O)CCC3=CNC4=CC=CC=C43,,,,,,
4325,134326,1-(tert-Butylamino)-3-(6-chlorophenoxy)-2-propanol,CC(C)(C)NCC(COC1=CC=CC=C1Cl)O,,,,,,
4326,134327,"4-[4-[6-[4-(Dibutylamino)phenyl]hexa-1,3,5-trienyl]pyridin-1-ium-1-yl]butane-1-sulfonate",CCCCN(CCCC)C1=CC=C(C=C1)C=CC=CC=CC2=CC=[N+](C=C2)CCCCS(=O)(=O)[O-],,,,,,
4327,134328,"4-[4-[6-[4-(Dibutylamino)phenyl]hexa-1,3,5-trienyl]pyridin-1-ium-1-yl]butane-1-sulfonic acid",CCCCN(CCCC)C1=CC=C(C=C1)C=CC=CC=CC2=CC=[N+](C=C2)CCCCS(=O)(=O)O,,,,,,
4328,134329,"4-[4-[4-[4-(Dibutylamino)phenyl]buta-1,3-dienyl]pyridin-1-ium-1-yl]butane-1-sulfonate",CCCCN(CCCC)C1=CC=C(C=C1)C=CC=CC2=CC=[N+](C=C2)CCCCS(=O)(=O)[O-],,,,,,
4329,134330,"4-[4-[4-[4-(Dibutylamino)phenyl]buta-1,3-dienyl]pyridin-1-ium-1-yl]butane-1-sulfonic acid",CCCCN(CCCC)C1=CC=C(C=C1)C=CC=CC2=CC=[N+](C=C2)CCCCS(=O)(=O)O,,,,,,
4330,134331,6-Sulfoaminopenicillanic acid,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NS(=O)(=O)O)C(=O)O)C,,,['Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)'],,,
4331,134332,"1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(3,6-dihydro-4-(2-methylphenyl)-1(2H)-pyridinyl)propyl)-",CC1=CC=CC=C1C2=CCN(CC2)CCCN3C(=O)N4C=CC=CC4=N3,,,,,,
4332,134333,"1H-(1)Benzoxepino(2,3,4-ij)isoquinoline, 2,3,12,12a-tetrahydro-5,8,10-trimethoxy-1-methyl-, (S)-",CN1CCC2=C3[C@@H]1CC4=C(C(=CC(=C4)OC)OC)OC3=CC(=C2)OC,,,,,,
4333,134334,CID 134334,CCCCCCCCC=CCCCCCCCC(=O)NCCSC,,,,,,
4334,134335,"Methyl 12,13-epoxy-9-hydroperoxy-10-octadecenoate",CCCCCC1C(O1)C=CC(CCCCCCCC(=O)OC)OO,,,,,,
4335,134336,CID 134336,C1CC(CCC1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,,,,,
4336,134337,"Benzenemethanaminium, N,N,alpha-trimethyl-N-tetradecyl-, chloride, (S)-",CCCCCCCCCCCCCC[N+](C)(C)[C@@H](C)C1=CC=CC=C1.[Cl-],,,,,,
4337,134338,dimethyl-[(1S)-1-phenylethyl]-tetradecylazanium,CCCCCCCCCCCCCC[N+](C)(C)[C@@H](C)C1=CC=CC=C1,,,,,,
4338,134339,"1,3-Propanediamine, N'-(2,4-dinitrophenyl)-N-methyl-N-2-propynyl-",CN(CCCNC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-])CC#C,,,,,,
4339,134340,Lanthionine ketimine,C1C(N=C(CS1)C(=O)O)C(=O)O,,,,,,
4340,134341,"12-Oxoheptadeca-8,10-dienoic acid",CCCCCC(=O)C=CC=CCCCCCCC(=O)O,,,,,,
4341,134342,"2-Amino-6-(p-chlorobenzyl)-4H-5,6,7,8-tetrahydrothiazolo(5,4-d)azepine",C1CN(CCC2=C1N=C(S2)N)CC3=CC=C(C=C3)Cl,,,,,,
4342,134343,(2R)-2-Amino-4-(S-hexylsulfonimidoyl)butanoic acid,CCCCC(C)S(=N)(=O)CC[C@H](C(=O)O)N,,,,,,
4343,134344,2-(1H-Indol-3-ylthio)-N-(1-phenyl-2-pyrrolidinylidene)ethanamine,C1CC(=NCCSC2=CNC3=CC=CC=C32)N(C1)C4=CC=CC=C4,,,,,,
4344,134345,CID 134345,CCN(CC(CS(=O)(=O)[O-])O)C1=CC(=CC(=C1)OC)OC.[Na+],,,,,,
4345,134346,"N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline",CCN(CC(CS(=O)(=O)O)O)C1=CC(=CC(=C1)OC)OC,,,,,,
4346,134347,2-Isocyanatoethyl propionate,CCC(=O)OCCN=C=O,,,,,,
4347,134348,1-(4-Amidinobenzyl)indole,C1=CC=C2C(=C1)C=CN2CC3=CC=C(C=C3)C(=N)N,,,,,,
4348,134349,CID 134349,CC(=O)OC1=C(C=C(C=C1)C=C(C(=O)O)OC(=O)C)OC(=O)C,,,,,,
4349,134350,"Benzeneacetic acid, 2-((1-oxohexadecyl)oxy)-1-(((1-oxohexadecyl)oxy)methyl)ethyl ester",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CC1=CC=CC=C1,,,,,,
4350,134351,N-Pentafluorobenzoylmethionylglycine-N-hydroxysuccinimide ester,CSCC[C@@H](C(=O)NCC(=O)ON1C(=O)CCC1=O)NC(=O)C2=C(C(=C(C(=C2F)F)F)F)F,,,,,,
4351,134352,1-((4-Bromophenyl)sulfonyl)hydantoin,C1C(=O)NC(=O)N1S(=O)(=O)C2=CC=C(C=C2)Br,,,,,,
4352,134353,"3-(2,3-Dihydroxyphenyl)butanoic acid",CC(CC(=O)O)C1=C(C(=CC=C1)O)O,,,,,,
4353,134354,"3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl fluoride",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)F)C)C,,,,,,
4354,134355,"4-(5-Hydroxy-4,8-dimethyl-7-nonenyl)-4-methyl-3,8-dioxabicyclo(3.2.1)octane-1-acetic acid",CC(CCCC1(C2CCC(O2)(CO1)CC(=O)[O-])C)C(CC=C(C)C)O.CC(CCCC1(C2CCC(O2)(CO1)CC(=O)[O-])C)C(CC=C(C)C)O.[Ca+2],,,,,,
4355,134356,"3,8-Dioxabicyclo(3.2.1)octane-1-acetic acid, 4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-",CC(CCCC1(C2CCC(O2)(CO1)CC(=O)O)C)C(CC=C(C)C)O,,,,,,
4356,134357,CID 134357,CCCN[C@H](C)C(=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CCCC(=O)O,,,,,,
4357,134358,CID 134358,CCN[C@H](C)C(=O)NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)CCCC(=O)O,,,,,,
4358,134359,CID 134359,CCN1CCC[C@H]1C(=O)NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)CCCC(=O)O,,,,,,
4359,134360,"8-Hydroxy-4-methyl-3,4-dihydroxycoumarin",CC1CC(=O)OC2=C1C=CC=C2O,,,,,,
4360,134361,"3,5-diamino-6-chloro-N-[1-[2-[(2-hydroxy-3-naphthalen-1-yloxypropyl)amino]ethylamino]-2-methyl-1-oxopropan-2-yl]pyrazine-2-carboxamide",CC(C)(C(=O)NCCNCC(COC1=CC=CC2=CC=CC=C21)O)NC(=O)C3=C(N=C(C(=N3)Cl)N)N,,,,,,
4361,134362,"4-Amino-3,4-dihydro-3-imino-1-beta-D-ribofuranosyl-2(1H)-pyrazinone monohydrochloride",C1=CN(C(=N)C(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N.Cl,,,,,,
4362,134363,"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-iminopyrazin-2-one",C1=CN(C(=N)C(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,,,,,,
4363,134364,1-(2-O-Nitro-beta-D-arabinofuranosyl)cytosine,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O[N+](=O)[O-],,,,,,
4364,134365,"1-(2,6-Dimethylphenylamino)-2-dimethylaminopropane",CC1=C(C(=CC=C1)C)NCC(C)N(C)C,,,,,,
4365,134366,"7-(Hydroxymethyl)-1,6,10,14-tetramethyl-3-oxabicyclo[11.4.0]heptadeca-5,7,9,11,13-pentaen-4-one",CC1=C2C=CC(=CC=C(C(=CC(=O)OCC2(CCC1)C)C)CO)C,,,,,,
4366,134367,"3-[3,4-Dihydroxy-5-(4-prop-2-enylphenoxy)phenyl]prop-2-enal",C=CCC1=CC=C(C=C1)OC2=CC(=CC(=C2O)O)C=CC=O,,,,,,
4367,134368,Cezomycin,C[C@@H]1CCC2(C(CC([C@H](O2)C(C)C(=O)C3=CC=CN3)C)C)O[C@@H]1CC4=NC5=C(C=CC=C5O4)C(=O)O,,,,,,
4368,134369,Marsupsin,COC1=CC(=CC2=C1C(=O)C(O2)(CC3=CC=C(C=C3)O)O)O,,,,,,
4369,134370,4-((N-(alpha-Phenyl-2-piperidinobenzyl)carbamoyl)methyl)benzoic acid,C1CCN(CC1)C2=CC=CC=C2C(C3=CC=CC=C3)NC(=O)CC4=CC=C(C=C4)C(=O)O,,,,,,
4370,134371,Tryptophyl-norleucyl-arginyl-phenylalaninamide,CCCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N,,,,,,
4371,134372,CID 134372,CNC1=NN(CC1)C2=CC=CC(=C2)C(F)(F)F,,,,,,
4372,134373,"6-Methyl-4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol",CN1CCC2=C(C1)ONC2=O,,,,,,
4373,134374,"3(2H)-Isothiazolone, 5-((dimethylamino)methyl)-",CN(C)CC1=CC(=O)NS1,,,,,,
4374,134375,"2-(1-Methyl-2-oxo-2,3-dihydrobenzimidazol-3-ylmethyl)morpholine monohydrochloride",CN1C2=CC=CC=C2N(C1=O)CC3CNCCO3.Cl,,,,,,
4375,134376,1-Methyl-3-(morpholin-2-ylmethyl)benzimidazol-2-one,CN1C2=CC=CC=C2N(C1=O)CC3CNCCO3,,,,,,
4376,134377,(2S)-2-amino-N-[(2S)-1-[[2-[[(2S)-1-[2-[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]hydrazinyl]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide,C[C@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
4377,134378,CID 134378,C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCCCN[C@@H](CC2=CC=CC=C2)C(=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
4378,134379,"2-[[(2S,3R,6S,8R,9R)-3,9-dimethyl-2-[1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-5-hydroxy-1,3-benzoxazole-4-carboxylic acid",C[C@@H]1CC[C@]2(CC[C@H]([C@H](O2)C(C)C(=O)C3=CC=CN3)C)O[C@@H]1CC4=NC5=C(O4)C=CC(=C5C(=O)O)O,,,,,,
4379,134380,CID 134380,C1=CC(=C(C=C1N=NC2=CC3=NC=C(C3=CC2=O)CCN)N(O)[O-])N[N+]#N,,,,,,
4380,134381,Lysine theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CCN)C[C@@H](C(=O)O)N,,,,,,
4381,134382,"3-Benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide;1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol",CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,,,,,,
4382,134383,"Glycine, N-(3-(4-azidophenyl)-2-(mercaptomethyl)-1-oxopropyl)-, (+-)-",C1=CC(=CC=C1CC(CS)C(=O)NCC(=O)O)N=[N+]=[N-],,,,,,
4383,134384,Formylmethionyl-alanyl-leucine,C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCSC)NC=O,,,,,,
4384,134385,"2-Di-n-propylamino-5,8-dimethoxytetralin",CCCN(CCC)C1CCC2=C(C=CC(=C2C1)OC)OC,,,,,,
4385,134386,"1-Ethyl-1,2,3,4,4a,5,5a,9a-octahydrobenzo[g]quinoline-6,7-diol",CCN1CCCC2C1=CC3C=CC(=C(C3C2)O)O,,,,,,
4386,134387,Apa-orn-dns,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCC[C@@H](C(=O)O)NC(=O)C3=CC=C(C=C3)N(C)CC4=CN=C5C(=N4)C(=NC(=N5)N)N,,,,,,
4387,134388,"4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine-1-ethanamine, 8-chloro-N,N-dimethyl-6-phenyl-, 4-methylbenzenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)O.CN(C)CCC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,,,,,,
4388,134389,"1-[2-(dimethylamino)ethyl]-8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine",CN(C)CCC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,,,,,,
4389,134390,CID 134390,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNCC(=O)NC1CC(N(C(C1)(C)C)[O])(C)C)OC(=O)CCCCCCCCCCCCCCC,,,,,,
4390,134391,N-[(1-prop-2-enylpyridin-1-ium-2-yl)methylidene]hydroxylamine,C=CC[N+]1=CC=CC=C1C=NO,,,,,,
4391,134392,2-Fluoro-9-benzylpurine,C1=CC=C(C=C1)CN2C=NC3=CN=C(N=C32)F,,,,,,
4392,134393,"[(3R,4aR,5R,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] 4-methylbenzenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)O[C@@H]2[C@H]([C@@H]3[C@]([C@H](CCC3(C)C)O)([C@@]4([C@@]2(O[C@@](CC4=O)(C)C=C)C)O)C)O,,,,,,
4393,134394,2-Hydroxy-3-(phosphonooxy)propyl laurate,CCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O,,,,,,
4394,134395,Ethyl 8-methoxy-4-(2-propan-2-ylanilino)quinoline-3-carboxylate,CCOC(=O)C1=CN=C2C(=C1NC3=CC=CC=C3C(C)C)C=CC=C2OC,,,,,,
4395,134396,5-((2-Hydroxyethyl)amino)-2-methylphenol,CC1=C(C=C(C=C1)NCCO)O,,,,,,
4396,134397,"s-Triazolo(5,1-a)isoquinoline, 5,6-dihydro-2-phenyl-",C1CN2C(=NC(=N2)C3=CC=CC=C3)C4=CC=CC=C41,,,,,,
4397,134398,"2-(p-Chlorophenyl)-5,6-dihydro-s-triazolo(5,1-a)isoquinoline",C1CN2C(=NC(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C41,,,,,,
4398,134399,3-Ethylpentanamide,CCC(CC)CC(=O)N,,,,,,
4399,134400,"2-(m-Methoxyphenyl)-s-triazolo(5,1-a)isoquinoline",COC1=CC=CC(=C1)C2=NN3C=CC4=CC=CC=C4C3=N2,,,,,,
4400,134401,"m-(5,6-Dihydro-s-triazolo(5,1-a)isoquinolin-2-yl)phenol",C1CN2C(=NC(=N2)C3=CC(=CC=C3)O)C4=CC=CC=C41,,,,,,
4401,134402,4-Methoxypyridoxine hydrochloride,CC1=NC=C(C(=C1O)C(O)OC)CO.Cl,,,,,,
4402,134403,4-[Hydroxy(methoxy)methyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol,CC1=NC=C(C(=C1O)C(O)OC)CO,,,,,,
4403,134404,"Imidazo(1,2-a)quinoline, 4,5-dihydro-2-phenyl-",C1CC2=NC(=CN2C3=CC=CC=C31)C4=CC=CC=C4,,,,,,
4404,134405,CID 134405,C[C@H](CC[C@@H](C(C)(C)O)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=C)O)C,,,,,,
4405,134406,"1,2-Propanediol, 3-(6-amino-9H-purin-9-yl)-, (R)-",C1=NC(=C2C(=N1)N(C=N2)C[C@H](CO)O)N,,,['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)'],,,
4406,134407,CID 134407,COC1=CC(=O)C(=C2C1=C3CCC(=O)C3=C(O2)O)[C@H](CCO)CO,,,,,,
4407,134408,"Ethanone, 1-(2-(((methylamino)carbonyl)oxy)phenyl)-",CC(=O)C1=CC=CC=C1OC(=O)NC,,,,,,
4408,134409,"Butanenitrile, 4-chloro-3-(1-oxopropoxy)-",CCC(=O)OC(CC#N)CCl,,,,,,
4409,134410,"Undecanoic acid, 2-chloro-1-(cyanomethyl)ethyl ester",CCCCCCCCCCC(=O)OC(CC#N)CCl,,,,,,
4410,134411,"Acetamide, N-(3-((bis(2-chloroethyl)amino)methyl)-4-ethoxyphenyl)-",CCOC1=C(C=C(C=C1)NC(=O)C)CN(CCCl)CCCl,,,,,,
4411,134412,"Acetamide, N-(3-((bis(2-bromoethyl)amino)methyl)-4-methoxyphenyl)-",CC(=O)NC1=CC(=C(C=C1)OC)CN(CCBr)CCBr,,,,,,
4412,134413,"Acetamide, N-(3-(((2-bromoethyl)amino)methyl)-4-methoxyphenyl)-",CC(=O)NC1=CC(=C(C=C1)OC)CNCCBr,,,,,,
4413,134414,"1,2-Dimethylhydrazine hydrochloride",CNNC.Cl,,,,,,
4414,134415,"1,1-Di(4-methoxyphenyl)-2-phenyl-2-(2-pyridyl)ethanol",COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)(C(C3=CC=CC=C3)C4=CC=CC=N4)O,,,,,,
4415,134416,"1,1,2-Triphenyl-2-(4-pyridyl)ethanol",C1=CC=C(C=C1)C(C2=CC=NC=C2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O,,,,,,
4416,134417,"1,1-Di(4-methylphenyl)-2-phenyl-2-(2-pyridyl)ethanol",CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)(C(C3=CC=CC=C3)C4=CC=CC=N4)O,,,,,,
4417,134418,"1,1-Di(4-methoxyphenyl)-2-phenyl-2-(4-pyridyl)ethanol",COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)(C(C3=CC=CC=C3)C4=CC=NC=C4)O,,,,,,
4418,134419,"1-(4-Diethylaminoethoxyphenyl)-1,2-di(phenyl)-2-(4-pyridyl)ethanol",CCN(CC)CCOC1=CC=C(C=C1)C(C2=CC=CC=C2)(C(C3=CC=CC=C3)C4=CC=NC=C4)O,,,,,,
4419,134420,1-Di(4-chlorophenyl)-1-phenyl-2-(2-pyridyl)ethanol,C1=CC=C(C=C1)C(C2=CC=CC=N2)C(C3=CC=C(C=C3)Cl)(C4=CC=C(C=C4)Cl)O,,,,,,
4420,134421,"1-(4-Diethylaminoethoxyphenyl)-1,2-di(phenyl)-2-(2-pyridyl)ethanol",CCN(CC)CCOC1=CC=C(C=C1)C(C2=CC=CC=C2)(C(C3=CC=CC=C3)C4=CC=CC=N4)O,,,,,,
4421,134422,"1,2,2-Triphenyl-1-(2-pyridyl)ethanol",C1=CC=C(C=C1)C(C2=CC=CC=C2)C(C3=CC=CC=C3)(C4=CC=CC=N4)O,,,,,,
4422,134423,"1,2,2-Triphenyl-1-(3-pyridyl)ethanol",C1=CC=C(C=C1)C(C2=CC=CC=C2)C(C3=CC=CC=C3)(C4=CN=CC=C4)O,,,,,,
4423,134424,1-(4-Diethylaminoethoxyphenyl)-1-(4-methoxyphenyl)-2-phenyl-2-(2-pyridyl)ethanol,CCN(CC)CCOC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)(C(C3=CC=CC=C3)C4=CC=CC=N4)O,,,,,,
4424,134425,"1,1-Di(3-chlorophenyl)-2-phenyl-2-(2-pyridyl)ethanol",C1=CC=C(C=C1)C(C2=CC=CC=N2)C(C3=CC(=CC=C3)Cl)(C4=CC(=CC=C4)Cl)O,,,,,,
4425,134426,"1,2,2-Triphenyl-1-(4-pyridyl)methanol",C1=CC=C(C=C1)C(C2=CC=CC=C2)C(C3=CC=CC=C3)(C4=CC=NC=C4)O,,,,,,
4426,134427,"1,2-Diphenyl-1,2-di(2-pyridyl)ethanol",C1=CC=C(C=C1)C(C2=CC=CC=N2)C(C3=CC=CC=C3)(C4=CC=CC=N4)O,,,,,,
4427,134428,"1,1-Di(4-dimethylaminophenyl)-2-phenyl-2-(2-pyridyl)ethanol",CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)(C(C3=CC=CC=C3)C4=CC=CC=N4)O,,,,,,
4428,134429,"1,2-Diphenyl-1-(3-pyridyl)-2-(2-pyridyl)ethanol",C1=CC=C(C=C1)C(C2=CC=CC=N2)C(C3=CC=CC=C3)(C4=CN=CC=C4)O,,,,,,
4429,134430,"1,2-Diphenyl-1-(4-pyridyl)-2-(2-pyridyl)ethanol",C1=CC=C(C=C1)C(C2=CC=CC=N2)C(C3=CC=CC=C3)(C4=CC=NC=C4)O,,,,,,
4430,134431,"2-Pyridinemethanol, alpha-(diphenylmethyl)-alpha-(4-methoxyphenyl)-",COC1=CC=C(C=C1)C(C2=CC=CC=N2)(C(C3=CC=CC=C3)C4=CC=CC=C4)O,,,,,,
4431,134432,alpha-(9-Fluorenyl)-alpha-phenyl-2-pyridinemethanol,C1=CC=C(C=C1)C(C2C3=CC=CC=C3C4=CC=CC=C24)(C5=CC=CC=N5)O,,,,,,
4432,134433,"3-Pyridinemethanol, alpha-9H-fluoren-9-yl-alpha-phenyl-",C1=CC=C(C=C1)C(C2C3=CC=CC=C3C4=CC=CC=C24)(C5=CN=CC=C5)O,,,,,,
4433,134434,alpha-(9-Fluorenyl)-alpha-phenyl-4-pyridinemethanol,C1=CC=C(C=C1)C(C2C3=CC=CC=C3C4=CC=CC=C24)(C5=CC=NC=C5)O,,,,,,
4434,134435,"2-(2,2-Bis(4-methoxyphenyl)-1-phenylethenyl)pyridine",COC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=CC=N3)C4=CC=C(C=C4)OC,,,,,,
4435,134436,CID 134436,COC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=CC=N3)C4=CC=CC=C4,,,,,,
4436,134437,CID 134437,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=CC=N3)C4=CC=CC=C4,,,,,,
4437,134438,"alpha,alpha-Bis(p-(2-(diethylamino)ethoxy)phenyl)-beta-phenyl-2-pyridineethanol",CCN(CC)CCOC1=CC=C(C=C1)C(C2=CC=C(C=C2)OCCN(CC)CC)(C(C3=CC=CC=C3)C4=CC=CC=N4)O,,,,,,
4438,134439,"2-(2,2-Bis(p-(2-(diethylamino)ethoxy)phenyl)-1-phenylvinyl)pyridine",CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=CC=N3)C4=CC=C(C=C4)OCCN(CC)CC,,,,,,
4439,134440,"2-(3-Ethoxy-1H-inden-1-ylidene)-1H-indene-1,3(2H)-dione",CCOC1=CC(=C2C(=O)C3=CC=CC=C3C2=O)C4=CC=CC=C41,,,,,,
4440,134441,CID 134441,COCCC(=O)[O-].[Na+],,,,,,
4441,134442,3-Methoxypropanoic acid,COCCC(=O)O,,,,,,
4442,134443,"(S)-2,3-Dihydro-2-(hydroxymethyl)-6-(2-methoxyethyl)-2,5,7-trimethyl-1H-inden-1-one",CC1=CC2=C(C(=C1CCOC)C)C(=O)[C@](C2)(C)CO,,,,,,
4443,134444,2-Chloroacetonitrile-1-14C,C([14C]#N)Cl,,,,,,
4444,134445,"2-Chloro-(1,1'-biphenyl)-4,4'-diol",C1=CC(=CC=C1C2=C(C=C(C=C2)O)Cl)O,,,,,,
4445,134446,"2,4-Dibenzyl-3-pentanone",CC(CC1=CC=CC=C1)C(=O)C(C)CC2=CC=CC=C2,,,,,,
4446,134447,"2-Phenylpyrazolo[1,5-a]quinoline",C1=CC=C(C=C1)C2=NN3C(=C2)C=CC4=CC=CC=C43,,,,,,
4447,134448,Tiropramide hydrochloride,CCCN(CCC)C(=O)C(CC1=CC=C(C=C1)OCCN(CC)CC)NC(=O)C2=CC=CC=C2.Cl,,,,,,
4448,134449,"5H-s-Triazolo(5,1-a)isoindole, 2-phenyl-",C1C2=CC=CC=C2C3=NC(=NN31)C4=CC=CC=C4,,,,,,
4449,134450,"2-(4-chlorophenyl)-5H-[1,2,4]triazolo[5,1-a]isoindole",C1C2=CC=CC=C2C3=NC(=NN31)C4=CC=C(C=C4)Cl,,,,,,
4450,134451,"2-(3-Ethoxyphenyl)-5h-[1,2,4]triazolo[5,1-a]isoindole",CCOC1=CC=CC(=C1)C2=NN3CC4=CC=CC=C4C3=N2,,,,,,
4451,134452,[(2-methyl-2-methylsulfanylpropylidene)amino] N-methyl-N-nitrosocarbamate,CC(C)(C=NOC(=O)N(C)N=O)SC,,,,,,
4452,134453,Nisoxetine hydrochloride,CNCCC(C1=CC=CC=C1)OC2=CC=CC=C2OC.Cl,,,,,,
4453,134454,4-Methylumbelliferylguanidinobenzoate,CC1=CC(=O)OC2=C1C=CC(=C2)OC(=O)C3=CC=C(C=C3)N=C(N)N,,,,,,
4454,134455,CID 134455,C[NH+](C)[N+](C)(C)C1=CC=CC=C1C(=O)C2=CC=CC=C2,,,,,,
4455,134456,CID 134456,CN(C)[N+](C)(C)C1=CC=CC=C1C(=O)C2=CC=CC=C2,,,,,,
4456,134457,CID 134457,C1=C2C(=CC(=C1Cl)Cl)N=C3C(=NC(=O)NC3=O)N2,,,,,,
4457,134458,"(1S,9S)-1,13-dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol",CC1[C@@H]2CC3=C([C@]1(CCN2CC=C)C)C=C(C=C3)O,,,,,,
4458,134459,3-Hydroxyvalproic acid,CCCC(C(CC)O)C(=O)O,,,,,['3-Hydroxyvalproate is a known human metabolite of valproic acid.'],
4459,134460,3-Ethylpentanoic acid,CCC(CC)CC(=O)O,,,,,,
4460,134461,"1H-Benzimidazol-2-amine, 5-(phenylsulfonyl)-",C1=CC=C(C=C1)S(=O)(=O)C2=CC3=C(C=C2)N=C(N3)N,,,,,,
4461,134462,"1,2-Ethanediol-1,2-14C2",[14CH2]([14CH2]O)O,,,,,,
4462,134463,2-Chlorocyclohexylthiophthalimide,C1CCC(C(C1)SC2=CC=CC3=C2C(=O)NC3=O)Cl,,,,,,
4463,134464,"2-Nitro-5-(2,4-dichlorophenoxy)aniline",C1=CC(=C(C=C1OC2=C(C=C(C=C2)Cl)Cl)N)[N+](=O)[O-],,,,,,
4464,134465,2-Deoxyglucitol,C(CO)[C@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
4465,134466,4-Hydroxy-2-propylpentanoate,CCCC(CC(C)O)C(=O)[O-],,,,,,
4466,134467,4-Hydroxyvalproic acid,CCCC(CC(C)O)C(=O)O,,,,,['4-Hydroxyvalproate is a known human metabolite of valproic acid.'],
4467,134468,"Pyrazolo(1,5-a)quinoline, 4,5-dihydro-2-phenyl-",C1CC2=CC(=NN2C3=CC=CC=C31)C4=CC=CC=C4,,,,,,
4468,134469,"2-Phenyl-4H-pyrazolo(1,5-a)indole",C1C2=CC=CC=C2N3C1=CC(=N3)C4=CC=CC=C4,,,,,,
4469,134470,"Semicarbazide, 1-phenethyl-",C1=CC=C(C=C1)CCNNC(=O)N,,,,,,
4470,134471,9-cis Retinoic Acid Ethyl Ester,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,,,,,,
4471,134472,"N,N-Dimethylsulfamide",CN(C)S(=O)(=O)N,,,,,,
4472,134473,"3-Heptanone, 4-amino-6-methyl-, hydrochloride",CCC(=O)C(CC(C)C)N.Cl,,,,,,
4473,134474,4-Amino-6-methyl-3-heptanone,CCC(=O)C(CC(C)C)N,,,,,,
4474,134475,"2-Propanol, 1-((2,3-dihydro-1H-inden-4-yl)oxy)-3-((1-methylethyl)amino)-, hydrochloride",CC(C)NCC(COC1=CC=CC2=C1CCC2)O.Cl,,,,,,
4475,134476,"5-Bromo-1-ethyl-1,2-dihydro-2-iminopyrimidine monohydriodide",CCN1C=C(C=NC1=N)Br.I,,,,,,
4476,134477,5-Bromo-1-ethyl-2(1H)-pyrimidinimine,CCN1C=C(C=NC1=N)Br,,,,,,
4477,134478,"(2S)-2,6-diamino-4,5-ditritiohexanoic acid",[3H]C(C[C@@H](C(=O)O)N)C([3H])CN,,,,,,
4478,134479,Cycloheptanecarboxamide,C1CCCC(CC1)C(=O)N,,,,,,
4479,134480,Dextroamphetamine hydrochloride,C[C@@H](CC1=CC=CC=C1)N.Cl,,,,,,
4480,134481,5-Azauridine,C1=NC(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
4481,134482,2-Succinimidoglutarimide,C1CC(=O)NC(=O)C1N2C(=O)CCC2=O,,,,,,
4482,134483,"3-(Diethylamino)-1,2-dimethylpropyl 4-(2-methylpropoxy)benzoate hydrochloride",CCN(CC)CC(C)C(C)OC(=O)C1=CC=C(C=C1)OCC(C)C.Cl,,,['Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)'],,,
4483,134484,"1,2-Oxathiolane, 5-tridecyl-, 2,2-dioxide",CCCCCCCCCCCCCC1CCS(=O)(=O)O1,,,,,,
4484,134485,2-Ethynyl-5-phenylthiophene,C#CC1=CC=C(S1)C2=CC=CC=C2,,,,,,
4485,134486,CID 134486,C.C1=CC=C2C(=C1)C3=C(OC4=CC(=O)C=CC4=C3O2)O,,,,,,
4486,134487,CID 134487,C1=CC=C2C(=C1)C3=C(OC4=CC(=O)C=CC4=C3O2)O,,,,,,
4487,134488,"Phosphoric acid, diisopropyl 2-isopropyl-6-methyl-4-pyrimidinyl ester",CC1=CC(=NC(=N1)C(C)C)OP(=O)(OC(C)C)OC(C)C,,,,,,
4488,134489,"Phosphoric acid, 6-methyl-2-(1-methylethyl)-4-pyrimidinyl dipropyl ester",CCCOP(=O)(OCCC)OC1=NC(=NC(=C1)C)C(C)C,,,,,,
4489,134490,"L-2,4-diaminobutyric acid",C(CN)[C@@H](C(=O)O)N,,,,,,
4490,134491,"16beta-Bromo-3beta,17alpha-dihydroxy-5alpha-pregnane-11,20-dione",CC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)Br)O,,,,,,
4491,134492,CID 134492,COC1=CC(=C2C(=C1)OC3=C4C=CC(=O)C=C4OC(=C23)O)O,,,,,,
4492,134493,"(2R,3R,4R,5S)-2-[(1R)-1,2-dihydroxyethyl]-5-methoxyoxolane-3,4-diol",CO[C@@H]1[C@@H]([C@H]([C@H](O1)[C@@H](CO)O)O)O,,,,,,
4493,134494,"5beta-Androstane-3alpha,17beta-diol",C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C)O,,,,,,
4494,134495,Butoxamine,C[C@@H]([C@@H](C1=C(C=CC(=C1)OC)OC)O)NC(C)(C)C,,,"['Drugs that bind to and block the activation of ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Antagonists.)', 'Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)', 'Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)', 'Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)']",,,
4495,134496,2-[3-(Diaminomethylidenehydrazinylidene)propylideneamino]guanidine,C(C=NN=C(N)N)C=NN=C(N)N,,,,,,
4496,134497,4-Iodo-L-phenylalanine,C1=CC(=CC=C1C[C@@H](C(=O)O)N)I,,,,,,
4497,134498,2-[3-(Diaminomethylidenehydrazinylidene)butan-2-ylideneamino]guanidine,CC(=NN=C(N)N)C(=NN=C(N)N)C,,,,,,
4498,134499,CID 134499,CC1=NC=C(C(=N1)N)CN(C=C(CCO)SSCC2CCCO2)C=O.Cl,,,,,,
4499,134500,CID 134500,CC1=NC=C(C(=N1)N)CN(C=C(CCO)SSCC2CCCO2)C=O,,,,,,
4500,134501,1-(4-Chlorophenyl)sulfonyl-3-propan-2-ylurea,CC(C)NC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,,,,,,
4501,134502,"[(8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate",CC(=O)OC1=CC2=CC[C@@H]3[C@@H]([C@H]2CC1)CC[C@]4([C@H]3CC[C@]4(C#C)OC(=O)C)C,,,,,,
4502,134503,3-beta-Hydroxynorethynodrel,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3CC[C@@H](C4)O,,,,,,
4503,134504,"[2-Chloro-1-(2,5-dichlorophenyl)ethenyl] dimethyl phosphate",COP(=O)(OC)OC(=CCl)C1=C(C=CC(=C1)Cl)Cl,,,,,,
4504,134505,Homocysteine thiolactone,C1CSC(=O)[C@H]1N,,,"['Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)']",,,
4505,134506,Dehydroandrosterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@H](C4)O)C,,,,,,
4506,134507,N-(1-Carbamoyl-3-carboxypropyl)phthalamic acid,C1=CC=C(C(=C1)C(=O)NC(CCC(=O)O)C(=O)N)C(=O)O,,,,,,
4507,134508,"3-Aminopiperidine-2,6-dione",C1CC(=O)NC(=O)C1N,,,,,,
4508,134509,CID 134509,C1=CC(=C(C(=C1)O)N)C(=O)[O-].[Na+],,,,,,
4509,134510,CID 134510,CS(=O)(=O)[O-].[Na+],,,,,,
4510,134511,2-(o-Carboxybenzamido)glutaramic acid,C1=CC=C(C(=C1)C(=O)NC(CCC(=O)N)C(=O)O)C(=O)O,,,,,,
4511,134512,"(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxy-3-tritiohexanal",[3H][C@@]([C@H](C=O)O)([C@@H]([C@@H](CO)O)O)O,,,,,,
4512,134513,CID 134513,CC1=CC=C(C=C1)CCN(C(=N)S)N,,,,,,
4513,134514,2-(Phthalimido)-butyramide,CCC(C(=O)N)N1C(=O)C2=CC=CC=C2C1=O,,,,,,
4514,134515,CID 134515,C1=CC=C(C(=C1)CCN(C(=N)S)N)Cl,,,,,,
4515,134516,"Phosphoric acid, 2,2-dichloro-1-(3,5-dichlorophenyl)vinyl diethyl ester",CCOP(=O)(OCC)OC(=C(Cl)Cl)C1=CC(=CC(=C1)Cl)Cl,,,,,,
4516,134517,"12'-Hydroxy-2',5'alpha-diisopropylergotaman-3',6',18-trione monomethanesulfonate",CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)OS(=O)(=O)C,,,,,,
4517,134518,CID 134518,C(CO)N(CCO)C(=S)[S-].[Na+],,,,,,
4518,134519,L-Tryptophan ethyl ester hydrochloride,CCOC(=O)[C@H](CC1=CNC2=CC=CC=C21)N.Cl,,,,,,
4519,134520,Ethyl 2-amino-3-(1H-indol-3-yl)propanoate,CCOC(=O)C(CC1=CNC2=CC=CC=C21)N,,,,,,
4520,134521,"4,4'-Biphenyldiglyoxylaldehyde, compd. with disodium bisulfite",C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)C(O)S(=O)(=O)[O-])C(=O)C(O)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
4521,134522,1-Hydroxy-2-[4-[4-(2-hydroxy-2-sulfo-acetyl)phenyl]phenyl]-2-oxo-ethanesulfonic acid,C1=CC(=CC=C1C2=CC=C(C=C2)C(=O)C(O)S(=O)(=O)O)C(=O)C(O)S(=O)(=O)O,,,,,,
4522,134523,"3-tert-Butyl-5-methoxy-1,2-benzoquinone",CC(C)(C)C1=CC(=CC(=O)C1=O)OC,,,,,,
4523,134524,"[2-Chloro-1-(2,4-dibromophenyl)ethenyl] dimethyl phosphate",COP(=O)(OC)OC(=CCl)C1=C(C=C(C=C1)Br)Br,,,,,,
4524,134525,3-(2-Ammonioethyl)-5-hydroxy-1H-indolium oxalate,C1=CC2=C(C=C1O)C(=C[NH2+]2)CC[NH3+].C(=O)(C(=O)[O-])[O-],,,,,,
4525,134526,Methanol-14C,[14CH3]O,,,,,,
4526,134527,"N-[(2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide",CCCCCCCCCCCCCC=C[C@H]([C@H](CO)NC(=O)C)O,,,,,,
4527,134528,3-Phenyl-5-p-tolyl-S-triazole,CC1=CC=C(C=C1)C2=NC(=NN2)C3=CC=CC=C3,,,,,,
4528,134529,2-Methylnorvaline,CCC[C@@](C)(C(=O)O)N,,,,,,
4529,134530,CID 134530,CC1=CN=C(N1)S,,,,,,
4530,134531,"5-(4-Chlorophenyl)-6-methylpyrimidine-2,4-diamine",CC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,,,,,,
4531,134532,CID 134532,COC1=CC2=C(C(=C1)OCCN3CCCC3)C(=C(O2)C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
4532,134533,"1H-Indole-2-ethanamine, alpha,alpha-dimethyl-, monohydrochloride",CC(C)(CC1=CC2=CC=CC=C2N1)N.Cl,,,,,,
4533,134534,1-(1H-indol-2-yl)-2-methylpropan-2-amine,CC(C)(CC1=CC2=CC=CC=C2N1)N,,,,,,
4534,134535,"cis-3-Methylcholanthrene-1,2-diol",CC1=C2[C@@H]([C@@H](C3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)O)O,,,,,,
4535,134536,Chloro(tripentyl)stannane,CCCCC[Sn](CCCCC)(CCCCC)Cl,,,,,,
4536,134537,[4-[(4-Amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-benzoylsulfanylpent-3-enyl] benzoate;hydrochloride,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOC(=O)C2=CC=CC=C2)SC(=O)C3=CC=CC=C3)C.Cl,,,,,,
4537,134538,Dibenzoyl thiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOC(=O)C2=CC=CC=C2)SC(=O)C3=CC=CC=C3)C,,,,,,
4538,134539,"(2S,3S,4S,5R)-3,4,5-trihydroxy-6-[4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenoxy]oxane-2-carboxylic acid",CCC(=C(CC)C1=CC=C(C=C1)OC2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)C3=CC=C(C=C3)O,,,,,,
4539,134540,"(2,4-Dichloro-5-methoxyphenoxy)acetic acid",COC1=CC(=C(C=C1Cl)Cl)OCC(=O)O,,,,,,
4540,134541,C.I. Direct Red 10,C1=CC=C2C(=C1)C(=CC(=C2N)N=NC3=CC=C(C=C3)C4=CC=C(C=C4)N=NC5=C(C6=CC=CC=C6C(=C5)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
4541,134542,Benzanol Garnet,C1=CC=C2C(=C1)C(=CC(=C2N)N=NC3=CC=C(C=C3)C4=CC=C(C=C4)N=NC5=C(C6=CC=CC=C6C(=C5)S(=O)(=O)O)O)S(=O)(=O)O,,,,,,
4542,134543,Oxamine Blue 4R,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)[O-])C)N=NC5=C(C6=CC=CC=C6C(=C5)S(=O)(=O)[O-])O.[Na+].[Na+],,,,,,
4543,134544,Direct Blue 3 free acid,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O)C)N=NC5=C(C6=CC=CC=C6C(=C5)S(=O)(=O)O)O,,,,,,
4544,134545,omega-Methyl pantothenic acid,CC(C(C)(C)C(C(=O)NCCC(=O)O)O)O,,,,,,
4545,134546,CID 134546,C[C@H](CCCC(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3C2CC=C4[C@@]3(CCC(C4(C)C)OC(=O)C)C)C)C,,,,,,
4546,134547,"2,4-Dibromo-1-(4-nitrophenoxy)benzene",C1=CC(=CC=C1[N+](=O)[O-])OC2=C(C=C(C=C2)Br)Br,,,,,,
4547,134548,"3-Aminopiperidine-2,6-dione hydrochloride",C1CC(=O)NC(=O)C1N.Cl,,,,,,
4548,134549,"Phenol, 4-(1,1-dimethyl-4-penten-2-ynyl)-",CC(C)(C#CC=C)C1=CC=C(C=C1)O,,,,,,
4549,134550,alpha-Ergocryptine mesylate,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O.CS(=O)(=O)O,,,['Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)'],,,
4550,134551,alpha-Ergocryptine,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,['Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)'],,,
4551,134552,CID 134552,CCC1=C2C(=C)C=C3C(=C2[C@H]([C@@H]1O)O)C=CC4=CC=CC=C43,,,,,,
4552,134553,Lysergic acid alpha-hydroxyethylamide,CC(NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C)O,,,,,,
4553,134554,"Palmitic-9,10-t2-acid",[3H]C(CCCCCC)C([3H])CCCCCCCC(=O)O,,,,,,
4554,134555,CID 134555,C1=CC=C(C=C1)CCN(C(=N)S)N,,,,,,
4555,134556,Thymidine-14C,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)[14CH2]O)O,,,,,,
4556,134557,1-Benzoyloxy-3-chloropropan-2-ol,C1=CC=C(C=C1)C(=O)OCC(CCl)O,,,,,,
4557,134558,"Morpholine, 4-(N-(1,4-benzodioxan-2-ylmethyl)glycyl)-",C1COCCN1C(=O)CNCC2COC3=CC=CC=C3O2,,,,,,
4558,134559,CID 134559,[Li+].CC(=O)CC(=O)[O-],,,,,,
4559,134560,"1,3,4-Thiadiazole-2-sulfonamide, 5-(((4-aminophenyl)sulfonyl)amino)-",C1=CC(=CC=C1N)S(=O)(=O)NC2=NN=C(S2)S(=O)(=O)N,,,,,,
4560,134561,"1,3-Bis-(4-hydroxyphenyl)-2-propen-1-one",C1=CC(=CC=C1C=CC(=O)C2=CC=C(C=C2)O)O,,,,,,
4561,134562,Afridol Blue,C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)N)O)Cl)Cl)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)N)O,,,,,,
4562,134563,CID 134563,C(=[Se])[C@@H](C(=O)O)N,,,,,,
4563,134564,"3,7,11,15-Tetramethylhexadec-2-enoic acid",CC(C)CCCC(C)CCCC(C)CCCC(=CC(=O)O)C,,,,,,
4564,134565,Methyl D-tyrosinate hydrochloride,COC(=O)[C@@H](CC1=CC=C(C=C1)O)N.Cl,,,,,,
4565,134566,"Pseudourea, 2-(2-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurin-7-yl)ethyl)-2-thio-, monohydriodide",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCSC(=N)N.I,,,,,,
4566,134567,"2-[2-[(1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin)-7-yl]ethyl]isothiourea",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCSC(=N)N,,,,,,
4567,134568,"Phosphinothioic amide, P,P-bis(1-aziridinyl)-N,N-dimethyl-",CN(C)P(=S)(N1CC1)N2CC2,,,,,,
4568,134569,CID 134569,CCC1=NC=CC(=C1)C(=N)S.Cl,,,,,,
4569,134570,CID 134570,CC1=CC(=O)C2=C(C3=C(C[C@H]2O1)C(C(=CC3(O)O)O)C4=C(C=CC5=C(C6=C(C=C54)OC(=CC6=O)C)O)O)O,,,,,,
4570,134571,N-Hydroxypentanamide,CCCCC(=O)NO,,,,,,
4571,134572,"Androstane-3,17-diol dipropionate",CCC(=O)O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4OC(=O)CC)C)C,,,,,,
4572,134573,"[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dihydrogen phosphate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OP(=O)(O)O)C)C,,,,,,
4573,134574,Dimethyl selenoxide,C[Se](=O)C,,,,,,
4574,134575,Pyridostigmine iodide,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[I-],,,,,,
4575,134576,"2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)propanamide",CC(C(=O)N)N1C(=O)C2=CC=CC=C2C1=O,,,,,,
4576,134577,Gold(1+);4-hydroxy-4-oxo-2-sulfanylbutanoate,C(C(C(=O)[O-])S)C(=O)O.[Au+],,,['Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)'],,,
4577,134578,Mephenhydramine hydrochloride,CC(C1=CC=CC=C1)(C2=CC=CC=C2)OCCN(C)C.Cl,,,,,,
4578,134579,"Pyrimidine-2,5-diol",C1=C(C=NC(=O)N1)O,,,,,,
4579,134580,"Pregna-3,5-dien-20-one, 3-(acetyloxy)-",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC(=C4)OC(=O)C)C)C,,,,,,
4580,134581,"2,3,4,5-Tetrachlorophenyl acetate",CC(=O)OC1=CC(=C(C(=C1Cl)Cl)Cl)Cl,,,,,,
4581,134582,"5h-Pyrrolo[3,4-b]pyrazine-5,7(6h)-dione",C1=CN=C2C(=N1)C(=O)NC2=O,,,,,,
4582,134583,1-(2-(4-o-Tolyl-1-piperazinyl)ethyl)-2(1H)-pyridone monohydrochloride,CC1=CC=CC=C1N2CCN(CC2)CCN3C=CC=CC3=O.Cl,,,,,,
4583,134584,1-[2-[4-(2-Methylphenyl)piperazin-1-yl]ethyl]pyridin-2-one,CC1=CC=CC=C1N2CCN(CC2)CCN3C=CC=CC3=O,,,,,,
4584,134585,2-heptyl-6-methyl-1H-benzimidazole,CCCCCCCC1=NC2=C(N1)C=C(C=C2)C,,,,,,
4585,134586,"1,4-Dihydro-2H,5H-pyrano(3,4-c)(1)benzopyran-5-one",C1COCC2=C1C3=CC=CC=C3OC2=O,,,,,,
4586,134587,"5-(4-Chlorophenyl)-5-methylimidazolidine-2,4-dione",CC1(C(=O)NC(=O)N1)C2=CC=C(C=C2)Cl,,,,,,
4587,134588,"9-Fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl acetate",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3([C@H](C[C@@]2([C@]1(C(=O)CO)OC(=O)C)C)O)F)C,,,,,,
4588,134589,Acetamidoxime hydrochloride,CC(=NO)N.Cl,,,,,,
4589,134590,CID 134590,CC=CCC[C@@H](C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CCC4[C@@]3(CCC(=O)C4(C)C)C)C)C,,,,,,
4590,134591,Trioxypurin,C1=NC2=C(N1O)C(=O)NC(=O)N2,,,,,,
4591,134592,Cyclohexylmelamine,C1CCC(CC1)NC2=NC(=NC(=N2)N)N,,,,,,
4592,134593,"1,3-Oxazinane-2,6-dione",C1CNC(=O)OC1=O,,,,,,
4593,134594,CID 134594,CC1=CN=C(C(=N1)S)C,,,,,,
4594,134595,"Pregnenolone-3,21-disulfate",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)COS(=O)(=O)O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C,,,,,,
4595,134596,Ecgonine HCl,CN1[C@@H]2CC[C@@H]1[C@H]([C@H](C2)O)C(=O)O.Cl,,,,,,
4596,134597,CID 134597,CN1[C@@H]2CC[C@@H]1C([C@H](C2)O)C(=O)O,,,,,,
4597,134598,"Hexanoic acid, 2-(2-propynyl)-",CCCCC(CC#C)C(=O)O,,,,,,
4598,134599,Ethyl salicylurate,CCOC(=O)CNC(=O)C1=CC=CC=C1O,,,,,,
4599,134600,Aspartame Hydrochloride,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N.Cl,,,,,,
4600,134601,Aspartame,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N,['Used as a diet supplement and sugar substitute.'],"['Aspartame (L-alpha-aspartyl-L-phenylalanine methyl ester) is a low-calorie sweetener used to sweeten a wide variety of low- and reduced-calorie foods and beverages, including low-calorie tabletop sweeteners. Aspartame is composed of two amino acids, aspartic acid and phenylalanine, as the methyl ester. Aspartic acid and phenylalanine are also found naturally in protein containing foods, including meats, grains and dairy products. Methyl esters are also found naturally in many foods such as fruits and vegetable and their juices. Upon digestion, aspartame breaks down into three components (aspartic acid, phenylalanine and methanol), which are then absorbed into the blood and used in normal body processes. Neither aspartame nor its components accumulates in the body. These components are used in the body in the same ways as when they are derived from common foods.']","['Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)']","['Absorbed in the small intestine, aspartame is metabolized and absorbed very quickly.']","['Approximately 10% of aspartame (by weight) is broken down into methanol in the small intestine. Most of the methanol is absorbed and quickly converted into formaldehyde. Approximately 50% of aspartame (by weight) is broken down into phenylalanine. Approximately 40% of aspartame (by mass) is broken down into aspartic acid.', 'Unlike some other intense sweeteners, aspartame is metabolized in the body and consequently has some nutritive value: 1 g provides approx 17 kJ (4 kcal). However, in practice, the small quantity of aspartame consumed provides a minimal nutritive effect.', 'The use of aspartame has been of some concern owing to the formation of the potentially toxic metabolites methanol, aspartic acid, and phenylalanine. Of these materials,  only phenylalanine is produced in sufficient quantities, at normal aspartame intake levels, to cause concern.', 'Aspartame [SC-18862; 3-amino-N-(alpha-carboxyphenethyl) succinamic acid, methyl ester, the methyl ester of aspartylphenylalanine] is a sweetening agent that organoleptically has about 180 times the sweetness of sugar. The metabolism of aspartame has been studied in mice, rats, rabbits, dogs, monkeys, and humans. The compound was digested in all species in the same way as are natural constituents of the diet. Hydrolysis of the methyl group by intestinal esterases yielded methanol, which was oxidized in the one-carbon metabolic pool to CO2. The resultant dipeptide was split at the mucosal surface by dipeptidases and the free amino acids were absorbed. The aspartic acid moiety was transformed in large part to CO2 through its entry into the tricarboxylic acid cycle. Phenylalanine was primarily incorporated into body protein either unchanged or as its major metabolite, tyrosine.', 'Although aspartame was hydrolyzed in the gut of the monkey to its constituent moieties, methanol, aspartic acid, and phenylalanine, the ingestion of 15 or 60 mg/kg doses for 10 days did not modify phenylalanine metabolism. Aspartame had little effect on the disappearance of iv admin (14)C-phenylalanine from the plasma, it did not substantially affect the conversion of phenylalanine into tyrosine or carbon dioxide, and it did not alter the rate of incorporation of label into protein. The majority of phenylalanine derived from aspartame was incorporated into body protein, with only 20-25% of the compound being excreted. 60-80% of the derived methanol and aspartic acid was oxidized to carbon dioxide.', 'For more Metabolism/Metabolites (Complete) data for Aspartame (7 total), please visit the HSDB record page.']","['At room temperature, aspartame is most stable at pH 4.3, where its half-life is nearly 300 days. At pH 7, its half-life is shortened to only a few days.']"
4601,134602,CID 134602,CC1CCCC(CCCC=CC2=C(C(=CC(=C2)O)O)C(=O)O1)O,,,,,,
4602,134603,D-Homocysteine,C(CS)[C@H](C(=O)O)N,,,,,,
4603,134604,(1-14C)Leucine,CC(C)C[C@@H]([14C](=O)O)N,,,,,,
4604,134605,CID 134605,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@H]([C@H]([C@H](COP(=O)(O)O)O)O)[O-].O.O.[Na+],,,,,,
4605,134606,Trigonelline hydrochloride,C[N+]1=CC=CC(=C1)C(=O)O.[Cl-],,,,,,
4606,134607,4-[4-(4-Phenylmethoxyphenyl)hex-3-en-3-yl]phenol,CCC(=C(CC)C1=CC=C(C=C1)OCC2=CC=CC=C2)C3=CC=C(C=C3)O,,,,,,
4607,134608,L-Tryptophan monohydrochloride,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N.Cl,,,,,,
4608,134609,2-(Carbamimidamidoimino)propanoic acid,CC(=NN=C(N)N)C(=O)O,,,,,,
4609,134610,alpha-(alpha-Methylaminobenzyl)benzyl alcohol hydrochloride,CNC(C1=CC=CC=C1)C(C2=CC=CC=C2)O.Cl,,,,,,
4610,134611,beta-Hydroxyleucine,CC(C)C([C@@H](C(=O)O)N)O,,,,,,
4611,134612,"16,28-Secosolanid-5-ene-3,16-diol, (3beta,16beta,22alpha,25beta)-",C[C@@H]1CC[C@@H](NC1)[C@@H](C)C2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C)O,,,,,,
4612,134613,Diphenylhydantoic acid,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C(=O)O)NC(=O)N,,,,,,
4613,134614,"1H-Imidazole-4-ethanamine, phosphate",C1=C(NC=N1)CCN.OP(=O)(O)O,,,,,,
4614,134615,"3-[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenylidene]pentane-2,4-dione",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=C(C(=O)C)C(=O)C)C)C,,,,,,
4615,134616,4-Benzyloxyamphetamine,CC(CC1=CC=C(C=C1)OCC2=CC=CC=C2)N,,,,,,
4616,134617,1-14C-Trichloroacetonitrile,[14C](#N)C(F)(F)F,,,,,,
4617,134618,"(2S)-2-amino-3-(4-hydroxy-3,5-ditritiophenyl)propanoic acid",[3H]C1=CC(=CC(=C1O)[3H])C[C@@H](C(=O)O)N,,,,,,
4618,134619,"2,4-Diamino-5-(p-nitrobenzyl)-6-methylpyrimidine",CC1=C(C(=NC(=N1)N)N)CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
4619,134620,2-amino-4-methyl(74Se)selanylbutanoic acid,C[74Se]CCC(C(=O)O)N,,,,,,
4620,134621,"2,4-Diamino-5-(p-chlorobenzyl)-6-methylpyrimidine",CC1=C(C(=NC(=N1)N)N)CC2=CC=C(C=C2)Cl,,,,,,
4621,134622,"Pyrimidine, 2,4-diamino-5-(p-chlorophenyl)-6-pentyl-",CCCCCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,,,,,,
4622,134623,"Pyrimidine, 2,4-diamino-5-(p-bromophenyl)-6-methyl-",CC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Br,,,,,,
4623,134624,1-Methyl-2-(2-(trimethylammonio)ethyl)pyridinium diiodide,C[N+]1=CC=CC=C1CC[N+](C)(C)C.[I-].[I-],,,,,,
4624,134625,Trimethyl-[2-(1-methylpyridin-1-ium-2-yl)ethyl]azanium,C[N+]1=CC=CC=C1CC[N+](C)(C)C,,,,,,
4625,134626,"5-(4-Bromophenyl)-6-ethylpyrimidine-2,4-diamine",CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Br,,,,,,
4626,134627,Glycine-15N,C(C(=O)O)[15NH2],,,,,,
4627,134628,"(3S,5S,7S,8S,9S,10S,13S,14S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol",C[C@@]12CCC[C@H]1[C@H]3[C@H](CC2)[C@]4(CC[C@@H](C[C@H]4C[C@@H]3O)O)C,,,,,,
4628,134629,"N-(2,6-Dioxo-3-piperidyl)phthalamic acid",C1CC(=O)NC(=O)C1NC(=O)C2=CC=CC=C2C(=O)O,,,,,,
4629,134630,"Ergotamine, monomethanesulfonate (1:1) (salt)",C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C.CS(=O)(=O)O,,,,,,
4630,134631,CID 134631,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@H]([C@@H]([C@H](C3=CC4=C(C=C23)OCO4)O)CO)C(=O)[O-].[Na+],,,,,,
4631,134632,Podophyllinic acid,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@H]([C@@H]([C@H](C3=CC4=C(C=C23)OCO4)O)CO)C(=O)O,,,,,,
4632,134633,2-14C-Trichloroacetonitrile,C(#N)[14C](F)(F)F,,,,,,
4633,134634,"cis-(+-)-3-Allyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol",CC1[C@H]2CC3=C([C@@]1(CCN2CC=C)C)C=C(C=C3)O,,,,,,
4634,134635,N-(Acetyloxy)acetamide,CC(=O)NOC(=O)C,,,,,,
4635,134636,1-Azabicyclo[2.2.2]octan-2-yl benzoate--hydrogen chloride (1/1),C1CN2CCC1CC2OC(=O)C3=CC=CC=C3.Cl,,,,,,
4636,134637,Quinuclidinyl benzoate,C1CN2CCC1CC2OC(=O)C3=CC=CC=C3,,,,,,
4637,134638,2-(2-(Dimethylethylammonio)ethyl)-1-ethylpyridinium diiodide,CC[N+]1=CC=CC=C1CC[N+](C)(C)CC.[I-].[I-],,,,,,
4638,134639,Ethyl-[2-(1-ethylpyridin-1-ium-2-yl)ethyl]-dimethylazanium,CC[N+]1=CC=CC=C1CC[N+](C)(C)CC,,,,,,
4639,134640,"2,4-Diamino-5-methyl-6-sec-butylpyrido(2,3-d)pyrimidine",CCC(C)C1=CN=C2C(=C1C)C(=NC(=N2)N)N,,,,,,
4640,134641,CID 134641,C1=CC=C2C(=C1)C3=C(NC=CC3=N2)Br,,,,,,
4641,134642,S-(N-Methylcarbamoyl)-L-cysteine,CNC(=O)SC[C@@H](C(=O)O)N,,,,,,
4642,134643,"cis-3-Methylcholanthrene-11,12-dihydrodiol",CC1=C2CCC3=C2C(=CC4=C3[C@H]([C@H](C5=CC=CC=C54)O)O)C=C1,,,,,,
4643,134644,"Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, disodium salt, (11beta,16beta)-",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)[O-])C)[O-])F)C.[Na+].[Na+],,,,,,
4644,134645,"(8S,9R,10S,11S,13S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",C[C@H]1CC2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,,,,,,
4645,134646,"3,7-Dihydro-1,3-dimethyl-7-(2-(4-morpholinyl)ethyl)-8-(phenylmethyl)-1H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)CC3=CC=CC=C3)CCN4CCOCC4,,,,,,
4646,134647,"D-Homopregn-4-ene-3,20-dione",CC(=O)[C@H]1CCC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
4647,134648,"Indolizino(1,2-b)quinoline-7-acetamide, 8-((acetyloxy)methyl)-alpha-ethyl-9,11-dihydro-alpha-hydroxy-N-(1-methylethyl)-9-oxo-, (S)-",CC[C@](C1=C(C(=O)N2CC3=CC4=CC=CC=C4N=C3C2=C1)COC(=O)C)(C(=O)NC(C)C)O,,,,,,
4648,134649,trans-2-Ethyl-3-phenyloxirane,CC[C@@H]1[C@H](O1)C2=CC=CC=C2,,,,,,
4649,134650,"9-(4-(Diethylamino)butoxy)-7H-furo(3,2-g)(1)benzopyran-7-one hydrochloride",CCN(CC)CCCCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2.Cl,,,,,,
4650,134651,"9-[4-(Diethylamino)butoxy]furo[3,2-g]chromen-7-one",CCN(CC)CCCCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,,,,,,
4651,134652,2-(Methylthio)-1H-imidazole,CSC1=NC=CN1,,,,,,
4652,134653,4-Hydroxynonanoic acid,CCCCCC(CCC(=O)O)O,,,,,,
4653,134654,Tetrafluorostannane,[F-].[F-].[F-].[F-].[Sn+4],,,"['Substances that inhibit or arrest DENTAL CARIES formation. (Boucher&apos;s Clinical Dental Terminology, 4th ed) (See all compounds classified as Cariostatic Agents.)']",,,
4654,134655,Barium selenate,[O-][Se](=O)(=O)[O-].[Ba+2],,,,,,
4655,134656,CID 134656,O[Se](=O)[O-].[K+],,,,,,
4656,134657,CID 134657,[3H]C1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
4657,134658,"Carbamic acid, 2-propenyl-, 1-naphthalenyl ester",C=CCNC(=O)OC1=CC=CC2=CC=CC=C21,,,,,,
4658,134659,"(22S,25R)-5alpha-Solanidan-3beta-ol",C[C@@H]1CC[C@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C,,,,,,
4659,134660,Calcium borate,B([O-])([O-])[O-].B([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2],,,,,,
4660,134661,Scandium(III) oxide,[O-2].[O-2].[O-2].[Sc+3].[Sc+3],,,,,,
4661,134662,CID 134662,C1=CC=C(C=C1)C2=CC(=C(C=C2)O)N=NC3=CC=C(C=C3)OCCOS(=O)(=O)[O-].[Na+],,,,,,
4662,134663,2-(4-((4-Hydroxybiphenyl-3-yl)azo)phenoxy)ethyl hydrogen sulphate,C1=CC=C(C=C1)C2=CC(=C(C=C2)O)N=NC3=CC=C(C=C3)OCCOS(=O)(=O)O,,,,,,
4663,134664,Benzodiazepine,C1=CC=C2C(=C1)C=CC=NN2,,,,,,
4664,134665,(7alpha-3H)Progesterone,[H][C@]1(CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@@H]([C@]4(CC3)C)C(=O)C)C)[3H],,,,,,
4665,134666,"2-[4-[2-(4-chlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]phenoxy]-N,N-diethylethanamine",CCN(CC)CCOC1=CC=C(C=C1)C2C(CCC3=CC=CC=C23)C4=CC=C(C=C4)Cl,,,,,,
4666,134667,Thymidine-6-t,[3H]C1=C(C(=O)NC(=O)N1[C@H]2C[C@@H]([C@H](O2)CO)O)C,,,,,,
4667,134668,"2,4-Dioxo-(614C)1H-pyrimidine-6-carboxylic acid",C1=[14C](NC(=O)NC1=O)C(=O)O,,,,,,
4668,134669,Fudosteine,C(CO)CSC[C@@H](C(=O)O)N,,,,,,
4669,134670,1-Acetyl-4-(5-nitro-2-thiazolyl)piperazine,CC(=O)N1CCN(CC1)C2=NC=C(S2)[N+](=O)[O-],,,,,,
4670,134671,CID 134671,CCCN=C(NN)S,,,,,,
4671,134672,Thorium nitrate tetrahydrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.O.O.O.[Th+4],,,,,,
4672,134673,"1-(3-Chlorophenyl)-1,2-dimethylguanidine",CN=C(N)N(C)C1=CC(=CC=C1)Cl,,,,,,
4673,134674,"l-2-(1-Methyl-2-piperidyl)-1,1-diphenylethyl propionate hydrochloride",CCC(=O)OC(CC1CCCCN1C)(C2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
4674,134675,"[2-(1-Methylpiperidin-2-yl)-1,1-diphenylethyl] propanoate",CCC(=O)OC(CC1CCCCN1C)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4675,134676,CID 134676,[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[NaH].[Na+].[SiH4].[SiH4].[SiH4],,,,,,
4676,134677,Isopropyl ethanesulfonate,CCS(=O)(=O)OC(C)C,,,,,,
4677,134678,L-alpha-Methyldopamine,C[C@@H](CC1=CC(=C(C=C1)O)O)N,,,,,,
4678,134679,"1,1-Dibutylstannole-2,5-dione",CCCC[Sn]1(C(=O)C=CC1=O)CCCC,,,,,,
4679,134680,CID 134680,C1=CC(=CN=C1)S(=O)(=O)[O-].[Na+],,,,,,
4680,134681,Trisodium phosphite,[O-]P([O-])[O-].[Na+].[Na+].[Na+],,,,,,
4681,134682,"Phosphorothioic acid, O,O-dimethyl O-2-naphthalenyl ester",COP(=S)(OC)OC1=CC2=CC=CC=C2C=C1,,,,,,
4682,134683,"s-Triazine, 2-chloro-4-(ethylamino)-6-(isopropylamino)-, monohydrochloride",CCNC1=NC(=NC(=N1)Cl)NC(C)C.Cl,,,,,,
4683,134684,N-(3-phenylpropyl)-9H-purin-6-amine,C1=CC=C(C=C1)CCCNC2=NC=NC3=C2NC=N3,,,,,,
4684,134685,Bikethoxal,CC(C(=O)C=O)OCCOC(C)C(=O)C=O,,,,,,
4685,134686,N-Maleoylmethionine sulfone,CS(=O)(=O)CC[C@@H](C(=O)O)N1C(=O)C=CC1=O,,,,,,
4686,134687,Minizide,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F.COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl,,,,,,
4687,134688,"Methyl 1,5-dibromo-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate",CO[C@H]1[C@@H](C[C@@H]2CN3[C@H](C[C@@H]2[C@@H]1C(=O)OC)C4=C(CC3Br)C5=C(N4Br)C=C(C=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,,,,,,
4688,134689,Bromoreserpine,CN1C2=C(C=CC(=C2)OC)C3=C1[C@H]4C[C@H]5[C@H](C[C@H]([C@@H]([C@H]5C(=O)OBr)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC)CN4CC3,,,,,,
4689,134690,Pagpc,CCCCCCCCCCCCCCCC(=O)OC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C,,,,,,
4690,134691,2-[[(2S)-2-acetyloxy-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCC(=O)OC[C@@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C,,,,,,
4691,134692,Btpdn,CC1=CC(=O)OC2=C1C(=C3C=C(OC3=C2C)C)CN(C)CCCN(C)CCCN(C)CCCN(C)CC4=C5C=C(OC5=C(C6=C4C(=CC(=O)O6)C)C)C,,,,,,
4692,134693,CID 134693,CC(CC1CC(C(=O)OO1)(C)O)C2CCC3C2(CCCC3=CC=C4CC(CCC4=C)O)C,,,,,,
4693,134694,"(6R,7R)-7-[[2-(carboxymethoxyimino)-2-(1H-pyrazol-5-yl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)C(=NOCC(=O)O)C4=CC=NN4)SC2)C(=O)O,,,,,,
4694,134695,"7-Azoniabicyclo(2.2.1)heptane, 2-((cyclopentylhydroxyphenylacetyl)oxy)-7,7-dimethyl-, bromide",C[N+]1(C2CCC1C(C2)OC(=O)C(C3CCCC3)(C4=CC=CC=C4)O)C.[Br-],,,,,,
4695,134696,"(7,7-Dimethyl-7-azoniabicyclo[2.2.1]heptan-2-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate",C[N+]1(C2CCC1C(C2)OC(=O)C(C3CCCC3)(C4=CC=CC=C4)O)C,,,,,,
4696,134697,Regelindiol B,C[C@]12CC[C@@H](C(C1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@@H]4C[C@@](C[C@@H]5O)(C)C(=O)OC)C)C)C)(C)C)O,,,,,,
4697,134698,CID 134698,CCCC[C@](CC=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)OC)O)O)(N)O,,,,,,
4698,134699,Punky blue,CC[NH+]=C1C=C2C(=NC3=C(O2)C=C(C=C3)N)C=C1C,,,,,,
4699,134700,7-Ethylimino-8-methylphenoxazin-3-amine,CCN=C1C=C2C(=NC3=C(O2)C=C(C=C3)N)C=C1C,,,,,,
4700,134701,1-(2-Hydroxyethyl)-2-methyl-5-aminoimidazole,CC1=NC=C(N1CCO)N,,,,,,
4701,134702,Dtale,C[C@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N)N,,,,,,
4702,134703,CID 134703,C[C@H](CC(C(=O)C(C)(C)O)O)[C@H]1CCC2[C@@]1(CCCC2=CC=C3C[C@H](CCC3=C)O)C,,,,,,
4703,134704,"4,5-Dichloro-2-(2,3,5,6-tetrachlorophenoxy)phenol",C1=C(C(=CC(=C1Cl)Cl)OC2=C(C(=CC(=C2Cl)Cl)Cl)Cl)O,,,,,,
4704,134705,"2,3,4,5-Tetrachloro-6-(2,3,4,5-tetrachlorophenoxy)phenol",C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)O,,,,,,
4705,134706,CID 134706,CC(=O)C(=O)CCN1C=NC2=C1NC=NC2=O,,,,,,
4706,134707,(2r)-2-(2-Hydroxypropan-2-yl)-10-methylspiro[4.5]dec-6-ene-6-carboxylic acid,CC1CCC=C(C12CC[C@H](C2)C(C)(C)O)C(=O)O,,,,,,
4707,134708,"2-[[2-[Bis(2-chloroethyl)amino]-1,3,2-oxazaphosphinan-4-yl]sulfanyl]ethanesulfonic acid;cyclohexanamine",C1CCC(CC1)N.C1COP(NC1SCCS(=O)(=O)O)N(CCCl)CCCl,,,,,,
4708,134709,"2-[[2-[Bis(2-chloroethyl)amino]-1,3,2-oxazaphosphinan-4-yl]sulfanyl]ethanesulfonic acid",C1COP(NC1SCCS(=O)(=O)O)N(CCCl)CCCl,,,,,,
4709,134710,Methylsulfenyl trifluoromethanesulfonate,CSOS(=O)(=O)C(F)(F)F,,,,,,
4710,134711,"4-(3-Trifluoromethylphenyl)-1-(2-cyanoethyl)-1,2,3,6-tetrahydropyridine hcl",C1CN(CC=C1C2=CC(=CC=C2)C(F)(F)F)CCC#N,,,,,,
4711,134712,Talopeptin,C[C@H]1[C@H]([C@H]([C@H]([C@@H](O1)OP(=O)(N[C@@H](CC(C)C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)O)O)O)O,,,,,,
4712,134713,"4,5-Dichloro-2-(pentachlorophenoxy)phenol",C1=C(C(=CC(=C1Cl)Cl)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)O,,,,,,
4713,134714,"1,2,3,4-Tetrachloro-7-fluorodibenzo-p-dioxin",C1=CC2=C(C=C1F)OC3=C(O2)C(=C(C(=C3Cl)Cl)Cl)Cl,,,,,,
4714,134715,Aminobenzyl-edta,C1=CC(=CC=C1CC(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O)N,,,,,,
4715,134716,CID 134716,C1=CC=C(C=C1)C[C@@H](C(=O)[O-])N.[Na+],,,,,,
4716,134717,Magnesium acetate tetrahydrate,CC(=O)[O-].CC(=O)[O-].O.O.O.O.[Mg+2],"['Used as magnesium salf-containing laxatives to prevent constipation. It can bring synergistic effect to restore normal bowel function when using in combination with aluminum salts that induce bowel retention. Magnesium acetate tetrahydrate is used as a source of water and electrolytes when combined with dextrose and other salts to form intravenous infusions. This injection can be used for patients with carbohydrate or magnesium deficiency, insulin hypoglycemia, constipation or hypertension during pregnancy.']","['Magnesium is an essential cofactor for many enzymatic reactions such as protein synthesis and ATP production. It also participates in adenylyl cyclase pathway and tyrosine kinase signalling pathways. Magnesium may also play a role in regulating glucose metabolism. It serves as an essential cation for a number of biochemical processes involved in nerve signaling, bone mineralization and muscle contractions.']",,"['Intestinal absorption is achieved mainly through passive diffusion.', 'Mainly renal exctretion, where up to 97% of magnesium may be excreted renally during hypermagnesemia.', 'Magnesium ions display approximate volume of distribution of 0.2 to 0.4 L/kg']",,['Elimination half-life has been reported to be 27.7 hours following an overdose of 400mEq magnesium in an adult.']
4717,134718,CID 134718,C(=O)([O-])[O-].O.O.[Na+].[AlH2+],,,,,,
4718,134719,"2,3,6-Trihydroxybenzoic acid",C1=CC(=C(C(=C1O)C(=O)O)O)O,,,,,,
4719,134720,1-(4-Hydroxyphenyl)-2-(methylamino)ethanol tartrate,CNCC(C1=CC=C(C=C1)O)O.C(C(C(=O)O)O)(C(=O)O)O,,,,,,
4720,134721,CID 134721,CN(C)CCC=C1C2=CC=CC=C2S(C3=C1C=C(C=C3)Cl)[O-],,,,,,
4721,134722,CID 134722,CN(C)CCC=C1C2=CC=CC=C2S(C3=C1C=C(C=C3)Cl)O,,,,,,
4722,134723,4-(2-Aminopropyl)-3-methylaniline,CC1=C(C=CC(=C1)N)CC(C)N,,,,,,
4723,134724,CID 134724,CCC1C(C(CC=C1C2=CC=CC=C2)C(=O)[O-])C.[Na+],,,,,,
4724,134725,"1H-2-Benzopyran-7-carboxylic acid, 5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-",CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)O)Cl,,,,,,
4725,134726,CID 134726,C[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)N,,,,,,
4726,134727,"tert-butyl N-[(2S,3S)-1-[[2-[[(2S)-2-amino-5-oxo-5-piperidin-1-ylpentanoyl]amino]acetyl]-[(2S)-5-(diaminomethylideneamino)-2-[(1,4-dioxo-2,3-dihydrophthalazin-6-yl)amino]pentanoyl]amino]-3-methyl-1-oxopentan-2-yl]carbamate",CC[C@H](C)[C@@H](C(=O)N(C(=O)CNC(=O)[C@H](CCC(=O)N1CCCCC1)N)C(=O)[C@H](CCCN=C(N)N)NC2=CC3=C(C=C2)C(=O)NNC3=O)NC(=O)OC(C)(C)C,,,,,,
4727,134728,"2,3,4,4a,9,9a-Hexahydro-2,9-dimethyl-1H-indeno(2,1-c)pyridine hydrochloride",CC1C2CN(CCC2C3=CC=CC=C13)C.Cl,,,,,,
4728,134729,"2,9-Dimethyl-1,3,4,4a,9,9a-hexahydroindeno[2,1-c]pyridine",CC1C2CN(CCC2C3=CC=CC=C13)C,,,,,,
4729,134730,3-Trimethylaminomethylcatechol,C[N+](C)(C)CC1=C(C(=CC=C1)O)O,,,,,,
4730,134731,CID 134731,CCCC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCCNC(=O)CCCCCN=C3C=CC(=N[N+]#N)C=C3N(O)[O-])C(=O)O)NC=O,,,,,,
4731,134732,Creatine hydrochloride,CN(CC(=O)O)C(=N)N.Cl,,,,,,
4732,134733,"[(8R,9S,13S,14S,16R,17R)-13-methyl-3,16-disulfooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] hydrogen sulfate",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2OS(=O)(=O)O)OS(=O)(=O)O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,,,,,,
4733,134734,Disodium sebacate,C(CCCCC(=O)[O-])CCCC(=O)[O-].[Na+].[Na+],,,,,,
4734,134735,Phenoxymethyl,[CH2]OC1=CC=CC=C1,,,,,,
4735,134736,(S)-2-(((4-Amino-1-carboxy-4-oxobutyl)amino)carbonyl)benzoic acid,C1=CC=C(C(=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)C(=O)O,,,,,,
4736,134737,Copper(I) sulfate,[O-]S(=O)(=O)[O-].[Cu+].[Cu+],,,,,,
4737,134738,3-[(Dimethoxyphosphoryl)oxy]but-2-enimidic acid,CC(=CC(=O)N)OP(=O)(OC)OC,,,,,,
4738,134739,CID 134739,C1C[C@@H](O[C@@H]1COP(=O)(O)OP(=O)(O)O)N2C=NC3=C2NC(=NC3=O)N,,,,,,
4739,134740,"(6aS,10aS)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol",CCCCCC1=CC(=C2[C@H]3C=C(CC[C@@H]3C(OC2=C1)(C)C)C)O,,,,,,
4740,134741,"6-Phenyl-7(6H)-isoselenazolo(4,3-d)pyrimidone",C1=CC=C(C=C1)N2C=NC3=C[Se]N=C3C2=O,,,,,,
4741,134742,"2,4-Imidazolidinedione, 5-(4-methoxyphenyl)-5-phenyl-",COC1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,,,,,,
4742,134743,CID 134743,C1=CC(=C(C=C1F)[Hg])O.C(=O)(C(F)(F)F)O,,,,,,
4743,134744,(5-Fluoro-2-hydroxyphenyl)mercury,C1=CC(=C(C=C1F)[Hg])O,,,,,,
4744,134745,Acetic acid;(4-azidophenyl)mercury,CC(=O)O.C1=CC(=CC=C1N=[N+]=[N-])[Hg],,,,,,
4745,134746,(4-Azidophenyl)mercury,C1=CC(=CC=C1N=[N+]=[N-])[Hg],,,,,,
4746,134747,Barium methacrylate,CC(=C)C(=O)[O-].CC(=C)C(=O)[O-].[Ba+2],,,,,,
4747,134748,"Benzoic acid, 3,4,5-trimethoxy-, 2-(methylamino)-2-phenylbutyl ester",CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)NC,,,,,,
4748,134749,"Pregn-4-ene-3,20-dione, 18,19,21-trihydroxy-",C1C[C@@H]([C@@]2([C@@H]1[C@@H]3CCC4=CC(=O)CC[C@@]4([C@H]3CC2)CO)CO)C(=O)CO,,,,,,
4749,134750,"1,1'-(Propylenedioxy)bis(3-chloro-2-propanol)",CC(COCC(CCl)O)OCC(CCl)O,,,,,,
4750,134751,"3-((N-Acetylseryl)amino)-3,6-dideoxyglucose",C[C@H]([C@H]([C@@H]([C@H](C=O)O)NC(=O)[C@H](CO)NC(=O)C)O)O,,,,,,
4751,134752,"2,7,9-Tricarboxypyrrolo(2,3-f)quinoline-4-ol-5-one",C1=C(NC2=C(C(=C3C=C(N=C3C2=C1C(=O)O)C(=O)O)[O])O)C(=O)O,,,,,,
4752,134753,5-(3-Chloro-2-hydroxypropoxy)-1-pentanol,C(CCO)CCOCC(CCl)O,,,,,,
4753,134754,"Estra-1,3,5(10)-trien-17-one, 6-(3-carboxy-1-oxopropoxy)-3,16-dihydroxy-, (6alpha,16alpha)-",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H](C2=O)O)C[C@@H](C4=C3C=CC(=C4)O)OC(=O)CCC(=O)O,,,,,,
4754,134755,"(3S,6S,8S,9S,13R,14S)-6-(2-fluoroethyl)-13-methyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol",C[C@H](CCCC(C)C)C1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H](C4=C3CC[C@@H](C4)O)CCF)C,,,,,,
4755,134756,Platinic chloride hexahydrate,[H+].[H+].O.O.O.O.O.O.Cl[Pt-2](Cl)(Cl)(Cl)(Cl)Cl,,,,,,
4756,134757,Flumazenil acid,CN1CC2=C(N=CN2C3=C(C1=O)C=C(C=C3)F)C(=O)O,,,,,,
4757,134758,[2-Octadec-9-enoyloxy-3-(10-oxo-10-perylen-3-yldecanoyl)oxypropyl] octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC(=O)C1=CC=C2C3=CC=CC4=C3C(=CC=C4)C5=C2C1=CC=C5)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
4758,134759,3-Admao,CC(=O)O[C@@H]1C[C@]2([C@@H](C[C@H]3[C@@H]4CCC(=O)[C@]4(CC[C@@H]3[C@]2(CC1=C)C)C)Cl)Cl,,,,,,
4759,134760,CID 134760,CCCCC[C@@H](C=C[C@H]1CC[C@@H]2[C@@H]1CC(=CCCCC(=O)O)O2)O,,,,,,
4760,134761,"2,4-Diamino-5-phenylpyrimidine",C1=CC=C(C=C1)C2=CN=C(N=C2N)N,,,,,,
4761,134762,CID 134762,C1=CC(=CC=C1C(=O)[C@]2([C@H](O[C@H]([C@@H]2O)N3C=NC4=C3NC(=NC4=O)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)N=[N+]=[N-],,,,,,
4762,134763,CID 134763,C1=CC(=CC=C1C(=O)[C@]2([C@H](O[C@@H]([C@@H]2O)N3C=NC4=C3NC(=NC4=O)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)N[N+]#N,,,,,,
4763,134764,3'-O-(5-Azidonaphthoyl)adenosine diphosphate,C1=CC2=C(C=CC=C2N=[N+]=[N-])C(=C1)C(=O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=NC5=C(N=CN=C54)N)COP(=O)(O)OP(=O)(O)O,,,,,,
4764,134765,CID 134765,C1=CC2=C(C=CC=C2N[N+]#N)C(=C1)C(=O)O[C@@H]3[C@H](O[C@@H]([C@@H]3O)N4C=NC5=C(N=CN=C54)N)COP(=O)(O)OP(=O)(O)O,,,,,,
4765,134766,"L-Cysteine, N-acetyl-, hydrochloride",CC(=O)N[C@@H](CS)C(=O)O.Cl,,,,,,
4766,134767,Difluorescein disulfide,C1=CC2=C(C=C1O)OC3=C(C24C5=C(C=C(C=C5)SSC6=CC7=C(C=C6)C8(C9=C(C=C(C=C9)O)OC1=C8C=CC(=C1)O)OC7=O)C(=O)O4)C=CC(=C3)O,,,,,,
4767,134768,"N-(2,4-Dibromo-6-((cyclohexylmethylamino)methyl)phenyl)-4-hydroxy-3-methoxybenzamide",CN(CC1=C(C(=CC(=C1)Br)Br)NC(=O)C2=CC(=C(C=C2)O)OC)C3CCCCC3,,,,,,
4768,134769,"Methyl 5-amino-4-(1,3-dioxoisoindol-2-yl)-5-oxopentanoate",COC(=O)CCC(C(=O)N)N1C(=O)C2=CC=CC=C2C1=O,,,,,,
4769,134770,"N-(4-amino-3,5-dibromophenyl)acetamide",CC(=O)NC1=CC(=C(C(=C1)Br)N)Br,,,,,,
4770,134771,Didesmethylsibutramine hydrochloride,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N.Cl,,,,,,
4771,134772,Didesmethylsibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N,,,"['Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)', 'Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)']",,"['1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine is a known human metabolite of Desmethylsibutramine, (S)-.']",
4772,134773,Iminocyclophosphamide,C1COP(=O)(N=C1)N(CCCl)CCCl,,,,,,
4773,134774,"N-(3-Carboxy-2,3-dihydroxypropyl)-4-((carboxymethyl)amino)threonine",C([C@H]([C@@H](C(=O)O)NCC(C(C(=O)O)O)O)O)NCC(=O)O,,,,,,
4774,134775,"2-(2,6-Dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione",C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)[N+](=O)[O-],,,,,,
4775,134776,1-Nitro-9-(5-dimethylaminopentylamino)-acridine dihydrochloride,CN(C)CCCCCNC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl.Cl,,,,,,
4776,134777,"N,N-dimethyl-N'-(1-nitro-9-acridinyl)-1,5-pentanediamine",CN(C)CCCCCNC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-],,,,,,
4777,134778,"3-((Imino((2,2,2-trifluoroethyl)amino)methyl)amino)-1H-pyrazole-1-pentanamide",C1=CN(N=C1NC(=NCC(F)(F)F)N)CCCCC(=O)N,,,,,,
4778,134779,"1-Methoxybicyclo[3.2.0]hepta-3,6-dien-2-one",COC12C=CC1C=CC2=O,,,,,,
4779,134780,Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,['Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.'],['Pomalidomide is more potent than thalidomide (100-times) and lenalidomide (10-times).'],"['Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)', 'Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)']","['Pomalidomide is generally well absorbed. The major circulating component is the parent compound.  Tmax, single oral dose = 2 -3 hours.  When 4 mg of promalidomide is given to patients with multiple myeloma, the steady-state pharmacokinetic parameters are as follows: AUC(T) = 400 ng.hr/mL; Cmax = 75 ng/mL.  Promalidomide accumulates following multiple doses.', 'When a single oral dose (2mg) is given to healthy subjects, 73% of the dose was eliminated in urine. 15% of the dose was eliminated in feces. 2% and 8% of the dose eliminated unchanged as pomalidomide in urine and feces, respectively.', 'Mean apparent volume of distribution (Vd/F), steady-state = 62 - 138 L', 'Total body clearance = 7-10 L/hour', 'Pomalidomide has a mean apparent volume of distribution (Vd/F) between 62 and 138 L at steady state. Pomalidomide is distributed in semen of healthy subjects at a concentration of approximately 67% of plasma level at 4 hours post-dose (approximate Tmax) after 4 days of once-daily dosing at 2 mg. Human plasma protein binding ranges from 12% to 44% and is not concentration dependent. Pomalidomide is a substrate for P-glycoprotein (P-gp).', 'In patients with multiple myeloma who received Pomalyst 4 mg daily alone or in combination with dexamethasone, pomalidomide steady-state drug exposure was characterized by AUC(T) of 400 ng*h/mL and Cmax of 75 ng/mL. Following multiple doses, pomalidomide has an accumulation ratio of 27% to 31%.', 'Following a single oral administration of (14)C-pomalidomide (2 mg) to healthy subjects, approximately 73% and 15% of the radioactive dose was eliminated in urine and feces, respectively, with approximately 2% and 8% of the radiolabeled dose eliminated unchanged as pomalidomide in urine and feces.', 'Pomalidomide has a mean total body clearance (CL/F) of 7-10 L/hr.', 'For more Absorption, Distribution and Excretion (Complete) data for Pomalidomide (12 total), please visit the HSDB record page.']","['Promalidomide is hepatically metabolized by CYP1A2 and CYP3A4. The metabolites are 26-fold less active than the parent compound. Minor contributions from CYP2C19 and CYP2D6 have been observed in vitro.', 'In hepatocytes from rabbit and human, and in vivo in rat, monkey and human, pomalidomide was metabolized primarily via hydroxylation of the phthalimide ring (M14, M16 and M17) followed by glucuronidation (M12 and M13), hydrolysis of the glutarimide ring (M10 and M11), and hydrolysis of the phthalimide ring (M2). There were no unique or disproportionate metabolites observed in humans, compared to rats and monkeys.', 'Pomalidomide is primarily metabolized in the liver by CYP1A2 and CYP3A4. In vitro, CYP1A2 and CYP3A4 were identified as the primary enzymes involved in the CYP-mediated hydroxylation of pomalidomide, with additional minor contributions from CYP2C19 and CYP2D6.']","['Healthy subjects = 9.4 hours; Multiple myeloma patients = 7.5 hours.', '... the terminal half-lives of pomalidomide in animals ranged from mean values of 4 to 7 hours following an IV dose.', 'Pomalidomide is eliminated with a median plasma half-life of approximately 9.5 hours in healthy subjects and approximately 7.5 hours in patients with multiple myeloma.']"
4780,134781,gamma ATP-Dnp,C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NCCCCCCNC2=NC3=C(N=CN=C3N2[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,,,,
4781,134782,Glorin,CCC(=O)N([C@H]1CCCNC1=O)[C@@H](CCC(=O)N)C(=O)OCC,,,,,,
4782,134783,3-Dehydrolithocholylglycine,C[C@H](CCC(=O)NCC(=O)OC)[C@H]1CCC2[C@@]1(CCC3C2CC[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
4783,134784,2-Aminoimidazoline,C1CN=C(N1)N,,,,,,
4784,134785,"2-[Bis(3,7-dimethylocta-2,6-dien-1-yl)amino]ethan-1-ol",CC(=CCCC(=CCN(CCO)CC=C(C)CCC=C(C)C)C)C,,,,,,
4785,134786,Human growth hormone (4-15),CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)O)N,,,,,,
4786,134787,"2,4-Dinitroestriol",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C(C(=C(C=C34)[N+](=O)[O-])O)[N+](=O)[O-],,,,,,
4787,134788,N-Nitroso-N-methyltyramine,CN(CCC1=CC=C(C=C1)O)N=O,,,,,,
4788,134789,"4-N-(1,1,2,2-tetrachloroethylsulfanyl)-7-oxabicyclo[4.1.0]heptane-3,4-dicarboxamide",C1C(C(CC2C1O2)C(=O)NSC(C(Cl)Cl)(Cl)Cl)C(=O)N,,,,,,
4789,134790,Methylamphetamine sulfate,CC(CC1=CC=CC=C1)NC.OS(=O)(=O)O,,,,,,
4790,134791,Phenyl hydrazinecarboxylate,C1=CC=C(C=C1)OC(=O)NN,,,,,,
4791,134792,"1H-Indole-3-methanamine, N-methyl-N,1-dinitroso-",CN(CC1=CN(C2=CC=CC=C21)N=O)N=O,,,,,,
4792,134793,"5-alpha-Stigmastane-3-beta,5,6-beta-triol 3-monobenzoate",CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H]([C@@]4([C@@]3(CC[C@@H](C4)OC(=O)C5=CC=CC=C5)C)O)O)C)C(C)C,,,,,,
4793,134794,"(3,4-Dichlorophenethyl)hydrazine",C1=CC(=C(C=C1CCNN)Cl)Cl,,,,,,
4794,134795,"5-Nitro-1H-benzo[d][1,3]oxazine-2,4-dione",C1=CC2=C(C(=C1)[N+](=O)[O-])C(=O)OC(=O)N2,,,,,,
4795,134796,"3,5-Dichlorophenyl p-nitrophenyl ether",C1=CC(=CC=C1[N+](=O)[O-])OC2=CC(=CC(=C2)Cl)Cl,,,,,,
4796,134797,(S)-(+)-2-Phenylglycinol,C1=CC=C(C=C1)[C@@H](CO)N,,,,,,
4797,134798,"Triazene, 1-ethyl-3-phenyl-",CCN=NNC1=CC=CC=C1,,,,,,
4798,134799,3alpha-Hydroxynorethynodrel,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3CC[C@H](C4)O,,,,,,
4799,134800,Calcium fusarate,CCCCC1=CN=C(C=C1)C(=O)[O-].CCCCC1=CN=C(C=C1)C(=O)[O-].[Ca+2],,,"['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)', 'Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)', 'Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)']",,,
4800,134801,"(6S,9S,11S,12S,14S,16R)-15-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-6,9,14-triol",C[C@]12CCC34CC35CC[C@@H](C(C5[C@H](C[C@H]4[C@@]1(C[C@@H](C2[C@@]6(CC[C@@H](O6)C(C)(C)O)C)O)C)O)(C)C)O,,,,,,
4801,134802,CID 134802,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)[N+](=O)[O-])C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
4802,134803,CID 134803,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)[N+](=O)[O-])C3=CC=CC=C3,,,,,,
4803,134804,CID 134804,C[C@@H](C(=O)N([C@H](C)C(=O)NC1=CC2=C(C=C1)N=CC=C2)C(=O)[C@@H](C)NC(=O)OCC3=CC=CC=C3)N,,,,,,
4804,134805,"2,5-Piperidine dicarboxylate",C1C[C@H](NC[C@H]1C(=O)O)C(=O)O,,,,,,
4805,134806,"2,8-Dibenzylidenecyclooctan-1-one",C1CCC(=CC2=CC=CC=C2)C(=O)C(=CC3=CC=CC=C3)CC1,,,,,,
4806,134807,Asparaginyl-alanyl-glycyl-alaninamide,C[C@@H](C(=O)N)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)N)N,,,,,,
4807,134808,Asparaginyl-alanyl-glycyl-alanyl-asparagine,C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N)N,,,,,,
4808,134809,CID 134809,C1=NC2=C(N1CCC(=O)O)NC(=NC2=O)N,,,,,,
4809,134810,CID 134810,CC(=NOCC(=O)O)O[C@@]1(CCC2[C@@]1(CCC3C2CCC4=CC(=O)CC[C@H]34)C)C#C,,,,,,
4810,134811,Di(1H-imidazol-1-yl)methane,C1=CN(C=N1)CN2C=CN=C2,,,,,,
4811,134812,3-(Hydroxymethyl)-4-(1-hydroxy-6-methylheptyl)tetrahydrofuran-5-one,CC(C)CCCCC(C1C(COC1=O)CO)O,,,,,,
4812,134813,Ala-leu-ala-leu,C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)N,,,,,,
4813,134814,4-Ethoxybenzenesulfonic acid 2-(dimethylamino)ethyl ester,CCOC1=CC=C(C=C1)S(=O)(=O)OCCN(C)C,,,,,,
4814,134815,Altruronic acid,C(=O)[C@H]([C@@H]([C@@H]([C@@H](C(=O)O)O)O)O)O,,,,,,
4815,134816,"(4,5-3H)-Leucine",[3H]CC([3H])(C)C[C@@H](C(=O)O)N,,,,,,
4816,134817,"3,5-Dibromo-1-acetoxy-4-oxo-2,5-cyclohexadiene-1-acetonitrile",CC(=O)OC1(C=C(C(=O)C(=C1)Br)Br)CC#N,,,,,,
4817,134818,N-Acetylisopenicillin,CC(=O)NC(CCCC(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
4818,134819,"(2S,5R,6R)-6-[(5-acetamido-5-carboxypentanoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC(=O)NC(CCCC(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)O)C(=O)O,,,,,,
4819,134820,Triisoamylphosphine oxide,CC(C)CCP(=O)(CCC(C)C)CCC(C)C,,,,,,
4820,134821,CID 134821,CCCCCCSSC(=C(C)N(CC1=CN=C(NC1=O)C)C=O)CCO,,,,,,
4821,134822,2-Phenyl-1-propyl glucuronide,CC(CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O)C2=CC=CC=C2,,,,,,
4822,134823,CID 134823,C1=CC=C2C(=C1)C(=O)N(C2=O)[C@](CCC(=O)O)(C(=O)O)N,,,,,,
4823,134824,Nadolol diacetate,CC(=O)OC1CC2=C(CC1OC(=O)C)C(=CC=C2)OCC(CNC(C)(C)C)O,,,,,,
4824,134825,3-(2-Imino-3-phosphonoimidazolidin-1-yl)propanoic acid,C1CN(C(=N)N1CCC(=O)O)P(=O)(O)O,,,,,,
4825,134826,1-(4-Chlorobenzyl)piperazine,C1CN(CCN1)CC2=CC=C(C=C2)Cl,,,,,,
4826,134827,CID 134827,CC(=O)C1=CC=CC2=C1C(=O)C(=C(C2=O)C(=O)N)N,,,,,,
4827,134828,5-Hydroxybendazac,C1=CC=C(C=C1)CN2C3=C(C=C(C=C3)O)C(=N2)OCC(=O)O,,,,,,
4828,134829,CID 134829,C1CCC=CCC=C[CH][CH][C@@H]2[C@@H](OS(O2)C[C@@H](C(=O)CC1)N)C(C(CCCC(=O)O)O)C(=O)CC[C@@H](C(=O)O)N,,,,,,
4829,134830,3-Amino-6-methoxyacridine,COC1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N,,,,,,
4830,134831,3-Dimethylamino-6-methoxyacridine,CN(C)C1=CC2=NC3=C(C=CC(=C3)OC)C=C2C=C1,,,,,,
4831,134832,"4-[2-(4-Benzylpiperidin-1-ium-1-yl)-1-hydroxypropyl]phenol;2,3,4-trihydroxy-4-oxobutanoate",CC(C(C1=CC=C(C=C1)O)O)[NH+]2CCC(CC2)CC3=CC=CC=C3.C(C(C(=O)[O-])O)(C(=O)O)O,,,,,,
4832,134833,Pellit,CCN(CC)C(=O)C1=CC=CC(=C1)C.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.COC(=O)C1=CC=CC=C1C(=O)OC,,,,,,
4833,134834,"1-(2,3-Bis((4-methoxyphenyl)methoxy)propyl)-1H-imidazole",COC1=CC=C(C=C1)COCC(CN2C=CN=C2)OCC3=CC=C(C=C3)OC,,,,,,
4834,134835,"(2S)-1-[(2S)-2-[[5-(2,3-dihydro-1-benzofuran-2-yl)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid",CCOC(=O)C(CCCC1CC2=CC=CC=C2O1)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)O,,,,,,
4835,134836,"Aziridine, 1-(1-naphthalenylcarbonyl)-",C1CN1C(=O)C2=CC=CC3=CC=CC=C32,,,,,,
4836,134837,"2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-(2-methoxypropyl)-6,11-dimethyl-",CC1C2CC3=C(C1(CCN2CC(C)OC)C)C=C(C=C3)O,,,,,,
4837,134838,"1,1,3-Tribromopropane",C(CBr)C(Br)Br,,,,,,
4838,134839,1-(4-Carboxyphenoxy)-10-(4-chlorophenoxy)decane,C1=CC(=CC=C1C(=O)O)OCCCCCCCCCCOC2=CC=C(C=C2)Cl,,,,,,
4839,134840,"Phenol, 4-(2-(1,1-dimethylethyl)-5-(3-pyridinyl)-1H-imidazol-4-yl)-",CC(C)(C)C1=NC(=C(N1)C2=CC=C(C=C2)O)C3=CN=CC=C3,,,,,,
4840,134841,"3-Acetoxy-7,15-oxido-16-oxaandrostan-17-one",CC(=O)O[C@@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]5C3[C@H](C[C@@H]2C1)O[C@@H]5OC4=O)C)C,,,,,,
4841,134842,CID 134842,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl.[Cl-].[K+],,,,,,
4842,134843,"Octadeca-9,12-dienoic acid;octadec-9-enoic acid",CCCCCCCCC=CCCCCCCCC(=O)O.CCCCCC=CCC=CCCCCCCCC(=O)O,,,,,,
4843,134844,"(7aS)-7-amino-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol",CN1CCC23[C@H]4C(CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)N,,,,,,
4844,134845,Paeonon,CC12CC(=O)C3CC1(C3(C(O2)OC)CO)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
4845,134846,CID 134846,CC1(CNC2=C(N1)C(=O)N=C(N2)N)C,,,,,,
4846,134847,2-(4-Isobutylcyclohexyl)-2-oxoethyl benzenesulfonate,CC(C)CC1CCC(CC1)C(=O)COS(=O)(=O)C2=CC=CC=C2,,,,,,
4847,134848,Sulfadimethoxine and ormetoprim,CC1=CC(=C(C=C1CC2=CN=C(N=C2N)N)OC)OC.COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,,,,,,
4848,134849,21-Amino-17-hydroxyprogesterone hydrochloride,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(=O)CN)O)C.Cl,,,,,,
4849,134850,CID 134850,C[C@]12CCC(=O)C=C1CC[C@@H]3C2CC[C@]4(C3CC[C@@]4(C(=O)CN)O)C,,,,,,
4850,134851,CID 134851,CC1=CC2=C(C=C1C(=O)O)N=C3C(=NC(=O)NC3=O)N2,,,,,,
4851,134852,CID 134852,CC1=CC2=C(C=C1C(=O)O)NC3=NC(=O)NC(=O)C3=N2,,,,,,
4852,134853,"24,26-Cyclocholest-5-en-3-ol",CC1CC1CC[C@@H](C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CCC(C5)O)C)C,,,,,,
4853,134854,CID 134854,CCC(=CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,,,,,,
4854,134855,"11-Oxapregna-1,4-diene-3,20-dione, 17,21-dihydroxy-",C[C@]12CO[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,,,,,,
4855,134856,N-Methyldehydroalanine,CNC(=C)C(=O)O,,,,,,
4856,134857,2-Methylcysteinesulfinic acid,C[C@](CS(=O)O)(C(=O)O)N,,,,,,
4857,134858,CID 134858,CC(C)[C@@H](C(=O)NC(=O)[C@H](CC1=CC=CC=C1)N[C@H](CC2=CC=C(C=C2)O)P(=O)(O)O)NC,,,,,,
4858,134859,tert-Butyloxycarbonyl-2-aminoisobutyryl-prolyl-prolyl-methylamide,CC(C)(C)OC(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)NC(=O)[C@@H]2CCCN2C,,,,,,
4859,134860,N-Pivaloylprolylproline,CC(C)(C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)O,,,,,,
4860,134861,CID 134861,CCC1CN(CCN1C(=O)C=CC(=O)OCC)C(=O)C=CC(=O)OCC,,,,,,
4861,134862,Eucebral-N,CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O.CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCO,,,,,,
4862,134863,"Ethanone, 1-(2-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-7-benzofuranyl)-",CC(=O)C1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O,,,,,,
4863,134864,"Ethanamine, N-(2-(2,6-dimethoxyphenoxy)ethyl)-2-(2-methoxyphenoxy)-",COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OC,,,,,,
4864,134865,"4-Ethenylideneandrostane-3,17-dione",C[C@]12CCC(=O)C(=C=C)[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,,,,,,
4865,134866,"4-Ethenylideneandrostane-3,17-diol",C[C@]12CC[C@@H](C(=C=C)[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C)O,,,,,,
4866,134867,"3,7,12-Triformoxycholan-24-al",C[C@H](CCC=O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)OC=O)C)OC=O)OC=O)C,,,,,,
4867,134868,"Octadecanoic acid, 12-((azidocarbonyl)oxy)-, methyl ester",CCCCCCC(CCCCCCCCCCC(=O)OC)OC(=O)N=[N+]=[N-],,,,,,
4868,134869,CID 134869,CCCCCCC(CCCCCCCCCCC(=O)OC)OC(=O)N[N+]#N,,,,,,
4869,134870,8-Azido-S-adenosylmethionine,C[S+](CCC(C(=O)[O-])N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=NC=NC(=C3N=C2N=[N+]=[N-])N)O)O,,,,,,
4870,134871,"[(2S,3S,4R,5R)-5-(6-amino-8-azidopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(3-amino-3-carboxypropyl)-methylsulfanium",C[S+](CCC(C(=O)O)N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=NC=NC(=C3N=C2N=[N+]=[N-])N)O)O,,,,,,
4871,134872,S-(5'-Deoxy-5'-adenosyl)methylthioethylhydroxylamine,CSCCN(C[C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
4872,134873,1-(3-Methoxyphenyl)-2-(methylamino)ethanol,CNCC(C1=CC(=CC=C1)OC)O,,,,,,
4873,134874,16alpha-Methylprogesterone,CC1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@]4([C@H]3CC[C@@]2([C@H]1C(=O)C)C)C,,,,,,
4874,134875,12a-Hydroxydalpanol,CC(C)([C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@]4(C3=O)O)OC)OC)O,,,,,,
4875,134876,"Nonanoic acid, 9-[3-(3H-diazirin-3-yl)phenoxy]-",C1=CC(=CC(=C1)OCCCCCCCCC(=O)O)C2N=N2,,,,,,
4876,134877,"1H-1,4-Benzodiazepine-1-acetaldehyde, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-",C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC=O,,,,,,
4877,134878,"3,4-Dihydroxy-1,2-epoxy 1,2,3,4-tetrahydrodibenzo(a,e)fluoranthene",C1=CC=C2C(=C1)C=C3C4=CC=CC=C4C5=C3C2=CC6=C5C(C(C7C6O7)O)O,,,,,,
4878,134879,"5-Amino-5-hydroxy-2,4,6(1H,3H,5H)pyrimidinetrione",C1(=O)C(C(=O)NC(=O)N1)(N)O.Cl,,,,,,
4879,134880,"5-Amino-5-hydroxy-2,4,6-pyrimidinetrione",C1(=O)C(C(=O)NC(=O)N1)(N)O,,,,,,
4880,134881,CID 134881,C[C@]12CCC(CC1CCC3C2[C@@H](C[C@]4(C3CC[C@@]4([C@H](CO)O)O)C)O)[C@@]5([C@@H]([C@@H]([C@@H]([C@H](O5)C(=O)O)O)O)O)O,,,,,,
4881,134882,"4-(6,7-Dihydro-5h-cyclopenta[d]pyrimidin-4-ylamino)benzonitrile",C1CC2=C(C1)N=CN=C2NC3=CC=C(C=C3)C#N,,,,,,
4882,134883,"Substance P (5-11), arg(5)-trp(7,9)-",CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC4=CNC5=CC=CC=C54)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
4883,134884,"7H-furo[3,2-g][1]benzopyran-7-one, 4-[3-(diethylamino)propoxy]-",CCN(CC)CCCOC1=C2C=CC(=O)OC2=CC3=C1C=CO3,,,,,,
4884,134885,"9-[3-(Diethylamino)propoxy]furo[3,2-g]chromen-7-one",CCN(CC)CCCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,,,,,,
4885,134886,"2-Propanol, 1-(2-((4-chloro-3-methyl-5-isoxazolyl)methoxy)phenoxy)-3-((1-methylethyl)amino)-",CC1=NOC(=C1Cl)COC2=CC=CC=C2OCC(CNC(C)C)O,,,,,,
4886,134887,"N-(1-Phenylcyclohexyl)-1,2,3,4-tetrahydropyridine",C1CCC(CC1)(C2=CC=CC=C2)N3CCCC=C3,,,,,,
4887,134888,"2H-5,1-Benzothiazocine-1(6H)-carboxylic acid, 3,4-dihydro-2-oxo-6-phenyl-",C1CSC(C2=CC=CC=C2N(C1=O)C(=O)O)C3=CC=CC=C3,,,,,,
4888,134889,4-Oxo-6-hydroxyheptanoic acid,CC(CC(=O)CCC(=O)O)O,,,,,,
4889,134890,N(6)-(p-Azidobenzyl)adenosine,C1=CC(=CC=C1CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N=[N+]=[N-],,,,,,
4890,134891,CID 134891,CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCSC)N=C(C1=CC=C(C=C1)N[N+]#N)[O-],,,,,,
4891,134892,CID 134892,CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)C1=CC=C(C=C1)N[N+]#N,,,,,,
4892,134893,CID 134893,C1=CC=C(C(=C1)C(C(=O)O)NCCNC(C2=C(C=CC(=C2)C(=O)O)O)C(=O)O)O,,,,,,
4893,134894,3-Iodocholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)I)C)O)O)C,,,,,,
4894,134895,4-Hydroxy-4-carboxy-3-benzylthiazolidin-2-thione,C1C(N(C(=S)S1)CC2=CC=CC=C2)(C(=O)O)O,,,,,,
4895,134896,Tinoridine hydrochloride,CCOC(=O)C1=C(SC2=C1CCN(C2)CC3=CC=CC=C3)N.Cl,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
4896,134897,"L-Lysine, N2-(N-(N-(N-(4-methyl-2-((N-(N-(1-(N-L-prolyl-L-histidyl)-L-prolyl)-L-phenylalanyl)-L-histidyl)amino)pentyl)-L-valyl)-L-isoleucyl)-L-histidyl)-, (S)-",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)NC[C@H](CC(C)C)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCCN6,,,,,,
4897,134898,Pefloxacin N-oxide,CC[N+]1(C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O)[O-],,,,,,
4898,134899,"3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-3-oxo-1-piperazinyl)-4-oxo-",CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(C(=O)C3)C)F)C(=O)O,,,,,,
4899,134900,"Piperazine, 1-((2-methylphenyl)phenylmethyl)-, hydrochloride",CC1=CC=CC=C1C(C2=CC=CC=C2)N3CCNCC3.Cl,,,,,,
4900,134901,1-[(2-Methylphenyl)(phenyl)methyl]piperazine,CC1=CC=CC=C1C(C2=CC=CC=C2)N3CCNCC3,,,,,,
4901,134902,"3,4,6a,7,12,12a-Hexahydro-4,6a,7,12-tetrahydroxy-8-methoxy-3-methylbenz(a)anthracen-1(2H)-one",CC1CC(=O)C2=C(C1O)C=CC3(C2C(C4=C(C3O)C(=CC=C4)OC)O)O,,,,,,
4902,134903,"(6beta)-6-Bromopregn-4-ene-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H](C4=CC(=O)CC[C@]34C)Br)C,,,,,,
4903,134904,3-Phosphonyl-2-hydroxypropanoic acid,C(C(C(=O)O)O)P(=O)O,,,,,,
4904,134905,"4-Hydroxy-4-oxobut-2-enoate;1-methyl-4-(6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene)piperidin-1-ium",C[NH+]1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1.C(=CC(=O)[O-])C(=O)O,,,,,,
4905,134906,Phenylalanyltryptophan,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N,,,,,,
4906,134907,"1,1'-(Decamethylenedioxy)bis(3-chloro-2-propanol)",C(CCCCCOCC(CCl)O)CCCCOCC(CCl)O,,,,,,
4907,134908,CID 134908,C1CN1C2=CC=C(C=C2)NP(=S)N3CC3,,,,,,
4908,134909,N-Benzyl-5-methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCNCC3=CC=CC=C3,,,,,,
4909,134910,CID 134910,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)[O-].[Na+],,,,,,
4910,134911,"(1-Hydroxyethylidene)bisphosphonic acid, zinc salt",CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-].[Zn+2].[Zn+2],,,,,,
4911,134912,"1H-Benzimidazol-5-amine, 2-(4-thiazolyl)-",C1=CC2=C(C=C1N)NC(=N2)C3=CSC=N3,,,,,,
4912,134913,N-(Octylphenyl)-1-naphthalenamine,CCCCCCCCC1=CC=CC=C1NC2=CC=CC3=CC=CC=C32,,,,,,
4913,134914,"Phosphoric acid, 1-naphthalenyl diphenyl ester",C1=CC=C(C=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC4=CC=CC=C43,,,,,,
4914,134915,(1-14C)Pyruvate,CC(=O)[14C](=O)O,,,,,,
4915,134916,"N-(3-((Bis(2-hydroxyethyl)amino)methyl)-2,4,6-triiodophenyl)-N-(2,3-dihydroxyphenyl)acetamide monohydrochloride",CC(=O)N(C1=C(C(=CC=C1)O)O)C2=C(C=C(C(=C2I)CN(CCO)CCO)I)I.Cl,,,,,,
4916,134917,"N-[3-[[bis(2-hydroxyethyl)amino]methyl]-2,4,6-triiodophenyl]-N-(2,3-dihydroxyphenyl)acetamide",CC(=O)N(C1=C(C(=CC=C1)O)O)C2=C(C=C(C(=C2I)CN(CCO)CCO)I)I,,,,,,
4917,134918,"L-Threonine, N-(4-(((2,4-diamino-6-pteridinyl)methyl)amino)benzoyl)-",C[C@H]([C@@H](C(=O)O)NC(=O)C1=CC=C(C=C1)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N)O,,,,,,
4918,134919,Propanediol,CCC(O)O,,,,,,
4919,134920,Cytidine 5'-phospho-2-methylimidazolide,CC1=NC=CN1P(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=NC3=O)N)O)O,,,,,,
4920,134921,Perfluorobutyltetrahydrofuran,C1CC(OC1)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
4921,134922,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(2-methylimidazol-1-id-4-yl)phosphinic acid",CC1=NC(=C[N-]1)P(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O,,,,,,
4922,134923,CID 134923,CC1=NC=C(N1)P(=O)(O)OC[C@@H]2[C@H]([C@H]([C@H](O2)N3C=CC(=O)NC3=O)O)O,,,,,,
4923,134924,"4-Oxobut-1-ene-1,2,4-tricarboxylic acid",C(C(=CC(=O)O)C(=O)O)C(=O)C(=O)O,,,,,,
4924,134925,20alpha-Dihydroprognenolone-sulfate,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C)C)O,,,,,,
4925,134926,Dansyl alprenolol,CC(C)N(C[C@@H](COC1=CC=C(C=C1)OCC=C)O)S(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C,,,,,,
4926,134927,CID 134927,C1=CC=NC(=C1)C(=NNC(=NN=C(C2=CC=CC=N2)C3=CC=CC=N3)S)C4=CC=CC=N4,,,,,,
4927,134928,"Phosphonic acid, phenyl-, mono(4-methyl-2-oxo-2H-1-benzopyran-7-yl) ester",CC1=CC(=O)OC2=C1C=CC(=C2)OP(=O)(C3=CC=CC=C3)O,,,,,,
4928,134929,"(4S)-4-[[(2S,3S)-2-acetamido-3-methylpentanoyl]amino]-5-[[2-[[(2S)-5-(diaminomethylideneamino)-2-(4-nitroanilino)pentanoyl]amino]-2-oxoethyl]amino]-5-oxopentanoic acid",CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NC(=O)[C@H](CCCN=C(N)N)NC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)C,,,,,,
4929,134930,Sodium selenite pentahydrate,O.O.O.O.O.[O-][Se](=O)[O-].[Na+].[Na+],,,"['A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)']",,,
4930,134931,CID 134931,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)[O-])C(=O)[O-])C.[Na+].[Na+],,,,,,
4931,134932,Dimethylaminoethyl-propoxyphenylmandelate hydrochloride,CCCOOC(C1=CC=CC=C1)(C2=CC=CC=C2CCN(C)C)C(=O)[O-].Cl,,,,,,
4932,134933,2-[2-[2-(Dimethylamino)ethyl]phenyl]-2-phenyl-2-propylperoxyacetic acid,CCCOOC(C1=CC=CC=C1)(C2=CC=CC=C2CCN(C)C)C(=O)O,,,,,,
4933,134934,3-Acetoxy-4-chloro-butyronitrile,CC(=O)OC(CC#N)CCl,,,,,,
4934,134935,4-(cis-4-Menthan-8-yloxy)benzanilide,CC1CCC(CC1)C(C)(C)OC2=CC=C(C=C2)NC(=O)C3=CC=CC=C3,,,,,,
4935,134936,CID 134936,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C=O.CC(=O)O,,,,,,
4936,134937,CID 134937,CC(=O)C1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C=O,,,,,,
4937,134938,6-(3-Methyl-2-butenyl)-1-phenazinecarboxylic acid,CC(=CCC1=C2C(=CC=C1)N=C3C(=N2)C=CC=C3C(=O)O)C,,,,,,
4938,134939,"10-(4,5-Dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-4,8-dimethyldeca-4,8-dienoic acid",CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC(=O)O,,,,,,
4939,134940,Hexanediamine,CCCCCC(N)N,,,,,,
4940,134941,"2-(3,4,alpha-Trihydroxybenzyl)imidazoline",C1CN=C(N1)C(C2=CC(=C(C=C2)O)O)O,,,,,,
4941,134942,CID 134942,C1=CC=C2C(=C1)C=CC(=N2)C(=S)C(=O)N,,,,,,
4942,134943,"Benzenesulfonic acid, 4-chloro-N-1H-1,2,4-triazol-3-yl-",C1=CC(=CC=C1SNC2=NC=NN2)Cl,,,,,,
4943,134944,L-(-)-Cystine Dihydrochloride,C([C@@H](C(=O)O)N)SSCC(C(=O)O)N.Cl.Cl,,,,,,
4944,134945,CID 134945,C1=CC=C(C=C1)COC(=O)S(C[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,,
4945,134946,"2-Propanamine, N,N,2-trimethyl-1-((3-phenyl-2-quinolinyl)thio)-",CC(C)(CSC1=NC2=CC=CC=C2C=C1C3=CC=CC=C3)N(C)C,,,,,,
4946,134947,2-Methyl-2-propylpentanoic acid,CCCC(C)(CCC)C(=O)O,,,,,,
4947,134948,CID 134948,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC1(N(C(CO1)(C)C)[O])C,,,,,,
4948,134949,CID 134949,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCC1(N(C(CO1)(C)C)[O])C,,,,,,
4949,134950,CID 134950,C1CC(=O)N(C1=O)OC(=O)CCCCCN=C(C2=CC=C(C=C2)N[N+]#N)[O-],,,,,,
4950,134951,CID 134951,C1CC(=O)N(C1=O)OC(=O)CCCCCNC(=O)C2=CC=C(C=C2)N[N+]#N,,,,,,
4951,134952,"2,5-Pyrrolidinedione, 1-((6-((4-azidophenyl)dithio)-1-oxohexyl)oxy)-",C1CC(=O)N(C1=O)OC(=O)CCCCCSSC2=CC=C(C=C2)N=[N+]=[N-],,,,,,
4952,134953,"[(2R,3S,4R,5S)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy(phosphonooxy)phosphoryl]oxyphosphoryl]oxymethyl]oxolan-3-yl] 2-aminobenzoate",C1=CC=C(C(=C1)C(=O)O[C@@H]2[C@H](O[C@@H]([C@@H]2O)N3C=NC4=C(N=CN=C43)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)N,,,,,,
4953,134954,Sodium bismuth tartrate,C(C(C(=O)[O-])O)(C(=O)[O-])O.C(C(C(=O)[O-])O)(C(=O)[O-])O.[Na+].[Bi+3],,,,,,
4954,134955,"Aluminium tris(2,4-dichlorophenoxyacetate)",C1=CC(=C(C=C1Cl)Cl)OCC(=O)[O-].C1=CC(=C(C=C1Cl)Cl)OCC(=O)[O-].C1=CC(=C(C=C1Cl)Cl)OCC(=O)[O-].[Al+3],,,,,,
4955,134956,"2-(1,3-Dihydro-1-oxo-2h-isoindol-2-yl)-acetamide",C1C2=CC=CC=C2C(=O)N1CC(=O)N,,,,,,
4956,134957,CID 134957,C1=CC=C2C(=C1)C=CC(=N2)CC(=N)S.Cl,,,,,,
4957,134958,CID 134958,C1=CC=C2C(=C1)C=CC(=N2)CC(=N)S,,,,,,
4958,134959,CID 134959,CC1C(C2C(C(CC(=O)C2=C(O1)O)O)O)NC(=O)C(C)N.OS(=O)(=O)O,,,,,,
4959,134960,"6-(2,6-Dioxopiperidin-3-yl)pyrrolo[3,4-b]pyridine-5,7-dione",C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)N=CC=C3,,,,,,
4960,134961,Nicergoline tartrate,CN1C[C@@H](C[C@@]2([C@H]1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=C[NH+]=C5)Br.[C@@H](C(C(=O)O)O)(C(=O)[O-])O,,,,,,
4961,134962,CID 134962,CN1CC(C[C@@]2([C@H]1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=CN=C5)Br,,,,,,
4962,134963,"17-Hydroxy-19-norpregn-4-ene-3,20-dione 17-acetate",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)OC(=O)C,,,,,,
4963,134964,"17beta-Ureido-1,4-androstadien-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2NC(=O)N)CCC4=CC(=O)C=C[C@]34C,,,,,,
4964,134965,(S)-Mevalonic acid,C[C@](CCO)(CC(=O)O)O,,,,,,
4965,134966,beta-(1-Phenyl-5-bis-(beta-chloroethyl)amino-2-benzimidazolyl)-DL-alanine,C1=CC=C(C=C1)N2C3=C(C=C(C=C3)N(CCCl)CCCl)N=C2CC(C(=O)O)N,,,,,,
4966,134967,"4-(3-Methyl-1,2-dihydrobenzimidazol-2-yl)-1,3-thiazole",CN1C(NC2=CC=CC=C21)C3=CSC=N3,,,,,,
4967,134968,"Phosphorothioic acid, O,O-diethyl O-2-pyridinyl ester",CCOP(=S)(OCC)OC1=CC=CC=N1,,,,,,
4968,134969,CID 134969,COP(=S)([O-])OC1=CC(=C(C=C1Cl)Br)Cl.O.O.O.[Na+],,,,,,
4969,134970,2-Propylglutaric acid,CCCC(CCC(=O)O)C(=O)O,,,,,,
4970,134971,14C-Salicylic acid,C1=CC=[14C](C(=C1)O)C(=O)O,,,,,,
4971,134972,7-Ketopregnenolone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
4972,134973,"2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole dihydrochloride",CC1=CC2=C(C=C1)NC3C2CN(CC3)C.Cl.Cl,,,"['Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)', 'Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)', 'Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)']",,,
4973,134974,"2,3,5-Trihydroxybenzoic acid",C1=C(C=C(C(=C1C(=O)O)O)O)O,,,,,,
4974,134975,"Pyrimidine, 2,4-diamino-6-isopropyl-5-phenyl-",CC(C)C1=C(C(=NC(=N1)N)N)C2=CC=CC=C2,,,,,,
4975,134976,tert-Butyl hydrogen phthalate,CC(C)(C)OC(=O)C1=CC=CC=C1C(=O)O,,,,,,
4976,134977,Pterosin Z,CC1=CC2=C(C(=C1CCO)C)C(=O)C(C2)(C)C,,,,,,
4977,134978,Pterosin F,CC1CC2=C(C1=O)C(=C(C(=C2)C)CCCl)C,,,,,,
4978,134979,1-Isothiocyanatobut-1-ene,CCC=CN=C=S,,,,,,
4979,134980,CID 134980,COC1=CC2=C(C=C1)C3C=CC(CCC4CCC(C(C4)OC5CCC(CC2)C=C5)O)CC3O,,,,,,
4980,134981,"Imidazo(1,2-a)pyrazin-3-amine, 2-methyl-8-(phenylmethoxy)-, monohydrochloride",CC1=C(N2C=CN=C(C2=N1)OCC3=CC=CC=C3)N.Cl,,,,,,
4981,134982,"8-(Benzyloxy)-2-methylimidazo[1,2-A]pyrazin-3-amine",CC1=C(N2C=CN=C(C2=N1)OCC3=CC=CC=C3)N,,,,,,
4982,134983,"9-Oxaergoline, 6-propyl-, monohydrochloride",CCCN1CCOC2[C@H]1CC3=CNC4=CC=CC2=C34.Cl,,,,,,
4983,134984,"(7R)-6-propyl-3-oxa-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene",CCCN1CCOC2[C@H]1CC3=CNC4=CC=CC2=C34,,,,,,
4984,134985,"3-Pyridinecarboxylic acid, 1-(4,4-diphenyl-3-butenyl)-1,2,5,6-tetrahydro-",C1CN(CC(=C1)C(=O)O)CCC=C(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4985,134986,"(1S,2R,6S,8R,11R,12S,15S,16S)-15-hydroxy-16-methyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-3-en-5-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@]45[C@@H]3C=CC(=O)[C@H]4O5,,,,,,
4986,134987,1-(3-Fluoropyridin-2-yl)piperazine,C1CN(CCN1)C2=C(C=CC=N2)F,,,,,,
4987,134988,"2-[(2,2-Dimethylcyclopropanecarbonyl)amino]oct-2-enoic acid",CCCCCC=C(C(=O)O)NC(=O)C1CC1(C)C,,,,,,
4988,134989,"3-(5-Methyl-2,4-dioxopyrimidin-1-yl)prop-2-enal",CC1=CN(C(=O)NC1=O)C=CC=O,,,,,,
4989,134990,Antibiotic OA-6129D,CC([C@@H]1[C@H]2C[C@@H]([C@@H](N2C1=O)C(=O)O)SCCNC(=O)CCNC(=O)[C@H](C(C)(C)CO)O)O,,,,,,
4990,134991,Antibiotic OA-6129E,CC(C)(CO)C(C(=O)NCCC(=O)NCCS[C@H]1C[C@@H]2[C@@H](C(=O)N2[C@H]1C(=O)O)C(C)(C)O)O,,,,,,
4991,134992,"1-Propanone, 1-(2-(3-(butylamino)-2-hydroxypropoxy)phenyl)-3-phenyl-",CCCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,,,,,,
4992,134993,7beta-(5-Hydroxy-5-carboxyvarelamido)-3-hydroxymethyl-3-cephem-4-carboxylic acid,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CCCC(C(=O)O)O)C(=O)O)CO,,,,,,
4993,134994,2-[(4-Azido-2-nitrophenoxy)methyl]oxirane,C1C(O1)COC2=C(C=C(C=C2)N=[N+]=[N-])[N+](=O)[O-],,,,,,
4994,134995,2-(5-hydroxy-1H-indol-3-yl)ethyl acetate,CC(=O)OCCC1=CNC2=C1C=C(C=C2)O,,,,,,
4995,134996,2-(6-Carboxyhexyl)cyclopentanone hexylhydrazone,CCCCCCNNC(=O)CCCCCCC1CCCC1=O,,,,,,
4996,134997,CID 134997,CCC1(C(NC(=O)NC1=O)OC(C)C)CC,,,,,,
4997,134998,2-n-Undecyltetrahydrothiophene,CCCCCCCCCCCC1CCCS1,,,,,,
4998,134999,"2-Pyridinecarboxylic acid, 5-butyl-, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl ester",CCCCC1=CN=C(C=C1)C(=O)OC2=C(C3=C(C(=C2C)C)OC(CC3)(C)CCCC(C)CCCC(C)CCCC(C)C)C,,,,,,
4999,135000,"Benzo(f)quinolinium, 4-methyl-, iodide",C[N+]1=CC=CC2=C1C=CC3=CC=CC=C32.[I-],,,,,,
5000,135001,"Benzo[f]quinolinium, 4-methyl-",C[N+]1=CC=CC2=C1C=CC3=CC=CC=C32,,,,,,
5001,135002,"Icosa-2,4,6,8,10-pentaenoic acid",CCCCCCCCCC=CC=CC=CC=CC=CC(=O)O,,,,,,
5002,135003,"Methyl 18-hydroxyoctadeca-9,12-dienoate",COC(=O)CCCCCCCC=CCC=CCCCCCO,,,,,,
5003,135004,Mazaticol hydrochloride,CC1(CCC2CC(CC1N2C)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)C.Cl,,,,,,
5004,135005,2-(2-Pyridyl)benzoxazole,C1=CC=C2C(=C1)N=C(O2)C3=CC=CC=N3,,,,,,
5005,135006,"Pregnane-2,3-dione",CC[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CC(=O)C(=O)C4)C)C,,,,,,
5006,135007,4-Keto Retinal,CC1=C(C(CCC1=O)(C)C)C=CC(=CC=CC(=CC=O)C)C,,,,,,
5007,135008,"9-(3,3-Dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dienoic acid",CC(=CCCC(=CC(=O)O)C)CCC1C(O1)(C)C,,,,,,
5008,135009,[3-Chloro-4-(dimethylamino)-4-oxobut-2-en-2-yl] dimethyl phosphate,CC(=C(C(=O)N(C)C)Cl)OP(=O)(OC)OC,,,,,,
5009,135010,(S)-1-Amino-3-chloro-2-propanol hydrochloride,C([C@@H](CCl)O)N.Cl,,,,,,
5010,135011,"(1R,2S,4S,7R,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]",C[C@@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CCC5[C@@]4(CCCC5)C)C)OC16CCC(CN6)C,,,,,,
5011,135012,"2-(Pyridin-3-yl)-1,4,5,6-tetrahydropyrimidine",C1CNC(=NC1)C2=CN=CC=C2,,,,,,
5012,135013,"2,4-Pyrimidinediamine, 6-(2-methylpropyl)-5-phenyl-",CC(C)CC1=C(C(=NC(=N1)N)N)C2=CC=CC=C2,,,,,,
5013,135014,"11-Methyl-n,n-bis(11-methyldodecyl)dodecan-1-amine",CC(C)CCCCCCCCCCN(CCCCCCCCCCC(C)C)CCCCCCCCCCC(C)C,,,,,,
5014,135015,"2,4-Pyrimidinediamine, 5-phenyl-6-(phenylmethyl)-",C1=CC=C(C=C1)CC2=C(C(=NC(=N2)N)N)C3=CC=CC=C3,,,,,,
5015,135016,N-(3-(2-Morpholinoethyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl)-4-morpholinecarboxamide hydrochloride,CC1=C(C(=O)OC2=C1C=CC(=C2)NC(=O)N3CCOCC3)CCN4CCOCC4.Cl,,,,,,
5016,135017,Pterosin A,CC1=CC2=C(C(=C1CCO)C)C(=O)[C@](C2)(C)CO,,,,,,
5017,135018,Ethyketazocine,CC[C@@]12CCN([C@H]([C@H]1C)C(=O)C3=C2C=C(C=C3)O)CC4CC4,,,"['Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,,
5018,135019,"4,4'-Diiodo-2,2',5,5'-tetrachlorobiphenyl",C1=C(C(=CC(=C1Cl)I)Cl)C2=CC(=C(C=C2Cl)I)Cl,,,,,,
5019,135020,Vinyl phosphate,C=COP(=O)(O)O,,,,,,
5020,135021,"1,1'-Diazenediylbis(3-methyl-2-phenyl-1H-imidazo[1,2-a]pyridin-4-ium)",CC1=C(N(C2=CC=CC=[N+]12)N=NN3C4=CC=CC=[N+]4C(=C3C5=CC=CC=C5)C)C6=CC=CC=C6,,,,,,
5021,135022,"5,5-Dimethyl-2-phenylmorpholine hydrochloride",CC1(COC(CN1)C2=CC=CC=C2)C.Cl,,,,,,
5022,135023,"1-((3,4-Dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-yl)oxy)-3-((1-methylethyl)amino)-2-propanol",CC1=C(C(=C(C2=C1OC(CC2)(C)C)C)OCC(CNC(C)C)O)C,,,,,,
5023,135024,2alpha-Bromoprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)[C@@H](C[C@]34C)Br)C,,,,,,
5024,135025,1-Naphthyl N-propylcarbamate,CCCNC(=O)OC1=CC=CC2=CC=CC=C21,,,,,,
5025,135026,2-Benzyl-8-[methoxy(phenyl)methyl]cyclooctan-1-one,COC(C1CCCCCC(C1=O)CC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
5026,135027,"6-(Methylamino)-4,4-diphenyl-3-heptanol",CCC(C(CC(C)NC)(C1=CC=CC=C1)C2=CC=CC=C2)O,,,"['Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)', 'Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,,
5027,135028,"2,4(1H,3H)-Pyrimidinedione, 1,6-dimethyl-3-phenyl-",CC1=CC(=O)N(C(=O)N1C)C2=CC=CC=C2,,,,,,
5028,135029,Pterosin H,CC1=CC2=C(C(=C1CCCl)C)C(=O)C(C2)(C)C,,,,,,
5029,135030,Octachlorobutene,C(=C(Cl)Cl)(C(C(Cl)(Cl)Cl)(Cl)Cl)Cl,,,,,,
5030,135031,"N,N-Diethyl-N'-methylurea",CCN(CC)C(=O)NC,,,,,,
5031,135032,Pterosin B benzoate,CC1CC2=C(C1=O)C(=C(C(=C2)C)CCOC(=O)C3=CC=CC=C3)C,,,,,,
5032,135033,Picolinoyl chloride hydrochloride,C1=CC=NC(=C1)C(=O)Cl.Cl,,,,,,
5033,135034,Pyridine-2-carbonyl chloride,C1=CC=NC(=C1)C(=O)Cl,,,,,,
5034,135035,"N-(3,5-Dimethyl-4-isoxazolylmethyl)phthalimide",CC1=C(C(=NO1)C)CN2C(=O)C3=CC=CC=C3C2=O,,,,,,
5035,135036,Methadone hydrobromide,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2.Br,,,,,,
5036,135037,N-((2-Chloro-1-naphthalenyl)methylene)-2-methylbenzenamine,CC1=CC=CC=C1N=CC2=C(C=CC3=CC=CC=C32)Cl,,,,,,
5037,135038,"S-ethyl 11-methoxy-3,7,11-trimethyldodeca-2,4-dienethioate",CCSC(=O)C=C(C)C=CCC(C)CCCC(C)(C)OC,,,,,,
5038,135039,N-((2-Chloro-1-naphthalenyl)methylene)-2-methoxybenzenamine,COC1=CC=CC=C1N=CC2=C(C=CC3=CC=CC=C32)Cl,,,,,,
5039,135040,"Methyl 9,10-epoxy-12-octadecenoate",CCCCCC=CCC1C(O1)CCCCCCCC(=O)OC,,,,,,
5040,135041,"1H-Indole-3-acetic acid, 5-methoxy-2-methyl-, 4-((2-(4-(2-(4-morpholinyl)ethyl)-1-piperazinyl)ethoxy)carbonyl)phenyl ester",CC1=C(C2=C(N1)C=CC(=C2)OC)CC(=O)OC3=CC=C(C=C3)C(=O)OCCN4CCN(CC4)CCN5CCOCC5,,,,,,
5041,135042,"1H-Indole-3-acetic acid, 5-methoxy-, 4-((2-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)-1-piperazinyl)ethoxy)carbonyl)phenyl ester, dihydrochloride",COC1=CC2=C(C=C1)NC=C2CC(=O)OC3=CC=C(C=C3)C(=O)OCCN4CCN(CC4)CC(=O)N5CCCC5.Cl.Cl,,,,,,
5042,135043,4-[(2-[4-(Pyrrolidinocarbonylmethyl)-piperazino]-ethyl)oxycarbonyl]phenyl 5-methoxyindole-3-acetate,COC1=CC2=C(C=C1)NC=C2CC(=O)OC3=CC=C(C=C3)C(=O)OCCN4CCN(CC4)CC(=O)N5CCCC5,,,,,,
5043,135044,"1-Naphthaleneacetic acid, 4-((2-(4-(2-oxo-2-(1-piperidinyl)ethyl)-1-piperazinyl)ethoxy)carbonyl)phenyl ester, dihydrochloride",C1CCN(CC1)C(=O)CN2CCN(CC2)CCOC(=O)C3=CC=C(C=C3)OC(=O)CC4=CC=CC5=CC=CC=C54.Cl.Cl,,,,,,
5044,135045,2-[4-(2-Oxo-2-piperidin-1-ylethyl)piperazin-1-yl]ethyl 4-(2-naphthalen-1-ylacetyl)oxybenzoate,C1CCN(CC1)C(=O)CN2CCN(CC2)CCOC(=O)C3=CC=C(C=C3)OC(=O)CC4=CC=CC5=CC=CC=C54,,,,,,
5045,135046,"(2S,6R,7R,10S,12R,13R)-6,13-bis(hydroxymethyl)-2,6-dimethyltetracyclo[10.3.1.01,10.02,7]hexadecan-13-ol",C[C@]1(CCC[C@]2([C@H]1CC[C@@H]3C24CC[C@@]([C@H](C3)C4)(CO)O)C)CO,,,,,,
5046,135047,"(4R,6S)-6-[2-[2-(4-fluoro-3-methylphenyl)-4,6-dimethylphenyl]ethenyl]-4-hydroxyoxan-2-one",CC1=CC(=C(C(=C1)C2=CC(=C(C=C2)F)C)C=C[C@@H]3C[C@H](CC(=O)O3)O)C,,,,,,
5047,135048,Ferruginine methiodide,CC(=O)C1=CCC2CCC1[N+]2(C)C.[I-],,,,,,
5048,135049,"1-(8,8-Dimethyl-8-azoniabicyclo[3.2.1]oct-2-en-2-yl)ethanone",CC(=O)C1=CCC2CCC1[N+]2(C)C,,,,,,
5049,135050,"[13-Acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] undeca-2,4-dienoate",CCCCCCC=CC=CC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C,,,,,,
5050,135051,CID 135051,C[C@@H]([C@H]1CCC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(CCC(=O)N4C)C)C)C(=O)[O-].[Na+],,,,,,
5051,135052,"(2S)-2-[(1R,5aR,9aR,11aS)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-1-yl]propanoic acid",C[C@@H]([C@H]1CCC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(CCC(=O)N4C)C)C)C(=O)O,,,,,,
5052,135053,3-Benzyl-6-chloro-2-pyrone,C1=CC=C(C=C1)CC2=CC=C(OC2=O)Cl,,,,,,
5053,135054,CID 135054,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=C(C=C3)O)NC(=O)C4=CN=C5C(=CN=C(N5)N6CCN(CC6)C=O)C4=O)C(=O)O)C,,,,,,
5054,135055,4-Iodospiperone,C1CN(CCC12C(=O)NCN2C3=CC=C(C=C3)I)CCCC(=O)C4=CC=C(C=C4)F,,,,,,
5055,135056,"2,5-Dimethoxy-N,N-dimethyl-4-iodoamphetamine",CC(CC1=CC(=C(C=C1OC)I)OC)N(C)C,,,,,,
5056,135057,"2-[Carboxymethyl-[[2-hydroxy-3-methyl-5-[4,5,6,7-tetrabromo-1-(4-hydroxy-3-methylphenyl)-3-oxo-2-benzofuran-1-yl]phenyl]methyl]amino]acetic acid",CC1=CC(=CC(=C1O)CN(CC(=O)O)CC(=O)O)C2(C3=C(C(=C(C(=C3Br)Br)Br)Br)C(=O)O2)C4=CC(=C(C=C4)O)C,,,,,,
5057,135058,Tyrosyl-prolyl-glycyl-glycine,C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)NCC(=O)NCC(=O)O,,,,,,
5058,135059,"2-(9-Hexadecoxy-3,7-dimethylnona-1,3,5,7-tetraenyl)-1,3,3-trimethylcyclohexene",CCCCCCCCCCCCCCCCOCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,,,,,,
5059,135060,10-Hydroxy-10-(3-pentyloxiran-2-yl)dec-8-enoic acid,CCCCCC1C(O1)C(C=CCCCCCCC(=O)O)O,,,,,,
5060,135061,CID 135061,CCCCCCCCC=CCCCCCCCC(=O)O[C@H]1C[C@@H]2C[C@@H](CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@H]([C@]4(CC3)C)[C@H](C)CCC(=O)O)C)O,,,,,,
5061,135062,14-(2-Iodophenyl)-3-methyltetradecanoic acid,CC(CCCCCCCCCCCC1=CC=CC=C1I)CC(=O)O,,,,,,
5062,135063,CID 135063,C1C2=C3C(=NOS3ON1)CS2,,,,,,
5063,135064,CID 135064,C1C2=C3C(=NOS3ON1)CS2=O,,,,,,
5064,135065,"2-(4-(4-(7,9-Dioxo-6-thia-8-azaspiro(4,4)nonan-8-yl)butyl)-1-piperazinyl)pyridine-3-carbonitrile hcl",C1CCC2(C1)C(=O)N(C(=O)S2)CCCCN3CCN(CC3)C4=C(C=CC=N4)C#N.Cl,,,,,,
5065,135066,"2-[4-[4-(2,4-Dioxo-1-thia-3-azaspiro[4.4]nonan-3-yl)butyl]-1-piperazinyl]-3-pyridinecarbonitrile",C1CCC2(C1)C(=O)N(C(=O)S2)CCCCN3CCN(CC3)C4=C(C=CC=N4)C#N,,,,,,
5066,135067,"2-(2h-Tetrazol-5-yl)indeno[1,2-b]pyran-4(5h)-one",C1C2=CC=CC=C2C3=C1C(=O)C=C(O3)C4=NNN=N4,,,,,,
5067,135068,Leucyl-alanyl-dansylethylenediamine,C[C@@H](C(=O)NC(=O)[C@H](CC(C)C)N)NCCNS(=O)(=O)C1=CC=CC2=C1C=CC=C2N(C)C,,,,,,
5068,135069,"10,11,12-Trihydroxyicosa-5,8,14-trienoic acid",CCCCCC=CCC(C(C(C=CCC=CCCCC(=O)O)O)O)O,,,,,,
5069,135070,"2-(2,2-Diphenylcyclopropyl)-1H-imidazole",C1C(C1(C2=CC=CC=C2)C3=CC=CC=C3)C4=NC=CN4,,,,,,
5070,135071,10-(Phosphonooxy)decyl methacrylate,CC(=C)C(=O)OCCCCCCCCCCOP(=O)(O)O,,,,,,
5071,135072,5-Hydroxy-2-methyl-2-dipropylaminotetralin,CCCN(CCC)C1(CCC2=C(C1)C=CC=C2O)C,,,,,,
5072,135073,1-Stearoyl-2-myristoylglycerol,CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCC,,,,,,
5073,135074,"(2R,3R,4S,5S,6R)-2-heptylsulfanyl-6-(hydroxymethyl)oxane-3,4,5-triol",CCCCCCCS[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
5074,135075,1-Nitropyrene-2-ol,C1=CC2=C3C(=C1)C=CC4=C3C(=CC(=C4[N+](=O)[O-])O)C=C2,,,,,,
5075,135076,3-(Deacetoxy)vecuronium,CC(=O)O[C@H]1[C@H](CC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(C[C@@H](CC4)N5CCCCC5)C)C)[N+]6(CCCCC6)C.[Br-],,,,,,
5076,135077,"[(2R,5S,10S,13S,16S,17R)-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CC(=O)O[C@H]1[C@H](CC2[C@@]1(CCC3C2CC[C@@H]4[C@@]3(C[C@@H](CC4)N5CCCCC5)C)C)[N+]6(CCCCC6)C,,,,,,
5077,135078,"1-{[2-(3,4-Dimethoxyphenyl)ethyl]amino}-3-{4-[4-(thiophen-2-yl)-1H-imidazol-2-yl]phenoxy}propan-2-ol--hydrogen chloride (1/2)",COC1=C(C=C(C=C1)CCNCC(COC2=CC=C(C=C2)C3=NC=C(N3)C4=CC=CS4)O)OC.Cl.Cl,,,,,,
5078,135079,"1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-[4-(5-thiophen-2-yl-1H-imidazol-2-yl)phenoxy]propan-2-ol",COC1=C(C=C(C=C1)CCNCC(COC2=CC=C(C=C2)C3=NC=C(N3)C4=CC=CS4)O)OC,,,,,,
5079,135080,Dmapa,CC(C)([C@H](C(=O)O)N)S[As](C)C,,,,,,
5080,135081,Dimethylarsinomercaptoethanol,C[As](C)SCCO,,,,,,
5081,135082,"(3-(3,4-Dichlorophenyl)indan-1-yl)-4-methylpiperazine",CN1CCN(CC1)C2CC(C3=CC=CC=C23)C4=CC(=C(C=C4)Cl)Cl,,,,,,
5082,135083,"3,4-Dinitrophenyl-beta-galactopyranoside",C1=CC(=C(C=C1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5083,135084,Cyclo(ethyltyrosylhomoarginyl),CCOC1=CC=C(C=C1)C[C@H]2C(=O)N[C@H](C(=O)N2)CCCCN=C(N)N,,,,,,
5084,135085,CID 135085,CCCC[C@H](C)C[C@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CC(=O)CCCCC(=O)OC)O)O,,,,,,
5085,135086,Metipamide,CN(C1=CC=CC=C1)NC(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N,,,,,,
5086,135087,Ac-Somatotropin (7-13),C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)C,,,,,,
5087,135088,Anisodinic acid,C1=CC=C(C=C1)[C@](CO)(C(=O)O)O,,,,,,
5088,135089,Lidocaine ethiodide,CC[N+](CC)(CC)CC(=O)NC1=C(C=CC=C1C)C.[I-],,,,,,
5089,135090,"(2-(3,4-Dimethoxyphenyl)ethyl)dimethylselenonium iodide",COC1=C(C=C(C=C1)CC[Se+](C)C)OC.[I-],,,,,,
5090,135091,"2-(3,4-Dimethoxyphenyl)ethyl-dimethylselanium",COC1=C(C=C(C=C1)CC[Se+](C)C)OC,,,,,,
5091,135092,"(2-(3,4-Dihydroxyphenyl)ethyl)-dimethylselenonium chloride",C[Se+](C)CCC1=CC(=C(C=C1)O)O.[Cl-],,,,,,
5092,135093,"Selenonium, [2-(3,4-dihydroxyphenyl)ethyl]dimethyl-",C[Se+](C)CCC1=CC(=C(C=C1)O)O,,,,,,
5093,135094,Dmda-fluorescein,CC(=O)OC1=C(C2=C(C=C1)C3(C4=C(O2)C(=C(C=C4)OC(=O)C)CN(CC=C)CC=C)C5=CC=CC=C5C(=O)O3)CN(CC=C)CC=C,,,,,,
5094,135095,Pentaerythritol trimethacrylate phosphate,CC(=C)C(=O)OCC(COC(=O)C(=C)C)(COC(=O)C(=C)C)COP(=O)(O)O,,,,,,
5095,135096,"7-(4-Chlorophenyl)-8-phenoxy-4,5-benzo-3-aza-2-nonem",CSC1=NC2=CC=CC=C2N3C(=O)C(C3(C1)C4=CC=C(C=C4)Cl)OC5=CC=CC=C5,,,,,,
5096,135097,"1,3-DP-Chlorambucil",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,,,,,,
5097,135098,CID 135098,C1=CC=C(C=C1)OC[C@@H]([C@H]2C(=O)C(=C(O2)O)O)O,,,,,,
5098,135099,CID 135099,C([C@@H]1[C@H]([C@H]([C@H](O1)N2C3=C(C(=O)N=C(N3)N)NC2=O)OP(=O)(O)O)O)O,,,,,,
5099,135100,"Msh, beta, (6-8)",CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
5100,135101,CID 135101,CC1(C2CC1C(C(C2)NCC(CC3=CC=CC=C3)O)CC=CCCCC(=O)O)C,,,,,,
5101,135102,"1,2,6,7,8,8a-Hexahydro-6-hydroxy-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2-methylbutanoate",CCC(C)C(=O)OC1CC=CC2=CC(C(C(C12)CCC3CC(CC(=O)O3)O)C)O,,,,,,
5102,135103,Alanyl-glycyl-serine,C[C@@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)O)N,,,,,,
5103,135104,"2,4-Piperidinedicarboxylic acid",C1CNC(CC1C(=O)O)C(=O)O,,,,,,
5104,135105,3-[4-Hydroxy-3-(4-hydroxy-3-methylbut-2-enyl)-5-(3-methylbut-2-enyl)phenyl]prop-2-enoic acid,CC(=CCC1=C(C(=CC(=C1)C=CC(=O)O)CC=C(C)CO)O)C,,,,,,
5105,135106,"3-Methylbutyl 2,3-dihydro-8-[2-hydroxy-3-[4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-1-piperazinyl]propoxy]-1,4-benzodioxin-5-carboxylate",CC(C)CCOC(=O)C1=C2C(=C(C=C1)OCC(CN3CCN(CC3)C(=O)C=CC4=CC(=C(C(=C4)OC)OC)OC)O)OCCO2,,,,,,
5106,135107,S-Aminoethylmercaptolactic acid,C(CSCC(C(=O)O)O)N,,,,,,
5107,135108,"2-(3-Chloro-4-((4-chlorophenyl)hydroxymethyl)phenyl)-1,2,4-triazine-3,5(2H,4H)-dione",C1=CC(=CC=C1C(C2=C(C=C(C=C2)N3C(=O)NC(=O)C=N3)Cl)O)Cl,,,,,,
5108,135109,"Benzoic acid, 4-(2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl)-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3=CC=C(C=C3)C(=O)O,,,,,,
5109,135110,"N,N-Dimethylkynuramine",CN(C)CCC(=O)C1=CC=CC=C1N,,,,,,
5110,135111,Lanthanum hydroxide,[OH-].[OH-].[OH-].[La+3],,,,,,
5111,135112,Diphloretin phosphate,C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O)O)O)OP(=O)(O)OC3=CC=C(C=C3)CCC(=O)C4=C(C=C(C=C4O)O)O,,,,,,
5112,135113,"2-Methyl-5-tert-butyl-1,3-benzodioxole",CC1OC2=C(O1)C=C(C=C2)C(C)(C)C,,,,,,
5113,135114,Pyr-Phe-Leu-Pna,CC(C)C[C@@H](C(=O)NC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H]3CCC(=O)N3,,,,,,
5114,135115,"N-{[5-Chloro-8-hydroxy-3-(hydroxymethyl)-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl](hydroxy)methylidene}phenylalanine",C1[C@@H](OC(=O)C2=C(C(=CC(=C21)Cl)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)O)CO,,,,,,
5115,135116,CID 135116,COC1=C(C=C(C=C1)CCNCC(=CC(=O)O)C(=O)OCC2=CC=CC=C2O)OC,,,,,,
5116,135117,"N,N'-Bis(S-benzoylmercaptoacetyl)-2,3-diaminopropionic acid ethyl ester",CCOC(=O)[C@H](CNC(=O)CSC(=O)C1=CC=CC=C1)NC(=O)CSC(=O)C2=CC=CC=C2,,,,,,
5117,135118,"O-Acetyl-N-amino-N,N-dimethylaminoethanol",CC(=O)OCC[N+](C)(C)N,,,,,,
5118,135119,"L-Ornithine, N5-(imino(nitroamino)methyl)-, monohydrochloride",C(C[C@@H](C(=O)O)N)CN=C(N)N[N+](=O)[O-].Cl,,,,,,
5119,135120,CID 135120,CCCCCC(C#C[C@H]1CCC[C@@H]1OCCCCCC(=O)O)O,,,,,,
5120,135121,N-Methyl-N-nitrosoadenosine,CN(C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=O,,,,,,
5121,135122,Methoxy 11-(3-pentyloxiran-2-yl)undec-9-eneperoxoate,CCCCCC1C(O1)CC=CCCCCCCCC(=O)OOOC,,,,,,
5122,135123,CID 135123,CCCCCCCCCCCCCCCC(=O)OC1[C@H]([C@@H]([C@@H](CO1)O)O)O.C1=C(NC(=O)N=C1)N,,,,,,
5123,135124,CID 135124,CCCCCCCCCCCCCCCC(=O)OC1[C@H]([C@@H]([C@@H](CO1)O)O)O,,,,,,
5124,135125,CID 135125,COC(=O)CCCCCCCC=CCC=CCCCCC=O,,,,,,
5125,135126,Estriol 17-sulfate,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2OS(=O)(=O)O)O)CCC4=C3C=CC(=C4)O,,,,,,
5126,135127,Methyl 5-amino-2-hydroxybenzoate,COC(=O)C1=C(C=CC(=C1)N)O,,,,,,
5127,135128,2-(Hydroxymethyl)-6-methylpyridin-3-ol,CC1=NC(=C(C=C1)O)CO,,,,,,
5128,135129,"10,10-Dimethylicosa-5,8,11,14-tetraenoic acid",CCCCCC=CCC=CC(C)(C)C=CCC=CCCCC(=O)O,,,,,,
5129,135130,"2-ethoxy-2-sulfanylidene-4H-1,3,2lambda5-benzodioxaphosphinine",CCOP1(=S)OCC2=CC=CC=C2O1,,,,,,
5130,135131,"4-(2-Tetradeca-2,5,8-trienylphenyl)butanoic acid",CCCCCC=CCC=CCC=CCC1=CC=CC=C1CCCC(=O)O,,,,,,
5131,135132,CID 135132,C[C@H](C=C[C@H](C)C(C)C)[C@@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=O)O)C,,,,,,
5132,135133,CID 135133,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)C(C)C)C3=CC=C(C=C3)OC.Cl,,,,,,
5133,135134,CID 135134,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)C(C)C)C3=CC=C(C=C3)OC,,,,,,
5134,135135,CID 135135,CCCCC[C@@H](C=CC=CC=CC=C[C@H]([C@H](CCCC(=O)O)O)SCC(C(=O)O)N)O,,,,,,
5135,135136,2-Aminoimidazole sulfate,C1=CN=C(N1)N.OS(=O)(=O)O,,,,,,
5136,135137,12-(5-Iodopent-4-enyltellanyl)dodecanoic acid,C(CCCCCC(=O)O)CCCCC[Te]CCCC=CI,,,,,,
5137,135138,6-(11-Iodoundec-10-enyltellanyl)hexanoic acid,C(CCCCC=CI)CCCC[Te]CCCCCC(=O)O,,,,,,
5138,135139,CID 135139,CCCCC[C@@H](C=CC=CC=CC=C[C@H](C(CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)N)O,,,,,,
5139,135140,CID 135140,C[C@@H](C(C=CC=CC(=O)O[C@@H]1C[C@@H]2[C@]3([C@]1([C@@]4(CCC(=C[C@H]4O2)CO)C)C)CO3)O)O,,,,,,
5140,135141,CID 135141,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCOCCC1=CC=C(C=C1)N2C(=N2)C(F)(F)F,,,,,,
5141,135142,CID 135142,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCOCCC1=CC=C(C=C1)N2C(=N2)C(F)(F)F,,,,,,
5142,135143,N-methyl-N-[(2S)-1-phenylpropan-2-yl]nitrous amide,C[C@@H](CC1=CC=CC=C1)N(C)N=O,,,,,,
5143,135144,CID 135144,C[C@H](C(C=CC=CC(=O)O[C@@H]1C[C@@H]2[C@]3([C@]1([C@@]4(CCC(=C[C@H]4O2)CO)C)C)CO3)O)O,,,,,,
5144,135145,"N,N'-Bis(benzyloxycarbonyl)cystine-bis(2,4-dibromo-6-(N-cyclohexyl-N-methyl)aminomethyl)anilide dihydrochloride",CN(CC1=C(C(=CC(=C1)Br)Br)NC(=O)[C@H](CSSC[C@@H](C(=O)NC2=C(C=C(C=C2Br)Br)CN(C)C3CCCCC3)NC(=O)OCC4=CC=CC=C4)NC(=O)OCC5=CC=CC=C5)C6CCCCC6.Cl.Cl,,,,,,
5145,135146,"(4-(2-Chlorobenzylthio)-1-methyl-1H-imidazo(4,5-c)pyridine)",CN1C=NC2=C1C=CN=C2SCC3=CC=CC=C3Cl,,,,,,
5146,135147,"3H-Imidazo(4,5-c)pyridine, 4-((benzo(b)thien-3-ylmethyl)thio)-3-methyl-",CN1C=NC2=C1C(=NC=C2)SCC3=CSC4=CC=CC=C43,,,,,,
5147,135148,Dofenapyn,C#CCCCOC1=CC=C(C=C1)OC2=CC=CC=C2,,,,,,
5148,135149,CID 135149,CC(=O)[C@H]1CC[C@H]2[C@]1(CCCC2=CC=C3C[C@H](CCC3=C)O)C,,,,,,
5149,135150,CID 135150,C(CC(CCl)O)COC(COCC(CCl)(O)OCCCC(CCl)O)(CCl)O,,,,,,
5150,135151,"5,5-Difluoropentane-1,4-diamine",C(CC(C(F)F)N)CN,,,['Substances and drugs that inhibit or block the activity of ORNITHINE DECARBOXYLASE. (See all compounds classified as Ornithine Decarboxylase Inhibitors.)'],,,
5151,135152,"9-Allyloxy-6-chloro-3-methyl-2,3,4,5-tetrahydro-1H-benzazepine",CN1CCC2=C(C=CC(=C2CC1)Cl)OCC=C,,,,,,
5152,135153,"Phosphorothioic acid, O,O-dimethyl O-(2-isopropyl-6-methyl-4-pyrimidinyl) ester",CC1=CC(=NC(=N1)C(C)C)OP(=S)(OC)OC,,,,,,
5153,135154,Bpe disaccharide,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@H]([C@H]([C@@H]([C@H](C=O)N)O)O)O)N)O)O)O,,,,,,
5154,135155,"alpha-Naphthoflavone-7,8-dihydrodiol",C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=C(C=C3)[C@H]([C@@H](C=C4)O)O,,,,,,
5155,135156,"3-Cyclobutene-1,2-dione, 3-amino-4-((3-(3-(1-piperidinylmethyl)phenoxy)propyl)amino)-",C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC3=C(C(=O)C3=O)N,,,,,,
5156,135157,"1,3,3',5'-Tetrabromophlorhizin",C1=C(C=C(C(=C1Br)O)Br)CCC(=O)C2=C(C(=C(C(=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Br)O)Br)O,,,,,,
5157,135158,"1,3,3'-Tribromophlorizin",C1=CC(=C(C=C1CCC(=O)C2=C(C(=C(C(=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Br)O)Br)O)Br)O,,,,,,
5158,135159,"3,3',5'-Tribromophlorhizin",C1=C(C=C(C(=C1Br)O)Br)CCC(=O)C2=C(C=C(C(=C2O)Br)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
5159,135160,[(2R)-2-(heptadec-10-enylcarbamoyloxy)-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)NCCCCCCCCCC=CCCCCCC,,,,,,
5160,135161,2-[[(2R)-2-(heptadec-10-enylcarbamoyloxy)-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)NCCCCCCCCCC=CCCCCCC,,,,,,
5161,135162,2-(4-(5-Bromo-3-methylpyrid-2-yl)butylamino)-5-(6-hydroxymethylpyrid-3-ylmethyl)pyrimidin-4(1H)-one,CC1=CC(=CN=C1CCCCNC2=NC=C(C(=O)N2)CC3=CN=C(C=C3)CO)Br,,,,,,
5162,135163,Blue flavin,CC1=CC2=C(C=C1C)N(C3=NC(=S=O)NC(=O)C3=N2)C,,,,,,
5163,135164,(4S)-4-amino-5-[(2S)-2-[[(2S)-3-methyl-2-(4-nitroanilino)butanoyl]carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid,CC(C)[C@@H](C(=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)N)NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5164,135165,Tertiary-butyloxycarbonyl-alanine imidazolide,CC(C(=O)N1C=CN=C1)NC(=O)O,,,,,,
5165,135166,"4-(4,10-Dihydro-10-oxothieno(3,2-c)(1)-benzoxepin-8-yl)butanol",C1C2=C(C(=O)C3=C(O1)C=CC(=C3)CCCCO)SC=C2,,,,,,
5166,135167,"5,6,7,8-Tetrahydrotrazodone",C1CCN2C(=NN(C2=O)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl)C1,,,,,,
5167,135168,Denitronipradilol,CC(C)NCC(COC1=CC=CC2=C1OCC(C2)O)O,,,,,,
5168,135169,18-Hydroxysclareol,C[C@@]1(CCC[C@]2([C@H]1CC[C@]([C@@H]2CCC(C)(C=C)O)(C)O)C)CO,,,,,,
5169,135170,CID 135170,C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](COCC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N,,,,,,
5170,135171,3-Carboxypropyl-(2-propenyl)nitrosamine,C=CCN(CCCC(=O)O)N=O,,,,,,
5171,135172,"1-Ethylimidazole-4,5-dicarboxylic acid",CCN1C=NC(=C1C(=O)O)C(=O)O,,,,,,
5172,135173,"2,6-Diamino-5-hydroxy-3-(phenylazo)pyridine",C1=CC=C(C=C1)N=NC2=CC(=C(N=C2N)N)O,,,,,,
5173,135174,11alpha-Diazoacetate progesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)OC(=O)C=[N+]=[N-])C,,,,,,
5174,135175,CID 135175,CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)OC(=C[N+]#N)O)C,,,,,,
5175,135176,6-Methylprednisolone 17-meoac,CC1C[C@H]2[C@@H]3CC[C@@]([C@]3(CC([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)OC(=O)COC,,,,,,
5176,135177,"1H-1,4-Benzodiazepine, 7-bromo-5-(2-chlorophenyl)-2,3-dihydro-2-(methoxymethyl)-",COCC1CN=C(C2=C(N1)C=CC(=C2)Br)C3=CC=CC=C3Cl,,,,,,
5177,135178,"1H-Imidazo(4,5-c)pyridine, 2-(2-methoxy-4-(methylthio)phenyl)-, monohydrochloride",COC1=C(C=CC(=C1)SC)C2=NC3=C(N2)C=NC=C3.Cl,,,,,,
5178,135179,"2-[2-methoxy-4-(methylthio)phenyl]-3H-imidazo[4,5-c]pyridine",COC1=C(C=CC(=C1)SC)C2=NC3=C(N2)C=NC=C3,,,,,,
5179,135180,"2-(4-(4-Azidobenzoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=C(C=C4)N=[N+]=[N-])N)OC,,,,,,
5180,135181,CID 135181,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=C(C=C4)N[N+]#N)N)OC,,,,,,
5181,135182,Spiro-arogenate,C1[C@H](NC(=O)C12C=CC(C=C2)O)C(=O)O,,,,,,
5182,135183,Purine-6-sulfenic acid,C1=NC2=C(N1)C(=NC=N2)SO,,,,,,
5183,135184,methyl (1S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate,CN1[C@H]2CCC1CC(C2C(=O)OC)OC(=O)C3=CC=CC=C3,,,,,,
5184,135185,trans-1-(4-Phenylcyclohexyl)ethylamine,CC(C1CCC(CC1)C2=CC=CC=C2)N,,,,,,
5185,135186,"1-(tert-Butylthio)-1,2-hydrazinedicarboxylic acid",CC(C)(C)SN(C(=O)O)NC(=O)O,,,,,,
5186,135187,"Benzenesulfonamide, N-(aminocarbonyl)-4-(methylamino)-",CNC1=CC=C(C=C1)S(=O)(=O)NC(=O)N,,,,,,
5187,135188,CID 135188,COCC(=O)[O-].[Na+],,,,,,
5188,135189,Methyl pantothenate,CC(C)(CO)[C@H](C(=O)NCCC(=O)OC)O,,,,,,
5189,135190,"N,N-Dimethyl-6-propyl-5H-indeno(5,6-d)-1,3-dioxol-5-amine",CCCC1=CC2=CC3=C(C=C2C1N(C)C)OCO3,,,,,,
5190,135191,D-Xylose,C1[C@H]([C@@H]([C@H](C(O1)O)O)O)O,,,,,,
5191,135192,"2-Oxazolidinone, (ethenylthio)-",C=CSN1CCOC1=O,,,,,,
5192,135193,Methyl N5-(imino(nitroamino)methyl)-L-ornithine monohydrochloride,COC(=O)[C@H](CCCN=C(N)N[N+](=O)[O-])N.Cl,,,,,,
5193,135194,16alpha-Bromoacetoxyprogesterone,CC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)OC(=O)CBr,,,,,,
5194,135195,"2-Pyridineethanamine, N,N-dipropyl-, dihydrochloride",CCCN(CCC)CCC1=CC=CC=N1.Cl.Cl,,,,,,
5195,135196,2-(2-Dipropylaminoethyl)-pyridine,CCCN(CCC)CCC1=CC=CC=N1,,,,,,
5196,135197,Ethyl 2-oxo-1-(2-phenylethyl)cyclooctanecarboxylate,CCOC(=O)C1(CCCCCCC1=O)CCC2=CC=CC=C2,,,,,,
5197,135198,"2,8-Bis(phenyl((phenylmethyl)thio)methyl)cyclooctanone",C1CCC(C(=O)C(CC1)C(C2=CC=CC=C2)SCC3=CC=CC=C3)C(C4=CC=CC=C4)SCC5=CC=CC=C5,,,,,,
5198,135199,[Amino(dodecan-2-ylsulfanyl)methylidene]azanium,CCCCCCCCCCC(C)SC(=[NH2+])N,,,,,,
5199,135200,Dodecan-2-yl carbamimidothioate,CCCCCCCCCCC(C)SC(=N)N,,,,,,
5200,135201,Phenylalanyl-prolyl-arginyl-3-carboxy-4-hydroxyaniline,C1C[C@H](N(C1)C(=O)[C@@H](CC2=CC=CC=C2)N)C(=O)NC(=O)[C@H](CCCN=C(N)N)NC3=CC(=C(C=C3)O)C(=O)O.Cl.Cl,,,,,,
5201,135202,CID 135202,C1C[C@H](N(C1)C(=O)[C@@H](CC2=CC=CC=C2)N)C(=O)NC(=O)C(CCCN=C(N)N)NC3=CC(=C(C=C3)O)C(=O)O,,,,,,
5202,135203,"3,4-Dihydro-2H-1,4-thiazine-3,5-dicarboxylic acid",C1C(NC(=CS1)C(=O)O)C(=O)O,,,,,,
5203,135204,"14-Hydroxydocosa-2,4,6,8,10,12-hexaenoic acid",CCCCCCCCC(C=CC=CC=CC=CC=CC=CC(=O)O)O,,,,,,
5204,135205,CID 135205,CCCCCCCCCC=CC(=O)C=CC=CC=CC=CC=C(O)O,,,,,,
5205,135206,"Cholest-5-en-3-ol, 6-fluoro-, (3beta)-",C[C@H](CCCC(C)C)[C@@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=C4[C@@]3(CCC(C4)O)C)F)C,,,,,,
5206,135207,"2'-O-(1,3-Benzodithiol-2-yl)-3',5'-O-(1,1,3,3-tetraisopropyldisiloxan-1,3-diyl)uridine",CC(C)[Si]1(OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)OC4SC5=CC=CC=C5S4)O[Si](O1)(C(C)C)C(C)C)C(C)C,,,,,,
5207,135208,O-tert-Butyl lysyl-tryptophyl-glycyl-lysinate,CC(C)(C)OC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCCN)N,,,,,,
5208,135209,"5H-(1)Benzopyrano(3,4-c)pyridin-5-one, 3-(2-(ethylamino)propyl)-1,2,3,4-tetrahydro-",CCNC(C)CN1CCC2=C(C1)C(=O)OC3=CC=CC=C23,,,,,,
5209,135210,"1,1,3,3-Tetraaziridino-2,4,6-triaza-5,5-dipyrrolidinyl-1,3,5-triphosphorin",C1CCN(C1)P2(=NP(=NP(=N2)(N3CC3)N4CC4)(N5CC5)N6CC6)N7CCCC7,,,,,,
5210,135211,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 6-((5-phenyl-1H-pyrazol-3-yl)oxy)hexyl ester",CC1=C(C(C(=C(N1)C)C(=O)OCCCCCCOC2=NNC(=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,,,,,,
5211,135212,Tnp-glutathione,C1=C(C=C(C(=C1[N+](=O)[O-])N(CC(=O)O)C(=O)[C@H](CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)NC(=O)CC[C@@H](C(=O)O)N)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5212,135213,CID 135213,C1=C(C(=O)NC(=O)N1[C@@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C=CBr,,,,,,
5213,135214,"(2-Sulfamoyl-6-benzothiazolyl)-2,2-dimethylpropionate",CC(C)(C)C(=O)OC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N,,,,,,
5214,135215,Baimuxinal,CC1CCC=C(C12CCC(C2)C(C)(C)O)C=O,,,,,,
5215,135216,N-[2-(2-iodophenoxy)ethyl]cyclopropanamine hydrochloride,C1CC1NCCOC2=CC=CC=C2I.Cl,,,,,,
5216,135217,N-[2-(2-iodophenoxy)ethyl]cyclopropanamine,C1CC1NCCOC2=CC=CC=C2I,,,,,,
5217,135218,Isohematinic acid,C=C1C(C(=O)NC1=O)CCC(=O)O,,,,,,
5218,135219,Thielavin C,CC1=C(C(=C(C(=C1C(=O)OC2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3C)C)C(=O)O)OC)C)OC)C)O)C)O)C,,,,,,
5219,135220,Sakyomicin C,C[C@@H]1[C@@H](CC[C@H](O1)O[C@]23C(=O)C[C@](C[C@]2(C=CC4=C3C(=O)C5=C(C4=O)C(=CC=C5)O)O)(C)O)O,,,,,,
5220,135221,"9,10,11-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,3-diol",COC1=C(C(=C2CN3CCC4=CC(=C(C=C4C3CC2=C1)O)O)OC)OC,,,,,,
5221,135222,Sakyomicin D,C[C@@]1(C[C@@]2(CCC3=C([C@@]2(C(=O)[C@H]1O)O)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O,,,,,,
5222,135223,"21-Hydroxy-9beta,10alpha-pregna-5,7-diene-3-ol-20-one",C[C@]12CC[C@@H]3C(=CC=C4[C@]3(CC[C@@H](C4)O)C)[C@@H]1CC[C@@H]2C(=O)CO,,,,,,
5223,135224,2-((Diethylmethylammonio)methyl)-1-methylpyridinium diiodide,CC[N+](C)(CC)CC1=CC=CC=[N+]1C.[I-].[I-],,,,,,
5224,135225,Diethyl-methyl-[(1-methylpyridin-1-ium-2-yl)methyl]azanium,CC[N+](C)(CC)CC1=CC=CC=[N+]1C,,,,,,
5225,135226,"2,8-Bis(phenyl(phenylthio)methyl)cyclooctanone",C1CCC(C(=O)C(CC1)C(C2=CC=CC=C2)SC3=CC=CC=C3)C(C4=CC=CC=C4)SC5=CC=CC=C5,,,,,,
5226,135227,"2,8-Bis(diphenylmethyl)cyclooctanone",C1CCC(C(=O)C(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)C(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
5227,135228,"2,8-Bis(2-methylbenzyl)cyclooctanone",CC1=CC=CC=C1CC2CCCCCC(C2=O)CC3=CC=CC=C3C,,,,,,
5228,135229,Diepoxydibenzylcyclooctanone,C1CCC2(C(O2)C3=CC=CC=C3)C(=O)C4(CC1)C(O4)C5=CC=CC=C5,,,,,,
5229,135230,"2,8-Bis(2-methoxybenzyl)cyclooctanone",COC1=CC=CC=C1CC2CCCCCC(C2=O)CC3=CC=CC=C3OC,,,,,,
5230,135231,"3,7-Bis(phenylthio)cyclooctanone",C1CC(CC(=O)CC(C1)SC2=CC=CC=C2)SC3=CC=CC=C3,,,,,,
5231,135232,CID 135232,C1=C(C=C(C=C1Cl)Cl)[O-].[Na+],,,,,,
5232,135233,"Pregna-1,4-diene-3,20-dione, 17-(acetyloxy)-11,21-dihydroxy-, (11beta)-",CC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)CO,,,,,,
5233,135234,CID 135234,C1CCC(=CC2=CC=CC=C2Cl)C(=O)C(=CC3=CC=CC=C3Cl)CC1,,,,,,
5234,135235,"Icosa-2,4,6,8-tetraynoic acid",CCCCCCCCCCCC#CC#CC#CC#CC(=O)O,,,,,,
5235,135236,p-Methoxyamphetamine hydrochloride,CC(CC1=CC=C(C=C1)OC)N.Cl,,,"['Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)']",,,
5236,135237,"2-[(5-Chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl)amino]-3-(4-hydroxyphenyl)propanoic acid",CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)Cl,,,,,,
5237,135238,Ochratoxin tc,CCOC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)C2=CC(=C3CC(OC(=O)C3=C2O)C)Cl,,,,,,
5238,135239,CID 135239,CC1CCCCN1CC2=C(C=C3CCCC3=C2)O.C(=CC(=O)O)C(=O)O,,,,,,
5239,135240,(+)-6-((2-Methylpiperidino)methyl)-5-indanol,CC1CCCCN1CC2=C(C=C3CCCC3=C2)O,,,,,,
5240,135241,"9alpha-Fluoro-11beta,17-dihydroxy-17-methyl-5beta-androstan-3-one",C[C@]12CCC(=O)C[C@H]1CC[C@@H]3C2([C@H](C[C@]4([C@H]3CC[C@@]4(C)O)C)O)F,,,,,,
5241,135242,Tilarginine Acetate,CC(=O)O.CN=C(N)NCCC[C@@H](C(=O)O)N,,,,,,
5242,135243,5-Hydroxy-2-propylpentanoate,CCCC(CCCO)C(=O)[O-],,,,,,
5243,135244,5-Hydroxyvalproic acid,CCCC(CCCO)C(=O)O,,,,,['5-Hydroxyvalproate is a known human metabolite of valproic acid.'],
5244,135245,3-Hydroxybutyl dibutyltin chloride,CCCC[Sn](CCCC)(CCC(C)O)Cl,,,,,,
5245,135246,"6,7,8,9-Tetrahydro-6-(phenylmethyl)-5H-benzocyclohepten-5-one",C1CC(C(=O)C2=CC=CC=C2C1)CC3=CC=CC=C3,,,,,,
5246,135247,"2,6-Dibenzyl-1-methylcyclohexan-1-ol",CC1(C(CCCC1CC2=CC=CC=C2)CC3=CC=CC=C3)O,,,,,,
5247,135248,"2,8-Bis(4-methoxybenzyl)cyclooctanone",COC1=CC=C(C=C1)CC2CCCCCC(C2=O)CC3=CC=C(C=C3)OC,,,,,,
5248,135249,"1-Methyl-2,8-dibenzylcyclooctanol",CC1(C(CCCCCC1CC2=CC=CC=C2)CC3=CC=CC=C3)O,,,,,,
5249,135250,4-Hydroxyphenytoin glucuronide,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=C(C=C3)OC4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,['4-Hydroxyphenytoin glucuronide is a known human metabolite of 4-Hydroxyphenytoin.'],
5250,135251,"Bicyclo(3.1.0)hexan-3-ol, 4-methylene-1-(1-methylethyl)-, acetate, (1alpha,3beta,5alpha)-",CC(C)[C@@]12C[C@@H]1C(=C)[C@@H](C2)OC(=O)C,,,,,,
5251,135252,"2,8-Bis(1-naphthalenylmethyl)cyclooctanone",C1CCC(C(=O)C(CC1)CC2=CC=CC3=CC=CC=C32)CC4=CC=CC5=CC=CC=C54,,,,,,
5252,135253,"cis-1,5-Bis(p-chlorobenzyloxy)cyclooctane",C1CC(CCCC(C1)OCC2=CC=C(C=C2)Cl)OCC3=CC=C(C=C3)Cl,,,,,,
5253,135254,CID 135254,CC1=C(CCCCCC1CC2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
5254,135255,Pterosin O,C[C@@H]1CC2=C(C1=O)C(=C(C(=C2)C)CCOC)C,,,,,,
5255,135256,"Pregn-4-ene-3,20-dione, 2-((bromoacetyl)oxy)-, (2alpha)-",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)[C@@H](C[C@]34C)OC(=O)CBr)C,,,,,,
5256,135257,CID 135257,CC(=CC=CC(=CC(=O)O)C)C=CC1=CC=CO1,,,,,,
5257,135258,CID 135258,CC(=CC=CC(=CC(=O)O)C)C=CC1=CN=CC=C1,,,,,,
5258,135259,"Noracymethadol hydrochloride, (-)-",CC[C@@H](C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C.Cl,,,,,,
5259,135260,"Noracymethadol, (-)-",CC[C@@H](C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,,,"['Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)', 'Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,,
5260,135261,CID 135261,CCOCC(=O)[O-].[Na+],,,,,,
5261,135262,"Thieno[3,2-c]phenanthridine",C1=CC=C2C3=C(C4=C(C=C3)C=CS4)N=CC2=C1,,,,,,
5262,135263,CID 135263,C1=NC=NC(=N1)C(=O)[O-].[K+],,,,,,
5263,135264,"1,3,5-triazine-2-carboxylic Acid",C1=NC=NC(=N1)C(=O)O,,,,,,
5264,135265,Anatoxin A hydrochloride,CC(=O)C1=CCCC2CC[C@@H]1N2.Cl,,,,,,
5265,135266,1-[(1S)-9-azabicyclo[4.2.1]non-2-en-2-yl]ethanone,CC(=O)C1=CCCC2CC[C@@H]1N2,,,,,,
5266,135267,5-Methoxy-alpha-methyltryptamine hydrochloride,CC(CC1=CNC2=C1C=C(C=C2)OC)N.Cl,,,,,,
5267,135268,"1-O-[(2R)-octan-2-yl] 2-O-[(2S)-octan-2-yl] benzene-1,2-dicarboxylate",CCCCCC[C@@H](C)OC(=O)C1=CC=CC=C1C(=O)O[C@@H](C)CCCCCC,,,,,,
5268,135269,"Salicylic acid, valerate",CCCCC(=O)OC1=CC=CC=C1C(=O)O,,,,,,
5269,135270,"2,10-Undecanediol, 1,11-dichloro-6,6-dimethyl-",CC(C)(CCCC(CCl)O)CCCC(CCl)O,,,,,,
5270,135271,Methyl 2-Phthalimido-glutaramate,COC(=O)C(CCC(=O)N)N1C(=O)C2=CC=CC=C2C1=O,,,,,,
5271,135272,"1,1'-(Pentamethylenedioxy)bis(3-bromo-2-propanol)",C(CCOCC(CBr)O)CCOCC(CBr)O,,,,,,
5272,135273,N-(Hydroxymethyl)-DL-methionine,CSCCC(C(=O)O)NCO,,,,,,
5273,135274,"1,1'-(Pentamethylenedioxy)bis(3-iodo-2-propanol)",C(CCOCC(CI)O)CCOCC(CI)O,,,,,,
5274,135275,N-Acetyl-N-hydroxyaminoacetic acid,CC(=O)N(CC(=O)O)O,,,,,,
5275,135276,"1,1'-(Pentamethylenedioxy)bis(3-fluoro-2-propanol)",C(CCOCC(CF)O)CCOCC(CF)O,,,,,,
5276,135277,Bis(N-Methyl pantoyl-beta-aminoethyl)disulfide,CC(C)(CO)[C@H](C(=O)N(C)CCSSCCN(C)C(=O)[C@@H](C(C)(C)CO)O)O,,,,,,
5277,135278,CID 135278,CCCCC[C@@H](C(=O)N[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O)O,,,,,,
5278,135279,"5-Methyl-tryptophan hydrochloride, DL-",CC1=CC2=C(C=C1)NC=C2CC(C(=O)O)N.Cl,,,,,,
5279,135280,CID 135280,CCCCC[C@@H](C(=O)N[C@H]1[C@@H](CC(=O)[C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
5280,135281,N-alpha-phthaloylglutamine anhydride,C1=CC=C2C(=C1)C(=O)N(C2=O)C(CCC(=O)N)C(=O)OC(=O)C(CCC(=O)N)N3C(=O)C4=CC=CC=C4C3=O,,,,,,
5281,135282,H-D-Arg(NO2)-OH,C(C[C@H](C(=O)O)N)CN=C(N)N[N+](=O)[O-],,,,,,
5282,135283,"s-Triazole, 3-(o-tolyl)-5-(m-tolyl)-",CC1=CC(=CC=C1)C2=NNC(=N2)C3=CC=CC=C3C,,,,,,
5283,135284,"3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)-4,5-ditritionona-2,4,6,8-tetraenoic acid",[3H]C(=C([3H])C(=CC(=O)O)C)C=C(C)C=CC1=C(CCCC1(C)C)C,,,,,,
5284,135285,CID 135285,CC1=CC(=C(C(=C1SCC(=CC=CC(=CC(=O)O)C)C)C)C)OC,,,,,,
5285,135286,"L-Cysteine, disodium salt",C([C@@H](C(=O)[O-])N)S.C([C@@H](C(=O)[O-])N)S.[Na+].[Na+],,,,,,
5286,135287,"Phenol-14C, pentachloro-",C1(=C(C(=[14C](C(=C1Cl)Cl)O)Cl)Cl)Cl,,,,,,
5287,135288,"Glycine, N-(5-ethoxy-1,6-dihydro-1-methyl-6-oxo-4-pyridazinyl)-",CCOC1=C(C=NN(C1=O)C)NCC(=O)O,,,,,,
5288,135289,"2-(2-((5-Ethoxy-1-methyl-6-oxo-1,6-dihydropyridazin-4-yl)amino)ethoxy)acetic acid",CCOC1=C(C=NN(C1=O)C)NCCOCC(=O)O,,,,,,
5289,135290,3-Hydroxycarbamazepine,C1=CC=C2C(=C1)C=CC3=C(N2C(=O)N)C=C(C=C3)O,,,,,['3-Hydroxycarbamazepine is a known human metabolite of carbamazepine.'],
5290,135291,9-(Hydroxymethyl)acridine-10(1h)-carboxamide,C1C=CC=C2C1=C(C3=CC=CC=C3N2C(=O)N)CO,,,,,,
5291,135292,"s-Triazole, 5-(p-fluorophenyl)-3-(o-tolyl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC=C(C=C3)F,,,,,,
5292,135293,5-(p-Chlorophenyl)-3-(o-tolyl)-s-triazole,CC1=CC=CC=C1C2=NC(=NN2)C3=CC=C(C=C3)Cl,,,,,,
5293,135294,"1H-1,2,4-Triazole, 3-(1,1'-biphenyl)-4-yl-5-(2-methylphenyl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
5294,135295,5-(m-(Allyloxy)phenyl)-3-(o-tolyl)-s-triazole,CC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)OCC=C,,,,,,
5295,135296,5-(m-Ethoxyphenyl)-3-(o-tolyl)-s-triazole,CCOC1=CC=CC(=C1)C2=NNC(=N2)C3=CC=CC=C3C,,,,,,
5296,135297,"s-Triazole, 3-(o-cumenyl)-5-phenyl-",CC(C)C1=CC=CC=C1C2=NC(=NN2)C3=CC=CC=C3,,,,,,
5297,135298,"alpha-(1,2,3,6-Tetrahydrophthalimido)glutarimide",C1CC(=O)NC(=O)C1N2C(=O)C3CC=CCC3C2=O,,,,,,
5298,135299,"3-methyl-7-(1,1,3,3-tetramethyl-2H-inden-5-yl)octa-2,4,6-trienoic acid",CC(=CC(=O)O)C=CC=C(C)C1=CC2=C(C=C1)C(CC2(C)C)(C)C,,,,,,
5299,135300,Iodide ion I-123,[123I-],['Administration of Sodium Iodide I 123 Capsules is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.'],,,,,['Iodine-123 decays by electron capture with a physical half-life of 13.2 hours']
5300,135301,"3-(2-Ethylphenyl)-5-phenyl-1H-1,2,4-triazole",CCC1=CC=CC=C1C2=NC(=NN2)C3=CC=CC=C3,,,,,,
5301,135302,3-(o-Cumenyl)-5-(m-methoxyphenyl)-s-triazole,CC(C)C1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)OC,,,,,,
5302,135303,"2-Phenylimidazo[2,1-a]isoquinoline",C1=CC=C(C=C1)C2=CN3C=CC4=CC=CC=C4C3=N2,,,,,,
5303,135304,4-[2-Ethyl-3-(4-hydroxyphenyl)pent-2-enyl]phenol,CCC(=C(CC)C1=CC=C(C=C1)O)CC2=CC=C(C=C2)O,,,,,,
5304,135305,"2-Ethyl-1,3-bis(4-methoxyphenyl)propane-1,3-dione",CCC(C(=O)C1=CC=C(C=C1)OC)C(=O)C2=CC=C(C=C2)OC,,,,,,
5305,135306,"4-(p-Hydroxyphenyl)-4-(p-tolyl)perhydroimidazole-2,5-dione",CC1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=C(C=C3)O,,,,,,
5306,135307,"[2-[(8S,9S,10R,13S,14S,17R)-17-acetyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] pentanoate",CCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)OC(=O)C,,,,,,
5307,135308,"[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)OC2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C)C,,,,,,
5308,135309,(S)-2-Ethylhexanoic acid,CCCC[C@H](CC)C(=O)O,,,,,,
5309,135310,2-Propyl-3-pentenoicacid,CCCC(C=CC)C(=O)O,,,,,,
5310,135311,CID 135311,CC1=C(C(=CC=C1)ONC2=CC=C(C=C2)C(=O)[O-])C.[Na+],,,,,,
5311,135312,"4-[(2,3-Dimethylphenoxy)amino]benzoic acid",CC1=C(C(=CC=C1)ONC2=CC=C(C=C2)C(=O)O)C,,,,,,
5312,135313,(S)-(-)-2-Guanidinoglutaric Acid,C(CC(=O)O)[C@@H](C(=O)O)N=C(N)N,,,,,,
5313,135314,"4-[[3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoic acid",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)C(=O)O)C)C,,,,,,
5314,135315,L-Leucine-1-13C,CC(C)C[C@@H]([13C](=O)O)N,,,,,,
5315,135316,"o,o-Diethyl o-pyridin-4-yl phosphorothioate",CCOP(=S)(OCC)OC1=CC=NC=C1,,,,,,
5316,135317,"9-(2-Ethyl-6,6-dimethylcyclohexen-1-yl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid",CCC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,,,,,,
5317,135318,CID 135318,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC2=NNN=N2)C)C,,,,,,
5318,135319,Ammonium 2-(butoxycarbonyl)benzoate,CCCCOC(=O)C1=CC=CC=C1C(=O)[O-].[NH4+],,,,,,
5319,135320,N-Acetylacebutolol,CCCC(=O)NC1=CC(=C(C=C1)OCC(CN(C(C)C)C(=O)C)O)C(=O)C,,,,,,
5320,135321,"s-Triazolo(5,1-a)isoquinoline, 5,6-dihydro-2-(4-biphenylyl)-",C1CN2C(=NC(=N2)C3=CC=C(C=C3)C4=CC=CC=C4)C5=CC=CC=C51,,,,,,
5321,135322,"2-(m-Ethoxyphenyl)-s-triazolo(5,1-a)isoquinoline",CCOC1=CC=CC(=C1)C2=NN3C=CC4=CC=CC=C4C3=N2,,,,,,
5322,135323,"5H-s-Triazolo(5,1-a)isoindole, 2-(4-biphenylyl)-",C1C2=CC=CC=C2C3=NC(=NN31)C4=CC=C(C=C4)C5=CC=CC=C5,,,,,,
5323,135324,Acetic acid;2-[2-(diaminomethylidenehydrazinylidene)ethylideneamino]guanidine,CC(=O)O.CC(=O)O.C(=NN=C(N)N)C=NN=C(N)N,,,,,,
5324,135325,"4-Amino-3,3'-dimethyl-4'-hydroxy-biphenyl",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)O)C)N,,,,,,
5325,135326,Iobenguane I 123,C1=CC(=CC(=C1)[123I])CN=C(N)N,,,,,,
5326,135327,Centbucridine hydrochloride,CCCCNC1CCCC2=NC3=CC=CC=C3C=C12.Cl,,,,,,
5327,135328,"1-Acridinamine, N-butyl-1,2,3,4-tetrahydro-",CCCCNC1CCCC2=NC3=CC=CC=C3C=C12,,,,,,
5328,135329,"Hydrazinecarboximidamide, 2-(4-(hydroxyimino)-2,5-cyclohexadien-1-ylidene)-",C1=CC(=CC=C1NN=C(N)N)N=O,,,,,,
5329,135330,2-(Phenacylideneamino)guanidine,C1=CC=C(C=C1)C(=O)C=NN=C(N)N,,,,,,
5330,135331,"1H-1,2,4-Triazole-1-ethanol, alpha,alpha-bis(4-chlorophenyl)-",C1=CC(=CC=C1C(CN2C=NC=N2)(C3=CC=C(C=C3)Cl)O)Cl,,,,,,
5331,135332,CID 135332,CN(CCCl)CC1=CC(=C(C(=C1)Cl)[N]C2=NCCN2)Cl,,,,,,
5332,135333,"Ethyl 4-[2-methyl-4-(2,6,6-trimethylcyclohexen-1-yl)buta-1,3-dienyl]benzoate",CCOC(=O)C1=CC=C(C=C1)C=C(C)C=CC2=C(CCCC2(C)C)C,,,,,,
5333,135334,"2,4-Imidazolidinedione, 5-(2-hydroxyphenyl)-",C1=CC=C(C(=C1)C2C(=O)NC(=O)N2)O,,,,,,
5334,135335,"4,4-Bis(difluoramino)pentanol",CC(CCCO)(N(F)F)N(F)F,,,,,,
5335,135336,CID 135336,C[C@]12CCC3C(C1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C.O.O.[Na+],,,,,,
5336,135337,"[(2R,5S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxidanesulfonic acid",C[C@]12CCC3C(C1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C,,,,,,
5337,135338,N-Desmethyldoxylamine,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCNC,,,,,,
5338,135339,N-(2-Oxo-3-piperidyl)phthalimide,C1CC(C(=O)NC1)N2C(=O)C3=CC=CC=C3C2=O,,,,,,
5339,135340,1-Octadecanoyl-2-acetyl-sn-glycero-3-phosphocholine,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C,,,,,,
5340,135341,O-(1-O-Octadecanoyl-2-O-acetyl-L-glycero-3-phospho)choline,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C,,,,,,
5341,135342,5-Phosphono-D-norvaline,C(C[C@H](C(=O)O)N)CP(=O)(O)O,,,"['Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)']",,,
5342,135343,"4-[2-(1,1,3,3-tetramethyl-2H-inden-5-yl)prop-1-enyl]benzoic acid",CC(=CC1=CC=C(C=C1)C(=O)O)C2=CC3=C(C=C2)C(CC3(C)C)(C)C,,,,,,
5343,135344,CID 135344,C1[C@@H]([C@@H]([C@H]([C@@H]1O)C=CC(CCC2=CC=CC=C2)O)CCOCCCC(=O)N)O,,,,,,
5344,135345,"Carbamic acid, (5-(cyanophenylmethyl)-1H-benzimidazol-2-yl)-, methyl ester",COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(C#N)C3=CC=CC=C3,,,,,,
5345,135346,"Carbamic acid, (5-(methylthio)-1H-benzimidazol-2-yl)-, methyl ester",COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC,,,,,,
5346,135347,"1H-1,2,4-Triazole-1-ethanol, alpha-(3-chlorophenyl)-alpha-(2,4-dichlorophenyl)-",C1=CC(=CC(=C1)Cl)C(CN2C=NC=N2)(C3=C(C=C(C=C3)Cl)Cl)O,,,,,,
5347,135348,Ketanserin tartrate,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O.C(C(C(=O)O)O)(C(=O)O)O,,,,,,
5348,135349,(+/-)-trans-U-50488 methanesulfonate salt,CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl.CS(=O)(=O)O,,,"['A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)']",,,
5349,135350,CID 135350,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)[O-])O.[Na+],,,,,,
5350,135351,"1H-1,2,4-Triazole, 3-(2,3-dimethoxyphenyl)-5-(2-ethylphenyl)-",CCC1=CC=CC=C1C2=NC(=NN2)C3=C(C(=CC=C3)OC)OC,,,,,,
5351,135352,3-(o-Ethylphenyl)-5-(m-fluorophenyl)-s-triazole,CCC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)F,,,,,,
5352,135353,"1H-1,2,4-Triazole, 3-(3,5-dimethoxyphenyl)-5-(2-ethylphenyl)-",CCC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC(=C3)OC)OC,,,,,,
5353,135354,5-(m-Methoxyphenyl)-3-(m-tolyl)-s-triazole,CC1=CC(=CC=C1)C2=NNC(=N2)C3=CC(=CC=C3)OC,,,,,,
5354,135355,3-(o-Butylphenyl)-5-phenyl-s-triazole,CCCCC1=CC=CC=C1C2=NC(=NN2)C3=CC=CC=C3,,,,,,
5355,135356,"5-(1,3-Benzodioxol-5-yl)-3-(2-ethylphenyl)-1H-1,2,4-triazole",CCC1=CC=CC=C1C2=NC(=NN2)C3=CC4=C(C=C3)OCO4,,,,,,
5356,135357,5-(m-Methoxyphenyl)-3-(p-tolyl)-s-triazole,CC1=CC=C(C=C1)C2=NC(=NN2)C3=CC(=CC=C3)OC,,,,,,
5357,135358,"5-Phenyl-3-(2,4-xylyl)-s-triazole",CC1=CC(=C(C=C1)C2=NC(=NN2)C3=CC=CC=C3)C,,,,,,
5358,135359,3-(5-Methoxy-o-tolyl)-5-(m-methoxyphenyl)-s-triazole,CC1=C(C=C(C=C1)OC)C2=NC(=NN2)C3=CC(=CC=C3)OC,,,,,,
5359,135360,"5-(m-Methoxyphenyl)-3-(2,4-xylyl)-s-triazole",CC1=CC(=C(C=C1)C2=NC(=NN2)C3=CC(=CC=C3)OC)C,,,,,,
5360,135361,"s-Triazole, 3,5-bis(o-tolyl)-",CC1=CC=CC=C1C2=NC(=NN2)C3=CC=CC=C3C,,,,,,
5361,135362,"s-Triazole, 3-(o-butylphenyl)-5-(m-methoxyphenyl)-",CCCCC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)OC,,,,,,
5362,135363,"s-Triazole, 5-(m-(allyloxy)phenyl)-3-(o-ethylphenyl)-, monohydrochloride",CCC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)OCC=C.Cl,,,,,,
5363,135364,M57Dak9xfq,CCC1=CC=CC=C1C2=NC(=NN2)C3=CC(=CC=C3)OCC=C,,,,,,
5364,135365,"1H-1,2,4-Triazole, 3-(2,5-dimethylphenyl)-5-phenyl-",CC1=CC(=C(C=C1)C)C2=NC(=NN2)C3=CC=CC=C3,,,,,,
5365,135366,Rhythmy,CN(C)C(=O)C1=NN(C(=N1)CNC(=O)CN)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl.O.O.Cl,,,['Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)'],,,
5366,135367,CID 135367,CCCOCC(=O)[O-].[Na+],,,,,,
5367,135368,"6-[2-(2,6,6-Trimethylcyclohexen-1-yl)ethenyl]naphthalene-2-carboxylic acid",CC1=C(C(CCC1)(C)C)C=CC2=CC3=C(C=C2)C=C(C=C3)C(=O)O,,,,,,
5368,135369,CID 135369,CC(=CC1=CC=C(C=C1)S(=O)[O-])C2=CC3=C(C=C2)C(CCC3(C)C)(C)C.[Na+],,,,,,
5369,135370,"4-[2-(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzenesulfinic acid",CC(=CC1=CC=C(C=C1)S(=O)O)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,,,,,,
5370,135371,"2-Phenyl-5,6-dihydroimidazo(2,1-a)isoquinoline",C1CN2C=C(N=C2C3=CC=CC=C31)C4=CC=CC=C4,,,,,,
5371,135372,CID 135372,CC(=CC1=CC=C(C=C1)S(=O)(=O)[O-])C2=CC3=C(C=C2)C(CCC3(C)C)(C)C.[Na+],,,,,,
5372,135373,"4-[2-(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzenesulfonic acid",CC(=CC1=CC=C(C=C1)S(=O)(=O)O)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,,,,,,
5373,135374,CID 135374,C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)[O-].[Na+],,,,,,
5374,135375,"2,3,4,5,6,7-Hexabromonaphthalene",C1=C2C=C(C(=C(C2=C(C(=C1Br)Br)Br)Br)Br)Br,,,,,,
5375,135376,CID 135376,CC(=CC1=CC=C(C=C1)C(=O)O)C2=CC3=C(C=C2OC)C(CCC3(C)C)(C)C,,,,,,
5376,135377,"4-[2-(4,4,7,7-Tetramethyl-5,6-dihydro-1-benzothiophen-2-yl)prop-1-enyl]benzoic acid",CC(=CC1=CC=C(C=C1)C(=O)O)C2=CC3=C(S2)C(CCC3(C)C)(C)C,,,,,,
5377,135378,2-Ethoxypentanoic acid,CCCC(C(=O)O)OCC,,,,,,
5378,135379,Histidine-14C,C1=C(NC=N1)C[C@@H]([14C](=O)O)N,,,,,,
5379,135380,"N,alpha-Dimethyl-1,3-benzodioxole-5-propanamine hydrochloride",CC(CCC1=CC2=C(C=C1)OCO2)NC.Cl,,,,,,
5380,135381,"3,4-Methylenedioxy-3-methylaminobutane",CC(CCC1=CC2=C(C=C1)OCO2)NC,,,,,,
5381,135382,CID 135382,CC1=C(C=CC(=C1)C=C(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C)C(=O)O,,,,,,
5382,135383,Yutac,CCN1CC2CN(CC(C1)C2OC(=O)C3=CC=C(C=C3)Cl)C.Cl,,,,,,
5383,135384,"1H-1,2,4-Triazole-1-ethanol, alpha,alpha-bis(2,4-difluorophenyl)-",C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,,,,,,
5384,135385,"1H-1,2,4-Triazole-1-ethanol, alpha-(2-bromophenyl)-alpha-(4-fluorophenyl)-",C1=CC=C(C(=C1)C(CN2C=NC=N2)(C3=CC=C(C=C3)F)O)Br,,,,,,
5385,135386,"1H-1,2,4-Triazole-1-ethanol, alpha-(2-bromophenyl)-alpha-(4-chlorophenyl)-",C1=CC=C(C(=C1)C(CN2C=NC=N2)(C3=CC=C(C=C3)Cl)O)Br,,,,,,
5386,135387,"2-Naphthalenecarboxylic acid, 6-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)-",CC1(CCSC2=C1C=C(C=C2)C3=CC4=C(C=C3)C=C(C=C4)C(=O)O)C,,,,,,
5387,135388,"5,7,9-Trimethyl-7H-dibenzo(c,g)carbazole",CC1=CC2=C(C3=CC=CC=C13)C4=C(N2C)C=C(C5=CC=CC=C54)C,,,,,,
5388,135389,"9-(6-Chloro-4-methoxy2,5-dimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-oic acid ethyl ester",CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)Cl,,,,,,
5389,135390,4-[2-(4-Propan-2-ylphenyl)prop-1-enyl]benzoic acid,CC(C)C1=CC=C(C=C1)C(=CC2=CC=C(C=C2)C(=O)O)C,,,,,,
5390,135391,"(2,2'-Binaphthalene)-6-carboxylic acid, 5',6',7',8'-tetrahydro-8',8'-dimethyl-",CC1(CCCC2=C1C=C(C=C2)C3=CC4=C(C=C3)C=C(C=C4)C(=O)O)C,,,,,,
5391,135392,1-Bromo-4-hydroxy-5-(2-prop-2-enylphenoxy)pentan-2-one,C=CCC1=CC=CC=C1OCC(CC(=O)CBr)O,,,,,,
5392,135393,"Ethanesulfonamide, N-(2-chloro-5-(3-chloro-4,5,6,7-tetrahydro-2H-indazol-2-yl)-4-fluorophenyl)-",CCS(=O)(=O)NC1=CC(=C(C=C1Cl)F)N2C(=C3CCCCC3=N2)Cl,,,,,,
5393,135394,"6alpha-Fluoro-17,21-dihydroxy-16beta-methyl-pregna-4,9(11)-diene-3,20-dione",C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)CC[C@@]4(C3=CC[C@@]2([C@]1(C(=O)CO)O)C)C)F,,,,,,
5394,135395,Octan-3-yl diphenyl phosphate,CCCCCC(CC)OP(=O)(OC1=CC=CC=C1)OC2=CC=CC=C2,,,,,,
5395,135396,"2-[2-(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid",CC(=CC1=CC=CC=C1C(=O)O)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,,,,,,
5396,135397,"3-[4-(2,6,6-Trimethylcyclohexen-1-yl)but-3-en-1-ynyl]benzoic acid",CC1=C(C(CCC1)(C)C)C=CC#CC2=CC(=CC=C2)C(=O)O,,,,,,
5397,135398,"2,4(1H,3H)-Pyrimidinedione, 3-(4-chloro-5-ethoxy-2-fluorophenyl)-1-methyl-6-(trifluoromethyl)-",CCOC1=C(C=C(C(=C1)N2C(=O)C=C(N(C2=O)C)C(F)(F)F)F)Cl,,,,,,
5398,135399,"2,4(1H,3H)-Pyrimidinedione, 3-(4-chloro-2-fluoro-5-((methylthio)methoxy)phenyl)-1-methyl-6-(trifluoromethyl)-",CN1C(=CC(=O)N(C1=O)C2=CC(=C(C=C2F)Cl)OCSC)C(F)(F)F,,,,,,
5399,135400,"2,4(1H,3H)-Pyrimidinedione, 3-(4-chloro-2-fluoro-5-(1-methylethoxy)phenyl)-1,6-dimethyl-",CC1=CC(=O)N(C(=O)N1C)C2=CC(=C(C=C2F)Cl)OC(C)C,,,,,,
5400,135401,"Benzoic acid, 2-chloro-4-fluoro-5-(2-methoxy-6-oxo-4-(pentafluoroethyl)-1(6H)-pyrimidinyl)-, 1-methyl ethyl ester",CC(C)OC(=O)C1=CC(=C(C=C1Cl)F)N2C(=O)C=C(N=C2OC)C(C(F)(F)F)(F)F,,,,,,
5401,135402,"2-Naphthaleneacetic acid, 7-propoxy-",CCCOC1=CC2=C(C=CC(=C2)CC(=O)O)C=C1,,,,,,
5402,135403,"Diphosphoric acid, mono(2-(dimethylamino)ethyl-14C2) ester",CN(C)[14CH2][14CH2]OP(=O)(O)OP(=O)(O)O,,,,,,
5403,135404,"Ethyl 6-[4-(2,6,6-trimethylcyclohexen-1-yl)but-3-en-1-ynyl]pyridine-3-carboxylate",CCOC(=O)C1=CN=C(C=C1)C#CC=CC2=C(CCCC2(C)C)C,,,,,,
5404,135405,"3,4-Dichloro-2-(2,4,5-trichlorophenoxy)phenol",C1=CC(=C(C(=C1O)OC2=CC(=C(C=C2Cl)Cl)Cl)Cl)Cl,,,,,,
5405,135406,Cidofovir sodium,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)([O-])[O-].[Na+].[Na+],,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
5406,135407,"4-[2-(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid",CC1(CCC(C2=C1C=CC(=C2)C=CC3=CC=C(C=C3)C(=O)O)(C)C)C,,,,,,
5407,135408,"Benzoic acid, 2-chloro-5-(3-(difluoromethyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl)-4-fluoro-, 1-methylethyl ester",CC1=CC(=O)N(C(=O)N1C(F)F)C2=C(C=C(C(=C2)C(=O)OC(C)C)Cl)F,,,,,,
5408,135409,CID 135409,CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)[O-].[K+],,,,,,
5409,135410,Amelometasone,CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)COC,,,,,,
5410,135411,6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic Acid,C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC6=C(C=C5)C=C(C=C6)C(=O)O)O,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
5411,135412,"1H-Indol-3-amine, 5-methyl-2-phenyl-N-(4-phenyl-2-thiazolyl)-",CC1=CC2=C(C=C1)NC(=C2NC3=NC(=CS3)C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
5412,135413,CID 135413,CC1=CC2=C(C=C1)NC(=C2NC(=NC(=O)C3=CC=CC=C3)S)C4=CC=CC=C4,,,,,,
5413,135414,CID 135414,C1C(=O)N=C(S1)NC2=C(NC3=C2C=C(C=C3)Cl)C4=CC=CC=C4,,,,,,
5414,135415,"1H-Indol-3-amine, 2-phenyl-N-(4-phenyl-2-thiazolyl)-",C1=CC=C(C=C1)C2=CSC(=N2)NC3=C(NC4=CC=CC=C43)C5=CC=CC=C5,,,,,,
5415,135416,"3,4-Dibromo-1-nitrosopyrrolidine",C1C(C(CN1N=O)Br)Br,,,,,,
5416,135417,"Pentanesulfonamide, N-(4-(acridin-9-ylamino)-3-methoxyphenyl)-, methanesulfonate",CCCCCS(=O)(=O)NC1=CC(=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42)OC.CS(=O)(=O)O,,,,,,
5417,135418,N-[4-(acridin-9-ylamino)-3-methoxyphenyl]pentane-1-sulfonamide,CCCCCS(=O)(=O)NC1=CC(=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42)OC,,,,,,
5418,135419,N-(2-Fluoroethyl)-N-nitrosourea,C(CF)N(C(=O)N)N=O,,,,,,
5419,135420,"4-Acridinecarboxamide, 9-((4-((ethylsulfonyl)amino)-2-methoxyphenyl)amino)-, monohydrochloride",CCS(=O)(=O)NC1=CC(=C(C=C1)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)N)OC.Cl,,,,,,
5420,135421,9-[4-(Ethylsulfonylamino)-2-methoxyanilino]acridine-4-carboxamide,CCS(=O)(=O)NC1=CC(=C(C=C1)NC2=C3C=CC=C(C3=NC4=CC=CC=C42)C(=O)N)OC,,,,,,
5421,135422,Nitrosobromoethylurea,C(CBr)N(C(=O)N)N=O,,,,,,
5422,135423,"1-Acenaphthenone, 5-amino-",C1C2=C3C(=C(C=C2)N)C=CC=C3C1=O,,,,,,
5423,135424,"Ethyl 3,5-dimethoxy-4-hydroxycinnamate",CCOC(=O)C=CC1=CC(=C(C(=C1)OC)O)OC,,,,,,
5424,135425,"10H-Pyrido(3',4':4,5)pyrrolo(2,3-g)isoquinolin-10-one, 5,9-dihydro-6-methyl-",CC1=C2C=CNC(=O)C2=CC3=C1NC4=C3C=NC=C4,,,,,,
5425,135426,(3-Chloro-2-octadec-9-enoyloxypropyl) octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCC(CCl)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5426,135427,"Phenanthridinium, 8-(acetylamino)-3-amino-5-ethyl-6-phenyl-",CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)NC(=O)C)N,,,,,,
5427,135428,(2-Methyl-3-oxoprop-1-enyl) benzoate,CC(=COC(=O)C1=CC=CC=C1)C=O,,,,,,
5428,135429,"3-Hydroxy-5-methyl-2-(6-methylheptan-2-yl)cyclohexa-2,5-diene-1,4-dione",CC1=CC(=O)C(=C(C1=O)O)C(C)CCCC(C)C,,,,,,
5429,135430,(Chloromethyl)phenylphosphinic acid p-nitrophenyl ester,C1=CC=C(C=C1)P(=O)(CCl)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5430,135431,"1H-Indole-3-ethanol, beta-1H-indol-3-yl-, acetate (ester)",CC(=O)OCC(C1=CNC2=CC=CC=C21)C3=CNC4=CC=CC=C43,,,,,,
5431,135432,"L-Cysteine, S-(2-fluoroethyl)-",C(CSC[C@@H](C(=O)O)N)F,,,,,,
5432,135433,4-Methyl-5-methylene-2(5H)-furanone,CC1=CC(=O)OC1=C,,,,,,
5433,135434,"methyl 9-oxo-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-10-enoate",CCCCC[C@H]1[C@H](O1)C=CC(=O)CCCCCCCC(=O)OC,,,,,,
5434,135435,"Ethyl (5-amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)-2-methylpyrido(3,4-b)pyrazin-7-yl)carbamate",CCOC(=O)NC1=NC(=C2C(=C1)NC(C(=N2)CN(C)C3=CC=C(C=C3)OC)C)N,,,,,,
5435,135436,"15,16-Dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-1(12),2,4(8),9,13,15,17-heptaene",CN1CC2=CC(=C(C=C2C3=C1C4=CC5=C(C=C4C3)OCO5)OC)OC,,,,,,
5436,135437,Phosphorylcholine,C[N+](C)(C)CCOP(=O)(O)[O-],,,,,,
5437,135438,CID 135438,CC(F)F.CN(C)[Se](=O)(=O)O,,,,,,
5438,135439,CID 135439,CN(C)[Se](=O)(=O)O,,,,,,
5439,135440,2-Chloropropanal,CC(C=O)Cl,,,,,,
5440,135441,1-Formyl-1-hydroxyurea,C(=O)N(C(=O)N)O,,,,,,
5441,135442,2-Ethenylphenol,C=CC1=CC=CC=C1O,,,,,,
5442,135443,"5-Amino-2-methoxy-2,4,6-cycloheptatrien-1-one",COC1=CC=C(C=CC1=O)N,,,,,,
5443,135444,Cyclopropylmethyl methanesulfonate,CS(=O)(=O)OCC1CC1,,,,,,
5444,135445,2-Isobutylthiazolidine,CC(C)CC1NCCS1,,,,,,
5445,135446,4-Phenyl-1-(2-sulfanylethyl)imidazolidin-2-one,C1C(NC(=O)N1CCS)C2=CC=CC=C2,,,,,,
5446,135447,"2-methyl-5-[(2R)-6-methylhept-5-en-2-yl]cyclohexa-2,5-diene-1,4-dione",CC1=CC(=O)C(=CC1=O)[C@H](C)CCC=C(C)C,,,,,,
5447,135448,"1-(2,4-Dichlorophenyl)-4-[(dimethylamino)methyl]non-1-en-3-one",CCCCCC(CN(C)C)C(=O)C=CC1=C(C=C(C=C1)Cl)Cl,,,,,,
5448,135449,4-((4-Aminophenyl)azo)-2-methylphenol,CC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)N)O,,,,,,
5449,135450,"2,5,11-Trimethyl-5a,6-dihydro-2h-pyrido[4,3-b]carbazol-6-ium acetate",CC1=C2C=CN(C=C2C(=C3C1[NH2+]C4=CC=CC=C43)C)C.CC(=O)[O-],,,,,,
5450,135451,"2,5,11-Trimethyl-5a,6-dihydropyrido[4,3-b]carbazole",CC1=C2C=CN(C=C2C(=C3C1NC4=CC=CC=C43)C)C,,,,,,
5451,135452,Acid Blue 175,C1CC(CC(C1)NC2=C3C(=C(C=C2)NC4CCCC(C4)CC5=CC(=CC=C5)S(=O)(=O)[O-])C(=O)C6=C(C3=O)C=CC=C6O)CC7=CC(=CC=C7)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
5452,135453,"3-[[3-[[5-Hydroxy-9,10-dioxo-4-[[3-[(3-sulfophenyl)methyl]cyclohexyl]amino]anthracen-1-yl]amino]cyclohexyl]methyl]benzenesulfonic acid",C1CC(CC(C1)NC2=C3C(=C(C=C2)NC4CCCC(C4)CC5=CC(=CC=C5)S(=O)(=O)O)C(=O)C6=C(C3=O)C=CC=C6O)CC7=CC(=CC=C7)S(=O)(=O)O,,,,,,
5453,135454,Cascarin,C[C@H]1[C@@H]([C@H]([C@H](C(O1)OC2=CC3=C(C(=C2)O)C(=O)C4=C(C3=O)C=C(C=C4O)C)O)O)O,,,,,,
5454,135455,CID 135455,C1C2=C3C(=CC=C2)C(=CC=C3C4=CC=CC=C41)OC5=CC=C(C=C5)S(=O)(=O)[O-].[Na+],,,,,,
5455,135456,4-(7H-benzo[a]phenalen-3-yloxy)benzenesulfonic acid,C1C2=C3C(=CC=C2)C(=CC=C3C4=CC=CC=C41)OC5=CC=C(C=C5)S(=O)(=O)O,,,,,,
5456,135457,5-Acenaphthylenecarbonitrile,C1=CC2=C3C(=CC=C(C3=C1)C#N)C=C2,,,,,,
5457,135458,1-Hydroxybenz[a]anthracene,C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C(=CC=C4)O,,,,,,
5458,135459,CID 135459,CN(C)N=NC1=CC=C(C=C1)C(=O)[O-].[K+],,,,,,
5459,135460,CID 135460,CCO[Si](CCCNC(=NCCC[Si](OCC)(OCC)OCC)S)(OCC)OCC,,,,,,
5460,135461,2-Iodotyrosine,C1=CC(=C(C=C1O)I)C[C@@H](C(=O)O)N,,,,,,
5461,135462,CID 135462,C1=CC=NC(=C1)C2=NC(=C(N=N2)C3=CC=C(C=C3)S(=O)(=O)O)C4=CC=C(C=C4)S(=O)(=O)[O-].[Na+],,,,,,
5462,135463,O-Ethyl O-isobutyl S-chloromethyl dithiophosphate,CCOP(=S)(OCC(C)C)SCCl,,,,,,
5463,135464,"9-Amino-2,5,11-trimethyl-6H-pyrido(4,3-b)carbazolium",CC1=C2C=C[N+](=CC2=C(C3=C1NC4=C3C=C(C=C4)N)C)C,,,,,,
5464,135465,"1,2,9-Trimethoxyoxoaporphine",COC1=CC2=C(C=C1)C3=C4C(=CC(=C3OC)OC)C=CN=C4C2=O,,,,,,
5465,135466,"9-Bromo-2,5,11-trimethyl-6H-pyrido(4,3-b)carbazolium",CC1=C2C=C[N+](=CC2=C(C3=C1NC4=C3C=C(C=C4)Br)C)C,,,,,,
5466,135467,"O,O-Diisobutyl S-chloromethyl dithiophosphate",CC(C)COP(=S)(OCC(C)C)SCCl,,,,,,
5467,135468,"9,10-Anthracenedione, 1,4-bis((2-(dimethylamino)ethyl)amino)-5,8-dihydroxy-",CN(C)CCNC1=C2C(=C(C=C1)NCCN(C)C)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
5468,135469,"1,4-Dihydroxy-5,8-bis((2-(methylamino)ethyl)amino)-9,10-anthracenedione dihydrochloride",CNCCNC1=C2C(=C(C=C1)NCCNC)C(=O)C3=C(C=CC(=C3C2=O)O)O.Cl.Cl,,,,,,
5469,135470,"1,4-Dihydroxy-5,8-bis[2-(methylamino)ethylamino]anthracene-9,10-dione",CNCCNC1=C2C(=C(C=C1)NCCNC)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
5470,135471,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-(1-pyrrolidinyl)ethyl)amino)-",C1CCN(C1)CCNC2=C3C(=C(C=C2)NCCN4CCCC4)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
5471,135472,"9,10-Anthracenedione, 1,4-bis((2-aminoethyl)amino)-5,8-dihydroxy-, dihydrochloride",C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCN.Cl.Cl,,,,,,
5472,135473,6-Iodo-8-quinolinecarboxylic acid,C1=CC2=CC(=CC(=C2N=C1)C(=O)O)I,,,,,,
5473,135474,"1,4-Dihydroxy-5,8-bis((2-((2-(methylamino)ethyl)amino)ethyl)amino)-9,10-anthracenedione tetrahydrochloride",CNCCNCCNC1=C2C(=C(C=C1)NCCNCCNC)C(=O)C3=C(C=CC(=C3C2=O)O)O.Cl.Cl.Cl.Cl,,,,,,
5474,135475,"1,4-Dihydroxy-5,8-bis[2-[2-(methylamino)ethylamino]ethylamino]anthracene-9,10-dione",CNCCNCCNC1=C2C(=C(C=C1)NCCNCCNC)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
5475,135476,"1,3-Bis(3-methoxyphenyl)propane-1,3-dione",COC1=CC=CC(=C1)C(=O)CC(=O)C2=CC(=CC=C2)OC,,,,,,
5476,135477,"1,5-Bis((3-(dimethylamino)propyl)amino)-9,10-anthracenedione",CN(C)CCCNC1=CC=CC2=C1C(=O)C3=C(C2=O)C(=CC=C3)NCCCN(C)C,,,,,,
5477,135478,(Butylnitrosoamino)acetaldehyde,CCCCN(CC=O)N=O,,,,,,
5478,135479,"1,8-Bis((3-(dimethylamino)propyl)amino)-9,10-anthracenedione",CN(C)CCCNC1=CC=CC2=C1C(=O)C3=C(C2=O)C=CC=C3NCCCN(C)C,,,,,,
5479,135480,Methyl 2-cyano-3-(2-mehtylphenyl)-2-propenoate,CC1=CC=CC=C1C=C(C#N)C(=O)OC,,,,,,
5480,135481,"Hydroxylamine, N-(2'-methylbiphenyl-4-yl)-",CC1=CC=CC=C1C2=CC=C(C=C2)NO,,,,,,
5481,135482,"4,4'-Methylenebis[2-(ethylsulfanyl)aniline]",CCSC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)SCC)N,,,,,,
5482,135483,"1,4-Bis((2-(dimethylamino)ethyl)amino)-6-methyl-9,10-anthracenedione",CC1=CC2=C(C=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCN(C)C)NCCN(C)C,,,,,,
5483,135484,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-(1-piperazinyl)ethyl)amino)-",C1CN(CCN1)CCNC2=C3C(=C(C=C2)NCCN4CCNCC4)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
5484,135485,"15(S)-hydroperoxy-5,8,11,13-eicosatetraenoic acid",CCCCC[C@@H](C=CC=CCC=CCC=CCCCC(=O)O)OO,,,,,,
5485,135486,"N,N-Bis(1-methylethyl)-1-((2,3,3-trichloro-2-propenyl)sulfinyl)formamide",CC(C)N(C(C)C)C(=O)S(=O)CC(=C(Cl)Cl)Cl,,,,,,
5486,135487,Methyl tetra-O-methylcarminate,CC1=C2C(=CC(=C1C(=O)OC)OC)C(=O)C3=C(C2=O)C(=C(C(=C3OC)OC)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC,,,,,,
5487,135488,"Benz(a)anthracene-7-methanol, 2-hydroxy-12-methyl-",CC1=C2C(=C(C3=CC=CC=C13)CO)C=CC4=C2C=C(C=C4)O,,,,,,
5488,135489,"1-(2-(2,4-Dichlorophenyl)-2-hydroxyethyl)-2,4-imidazolidinedione",C1C(=O)NC(=O)N1CC(C2=C(C=C(C=C2)Cl)Cl)O,,,,,,
5489,135490,trans-1-(3-Hydroxy-2-tetrahydrofuranyl)-5-fluorouracil,C1CO[C@@H]([C@H]1O)N2C=C(C(=O)NC2=O)F,,,,,,
5490,135491,"O,S-Dimethyl cyclohexylphosphoramidothioate",COP(=O)(NC1CCCCC1)SC,,,,,,
5491,135492,Cyanopentenone,C=CC(=O)CCC#N,,,,,,
5492,135493,"Benzo(a)naphth(2,1,8-cde)azulene",C1=CC=C2C(=C1)C3=C4C2=CC=CC5=C4C(=CC=C5)C=C3,,,,,,
5493,135494,Methyl 4-(butylnitrosoamino)butanoate,CCCCN(CCCC(=O)OC)N=O,,,,,,
5494,135495,"1,1-Bis(p-chlorophenyl)ethylene oxide",C1C(O1)(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl,,,,,,
5495,135496,Diethylthiocarbamic acid S-2-chloroallyl ester S-oxide,CCN(CC)C(=S)OOCC(=C)Cl,,,,,,
5496,135497,"Methyl 12,13-epoxy-9-hydroxy-10-octadecenoate",CCCCCC1C(O1)C=CC(CCCCCCCC(=O)OC)O,,,,,,
5497,135498,9-Phenanthridinamine,C1=CC=C2C(=C1)C3=C(C=CC(=C3)N)C=N2,,,,,,
5498,135499,"3-Methoxy-6-methyl-1,8,9-anthracenetriol",CC1=CC2=CC3=CC(=CC(=C3C(=C2C(=C1)O)O)O)OC,,,,,,
5499,135500,"Benzamide, 4-(bis(2-chloroethyl)amino)-N-propyl-",CCCNC(=O)C1=CC=C(C=C1)N(CCCl)CCCl,,,,,,
5500,135501,"Acetamide, 2,2-dichloro-N-((1S,2S)-2-hydroxy-1-(hydroxymethyl)-2-(4-(methylthio)phenyl)ethyl)-",CSC1=CC=C(C=C1)[C@@H]([C@H](CO)NC(=O)C(Cl)Cl)O,,,,,,
5501,135502,"Urea, 1-nitroso-1-tridecyl-",CCCCCCCCCCCCCN(C(=O)N)N=O,,,,,,
5502,135503,1-sec-Butyl-1-nitrosourea,CCC(C)N(C(=O)N)N=O,,,,,,
5503,135504,"D-Tyrosine, 3-hydroxy-, methyl ester",COC(=O)[C@@H](CC1=CC(=C(C=C1)O)O)N,,,,,,
5504,135505,"Urea, N-nitroso-N-undecyl-",CCCCCCCCCCCN(C(=O)N)N=O,,,,,,
5505,135506,"Dibenz(a,h)anthracen-2-ol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=C(C=C5)O,,,,,,
5506,135507,2-Ethyl-6-sec-butylaniline,CCC1=C(C(=CC=C1)C(C)CC)N,,,,,,
5507,135508,1-Benzyl-4-nitro-5-(2-phenylethenyl)imidazole,C1=CC=C(C=C1)CN2C=NC(=C2C=CC3=CC=CC=C3)[N+](=O)[O-],,,,,,
5508,135509,"5H-Pyrrolo(2,1-c)(1,4)benzodiazepin-5-one, 1,2,3,10,11,11a-hexahydro-3,8-dihydroxy-7-methoxy-, (3S-trans)-",COC1=C(C=C2C(=C1)C(=O)N3[C@@H](CC[C@@H]3O)CN2)O,,,,,,
5509,135510,1-Isopropyl-3-methyl-3-nitrosourea,CC(C)NC(=O)N(C)N=O,,,,,,
5510,135511,"cis-3,4-Dihydrocyclopenta(cd)pyrene-3,4-diol",C1=CC2=C3C(=C1)C=C4[C@@H]([C@@H](C5=C4C3=C(C=C2)C=C5)O)O,,,,,,
5511,135512,"3-Nitroso-2-propyl-1,3-thiazolidine",CCCC1N(CCS1)N=O,,,,,,
5512,135513,"Dichloro(4,5,6-trichloro-o-phenylenediammine)platinum (II)",C1=C(C(=C(C(=C1Cl)Cl)Cl)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
5513,135514,2-Isopropyl-3-nitrosothiazolidine,CC(C)C1N(CCS1)N=O,,,,,,
5514,135515,2-Butyl-3-nitrosothiazolidine,CCCCC1N(CCS1)N=O,,,,,,
5515,135516,"Androsta-1,4-diene-3,6,17-trione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=O)C4=CC(=O)C=C[C@]34C,,,,,,
5516,135517,N-Nitrosoisobutylthiazolidine,CC(C)CC1N(CCS1)N=O,,,,,,
5517,135518,Methm-deoxyuridine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COSC)O,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
5518,135519,(4-Benzoyl-o-phenylenediammine)dichloroplatinum (II),C1=CC=C(C=C1)C(=O)C2=CC(=C(C=C2)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
5519,135520,"3,4-Diaminobenzophenone",C1=CC=C(C=C1)C(=O)C2=CC(=C(C=C2)N)N,,,,,,
5520,135521,CID 135521,CNC1=CC=C(C=C1)N=NC2=CC=C(C=C2)OS(=O)(=O)[O-].[K+],,,,,,
5521,135522,[4-[[4-(Methylamino)phenyl]diazenyl]phenyl] hydrogen sulfate,CNC1=CC=C(C=C1)N=NC2=CC=C(C=C2)OS(=O)(=O)O,,,,,,
5522,135523,Dichloro(4-methoxycarbonyl-o-phenylenediammine)platinum (II),COC(=O)C1=CC(=C(C=C1)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
5523,135524,"Methyl 3,4-diaminobenzoate",COC(=O)C1=CC(=C(C=C1)N)N,,,,,,
5524,135525,"7-Bromo-4,6,8-trichloro-2,6-dimethylocta-1,4-dien-3-one",CC(=C)C(=O)C(=CC(C)(C(CCl)Br)Cl)Cl,,,,,,
5525,135526,"8-Bromo-1,3,4,7-tetrachloro-3,7-dimethylocta-1,5-diene",CC(CBr)(C=CC(C(C)(C=CCl)Cl)Cl)Cl,,,,,,
5526,135527,N-(p-(9-Acridinylamino)phenyl)pentanesulfonamide,CC(CCCS(=O)(=O)NC1=CC=CC=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
5527,135528,"2,7-Dinitrophenazine",C1=CC2=C(C=C1[N+](=O)[O-])N=C3C=CC(=CC3=N2)[N+](=O)[O-],,,,,,
5528,135529,CID 135529,CC1=CC(=C(C2=C1N=C3C2=CC(=O)C=C3)C)N(O)O,,,,,,
5529,135530,CID 135530,CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)C(=O)NN=C(N)N.Cl.Cl,,,,,,
5530,135531,CID 135531,CC(=NN=C(N)N)C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)C(=O)NN=C(N)N,,,,,,
5531,135532,Methyl N-acetyl-S-(2-(acetyloxy)cyclohexyl)-L-cysteine,CC(=O)N[C@@H](CSC1CCCCC1OC(=O)C)C(=O)OC,,,,,,
5532,135533,"Ethyl 2,3-dihydro-7-oxo-7H-furo(3,2-g)(1)benzopyran-6-carboxylate",CCOC(=O)C1=CC2=CC3=C(C=C2OC1=O)OCC3,,,,,,
5533,135534,"N-Nitroso-2-methoxy-2,6-dimethylmorpholine",CC1CN(CC(O1)(C)OC)N=O,,,,,,
5534,135535,(S)-methyl 2-chloropropanoate,C[C@@H](C(=O)OC)Cl,,,,,,
5535,135536,"6-(1-Oxobutyl)-7H-furo(3,2-g)(1)benzopyran-7-one",CCCC(=O)C1=CC2=C(C=C3C(=C2)C=CO3)OC1=O,,,,,,
5536,135537,"Acetamide, N-(2-acetamidofluoren-1-yl)-N-fluoren-2-yl-",CC(=O)NC1=C(C2=C(C=C1)C3=CC=CC=C3C2)N(C4=CC5=C(C=C4)C6=CC=CC=C6C5)C(=O)C,,,,,,
5537,135538,p-Hydroxymethylphenylhydrazine,C1=CC(=CC=C1CO)NN,,,,,,
5538,135539,"Quin 2,tetrapotassium salt",CC1=CC(=C(C=C1)N(CC(=O)[O-])CC(=O)[O-])OCC2=NC3=C(C=C(C=C3C=C2)OC)N(CC(=O)[O-])CC(=O)[O-].[K+].[K+].[K+].[K+],,,"['Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)', 'Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)', 'Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
5539,135540,"Acetic acid, (1,2-dihydro-5-iodo-2-oxo-3H-indol-3-ylidene)hydrazide",CC(=O)N=NC1=C(NC2=C1C=C(C=C2)I)O,,,,,,
5540,135541,Cyclopenta(cd)pyren-4(3H)-one,C1C2=C3C(=CC4=CC=CC5=C4C3=C(C=C2)C=C5)C1=O,,,,,,
5541,135542,"1H-Indole-2,3-dione, 1-((bis(2-chloroethyl)amino)methyl)-5-iodo-",C1=CC2=C(C=C1I)C(=O)C(=O)N2CN(CCCl)CCCl,,,,,,
5542,135543,4-Ethenylpyrene,C=CC1=CC2=CC=CC3=C2C4=C(C=CC=C14)C=C3,,,,,,
5543,135544,"Hexadeca-6,8,12,14-tetraen-10-ynyl acetate",CC=CC=CC#CC=CC=CCCCCCOC(=O)C,,,,,,
5544,135545,"1H-Indole-2,3-dione, 5-iodo-, 3-(methylhydrazone)",CN=NC1=C(NC2=C1C=C(C=C2)I)O,,,,,,
5545,135546,CID 135546,CC1=C2C(=C3C=CC(=CC3=N2)OC)C=CN1.O.Cl,,,,,,
5546,135547,N-(2-(Hydroxyamino)-2-oxoethyl)dodecanamide,CCCCCCCCCCCC(=O)NCC(=O)NO,,,,,,
5547,135548,CID 135548,C1[C@H](N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
5548,135549,"Decanamide, N-(2-(hydroxyamino)-2-oxoethyl)-",CCCCCCCCCC(=O)NCC(=O)NO,,,,,,
5549,135550,CID 135550,CC1=C2C3=CC=CC=C3N=C2C=C(N1)NC(=O)C,,,,,,
5550,135551,"Nonanamide, N-(2-(hydroxyamino)-2-oxoethyl)-",CCCCCCCCC(=O)NCC(=O)NO,,,,,,
5551,135552,CID 135552,CCNC1=CC2=NC3=CC=CC=C3C2=C(N1)C,,,,,,
5552,135553,CID 135553,CC1=C2C(=C3C=C(C=C(C3=N2)[N+](=O)[O-])[N+](=O)[O-])C=C(N1)[N+](=O)[O-],,,,,,
5553,135554,"9H-Carbazole-4-ethanamine, 5,8-dimethyl-N,N-dipropyl-, monohydrochloride",CCCN(CCC)CCC1=C2C(=CC=C1)NC3=C(C=CC(=C23)C)C.Cl,,,,,,
5554,135555,"N-[2-(5,8-dimethyl-9H-carbazol-4-yl)ethyl]-N-propylpropan-1-amine",CCCN(CCC)CCC1=C2C(=CC=C1)NC3=C(C=CC(=C23)C)C,,,,,,
5555,135556,tert-Butyloxycarbonyl-mononitrosamidocaffeidine,CC(C)(C)OC(=O)N(C)C1=C(N(C=N1)C)C(=O)N(C)N=O,,,,,,
5556,135557,"1-(3-Azido-2-hydroxypropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione",CC1=CN(C(=O)NC1=O)CC(CN=[N+]=[N-])O,,,,,,
5557,135558,Ccris 7974,CC1=CC2=C(C3=CC(=CC(=O)C3=C(C2=C(O1)O)O)OC)OC,,,,,,
5558,135559,CID 135559,CCN(CC)C1=CC2=NC3=CC=CC=C3C2=C(N1)C,,,,,,
5559,135560,"9-Acridinamine, N-pentyl-",CCCCCNC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
5560,135561,"9-Acridinamine, N-hexyl-",CCCCCCNC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
5561,135562,"5-Chloro-3-ethynyl-4-pentene-2,3-diol",CC(C(C=CCl)(C#C)O)O,,,,,,
5562,135563,2-(2-Chloroethenyl)-2-ethynyl-3-methyloxirane,CC1C(O1)(C=CCl)C#C,,,,,,
5563,135564,"2-(2,2-Bis(methylthio)ethenyl)-1,6-dimethylquinolinium iodide",CC1=CC2=C(C=C1)[N+](=C(C=C2)C=C(SC)SC)C.[I-],,,,,,
5564,135565,"2-[2,2-Bis(methylsulfanyl)ethenyl]-1,6-dimethylquinolin-1-ium",CC1=CC2=C(C=C1)[N+](=C(C=C2)C=C(SC)SC)C,,,,,,
5565,135566,"1H-Indole, 6-(1H-imidazol-2-yl)-2-(4-(1H-imidazole-2-yl)phenyl)-, dihydrochloride",C1=CC(=CC=C1C2=CC3=C(N2)C=C(C=C3)C4=NC=CN4)C5=NC=CN5.Cl.Cl,,,,,,
5566,135567,"1H-Indole, 6-(1H-imidazol-2-yl)-2-[4-(1H-imidazol-2-yl)phenyl]-",C1=CC(=CC=C1C2=CC3=C(N2)C=C(C=C3)C4=NC=CN4)C5=NC=CN5,,,,,,
5567,135568,Ergosinine methanesulfonate,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C)NC(=O)[C@H]4CN([C@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O.CS(=O)(=O)O,,,,,,
5568,135569,"(6aS,9R)-N-[(1S,2S,4R,7S)-2-hydroxy-4-methyl-7-(2-methylpropyl)-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C)NC(=O)[C@H]4CN([C@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,,,,
5569,135570,"3H-Pyrido(4,3-b)indol-3-one, 2,5-dihydro-1-methyl-",CC1=C2C3=CC=CC=C3NC2=CC(=O)N1,,,,,,
5570,135571,CID 135571,CC1=CC2=C(C=C1)C3=C(NC(=CC3=N2)N)C,,,,,,
5571,135572,"2-(3,7-Dimethyl-9-methylsulfanylnona-1,3,5,7-tetraenyl)-1,3,3-trimethylcyclohexene",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCSC)C)C,,,,,,
5572,135573,"4-[2-(1,6-Dimethylquinolin-1-ium-2-yl)-1-methylsulfanylethenyl]morpholine;iodide",CC1=CC2=C(C=C1)[N+](=C(C=C2)C=C(N3CCOCC3)SC)C.[I-],,,,,,
5573,135574,"4-[2-(1,6-Dimethylquinolin-1-ium-2-yl)-1-methylsulfanylethenyl]morpholine",CC1=CC2=C(C=C1)[N+](=C(C=C2)C=C(N3CCOCC3)SC)C,,,,,,
5574,135575,"Benz(a)anthracene-5,6-diol, 5,6-dihydro-12-(hydroxymethyl)-7-methyl-, trans-",CC1=C2[C@@H]([C@H](C3=CC=CC=C3C2=C(C4=CC=CC=C14)CO)O)O,,,,,,
5575,135576,"Hydroxylamine, N,O-diacetyl-N-(2-methoxy-3-fluorenyl)-",CC(=O)N(C1=C(C=C2CC3=CC=CC=C3C2=C1)OC)OC(=O)C,,,,,,
5576,135577,CID 135577,CC1=C2C3=CC=CC=C3N=C2C=C(N1)N=O,,,,,,
5577,135578,"1,2-Chrysenediol, 1,2-dihydro-6-methyl-, trans-",CC1=CC2=C(C=CC3=C2C=C[C@H]([C@@H]3O)O)C4=CC=CC=C14,,,,,,
5578,135579,"trans-1,2-Dihydrodibenz(a,e)aceanthrylene-1,2-diol",C1=CC=C2C(=C1)C=C3C4=CC=CC=C4C5=C3C2=CC6=C5C=C[C@@H]([C@H]6O)O,,,,,,
5579,135580,"7-Hydroxydibenzo(a,e)fluoranthene",C1=CC=C2C(=C1)C=C3C4=C(C=CC(=C4)O)C5=C3C2=CC6=CC=CC=C65,,,,,,
5580,135581,5-Ethyl-6-phenylphenanthridinium,CC[N+]1=C(C2=CC=CC=C2C3=CC=CC=C31)C4=CC=CC=C4,,,,,,
5581,135582,8-Phenanthridinamine,C1=CC=C2C(=C1)C3=C(C=C(C=C3)N)C=N2,,,,,,
5582,135583,"Benzo(6,7)phenanthro(3,4-b)oxirene-2,3-diol, 1a,2,3,11c-tetrahydro-6,11-dimethyl-",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C5C(O5)C(C3O)O,,,,,,
5583,135584,8-Azido-5-ethyl-6-phenylphenanthridinium,CC[N+]1=C(C2=C(C=CC(=C2)N=[N+]=[N-])C3=CC=CC=C31)C4=CC=CC=C4,,,,,,
5584,135585,"1,2-Epoxy-1,2,3,4-tetrahydrotriphenylene",C1CC2=C(C3C1O3)C4=CC=CC=C4C5=CC=CC=C25,,,,,,
5585,135586,TP diol epoxide-1,C1=CC=C2C(=C1)C3=CC=CC=C3C4=C2[C@@H]([C@H]([C@H]5[C@@H]4O5)O)O,,,,,,
5586,135587,"3,8-Bis((ethoxycarbonyl)amino)-5-ethyl-6-phenylphenanthridinium",CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)NC(=O)OCC)NC(=O)OCC,,,,,,
5587,135588,"2-Methyl-1,4-benzenediamine monohydrochloride",CC1=C(C=CC(=C1)N)N.Cl,,,,,,
5588,135589,"trans-3,4-dihydrodibenz(a,H)anthracene-3,4-diol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=C[C@@H]([C@H]5O)O,,,,,,
5589,135590,"Urea, N-(2-chloroethyl)-N'-(2,2,3,3,4,4,5,5,6,6-decafluorocyclohexyl)-N-nitroso-",C(CCl)N(C(=O)NC1C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)N=O,,,,,,
5590,135591,CID 135591,C1=CC(=C(C=C1O)C2=CC(=C3C(=CC(=O)C=C3O2)O)O)O,,,,,,
5591,135592,CID 135592,C1=CC(=CC(=C1)O)C2=CC(=C3C(=CC(=O)C=C3O2)O)O,,,,,,
5592,135593,"N'-(9-methoxy-5-methyl-6H-pyrido[4,3-b]carbazol-1-yl)propane-1,3-diamine;dihydrate",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCCN.O.O,,,,,,
5593,135594,"6H-Pyrido(4,3-b)carbazole, 1-((3-aminopropyl)amino)-9-methoxy-5-methyl-, dihydrate",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCCN,,,,,,
5594,135595,"1-((3-(N-Aminopropyl-N-ethylamino)propyl)amino)-9-methoxy-5-methyl-6H-pyrido(4,3-b)carbazole",CCN(CCCN)CCCNC1=NC=CC2=C(C3=C(C=C21)C4=C(N3)C=CC(=C4)OC)C,,,,,,
5595,135596,"Benz(a)anthracene-3,4-dione",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C=CC(=O)C4=O,,,,,,
5596,135597,"Phenanthridinium, 8-amino-5-ethyl-6-phenyl-, chloride",CC[N+]1=C(C2=C(C=CC(=C2)N)C3=CC=CC=C31)C4=CC=CC=C4.[Cl-],,,,,,
5597,135598,8-Amino-5-ethyl-6-phenylphenanthridinium,CC[N+]1=C(C2=C(C=CC(=C2)N)C3=CC=CC=C31)C4=CC=CC=C4,,,,,,
5598,135599,CID 135599,CCC=CCC=CCC=CCCCCCCCC(=O)OC.O[O-],,,,,,
5599,135600,"8-Hydroxy-4-methoxy-1,11-dioxo-1,2,3,6a,8,9,9a,11-octahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-9-yl chloroacetate",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C(C(OC5OC4=C1)O)OC(=O)CCl,,,,,,
5600,135601,"Butylamine, N-(hydroperoxymethyl)-N-nitroso-",CCCCN(COO)N=O,,,,,,
5601,135602,8-Amino-3-azido-5-ethyl-6-phenylphenanthridinium chloride,CCN1C2=CC(=N[N+]#N)C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N.[Cl-],,,,,,
5602,135603,3-Azidoethidium,CCN1C2=CC(=N[N+]#N)C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N,,,,,,
5603,135604,"8-Acetoxy-2,3,6a,8,9,9a-hexahydro-9-hydroxy-4-methoxycyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-1,11-dione",CC(=O)OC1C(C2C(O1)OC3=CC(=C4C5=C(C(=O)CC5)C(=O)OC4=C23)OC)O,,,,,,
5604,135605,"Butylamine, 1-(hydroperoxy)-N-methyl-N-nitroso-",CCCC(N(C)N=O)OO,,,,,,
5605,135606,2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)C2=CC=C(C=C2)C3=CC=CC=C3,,,,,,
5606,135607,"8-(4-Nitrobenzoyloxy)-9-hydroxy-8,9-dihydro-aflatoxin B1",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C(C(OC5OC4=C1)OC(=O)C6=CC=C(C=C6)[N+](=O)[O-])O,,,,,,
5607,135608,"6H-Pyrido(4,3-b)carbazole, 1-((3-(4-aminopropyl-1-piperazinyl)propyl)amino)-9-methoxy-5-methyl-",CC1=C2C=CN=C(C2=CC3=C1NC4=C3C=C(C=C4)OC)NCCCN5CCN(CC5)CCCN,,,,,,
5608,135609,5-Ethyl-6-phenylphenanthridinium chloride,CC[N+]1=C(C2=CC=CC=C2C3=CC=CC=C31)C4=CC=CC=C4.[Cl-],,,,,,
5609,135610,ethyl N-ethylsulfamate,CCNS(=O)(=O)OCC,,,,,,
5610,135611,"Cyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione, 2,3,6a,8,9,9a-hexahydro-8-hydroxy-4-methoxy-, dichloroacetate",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5CC(OC5OC4=C1)OC(=O)C(Cl)Cl,,,,,,
5611,135612,3-((p-(Dimethylamino)phenyl)azo)benzyl alcohol acetate,CC(=O)OCC1=CC(=CC=C1)N=NC2=CC=C(C=C2)N(C)C,,,,,,
5612,135613,"Cyclohexanecarboxylic acid, 3-amino-, 3-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl ester",CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC(=O)C5CCCC(C5)N)O,,,,,,
5613,135614,Bis(3-(chloromethyl)phenyl)diazene,C1=CC(=CC(=C1)N=NC2=CC=CC(=C2)CCl)CCl,,,,,,
5614,135615,CID 135615,CCC1=C2C3=CC=CC=C3N=C2C=C(N1)N.CC(=O)O,,,,,,
5615,135616,CID 135616,CCC1=C2C3=CC=CC=C3N=C2C=C(N1)N,,,,,,
5616,135617,"5H-Pyrido(4,3-b)indol-3-amine, monohydrochloride",C1=CC=C2C(=C1)C3=CN=C(C=C3N2)N.Cl,,,,,,
5617,135618,"3-Amino-5H-pyrido(4,3-b)indole",C1=CC=C2C(=C1)C3=CN=C(C=C3N2)N,,,,,,
5618,135619,"5H-Pyrido(4,3-b)indole, 3-amino-1-phenyl-, acetate",CC(=O)O.C1=CC=C(C=C1)C2=C3C4=CC=CC=C4NC3=CC(=N2)N,,,,,,
5619,135620,"1-phenyl-5H-pyrido[4,3-b]indol-3-amine",C1=CC=C(C=C1)C2=C3C4=CC=CC=C4NC3=CC(=N2)N,,,,,,
5620,135621,"4-Methyl-5H-pyrido(4,3-b)indol-3-amine monoacetate",CC1=C2C(=CN=C1N)C3=CC=CC=C3N2.CC(=O)O,,,,,,
5621,135622,"4-Methyl-5h-pyrido[4,3-b]indol-3-amine",CC1=C2C(=CN=C1N)C3=CC=CC=C3N2,,,,,,
5622,135623,"7H-Furo(3,2-g)(1)benzopyran-7-one, 9-(oxiranylmethoxy)-",C1C(O1)COC2=C3C(=CC4=C2OC=C4)C=CC(=O)O3,,,,,,
5623,135624,"8,9-Dehydro-zeta-rhodomycinone 8,9-beta-epoxide",CC[C@@]12[C@@H](O1)CC3=C([C@H]2C(=O)OC)C(=C4C(=C3O)C(=O)C5=C(C4=O)C=CC=C5O)O,,,,,,
5624,135625,"N-9-Acridinyl-N'-(3-(9-acridinylamino)propyl)-1,4-butanediamine trihydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCNCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64.Cl.Cl.Cl,,,,,,
5625,135626,4-[(Acridin-9(10H)-ylidene)amino]-N-{3-[(acridin-9(10H)-ylidene)amino]propyl}butan-1-amine,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCNCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
5626,135627,"1,3,5-Triazine-2,4-diamine, 6-(tetrahydro-2-furanyl)-",C1CC(OC1)C2=NC(=NC(=N2)N)N,,,,,,
5627,135628,CID 135628,CC1=C2C3=CC=CC=C3N=C2C=C(N1)[N+](=O)[O-],,,,,,
5628,135629,"4,9-Dichloro-1-nitroacridine",C1=CC=C2C(=C1)C(=C3C(=CC=C(C3=N2)Cl)[N+](=O)[O-])Cl,,,,,,
5629,135630,"4-Pyridazinecarbonitrile, 2-(2-chloroethyl)-5,6-bis(4-chlorophenyl)-2,3-dihydro-3-oxo-",C1=CC(=CC=C1C2=C(C(=O)N(N=C2C3=CC=C(C=C3)Cl)CCCl)C#N)Cl,,,,,,
5630,135631,"Acridinium, 9-chloro-10-methyl-, chloride",C[N+]1=C2C=CC=CC2=C(C3=CC=CC=C31)Cl.[Cl-],,,,,,
5631,135632,2-Acridinecarbonitrile,C1=CC=C2C(=C1)C=C3C=C(C=CC3=N2)C#N,,,,,,
5632,135633,"3-Acridinamine, 9,10-dihydro-",C1C2=C(C=C(C=C2)N)NC3=CC=CC=C31,,,,,,
5633,135634,2-Methyl-2-(4-nitrophenyl)oxirane,CC1(CO1)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5634,135635,"4-Pyridazinecarbonitrile, 2,3-dihydro-5,6-bis(4-methylphenyl)-3-oxo-",CC1=CC=C(C=C1)C2=C(C(=O)NN=C2C3=CC=C(C=C3)C)C#N,,,,,,
5635,135636,"4-Pyridazinecarbonitrile, 5,6-bis(4-bromophenyl)-2,3-dihydro-3-oxo-",C1=CC(=CC=C1C2=C(C(=O)NN=C2C3=CC=C(C=C3)Br)C#N)Br,,,,,,
5636,135637,"4-Pyridazinecarbonitrile, 5,6-bis(4-chlorophenyl)-2,3-dihydro-3-oxo-2-(2-oxopropyl)-",CC(=O)CN1C(=O)C(=C(C(=N1)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)C#N,,,,,,
5637,135638,"1(6H)-Pyridazineacetic acid, 3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-, methyl ester",COC(=O)CN1C(=O)C(=C(C(=N1)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)C#N,,,,,,
5638,135639,"2H-Furo(2,3-h)-1-benzopyran-2-one, 9-(methoxymethyl)-4,8-dimethyl-",CC1=CC(=O)OC2=C1C=CC3=C2C(=C(O3)C)COC,,,,,,
5639,135640,"Methanesulfonamide, N-(p-(acridin-9-ylamino)phenyl)-, hydrochloride",CS(=O)(=O)NC1=CC=C(C=C1)NC2=C(C=NC3=CC=CC=C32)C=C.Cl,,,,,,
5640,135641,N-[4-[(3-ethenylquinolin-4-yl)amino]phenyl]methanesulfonamide,CS(=O)(=O)NC1=CC=C(C=C1)NC2=C(C=NC3=CC=CC=C32)C=C,,,,,,
5641,135642,"Methanesulfonamide, N-(o-(9-acridinylamino)benzyl)-, hydrochloride",CS(=O)(=O)NCC1=CC=CC=C1NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,,,,,,
5642,135643,N-[[2-(acridin-9-ylamino)phenyl]methyl]methanesulfonamide,CS(=O)(=O)NCC1=CC=CC=C1NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
5643,135644,"Phenol, o-(9-acridinylamino)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=CC=C4O,,,,,,
5644,135645,"Benzenamine, 5-[(4-aminophenyl)methyl]-2-methyl-",CC1=C(C=C(C=C1)CC2=CC=C(C=C2)N)N,,,,,,
5645,135646,"Methanesulfonanilide, 2'-(9-acridinylamino)-N-methyl-, hydrochloride",CN(C1=CC=CC=C1NC2=C3C=CC=CC3=NC4=CC=CC=C42)S(=O)(=O)C.Cl,,,,,,
5646,135647,N-[2-(acridin-9-ylamino)phenyl]-N-methylmethanesulfonamide,CN(C1=CC=CC=C1NC2=C3C=CC=CC3=NC4=CC=CC=C42)S(=O)(=O)C,,,,,,
5647,135648,2-Phenylpropyl mesylate,CC(COS(=O)(=O)C)C1=CC=CC=C1,,,,,,
5648,135649,1-Phenyl-2-butylmethanesulphonate,CCC(CC1=CC=CC=C1)OS(=O)(=O)C,,,,,,
5649,135650,"1,2-Bis(5-amidino-2-benzimidazolyl)ethane",C1=CC2=C(C=C1C(=N)N)NC(=N2)CCC3=NC4=C(N3)C=C(C=C4)C(=N)N,,,,,,
5650,135651,"3-Methyl-1-nitroso-1,2,5,6-tetrahydropyridine",CC1=CCCN(C1)N=O,,,,,,
5651,135652,"1-Nitroso-4-acetyl-3,5-dimethylpiperazine",CC1CN(CC(N1C(=O)C)C)N=O,,,,,,
5652,135653,1-Nitroso-4-cyclohexylpiperidine,C1CCC(CC1)C2CCN(CC2)N=O,,,,,,
5653,135654,N-Nitroso-(2-hydroxypropyl)-(2-hydroxyethyl)amine,CC(CN(CCO)N=O)O,,,,,,
5654,135655,"2,4,6-Cycloheptatrien-1-one, 5-(9-acridinylamino)-2-hydroxy-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C(=O)C=C4)O,,,,,,
5655,135656,CID 135656,C=CCC(=O)NC1=CC=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
5656,135657,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-1-methyl-",CC1=CC=C(C2=NC3=CC=CC=C3C=C12)C(=O)NCCN(C)C,,,,,,
5657,135658,"4-Acridinecarboxamide, 1-chloro-N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)C1=CC=C(C2=CC3=CC=CC=C3N=C12)Cl,,,,,,
5658,135659,"4-Acridinecarboxamide, 9-((2-(dimethylamino)-4-((methylsulfonyl)amino)phenyl)amino)-5-methoxy-N-methyl-",CNC(=O)C1=CC=CC2=C1N=C3C(=C2NC4=C(C=C(C=C4)NS(=O)(=O)C)N(C)C)C=CC=C3OC,,,,,,
5659,135660,"1,1'-Biphenyl, 2,3',6-trinitro-",C1=CC(=CC(=C1)[N+](=O)[O-])C2=C(C=CC=C2[N+](=O)[O-])[N+](=O)[O-],,,,,,
5660,135661,"Methanesulfonamide, N-(4-(benz(c)acridin-7-ylamino)-3-(dimethylamino)phenyl)-",CN(C)C1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC4=CC=CC=C4C3=NC5=CC=CC=C52,,,,,,
5661,135662,"1,2-Dihydrodibenz(a,j)acridine",C1CC2=C(C=C1)C=CC3=C2C=C4C(=N3)C=CC5=CC=CC=C54,,,,,,
5662,135663,"1H-Pyrido(3,4-b)indole-3-carboxylic acid, 2-acetyl-2,3,4,9-tetrahydro-1-methyl-, (1S-cis)-",C[C@H]1C2=C(C[C@H](N1C(=O)C)C(=O)O)C3=CC=CC=C3N2,,,,,,
5663,135664,"Benz(a)anthracene-3,4-diol, 3,4-dihydro-7-nitro-, trans-",C1=CC=C2C(=C1)C=C3C4=C(C=CC3=C2[N+](=O)[O-])[C@@H]([C@H](C=C4)O)O,,,,,,
5664,135665,"1-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)C1=CC=CC2=NC3=CC=CC=C3C=C21,,,,,,
5665,135666,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-1-methoxy-",CN(C)CCNC(=O)C1=CC=C(C2=CC3=CC=CC=C3N=C12)OC,,,,,,
5666,135667,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-2-methyl-",CC1=CC2=CC3=CC=CC=C3N=C2C(=C1)C(=O)NCCN(C)C,,,,,,
5667,135668,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-2-methoxy-",CN(C)CCNC(=O)C1=CC(=CC2=CC3=CC=CC=C3N=C21)OC,,,,,,
5668,135669,"4-Acridinecarboxamide, 5-chloro-N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)C1=CC=CC2=CC3=C(C(=CC=C3)Cl)N=C21,,,,,,
5669,135670,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-6-methyl-",CC1=CC2=C(C=C1)C=C3C=CC=C(C3=N2)C(=O)NCCN(C)C,,,,,,
5670,135671,"Imidazo(2,1-b)thiazole, 6-(p-nitrophenyl)-5-nitroso-",C1=CC(=CC=C1C2=C(N3C=CSC3=N2)N=O)[N+](=O)[O-],,,,,,
5671,135672,"Imidazo(2,1-b)thiazole, 6-(p-chlorophenyl)-5-nitroso-",C1=CC(=CC=C1C2=C(N3C=CSC3=N2)N=O)Cl,,,,,,
5672,135673,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-6-methoxy-",CN(C)CCNC(=O)C1=CC=CC2=CC3=C(C=C(C=C3)OC)N=C21,,,,,,
5673,135674,"4-Acridinecarboxamide, 6-chloro-N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)C1=CC=CC2=CC3=C(C=C(C=C3)Cl)N=C21,,,,,,
5674,135675,N-(2-Anthracenylmethyl)-N'-nitrosourea,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)CNC(=O)NN=O,,,,,,
5675,135676,"8-Quinolinecarboxamide, N-(2-(dimethylamino)ethyl)-2-phenyl-",CN(C)CCNC(=O)C1=CC=CC2=C1N=C(C=C2)C3=CC=CC=C3,,,,,,
5676,135677,4-Methoxy-2-(3-methyloxiranyl)phenyl 2-methylpropanoate,CC1C(O1)C2=C(C=CC(=C2)OC)OC(=O)C(C)C,,,,,,
5677,135678,"Urea, (1-anthracenylmethyl)nitroso-",C1=CC=C2C=C3C(=CC2=C1)C=CC=C3CN(C(=O)N)N=O,,,,,,
5678,135679,"4-Acridinecarboxamide, 2-chloro-N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)C1=CC(=CC2=CC3=CC=CC=C3N=C21)Cl,,,,,,
5679,135680,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-3-methyl-",CC1=C(C2=NC3=CC=CC=C3C=C2C=C1)C(=O)NCCN(C)C,,,,,,
5680,135681,"Oxiranemethanol, 3-(4-bromophenyl)-, (2S-trans)-",C1=CC(=CC=C1[C@H]2[C@@H](O2)CO)Br,,,,,,
5681,135682,"4-Acridinesulfonamide, 9-amino-N-(2-(dimethylamino)ethyl)-",CN(C)CCNS(=O)(=O)C1=CC=CC2=C(C3=CC=CC=C3N=C21)N,,,,,,
5682,135683,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-5-methoxy-",CN(C)CCNC(=O)C1=CC=CC2=CC3=C(C(=CC=C3)OC)N=C21,,,,,,
5683,135684,"4-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-7-methoxy-",CN(C)CCNC(=O)C1=CC=CC2=CC3=C(C=CC(=C3)OC)N=C21,,,,,,
5684,135685,"Urea, (9-anthracenylmethyl)nitroso-",C1=CC=C2C(=C1)C=C3C=CC=CC3=C2CN(C(=O)N)N=O,,,,,,
5685,135686,N-Butyl-N'-methyl-N-nitrosourea,CCCCN(C(=O)NC)N=O,,,,,,
5686,135687,"Cyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione, 8,9-dibromo-2,3,6a,9a-tetrahydro-4-methoxy-, (6aS-cis)-",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@H]5[C@@H](OC4=C1)OC(=C5Br)Br,,,,,,
5687,135688,2-Nitrobenz(j)aceanthrylene,C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC=C5C4=C3C=C5[N+](=O)[O-],,,,,,
5688,135689,"Benz(e)aceanthrylene, 6-nitro-",C1=CC=C2C(=C1)C=C3C(=CC4=C3C2=CC5=CC=CC=C54)[N+](=O)[O-],,,,,,
5689,135690,"1-Piperazineethanol, 4-(3-(8H-dibenz(b,f)(1,2,5)oxadiazolo(3,4-d)azepin-8-yl)propyl)-, N-oxide",C1C[N+](CCN1CCCN2C3=CC=CC=C3C4=NON=C4C5=CC=CC=C52)(CCO)[O-],,,,,,
5690,135691,"2,2'-((9-((3-(Dimethylamino)propyl)amino)-1-nitro-4-acridinyl)imino)bisethanol diacetate",CC(=O)OCCN(CCOC(=O)C)C1=CC=C(C2=C(C3=CC=CC=C3N=C12)NCCCN(C)C)[N+](=O)[O-],,,,,,
5691,135692,"2,2'-((9-((3-(Dimethylamino)propyl)amino)-1-nitro-4-acridinyl)imino)bisethanol",CN(C)CCCNC1=C2C(=CC=C(C2=NC3=CC=CC=C31)N(CCO)CCO)[N+](=O)[O-],,,,,,
5692,135693,CID 135693,C1=CC=C(C=C1)NN=C2C=CC3=C(C2=O)C(=N)C(=NNC4=C(C=C(C=C4)NC(=O)C5=CC=C(C=C5)N=NC6=C(C=C(C=C6O)O)O)S(=O)(=O)O)C=C3S(=O)(=O)O,,,,,,
5693,135694,2-Nitrobenz(l)aceanthrylene,C1=CC=C2C(=C1)C=CC3=C2C4=C5C(=C3)C=CC=C5C(=C4)[N+](=O)[O-],,,,,,
5694,135695,"1H-Imidazo(4,5-f)quinoxalin-2-amine, 8-methyl-",CC1=CN=C2C=CC3=NC(=NC3=C2N1)N,,,,,,
5695,135696,Galamustine hydrochloride,C(CCl)N(CCCl)C[C@@H]1[C@@H]([C@@H]([C@H](C(O1)O)O)O)O.Cl,,,,,,
5696,135697,"2(5H)-Furanone, 5-(hydroxymethylene)-",C1=C(OC(=C1)O)C=O,,,,,,
5697,135698,4-Nitrobenz(k)acephenanthrylene,C1=CC=C2C=C3C4=C5C(=CC=C4)C(=CC5=CC3=CC2=C1)[N+](=O)[O-],,,,,,
5698,135699,"1H-Purine-2,6-diamine, N6-ethyl-",CCNC1=NC(=NC2=C1NC=N2)N,,,,,,
5699,135700,"N,N'-Dimethoxy-1H-purine-2,6-diamine",CONC1=NC(=NC2=C1NC=N2)NOC,,,,,,
5700,135701,N-Methoxycarbonylmethyl-N-nitrosourea,COC(=O)CN(C(=O)N)N=O,,,,,,
5701,135702,"3-Acridinecarboxamide, N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)C1=CC2=NC3=CC=CC=C3C=C2C=C1,,,,,,
5702,135703,"Benzamide, N-(2-aminocyclohexyl)-4-bromo-, trans-, monomethanesulfonate",CS(=O)(=O)O.C1CC[C@H]([C@@H](C1)N)NC(=O)C2=CC=C(C=C2)Br,,,,,,
5703,135704,"beta-Alanine, N-(aminocarbonyl)-N-nitroso-, methyl ester",COC(=O)CCN(C(=O)N)N=O,,,,,,
5704,135705,"Alanine, 3-azido-, tert-butyl ester, DL-",CC(C)(C)OC(=O)[C@H](CN=[N+]=[N-])N,,,,,,
5705,135706,"(S)-4-(2-(Butylnitrosoamino)-1-hydroxyethyl)-6-diazo-2,4-cyclohexadien-1-one",CCCCN(C[C@H](C1=CC(=C(C=C1)[O-])[N+]#N)O)N=O,,,,,,
5706,135707,5-[(1S)-2-[butyl(nitroso)amino]-1-hydroxyethyl]-2-hydroxybenzenediazonium,CCCCN(C[C@H](C1=CC(=C(C=C1)O)[N+]#N)O)N=O,,,,,,
5707,135708,"Benzenemethanol, alpha-((butylnitrosoamino)methyl)-4-hydroxy-, (S)-",CCCCN(C[C@H](C1=CC=C(C=C1)O)O)N=O,,,,,,
5708,135709,"Butanoic acid, 4-((aminocarbonyl)nitrosoamino)-, methyl ester",COC(=O)CCCN(C(=O)N)N=O,,,,,,
5709,135710,"1H-Imidazole-4-ethanamine, N-chloro-",C1=C(NC=N1)CCNCl,,,,,,
5710,135711,"N,N'-Dichloro-1,4-butanediamine",C(CCNCl)CNCl,,,,,,
5711,135712,"1,4-Butanediamine, N-chloro-",C(CCNCl)CN,,,,,,
5712,135713,CID 135713,C1=CC(=CC=C1C2=NC(=O)C3=NC=NC3=N2)N(O)O,,,,,,
5713,135714,"5,6-Azulenedicarboxaldehyde, 1,2,3,3a,8,8a-hexahydro-2,2-dimethyl-8-methylene-, (3aS-cis)-",CC1(C[C@H]2C=C(C(=CC(=C)[C@H]2C1)C=O)C=O)C,,,,,,
5714,135715,"3-Fluoranthenesulfonic acid, 9-amino-4-iodo-",C1=CC2=C(C=C1N)C3=C4C2=CC=C(C4=C(C=C3)S(=O)(=O)O)I,,,,,,
5715,135716,"1,2-Benzenediol, 3-methoxy-6-(2-(3,4,5-trimethoxyphenyl)ethyl)-",COC1=C(C(=C(C=C1)CCC2=CC(=C(C(=C2)OC)OC)OC)O)O,,,,,,
5716,135717,"7H-Dibenzo(c,g)carbazol-1-ol",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C=CC5=C4C(=CC=C5)O,,,,,,
5717,135718,"1,3-Dinitrofluoranthene",C1=CC=C2C(=C1)C3=CC=CC4=C3C2=C(C=C4[N+](=O)[O-])[N+](=O)[O-],,,,,,
5718,135719,"Phenanthro(9,10-g)isoquinoline",C1=CC=C2C(=C1)C3=CC=CC=C3C4=C2C=C5C=CN=CC5=C4,,,,,,
5719,135720,1-(2-Oxopropyl)nitroso-3-(2-chloroethyl)urea,CC(=O)CN(C(=O)NCCCl)N=O,,,,,,
5720,135721,"Benzo(a)pyren-3-ol, 6-nitro-, acetate (ester)",CC(=O)OC1=C2C=CC3=C(C4=CC=CC=C4C5=C3C2=C(C=C5)C=C1)[N+](=O)[O-],,,,,,
5721,135722,o-Nitrobenzyl benzoate,C1=CC=C(C=C1)C(=O)OCC2=CC=CC=C2[N+](=O)[O-],,,,,,
5722,135723,"Isothiazolo(5,4-b)quinoline-3,4(2H,9H)-dione, 9-ethyl-6,8-difluoro-7-(1-piperazinyl)-",CCN1C2=C(C(=C(C=C2C(=O)C3=C1SNC3=O)F)N4CCNCC4)F,,,,,,
5723,135724,"2,3,3-Trimethyloxiranemethanol",CC1(C(O1)(C)CO)C,,,,,,
5724,135725,N-(benzimidazol-1-yl)-1-(5-nitrofuran-2-yl)methanimine,C1=CC=C2C(=C1)N=CN2N=CC3=CC=C(O3)[N+](=O)[O-],,,,,,
5725,135726,"2-Acetamidodipyrido(1,2-a:3',2'-d)imidazole",CC(=O)NC1=NC2=C(C=C1)N=C3N2C=CC=C3,,,,,,
5726,135727,CID 135727,COC1=C(C=CC(=C1)C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OS(=O)(=O)O)O,,,,,,
5727,135728,Gyrophoric acid,CC1=CC(=CC(=C1C(=O)OC2=CC(=C(C(=C2)C)C(=O)OC3=CC(=C(C(=C3)C)C(=O)O)O)O)O)O,,,,,,
5728,135729,2-Methyl-L-methionine,C[C@](CCSC)(C(=O)O)N,,,,,,
5729,135730,1-Hydroxypropan-2-yl methanesulfonate,CC(CO)OS(=O)(=O)C,,,,,,
5730,135731,"Urea, 1,3-dimethyl-1-hydroxy-",CNC(=O)N(C)O,,,,,,
5731,135732,Butyl diazoacetate,CCCCOC(=O)C=[N+]=[N-],,,,,,
5732,135733,CID 135733,CCCCOC(=C[N+]#N)O,,,,,,
5733,135734,"Phenanthro(3,2-h)isoquinoline",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=NC=C5,,,,,,
5734,135735,"Ethyl 11-chloro-3,7,11-trimethyldodec-2-enoate",CCOC(=O)C=C(C)CCCC(C)CCCC(C)(C)Cl,,,,,,
5735,135736,"Phenanthro(2,3-h)isoquinoline",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C5=C(C=C4)C=CN=C5,,,,,,
5736,135737,"Urea, 1-(bis(1-aziridinyl)phosphinyl)-3-(3-nitro-p-tolyl)-",CC1=C(C=C(C=C1)NC(=O)NP(=O)(N2CC2)N3CC3)[N+](=O)[O-],,,,,,
5737,135738,"Urea, 1-(bis(1-aziridinyl)phosphinyl)-3-(p-iodophenyl)-",C1CN1P(=O)(NC(=O)NC2=CC=C(C=C2)I)N3CC3,,,,,,
5738,135739,"2,5-Dimethoxy-4-methylphenethylamine hydrochloride",CC1=CC(=C(C=C1OC)CCN)OC.Cl,,,,,,
5739,135740,"2,5-Dimethoxy-4-methylphenethylamine",CC1=CC(=C(C=C1OC)CCN)OC,,,,,,
5740,135741,(+-)-alpha-Amino-2-(bis(2-chloroethyl)amino)-alpha-methylbenzeneacetic acid,CC(C1=CC=CC=C1N(CCCl)CCCl)(C(=O)O)N,,,,,,
5741,135742,"3-Amino-3,4-dihydro-1-hydroxy-2(1H)-quinolinone",C1C(C(=O)N(C2=CC=CC=C21)O)N,,,,,,
5742,135743,"Propane-1,3-diyl bis(4-nitrobenzene-1-sulfonate)",C1=CC(=CC=C1[N+](=O)[O-])S(=O)(=O)OCCCOS(=O)(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5743,135744,4-(1H-imidazol-1-yl)benzonitrile,C1=CC(=CC=C1C#N)N2C=CN=C2,,,,,,
5744,135745,"N-(2-Chloroethyl)-N-methyl-1,3-propanediamine",CN(CCCN)CCCl,,,,,,
5745,135746,"(2-Indolo[2,3-b]quinoxalin-6-yl-ethyl)-dimethyl-amine",CN(C)CCN1C2=CC=CC=C2C3=NC4=CC=CC=C4N=C31,,,,,,
5746,135747,"1,4-Bis[(1-piperazinyl)methyl]benzene",C1CN(CCN1)CC2=CC=C(C=C2)CN3CCNCC3,,,,,,
5747,135748,4-(2-Pyridinylazo)benzenamine,C1=CC=NC(=C1)N=NC2=CC=C(C=C2)N,,,,,,
5748,135749,Terflavoxate hydrochloride,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OC(C)(C)CN3CCCCC3)C4=CC=CC=C4.Cl,,,,,,
5749,135750,Terflavoxate,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OC(C)(C)CN3CCCCC3)C4=CC=CC=C4,,,,,,
5750,135751,"2-(1-(3-Methoxyphenyl)-2-cyclohexen-1-yl)-N,N-dimethylethylamine hcl",CN(C)CCC1(CCCC=C1)C2=CC(=CC=C2)OC.Cl,,,,,,
5751,135752,"rac. 1-(m-methoxyphenyl)-N,N-dimethyl-2-cyclohexene-1-ethylamine",CN(C)CCC1(CCCC=C1)C2=CC(=CC=C2)OC,,,,,,
5752,135753,"4-(Methylthio)phenyl 4-((2,5-dioxo-1-pyrrolidinyl)oxy)-4-oxobutanoate",CSC1=CC=C(C=C1)OC(=O)CCC(=O)ON2C(=O)CCC2=O,,,,,,
5753,135754,"6-(1,2,3,4-Tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acid",CC1(CCC(C2=C1C=CC(=C2)C3=CC4=C(C=C3)C=C(C=C4)C(=O)O)(C)C)C,,,,,,
5754,135755,Benzyl-2-pyridylketon-2-chinolylhydrazon,C1=CC=C(C=C1)CC(=NNC2=NC3=CC=CC=C3C=C2)C4=CC=CC=N4,,,,,,
5755,135756,CID 135756,CC1[C@@H]2CC3=C([C@@]1(CCN2CCC4=CC=C(C=C4)F)C)C=C(C=C3)O,,,,,,
5756,135757,24-(Isopropylseleno)chol-5-en-3-ol,C[C@H](CCC[Se]C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
5757,135758,20-Hyp-diol,CCCCC#C[C@@](C)([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
5758,135759,Hdypd,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2[C@](C)(C#CCCC#C)O)CC=C4[C@@]3(CC[C@@H](C4)O)C,,,,,,
5759,135760,6-Methylspirost-5-en-3-ol,C[C@@H]1CCC2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC(=C6[C@@]5(CC[C@@H](C6)O)C)C)C)C)OC1,,,,,,
5760,135761,CID 135761,C1=CC(=C[CH]C1C2=C(C(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)OC(=O)CC(=O)O)O,,,,,,
5761,135762,"2-Butenamide, N-(diaminophosphinyl)-3-methyl-",CC(=CC(=O)NP(=O)(N)N)C,,,,,,
5762,135763,"2,4-Dihydro-2,4-bis(oxiranylmethyl)-5-methyl-3H-1,2,4-triazol-3-one",CC1=NN(C(=O)N1CC2CO2)CC3CO3,,,,,,
5763,135764,Methyl-8-(2-anthroyl)octanoate,COC(=O)CCCCCCCC(=O)C1=CC2=CC3=CC=CC=C3C=C2C=C1,,,,,,
5764,135765,Malantide,CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCN=C(N)N)N,,,,,,
5765,135766,"20-(1-Propynyl)-5-pregnen-3,20-diol",CC#C[C@@](C)([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
5766,135767,"1,1,1-Trifluoro-4-phenylbutan-2-one",C1=CC=C(C=C1)CCC(=O)C(F)(F)F,,,,,,
5767,135768,"[(2R,3R)-2-[(3S,5R,9R,10R,13R,17S)-3,14-dihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2,6-dihydroxy-6-methylheptan-3-yl] dihydrogen phosphate",C[C@]12CC[C@@H](C[C@H]1C(=O)C=C3[C@@H]2CC[C@]4(C3(CC[C@@H]4[C@](C)([C@@H](CCC(C)(C)O)OP(=O)(O)O)O)O)C)O,,,,,,
5768,135769,"(2|A,3|A,5|A,14xi,22r)-2,3,14,20,25-pentahydroxy-6-oxocholest-7-en-22-yl dihydrogen phosphate",C[C@]12CC[C@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C1(CC[C@@H]2[C@](C)([C@@H](CCC(C)(C)O)OP(=O)(O)O)O)O,,,,,,
5769,135770,4-amino-5-chloro-N-[9-[(4-fluorophenyl)methyl]-9-azabicyclo[3.3.1]nonan-3-yl]-2-methoxybenzamide,COC1=CC(=C(C=C1C(=O)NC2CC3CCCC(C2)N3CC4=CC=C(C=C4)F)Cl)N,,,,,,
5770,135771,6-Fluoropalmitic acid,CCCCCCCCCCC(CCCCC(=O)O)F,,,,,,
5771,135772,7-Fluorohexadecanoic acid,CCCCCCCCCC(CCCCCC(=O)O)F,,,,,,
5772,135773,Iodoacetamidoerythrosin,C1=CC2=C(C=C1NC(=O)CI)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)I)O)I)I)O)I,,,,,,
5773,135774,2-((3-Methyl-4-methoxy-2-pyridylmethyl)sulfinyl)-5-trifluoromethyl-1H-benzimidazole,CC1=C(C=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)C(F)(F)F)OC,,,['Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)'],,,
5774,135775,Pyronopaline,C1CC(=O)N([C@@H]1C(=O)O)[C@H](CCCN=C(N)N)C(=O)O,,,,,,
5775,135776,"3,6,7,8-Tetrahydro-3-((2-hydroxyethoxy)methyl)imidazo(4,5-d)(1,3)diazepin-8-ol",C1C(C2=C(NC=N1)N(C=N2)COCCO)O,,,['Drugs that inhibit ADENOSINE DEAMINASE activity. (See all compounds classified as Adenosine Deaminase Inhibitors.)'],,,
5776,135777,"7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-methoxyiminocyclopentyl]hept-5-enoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](CC(=NOC)[C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
5777,135778,"(1S,3R)-5-[2-[(1R,3aS,7aR)-1-[(2R,5R)-5-fluoro-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C[C@H](CC[C@H](C(C)(C)O)F)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](C[C@H](C3=C)O)O)C,,,,,,
5778,135779,CID 135779,CN1C2=C(C=CC=C2O)C(=C3C1=C(C(=CC3=O)OC)OC)O,,,,,,
5779,135780,"N,N,4,8,13,17,21-heptamethyldocosa-4,8,12,16,20-pentaen-1-amine",CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCCN(C)C)C)C)C,,,,,,
5780,135781,CID 135781,CCN(CC)CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(C)C)C)C,,,,,,
5781,135782,CID 135782,C[C@H](C[C@@H](CC(C)(C)O)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](C[C@H](C3=C)O)O)C,,,,,,
5782,135783,Magnoshinin,C[C@H]1[C@@H](C2=C(C=C1C)C(=CC(=C2OC)OC)OC)C3=CC(=C(C=C3OC)OC)OC,,,,,,
5783,135784,Cefoperazone monobactam,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3CN(C3=O)S(=O)(=O)O,,,,,,
5784,135785,"3-(1,3-Dioxo-1H-benzo[DE]isoquinolin-2(3H)-YL)propanoic acid",C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CCC(=O)O,,,,,,
5785,135786,5-Deoxyribose 1-phosphate,C[C@@H]1[C@H]([C@H](C(O1)OP(=O)(O)O)O)O,,,,,,
5786,135787,"(2S)-2-[(1S)-1-(2,4-dioxo-1H-pyrimidin-5-yl)-2-oxoethoxy]-3-hydroxypropanal",C1=C(C(=O)NC(=O)N1)[C@@H](C=O)O[C@@H](CO)C=O,,,,,,
5787,135788,1-[2-Oxo-2-[4-(3-phenylprop-2-enyl)piperazin-1-yl]ethyl]pyrrolidin-2-one,C1CC(=O)N(C1)CC(=O)N2CCN(CC2)CC=CC3=CC=CC=C3,,,,,,
5788,135789,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, cyclopropylmethyl methyl ester",CC1=C(C(C(=C(N1)C)C(=O)OCC2CC2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,,,,,,
5789,135790,CID 135790,CC1CCCC2=C(NC(=C12)C=C3C(=CC(=C4C=CC=N4)N3)OC)C,,,,,,
5790,135791,"2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-N-(2-hydroxyethyl)-, monohydrochloride, (+-)-",CC1=C(C(=CC=C1)C)N(CCO)C(=O)C2CCCCN2.Cl,,,,,,
5791,135792,"N-(2,6-Dimethylphenyl)-N-(2-hydroxyethyl)-2-piperidinecarboxamide",CC1=C(C(=CC=C1)C)N(CCO)C(=O)C2CCCCN2,,,,,,
5792,135793,"3-(2,4-Dioxopyrimidin-1-yl)prop-2-enal",C1=CN(C(=O)NC1=O)C=CC=O,,,,,,
5793,135794,"N,N-Dimethyl-4-amino-3-chloroangelicin",CN(C)C1=C(C(=O)OC2=C1C=CC3=C2C=CO3)Cl,,,,,,
5794,135795,CID 135795,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)N=C(N3)N)N=C2Br)OP(=O)(O)O)O)O,,,,,,
5795,135796,CID 135796,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)N=C(N3)N)N=C2Br)O)OP(=O)(O)O)O,,,,,,
5796,135797,tert-Boc-leu-phe-EA,CC(C)C[C@H](C(=O)NC(=O)[C@H](CC1=CC=CC=C1)NCCO)NC(=O)OC(C)(C)C,,,,,,
5797,135798,Lysine valproate,CCCC(CCC)C(=O)[O-].C(CCN)C[C@@H](C(=O)O)N,,,,,,
5798,135799,(S)-N-((Phenylmethoxy)carbonyl)-L-alanyl-N-(3-chloro-2-oxo-1-(phenylmethyl)propyl)-L-alaninamide,C[C@@H](C(=O)NC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1)N[C@@H](CC2=CC=CC=C2)C(=O)CCl,,,,,,
5799,135800,CID 135800,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](CCC3=O)O)C,,,,,,
5800,135801,CID 135801,C1CSC2=NC3=C(N21)NC=NC3=O,,,,,,
5801,135802,CID 135802,CC1(CC(CC(N1[O])(C)C)N=C(NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)[N+](=O)[O-])S(=O)(=O)O)S(=O)(=O)O)S)C,,,,,,
5802,135803,3-Carboxy-5-propyl-2-furanpropionic acid,CCCC1=CC(=C(O1)CCC(=O)O)C(=O)O,,,,,,
5803,135804,4-Arsono-2-hydroxybutanoic acid,C(C[As](=O)(O)O)C(C(=O)O)O,,,,,,
5804,135805,2-Amino-4-arsonobutyric acid,C(C[As](=O)(O)O)C(C(=O)O)N.O,,,,,,
5805,135806,CID 135806,C(C[As](=O)(O)O)C(C(=O)O)N,,,,,,
5806,135807,"1,4-Dihydro-2,6-dimethyl-4-(2-isothiocyanatophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester",CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2N=C=S)C(=O)OC,,,,,,
5807,135808,N-Sulfo-2-aminotricarballylate,C(C(=O)O)C(CC(=O)O)(C(=O)O)NS(=O)(=O)O,,,,,,
5808,135809,"7-Bromo-5-(2-fluorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",CN1C(=O)CN=C(C2=C1C=CC(=C2)Br)C3=CC=CC=C3F,,,,,,
5809,135810,"2-Trifluoroacetamido-1,3,4,6-tetra-O-acetyl-2-deoxymannopyranose",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@@H](C(O1)OC(=O)C)NC(=O)C(F)(F)F)OC(=O)C)OC(=O)C,,,,,,
5810,135811,CID 135811,CC=CCCC(=O)C[C@H](CCO)O,,,,,,
5811,135812,"7H-Benzo(c)fluorene-6-carboxylic acid, 5-(2-(dimethylamino)ethoxy)-7-oxo-, 2-(dimethylamino)ethyl ester",CN(C)CCOC1=C(C2=C(C3=CC=CC=C31)C4=CC=CC=C4C2=O)C(=O)OCCN(C)C,,,,,,
5812,135813,2-Acetamido-N-benzyl-2-methylacetamide,CC(C(=O)NCC1=CC=CC=C1)NC(=O)C,,,,,,
5813,135814,Prolyl Endopeptidase Inhibitor 1,CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C=O,,,,,,
5814,135815,"13-hydroxy-N-(1-hydroxypropan-2-yl)-2,10,12,14-tetramethylhexadeca-2,4,6,8,10,14-hexaenamide",CC=C(C)C(C(C)C=C(C)C=CC=CC=CC=C(C)C(=O)NC(C)CO)O,,,,,,
5815,135816,"13-hydroxy-N-(1-hydroxypropan-2-yl)-2,10,12,14-tetramethylheptadeca-2,4,6,8,10,14-hexaenamide",CCC=C(C)C(C(C)C=C(C)C=CC=CC=CC=C(C)C(=O)NC(C)CO)O,,,,,,
5816,135817,1-[4-[2-[2-(4-Fluorophenyl)ethoxy]ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol,CC(C)NCC(COC1=CC=C(C=C1)OCCOCCC2=CC=C(C=C2)F)O,,,,,,
5817,135818,"3-(2,4-dichlorophenyl)-N,N-dimethyl-2,3-dihydro-1H-inden-1-amine",CN(C)C1CC(C2=CC=CC=C12)C3=C(C=C(C=C3)Cl)Cl,,,,,,
5818,135819,"4-Ethyl-4,7-dihydro-2-phenylpyrazolo(1,5-a)pyrimidin-7-one",CCN1C=CC(=O)N2C1=CC(=N2)C3=CC=CC=C3,,,,,,
5819,135820,3'-Octanoyl-5-fluoro-2'-deoxyuridine,CCCCCCCC(=O)[C@@]1(C[C@@H](O[C@@H]1CO)N2C=C(C(=O)NC2=O)F)O,,,,,,
5820,135821,CID 135821,C1=C(C(=C(C(=C1I)N[N+]#N)I)[O-])C(=O)NC[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O,,,,,,
5821,135822,CID 135822,C1=C(C(=C(C(=C1I)N[N+]#N)I)O)C(=O)NC[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O,,,,,,
5822,135823,"1-(2-(2,4-Dichlorobenzyloxy)-N-octyl)imidazole oxalate",CCCCCCC(CN1C=CN=C1)OCC2=C(C=C(C=C2)Cl)Cl.C(=O)(C(=O)O)O,,,,,,
5823,135824,"(R)-1-[2-[(2,4-Dichlorobenzyl)oxy]octyl]-1H-imidazole",CCCCCCC(CN1C=CN=C1)OCC2=C(C=C(C=C2)Cl)Cl,,,,,,
5824,135825,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2,6,8-trioxo-7,9-dihydropurin-3-yl)oxolan-2-yl]methyl dihydrogen phosphate",C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)NC2=O)NC(=O)N3)O)O)OP(=O)(O)O,,,,,,
5825,135826,benzyl N-[2-[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[(9-ethylcarbazol-3-yl)amino]pentanoyl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]carbamate,CCN1C2=C(C=C(C=C2)N[C@@H](CCCN=C(N)N)C(=O)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)OCC4=CC=CC=C4)C5=CC=CC=C51,,,,,,
5826,135827,"Acetamide, N-(acetyloxy)-N-(7-butyl-9H-fluoren-2-yl)-",CCCCC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)N(C(=O)C)OC(=O)C,,,,,,
5827,135828,"Phenoxy, 4-(acetylamino)-",CC(=O)NC1=CC=C(C=C1)[O],,,,,,
5828,135829,"1,6-Dimethyl-4-isopropyl-5,8-naphthoquinone",CC1=C2C(=O)C=C(C(=O)C2=C(C=C1)C(C)C)C,,,,,,
5829,135830,CID 135830,C1=CC=C2C(=C1)C=NN2N=CC3=CC=C(O3)[N+](=O)[O-],,,,,,
5830,135831,"2-Methyl-5-methylsulfanyl-4-[(5-nitrofuran-2-yl)methylideneamino]-1,2,4-triazole-3-thione",CN1C(=S)N(C(=N1)SC)N=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
5831,135832,CID 135832,C1=CN(N=C1)N=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
5832,135833,"1-[(5-Nitrofuran-2-yl)methylideneamino]-4,6-diphenylpyridin-2-one",C1=CC=C(C=C1)C2=CC(=O)N(C(=C2)C3=CC=CC=C3)N=CC4=CC=C(O4)[N+](=O)[O-],,,,,,
5833,135834,"9-Acridinamine, N-octyl-",CCCCCCCCNC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
5834,135835,"2-((2-Chloro-1,1,2-trifluoroethyl)thio)-2-methylpropane",CC(C)(C)SC(C(F)Cl)(F)F,,,,,,
5835,135836,Piroxicam pivalic ester,CC(C)(C)C(=O)OC1=C(N(S(=O)(=O)C2=CC=CC=C21)C)C(=O)NC3=CC=CC=N3,,,,,,
5836,135837,CID 135837,C[C@H](C=C[C@@H](CCF)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
5837,135838,CID 135838,CCCN(CCCS(=O)(=O)[O-])C1=CC(=C(C=C1)N=NC2=NC=C(C=C2)Br)N.[Na+],,,,,,
5838,135839,2-(5-Bromo-2-pyridylazo)-5-(N-propyl-N-sulfopropylamino)aniline,CCCN(CCCS(=O)(=O)O)C1=CC(=C(C=C1)N=NC2=NC=C(C=C2)Br)N,,,,,,
5839,135840,CID 135840,C1=CC=C2C(=C1)C=CC=C2C=CC3=CC=[N+](C=C3)CCCCCCCCCCC(=O)O.[Cl-],,,,,,
5840,135841,CID 135841,C1=CC=C2C(=C1)C=CC=C2C=CC3=CC=[N+](C=C3)CCCCCCCCCCC(=O)O,,,,,,
5841,135842,p-Methylphenylbutylene oxide,CC1=CC=C(C=C1)CCC2CO2,,,,,,
5842,135843,"Oxirane, 2-(2-(1-naphthalenyl)ethyl)-",C1C(O1)CCC2=CC=CC3=CC=CC=C32,,,,,,
5843,135844,"9,10-Dihydro-N-(2-(dimethylamino)ethyl)-9,10-dioxo-1-anthracenecarboxamide",CN(C)CCNC(=O)C1=CC=CC2=C1C(=O)C3=CC=CC=C3C2=O,,,,,,
5844,135845,"9H-Thioxanthene-4-carboxamide, N-(2-(dimethylamino)ethyl)-9-oxo-",CN(C)CCNC(=O)C1=CC=CC2=C1SC3=CC=CC=C3C2=O,,,,,,
5845,135846,"Benzamide, N-(4-(9-acridinylamino)butyl)-4-nitro-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCNC(=O)C4=CC=C(C=C4)[N+](=O)[O-].Cl,,,,,,
5846,135847,N-[4-(acridin-9-ylamino)butyl]-4-nitrobenzamide,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCNC(=O)C4=CC=C(C=C4)[N+](=O)[O-],,,,,,
5847,135848,"Benzamide, N-(8-(9-acridinylamino)octyl)-4-nitro-, monohydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCCCNC(=O)C4=CC=C(C=C4)[N+](=O)[O-].Cl,,,,,,
5848,135849,N-[8-(acridin-9-ylamino)octyl]-4-nitrobenzamide,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCCCCCCNC(=O)C4=CC=C(C=C4)[N+](=O)[O-],,,,,,
5849,135850,9-Fluorobenzo[k]fluoranthene,C1=CC2=C3C(=C1)C4=C(C3=CC=C2)C=C5C=C(C=CC5=C4)F,,,,,,
5850,135851,8-Fluorobenzo(k)fluoranthene,C1=CC2=C3C(=C1)C4=C(C3=CC=C2)C=C5C(=C4)C=CC=C5F,,,,,,
5851,135852,S-(2-(Bis(1-methylethyl)amino)ethyl) O-ethyl O-methyl phosphorothioate,CCOP(=O)(OC)SCCN(C(C)C)C(C)C,,,,,,
5852,135853,"2,2'-Ethylenebis(6-hydroxymethyl)-4-benzoquinone",CC(=O)OCC1=CC(=O)C=C(C1=O)CCC2=CC(=O)C=C(C2=O)COC(=O)C,,,,,,
5853,135854,"2,4,6-Trimethylpyrylium perchlorate",CC1=CC(=[O+]C(=C1)C)C.[O-]Cl(=O)(=O)=O,,,,,,
5854,135855,"2,4,6-Trimethylpyran",CC1=CC(=[O+]C(=C1)C)C,,,,,,
5855,135856,"2,2'-Ethylenebis(6-(bromomethyl)-4-benzoquinone)",C1=C(C(=O)C(=CC1=O)CBr)CCC2=CC(=O)C=C(C2=O)CBr,,,,,,
5856,135857,2-(3-Methylbutyl)-1H-benzimidazole,CC(C)CCC1=NC2=CC=CC=C2N1,,,,,,
5857,135858,"2-Methyl-5-[2-(4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)cyclopropyl]cyclohexa-2,5-diene-1,4-dione",CC1=CC(=O)C(=CC1=O)C2CC2C3=CC(=O)C(=CC3=O)C,,,,,,
5858,135859,"4,8-Dimethyl-2-oxabicyclo[9.3.1]pentadeca-1(15),4,8,11,13-pentaen-12-ol",CC1=CCC2=C(C=CC(=C2)OCC(=CCC1)C)O,,,,,,
5859,135860,"7-Chloro-1-(2,2,2-trifluoroethyl)-3-hydroxy-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one",C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CC(F)(F)F)O)F,,,,,['3-Hydroxy-2-oxoquazepam is a known human metabolite of 2-oxoquazepam.'],
5860,135861,3-Chloromethylfluoranthene,C1=CC=C2C(=C1)C3=C4C2=CC=CC4=C(C=C3)CCl,,,,,,
5861,135862,4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]naphthalen-1-yl hydrogen sulfate,CC(C)NCC(COC1=CC=C(C2=CC=CC=C21)OS(=O)(=O)O)O,,,,,,
5862,135863,9-Piperidinoacridine,C1CCN(CC1)C2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
5863,135864,Tripalmitoyl cysteine,CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)OC,,,,,,
5864,135865,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(4-hydroxy-1-methylbutyl)-",CCC1(C(=O)NC(=O)NC1=O)C(C)CCCO,,,,,,
5865,135866,Texazone,CNC1=CC2=NC3=C(C=CC(=C3)C(=O)O)OC2=CC1=O,,,,,,
5866,135867,"Methyl 2-(methoxymethylidene)-3-methyl-6-[3-(3-methylbut-2-enoxy)phenyl]hexa-3,5-dienoate",CC(=CCOC1=CC=CC(=C1)C=CC=C(C)C(=COC)C(=O)OC)C,,,,,,
5867,135868,"3,3-Bis(1-aziridinyl)propionitrile",C1CN1C(CC#N)N2CC2,,,,,,
5868,135869,"3,4-Dihydroxyphenylacetamidine",C1=CC(=C(C=C1CC(=N)N)O)O,,,,,,
5869,135870,"Butanamide, N-(3-(dimethylamino)propyl)-2,2,3,3,4,4-hexafluoro-4-(heptafluoropropoxy)-, N-oxide",CN(C)CCC[NH+](C(=O)C(C(C(OC(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-],,,,,,
5870,135871,"N-[3-(dimethylamino)propyl]-2,2,3,3,4,4-hexafluoro-4-(1,1,2,2,3,3,3-heptafluoropropoxy)-N-oxidobutanamide",CN(C)CCCN(C(=O)C(C(C(OC(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-],,,,,,
5871,135872,"2-Isopropyl-8-methylphenanthrene-3,4-dione",CC1=C2C=CC3=C(C2=CC=C1)C(=O)C(=O)C(=C3)C(C)C,,,,,,
5872,135873,"4-Aminoquinoline 1-oxide, monohydrochloride",C1=CC=C2C(=C1)C(=N)C=CN2O.Cl,,,,,,
5873,135874,4-Aminoquinoline 1-oxide,C1=CC=C2C(=C1)C(=N)C=CN2O,,,,,,
5874,135875,"1-(((3,4-Dimethoxyphenyl)ethyl)amino)-3-(4-hydroxyphenoxy)-2-propanol",COC1=C(C=C(C=C1)CCNC[C@@H](COC2=CC=C(C=C2)O)O)OC,,,,,,
5875,135876,"1H-Imidazol-2-amine, N-(3,4-dimethoxyphenyl)-4,5-dihydro-, monohydrochloride",COC1=C(C=C(C=C1)NC2=NCCN2)OC.Cl,,,,,,
5876,135877,"N-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-imidazol-2-amine",COC1=C(C=C(C=C1)NC2=NCCN2)OC,,,,,,
5877,135878,"1,4-Bis(2-chloroethyl)-1,4-diazoniabicyclo(2.2.1)heptane diperchlorate",C1C[N+]2(CC[N+]1(C2)CCCl)CCCl.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O,,,,,,
5878,135879,"1-(2-Chloro-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,9a,10,10a,10b,11-decahydro-6bH,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-hydroxyethan-1-one",C[C@]12C[C@@H](C3([C@H]([C@@H]1C[C@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CC=C5[C@@]3(C=CC(=C5)Cl)C)F)O,,,,,,
5879,135880,"1-(2-Chloro-4b,12-difluoro-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,9a,10,10a,10b,11-decahydro-6bH,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-hydroxyethan-1-one",C[C@]12C[C@@H](C3([C@H]([C@@H]1C[C@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CC(=C5[C@@]3(C=CC(=C5)Cl)C)F)F)O,,,,,,
5880,135881,"Phenol, 4-(1-aminoethyl)-2,6-bis(1,1-dimethylethyl)-, hydrochloride",CC(C1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)N.Cl,,,,,,
5881,135882,"4-(1-Aminoethyl)-2,6-di-tert-butylphenol",CC(C1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)N,,,,,,
5882,135883,CID 135883,C[C@H](CC(C(=O)C(C)(C)O)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@@H](C[C@H](C3=C)O)O)C,,,,,,
5883,135884,"Propionic acid, 3,3-bis(1-aziridinyl)-, methyl ester",COC(=O)CC(N1CC1)N2CC2,,,,,,
5884,135885,1-Pyrenylalanine,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)C[C@@H](C(=O)O)N,,,,,,
5885,135886,"3-(2-pyridin-4-ylethenyl)-4,5-dihydro-1H-pyridazin-6-one",C1CC(=O)NN=C1C=CC2=CC=NC=C2,,,,,,
5886,135887,3-HDH-withanolide F,CC1=C(C(=O)O[C@H](C1)[C@@](C)([C@]2(CC[C@@]3([C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(C(=O)C[C@@H](C5)O)C)C)O)O)O)C,,,,,,
5887,135888,"3-[(2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimido[1,2-a]purin-10-one",C1[C@@H]([C@H](O[C@@H]1N2C=NC3=C2N=C4N=CC=CN4C3=O)CO)O,,,,,,
5888,135889,Tripalmitoyl pentapeptide,CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O,,,,,,
5889,135890,CID 135890,CCCCCCCCCCCCCC=C[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)NC(=O)C2=CN=CC=C2)O,,,,,,
5890,135891,CID 135891,C[C@H](C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC1=CC(=CC=C1)F)N,,,,,,
5891,135892,"5,6-Bis(4-methylphenyl)-3-(4-hydroxypiperidino)-1,2,4-triazine",CC1=CC=C(C=C1)C2=C(N=NC(=N2)N3CCC(CC3)O)C4=CC=C(C=C4)C,,,,,,
5892,135893,Prodiame,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2NCCCN)CCC4=C3C=CC(=C4)O,,,,,,
5893,135894,2-(4-Methoxyphenyl)-4'-(2-(1-pyrrolidinyl)ethoxy)deoxybenzoin,COC1=CC=C(C=C1)C2=CC=CC=C2C(=O)CC3=CC=C(C=C3)OCCN4CCCC4,,,,,,
5894,135895,4-(2-Succinimidyloxycarbonylethyl)phenyl-10-methylacridinium-9-carboxylate,C[N+]1=C2C=CC=CC2=C(C3=CC=CC=C31)C(=O)OC4=CC=C(C=C4)CCC(=O)ON5C(=O)CCC5=O.[O-]S(=O)(=O)F,,,,,,
5895,135896,Acridinium NHS ester,C[N+]1=C2C=CC=CC2=C(C3=CC=CC=C31)C(=O)OC4=CC=C(C=C4)CCC(=O)ON5C(=O)CCC5=O,,,,,,
5896,135897,beta-Chloroalanyl-beta-chloroalanine,C([C@@H](C(=O)N[C@@H](CCl)C(=O)O)N)Cl,,,,,,
5897,135898,Glycyl-seryl-histidyl-lysine,C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)NC(=O)CN,,,,,,
5898,135899,Phosphono-platelet activating factor,CCCCCCCCCCCCCCCCOCC(COP(=O)(CC[N+](C)(C)C)[O-])OC(=O)C,,,,,,
5899,135900,2-[(2-Acetyloxy-3-hexadecoxypropoxy)-hydroxyphosphoryl]ethyl-trimethylazanium,CCCCCCCCCCCCCCCCOCC(COP(=O)(CC[N+](C)(C)C)O)OC(=O)C,,,,,,
5900,135901,Tyrosylvalinamide,CC(C)[C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N,,,,,,
5901,135902,1-Dodecylpyridoxal chloride,CCCCCCCCCCCC[N+]1=C(C(=C(C(=C1)CO)C=O)O)C.[Cl-],,,,,,
5902,135903,1-Dodecylpyridoxal,CCCCCCCCCCCC[N+]1=C(C(=C(C(=C1)CO)C=O)O)C,,,,,,
5903,135904,2-(2-Methylsulfanylpropanoylamino)acetic acid,CC(C(=O)NCC(=O)O)SC,,,,,,
5904,135905,Cystathionine ketimine,C1CSCC(=N[C@H]1C(=O)O)C(=O)O,,,,,,
5905,135906,Arnebinone,CC(=C)C1CCC(C2=C1C(=O)C(=C(C2=O)OC)OC)(C)C=C,,,,,,
5906,135907,CID 135907,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@@H]2[C@H]3N(C2=O)C(=C(CS3)CS(=O)C4=CC=CC=[N+]4CC=C)C(=O)[O-],,,,,,
5907,135908,CID 135908,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@@H]2[C@H]3N(C2=O)C(=C(CS3)CS(=O)C4=CC=CC=[N+]4CC=C)C(=O)O,,,,,,
5908,135909,"1,6-Dithiabenz(3,4)estra-3,5(10),8,14-tetraen-17-one",C[C@]12CCC3=C(C1=CCC2=O)CSC4=C3SCC5=CC=CC=C54,,,,,,
5909,135910,CID 135910,CC(CCCN)NC1=C2C(=CC=CN2)C(=O)C(=C1)O,,,,,,
5910,135911,Tolmetin glycinamide,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)NCC(=O)O,,,,,,
5911,135912,"1H-Imidazo(4,5-c)pyridine, 2-(2-methoxy-4-(methylsulfonyl)phenyl)-, monohydrochloride",COC1=C(C=CC(=C1)S(=O)(=O)C)C2=NC3=C(N2)C=NC=C3.Cl,,,,,,
5912,135913,"2-(2-methoxy-4-methylsulfonylphenyl)-3H-imidazo[4,5-c]pyridine",COC1=C(C=CC(=C1)S(=O)(=O)C)C2=NC3=C(N2)C=NC=C3,,,,,,
5913,135914,"1-(omega-Diethylaminopropylamido)-4-hydroxy-9,10-anthracenedione",CCN(CC)CCC(=O)NC1=C2C(=C(C=C1)O)C(=O)C3=CC=CC=C3C2=O.Cl,,,,,,
5914,135915,"3-(Diethylamino)-N-(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)-propanamide",CCN(CC)CCC(=O)NC1=C2C(=C(C=C1)O)C(=O)C3=CC=CC=C3C2=O,,,,,,
5915,135916,"1-(omega-Diethylaminopropylamide)-2-methoxy-4-hydroxy-9,10-anthracenedione",CCN(CC)CCC(=O)NC1=C(C=C(C2=C1C(=O)C3=CC=CC=C3C2=O)O)OC.Cl,,,,,,
5916,135917,"3-(diethylamino)-N-(4-hydroxy-2-methoxy-9,10-dioxoanthracen-1-yl)propanamide",CCN(CC)CCC(=O)NC1=C(C=C(C2=C1C(=O)C3=CC=CC=C3C2=O)O)OC,,,,,,
5917,135918,2-Methyl-1-phenyl-2-(3-pyridinyl)-1-propanone,CC(C)(C1=CN=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
5918,135919,"(2S,5R,6R)-6-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;[(2R,3S)-3-methyloxiran-2-yl]phosphonic acid",C[C@H]1[C@H](O1)P(=O)(O)O.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,,,,,,
5919,135920,"4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,,,,,,
5920,135921,2-Methylene beta-alanine methyl ester,COC(=O)C(=C)CN,,,,,,
5921,135922,N-Bromoacetyl-N'-(1-sulfo-5-naphthyl)ethylenediamine,C1=CC2=C(C=CC=C2S(=O)(=O)O)C(=C1)NCCNC(=O)CBr,,,,,,
5922,135923,CID 135923,C1=C(C=C(C(=O)C1=C2C(=CC(=N2)Cl)N(O)O)Cl)Cl,,,,,,
5923,135924,9-Atfmb,C1CC2C(C1C3=C2C=C(C=C3)C(F)(F)F)N,,,,,,
5924,135925,CID 135925,CC(CNCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,,,,,,
5925,135926,"N-Palmitoyl-2,3-bis(palmitoyloxy)-2-propylcysteine",CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)O,,,,,,
5926,135927,"2-(2,3,3-Triiodoallyl)-2H-tetrazole",C1=NN(N=N1)CC(=C(I)I)I,,,,,,
5927,135928,"14-Amino-7-methoxy-3-methyl-1,2,3,4,7,7a-hexahydro-4a,7-ethano-4,12-methano[1]benzofuro[3,2-e]isoquinolin-9-ol",CN1CCC23[C@H]4C5(C=CC2(C1CC6=C3C(=C(C=C6)O)O4)C[C@H]5N)OC,,,,,,
5928,135929,"Pyridinium, 3-acetyl-1,2,5,6-tetrahydro-1,1-dimethyl-, iodide",CC(=O)C1=CCC[N+](C1)(C)C.[I-],,,,,,
5929,135930,"1-(1,1-dimethyl-3,6-dihydro-2H-pyridin-1-ium-5-yl)ethanone",CC(=O)C1=CCC[N+](C1)(C)C,,,,,,
5930,135931,"6H-Thiopyrano(3,2-d)pyrimidin-2-amine, 7,8-dihydro-4-(1-piperazinyl)-",C1CC2=C(C(=NC(=N2)N)N3CCNCC3)OC1S,,,,,,
5931,135932,Isopropyl-2-acetoxyethyl-2'-chloroethylamine,CC(C)N(CCOC(=O)C)CCCl,,,,,,
5932,135933,CID 135933,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC3=NS(=O)(=O)C4=CC=CC=C43,,,,,,
5933,135934,CID 135934,C1CCN(C1)CC2=CC(=CC=C2)OCCCNC3=NS(=O)(=O)C4=CC=CC=C43,,,,,,
5934,135935,"2-Piperazinyl-4-methylamino-5-methylthieno(2,3-d)pyrimidine",CC1=CSC2=NC(=NC(=C12)NC)N3CCNCC3,,,,,,
5935,135936,CID 135936,CC(CSCC(C)(C)O)C1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,,,,,,
5936,135937,Cyclohexyl-2-acetoxyethyl-2'-chloroethylamine,CC(=O)OCCN(CCCl)C1CCCCC1,,,,,,
5937,135938,N-Hydroxymethyl-N-methylbenzamide,CN(CO)C(=O)C1=CC=CC=C1,,,,,,
5938,135939,(2S)-2-amino-6-[[2-chloroethyl(nitroso)carbamoyl]amino]hexanoic acid,C(CCNC(=O)N(CCCl)N=O)C[C@@H](C(=O)O)N,,,,,,
5939,135940,Alanyl-seryl-glycine,C[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N,,,,,,
5940,135941,Glycyl-seryl-phenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN,,,,,,
5941,135942,Efavit,CC1=NC=C(C(=C1O)CO)CO.C1=CC(=CN=C1)C(=O)OC2=C(C(=O)O[C@@H]2[C@H](CO)O)O.[O-]S(=O)(=O)[O-].[Zn+2],,,,,,
5942,135943,Ascorbyl nicotinate,C1=CC(=CN=C1)C(=O)OC2=C(C(=O)O[C@@H]2[C@H](CO)O)O,,,,,,
5943,135944,Antibiotic 79005,CCCCCCCCN1C2=CC=CC=C2C(=C1O)C3=NC4=CC=CC=C4C3=O,,,,,,
5944,135945,Oxalyl-(met-onp)2,CSCC[C@@H](C(=O)O)NC(=O)C(=O)[N+](C1=CC=C(C=C1)[N+](=O)[O-])(C2=CC=C(C=C2)[N+](=O)[O-])[C@@H](CCSC)C(=O)O,,,,,,
5945,135946,Malonylbis(methionyl-4-nitrophenyl ester),CSCC[C@@H](C(=O)O)NC(=O)CC(=O)[N+](C1=CC=C(C=C1)[N+](=O)[O-])(C2=CC=C(C=C2)[N+](=O)[O-])[C@@H](CCSC)C(=O)O,,,,,,
5946,135947,"(2S,3S)-2-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-3-(sulfoamino)butanoic acid",C[C@@H]([C@@H](C(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C1=CSC(=N1)N)NS(=O)(=O)O,,,,,,
5947,135948,4(5-(Hydroxymethyl)-2-oxo-3-oxazolidinyl)benzene sulfonamide,C1[C@@H](OC(=O)N1C2=CC=C(C=C2)S(=O)(=O)N)CO,,,,,,
5948,135949,"1,2,3,4,6,10b-Hexahydro-6-phenylpyrrolo(2,1-a)isoquinoline",C1C[C@@H]2C3=CC=CC=C3[C@@H](CN2C1)C4=CC=CC=C4,,,,,,
5949,135950,3-Hydroxy-1-methyl-3-phenyl-2-piperidinone,CN1CCCC(C1=O)(C2=CC=CC=C2)O,,,,,,
5950,135951,4-Nitro-N-2-pyridinylbenzenesulfonamide,C1=CC=C(C=C1)S(=O)(=O)N(C2=CC=CC=N2)[N+](=O)[O-],,,,,,
5951,135952,"4H-1-Benzopyran-4-one, 5,7-bis(acetyloxy)-2-(3,4-bis(acetyloxy)phenyl)-",CC(=O)OC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
5952,135953,"1,1'-(2,4-Dimethyl-1,4-dihydropyridine-3,5-diyl)di(ethan-1-one)",CC1C(=CNC(=C1C(=O)C)C)C(=O)C,,,,,,
5953,135954,CID 135954,COC1=C(C(=O)C2=C(C(=COC2=C1)C3=CC=C(C=C3)O)O)OC,,,,,,
5954,135955,"(3,4-Epoxybutyl)benzene",C1C(O1)CCC2=CC=CC=C2,,,,,,
5955,135956,1-Naphthyl carbamate,C1=CC=C2C(=C1)C=CC=C2OC(=O)N,,,,,,
5956,135957,"Cyclopenta(c)(1)benzopyran-3,4-dione, 1,2-dihydro-7,9-dimethoxy-",COC1=CC2=C(C3=C(C(=O)CC3)C(=O)O2)C(=C1)OC,,,,,,
5957,135958,"N,N-Bis(1-aziridinylmethyl)-1-aziridineethanamine",C1CN1CCN(CN2CC2)CN3CC3,,,,,,
5958,135959,CID 135959,C1C(=O)NC2=C(N1)NC(=NC2=O)N,,,,,,
5959,135960,"1H-Pyrrolo[2,3-b]pyridine-3-propanoicacid,a-amino-",C1=CC2=C(C(=C1)C(=O)O)NC=C2CC(N)N,,,,,,
5960,135961,Pentyl hydroperoxide,CCCCCOO,,,,,,
5961,135962,Violanthrene,C1C2=C3C(=CC=C4C3=C(C=C2)C5=C6C4=CC=C7C6=C(CC8=CC=CC=C87)C=C5)C9=CC=CC=C91,,,,,,
5962,135963,N-Methyl-N-phenylbenzenesulfonamide,CN(C1=CC=CC=C1)S(=O)(=O)C2=CC=CC=C2,,,,,,
5963,135964,"2,3-Dimethoxyphenylacetic acid",COC1=CC=CC(=C1OC)CC(=O)O,,,,,,
5964,135965,6-Chloro-2-methylquinoline,CC1=NC2=C(C=C1)C=C(C=C2)Cl,,,,,,
5965,135966,Ethylene glycol di-N-butyrate,CCCC(=O)OCCOC(=O)CCC,,,,,,
5966,135967,"2-Methyl 1,2,3-triprop-2-en-1-yl propane-1,2,2,3-tetracarboxylate",COC(=O)C(CC(=O)OCC=C)(CC(=O)OCC=C)C(=O)OCC=C,,,,,,
5967,135968,"1,2-Ethanediol, dipropanoate",CCC(=O)OCCOC(=O)CC,,,,,,
5968,135969,"4,7-Dimethyl-5-decyne-4,7-diol",CCCC(C)(C#CC(C)(CCC)O)O,,,,,,
5969,135970,"1-Chloro-5,5,7,7-tetramethyl-2-octene",CC(C)(C)CC(C)(C)CC=CCCl,,,,,,
5970,135971,"Phosphoroselenoic acid, O,O',O''-trimethyl-",COP(=[Se])(OC)OC,,,,,,
5971,135972,2H-Azirine,C1C=N1,,,,,,
5972,135973,Bicyclo[1.1.0]butane,C1C2C1C2,,,,,,
5973,135974,Spirohexane,C1CC2(C1)CC2,,,,,,
5974,135975,"9,9'-Spirobi[9H-fluorene]",C1=CC=C2C(=C1)C3=CC=CC=C3C24C5=CC=CC=C5C6=CC=CC=C46,,,,,,
5975,135976,"5,5'-Spirobi(dibenzosilole)",C1=CC=C2C(=C1)C3=CC=CC=C3[Si]24C5=CC=CC=C5C6=CC=CC=C46,,,,,,
5976,135977,"1,1'-Spirobi(1H-indene)",C1=CC=C2C(=C1)C=CC23C=CC4=CC=CC=C34,,,,,,
5977,135978,"Spiro[bicyclo[2.2.1]heptane-2,1'-cyclopropane]",C1CC2CCC1C23CC3,,,,,,
5978,135979,"Tricyclo[4.1.0.01,3]heptane",C1CC2CC23C1C3,,,,,,
5979,135980,Spiro[3.4]octane,C1CCC2(C1)CCC2,,,,,,
5980,135981,"Ethane-1,2-dithiolate;tin(4+)",C(C[S-])[S-].C(C[S-])[S-].[Sn+4],,,,,,
5981,135982,Spiro[4.5]decane,C1CCC2(CC1)CCCC2,,,,,,
5982,135983,Spiro[5.5]undecane,C1CCC2(CC1)CCCCC2,,,,,,
5983,135984,"1,5,7,11-Tetrathiaspiro[5.5]undecane",C1CSC2(SC1)SCCCS2,,,,,,
5984,135985,"7,8,15,16-Tetrathiadispiro(5.2.5.2)hexadecane",C1CCC2(CC1)SSC3(CCCCC3)SS2,,,,,,
5985,135986,"1,4-Cyclohexanedione bis(ethylene ketal)",C1CC2(CCC13OCCO3)OCCO2,,,,,,
5986,135987,"6,7,13,14-Tetrathiadispiro[4.2.4.2]tetradecane",C1CCC2(C1)SSC3(CCCC3)SS2,,,,,,
5987,135988,Spiro[2.5]octane,C1CCC2(CC1)CC2,,,,,,
5988,135989,Bicyclo[2.2.0]hexane,C1CC2C1CC2,,,,,,
5989,135990,"Dibenzo[fg,ij]phenanthro[2,1,10,9,8,7-pqrstuv]pentaphene",C1=CC2=C3C(=C1)C4=C5C(=CC=C4)C6=CC=CC7=C6C8=C9C(=C(C3=C58)C=C2)C=CC1=C9C7=CC=C1,,,,,,
5990,135991,"Tribenzo[de,h,kl]naphtho[1,2,3,4-rst]pentaphene",C1=CC=C2C(=C1)C3=C4C(=C5C=CC=CC5=C6C4=C2C7=CC=CC8=C7C6=CC=C8)C9=CC=CC1=C9C3=CC=C1,,,,,,
5991,135992,"Dibenzo[fg,ij]phenanthro[9,10,1,2,3-pqrst]pentaphene",C1=CC=C2C(=C1)C3=C4C(=CC=C3)C5=C6C(=CC=C5)C7=CC=CC8=C7C9=C(C=C2C4=C69)C1=CC=CC=C81,,,,,,
5992,135993,"Benzo[pqr]dinaphtho[8,1,2-bcd:2',1',8'-lmn]perylene",C1=CC2=C3C(=C1)C4=C5C6=C(C=CC(=C36)C=C2)C7=C8C5=C(C=C4)C9=CC=CC1=C9C8=C(C=C1)C=C7,,,,,,
5993,135994,"Tetrabenzo[de,h,kl,rst]pentaphene",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C2C6=CC=CC7=C6C5=CC=C7)C8=CC=CC9=C8C3=CC=C9,,,,,,
5994,135995,"Naphthaceno[2,1,12,11-opqra]naphthacene",C1=CC=C2C3=C4C(=CC2=C1)C=C5C=CC6=C7C5=C4C(=CC7=CC8=CC=CC=C68)C=C3,,,,,,
5995,135996,Quaterrylene,C1=CC2=C3C(=C1)C4=C5C(=CC=C6C5=C(C=C4)C7=C8C6=CC=C9C8=C(C=C7)C1=CC=CC4=C1C9=CC=C4)C3=CC=C2,,,,,,
5996,135997,"Dinaphtho(1,2,3-cd:1',2',3'-lm)perylene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C6C=CC7=CC8=CC=CC=C8C9=C7C6=C5C=C9)C=C3,,,,,,
5997,135998,"Tetrabenzo(c,m,pqr,tuv)picene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C6C=CC7=CC8=CC=CC=C8C9=C7C6=C(C=C9)C(=C54)C=C3,,,,,,
5998,135999,"Hexabenzo[a,cd,f,j,lm,o]perylene",C1=CC=C2C(=C1)C3=C4C(=CC=C3)C5=CC=CC=C5C6=C4C2=C7C8=CC=CC=C8C9=C1C7=C6C2=CC=CC=C2C1=CC=C9,,,,,,
5999,136000,"Dibenzo[f,j]phenanthro[9,10-s]picene",C1=CC=C2C(=C1)C3=CC=CC=C3C4=C5C6=CC=CC=C6C7=CC=CC=C7C5=C8C9=CC=CC=C9C1=CC=CC=C1C8=C24,,,,,,
6000,136001,"Hexabenzo[bc,ef,hi,kl,no,qr]coronene",C1=CC2=C3C=CC=C4C3=C5C6=C2C(=C1)C7=C8C6=C9C1=C(C8=CC=C7)C=CC=C1C1=CC=CC2=C1C9=C5C1=C4C=CC=C21,,,,,,
6001,136002,"Dibenzo[a,o]perylene",C1=CC=C2C(=C1)C=C3C=CC=C4C3=C2C5=C6C4=CC=CC6=CC7=CC=CC=C75,,,,,,
6002,136003,"Phenanthro[1,10,9,8-opqra]perylene",C1=CC2=CC3=C4C(=CC=C3)C5=CC=CC6=C5C7=C8C(=C6)C=CC=C8C(=C1)C2=C47,,,,,,
6003,136004,"Dinaphtho[8,1,2-abc:8',1',2'-jkl]coronene",C1=CC2=C3C(=C1)C4=C5C6=C(C=C4)C=C7C=CC8=C9C7=C6C1=C(C9=CC=C8)C=CC4=C1C5=C3C(=C4)C=C2,,,,,,
6004,136005,"Dibenzo[bc,kl]coronene",C1=CC2=CC3=C4C5=C(C=C3)C=C6C=CC=C7C6=C5C8=C9C4=C2C(=C1)C=C9C=CC8=C7,,,,,,
6005,136006,"Dibenzo[a,g]coronene",C1=CC=C2C3=C4C5=C(C2=C1)C=CC6=C5C7=C(C=C6)C=CC8=C7C4=C(C=C3)C9=CC=CC=C89,,,,,,
6006,136007,"Naphtho[2,3-a]coronene",C1=CC=C2C=C3C4=C5C6=C(C=CC7=C6C8=C(C=C7)C=CC9=C8C5=C(C3=CC2=C1)C=C9)C=C4,,,,,,
6007,136008,"Tribenzo(b,n,pqr)perylene",C1=CC=C2C3=C4C5=C(C2=C1)C=CC=C5C6=CC=CC7=C6C4=C(C=C3)C8=CC=CC=C78,,,,,,
6008,136009,"Anthra[1,2,3,4-ghi]perylene",C1=CC=C2C=C3C4=C5C6=C(C=CC=C6C7=CC=CC8=C7C5=C(C3=CC2=C1)C=C8)C=C4,,,,,,
6009,136010,"Benzo(qr)naphtho(2,1,8,7-fghi)pentacene",C1=CC=C2C3=C4C(=CC2=C1)C5=CC=CC6=C5C7=C(C=CC(=C47)C=C3)C8=CC=CC=C68,,,,,,
6010,136011,"Dibenzo[jk,uv]dinaphtho[2,1,8,7-defg:2',1',8',7'-opqr]pentacene",C1=CC2=C3C(=C1)C4=C5C=CC6=C7C5=C(C8=C4C9=C(C=CC(=C39)C=C2)C=C8)C1=CC=CC2=C1C7=C(C=C2)C=C6,,,,,,
6011,136012,"Benzo[rs]dinaphtho[2,1,8,7-klmn:3',2',1',8',7'-vwxyz]hexaphene",C1=CC2=C3C(=C1)C=C4C=CC5=C6C=CC7=C8C6=C(C9=CC=CC1=C9C8=C(C=C1)C=C7)C1=C5C4=C3C(=C1)C=C2,,,,,,
6012,136013,"Dibenzo(m,pqr)naptho(1,2,3,4-tuv)picene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C6C=CC7=C8C6=C5C9=CC=CC=C9C8=CC=C7)C=C3,,,,,,
6013,136014,"Dibenzo[b,pqr]perylene",C1=CC=C2C3=C4C5=C(C=CC6=C5C(=CC=C6)C7=CC=CC(=C74)C2=C1)C=C3,,,,,,
6014,136015,"Dibenzo[a,rst]naphtho[8,1,2-cde]pentaphene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C6C=CC7=C8C6=C(C(=C54)C=C3)C9=CC=CC=C9C8=CC=C7,,,,,,
6015,136016,"Tetrabenzo(de,hi,op,st)pentacene",C1=CC2=C3C(=C1)C4=C5C(=CC=C4)C6=C7C(=C5C3=CC=C2)C=CC=C7C8=CC=CC9=C8C6=CC=C9,,,,,,
6016,136017,Tetrathianaphthacene,C1=CC=C2C(=C1)C3=C4C5=C2SSC5=C6C=CC=CC6=C4SS3,,,,,,
6017,136018,Aceplaidylene,C1=CC=C2C=CC3=CC=C4C3=C2C(=C1)C=C4,,,,,,
6018,136019,Trinaphthylene,C1=CC=C2C=C3C(=CC2=C1)C4=CC5=CC=CC=C5C=C4C6=CC7=CC=CC=C7C=C36,,,,,,
6019,136020,"Naphtho[2,3-g]chrysene",C1=CC=C2C(=C1)C=CC3=C2C4=CC5=CC=CC=C5C=C4C6=CC=CC=C36,,,,,,
6020,136021,"Dibenzo[fg,ij]pentaphene",C1=CC=C2C3=C4C(=CC=C3)C5=CC=CC6=C5C(=CC7=CC=CC=C67)C4=CC2=C1,,,,,,
6021,136022,"Dibenzo(hi,wx)heptacene",C1=CC=C2C=C3C4=C5C(=CC=C4)C6=CC7=CC8=CC=CC=C8C=C7C9=C6C(=CC=C9)C5=CC3=CC2=C1,,,,,,
6022,136023,"Dibenzo[fg,qr]pentacene",C1=CC=C2C3=C4C(=CC=C3)C5=CC6=CC=CC=C6C7=C5C(=CC=C7)C4=CC2=C1,,,,,,
6023,136024,"Naphtho(2,3-c)carbazole",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C5=CC=CC=C5N4,,,,,,
6024,136025,"1H,3H-Naphtho[1,8-cd]thiopyran",C1C2=CC=CC3=C2C(=CC=C3)CS1,,,,,,
6025,136026,"Naphtho[1,8-de]-1,3-dithiin",C1SC2=CC=CC3=C2C(=CC=C3)S1,,,,,,
6026,136027,"1,3,4,6,7,9,9b-Heptaazaphenalene",C1=NC2=NC=NC3=NC=NC(=N1)N23,,,,,,
6027,136028,"Acenaphtho[1,2-b]quinoxaline",C1=CC=C2C(=C1)N=C3C4=CC=CC5=C4C(=CC=C5)C3=N2,,,,,,
6028,136029,"7,8,9,10-Tetrahydrocyclohepta[de]naphthalene",C1CCC2=CC=CC3=C2C(=CC=C3)C1,,,,,,
6029,136030,"1,2-Dithiaacenaphthene",C1=CC2=C3C(=C1)SSC3=CC=C2,,,,,,
6030,136031,Cyclopenta(ef)heptalene,C1=CC=C2C=CC3=C2C(=C1)C=CC=C3,,,,,,
6031,136032,"Pyrrolo[2,1,5-cd]indolizine",C1=CC2=CC=C3N2C(=C1)C=C3,,,,,,
6032,136033,"Dibenzo[b,n]picene",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C=CC5=C4C=CC6=CC7=CC=CC=C7C=C65,,,,,,
6033,136034,"Anthra[2,3-j]heptaphene",C1=CC=C2C=C3C=C4C(=CC3=CC2=C1)C5=CC6=CC7=CC=CC=C7C=C6C=C5C8=CC9=CC1=CC=CC=C1C=C9C=C48,,,,,,
6034,136035,Benz[j]heptaphene,C1=CC=C2C=C3C=C4C(=CC3=CC2=C1)C5=CC=CC=C5C6=CC7=CC8=CC=CC=C8C=C7C=C64,,,,,,
6035,136036,"Tetrabenz(a,c,h,j)anthracene",C1=CC=C2C(=C1)C3=CC=CC=C3C4=CC5=C(C=C24)C6=CC=CC=C6C7=CC=CC=C75,,,,,,
6036,136037,"Tribenzo[a,c,h]phenazine",C1=CC=C2C(=C1)C=CC3=C2N=C4C5=CC=CC=C5C6=CC=CC=C6C4=N3,,,,,,
6037,136038,"Tetrabenzo(a,c,j,l)naphthacene",C1=CC=C2C(=C1)C3=CC=CC=C3C4=CC5=CC6=C(C=C5C=C24)C7=CC=CC=C7C8=CC=CC=C86,,,,,,
6038,136039,"Tetrabenzo(a,c,l,o)pentacene",C1=CC=C2C(=C1)C3=CC=CC=C3C4=CC5=CC6=CC7=C(C=C6C=C5C=C24)C8=CC=CC=C8C9=CC=CC=C97,,,,,,
6039,136040,"Dibenzo[a,c]pentacene",C1=CC=C2C=C3C=C4C=C5C6=CC=CC=C6C7=CC=CC=C7C5=CC4=CC3=CC2=C1,,,,,,
6040,136041,Anthracene endoperoxide,C1=CC=C2C3C4=CC=CC=C4C(C2=C1)OO3,,,,,,
6041,136042,"Dibenzo[c,m]pentaphene",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=CC6=C(C=CC7=CC=CC=C76)C=C5C4=C3,,,,,,
6042,136043,"Naphtho[2,3-c]pentaphene",C1=CC=C2C=C3C(=CC2=C1)C=CC4=CC5=C(C=CC6=CC7=CC=CC=C7C=C65)C=C43,,,,,,
6043,136044,Benzo(p)hexaphene,C1=CC=C2C=C3C(=CC2=C1)C=CC4=CC5=CC6=CC7=CC=CC=C7C=C6C=C5C=C43,,,,,,
6044,136045,Benzo[a]phenazine,C1=CC=C2C(=C1)C=CC3=NC4=CC=CC=C4N=C32,,,,,,
6045,136046,"(1,2,4,5)Tetrazino(1,6-a:4,3-a')diisoquinoline",C1=CC=C2C(=C1)C=CN3C2=NN4C=CC5=CC=CC=C5C4=N3,,,,,,
6046,136047,"6H-Dibenzo(b,d)pyran",C1C2=CC=CC=C2C3=CC=CC=C3O1,,,,,,
6047,136048,"1H-Naphtho(1,2-d)triazole",C1=CC=C2C(=C1)C=CC3=NNN=C32,,,,,,
6048,136049,"Dithieno[2,3-b:3',2'-d]thiophene",C1=CSC2=C1C3=C(S2)SC=C3,,,,,,
6049,136050,"Acenaphtho[1,2-b]benzo[f]quinoxaline",C1=CC=C2C(=C1)C=CC3=C2N=C4C5=CC=CC6=C5C(=CC=C6)C4=N3,,,,,,
6050,136051,"2,3-5,6-Dibenzoxalene",C1=CC=C2C(=C1)C=C3C2=CC4=CC=CC=C4O3,,,,,,
6051,136052,Dibenzoselenophene,C1=CC=C2C(=C1)C3=CC=CC=C3[Se]2,,,,,,
6052,136053,Dibenzotellurophene,C1=CC=C2C(=C1)C3=CC=CC=C3[Te]2,,,,,,
6053,136054,"5,26:13.18-Diimino-7,11:20,24-dimethenodibenzo(c,N)(1,6,12,17)tetraazacyclodocosine",C1=CC=C2C(=C1)C3=NC2=NC4=CC(=CC=C4)N=C5C6=CC=CC=C6C(=N5)NC7=CC=CC(=C7)N3,,,,,,
6054,136055,"2,7-Diazatetracyclo(3.3.3.04,9.08,11)undecane",C1C2C3CNC2C4C1C3CN4,,,,,,
6055,136056,"[1]Benzothieno[3,2-b][1]benzothiophene",C1=CC=C2C(=C1)C3=C(S2)C4=CC=CC=C4S3,,,,,,
6056,136057,"5H-Naphtho[2,3-b]carbazole",C1=CC=C2C=C3C=C4C(=CC3=CC2=C1)C5=CC=CC=C5N4,,,,,,
6057,136058,"Tricyclo[4.2.2.02,5]decane",C1CC2CCC1C3C2CC3,,,,,,
6058,136059,"Tricyclo[3.3.0.02,6]octane",C1CC2C3C2C1CC3,,,,,,
6059,136060,"Tricyclo(3.2.1.03,6)octane",C1C2CC3CC1C3C2,,,,,,
6060,136061,"Selenolo[3,4-b]selenophene",C1=C[Se]C2=C[Se]C=C21,,,,,,
6061,136062,"Thieno[2,3-b]thiophene",C1=CSC2=C1C=CS2,,,,,,
6062,136063,"Thieno[3,2-b]thiophene",C1=CSC2=C1SC=C2,,,,,,
6063,136064,"(1,2)Dithiolo(1,5-b)(1,2)dithiole-7-s(iv)",C1=CSS2=C1C=CS2,,,,,,
6064,136065,Isophosphinoline,C1=CC=C2C=PC=CC2=C1,,,,,,
6065,136066,"2,7-Naphthyridine",C1=CN=CC2=C1C=CN=C2,,,,,,
6066,136067,"2,6-Naphthyridine",C1=CN=CC2=C1C=NC=C2,,,,,,
6067,136068,4H-1-Benzopyran,C1C=COC2=CC=CC=C21,,,,,,
6068,136069,"1,8-Naphthyridine",C1=CC2=C(N=C1)N=CC=C2,,,,,,
6069,136070,"1,5-Naphthyridine",C1=CC2=C(C=CC=N2)N=C1,,,,,,
6070,136071,"1,4-Benzodioxin",C1=CC=C2C(=C1)OC=CO2,,,,,,
6071,136072,"Pyrazino[2,3-b]pyrazine",C1=CN=C2C(=N1)N=CC=N2,,,,,,
6072,136073,"Dibenz[b,f]oxepin",C1=CC=C2C(=C1)C=CC3=CC=CC=C3O2,,,,,,
6073,136074,"Dibenzo[b,f]thiepin",C1=CC=C2C(=C1)C=CC3=CC=CC=C3S2,,,,,,
6074,136075,Octalene,C1=CC=CC2=CC=CC=CC=C2C=C1,,,,,,
6075,136076,"1,8-Diazabiphenylene",C1=CC2=C(C3=C2C=CC=N3)N=C1,,,,,,
6076,136077,Phenoxaselenin,C1=CC=C2C(=C1)OC3=CC=CC=C3[Se]2,,,,,,
6077,136078,Selenanthrene,C1=CC=C2C(=C1)[Se]C3=CC=CC=C3[Se]2,,,,,,
6078,136079,"Tricyclo[10.4.0.04,9]hexadeca-1(16),2,4,6,8,10,12,14-octaene",C1=CC=C2C=CC3=CC=CC=C3C=CC2=C1,,,,,,
6079,136080,5H-benzocycloheptene,C1C=CC=CC2=CC=CC=C21,,,,,,
6080,136081,Benzo[c]thiophene,C1=CC2=CSC=C2C=C1,,,,,,
6081,136082,Benzo[b]selenophene,C1=CC=C2C(=C1)C=C[Se]2,,,,,,
6082,136083,Benzo[b]tellurophene,C1=CC=C2C(=C1)C=C[Te]2,,,,,,
6083,136084,"3H-[1,2,3]Triazolo[4,5-c]pyridine",C1=CN=CC2=NNN=C21,,,,,,
6084,136085,"1H-1,2,3-Triazolo[4,5-b]pyridine",C1=CC2=NNN=C2N=C1,,,,,,
6085,136086,"1,2,3-Benzoxadiazole",C1=CC=C2C(=C1)N=NO2,,,,,,
6086,136087,Benzoselenazole,C1=CC=C2C(=C1)N=C[Se]2,,,,,,
6087,136088,"1,2,3-Benzoselenadiazole",C1=CC=C2C(=C1)N=N[Se]2,,,,,,
6088,136089,"Tetrazolo[1,5-a]pyridine",C1=CC2=NN=NN2C=C1,,,,,,
6089,136090,Cubane,C12C3C4C1C5C2C3C45,,,,,,
6090,136091,Bicyclo[4.2.0]octane,C1CCC2CCC2C1,,,,,,
6091,136092,"Tricyclo[3.2.2.02,4]nonane",C1CC2CCC1C3C2C3,,,,,,
6092,136093,7-Azabicyclo[2.2.1]heptane,C1CC2CCC1N2,,,,,,
6093,136094,"2,6,7-Trioxa-1-phosphabicyclo[2.2.1]heptane",C1C2COP(O1)O2,,,,,,
6094,136095,7-Thiabicyclo[2.2.1]heptane,C1CC2CCC1S2,,,,,,
6095,136096,3-Thiabicyclo[3.2.1]octane,C1CC2CC1CSC2,,,,,,
6096,136097,8-Azabicyclo[3.2.1]octane,C1CC2CCC(C1)N2,,,,,,
6097,136098,"6,7,8-Trioxabicyclo[3.2.1]octane",C1CC2OC(C1)OO2,,,,,,
6098,136099,"1,5-Diazabicyclo[3.2.1]octane",C1CN2CCN(C1)C2,,,,,,
6099,136100,"2,3-Dioxabicyclo[2.2.2]octane",C1CC2CCC1OO2,,,,,,
6100,136101,Bicyclo[3.3.1]nonane,C1CC2CCCC(C1)C2,,,,,,
6101,136102,9-Oxabicyclo[3.3.1]nonane,C1CC2CCCC(C1)O2,,,,,,
6102,136103,9-Thiabicyclo[3.3.1]nonane,C1CC2CCCC(C1)S2,,,,,,
6103,136104,"1,5-Diazabicyclo[3.3.1]nonane",C1CN2CCCN(C1)C2,,,,,,
6104,136105,2-Thiaadamantane,C1C2CC3CC1CC(C2)S3,,,,,,
6105,136106,"1-Azatricyclo(3.3.1.13,7)decane",C1C2CC3CC1CN(C2)C3,,,,,,
6106,136107,"1,3-Diazaadamantane",C1C2CN3CC1CN(C2)C3,,,,,,
6107,136108,"2,8,9-Trioxa-1-phosphadamantane",C1C2CC3CC1OP(O2)O3,,,,,,
6108,136109,"1,3,5,7-Tetrasilatricyclo(3.3.1.13,7)decane",C1[SiH]2C[SiH]3C[SiH]1C[SiH](C2)C3,,,,,,
6109,136110,"Tricyclo[6.2.1.13,6]dodecane",C1CC2CC1CC3CCC(C3)C2,,,,,,
6110,136111,Bicyclo[3.2.2]nonane,C1CC2CCC(C1)CC2,,,,,,
6111,136112,"3-Oxabicyclo(3,2,2)nonane",C1CC2CCC1COC2,,,,,,
6112,136113,"6,7-Dioxabicyclo[3.2.2]nonane",C1CC2CCC(C1)OO2,,,,,,
6113,136114,"1,5-Diazabicyclo[3.2.2]nonane",C1CN2CCN(C1)CC2,,,,,,
6114,136115,"Tricyclo[3.3.2.02,8]decane",C1CC2C3C2CCC1CC3,,,,,,
6115,136116,"1,5-Diazabicyclo[3.3.3]undecane",C1CN2CCCN(C1)CCC2,,,,,,
6116,136117,"Tricyclo(8.2.2.24,7)-hexadecane",C1CC2CCC1CCC3CCC(CC3)CC2,,,,,,
6117,136118,9-Azabicyclo[4.2.1]nonane,C1CCC2CCC(C1)N2,,,,,,
6118,136119,9-Oxabicyclo[4.2.1]nonane,C1CCC2CCC(C1)O2,,,,,,
6119,136120,"7,8,9-Trioxabicyclo[4.2.1]nonane",C1CCC2OC(C1)OO2,,,,,,
6120,136121,1-Azabicyclo[3.1.0]hexane,C1CC2CN2C1,,,,,,
6121,136122,Bicyclo(2.1.1)hexane,C1CC2CC1C2,,,,,,
6122,136123,Bicyclo[5.1.0]octane,C1CCC2CC2CC1,,,,,,
6123,136124,Bicyclo[6.1.0]nonane,C1CCCC2CC2CC1,,,,,,
6124,136125,"Tricyclo[7.1.0.04,6]decane",C1CC2CC2CCC3C1C3,,,,,,
6125,136126,1H-Cyclopropa(b)naphthalene,C1C2=CC3=CC=CC=C3C=C21,,,,,,
6126,136127,Cyclopropa(b)anthracene,C1C2=CC3=CC4=CC=CC=C4C=C3C=C21,,,,,,
6127,136128,"Tricyclo[3.1.0.02,6]hexane",C1CC2C3C1C23,,,,,,
6128,136129,"1,3-Dithietane",C1SCS1,,,,,,
6129,136130,Selenophene,C1=C[Se]C=C1,,,,,,
6130,136131,Tellurophene,C1=C[Te]C=C1,,,,,,
6131,136132,Arsabenzene,C1=CC=[As]C=C1,,,,,,
6132,136133,Bismin,C1=CC=[Bi]C=C1,,,,,,
6133,136134,CID 136134,B1OBOBO1,,,,,,
6134,136135,4H-Pyran,C1C=COC=C1,,,,,,
6135,136136,4H-Thiopyran,C1C=CSC=C1,,,,,,
6136,136137,Antimonin,C1=CC=[Sb]C=C1,,,,,,
6137,136138,Silabenzene,C1=CC=[SiH]C=C1,,,,,,
6138,136139,"1,4-Dithiin",C1=CSC=CS1,,,,,,
6139,136140,"1,4-Thiaselenin",C1=C[Se]C=CS1,,,,,,
6140,136141,"1,3,5-Triselenane",C1[Se]C[Se]C[Se]1,,,,,,
6141,136142,"1,3-Dioxepin",C1OC=CC=CO1,,,,,,
6142,136143,Cyclononane,C1CCCCCCCC1,,,,,,
6143,136144,Cycloundecane,C1CCCCCCCCCC1,,,,,,
6144,136145,Cyclotridecane,C1CCCCCCCCCCCC1,,,,,,
6145,136146,Cycloheptadecane,C1CCCCCCCCCCCCCCCC1,,,,,,
6146,136147,Cyclooctadecane,C1CCCCCCCCCCCCCCCCC1,,,,,,
6147,136148,"1H,1H-Pentadecafluorooctylamine",C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)N,,,,,,
6148,136149,"N,N-Diethyl-1,1,2,3,3,3-hexafluoropropylamine",CCN(CC)C(C(C(F)(F)F)F)(F)F,,,,,,
6149,136150,CID 136150,[CH-]1[CH-][CH-][CH-][CH-]1.[CH-]1[CH-][CH-][CH-][CH-]1.F[Ti]F,,,,,,
6150,136151,Titanium difluoride,F[Ti]F,,,,,,
6151,136152,"2-Chloro-1,1,2-trifluoroethyl ethyl ether",CCOC(C(F)Cl)(F)F,,,,,,
6152,136153,Bicyclo[1.1.1]pentane,C1C2CC1C2,,,,,,
6153,136154,"Tribenzo(a,d,g)coronene",C1=CC=C2C3=C4C5=C(C2=C1)C=CC6=C5C7=C(C=CC8=C7C4=C(C=C3)C9=CC=CC=C89)C1=CC=CC=C61,,,,,,
6154,136155,"Dibenzo[fg,ij]naphtho[1,2,3,4-rst]pentaphene",C1=CC=C2C(=C1)C3=C4C(=CC=C3)C5=CC=CC6=C5C7=C(C8=CC=CC=C68)C9=CC=CC=C9C2=C47,,,,,,
6155,136156,"Anthra(2,3-c)carbazole",C1=CC=C2C=C3C=C4C(=CC3=CC2=C1)C=CC5=C4C6=CC=CC=C6N5,,,,,,
6156,136157,"Anthra[2,3-b]carbazole",C1=CC=C2C=C3C=C4C=C5C(=CC4=CC3=CC2=C1)C6=CC=CC=C6N5,,,,,,
6157,136158,"Benzene, 1,2,4,5-tetrachloro-3-fluoro-",C1=C(C(=C(C(=C1Cl)Cl)F)Cl)Cl,,,,,,
6158,136159,"Phthalic acid, 4-fluoro-, diethyl ester",CCOC(=O)C1=C(C=C(C=C1)F)C(=O)OCC,,,,,,
6159,136160,"N,N-Bis(2-hydroxyethyl)-m-fluoroaniline",C1=CC(=CC(=C1)F)N(CCO)CCO,,,,,,
6160,136161,"Diazene, bis(4-fluorophenyl)-, 1-oxide",C1=CC(=CC=C1N=[N+](C2=CC=C(C=C2)F)[O-])F,,,,,,
6161,136162,"Azobenzene, 2,2',4,4'-tetrafluoro-",C1=CC(=C(C=C1F)F)N=NC2=C(C=C(C=C2)F)F,,,,,,
6162,136163,"Thieno[3,4-d]thiepin",C1=CSC=CC2=CSC=C21,,,,,,
6163,136164,"2,4-Bis(trifluoromethyl)bromobenzene",C1=CC(=C(C=C1C(F)(F)F)C(F)(F)F)Br,,,,,,
6164,136165,"1,2-Diazabicyclo[2.2.2]octane",C1CN2CCC1CN2,,,,,,
6165,136166,"Azobenzene, 4,4'-difluoro-",C1=CC(=CC=C1N=NC2=CC=C(C=C2)F)F,,,,,,
6166,136167,Pentafluoromethylamine,C(N(F)F)(F)(F)F,,,,,,
6167,136168,"4,4,4-Trifluoro-3-hydroxy-3-methylbutanoic acid",CC(CC(=O)O)(C(F)(F)F)O,,,,,,
6168,136169,"2,2-Bis(fluoromethyl)-1,3-difluoropropane",C(C(CF)(CF)CF)F,,,,,,
6169,136170,"Ethyl 7-phenylbicyclo[4.1.0]hepta-2,4-diene-7-carboxylate",CCOC(=O)C1(C2C1C=CC=C2)C3=CC=CC=C3,,,,,,
6170,136171,5-Bromo-2-nitrobenzotrifluoride,C1=CC(=C(C=C1Br)C(F)(F)F)[N+](=O)[O-],,,,,,
6171,136172,2-Bromo-5-chlorobenzotrifluoride,C1=CC(=C(C=C1Cl)C(F)(F)F)Br,,,,,,
6172,136173,"2,5-Dichlorofluorobenzene",C1=CC(=C(C=C1Cl)F)Cl,,,,,,
6173,136174,3-(Trifluoromethyl)butyric acid,CC(CC(=O)O)C(F)(F)F,,,,,,
6174,136175,"2,2,2-trifluoro-N-(4-methylphenyl)acetamide",CC1=CC=C(C=C1)NC(=O)C(F)(F)F,,,,,,
6175,136176,"2,2,2-Trifluoro-N,1-diphenylethanimine",C1=CC=C(C=C1)C(=NC2=CC=CC=C2)C(F)(F)F,,,,,,
6176,136177,2-Cyanoethylhydrazine,C(CNN)C#N,,,,,,
6177,136178,"Borane, fluorodimethyl-",B(C)(C)F,,,,,,
6178,136179,Dibromofluoroacetic acid,C(=O)(C(F)(Br)Br)O,,,,,,
6179,136180,"Iodo-1,1,2,2-tetrafluoroethane",C(C(F)(F)I)(F)F,,,,,,
6180,136181,"2,2,3,3,4,4,5,5-Octafluoro-1,6-hexanediol",C(C(C(C(C(CO)(F)F)(F)F)(F)F)(F)F)O,,,,,,
6181,136182,"1,1,2,2-Tetrafluoro-1,2-dinitroethane",C(C([N+](=O)[O-])(F)F)([N+](=O)[O-])(F)F,,,,,,
6182,136183,Bis(heptafluoropropyl) ether,C(C(OC(C(C(F)(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)(F)F,,,,,,
6183,136184,"(2-Chloro-1,1,2-trifluoroethyl)diethylamine",CCN(CC)C(C(F)Cl)(F)F,,,,,,
6184,136185,Vinyldifluoroborane,B(C=C)(F)F,,,,,,
6185,136186,"2-Bromo-1,1-difluoroethane",C(C(F)F)Br,,,,,,
6186,136187,"2,2-Difluoroethanol",C(C(F)F)O,,,,,,
6187,136188,"Boranamine, 1,1-difluoro-N,N-dimethyl-",B(N(C)C)(F)F,,,,,,
6188,136189,Chlorobis(trifluomethyl)arsine,C(F)(F)(F)[As](C(F)(F)F)Cl,,,,,,
6189,136190,Perfluoroethanamine,C(C(F)(F)F)(N(F)F)(F)F,,,,,,
6190,136191,Bis(trifluoromethyl)phosphinous acid,C(F)(F)(F)P(C(F)(F)F)O,,,,,,
6191,136192,"Diarsine, tetrakis(trifluoromethyl)-",C(F)(F)(F)[As](C(F)(F)F)[As](C(F)(F)F)C(F)(F)F,,,,,,
6192,136193,"1,1,1,4,4,4-Hexafluoro-2,3-bis(trifluoromethyl)but-2-ene",C(=C(C(F)(F)F)C(F)(F)F)(C(F)(F)F)C(F)(F)F,,,,,,
6193,136194,"3,4-Bis(trifluoromethyl)-1,2-dithiete",C1(=C(SS1)C(F)(F)F)C(F)(F)F,,,,,,
6194,136195,"Benzene, 1,3,5-trifluoro-2,4,6-trimethyl-",CC1=C(C(=C(C(=C1F)C)F)C)F,,,,,,
6195,136196,"Phosphoramidous difluoride, diethyl-",CCN(CC)P(F)F,,,,,,
6196,136197,"2-(Trifluoromethyl)benzene-1,4-diamine",C1=CC(=C(C=C1N)C(F)(F)F)N,,,,,,
6197,136198,2-Bromo-5-nitrobenzotrifluoride,C1=CC(=C(C=C1[N+](=O)[O-])C(F)(F)F)Br,,,,,,
6198,136199,2-(Trifluoromethyl)pyridine,C1=CC=NC(=C1)C(F)(F)F,,,,,,
6199,136200,4-(Trifluoromethyl)phenylhydrazine,C1=CC(=CC=C1C(F)(F)F)NN,,,,,,
6200,136201,Difluoro(phenyl)borane,B(C1=CC=CC=C1)(F)F,,,,,,
6201,136202,Isopropyl m-trifluoromethylcarbanilate,CC(C)OC(=O)NC1=CC=CC(=C1)C(F)(F)F,,,,,,
6202,136203,"Tris(2,2,2-trifluoroethyl) phosphite",C(C(F)(F)F)OP(OCC(F)(F)F)OCC(F)(F)F,,,,,,
6203,136204,"Bibenzyl, 4-fluoro-",C1=CC=C(C=C1)CCC2=CC=C(C=C2)F,,,,,,
6204,136205,Bistrifluoromethylarsine,C(F)(F)(F)[AsH]C(F)(F)F,,,,,,
6205,136206,Bis(trifluoromethyl) sulfide,C(F)(F)(F)SC(F)(F)F,,,,,,
6206,136207,Bis(trifluoromethyl)trisulfane,C(F)(F)(F)SSSC(F)(F)F,,,,,,
6207,136208,Bis(trifluoromethyl)tetrasulfide,C(F)(F)(F)SSSSC(F)(F)F,,,,,,
6208,136209,"2-Butenoic acid, 3-amino-4,4,4-trifluoro-, ethyl ester",CCOC(=O)C=C(C(F)(F)F)N,,,,,,
6209,136210,"Ethyl 3-hydroxy-4,4,4-trifluorobutyrate",CCOC(=O)CC(C(F)(F)F)O,,,,,,
6210,136211,Hexafluoroazomethane,C(N=NC(F)(F)F)(F)(F)F,,,,,,
6211,136212,"Borane, difluoromethyl-",B(C)(F)F,,,,,,
6212,136213,"Sulfur, pentafluoro(trifluoromethyl)-",C(F)(F)(F)S(F)(F)(F)(F)F,,,,,,
6213,136214,"1-Propene, 3,3,3-trifluoro-2-methyl-",CC(=C)C(F)(F)F,,,,,,
6214,136215,"1,1,2,2-Tetrafluorocyclobutane",C1CC(C1(F)F)(F)F,,,,,,
6215,136216,"2,3-Dichloro-1,1,1-trifluoro-2-methylpropane",CC(CCl)(C(F)(F)F)Cl,,,,,,
6216,136217,"4-Bromo-3-chloro-3,4,4-trifluorobut-1-ene",C=CC(C(F)(F)Br)(F)Cl,,,,,,
6217,136218,"1,1,1,2,2,3,3-Heptafluoro-4-chlorobutane",C(C(C(C(F)(F)F)(F)F)(F)F)Cl,,,,,,
6218,136219,"1,4-Dibromo-2,3-dichlorohexafluorobutane",C(C(C(F)(F)Br)(F)Cl)(C(F)(F)Br)(F)Cl,,,,,,
6219,136220,"1,2-Dichlorotetrafluorocyclobutene-1",C1(=C(C(C1(F)F)(F)F)Cl)Cl,,,,,,
6220,136221,"1,4-Dibromo-2-chloro-1,1,2-trifluorobutane",C(CBr)C(C(F)(F)Br)(F)Cl,,,,,,
6221,136222,"2-Bromo-1,1,2-trifluoroethyl ethyl ether",CCOC(C(F)Br)(F)F,,,,,,
6222,136223,Methoxydifluoroborane,B(OC)(F)F,,,,,,
6223,136224,Methylthiodifluoroborane,B(F)(F)SC,,,,,,
6224,136225,"1-Chloro-3,3,3-trifluoro-2-methylpropene",C=C(CCl)C(F)(F)F,,,,,,
6225,136226,"2-(Trifluoromethyl)-1,1,1,3,3,3-hexafluoropropane",C(C(F)(F)F)(C(F)(F)F)C(F)(F)F,,,,,,
6226,136227,N-(Trifluoroacetyl)aminoacetic acid,C(C(=O)O)NC(=O)C(F)(F)F,,,,,,
6227,136228,"Glycine, N-(trifluoroacetyl)-, methyl ester",COC(=O)CNC(=O)C(F)(F)F,,,,,,
6228,136229,"Boranediamine, 1-fluoro-N,N,N',N'-tetramethyl-",B(N(C)C)(N(C)C)F,,,,,,
6229,136230,"Tetrabenzo(b,g,k,p)chrysene",C1=CC=C2C=C3C(=CC2=C1)C4=CC=CC=C4C5=C3C6=CC=CC=C6C7=CC8=CC=CC=C8C=C75,,,,,,
6230,136231,"Benzo[a]phenanthro[9,10-c]naphthacene",C1=CC=C2C=C3C=C4C(=CC3=CC2=C1)C5=CC=CC=C5C6=C4C7=CC=CC=C7C8=CC=CC=C86,,,,,,
6231,136232,"4H-Cyclopenta[2,1-b:3,4-b']dithiophene",C1C2=C(C3=C1C=CS3)SC=C2,,,,,,
6232,136233,"N,N-diethyl-2,2,3,3-tetrafluoropropanamide",CCN(CC)C(=O)C(C(F)F)(F)F,,,,,,
6233,136234,"2-Fluoro-1,3,5-trimethylbenzene",CC1=CC(=C(C(=C1)C)F)C,,,,,,
6234,136235,"Cyclobutaphosphane, tetrakis(trifluoromethyl)-",C(F)(F)(F)P1P(P(P1C(F)(F)F)C(F)(F)F)C(F)(F)F,,,,,,
6235,136236,4-Fluoro-2-nitrophenol,C1=CC(=C(C=C1F)[N+](=O)[O-])O,,,,,,
6236,136237,4-(Trifluoroacetyl)toluene,CC1=CC=C(C=C1)C(=O)C(F)(F)F,,,,,,
6237,136238,Acridophosphine,C1=CC=C2C(=C1)C=C3C=CC=CC3=P2,,,,,,
6238,136239,4-Fluoro-2-methylanisole,CC1=C(C=CC(=C1)F)OC,,,,,,
6239,136240,2-Fluoro-4-methylanisole,CC1=CC(=C(C=C1)OC)F,,,,,,
6240,136241,"[1,2,4]Triazolo[1,5-a]pyrazine",C1=CN2C(=NC=N2)C=N1,,,,,,
6241,136242,"1,4-Dichloro-2,5-difluorobenzene",C1=C(C(=CC(=C1Cl)F)Cl)F,,,,,,
6242,136243,2-Fluorothiophene,C1=CSC(=C1)F,,,,,,
6243,136244,t-Butyl trifluoroacetate,CC(C)(C)OC(=O)C(F)(F)F,,,,,,
6244,136245,N-(N-(Trifluoroacetyl)glycylglycine,C(C(=O)NCC(=O)O)NC(=O)C(F)(F)F,,,,,,
6245,136246,3-Methylbenzotrifluoride,CC1=CC(=CC=C1)C(F)(F)F,,,,,,
6246,136247,"3,5-Bis(trifluoromethyl)benzaldehyde",C1=C(C=C(C=C1C(F)(F)F)C(F)(F)F)C=O,,,,,,
6247,136248,2-[2-(4-Pyridinylcarbonyl)hydrazinylidene]pentanedioic acid,C1=CN=CC=C1C(=O)NN=C(CCC(=O)O)C(=O)O,,,,,,
6248,136249,"4-Fluoro-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)F,,,,,,
6249,136250,"N,N'-Di-(m-trifluoromethylphenyl)urea",C1=CC(=CC(=C1)NC(=O)NC2=CC=CC(=C2)C(F)(F)F)C(F)(F)F,,,,,,
6250,136251,3-Fluoro-4-methoxyphenylacetonitrile,COC1=C(C=C(C=C1)CC#N)F,,,,,,
6251,136252,Di-4-fluorophenyl sulfide,C1=CC(=CC=C1F)SSC2=CC=C(C=C2)F,,,,,,
6252,136253,4-Fluorophenyl acetate,CC(=O)OC1=CC=C(C=C1)F,,,,,,
6253,136254,"Benzene, 2-fluoroethoxy-",C1=CC=C(C=C1)OCCF,,,,,,
6254,136255,"1,1,1-Trifluoro-3-methylbutane",CC(C)CC(F)(F)F,,,,,,
6255,136256,"2,2,2-Trifluoroethyl acetate",CC(=O)OCC(F)(F)F,,,,,,
6256,136257,"1,1,4,4-Tetrafluoro-1,3-butadiene",C(=C(F)F)C=C(F)F,,,,,,
6257,136258,Trifluoromethylarsane,C(F)(F)(F)[AsH2],,,,,,
6258,136259,"1-Bromo-1,1-difluoroethane",CC(F)(F)Br,,,,,,
6259,136260,"Phosphine, (trifluoromethyl)-",C(F)(F)(F)P,,,,,,
6260,136261,"Mercury, iodo(trifluoromethyl)-",C(F)(F)(F)[Hg]I,,,,,,
6261,136262,"Methane, chlorodifluoronitroso-",C(N=O)(F)(F)Cl,,,,,,
6262,136263,Methyl(trifluoromethyl) sulfide,CSC(F)(F)F,,,,,,
6263,136264,"Arsine, dimethyl(trifluoromethyl)-",C[As](C)C(F)(F)F,,,,,,
6264,136265,"Phosphine, dimethyl(trifluoromethyl)-",CP(C)C(F)(F)F,,,,,,
6265,136266,"Phosphonous dichloride, (trifluoromethyl)-",C(F)(F)(F)P(Cl)Cl,,,,,,
6266,136267,"Stibine, dimethyl(trifluoromethyl)-",C[Sb](C)C(F)(F)F,,,,,,
6267,136268,1-Chloro-2-iodotetrafluoroethane,C(C(F)(F)I)(F)(F)Cl,,,,,,
6268,136269,"(1,1,2,2-Tetrafluoro-2-phenylethyl)benzene",C1=CC=C(C=C1)C(C(C2=CC=CC=C2)(F)F)(F)F,,,,,,
6269,136270,"2,2,3,3-Tetrafluoro-1,4-butanediol",C(C(C(CO)(F)F)(F)F)O,,,,,,
6270,136271,Ethylidifluoroborane,B(CC)(F)F,,,,,,
6271,136272,3-Fluoroprop-2-enenitrile,C(=CF)C#N,,,,,,
6272,136273,"1,2-Propadiene, 1,1-difluoro-",C=C=C(F)F,,,,,,
6273,136274,"2,2-Difluoroethylamine",C(C(F)F)N,,,,,,
6274,136275,"2,2,3,3-Tetrafluoropropionitrile",C(#N)C(C(F)F)(F)F,,,,,,
6275,136276,"Arsine, methylbis(trifluoromethyl)-",C[As](C(F)(F)F)C(F)(F)F,,,,,,
6276,136277,"Phosphinous amide, N,N-dimethyl-P,P-bis(trifluoromethyl)-",CN(C)P(C(F)(F)F)C(F)(F)F,,,,,,
6277,136278,"Arsine, tris(trifluoromethyl)-",C(F)(F)(F)[As](C(F)(F)F)C(F)(F)F,,,,,,
6278,136279,Tris(trifluoromethyl)amine,C(N(C(F)(F)F)C(F)(F)F)(F)(F)F,,,,,,
6279,136280,Tris(trifluoromethyl)phosphine,C(F)(F)(F)P(C(F)(F)F)C(F)(F)F,,,,,,
6280,136281,"Stibine, tris(trifluoromethyl)-",C(F)(F)(F)[Sb](C(F)(F)F)C(F)(F)F,,,,,,
6281,136282,N-(N-(Trifluoroacetyl)glycyl)glycine methyl ester,COC(=O)CNC(=O)CNC(=O)C(F)(F)F,,,,,,
6282,136283,"2-Propenenitrile, 2,3,3-trifluoro-",C(#N)C(=C(F)F)F,,,,,,
6283,136284,"2,6-Difluorobenzaldehyde",C1=CC(=C(C(=C1)F)C=O)F,,,,,,
6284,136285,"2-Bromo-4,6-Difluoroaniline",C1=C(C=C(C(=C1F)N)Br)F,,,,,,
6285,136286,5-Fluoro-2-methylbenzenesulfonyl chloride,CC1=C(C=C(C=C1)F)S(=O)(=O)Cl,,,,,,
6286,136287,4-Fluoro-3-nitrotoluene,CC1=CC(=C(C=C1)F)[N+](=O)[O-],,,,,,
6287,136288,2-Fluorobenzohydrazide,C1=CC=C(C(=C1)C(=O)NN)F,,,,,,
6288,136289,4'-Fluoro-2'-nitroacetanilide,CC(=O)NC1=C(C=C(C=C1)F)[N+](=O)[O-],,,,,,
6289,136290,"2,8,12,18-Tetraethyl-3,7,13,18-tetramethyl-21H,23H-porphin",CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1N2)CC)C)C)CC)CC)C)C,,,,,,
6290,136291,2-Fluorophenetole,CCOC1=CC=CC=C1F,,,,,,
6291,136292,2-Bromo-4-fluoroanisole,COC1=C(C=C(C=C1)F)Br,,,,,,
6292,136293,"2,4-Difluoroanisole",COC1=C(C=C(C=C1)F)F,,,,,,
6293,136294,"Pentacyclo[4.3.0.02,5.03,8.04,7]nonane",C1C2C3C4C1C5C2C3C45,,,,,,
6294,136295,4-Fluoro-2-methylphenol,CC1=C(C=CC(=C1)F)O,,,,,,
6295,136296,1-(3-(Trifluoromethyl)phenyl)ethanol,CC(C1=CC(=CC=C1)C(F)(F)F)O,,,,,,
6296,136297,4-Androstenediol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C[C@H](CC[C@]34C)O,,,,,,
6297,136298,1-Fluoro-4-(trimethylsilyl)benzene,C[Si](C)(C)C1=CC=C(C=C1)F,,,,,,
6298,136299,3-Fluorobenzal bromide,C1=CC(=CC(=C1)F)C(Br)Br,,,,,,
6299,136300,4-fluoro-N-hydroxybenzamide,C1=CC(=CC=C1C(=O)NO)F,,,,,,
6300,136301,1-Ethoxy-3-fluorobenzene,CCOC1=CC(=CC=C1)F,,,,,,
6301,136302,3-(4-Fluorophenyl)propionic acid,C1=CC(=CC=C1CCC(=O)O)F,,,,,,
6302,136303,1-Ethyl-4-fluorobenzene,CCC1=CC=C(C=C1)F,,,,,,
6303,136304,"2,2,2-Trifluoroethyl methyl ether",COCC(F)(F)F,,,,,,
6304,136305,"Phosphine, bis(trifluoromethyl)-",C(F)(F)(F)PC(F)(F)F,,,,,,
6305,136306,"Carbonotrithioic acid, bis(trifluoromethyl) ester",C(=S)(SC(F)(F)F)SC(F)(F)F,,,,,,
6306,136307,"4,4,4-Trifluoro-1-butanol",C(CC(F)(F)F)CO,,,,,,
6307,136308,Nitric acid;trifluoromethylmercury,C(F)(F)(F)[Hg].[N+](=O)(O)[O-],,,,,,
6308,136309,Trifluoromethylmercury,C(F)(F)(F)[Hg],,,,,,
6309,136310,Phosphorisocyanatidous difluoride,C(=NP(F)F)=O,,,,,,
6310,136311,Difluoroisothiocyanatophosphine,C(=NP(F)F)=S,,,,,,
6311,136312,Perfluoroallene,C(=C(F)F)=C(F)F,,,,,,
6312,136313,"1-Bromo-3,5-difluorobenzene",C1=C(C=C(C=C1F)Br)F,,,,,,
6313,136314,"1,1'-Oxybis(1,1,2,2,3,3,4,4,5,5,5-undecafluoropentane)",C(C(C(OC(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F,,,,,,
6314,136315,4-(Trifluoromethylsulfonyl)aniline,C1=CC(=CC=C1N)S(=O)(=O)C(F)(F)F,,,,,,
6315,136316,"1,2,3-Trimethylcyclopentene",CC1CCC(=C1C)C,,,,,,
6316,136317,"2a,3,4,5-Tetrahydroacenaphthene",C1CC2CCC3=CC=CC(=C23)C1,,,,,,
6317,136318,9-Methyl-9-azabicyclo[3.3.1]nonane,CN1C2CCCC1CCC2,,,,,,
6318,136319,Chromane,C1CC2=CC=CC=C2OC1,,,,,,
6319,136320,Cerulignone,COC1=CC(=C2C=C(C(=O)C(=C2)OC)OC)C=C(C1=O)OC,,,,,,
6320,136321,"1,2,3,5,6,7-Hexahydro-s-indacene",C1CC2=CC3=C(CCC3)C=C2C1,,,,,,
6321,136322,"1,2-Dibenzoylethane",C1=CC=C(C=C1)C(=O)CCC(=O)C2=CC=CC=C2,,,,,,
6322,136323,Fulvene,C=C1C=CC=C1,,,,,,
6323,136324,2-Methylenenorbornane,C=C1CC2CCC1C2,,,,,,
6324,136325,"Bicyclo[2.2.2]octa-2,5-diene",C1CC2C=CC1C=C2,,,,,,
6325,136326,"Bicyclo[2.2.2]octa-2,5,7-triene",C1=CC2C=CC1C=C2,,,,,,
6326,136327,"3,6-Dimethylidenecyclohexa-1,4-diene",C=C1C=CC(=C)C=C1,,,,,,
6327,136328,"4-Methylene-2,5-cyclohexadiene-1-one",C=C1C=CC(=O)C=C1,,,,,,
6328,136329,"2,3-Diazabutadiene",C=NN=C,,,,,,
6329,136330,Eucarvone,CC1=CC=CC(CC1=O)(C)C,,,,,,
6330,136331,"2,6,11,15-Tetramethylhexadecane",CC(C)CCCC(C)CCCCC(C)CCCC(C)C,,,,,,
6331,136332,Carbon suboxide,C(=C=O)=C=O,,,,,,
6332,136333,Isoxazolidine,C1CNOC1,,,,,,
6333,136334,Hexahydropyridazine,C1CCNNC1,,,,,,
6334,136335,"1,2-Dithiane",C1CCSSC1,,,,,,
6335,136336,"1,2-Dioxepane",C1CCOOCC1,,,,,,
6336,136337,Dimethylberyllium,[Be+2].[CH3-].[CH3-],,,,,,
6337,136338,Dimethyl fluorophosphine,CP(C)F,,,,,,
6338,136339,Hexafluoroglutaramide,C(=O)(C(C(C(C(=O)N)(F)F)(F)F)(F)F)N,,,,,,
6339,136340,"Tricyclo(2.2.1.02,6)heptane-1-carboxylic acid, 7,7-dimethyl-",CC1(C2CC3C1(C3C2)C(=O)O)C,,,,,,
6340,136341,Acepleiadane,C1CCC2=CC=C3CCC4=C3C2=C(C1)C=C4,,,,,,
6341,136342,"Cyclohept(fg)acenaphthylene, 1,2-dihydro-",C1CC2=CC=C3C=CC=CC4=C3C2=C1C=C4,,,,,,
6342,136343,"Pyrido[2,1,6-de]quinolizine",C1=CC2=CC=CC3=CC=CC(=C1)N23,,,,,,
6343,136344,"Dodecahydro-4H,8H,12H-4a,8a,12a-triazatriphenylene",C1CCN2C3CCCCN3C4CCCCN4C2C1,,,,,,
6344,136345,Conduritol B,C1=CC(C(C(C1O)O)O)O,,,['Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)'],,,
6345,136346,Durohydroquinone,CC1=C(C(=C(C(=C1O)C)C)O)C,,,,,,
6346,136347,9-Fluoroanthracene,C1=CC=C2C(=C1)C=C3C=CC=CC3=C2F,,,,,,
